Citrus Sinensis ID: 036225
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 622 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | yes | no | 0.993 | 0.968 | 0.796 | 0.0 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.959 | 0.940 | 0.764 | 0.0 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.975 | 0.957 | 0.633 | 0.0 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.985 | 0.969 | 0.640 | 0.0 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.967 | 0.929 | 0.625 | 0.0 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.942 | 0.954 | 0.560 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.948 | 0.944 | 0.567 | 1e-179 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.948 | 0.939 | 0.564 | 1e-178 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.963 | 0.973 | 0.532 | 1e-172 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.872 | 0.875 | 0.558 | 1e-166 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1030 bits (2664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/633 (79%), Positives = 556/633 (87%), Gaps = 15/633 (2%)
Query: 1 MAIREVFAICFVAFLCFW-TTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAV 59
M R F CF+ FLC ++ +GLLS KGVN+EVQALM +K SLHDPHGVL+NWD DAV
Sbjct: 10 MITRSFF--CFLGFLCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAV 67
Query: 60 DPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR 119
DPCSWTMVTCS E+ VIGLG PSQNLSGTLSPSI NLTNL+IVLLQNNNI G IPAEIGR
Sbjct: 68 DPCSWTMVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGR 127
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
LT+L+TLDLS+NFF GEIP S+G+L+SLQY+R NNNSLSG FP SL++MTQL FLDLSYN
Sbjct: 128 LTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYN 187
Query: 180 NLSGPVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASP---GRTRSH 236
NLSGPVPRF+AKTF+IVGNPLIC TG+EPDC GT L+PMSMNLN QT P G +R+H
Sbjct: 188 NLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLN--QTGVPLYAGGSRNH 245
Query: 237 KLSLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKE-RHHEEVSLGNLRRFQFREL 295
K+++ G SVG VSLI + GLFLWWRQR NQ FFDVK+ HHEEVSLGNLRRF FREL
Sbjct: 246 KMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFREL 305
Query: 296 QVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 355
Q+AT+NFSSKN+LGKGG+G VYKGIL D TVVAVKRLKDG A+GGEIQFQTEVEMISLAV
Sbjct: 306 QIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAV 365
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
HRNLLRLYGFC+T TE+LLVYPYMSNGSVASR+K KP+LDWS RKRIA+GAARGL+YLHE
Sbjct: 366 HRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHE 425
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
QCDPKIIHRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST
Sbjct: 426 QCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 485
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL- 534
GQSSEKTDVFGFGILLLEL+TGQRA E+GKAANQKG MLDWVKKIHQEKKLE+LVDK+L
Sbjct: 486 GQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELL 545
Query: 535 -KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKP 593
K +YD IEL+EMV+VALLCTQYLP HRPKMSEVVRMLEGDGLAE+WEASQR+++
Sbjct: 546 KKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCS 605
Query: 594 HEF----SSSDRYSDLTDDSSLLVQAMELSGPR 622
+ SSSDRYSDLTDDSSLLVQAMELSGPR
Sbjct: 606 NRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 946 bits (2444), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/603 (76%), Positives = 524/603 (86%), Gaps = 6/603 (0%)
Query: 25 LSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQN 84
L+ KGVN+EV AL+G+K SL DPHGVL NWD+ AVDPCSW M+TCS + VI L PSQN
Sbjct: 34 LTDKGVNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPSQN 92
Query: 85 LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHL 144
LSGTLS SIGNLTNLQ VLLQNN ITG IP EIG+L KL+TLDLS N FTG+IP +L +
Sbjct: 93 LSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYS 152
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICAT 204
++LQY+R NNNSL+G P+SLA+MTQL FLDLSYNNLSGPVPR AKTFN++GN IC T
Sbjct: 153 KNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPT 212
Query: 205 GSEPDCYGTQLMPMSMNLNSSQT-ASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWR 263
G+E DC GTQ PMS+ LNSSQ +S G T++ K+++VFG+S+ CV L+I+ FG LWWR
Sbjct: 213 GTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWR 272
Query: 264 QRRNQQ-MFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQ 322
+R N+Q +FFD+ E++ EE+ LGNLRRF F+ELQ AT NFSSKN++GKGGFG VYKG L
Sbjct: 273 RRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLH 332
Query: 323 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382
DG+++AVKRLKD N GGE+QFQTE+EMISLAVHRNLLRLYGFC T +ERLLVYPYMSNG
Sbjct: 333 DGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNG 392
Query: 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442
SVASRLK KP+LDW TRKRIALGA RGLLYLHEQCDPKIIHRDVKAANILLDD EAVVG
Sbjct: 393 SVASRLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVG 452
Query: 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
DFGLAKLLDH++SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG RALE
Sbjct: 453 DFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALE 512
Query: 503 YGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRP 562
+GKAANQ+GA+LDWVKK+ QEKKLE +VDKDLK+NYDRIE+EEMVQVALLCTQYLP HRP
Sbjct: 513 FGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRP 572
Query: 563 KMSEVVRMLEGDGLAERWEA-SQRAEATK--SKPHEFSSSDRYSDLTDDSSLLVQAMELS 619
KMSEVVRMLEGDGL E+WEA SQRAE + SKP+EFSSS+RYSDLTDDSS+LVQAMELS
Sbjct: 573 KMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQAMELS 632
Query: 620 GPR 622
GPR
Sbjct: 633 GPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 793 bits (2049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/636 (63%), Positives = 486/636 (76%), Gaps = 29/636 (4%)
Query: 5 EVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSW 64
++F++ + LCF+ T + LS++ N EV+AL+ +K+ LHDPHGV +NWDE +VDPCSW
Sbjct: 10 KIFSVLLL--LCFFVTCS--LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSW 65
Query: 65 TMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQ 124
TM++CS ++LVIGLG PSQ+LSGTLS SIGNLTNL+ V LQNNNI+G IP EI L KLQ
Sbjct: 66 TMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQ 125
Query: 125 TLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184
TLDLSNN F+GEIP S+ L +LQY+R NNNSLSG FP SL+ + L FLDLSYNNL GP
Sbjct: 126 TLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGP 185
Query: 185 VPRFSAKTFNIVGNPLICATGSEPDCYGT-QLMPMSMNLNSSQTASPGRTRSHKLSLVFG 243
VP+F A+TFN+ GNPLIC C G+ P+S++L SS GR R++ L++ G
Sbjct: 186 VPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSS----GR-RTNILAVALG 240
Query: 244 LSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEV-SLGNLRRFQFRELQVATHNF 302
+S+G +IL G F+W+R+++ + + ++ E + LGNLR F FREL VAT F
Sbjct: 241 VSLGFAVSVILSLG-FIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGF 299
Query: 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
SSK+ILG GGFG VY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRL
Sbjct: 300 SSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRL 359
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
G+C + +ERLLVYPYMSNGSVASRLK KP LDW+TRK+IA+GAARGL YLHEQCDPKII
Sbjct: 360 IGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKII 419
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVKAANILLD+ EAVVGDFGLAKLL+H+DSHVTTAVRGTVGHIAPEYLSTGQSSEKT
Sbjct: 420 HRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 479
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DVFGFGILLLELITG RALE+GK+ +QKGAML+WV+K+H+E K+E LVD++L YDRIE
Sbjct: 480 DVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIE 539
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQ----------------RA 586
+ EM+QVALLCTQ+LPAHRPKMSEVV+MLEGDGLAERW AS
Sbjct: 540 VGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHSHFYHANMSYRTITST 599
Query: 587 EATKSKPHEFSSSDRYSDLTDDSSLLVQAMELSGPR 622
+ H F SS + D D+ +L AMELSGPR
Sbjct: 600 DGNNQTKHLFGSSG-FEDEDDNQALDSFAMELSGPR 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 776 bits (2005), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/629 (64%), Positives = 491/629 (78%), Gaps = 16/629 (2%)
Query: 6 VFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWT 65
V+ + F+ F+ F+ ++ LS GVNYEV AL+ VK+ L+DP+ VLENWD ++VDPCSW
Sbjct: 8 VWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWR 67
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQT 125
MV+C+ + V L +PSQ+LSGTLSP IGNLT LQ V+LQNN ITGPIP IGRL KLQ+
Sbjct: 68 MVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQS 126
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185
LDLSNN FTGEIP+SLG L++L Y+R NNNSL G P SL+ + L +D+SYNNLSG +
Sbjct: 127 LDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSL 186
Query: 186 PRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG-RTRSHKLSLVFGL 244
P+ SA+TF ++GN LIC + +C +P + L G RT H ++L F
Sbjct: 187 PKVSARTFKVIGNALICGPKAVSNCSA---VPEPLTLPQDGPDESGTRTNGHHVALAFAA 243
Query: 245 SVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSS 304
S + G+FLWWR RRN+Q+FFDV E++ EVSLG+L+R+ F+EL+ AT++F+S
Sbjct: 244 SFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNS 303
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
KNILG+GG+GIVYKG L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL G
Sbjct: 304 KNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRG 363
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
FC + ER+LVYPYM NGSVASRLK G+P LDWS RK+IA+G ARGL+YLHEQCDPK
Sbjct: 364 FCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPK 423
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IIHRDVKAANILLD+ EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 424 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 483
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
KTDVFGFGILLLELITGQ+AL++G++A+QKG MLDWVKK+HQE KL+ L+DKDL + +DR
Sbjct: 484 KTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDR 543
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPH----EF 596
+ELEE+VQVALLCTQ+ P+HRPKMSEV++MLEGDGLAERWEA+Q P
Sbjct: 544 VELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMV 603
Query: 597 SSSDR---YSDLTDDSSLLVQAMELSGPR 622
SSS R YSD +SSL+V+A+ELSGPR
Sbjct: 604 SSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/635 (62%), Positives = 478/635 (75%), Gaps = 33/635 (5%)
Query: 14 FLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPES 73
FLCF T LS++ N EV+AL+ ++++LHDPHG L NWDE +VDPCSW M+TCSP++
Sbjct: 21 FLCFSTLT---LSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDN 77
Query: 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133
LVIGLG PSQ+LSG LS SIGNLTNL+ V LQNNNI+G IP E+G L KLQTLDLSNN F
Sbjct: 78 LVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRF 137
Query: 134 TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTF 193
+G+IP S+ L SLQY+R NNNSLSG FP SL+ + L FLDLSYNNLSGPVP+F A+TF
Sbjct: 138 SGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTF 197
Query: 194 NIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLII 253
N+ GNPLIC + C G+ ++ + S +S RS++L++ +S+G V +++
Sbjct: 198 NVAGNPLICRSNPPEICSGS----INASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILV 253
Query: 254 LVFGLFLWWRQRRNQQMFFDVKERHHEEVS-LGNLRRFQFRELQVATHNFSSKNILGKGG 312
L G F W+R+++ + + ++ ++ E + LGNLR F FREL V T FSSKNILG GG
Sbjct: 254 LALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGG 313
Query: 313 FGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372
FG VY+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRL G+C T ER
Sbjct: 314 FGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGER 373
Query: 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432
LLVYPYM NGSVAS+LK KP LDW+ RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANIL
Sbjct: 374 LLVYPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANIL 433
Query: 433 LDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 492
LD+C EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL
Sbjct: 434 LDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 493
Query: 493 ELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL 552
ELITG RALE+GK +QKGAML+WV+K+H+E K+E L+D++L NYD+IE+ EM+QVALL
Sbjct: 494 ELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALL 553
Query: 553 CTQYLPAHRPKMSEVVRMLEGDGLAERWEASQ------------------------RAEA 588
CTQYLPAHRPKMSEVV MLEGDGLAERW AS R +A
Sbjct: 554 CTQYLPAHRPKMSEVVLMLEGDGLAERWAASHNHSHFYHANISFKTISSLSTTSVSRLDA 613
Query: 589 TKSKP-HEFSSSDRYSDLTDDSSLLVQAMELSGPR 622
+ P ++ S + D D L AMELSGPR
Sbjct: 614 HCNDPTYQMFGSSAFDDDDDHQPLDSFAMELSGPR 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/608 (56%), Positives = 434/608 (71%), Gaps = 22/608 (3%)
Query: 19 TTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGL 78
+ + LLS KGVNYEV ALM VK+ + D VL WD ++VDPC+W MV CS E V+ L
Sbjct: 25 SAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVSL 84
Query: 79 GIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP 138
+ S+ LSG LS SIG LT+L +LLQNN +TGPIP+E+G+L++L+TLDLS N F+GEIP
Sbjct: 85 EMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIP 144
Query: 139 SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGN 198
+SLG L L Y+R + N LSG P +A ++ L FLDLS+NNLSGP P SAK + IVGN
Sbjct: 145 ASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGN 204
Query: 199 PLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGL 258
+C S+ C + P+ N++ + ++ H L L F + V+ II + L
Sbjct: 205 AFLCGPASQELC--SDATPVR---NATGLSEKDNSKHHSLVLSFAFGI-VVAFIISLMFL 258
Query: 259 FLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYK 318
F W R++ V++ + E +G+L+RF FRE+Q AT NFS KNILG+GGFG+VYK
Sbjct: 259 FFWVLWHRSRLSRSHVQQDY--EFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYK 316
Query: 319 GILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378
G L +GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL+GFCMTP ER+LVYPY
Sbjct: 317 GYLPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPY 375
Query: 379 MSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434
M NGSVA RL+ KP LDW+ R IALGAARGL+YLHEQC+PKIIHRDVKAANILLD
Sbjct: 376 MPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLD 435
Query: 435 DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 494
+ EA+VGDFGLAKLLD +DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LEL
Sbjct: 436 ESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILEL 495
Query: 495 ITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCT 554
ITG + ++ G +KG +L WV+ + EK+ +VD+DLK +D + LEE+V++ALLCT
Sbjct: 496 ITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCT 555
Query: 555 QYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSLLVQ 614
Q P RP+MS+V+++LE GL E+ E A A S S YS+ ++ S +++
Sbjct: 556 QPHPNLRPRMSQVLKVLE--GLVEQCEGGYEARAP-------SVSRNYSNGHEEQSFIIE 606
Query: 615 AMELSGPR 622
A+ELSGPR
Sbjct: 607 AIELSGPR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 628 bits (1620), Expect = e-179, Method: Compositional matrix adjust.
Identities = 341/601 (56%), Positives = 419/601 (69%), Gaps = 11/601 (1%)
Query: 31 NYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLS 90
N E AL ++ +L DP+ VL++WD V+PC+W VTC+ E+ VI + + + LSG L
Sbjct: 27 NLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNAELSGHLV 86
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
P +G L NLQ + L +NNITGPIP+ +G LT L +LDL N F+G IP SLG L L+++
Sbjct: 87 PELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFL 146
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP---RFSAKT-FNIVGNPLICATGS 206
R NNNSL+G+ P SL ++T L LDLS N LSG VP FS T + N +C +
Sbjct: 147 RLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 206
Query: 207 EPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWRQRR 266
C G+ S ++ G++ G L F WWR+R+
Sbjct: 207 SHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRK 266
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTV 326
+FFDV EV LG L+RF RELQVA+ FS+KNILG+GGFG VYKG L DGT+
Sbjct: 267 PLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTL 326
Query: 327 VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 386
VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMTPTERLLVYPYM+NGSVAS
Sbjct: 327 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 386
Query: 387 RLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442
L+ +P LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVG
Sbjct: 387 CLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 446
Query: 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
DFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITGQRA +
Sbjct: 447 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 506
Query: 503 YGKAANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR 561
+ AN M LDWVK + +EKKLEMLVD DL+ NY+ ELE+++QVALLCTQ P R
Sbjct: 507 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMER 566
Query: 562 PKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSLLVQAMELSGP 621
PKMSEVVRMLEGDGLAE+W+ Q+ E + + S + SD DS+ + A+ELSGP
Sbjct: 567 PKMSEVVRMLEGDGLAEKWDEWQKVEILREEID--LSPNPNSDWILDSTYNLHAVELSGP 624
Query: 622 R 622
R
Sbjct: 625 R 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 339/601 (56%), Positives = 420/601 (69%), Gaps = 11/601 (1%)
Query: 31 NYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLS 90
N E AL ++ +L DP+ VL++WD V+PC+W VTC+ E+ VI + + + +LSG L
Sbjct: 30 NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQLV 89
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
P +G L NLQ + L +NNITGP+P+++G LT L +LDL N FTG IP SLG L L+++
Sbjct: 90 PQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFL 149
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP---RFSAKT-FNIVGNPLICATGS 206
R NNNSL+G P SL ++ L LDLS N LSG VP FS T + N +C +
Sbjct: 150 RLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 209
Query: 207 EPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWRQRR 266
C G+ S ++ G++ G L F WWR+R+
Sbjct: 210 SRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRK 269
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTV 326
Q+ FFDV EV LG L+RF RELQVAT +FS+KNILG+GGFG VYKG L DGT+
Sbjct: 270 PQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTL 329
Query: 327 VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 386
VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMTPTERLLVYPYM+NGSVAS
Sbjct: 330 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 389
Query: 387 RLKGKP----ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442
L+ +P L WS R++IALG+ARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVG
Sbjct: 390 CLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 449
Query: 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
DFGLA+L+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITGQRA +
Sbjct: 450 DFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 509
Query: 503 YGKAANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR 561
+ AN M LDWVK + +EKKLEMLVD DL++NY E+E+++QVALLCTQ P R
Sbjct: 510 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMER 569
Query: 562 PKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSLLVQAMELSGP 621
PKMSEVVRMLEGDGLAE+W+ Q+ E + + SS SD DS+ + AMELSGP
Sbjct: 570 PKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVE--LSSHPTSDWILDSTDNLHAMELSGP 627
Query: 622 R 622
R
Sbjct: 628 R 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 604 bits (1558), Expect = e-172, Method: Compositional matrix adjust.
Identities = 337/633 (53%), Positives = 425/633 (67%), Gaps = 34/633 (5%)
Query: 4 REVFAICFVAFLCFWT--TANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDP 61
R + CF FW + +L G N E AL +K+SL DP+ VL++WD V P
Sbjct: 3 RRLMIPCF-----FWLILVLDLVLRVSG-NAEGDALSALKNSLADPNKVLQSWDATLVTP 56
Query: 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLT 121
C+W VTC+ ++ V + + + NLSG L +G L NLQ + L +NNITG IP ++G LT
Sbjct: 57 CTWFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLT 116
Query: 122 KLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
+L +LDL N +G IPS+LG L+ L+++R NNNSLSG P SL ++ L LDLS N L
Sbjct: 117 ELVSLDLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPL 176
Query: 182 SGPVP---RFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKL 238
+G +P FS T N + + P + P N T + +
Sbjct: 177 TGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRI-TGAIAGGVAAGA 235
Query: 239 SLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVA 298
+L+F +V ++L WWR+++ Q FFDV EV LG L+RF RELQVA
Sbjct: 236 ALLF--AVPAIALA--------WWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 285
Query: 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+ NFS+KNILG+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRN
Sbjct: 286 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 345
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVAS----RLKGKPILDWSTRKRIALGAARGLLYLH 414
LLRL GFCMTPTERLLVYPYM+NGSVAS R + +P LDW R+RIALG+ARGL YLH
Sbjct: 346 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 405
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
+ CDPKIIHRDVKAANILLD+ EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLS
Sbjct: 406 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 465
Query: 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM-LDWVKKIHQEKKLEMLVDKD 533
TG+SSEKTDVFG+G++LLELITGQRA + + AN M LDWVK + +EKKLE LVD D
Sbjct: 466 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 525
Query: 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKP 593
L+ NY E+E+++QVALLCTQ P RPKMSEVVRMLEGDGLAERWE Q+ E +
Sbjct: 526 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR--- 582
Query: 594 HEFSSSDRYSDLT----DDSSLLVQAMELSGPR 622
+F+ + ++ DS+ ++ SGPR
Sbjct: 583 QDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 587 bits (1512), Expect = e-166, Method: Compositional matrix adjust.
Identities = 318/569 (55%), Positives = 390/569 (68%), Gaps = 26/569 (4%)
Query: 31 NYEVQALMGVKHSLH--DP-HGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSG 87
N E AL +K+SL DP + VL++WD V PC+W VTC+PE+ V + + + LSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
L P +G L NLQ + L +NNITG IP E+G L +L +LDL N +G IPSSLG L L
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICATGSE 207
+++R NNNSLSG P +L S+ QL LD+S N LSG +P +F++ P+ A S
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIP--VNGSFSLF-TPISFANNSL 205
Query: 208 PDC----YGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWR 263
D + TA+ + +L+F + F WW
Sbjct: 206 TDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIA----------FAWWL 255
Query: 264 QRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQD 323
+R+ Q FFDV EV LG L+RF REL VAT NFS+KN+LG+GGFG VYKG L D
Sbjct: 256 RRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLAD 315
Query: 324 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS 383
G +VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMTPTERLLVYPYM+NGS
Sbjct: 316 GNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 375
Query: 384 VAS----RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439
VAS R +G P LDW RK IALG+ARGL YLH+ CD KIIHRDVKAANILLD+ EA
Sbjct: 376 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEA 435
Query: 440 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499
VVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+
Sbjct: 436 VVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQK 495
Query: 500 ALEYGKAANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLP 558
A + + AN M LDWVK++ +EKKLE LVD +L+ Y E+E+++Q+ALLCTQ
Sbjct: 496 AFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSA 555
Query: 559 AHRPKMSEVVRMLEGDGLAERWEASQRAE 587
RPKMSEVVRMLEGDGLAERWE Q+ E
Sbjct: 556 MERPKMSEVVRMLEGDGLAERWEEWQKEE 584
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 622 | ||||||
| 224077568 | 622 | predicted protein [Populus trichocarpa] | 0.998 | 0.998 | 0.881 | 0.0 | |
| 255584308 | 624 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.995 | 0.991 | 0.890 | 0.0 | |
| 449447454 | 626 | PREDICTED: protein NSP-INTERACTING KINAS | 1.0 | 0.993 | 0.850 | 0.0 | |
| 298204417 | 622 | unnamed protein product [Vitis vinifera] | 0.991 | 0.991 | 0.865 | 0.0 | |
| 225451885 | 624 | PREDICTED: protein NSP-INTERACTING KINAS | 0.991 | 0.988 | 0.865 | 0.0 | |
| 356526591 | 623 | PREDICTED: protein NSP-INTERACTING KINAS | 0.993 | 0.991 | 0.835 | 0.0 | |
| 356568861 | 623 | PREDICTED: protein NSP-INTERACTING KINAS | 0.956 | 0.955 | 0.850 | 0.0 | |
| 356573805 | 624 | PREDICTED: protein NSP-INTERACTING KINAS | 0.995 | 0.991 | 0.816 | 0.0 | |
| 225425033 | 625 | PREDICTED: protein NSP-INTERACTING KINAS | 0.996 | 0.992 | 0.815 | 0.0 | |
| 90657574 | 634 | hypothetical protein [Cleome spinosa] | 0.987 | 0.968 | 0.827 | 0.0 |
| >gi|224077568|ref|XP_002305306.1| predicted protein [Populus trichocarpa] gi|222848270|gb|EEE85817.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1137 bits (2942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/623 (88%), Positives = 582/623 (93%), Gaps = 2/623 (0%)
Query: 1 MAIREVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVD 60
M IREV + FV FL F TTANGLLS KGVNYEVQAL+G+K SLHDPHGVL+NWD DAVD
Sbjct: 1 MRIREV-GLHFVVFLWFSTTANGLLSPKGVNYEVQALIGIKASLHDPHGVLDNWDGDAVD 59
Query: 61 PCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
PCSWTMVTCSPESLVIGLG PSQNLSGTLSP+IGNLTNLQ VLLQ+NNITGPIPAEI RL
Sbjct: 60 PCSWTMVTCSPESLVIGLGTPSQNLSGTLSPTIGNLTNLQTVLLQSNNITGPIPAEIARL 119
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
+KL TLDLS+NFFTG+IPSSLGHLRSL+YMR NNNSLSG FP SLA+MTQL+ LDLS+NN
Sbjct: 120 SKLHTLDLSDNFFTGKIPSSLGHLRSLEYMRLNNNSLSGEFPLSLANMTQLVLLDLSFNN 179
Query: 181 LSGPVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG-RTRSHKLS 239
LSGPVPRF KTF+I GNPLIC TGSEP+C+GT LMPMSMNLNS+QTA P + +SHK++
Sbjct: 180 LSGPVPRFPTKTFSIAGNPLICPTGSEPECFGTTLMPMSMNLNSTQTALPSNKPKSHKIA 239
Query: 240 LVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVAT 299
+ FG SVG SLIILVFGLFLWWR+R NQ FFDVK+R HEEVSLGNLRRFQFRELQ++T
Sbjct: 240 VAFGSSVGSASLIILVFGLFLWWRRRHNQPTFFDVKDRQHEEVSLGNLRRFQFRELQIST 299
Query: 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+NFS+KNILGKGGFGIVYKGIL DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL
Sbjct: 300 NNFSNKNILGKGGFGIVYKGILHDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
LRLYGFCMTPTERLLVYPYMSNGSVA RLKGKP+LDW TRKRIALGAARGLLYLHEQCDP
Sbjct: 360 LRLYGFCMTPTERLLVYPYMSNGSVALRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDP 419
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
KIIHRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 420 KIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
EKTDVFGFGILLLELITGQRA+E+GKAANQKGAMLDWVKKIHQEKKLEMLVDKD+K NYD
Sbjct: 480 EKTDVFGFGILLLELITGQRAIEFGKAANQKGAMLDWVKKIHQEKKLEMLVDKDIKGNYD 539
Query: 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSS 599
RIELEEMVQVALL TQYLP+HRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSS
Sbjct: 540 RIELEEMVQVALLSTQYLPSHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSS 599
Query: 600 DRYSDLTDDSSLLVQAMELSGPR 622
DRYSDLTDDSSLLVQAMELSGPR
Sbjct: 600 DRYSDLTDDSSLLVQAMELSGPR 622
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584308|ref|XP_002532890.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527350|gb|EEF29495.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1133 bits (2930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/620 (89%), Positives = 583/620 (94%), Gaps = 1/620 (0%)
Query: 4 REVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCS 63
R V A F+ L F +TANGLLS KGVN+EVQALMG+K SLHDPHGVL+NWD DAVDPCS
Sbjct: 5 RRVVAFAFICLLWFCSTANGLLSPKGVNFEVQALMGIKASLHDPHGVLDNWDGDAVDPCS 64
Query: 64 WTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123
WTMVTCSPESLVIGLG PSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE+GRL KL
Sbjct: 65 WTMVTCSPESLVIGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAELGRLRKL 124
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
QTLDLSNNFFTG++PSSLGHLR+LQYMR NNNSLSG FP SLA+MTQL+FLDLSYNNLSG
Sbjct: 125 QTLDLSNNFFTGDVPSSLGHLRNLQYMRLNNNSLSGIFPMSLANMTQLVFLDLSYNNLSG 184
Query: 184 PVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASP-GRTRSHKLSLVF 242
PVPRF AKTFNIVGNPLIC TGSEP+C+GT LMPMSMNLNS+QTA P GR R+HK++L F
Sbjct: 185 PVPRFPAKTFNIVGNPLICPTGSEPECFGTALMPMSMNLNSTQTALPSGRPRNHKIALAF 244
Query: 243 GLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNF 302
G SVG VS+IIL+ G LWWRQRRNQ FFDVK+RHHEEVSLGNLRRFQFRELQVAT+NF
Sbjct: 245 GSSVGTVSIIILILGFLLWWRQRRNQPTFFDVKDRHHEEVSLGNLRRFQFRELQVATNNF 304
Query: 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
S+KNILGKGGFG VYKGIL DG++VAVKRLKDGNA GGEIQFQTEVEMISLAVHRNLLRL
Sbjct: 305 SNKNILGKGGFGNVYKGILHDGSIVAVKRLKDGNAAGGEIQFQTEVEMISLAVHRNLLRL 364
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
YGFC+T TERLLVYPYMSNGSVASRLKGKP+LDW TRKRIALGAARGLLYLHEQCDPKII
Sbjct: 365 YGFCITSTERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPKII 424
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT
Sbjct: 425 HRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 484
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DVFGFGILLLELITGQRALE+GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK+NYDRIE
Sbjct: 485 DVFGFGILLLELITGQRALEFGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKSNYDRIE 544
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRY 602
LEEMVQVALLCTQ+LP+HRPKMSEVVRMLEGDGLAERWEASQRAE+TKSK HEFSSSDRY
Sbjct: 545 LEEMVQVALLCTQFLPSHRPKMSEVVRMLEGDGLAERWEASQRAESTKSKLHEFSSSDRY 604
Query: 603 SDLTDDSSLLVQAMELSGPR 622
SDLTDDSSLLVQAMELSGPR
Sbjct: 605 SDLTDDSSLLVQAMELSGPR 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447454|ref|XP_004141483.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1102 bits (2850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/624 (85%), Positives = 569/624 (91%), Gaps = 2/624 (0%)
Query: 1 MAIREVFAICFVAFLCFWTTA-NGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAV 59
M E C VA L FW ++ NGLLS KGVNYEVQALMG+K SL DPHGVLENWD DAV
Sbjct: 3 MKRTEATVSCLVASLLFWVSSINGLLSPKGVNYEVQALMGIKASLQDPHGVLENWDGDAV 62
Query: 60 DPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR 119
DPCSWTMVTCSPESLVIGLG PSQNLSGTLS +IGNLTNLQIVLLQNNNITGPIP E GR
Sbjct: 63 DPCSWTMVTCSPESLVIGLGTPSQNLSGTLSSTIGNLTNLQIVLLQNNNITGPIPPEFGR 122
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
L+KLQTLDLSNNFFTGEIPSSLGHLRSLQY+R NNNSLSGA P SLA+MTQL FLD+SYN
Sbjct: 123 LSKLQTLDLSNNFFTGEIPSSLGHLRSLQYLRLNNNSLSGAIPMSLANMTQLAFLDVSYN 182
Query: 180 NLSGPVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG-RTRSHKL 238
N+SGP+PRF +KTFNIVGNPLICATGSE C+GT LMPMSMNLNS+QT P R +SHK+
Sbjct: 183 NISGPLPRFPSKTFNIVGNPLICATGSEAGCHGTTLMPMSMNLNSTQTGLPAVRLKSHKM 242
Query: 239 SLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVA 298
+L FGLS+ C+ LI LVFGLF+WWR+R N+ FFDVK++ HEE+SLGNLRRFQFRELQ+A
Sbjct: 243 ALTFGLSLACLCLIFLVFGLFIWWRRRSNRPTFFDVKDQQHEEISLGNLRRFQFRELQIA 302
Query: 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
T+NFSSKNILGKGGFG VYKGIL DGTVVAVKRLKDGNA GEIQFQTEVEMISLAVHR+
Sbjct: 303 TNNFSSKNILGKGGFGNVYKGILSDGTVVAVKRLKDGNASRGEIQFQTEVEMISLAVHRH 362
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
LLRLYGFC TPTERLLVYPYMSNGSVASRLKGKP+LDW TRKRIA+GAARGLLYLHEQCD
Sbjct: 363 LLRLYGFCNTPTERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIAIGAARGLLYLHEQCD 422
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
PKIIHRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS
Sbjct: 423 PKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 482
Query: 479 SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538
SEKTDVFGFGILLLELITGQRALE+GKAANQKG +LDWVK+IH EKKLE+LVDKDLK NY
Sbjct: 483 SEKTDVFGFGILLLELITGQRALEFGKAANQKGGILDWVKRIHLEKKLEVLVDKDLKANY 542
Query: 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSS 598
DR+ELEEMVQVALLCTQYLP HRPKMSEVVRMLEG+GLA RWEASQR ++TK KPH+FSS
Sbjct: 543 DRVELEEMVQVALLCTQYLPGHRPKMSEVVRMLEGEGLAVRWEASQRVDSTKCKPHDFSS 602
Query: 599 SDRYSDLTDDSSLLVQAMELSGPR 622
SDRYSDLTDDSSLLVQAMELSGPR
Sbjct: 603 SDRYSDLTDDSSLLVQAMELSGPR 626
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204417|emb|CBI16897.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1099 bits (2843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/618 (86%), Positives = 570/618 (92%), Gaps = 1/618 (0%)
Query: 6 VFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWT 65
V A FV FL FWT+ANGLLS KGVN+EVQALMG+K L DPHGVL+NWD DAVDPCSWT
Sbjct: 5 VIAFWFVPFLWFWTSANGLLSPKGVNFEVQALMGIKAFLVDPHGVLDNWDGDAVDPCSWT 64
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQT 125
MVTCS +SLV+GLG PSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP E+GRL+KL T
Sbjct: 65 MVTCSTDSLVVGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPQELGRLSKLHT 124
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185
LDLSNNFFT E+PSSLGHL SLQY+R NNNSLSG FP SLA+MTQL FLDLS+NNLSGPV
Sbjct: 125 LDLSNNFFTDEVPSSLGHLTSLQYLRLNNNSLSGPFPVSLANMTQLAFLDLSFNNLSGPV 184
Query: 186 PRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGR-TRSHKLSLVFGL 244
PRF AKTFNIVGNPLICATGSE +CYGT LMPMSM LNSSQTA P R +++HKL+L FG
Sbjct: 185 PRFPAKTFNIVGNPLICATGSEQECYGTTLMPMSMTLNSSQTALPTRRSKNHKLALAFGT 244
Query: 245 SVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSS 304
S+GC+ L+I GL LWWRQR NQQMFFDV +RHHEEVSLGNL+RFQFRELQ+AT NFSS
Sbjct: 245 SLGCICLLIFGGGLLLWWRQRHNQQMFFDVNDRHHEEVSLGNLKRFQFRELQIATDNFSS 304
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
KNILGKGGFG VYKG LQDGT+VAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLLRLYG
Sbjct: 305 KNILGKGGFGNVYKGYLQDGTIVAVKRLKDGNAVGGEIQFQTEVEMISLAVHRNLLRLYG 364
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
FC+T +ERLLVYPYMSNGSVASRLKGKP+LDW TRKRIALGAARGLLYLHEQCDPKIIHR
Sbjct: 365 FCITTSERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPKIIHR 424
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
DVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct: 425 DVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
Query: 485 FGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 544
FGFGILLLELITGQRALE+GKAANQKGAMLDWVKKIHQEK+LE+LVDKDLK+ YDR+ELE
Sbjct: 485 FGFGILLLELITGQRALEFGKAANQKGAMLDWVKKIHQEKRLEILVDKDLKHFYDRVELE 544
Query: 545 EMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSD 604
EMVQVALLCTQYLP HRPKMSEVV+MLEGDGLAERWEASQR E TK KPHE SSS+RYSD
Sbjct: 545 EMVQVALLCTQYLPGHRPKMSEVVQMLEGDGLAERWEASQRGEVTKCKPHELSSSERYSD 604
Query: 605 LTDDSSLLVQAMELSGPR 622
LTDDSSLLVQAMELSGPR
Sbjct: 605 LTDDSSLLVQAMELSGPR 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451885|ref|XP_002278965.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1099 bits (2843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/618 (86%), Positives = 570/618 (92%), Gaps = 1/618 (0%)
Query: 6 VFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWT 65
V A FV FL FWT+ANGLLS KGVN+EVQALMG+K L DPHGVL+NWD DAVDPCSWT
Sbjct: 7 VIAFWFVPFLWFWTSANGLLSPKGVNFEVQALMGIKAFLVDPHGVLDNWDGDAVDPCSWT 66
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQT 125
MVTCS +SLV+GLG PSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP E+GRL+KL T
Sbjct: 67 MVTCSTDSLVVGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPQELGRLSKLHT 126
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185
LDLSNNFFT E+PSSLGHL SLQY+R NNNSLSG FP SLA+MTQL FLDLS+NNLSGPV
Sbjct: 127 LDLSNNFFTDEVPSSLGHLTSLQYLRLNNNSLSGPFPVSLANMTQLAFLDLSFNNLSGPV 186
Query: 186 PRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGR-TRSHKLSLVFGL 244
PRF AKTFNIVGNPLICATGSE +CYGT LMPMSM LNSSQTA P R +++HKL+L FG
Sbjct: 187 PRFPAKTFNIVGNPLICATGSEQECYGTTLMPMSMTLNSSQTALPTRRSKNHKLALAFGT 246
Query: 245 SVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSS 304
S+GC+ L+I GL LWWRQR NQQMFFDV +RHHEEVSLGNL+RFQFRELQ+AT NFSS
Sbjct: 247 SLGCICLLIFGGGLLLWWRQRHNQQMFFDVNDRHHEEVSLGNLKRFQFRELQIATDNFSS 306
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
KNILGKGGFG VYKG LQDGT+VAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLLRLYG
Sbjct: 307 KNILGKGGFGNVYKGYLQDGTIVAVKRLKDGNAVGGEIQFQTEVEMISLAVHRNLLRLYG 366
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
FC+T +ERLLVYPYMSNGSVASRLKGKP+LDW TRKRIALGAARGLLYLHEQCDPKIIHR
Sbjct: 367 FCITTSERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPKIIHR 426
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
DVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct: 427 DVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 486
Query: 485 FGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 544
FGFGILLLELITGQRALE+GKAANQKGAMLDWVKKIHQEK+LE+LVDKDLK+ YDR+ELE
Sbjct: 487 FGFGILLLELITGQRALEFGKAANQKGAMLDWVKKIHQEKRLEILVDKDLKHFYDRVELE 546
Query: 545 EMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSD 604
EMVQVALLCTQYLP HRPKMSEVV+MLEGDGLAERWEASQR E TK KPHE SSS+RYSD
Sbjct: 547 EMVQVALLCTQYLPGHRPKMSEVVQMLEGDGLAERWEASQRGEVTKCKPHELSSSERYSD 606
Query: 605 LTDDSSLLVQAMELSGPR 622
LTDDSSLLVQAMELSGPR
Sbjct: 607 LTDDSSLLVQAMELSGPR 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526591|ref|XP_003531900.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1078 bits (2788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/620 (83%), Positives = 563/620 (90%), Gaps = 2/620 (0%)
Query: 4 REVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCS 63
R + + F +FL FW++AN LLS KGVN+EVQALMG+K+SL DPHGVL+NWD DAVDPCS
Sbjct: 5 RGIALLSFTSFL-FWSSANALLSPKGVNFEVQALMGIKYSLEDPHGVLDNWDGDAVDPCS 63
Query: 64 WTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123
WTMVTCS E+LVIGLG PSQ+LSGTLSPSIGNLTNLQIVLLQNNNI+GPIP+E+G+L KL
Sbjct: 64 WTMVTCSSENLVIGLGTPSQSLSGTLSPSIGNLTNLQIVLLQNNNISGPIPSELGKLPKL 123
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
QTLDLSNNFF GEIP SLGHLRSLQY+R NNNSL G P SLA+MTQL FLDLSYNNLS
Sbjct: 124 QTLDLSNNFFKGEIPPSLGHLRSLQYLRLNNNSLVGECPESLANMTQLNFLDLSYNNLSD 183
Query: 184 PVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTA-SPGRTRSHKLSLVF 242
PVPR AK+F+IVGNPL+CATG EP+C+G LMPMSMNLN+++ A GR ++HK+++ F
Sbjct: 184 PVPRILAKSFSIVGNPLVCATGKEPNCHGMTLMPMSMNLNNTEDALQSGRPKTHKMAIAF 243
Query: 243 GLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNF 302
GLS+GC+ LI++ FGL LWWR + NQQ FFDVK+RHHEEV LGNL+RFQFRELQ+AT NF
Sbjct: 244 GLSLGCLCLIVIGFGLVLWWRHKHNQQAFFDVKDRHHEEVYLGNLKRFQFRELQIATKNF 303
Query: 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
SSKNILGKGGFG VYKGIL DGT+VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL
Sbjct: 304 SSKNILGKGGFGNVYKGILPDGTLVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 363
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
YGFCMTP+ERLLVYPYMSNGSVASRLKGKP+LDW TRK IALGA RGLLYLHEQCDPKII
Sbjct: 364 YGFCMTPSERLLVYPYMSNGSVASRLKGKPVLDWGTRKHIALGAGRGLLYLHEQCDPKII 423
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVKAANILLDD EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT
Sbjct: 424 HRDVKAANILLDDYYEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 483
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DVFGFGILLLELITGQRALE+GK+AN KGAMLDWVKKIHQEKKLEMLVDKDLK+NYDRIE
Sbjct: 484 DVFGFGILLLELITGQRALEFGKSANNKGAMLDWVKKIHQEKKLEMLVDKDLKSNYDRIE 543
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRY 602
EEMVQVALLCTQYLP HRPKMSEVVRMLEGDGLAERWEASQR + TK KP E SSSDRY
Sbjct: 544 FEEMVQVALLCTQYLPGHRPKMSEVVRMLEGDGLAERWEASQRVDTTKCKPQESSSSDRY 603
Query: 603 SDLTDDSSLLVQAMELSGPR 622
SDLTDDS LLVQAMELSGPR
Sbjct: 604 SDLTDDSLLLVQAMELSGPR 623
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568861|ref|XP_003552626.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/596 (85%), Positives = 550/596 (92%), Gaps = 1/596 (0%)
Query: 28 KGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSG 87
KGVN+EVQALMG+K SL DPHGVL+NWD DAVDPCSWTMVTCS E+LVIGLG PSQ+LSG
Sbjct: 28 KGVNFEVQALMGIKDSLEDPHGVLDNWDGDAVDPCSWTMVTCSSENLVIGLGTPSQSLSG 87
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
TLSPSIGNLTNLQIVLLQNNNI+GPIP+E+G+L+KLQTLDLSNNFF+G IP SLGHLRSL
Sbjct: 88 TLSPSIGNLTNLQIVLLQNNNISGPIPSELGKLSKLQTLDLSNNFFSGGIPPSLGHLRSL 147
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICATGSE 207
QY+RFNNNSL G P SLA+MTQL FLDLSYNNLSGPVPR AK+F+I+GNPL+CATG E
Sbjct: 148 QYLRFNNNSLVGECPESLANMTQLNFLDLSYNNLSGPVPRILAKSFSIIGNPLVCATGKE 207
Query: 208 PDCYGTQLMPMSMNLNSSQTA-SPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWRQRR 266
P+C+G LMPMSMNLN+++ A GR ++HK+++ FGLS+GC+ LI+L FGL LWWR +
Sbjct: 208 PNCHGMTLMPMSMNLNNTEDALQSGRPKTHKMAIAFGLSLGCLCLIVLGFGLVLWWRHKH 267
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTV 326
NQQ FFDVK+RHHEEV LGNL+RFQFRELQ+AT+NFSSKNILGKGGFG VYKG+ DGT+
Sbjct: 268 NQQAFFDVKDRHHEEVYLGNLKRFQFRELQIATNNFSSKNILGKGGFGNVYKGVFPDGTL 327
Query: 327 VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 386
VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS
Sbjct: 328 VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 387
Query: 387 RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446
RLKGKP+LDW TRK IALGA RGLLYLHEQCDPKIIHRDVKAANILLDD EAVVGDFGL
Sbjct: 388 RLKGKPVLDWGTRKHIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYYEAVVGDFGL 447
Query: 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506
AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE+GK+
Sbjct: 448 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEFGKS 507
Query: 507 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSE 566
AN KGAMLDWVKKIHQEKKL+MLVDKDLKNNYDRIELEEMVQVALLCTQYLP HRPKMSE
Sbjct: 508 ANNKGAMLDWVKKIHQEKKLDMLVDKDLKNNYDRIELEEMVQVALLCTQYLPGHRPKMSE 567
Query: 567 VVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSLLVQAMELSGPR 622
VVRMLEGDGLAE+WEASQR + TK KP E SSSDRYSDLTDDS LLVQAMELSGPR
Sbjct: 568 VVRMLEGDGLAEKWEASQRVDTTKCKPQESSSSDRYSDLTDDSLLLVQAMELSGPR 623
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573805|ref|XP_003555046.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/620 (81%), Positives = 558/620 (90%), Gaps = 1/620 (0%)
Query: 4 REVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCS 63
R +CFV F F + +N LLS KGVN+EV ALMG+K SL DPHG+L+NWDEDAVDPCS
Sbjct: 5 RREDVLCFVLFFWFCSFSNALLSPKGVNFEVLALMGIKASLVDPHGILDNWDEDAVDPCS 64
Query: 64 WTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123
W MVTCSPE+LVI LGIPSQNLSGTLSPSIGNLTNLQ V+LQNNNITGPIP+EIG+L+KL
Sbjct: 65 WNMVTCSPENLVISLGIPSQNLSGTLSPSIGNLTNLQTVVLQNNNITGPIPSEIGKLSKL 124
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
QTLDLS+NFF+GEIP S+GHLRSLQY+R NNNS G P SLA+M QL FLDLSYNNLSG
Sbjct: 125 QTLDLSDNFFSGEIPPSMGHLRSLQYLRLNNNSFDGQCPESLANMAQLAFLDLSYNNLSG 184
Query: 184 PVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASP-GRTRSHKLSLVF 242
P+P+ AK+F+IVGNPL+CAT E +C+G LMPMSMNLN ++ A P GR ++HK+++ F
Sbjct: 185 PIPKMLAKSFSIVGNPLVCATEKEKNCHGMTLMPMSMNLNDTEHALPSGRKKAHKMAIAF 244
Query: 243 GLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNF 302
GL +GC+SLI+L GL LW R + QQ FFDVK+RHHEEV LGNL+RF RELQ+AT+NF
Sbjct: 245 GLILGCLSLIVLGVGLVLWRRHKHKQQAFFDVKDRHHEEVYLGNLKRFHLRELQIATNNF 304
Query: 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
S+KNILGKGGFG VYKGIL DGT+VAVKRLKDGNAIGG+IQFQTEVEMISLAVHRNLL+L
Sbjct: 305 SNKNILGKGGFGNVYKGILPDGTLVAVKRLKDGNAIGGDIQFQTEVEMISLAVHRNLLKL 364
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
YGFCMTPTERLLVYPYMSNGSVASRLKGKP+LDW TRK+IALGAARGLLYLHEQCDPKII
Sbjct: 365 YGFCMTPTERLLVYPYMSNGSVASRLKGKPVLDWGTRKQIALGAARGLLYLHEQCDPKII 424
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT
Sbjct: 425 HRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 484
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DVFGFGILLLELITGQRALE+GKAANQKGAMLDWV+K+HQEKKLE+LVDKDLK NYDRIE
Sbjct: 485 DVFGFGILLLELITGQRALEFGKAANQKGAMLDWVRKLHQEKKLELLVDKDLKTNYDRIE 544
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRY 602
LEE+VQVALLCTQYLP HRPKMSEVVRMLEGDGLAE+WEASQ A+ TK KP E SSSDRY
Sbjct: 545 LEEIVQVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQSADTTKCKPQELSSSDRY 604
Query: 603 SDLTDDSSLLVQAMELSGPR 622
SDLTDDSSLLVQAMELSGPR
Sbjct: 605 SDLTDDSSLLVQAMELSGPR 624
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425033|ref|XP_002269902.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] gi|297738231|emb|CBI27432.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/622 (81%), Positives = 563/622 (90%), Gaps = 2/622 (0%)
Query: 3 IREVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPC 62
+R +CFVAFLC W +A+ LLS KGVN+EVQALM +K+SL DP VLENWD+DAVDPC
Sbjct: 4 LRREAVLCFVAFLCLWNSASSLLSPKGVNFEVQALMSIKNSLIDPRSVLENWDKDAVDPC 63
Query: 63 SWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTK 122
SW M+TCS + LVI LG PSQNLSGTLSPSIGNLTNLQ VLLQ+N+I+GPIP+E+G+L+K
Sbjct: 64 SWNMITCSDDKLVISLGTPSQNLSGTLSPSIGNLTNLQTVLLQDNSISGPIPSELGKLSK 123
Query: 123 LQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L LDLSNNFF GEIP+SL HL+SLQY+R NNNSLSGA P+SLA+MT L FLD+SYNNLS
Sbjct: 124 LHLLDLSNNFFNGEIPTSLSHLKSLQYLRLNNNSLSGAIPSSLANMTHLAFLDMSYNNLS 183
Query: 183 GPVPRFSAKTFNIVGNPLICATGSEPDCYGTQL-MPMSMNLNSSQTASP-GRTRSHKLSL 240
GPVP F+A+TFNIVGNPLIC TG+E DC+G +P+S+++N+SQ++ P R +SHK++L
Sbjct: 184 GPVPGFAARTFNIVGNPLICPTGTEKDCFGRPTPLPVSISMNNSQSSQPSARPKSHKVAL 243
Query: 241 VFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATH 300
FG S+GC+ L+IL FG LWWRQR NQQ+FFDV E++ EEV LGNLRRF F+ELQ+AT+
Sbjct: 244 AFGSSLGCICLLILGFGFLLWWRQRHNQQIFFDVNEQYREEVCLGNLRRFPFKELQIATN 303
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
NFSSKNILGKGGFG VYKG LQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLL
Sbjct: 304 NFSSKNILGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLL 363
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
RLYGFCMT TERLLVYPYMSNGSVA RLK KP LDWSTRKRIALGAARGLLYLHEQCDPK
Sbjct: 364 RLYGFCMTTTERLLVYPYMSNGSVAYRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPK 423
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IIHRDVKAANILLDD CEAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 424 IIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 483
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
KTDVFGFGILLLELITGQRALE+GKAANQKGAMLDWVKKIHQEKKL+MLVDKDLK NYDR
Sbjct: 484 KTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWVKKIHQEKKLDMLVDKDLKANYDR 543
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSD 600
IELEEMVQVALLCTQYLP+HRPKMSEVVRMLEGDGLAE+WEA+QRAEAT+ K +EFSSS+
Sbjct: 544 IELEEMVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKWEATQRAEATRCKANEFSSSE 603
Query: 601 RYSDLTDDSSLLVQAMELSGPR 622
RYSDLTDDSSLLVQAMELSGPR
Sbjct: 604 RYSDLTDDSSLLVQAMELSGPR 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|90657574|gb|ABD96874.1| hypothetical protein [Cleome spinosa] | Back alignment and taxonomy information |
|---|
Score = 1043 bits (2696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/622 (82%), Positives = 564/622 (90%), Gaps = 8/622 (1%)
Query: 7 FAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTM 66
F++CF FL +A+ LLS +GVN+EV+ALM +K SL+DPHGVLE+WD DAVDPCSWTM
Sbjct: 15 FSVCFFGFLWLLGSASALLSPQGVNFEVRALMDIKASLNDPHGVLESWDRDAVDPCSWTM 74
Query: 67 VTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTL 126
VTCS E+ VI LG PSQ+LSGTLSPSIGNLTNLQIVLLQNNNI+G +P E+GRLTKLQTL
Sbjct: 75 VTCSSENFVISLGTPSQSLSGTLSPSIGNLTNLQIVLLQNNNISGRLPTELGRLTKLQTL 134
Query: 127 DLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
DLS+NFF GEIPSSLG LRSLQY+R NNNSLSGAFP SLA+MTQL FLDLSYNNLSGPVP
Sbjct: 135 DLSDNFFHGEIPSSLGRLRSLQYLRLNNNSLSGAFPLSLANMTQLAFLDLSYNNLSGPVP 194
Query: 187 RFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHK---LSLVFG 243
F+AKTF+IVGNPLIC TG+EPDC GT LMPMSMNLN +T + SHK +++VFG
Sbjct: 195 SFAAKTFSIVGNPLICPTGAEPDCNGTTLMPMSMNLN--ETGALLYNESHKRNKMAIVFG 252
Query: 244 LSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFS 303
SV VS IILVFGLFLWWRQRR+Q+ FFDVK+ HHEEVSLGNLRRF FRELQ++THNFS
Sbjct: 253 SSVSSVSFIILVFGLFLWWRQRRHQRTFFDVKDGHHEEVSLGNLRRFSFRELQISTHNFS 312
Query: 304 SKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
SKN+LGKGG+G VYKGIL DGTVVAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLLRL+
Sbjct: 313 SKNLLGKGGYGNVYKGILADGTVVAVKRLKDGNALGGEIQFQTEVEMISLAVHRNLLRLF 372
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
GFC+TP E+LLVYPYMSNGSVASRLKGKP+LDWSTRKRIA+GAARGL+YLHEQCDPKIIH
Sbjct: 373 GFCITPAEKLLVYPYMSNGSVASRLKGKPVLDWSTRKRIAIGAARGLVYLHEQCDPKIIH 432
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD
Sbjct: 433 RDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 492
Query: 484 VFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543
VFGFGILLLELITGQRALE+ KAANQKGAML+WVKKIHQ+KKLE+LVDKDLK NYD IEL
Sbjct: 493 VFGFGILLLELITGQRALEFSKAANQKGAMLEWVKKIHQDKKLEVLVDKDLKGNYDGIEL 552
Query: 544 EEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEAT---KSKPHEFSSSD 600
EEMV+VALLCTQYLP HRPKMSEVVRMLEGDGLAERWEASQR E+T S+P+E SSSD
Sbjct: 553 EEMVKVALLCTQYLPGHRPKMSEVVRMLEGDGLAERWEASQRTESTSKCSSRPNELSSSD 612
Query: 601 RYSDLTDDSSLLVQAMELSGPR 622
RYSDLTDDS+LLVQAMELSGPR
Sbjct: 613 RYSDLTDDSTLLVQAMELSGPR 634
|
Source: Cleome spinosa Species: Cleome spinosa Genus: Cleome Family: Cleomaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 622 | ||||||
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.993 | 0.968 | 0.775 | 3.3e-260 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.985 | 0.969 | 0.621 | 4.2e-205 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.903 | 0.867 | 0.655 | 6.5e-201 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.975 | 0.957 | 0.614 | 6.8e-198 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.937 | 0.949 | 0.550 | 3.8e-165 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.982 | 0.972 | 0.542 | 5e-163 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.961 | 0.956 | 0.548 | 1.2e-161 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.958 | 0.961 | 0.523 | 1.4e-151 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.948 | 0.962 | 0.483 | 4.8e-142 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.808 | 0.836 | 0.537 | 7.3e-130 |
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2504 (886.5 bits), Expect = 3.3e-260, P = 3.3e-260
Identities = 491/633 (77%), Positives = 544/633 (85%)
Query: 1 MAIREVFAICFVAFLCFW-TTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAV 59
M R F CF+ FLC ++ +GLLS KGVN+EVQALM +K SLHDPHGVL+NWD DAV
Sbjct: 10 MITRSFF--CFLGFLCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAV 67
Query: 60 DPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGR 119
DPCSWTMVTCS E+ VIGLG PSQNLSGTLSPSI G IPAEIGR
Sbjct: 68 DPCSWTMVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGR 127
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
LT+L+TLDLS+NFF GEIP S+G+L+SLQY+R NNNSLSG FP SL++MTQL FLDLSYN
Sbjct: 128 LTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYN 187
Query: 180 NLSGPVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASP---GRTRSH 236
NLSGPVPRF+AKTF+IVGNPLIC TG+EPDC GT L+PMSMNLN QT P G +R+H
Sbjct: 188 NLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLN--QTGVPLYAGGSRNH 245
Query: 237 KLSLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKE-RHHEEVSLGNLRRFQFREL 295
K+++ G SVG VSLI + GLFLWWRQR NQ FFDVK+ HHEEVSLGNLRRF FREL
Sbjct: 246 KMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFREL 305
Query: 296 QVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 355
Q+AT+NFSSKN+LGKGG+G VYKGIL D TVVAVKRLKDG A+GGEIQFQTEVEMISLAV
Sbjct: 306 QIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAV 365
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
HRNLLRLYGFC+T TE+LLVYPYMSNGSVASR+K KP+LDWS RKRIA+GAARGL+YLHE
Sbjct: 366 HRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHE 425
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
QCDPKIIHRDVKAANILLDD CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST
Sbjct: 426 QCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 485
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL- 534
GQSSEKTDVFGFGILLLEL+TGQRA E+GKAANQKG MLDWVKKIHQEKKLE+LVDK+L
Sbjct: 486 GQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELL 545
Query: 535 -KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATK--- 590
K +YD IEL+EMV+VALLCTQYLP HRPKMSEVVRMLEGDGLAE+WEASQR+++
Sbjct: 546 KKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCS 605
Query: 591 SKPHEF-SSSDRYSDLTDDSSLLVQAMELSGPR 622
++ +E SSSDRYSDLTDDSSLLVQAMELSGPR
Sbjct: 606 NRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1984 (703.5 bits), Expect = 4.2e-205, P = 4.2e-205
Identities = 391/629 (62%), Positives = 478/629 (75%)
Query: 6 VFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWT 65
V+ + F+ F+ F+ ++ LS GVNYEV AL+ VK+ L+DP+ VLENWD ++VDPCSW
Sbjct: 8 VWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWR 67
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQT 125
MV+C+ + V L +PSQ+LSGTLSP IG GPIP IGRL KLQ+
Sbjct: 68 MVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQS 126
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185
LDLSNN FTGEIP+SLG L++L Y+R NNNSL G P SL+ + L +D+SYNNLSG +
Sbjct: 127 LDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSL 186
Query: 186 PRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG-RTRSHKLSLVFGL 244
P+ SA+TF ++GN LIC + +C +P + L G RT H ++L F
Sbjct: 187 PKVSARTFKVIGNALICGPKAVSNC---SAVPEPLTLPQDGPDESGTRTNGHHVALAFAA 243
Query: 245 SVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSS 304
S + G+FLWWR RRN+Q+FFDV E++ EVSLG+L+R+ F+EL+ AT++F+S
Sbjct: 244 SFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNS 303
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
KNILG+GG+GIVYKG L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL G
Sbjct: 304 KNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRG 363
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
FC + ER+LVYPYM NGSVASRLK G+P LDWS RK+IA+G ARGL+YLHEQCDPK
Sbjct: 364 FCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPK 423
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IIHRDVKAANILLD+ EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 424 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 483
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
KTDVFGFGILLLELITGQ+AL++G++A+QKG MLDWVKK+HQE KL+ L+DKDL + +DR
Sbjct: 484 KTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDR 543
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPH----EF 596
+ELEE+VQVALLCTQ+ P+HRPKMSEV++MLEGDGLAERWEA+Q P
Sbjct: 544 VELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMV 603
Query: 597 SSSDR---YSDLTDDSSLLVQAMELSGPR 622
SSS R YSD +SSL+V+A+ELSGPR
Sbjct: 604 SSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1916 (679.5 bits), Expect = 6.5e-201, Sum P(2) = 6.5e-201
Identities = 375/572 (65%), Positives = 449/572 (78%)
Query: 14 FLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPES 73
FLCF T LS++ N EV+AL+ ++++LHDPHG L NWDE +VDPCSW M+TCSP++
Sbjct: 21 FLCFSTLT---LSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDN 77
Query: 74 LVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQTLDLSNNFF 133
LVIGLG PSQ+LSG LS SIG G IP E+G L KLQTLDLSNN F
Sbjct: 78 LVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRF 137
Query: 134 TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTF 193
+G+IP S+ L SLQY+R NNNSLSG FP SL+ + L FLDLSYNNLSGPVP+F A+TF
Sbjct: 138 SGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTF 197
Query: 194 NIVGNPLICATGSEPDCYGT-QLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLI 252
N+ GNPLIC + C G+ P+S++L+SS GR RS++L++ +S+G V ++
Sbjct: 198 NVAGNPLICRSNPPEICSGSINASPLSVSLSSSS----GR-RSNRLAIALSVSLGSVVIL 252
Query: 253 ILVFGLFLWWRQRRNQQMFFDVKERHHEEVS-LGNLRRFQFRELQVATHNFSSKNILGKG 311
+L G F W+R+++ + + ++ ++ E + LGNLR F FREL V T FSSKNILG G
Sbjct: 253 VLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAG 312
Query: 312 GFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371
GFG VY+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRL G+C T E
Sbjct: 313 GFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGE 372
Query: 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431
RLLVYPYM NGSVAS+LK KP LDW+ RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANI
Sbjct: 373 RLLVYPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANI 432
Query: 432 LLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 491
LLD+C EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL
Sbjct: 433 LLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 492
Query: 492 LELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVAL 551
LELITG RALE+GK +QKGAML+WV+K+H+E K+E L+D++L NYD+IE+ EM+QVAL
Sbjct: 493 LELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVAL 552
Query: 552 LCTQYLPAHRPKMSEVVRMLEGDGLAERWEAS 583
LCTQYLPAHRPKMSEVV MLEGDGLAERW AS
Sbjct: 553 LCTQYLPAHRPKMSEVVLMLEGDGLAERWAAS 584
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1916 (679.5 bits), Expect = 6.8e-198, P = 6.8e-198
Identities = 391/636 (61%), Positives = 472/636 (74%)
Query: 5 EVFAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSW 64
++F++ + LCF+ T + LS++ N EV+AL+ +K+ LHDPHGV +NWDE +VDPCSW
Sbjct: 10 KIFSVLLL--LCFFVTCS--LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSW 65
Query: 65 TMVTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQ 124
TM++CS ++LVIGLG PSQ+LSGTLS SIG G IP EI L KLQ
Sbjct: 66 TMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQ 125
Query: 125 TLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184
TLDLSNN F+GEIP S+ L +LQY+R NNNSLSG FP SL+ + L FLDLSYNNL GP
Sbjct: 126 TLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGP 185
Query: 185 VPRFSAKTFNIVGNPLICATGSEPDCYGT-QLMPMSMNLNSSQTASPGRTRSHKLSLVFG 243
VP+F A+TFN+ GNPLIC C G+ P+S++L SS GR R++ L++ G
Sbjct: 186 VPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSS----GR-RTNILAVALG 240
Query: 244 LSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEV-SLGNLRRFQFRELQVATHNF 302
+S+G +IL G F+W+R+++ + + ++ E + LGNLR F FREL VAT F
Sbjct: 241 VSLGFAVSVILSLG-FIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGF 299
Query: 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
SSK+ILG GGFG VY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRL
Sbjct: 300 SSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRL 359
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
G+C + +ERLLVYPYMSNGSVASRLK KP LDW+TRK+IA+GAARGL YLHEQCDPKII
Sbjct: 360 IGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKII 419
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVKAANILLD+ EAVVGDFGLAKLL+H+DSHVTTAVRGTVGHIAPEYLSTGQSSEKT
Sbjct: 420 HRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 479
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DVFGFGILLLELITG RALE+GK+ +QKGAML+WV+K+H+E K+E LVD++L YDRIE
Sbjct: 480 DVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIE 539
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQ----------------RA 586
+ EM+QVALLCTQ+LPAHRPKMSEVV+MLEGDGLAERW AS
Sbjct: 540 VGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHSHFYHANMSYRTITST 599
Query: 587 EATKSKPHEFSSSDRYSDLTDDSSLLVQAMELSGPR 622
+ H F SS + D D+ +L AMELSGPR
Sbjct: 600 DGNNQTKHLFGSSG-FEDEDDNQALDSFAMELSGPR 634
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1607 (570.8 bits), Expect = 3.8e-165, P = 3.8e-165
Identities = 333/605 (55%), Positives = 422/605 (69%)
Query: 22 NGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIP 81
+ LLS KGVNYEV ALM VK+ + D VL WD ++VDPC+W MV CS E V+ L +
Sbjct: 28 DSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVSLEMA 87
Query: 82 SQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S+ LSG LS SIG GPIP+E+G+L++L+TLDLS N F+GEIP+SL
Sbjct: 88 SKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASL 147
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLI 201
G L L Y+R + N LSG P +A ++ L FLDLS+NNLSGP P SAK + IVGN +
Sbjct: 148 GFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFL 207
Query: 202 CATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLW 261
C S+ C + P+ N++ + ++ H L L F + +I L+F LF W
Sbjct: 208 CGPASQELC--SDATPVR---NATGLSEKDNSKHHSLVLSFAFGIVVAFIISLMF-LFFW 261
Query: 262 WRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGIL 321
R++ V++ + E +G+L+RF FRE+Q AT NFS KNILG+GGFG+VYKG L
Sbjct: 262 VLWHRSRLSRSHVQQDY--EFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYL 319
Query: 322 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381
+GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL+GFCMTP ER+LVYPYM N
Sbjct: 320 PNGTVVAVKRLKDP-IYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPN 378
Query: 382 GSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437
GSVA RL+ KP LDW+ R IALGAARGL+YLHEQC+PKIIHRDVKAANILLD+
Sbjct: 379 GSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESF 438
Query: 438 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
EA+VGDFGLAKLLD +DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELITG
Sbjct: 439 EAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITG 498
Query: 498 QRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 557
+ ++ G +KG +L WV+ + EK+ +VD+DLK +D + LEE+V++ALLCTQ
Sbjct: 499 HKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPH 558
Query: 558 PAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSLLVQAME 617
P RP+MS+V+++LEG L E+ E A A P S S YS+ ++ S +++A+E
Sbjct: 559 PNLRPRMSQVLKVLEG--LVEQCEGGYEARA----P---SVSRNYSNGHEEQSFIIEAIE 609
Query: 618 LSGPR 622
LSGPR
Sbjct: 610 LSGPR 614
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 5.0e-163, P = 5.0e-163
Identities = 341/629 (54%), Positives = 426/629 (67%)
Query: 5 EVFA-ICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCS 63
E F +C ++ L + N L A N E AL ++ +L DP+ VL++WD V+PC+
Sbjct: 7 EAFGFVCLISLLLLF---NSLWLASS-NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCT 62
Query: 64 WTMVTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKL 123
W VTC+ E+ VI + + + +LSG L P +G GP+P+++G LT L
Sbjct: 63 WFHVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNL 122
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+LDL N FTG IP SLG L L+++R NNNSL+G P SL ++ L LDLS N LSG
Sbjct: 123 VSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSG 182
Query: 184 PVP---RFSAKT-FNIVGNPLICATGSEPDCYGTQ-LMPMSMNLNSSQTASPGRTRSHKL 238
VP FS T + N +C + C G+ P + +PG S
Sbjct: 183 SVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFIPPPIVPTPGGY-SATG 241
Query: 239 SLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVA 298
++ G++ G L F WWR+R+ Q+ FFDV EV LG L+RF RELQVA
Sbjct: 242 AIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVA 301
Query: 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
T +FS+KNILG+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRN
Sbjct: 302 TDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 361
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI----LDWSTRKRIALGAARGLLYLH 414
LLRL GFCMTPTERLLVYPYM+NGSVAS L+ +P L WS R++IALG+ARGL YLH
Sbjct: 362 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLH 421
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
+ CDPKIIHRDVKAANILLD+ EAVVGDFGLA+L+D++D+HVTTAVRGT+GHIAPEYLS
Sbjct: 422 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLS 481
Query: 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML-DWVKKIHQEKKLEMLVDKD 533
TG+SSEKTDVFG+GI+LLELITGQRA + + AN ML DWVK + +EKKLEMLVD D
Sbjct: 482 TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 541
Query: 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKP 593
L++NY E+E+++QVALLCTQ P RPKMSEVVRMLEGDGLAE+W+ Q+ E + +
Sbjct: 542 LQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEV 601
Query: 594 HEFSSSDRYSDLTDDSSLLVQAMELSGPR 622
E SS SD DS+ + AMELSGPR
Sbjct: 602 -ELSSHPT-SDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1574 (559.1 bits), Expect = 1.2e-161, P = 1.2e-161
Identities = 335/611 (54%), Positives = 415/611 (67%)
Query: 22 NGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIP 81
N L N E AL ++ +L DP+ VL++WD V+PC+W VTC+ E+ VI + +
Sbjct: 18 NHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLG 77
Query: 82 SQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ LSG L P +G GPIP+ +G LT L +LDL N F+G IP SL
Sbjct: 78 NAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESL 137
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP---RFSAKT-FNIVG 197
G L L+++R NNNSL+G+ P SL ++T L LDLS N LSG VP FS T +
Sbjct: 138 GKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFAN 197
Query: 198 NPLICATGSEPDCYGTQ-LMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVF 256
N +C + C G+ P + ++P ++ G++ G L
Sbjct: 198 NLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITG-AIAGGVAAGAALLFAAPA 256
Query: 257 GLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIV 316
F WWR+R+ +FFDV EV LG L+RF RELQVA+ FS+KNILG+GGFG V
Sbjct: 257 IAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKV 316
Query: 317 YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376
YKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMTPTERLLVY
Sbjct: 317 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 376
Query: 377 PYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432
PYM+NGSVAS L+ +P LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANIL
Sbjct: 377 PYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 436
Query: 433 LDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 492
LD+ EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LL
Sbjct: 437 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLL 496
Query: 493 ELITGQRALEYGKAANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVAL 551
ELITGQRA + + AN ML DWVK + +EKKLEMLVD DL+ NY+ ELE+++QVAL
Sbjct: 497 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVAL 556
Query: 552 LCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDSSL 611
LCTQ P RPKMSEVVRMLEGDGLAE+W+ Q+ E + + + S + SD DS+
Sbjct: 557 LCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEI-DLSPNPN-SDWILDSTY 614
Query: 612 LVQAMELSGPR 622
+ A+ELSGPR
Sbjct: 615 NLHAVELSGPR 625
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1479 (525.7 bits), Expect = 1.4e-151, P = 1.4e-151
Identities = 328/627 (52%), Positives = 408/627 (65%)
Query: 9 ICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLH--DP-HGVLENWDEDAVDPCSWT 65
+CF+ L + N L G N E AL +K+SL DP + VL++WD V PC+W
Sbjct: 12 LCFLYLLLLF---NFTLRVAG-NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWF 67
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQT 125
VTC+PE+ V + + + LSG L P +G G IP E+G L +L +
Sbjct: 68 HVTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVS 127
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185
LDL N +G IPSSLG L L+++R NNNSLSG P +L S+ QL LD+S N LSG +
Sbjct: 128 LDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDI 186
Query: 186 PRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLS 245
P + F++ P+ A S D +P ++S T P ++ G++
Sbjct: 187 PVNGS--FSLF-TPISFANNSLTD------LPEPPPTSTSPTPPPPSGGQMTAAIAGGVA 237
Query: 246 VGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSK 305
G L + F WW +R+ Q FFDV EV LG L+RF REL VAT NFS+K
Sbjct: 238 AGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNK 297
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
N+LG+GGFG VYKG L DG +VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GF
Sbjct: 298 NVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGF 357
Query: 366 CMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
CMTPTERLLVYPYM+NGSVAS L+ G P LDW RK IALG+ARGL YLH+ CD KI
Sbjct: 358 CMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKI 417
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
IHRDVKAANILLD+ EAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEK
Sbjct: 418 IHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEK 477
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDR 540
TDVFG+G++LLELITGQ+A + + AN ML DWVK++ +EKKLE LVD +L+ Y
Sbjct: 478 TDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVE 537
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSD 600
E+E+++Q+ALLCTQ RPKMSEVVRMLEGDGLAERWE Q+ E H+F+
Sbjct: 538 TEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPI---HDFNYQ- 593
Query: 601 RYSDLTDD-----SSLLVQAMELSGPR 622
Y D S+ L++ SGPR
Sbjct: 594 AYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 303/627 (48%), Positives = 400/627 (63%)
Query: 7 FAICFVAFLCFWTTANGLLSAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTM 66
F + F A LC + + + A+G AL ++ SL L +W+++ V+PC+W+
Sbjct: 13 FTLLFFACLCSFVSPD----AQG-----DALFALRISLRALPNQLSDWNQNQVNPCTWSQ 63
Query: 67 VTCSPESLVIGLGIPSQNLSGTLSPSIGXXXXXXXXXXXXXXXXGPIPAEIGRLTKLQTL 126
V C ++ V L + N SGTLS +G G IP + G LT L +L
Sbjct: 64 VICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSL 123
Query: 127 DLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
DL +N TG IPS++G+L+ LQ++ + N L+G P SL + L+ L L N+LSG +P
Sbjct: 124 DLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIP 183
Query: 187 R--FSAKTFNIVGNPLICATGSEPD-CYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFG 243
+ F +N N L C G +P C +S +S ++ P K ++ G
Sbjct: 184 QSLFEIPKYNFTSNNLNCG-GRQPHPC-------VSAVAHSGDSSKP------KTGIIAG 229
Query: 244 LSVGCVSLIILVFGLFLWWRQRRN---QQMFFDVKERHHEEVSLGNLRRFQFRELQVATH 300
+ G V++++ LFL+ + R + +F DV ++ G L+RF +RELQ+AT
Sbjct: 230 VVAG-VTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATD 288
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
NFS KN+LG+GGFG VYKG+L D T VAVKRL D + GG+ FQ EVEMIS+AVHRNLL
Sbjct: 289 NFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 348
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQ 416
RL GFC T TERLLVYP+M N S+A RL+ G P+LDW TRKRIALGAARG YLHE
Sbjct: 349 RLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEH 408
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
C+PKIIHRDVKAAN+LLD+ EAVVGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG
Sbjct: 409 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTG 468
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML-DWVKKIHQEKKLEMLVDKDLK 535
+SSE+TDVFG+GI+LLEL+TGQRA+++ + + +L D VKK+ +EK+L +VDK+L
Sbjct: 469 KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLD 528
Query: 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHE 595
Y + E+E M+QVALLCTQ P RP MSEVVRMLEG+GLAERWE Q E T+ HE
Sbjct: 529 GEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRR--HE 586
Query: 596 FSSSDRYSDLTDDSSLLVQAMELSGPR 622
F R D +DS A+ELSG R
Sbjct: 587 FERLQRRFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 283/527 (53%), Positives = 352/527 (66%)
Query: 111 GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170
G + ++ +L LQ L+L NN TGEIP LG L L + N++SG P+SL + +
Sbjct: 84 GELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKLGK 143
Query: 171 LIFLDLSYNNLSGPVPR-FSAKTFNIVGNPLICATGSEP-DCYGTQLMPMSMNLNS--SQ 226
L FL L N+LSG +PR +A +++ +G P + +Q MS N +
Sbjct: 144 LRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQFTSMSFANNKLRPR 203
Query: 227 TASPGRTRSH-KLSLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLG 285
ASP + S ++V G++ G L+F L WW +R+ Q F DV EV LG
Sbjct: 204 PASPSPSPSGTSAAIVVGVAAGAA----LLFAL-AWWLRRKLQGHFLDVPAEEDPEVYLG 258
Query: 286 NLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQ 345
+RF REL VAT FS +N+LGKG FGI+YKG L D T+VAVKRL + GGE+QFQ
Sbjct: 259 QFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQ 318
Query: 346 TEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKR 401
TEVEMIS+AVHRNLLRL GFCMTPTERLLVYPYM+NGSVAS L+ G P LDW RK
Sbjct: 319 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKH 378
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
IALG+ARGL YLH+ CD KIIH DVKAANILLD+ EAVVGDFGLAKL+++ DSHVTTAV
Sbjct: 379 IALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAV 438
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML-DWVKKI 520
RGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A + + AN ML DWVK++
Sbjct: 439 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEV 498
Query: 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERW 580
+EKKLE LVD +L+ Y E+E+++Q+ALLCTQ RPKMSEVVRMLEGDGLAERW
Sbjct: 499 LKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERW 558
Query: 581 EASQRAEATKSKPHEFSSSDRYSDLTDD-----SSLLVQAMELSGPR 622
E Q+ E H+F+ Y D S+ L++ SGPR
Sbjct: 559 EEWQKEEMPI---HDFNYQ-AYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RY65 | NIK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7645 | 0.9598 | 0.9401 | no | no |
| Q9LFS4 | NIK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7962 | 0.9935 | 0.9686 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.4247.1 | hypothetical protein (605 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 622 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 6e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-48
Identities = 70/191 (36%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+GGFG VY + G VA+K +K ++ + E+E++ H N+++LYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
LV Y GS+ LK L RI L GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 426 VKAANILLDDCC-EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTD 483
+K NILLD + + DFGL+KLL S + T + GT ++APE L SEK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 484 VFGFGILLLEL 494
++ G++L EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 25/273 (9%)
Query: 305 KNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G FG VYKG L+ VAVK LK+ + +F E ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCD 418
++L G C +V YM G + S L+ +P L S AL ARG+ YL +
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
IHRD+ A N L+ + + DFGL++ L D + + + +APE L G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 479 SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538
+ K+DV+ FG+LL E+ T G + + +L+++K ++ +
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKNGYRLPQPPNCPP------- 230
Query: 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
E+ + L C P RP SE+V +L
Sbjct: 231 ------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-47
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 26/272 (9%)
Query: 307 ILGKGGFGIVYKGILQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG VYKG L+ VAVK LK+ + +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDP 419
L G C ++V YM G + L+ L S AL ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
IHRD+ A N L+ + + DFGL++ L D + + + +APE L G+ +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
K+DV+ FG+LL E+ T G + + +L+++KK ++ K
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKKGYRLPKPPNCPP-------- 231
Query: 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
E+ ++ L C P RP SE+V +L
Sbjct: 232 -----ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-45
Identities = 89/290 (30%), Positives = 126/290 (43%), Gaps = 51/290 (17%)
Query: 306 NILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 360
LG+G FG VYKG L+ T VAVK LK+ + F E M L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLK---------GKPILDWSTRKRIALGAARGLL 411
RL G C LV YM G + L+ K L A+ A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI--- 468
YL + K +HRD+ A N L+ + + DFGL++ + D + G I
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
APE L G + K+DV+ FG+LL E+ T G A Y +N+ E
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLG--ATPYPGLSNE-----------------E 215
Query: 528 MLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+L + L+ Y R+ +E+ ++ L C Q P RP SE+V LE
Sbjct: 216 VL--EYLRKGY-RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+ LG+G FG VY + G +VA+K +K + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
RLY + LV Y G + LK + L + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
I+HRD+K NILLD+ + DFGLA+ LD +TT V GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 481 KTDVFGFGILLLELITGQ 498
D++ G++L EL+TG+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-44
Identities = 74/195 (37%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG VYK + G +VAVK L K + + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
LV Y G + L L K+IAL RGL YLH IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTD 483
D+K NILLD+ + DFGLAK L S +TT V GT ++APE L G K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 484 VFGFGILLLELITGQ 498
V+ G++L EL+TG+
Sbjct: 182 VWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 308 LGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
LG+G FG VYKG L T VAVK LK+G + +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKI 421
G C +V YM G + L+ L ++AL A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NF 123
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLSTG 476
+HRD+ A N L+ + + DFGL++ + D + ++ APE L G
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLKDG 179
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
+ + K+DV+ FG+LL E+ T G ++ + E +++ L++
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT------LG-------------EQPYPGMSNEEVLEL-LED 219
Query: 537 NYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRML 571
Y R+ +E+ ++ L C Y P RP SE+V L
Sbjct: 220 GY-RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 6e-43
Identities = 128/506 (25%), Positives = 248/506 (49%), Gaps = 54/506 (10%)
Query: 82 SQN-LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
S+N SG + +G+L+ L + L N ++G IP E+ KL +LDLS+N +G+IP+S
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIV 196
+ L + + N LSG P +L ++ L+ +++S+N+L G +P A +
Sbjct: 543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA 602
Query: 197 GNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGR--TRSHKLSLVFGLSVGCVSLIIL 254
GN +C +++ P + ++ ++G ++ L
Sbjct: 603 GNIDLCGG------------------DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLAL 644
Query: 255 VFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHN--FSSK---NILG 309
V F++ R R N ++K +E+ L+ F + + T N SS N++
Sbjct: 645 VAFGFVFIRGRNN----LELKRVENED-GTWELQFFDSKVSKSITINDILSSLKEENVIS 699
Query: 310 KGGFGIVYKG-ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368
+G G YKG +++G VK + D N+I +E+ + H N+++L G C +
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRS 754
Query: 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKA 428
L++ Y+ +++ L+ L W R++IA+G A+ L +LH +C P ++ ++
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 429 ANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 488
I++D E + L LL ++ ++APE T +EK+D++GFG
Sbjct: 812 EKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFG 865
Query: 489 ILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN--YDRIELEEM 546
++L+EL+TG+ + + G++++W + + + L+M +D ++ + ++ E+ E+
Sbjct: 866 LILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923
Query: 547 VQVALLCTQYLPAHRPKMSEVVRMLE 572
+ +AL CT P RP ++V++ LE
Sbjct: 924 MNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 306 NILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLY 363
+LG+G FG VY + +D G ++AVK ++ E+ + E+ ++S H N++R Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 364 GFCMTPTER-LLVY-PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G + L ++ Y+S GS++S LK L ++ GL YLH I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLL-DHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
+HRD+K ANIL+D + DFG AK L D + T +VRGT +APE + +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 481 KTDVFGFGILLLELITGQR 499
D++ G ++E+ TG+
Sbjct: 183 AADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 67/199 (33%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+GKGGFG VYK + G VA+K +K I EIQ + + H N+++
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNIVK 61
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPK 420
YG + E +V + S GS+ LK L S + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAK-LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
IIHRD+KAANILL E + DFGL+ L D + + GT +APE ++
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYD 175
Query: 480 EKTDVFGFGILLLELITGQ 498
K D++ GI +EL G+
Sbjct: 176 YKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 66/200 (33%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKD-GNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+GKG FG V G + G VAVK LKD A F E +++ H NL++L
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66
Query: 364 GFCMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G + +V YM+ GS+ R +G+ ++ + + AL G+ YL E+
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-RGTVGHIAPEYLSTGQSSE 480
+HRD+ A N+L+ + A V DFGLAK ++ + V APE L + S
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 481 KTDVFGFGILLLELITGQRA 500
K+DV+ FGILL E+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 358
N+ +++G+G FG+VYKG+ L+ G VA+K++ ++ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
+++ G T ++ Y NGS+ +K S +GL YLHEQ
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
+IHRD+KAANIL + DFG+A L+ S +V GT +APE + +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 479 SEKTDVFGFGILLLELITGQ 498
S +D++ G ++EL+TG
Sbjct: 177 STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 64/180 (35%), Positives = 92/180 (51%), Gaps = 28/180 (15%)
Query: 33 EVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPS 92
E++ L+ K S++DP L NW+ A D C W +TC+ S V+ + + +N+SG +S +
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSSA-DVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 93 IGNLTNLQIV-------------------------LLQNNNITGPIPAEIGRLTKLQTLD 127
I L +Q + L NNN TG IP G + L+TLD
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146
Query: 128 LSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
LSNN +GEIP+ +G SL+ + N L G P SL ++T L FL L+ N L G +PR
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-28
Identities = 81/278 (29%), Positives = 112/278 (40%), Gaps = 57/278 (20%)
Query: 33 EVQALMGVKHSLHDPHGVLENWDEDAVDPCS-----WTMVTCSPES-----LVIGLGIPS 82
EV AL +K SL P W+ D PC W+ C +S + GLG+ +
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
Q L G + I L +LQ + L N+I G IP +G +T L+ LDLS N F G IP SLG
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLIC 202
L SL+ + N NSLSG P +L + R S FN N +C
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALGGR---------------LLHRAS---FNFTDNAGLC 529
Query: 203 ATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWW 262
C P + K+ + FG+SV + LV WW
Sbjct: 530 GIPGLRAC------------------GPHLSVGAKIGIAFGVSVA---FLFLVICAMCWW 568
Query: 263 RQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATH 300
++R+N + E R R++Q+ H
Sbjct: 569 KRRQN---ILRAQRIAAREAPYAKARTHFSRDVQMTRH 603
|
Length = 623 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 79/282 (28%), Positives = 123/282 (43%), Gaps = 53/282 (18%)
Query: 308 LGKGGFGIVYKG-ILQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLYGF 365
+GKG FG VY DG + +K + N E + EV+++ H N+++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 366 CMTPTERLLVYPYMSNGSVASRLK-----GKP-----ILDWSTRKRIALGAARGLLYLHE 415
+ +V Y G ++ ++K GKP ILDW + + L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+ KI+HRD+K NI L +GDFG++K+L T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 476 GQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534
+ + K+D++ G +L EL T + E N L L K L
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---GEN-----------------LLELALKIL 216
Query: 535 KNNYDRI------ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
K Y I EL +V +LL P RP ++++++
Sbjct: 217 KGQYPPIPSQYSSELRNLVS-SLLQKD--PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 79/283 (27%), Positives = 117/283 (41%), Gaps = 25/283 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEI--QFQTEVE-MISLAVHR 357
++ LG+G FG VY +D +VA+K L + +F E++ + SL
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI---LDWSTRKRIALGAARGLLYLH 414
N+++LY F LV Y+ GS+ LK L S I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 415 EQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHV-----TTAVRGTVGHI 468
+ IIHRD+K NILLD D + DFGLAKLL S + GT G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 469 APEYL---STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
APE L S +S +D++ GI L EL+TG E K ++ L + ++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV 568
L + + + + P +R S +
Sbjct: 236 A-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 81/276 (29%), Positives = 128/276 (46%), Gaps = 32/276 (11%)
Query: 308 LGKGGFGIVYKGILQ--DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
LG G FG V KG+ G VAVK LK + G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
G C +LV G + LK + + S K +A A G+ YL + +H
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVH 118
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH--VTTAVRGTVGHIAPEYLSTGQSSEK 481
RD+ A N+LL + +A + DFG+++ L + TTA R + APE ++ G+ S K
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 482 TDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
+DV+ +G+ L E + G + YG+ KGA + + + ++L R
Sbjct: 179 SDVWSYGVTLWEAFSYGAKP--YGE---MKGA--EVIAMLESGERLP------------R 219
Query: 541 IEL--EEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574
E +E+ + L C +Y P RP SE+ D
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 43/282 (15%)
Query: 306 NILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
++G G FG V +G L+ VA+K LK G++ + F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCD 418
L G +++ YM NGS+ L+ GK + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 419 PKIIHRDVKAANILLDD--CCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPE 471
+HRD+ A NIL++ C+ V DFGL++ L+ ++ TT +R T APE
Sbjct: 127 --YVHRDLAARNILVNSNLVCK--VSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 472 YLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
++ + + +DV+ FGI++ E+++ G+R Y +NQ D +K + +L +
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQ-----DVIKAVEDGYRLPPPM 231
Query: 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
D + Q+ L C Q RP S++V L+
Sbjct: 232 DCP----------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 9/198 (4%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
F+ + LG G FG V++G+ ++ VA+K LK + + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCD 418
L+ C ++ M GS+ + L+ G+ +L ++ +A A G+ YL EQ
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
IHRD+ A NIL+ + V DFGLA+L+ +D ++++ + APE S G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 479 SEKTDVFGFGILLLELIT 496
S K+DV+ FGILL E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 361
N +G G FG VY + L G ++AVK R++D + EI E++++ L H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA--DEMKVLELLKHPNLVK 63
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
YG + + + Y S G++ L+ ILD + L GL YLH I
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG---HIAPEYLSTGQS 478
+HRD+K ANI LD +GDFG A L + + + V+ G ++APE ++ G+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 479 SEK---TDVFGFGILLLELITGQR 499
D++ G ++LE+ TG+R
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 82/269 (30%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 307 ILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+LGKG FG V+KG L+D T VAVK K+ +I+F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 367 MTPTERLLVYPYM---SNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
T+R +Y M G S L K K L + AL AA G+ YL + I
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRD+ A N L+ + + DFG+++ D + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DV+ +GILL E + Y NQ+ + EK M +
Sbjct: 176 DVWSYGILLWETFS-LGVCPYPGMTNQQA-------REQVEKGYRMSCPQKCP------- 220
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRML 571
+++ +V C Y P +RPK SE+ + L
Sbjct: 221 -DDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 4/192 (2%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G G+VYK + G + A+K++ Q E++ + +++ YG
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
E +V YM GS+A LK + IA +GL YLH IIHRD+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDI 126
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 486
K +N+L++ E + DFG++K+L++ T V GTV +++PE + S D++
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWS 185
Query: 487 FGILLLELITGQ 498
G+ LLE G+
Sbjct: 186 LGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG V+ G T VAVK LK G F E +++ H L++LY C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVC- 70
Query: 368 TPTERLLVY---PYMSNGSVASRLKGKPILDWSTRKRIALGA--ARGLLYLHEQCDPKII 422
+E +Y YMS GS+ LK + + + A A G+ YL + I
Sbjct: 71 --SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRD+ A NIL+ + + DFGLA+L++ + + + APE + G+ + K+
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 483 DVFGFGILLLELIT 496
DV+ FGILL E++T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 27/270 (10%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
+GKG FG VYKG+L+ T VAVK + + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+V + GS+ + L+ K L +++L AA G+ YL + IHRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDL 119
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT----VGHIAPEYLSTGQSSEKT 482
A N L+ + + DFG+++ ++ + T G + APE L+ G+ + ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DV+ +GILL E + Y +NQ+ E ++ + ++
Sbjct: 177 DVWSYGILLWETFSLG-DTPYPGMSNQQTR--------------ER-IESGYRMPAPQLC 220
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EE+ ++ L C Y P +RP SE+ L+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 307 ILGKGGFGIVYKGI-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+LG G FG VYKG+ + +G VA+K L++ + + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 362 LYGFCMTPTERLLVYPYMSNGSV-------ASRLKGKPILDWSTRKRIALGAARGLLYLH 414
L G C++ L+ M G + + + +L+W + A+G+ YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYL 473
E+ +++HRD+ A N+L+ + DFGLAKLLD + + + +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALE 502
+ K+DV+ +G+ + EL+T G + E
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG V++G+ + T VAVK LK G F E +++ H L++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA--ARGLLYLHEQCDPKIIHRD 425
+V M GS+ L+G + I + A A G+ YL Q IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 485
+ A N+L+ + V DFGLA+++ + + APE + S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 486 GFGILLLELITGQRALEYGK 505
FGILL E++T YG+
Sbjct: 189 SFGILLTEIVT------YGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 33/286 (11%)
Query: 306 NILGKGGFGIVYKG---ILQDGT--VVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHR 357
LG+G FG V L D T VAVK L N G E F+ E+E++ H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 358 NLLRLYGFCMTPTER--LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLH 414
N+++ G C P R L+ Y+ +GS+ L+ + ++ + +G+ YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT--VGHIAPEY 472
Q + IHRD+ A NIL++ + DFGLAK+L + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 473 LSTGQSSEKTDVFGFGILLLELITGQRALEYG-KAANQKGAMLDWVKKIHQEKKLEMLVD 531
L T + S +DV+ FG+ L EL T YG + + L + + + L++
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT------YGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 532 KDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
LK +R+ +E+ + LC + P RP ++++ +++
Sbjct: 238 L-LKEG-ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG V+ G T VA+K LK G+ F E ++ H L+RLY +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYA-VV 70
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA--ARGLLYLHEQCDPKIIHRD 425
T ++ YM NGS+ LK + + K I + A A G+ ++ + IHRD
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRD 127
Query: 426 VKAANILLDD--CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
++AANIL+ + CC+ + DFGLA+L++ + + + APE ++ G + K+D
Sbjct: 128 LRAANILVSETLCCK--IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 484 VFGFGILLLELITGQR 499
V+ FGILL E++T R
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 53/118 (44%), Positives = 73/118 (61%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
L + S L G + +G + +L+ + L NN++G IP EIG LT L LDL N TG I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNI 195
PSSLG+L++LQY+ N LSG P S+ S+ +LI LDLS N+LSG +P + N+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 359
F LG+G +G VYK I + G VVA+K + + ++Q E+ ++ +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYI 60
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIAL---GAARGLLYLH 414
++ YG T+ +V Y GSV+ ++ K + T + IA +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL----TEEEIAAILYQTLKGLEYLH 116
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTV-G---HIAP 470
K IHRD+KA NILL++ +A + DFG++ L T A R TV G +AP
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAP 168
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITG 497
E + + K D++ GI +E+ G
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 75/286 (26%), Positives = 142/286 (49%), Gaps = 30/286 (10%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
++ + + + ++G G FG V++GIL+ VA+K LK G F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 352 SLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL--GAARG 409
H N++RL G +++ YM NG++ L+ ++S+ + + + G A G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAG 119
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGH 467
+ YL D +HRD+ A NIL++ E V DFGL+++L D + ++ T+ + +
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKL 526
APE ++ + + +DV+ FGI++ E+++ G+R Y +N + +K I+ +L
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP--YWDMSNH-----EVMKAINDGFRL 229
Query: 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+D + Q+ L C Q A RP+ ++V +L+
Sbjct: 230 PAPMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 306 NILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
++GKG FG VY G L D AVK L + QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 362 LYGFCMTPTE--RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALG--AARGLLYLHEQC 417
L G C+ P+E L+V PYM +G + + ++ + + + I G A+G+ YL +
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAK-LLDHQ--DSHVTTAVRGTVGHIAPEYLS 474
K +HRD+ A N +LD+ V DFGLA+ + D + H T + V +A E L
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 475 TGQSSEKTDVFGFGILLLELIT 496
T + + K+DV+ FG+LL EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 8/191 (4%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
+G G FG+V+ G + VA+K +++G E F E +++ H L++LYG C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 368 TPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+ LV+ +M +G ++ L+ + T + L G+ YL +IHRD+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 427 KAANILLDDCCEAVVGDFGLAKL-LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 485
A N L+ + V DFG+ + LD Q + +T + V +PE S + S K+DV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 486 GFGILLLELIT 496
FG+L+ E+ +
Sbjct: 186 SFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 67/195 (34%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLY 363
+GKG FG VYK I + VVA+K L++ EI+ Q E++ +S + + Y
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED---EIEDIQQEIQFLSQCRSPYITKYY 65
Query: 364 GFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
G +L ++ Y GS LK LD + I GL YLHE+ I
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRD+KAANILL + + + DFG++ L S T V GT +APE + EK
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKA 179
Query: 483 DVFGFGILLLELITG 497
D++ GI +EL G
Sbjct: 180 DIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 86/273 (31%), Positives = 119/273 (43%), Gaps = 29/273 (10%)
Query: 308 LGKGGFGIVYKGILQD--GTV--VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRL 362
LG G FG+V +G G V VAVK LK F E M SL H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
YG +T ++V GS+ RL+ ST A+ A G+ YL + +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTV--GHIAPEYLSTGQS 478
IHRD+ A NILL + +GDFGL + L + H V APE L T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 479 SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538
S +DV+ FG+ L E+ T YG+ + +KKI +K+ E L +
Sbjct: 178 SHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKKI--DKEGERLERPEACP-- 227
Query: 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
+++ V L C + PA RP + + L
Sbjct: 228 -----QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFC 366
LG G FG V+ G + T VAVK LK G +Q F E ++ H L+RLY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 367 MTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGA--ARGLLYLHEQCDPK 420
++ YM+ GS+ LK GK +L K I A A G+ Y+ +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK---N 123
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IHRD++AAN+L+ + + DFGLA++++ + + + APE ++ G +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 481 KTDVFGFGILLLELITGQRALEYGK 505
K+DV+ FGILL E++T YGK
Sbjct: 184 KSDVWSFGILLYEIVT------YGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 70/229 (30%), Positives = 113/229 (49%), Gaps = 25/229 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHR 357
+F N +GKG FG+V+K + + D V A+K+ L N E E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLK---GKPILD---WSTRKRIALGAARGLL 411
++R Y + + +V Y NG + LK G+P+ + W R + GL
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
+LH + KI+HRD+K+ N+ LD +GD G+AKLL + T V GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520
+EK+DV+ G++L E TG+ + AN +GA+ + KI
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL---ILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 9e-22
Identities = 63/195 (32%), Positives = 88/195 (45%), Gaps = 9/195 (4%)
Query: 308 LGKGGFGIVYK-GILQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYG 364
LGKG FG V G + A+K LK I TE ++S H +++L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 365 FCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ E+L LV Y G + S L + + A L YLH II+
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIY 116
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RD+K NILLD + DFGLAK L + S T GT ++APE L + D
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVD 175
Query: 484 VFGFGILLLELITGQ 498
+ G+LL E++TG+
Sbjct: 176 WWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-21
Identities = 45/112 (40%), Positives = 68/112 (60%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
NL+G + S+GNL NLQ + L N ++GPIP I L KL +LDLS+N +GEIP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNI 195
L++L+ + +N+ +G P +L S+ +L L L N SG +P+ K N+
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 36/282 (12%)
Query: 308 LGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG+VY+G+ + T VA+K + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGK-------PILDWSTRKRI---ALGAARGLL 411
L G T L+V M+ G + S L+ + P L T ++ A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAP 470
YL + K +HRD+ A N ++ + +GDFG+ + + D + V +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
E L G + K+DV+ FG++L E+ T Y +N E+ L+ ++
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT-LAEQPYQGLSN--------------EEVLKFVI 235
Query: 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
D + + ++++++ +C QY P RP E+V L+
Sbjct: 236 DGGHLDLPENCP-DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 45/277 (16%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEI--QFQTEVEMISLAVHRNLLRL 362
LG G FG VY+G+ L DG AVK L D G E Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 363 YGFCMTPTERLLVY-PYMSNGSVASRLKG-----KPILDWSTRKRIALGAARGLLYLHEQ 416
G + L ++ + GS+A LK +P++ TR+ + GL YLH++
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL-ST 475
+HRD+K ANIL+D + DFG+AK + + +G+ +APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQ 176
Query: 476 GQSSEKTDVFGFGILLLELITGQ---RALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
G D++ G +LE+ TG+ LE A+ KI + K+L + D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVF----KIGRSKELPPIPD- 225
Query: 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
L + E ++ + L C Q P+ RP +E++
Sbjct: 226 HLSD-----EAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 30/269 (11%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG+V+ G + VA+K +++G E F E +++ H NL++LYG C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 368 TPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+V YM+NG + + L+ + L + + YL IHRD+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 427 KAANILLDDCCEAVVGDFGLAK-LLDHQDSHVTTAVRGT---VGHIAPEYLSTGQSSEKT 482
A N L+ + V DFGLA+ +LD Q T+ +GT V PE + S K+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
DV+ FG+L+ E+ + + + Y + +N + V+ + +L ++
Sbjct: 183 DVWSFGVLMWEVFSEGK-MPYERFSN-----SEVVESVSAGYRLYR----------PKLA 226
Query: 543 LEEMVQVALLCTQYLPAHRPKMSEVVRML 571
E+ + C P RP +++ L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 83/273 (30%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLY 363
++G G +VY I L + VA+KR+ D + + EV+ +S H N+++ Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ E LV PY+S GS+ +K LD + + +GL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGL-AKLLDHQD--SHVTTAVRGTVGHIAPEYLSTGQ 477
IHRD+KA NILL + + DFG+ A L D D V GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 478 S-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
K D++ FGI +EL TG A Y K K ML Q + D K
Sbjct: 183 GYDFKADIWSFGITAIELATG--AAPYSKYPPMKVLML-----TLQNDPPSLETGADYK- 234
Query: 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
Y + +M+ LC Q P+ RP E+++
Sbjct: 235 KYSK-SFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 41/102 (40%), Positives = 64/102 (62%)
Query: 85 LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHL 144
LSG + IG+ ++L+++ L N + G IP + LT L+ L L++N G+IP LG +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+SL+++ N+LSG P + +T L LDL YNNL+GP+P
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKR--LKDGNAIGGEIQF---QTEVEMISLAVHRNLL 360
+LGKG +G VY G+ G ++AVK+ L N + E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAARGLLYLHE 415
+ G C+ + ++ GS++S L +P+ T++ + G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT-----TAVRGTVGHIAP 470
C ++HRD+K N++L + DFG A+ L H T ++ GT +AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQ 498
E ++ K+D++ G + E+ TG+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 306 NILGKGGFGIVYKG----ILQDGT---VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
N LG G FG VY+G IL G+ VAVK L+ G + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLK-------GKPILDWSTRKRIALGAARGLL 411
+++L G C+ + ++ M G + S L+ G P+L I L A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 412 YLHEQCDPKIIHRDVKAANILL---DDCCEAVV--GDFGLAKLLDHQDSHVTTAVRG--- 463
YL IHRD+ A N L+ + VV GDFGLA+ + D + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 464 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
V +APE L G+ + ++DV+ FG+L+ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLK------DGNAIGGEIQFQTEVEMISLAVHRNL 359
++G+G +G VY+G + G VVA+K + D + I E+ ++ + + N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL----YLHE 415
+ YG + ++ Y GSV + +K PI K I++ R +L Y+H+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI----AEKYISV-IIREVLVALKYIHK 119
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+IHRD+KAANIL+ + + DFG+A LL+ S +T V GT +APE ++
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 476 GQSSE-KTDVFGFGILLLELITG 497
G+ + K D++ GI + E+ TG
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 307 ILGKGGFGIVYKGIL-QDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLR 361
ILG+G FG V +G L QD VAVK +K EI+ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 362 LYGFCMTPTER------LLVYPYMSNGSV-----ASRLKGKPI-LDWSTRKRIALGAARG 409
L G C + +++ P+M +G + SRL G P L T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT-AVRGTVGHI 468
+ YL + IHRD+ A N +L + V DFGL+K + D + + V I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
A E L+ + K+DV+ FG+ + E+ T GQ Y N + + D+++ ++ K+ E
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHE--IYDYLRHGNRLKQPE 238
Query: 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L+E+ + C + P RP +++ +LE
Sbjct: 239 DC-------------LDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 11/214 (5%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG+G FG V+ G T VA+K LK G F E +++ H L++LY +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYA-VV 70
Query: 368 TPTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
+ +V YMS GS+ LKG+ L +A A G+ Y+ +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD 127
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 485
++AANIL+ + V DFGLA+L++ + + + APE G+ + K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 486 GFGILLLELITGQRALEYGKAANQKGAMLDWVKK 519
FGILL EL T R + Y N++ +LD V++
Sbjct: 188 SFGILLTELTTKGR-VPYPGMVNRE--VLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 85/284 (29%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 308 LGKGGFGIVYK---GILQDGT--VVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLR 361
LGKG FG V LQD T VVAVK+L+ A ++ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVK 69
Query: 362 LYGFCMTPTER--LLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCD 418
G C + R LV Y+ GS+ L K + LD A +G+ YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLSTG 476
+ +HRD+ NIL++ +GDFGL K+L D + V + APE L+
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV---DKD 533
+ S +DV+ FG++L EL T Y + A +++ + +K+ +M+V +
Sbjct: 187 KFSVASDVWSFGVVLYELFT------YSDKSCSPPAE--FMRMMGNDKQGQMIVYHLIEL 238
Query: 534 LKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
LKNN R+ E+ + C P+ RP SE+ +E
Sbjct: 239 LKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRL--------KDGNAIGGEIQ-FQTEVEMISLAVH 356
++GKG +G VY + + G ++AVK++ + + ++ ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
N+++ GF T + Y+ GS+ S L+ + + GL YLH +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLST 475
I+HRD+KA N+L+D + DFG++K D D+ +++G+V +APE + +
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 476 GQS--SEKTDVFGFGILLLELITGQR 499
S K D++ G ++LE+ G+R
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 308 LGKGGFGIVYKG-ILQDGTVVAVKRLKDGNAIGGEIQFQ--TEVEMISLAVHRNLLRLYG 364
LG G G+V K G ++AVK ++ I IQ Q E++++ ++ YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ + YM GS+ LK I + +IA+ +GL YLHE+ KII
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHEKH--KII 123
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRDVK +NIL++ + + DFG++ L +S T V GT ++APE + S K+
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKS 180
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523
D++ G+ L+EL TG+ Y + + + ++ I E
Sbjct: 181 DIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQYIVNE 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 16/216 (7%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLY 363
+GKG FG V K DG ++ K + GN E Q +EV ++ H N++R Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 364 GFCMTPTERLLVYPYM---SNGSVASRL----KGKPILDWSTRKRIALGAARGLLYLH-- 414
+ + + L Y M G +A + K + ++ RI L H
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
++HRD+K ANI LD +GDFGLAK+L H S T V GT +++PE L+
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK 510
EK+D++ G L+ EL A NQ
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 36/233 (15%)
Query: 297 VATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEM 350
V K LG+G FG V+ G D +VAVK LK+ + F+ E E+
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV----------ASRLKGKPI----LDW 396
++ H N+++ YG C ++V+ YM +G + A+ LK L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 397 STRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
S +IA+ A G++YL Q +HRD+ N L+ +GDFG+++ + D +
Sbjct: 122 SQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 457 VTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGK 505
V G + + PE + + + ++DV+ FG++L E+ T YGK
Sbjct: 179 ---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------YGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G +G VYK + G +VA+K +L+ G+ Q E+ M+ H N++ +G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE---IIQQEISMLKECRHPNIVAYFG 67
Query: 365 FCMTPTERLLVYPYMSNGSVA---SRLKGKPILDWSTRKRIAL---GAARGLLYLHEQCD 418
+ + +V Y GS+ +G P+ + +IA +GL YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRG-PL----SELQIAYVCRETLKGLAYLHET-- 120
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL---ST 475
IHRD+K ANILL + + + DFG++ L + + + GT +APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 476 GQSSEKTDVFGFGILLLELITGQ 498
G K D++ GI +EL Q
Sbjct: 179 GGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 66/195 (33%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG V+ G T VAVK LK G F E +++ H L++LY +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYA-VV 70
Query: 368 TPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ +V YMS GS+ LK G+ L +A A G+ Y+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHR 126
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D+++ANIL+ D + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 485 FGFGILLLELITGQR 499
+ FGILL EL+T R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 307 ILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGE-IQFQTEVEMI-SLAVHRN 358
LG+G FG V K + VAVK LKD +A + +E+EM+ + H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKG--------KPILDWSTRKRI-------- 402
++ L G C +V Y ++G++ L+ P + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461
A ARG+ +L + K IHRD+ A N+L+ + + DFGLA+ + H D + TT
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 305 KNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
K+ LG G +G VY+G+ + VAVK LK+ E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G C ++ +M+ G++ L+ + ++ +A + + YL ++
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
IHRD+ A N L+ + V DFGL++L+ + + APE L+ + S K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 482 TDVFGFGILLLELIT 496
+DV+ FG+LL E+ T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRL---KDGNAIGGEI-QFQTEVEMISLAV 355
N+ +LG+G FG VY D G +AVK++ D E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 356 HRNLLRLYGFCMTPTERLLVY-PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
H +++ YG C+ E L ++ YM GSV +LK L + ++ G+ YLH
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTVGHIAPEY 472
I+HRD+K ANIL D +GDFG +K L S T +V GT ++PE
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 473 LSTGQSSEKTDVFGFGILLLELIT 496
+S K DV+ G ++E++T
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 80/274 (29%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 360
F+ +GKG FG V+KGI V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ YG + T+ ++ Y+ GS L+ P LD + I +GL YLH + K
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 121
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLA-KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
IHRD+KAAN+LL + E + DFG+A +L D Q GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYD 179
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD----LK 535
K D++ GI +EL G+ ++H K L L+ K+ L+
Sbjct: 180 SKADIWSLGITAIELAKGEPPHS----------------ELHPMKVL-FLIPKNNPPTLE 222
Query: 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
NY + L+E V+ C P+ RP E+++
Sbjct: 223 GNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 51/300 (17%)
Query: 305 KNILGKGGFGIVYKG------ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
K LG+G FG V+ +D +VAVK LKD + FQ E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEH 68
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLK-----------GKPI-----LDWSTRKRI 402
+++ YG C ++V+ YM +G + L+ G+P L S I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-----SHV 457
A A G++YL Q +HRD+ N L+ +GDFG+++ + D H
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517
+R + PE + + + ++DV+ FG++L E+ T YGK + + + +
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVI 235
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLA 577
+ I Q + LE R+ +E+ + L C Q P R + E+ ++L G A
Sbjct: 236 ECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 359
+ +G+G +G VYK + G +VA+K+++ + G I E++++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 360 LRLYGFCMTPTERL-----LVYPYMSN--GSVASRLKGKPILDWSTRKRIALGAARGLLY 412
+RL T + +V+ YM + + + K S K GL Y
Sbjct: 61 VRLKEIV---TSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQLLEGLQY 115
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
LH I+HRD+K +NIL+++ + DFGLA+ ++S T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 473 L--STGQSSEKTDVFGFGILLLELITG 497
L +T + + D++ G +L EL G
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G+G FG V+ G L+ D T VAVK ++ + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 367 MTPTERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
+V + G + L+ + P L ++ AA G+ YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT----VGHIAPEYLSTGQSSEK 481
+ A N L+ + + DFG+++ ++ V + G V APE L+ G+ S +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541
+DV+ FGILL E + A+ Y +NQ+ + E+ + + +
Sbjct: 177 SDVWSFGILLWEAFS-LGAVPYANLSNQQ-------TREAIEQGVRLPCPELCP------ 222
Query: 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
+ + ++ C +Y P RP S V + L
Sbjct: 223 --DAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 40/102 (39%), Positives = 63/102 (61%)
Query: 85 LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHL 144
L G + S+ NLT+L+ + L +N + G IP E+G++ L+ + L N +GEIP +G L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
SL ++ N+L+G P+SL ++ L +L L N LSGP+P
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVH 356
+ + +G+G G VYK G VA+K+++ I EI M H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILI-----MKDC-KH 74
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRK-------RIALGAARG 409
N++ Y + E +V YM GS+ I+ + + + +G
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTD------IITQNFVRMNEPQIAYVCREVLQG 128
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
L YLH Q +IHRD+K+ NILL + DFG A L + S + V GT +A
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMA 184
Query: 470 PEYLSTGQSSEKTDVFGFGILLLELITGQ 498
PE + K D++ GI+ +E+ G+
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 360
F+ +GKG FG VYKGI V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
R YG + T+ ++ Y+ GS LK P L+ + I +GL YLH + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE---R 121
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IHRD+KAAN+LL + + + DFG+A L T V GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 481 KTDVFGFGILLLELITGQ 498
K D++ GI +EL G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 308 LGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG+VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLK----------GKPILDWSTRKRIALGAARGLL 411
L G L+V M++G + S L+ G+P ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG--TVGHIA 469
YL+ + K +HRD+ A N ++ +GDFG+ + + D + +G V +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 189
Query: 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529
PE L G + +D++ FG++L E+ + A Q + + E+ L+ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 234
Query: 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574
+D + D E + + +C Q+ P RP E+V +L+ D
Sbjct: 235 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 29/206 (14%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+LG G FG VYKGI + +G V A+K L + ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 362 LYGFCMTPTERL----------LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
L G C++PT +L L Y + ++ S+L +L+W + A+G++
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQ------IAKGMM 123
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD-HQDSHVTTAVRGTVGHIAP 470
YL E+ +++HRD+ A N+L+ + DFGLA+LL+ + + + + +A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 471 EYLSTGQSSEKTDVFGFGILLLELIT 496
E + + + ++DV+ +G+ + EL+T
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 307 ILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
++G G FG V +G L+ VA+K LK G F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGK----PILDWSTRKRIALGAARGLLYLHEQCD 418
G +++ +M NG++ S L+ ++ R G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGT--VGHIAPEYLS 474
+HRD+ A NIL++ V DFGL++ L D D T+++ G + APE ++
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 475 TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
+ + +DV+ +GI++ E+++ G+R Y +NQ D + I Q+ +L +D
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVINAIEQDYRLPPPMDCP 237
Query: 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ Q+ L C Q RPK ++V L+
Sbjct: 238 ----------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 43/104 (41%), Positives = 59/104 (56%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
NLSG + IG LT+L + L NN+TGPIP+ +G L LQ L L N +G IP S+
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
L+ L + ++NSLSG P + + L L L NN +G +P
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 65/195 (33%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG+G FG V+ G T VA+K LK G + F E +++ H L+ LY +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE--AFLQEAQIMKKLRHDKLVPLYA-VV 70
Query: 368 TPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ +V +M GS+ LK GK L +A A G+ Y+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D++AANIL+ D + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 485 FGFGILLLELITGQR 499
+ FGILL EL+T R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRL-Y 363
LGKGGFG V ++ G + A K+L K GE E +++ R ++ L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
F T + LV M+ G + + G+P + A GL +LH++ +I
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
++RD+K N+LLDD + D GLA ++ + GT G++APE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 482 TDVFGFGILLLELITGQ 498
D F G L E+I G+
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 307 ILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
++G G FG V G L+ VA+K LK G F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL--GAARGLLYLHEQCDPK 420
G ++V YM NGS+ + L+ K ++ + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
+HRD+ A NIL++ V DFGL+++L D + ++ T + + APE ++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 479 SEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
+ +DV+ +GI++ E+++ G+R Y + +NQ D +K I + +L +D
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERP--YWEMSNQ-----DVIKAIEEGYRLPAPMDCPAA-- 237
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ Q+ L C Q RPK ++V +L+
Sbjct: 238 --------LHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 28/269 (10%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG V+ T VAVK +K G+ F E ++ H L++L+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA-VV 70
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA--ARGLLYLHEQCDPKIIHRD 425
T ++ +M+ GS+ LK K I A A G+ ++ ++ IHRD
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 485
++AANIL+ + DFGLA++++ + + + APE ++ G + K+DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 486 GFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-- 543
FGILL+E++T YG+ + + ++ + + ++ R E
Sbjct: 188 SFGILLMEIVT------YGRIPYPGMSNPEVIRALERGYRMP------------RPENCP 229
Query: 544 EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EE+ + + C + P RP + +L+
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG+V+ G + VA+K + +G E F E +++ H L++LYG C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR----GLLYLHEQCDPKIIH 423
+V +M NG + + L+ + K + L + G+ YL IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 424 RDVKAANILLDDCCEAVVGDFGLAK-LLDHQDSHVTTA-VRGTVGHIAPEYLSTGQSSEK 481
RD+ A N L+ V DFG+ + +LD D + +++ + V PE + + S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541
+DV+ FG+L+ E+ T GK +K + + V+ I + +L R
Sbjct: 182 SDVWSFGVLMWEVFT------EGKMPFEKKSNYEVVEMISRGFRLY------------RP 223
Query: 542 ELEEMV--QVALLCTQYLPAHRPKMSEVVRML 571
+L M +V C P RP +E++R +
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 359
F+ +GKG FG V+KGI + VVA+K + D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+ YG + T+ ++ Y+ GS L+ P ++ + +GL YLH +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSE--- 120
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLA-KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
K IHRD+KAAN+LL + + + DFG+A +L D Q T GT +APE +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAY 178
Query: 479 SEKTDVFGFGILLLELITGQ 498
K D++ GI +EL G+
Sbjct: 179 DSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-17
Identities = 44/113 (38%), Positives = 65/113 (57%), Gaps = 1/113 (0%)
Query: 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133
LV L I + NL G ++ ++ +LQ++ L N G +P G +L+ LDLS N F
Sbjct: 429 LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQF 487
Query: 134 TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+G +P LG L L ++ + N LSG P L+S +L+ LDLS+N LSG +P
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 51/285 (17%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLYG- 364
+G+G FG V K + + GT++AVKR++ + + +++++ + +++ YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 365 --------FCM----TPTERLLVYPYMS-NGSVASRLKGKPILDWSTRKRIALGAARGLL 411
CM ++ Y Y + + GK IA+ + L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK----------IAVATVKALN 121
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
YL E + KIIHRDVK +NILLD + DFG++ L DS T G ++APE
Sbjct: 122 YLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPE 177
Query: 472 YLSTGQSSE---KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528
+ ++DV+ GI L E+ TG+ Y K W Q L
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGK--FPYPK----------WNSVFDQ---LTQ 222
Query: 529 LVDKD---LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+V D L N+ +R V LC + RPK E++
Sbjct: 223 VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG+V G + VA+K +K+G+ E +F E +++ H L++LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALG--------AARGLLYLHEQCDP 419
+V YMSNG + + L+ KR G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR-------EHGKRFQPSQLLEMCKDVCEGMAYLESK--- 119
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAK--LLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+ IHRD+ A N L+DD V DFGL++ L D S V + + V PE L +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLLYSK 177
Query: 478 SSEKTDVFGFGILLLELIT 496
S K+DV+ FG+L+ E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 355
N+ +LG+G FG VY D G +AVK+++ + E+ + E++++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 356 HRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
H +++ YG P ER L +M GS+ +LK L + ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTVGHIAPE 471
H I+HRD+K ANIL D +GDFG +K L T +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 472 YLSTGQSSEKTDVFGFGILLLELIT 496
+S K D++ G ++E++T
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQ-------FQTEVEMISLAVHR 357
++G G FG VY G+ G ++AVK+++ + + + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
N+++ G + + Y+ GSVA+ L + + + +GL YLH +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT-----AVRGTVGHIAPEY 472
IIHRD+K ANIL+D+ + DFG++K L+ T +++G+V +APE
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 473 LSTGQSSEKTDVFGFGILLLELITG 497
+ + K D++ G L++E++TG
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 307 ILGKGGFGIVYKGILQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
I+G+G FG V +G G VAVK +K D A F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 366 CMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ +V MS G++ + R +G+ ++ + +L A G+ YL + K++H
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RD+ A NIL+ + A V DFGLA++ S + V APE L + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 484 VFGFGILLLELITGQRA 500
V+ +G+LL E+ + RA
Sbjct: 180 VWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 307 ILGKGGFGIVYKGI------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
LG+G FG V K T VAVK LK+ + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLK----------------GKPILDWSTRKRIAL 404
+LYG C LL+ Y GS+ S L+ LD + + +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 405 G--------AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
G +RG+ YL E K++HRD+ A N+L+ + + + DFGL++ + +DS+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 457 VTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
V + R V +A E L + ++DV+ FG+LL E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 355
N+ +LG+G FG VY D G +AVK++ D E+ + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 356 HRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
H +++ YG P E+ L YM GS+ +LK L + +R +G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD--HQDSHVTTAVRGTVGHIAPE 471
H I+HRD+K ANIL D +GDFG +K + +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 472 YLSTGQSSEKTDVFGFGILLLELIT 496
+S K DV+ ++E++T
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMIS-LAV 355
+F I+G+G F V + A+K L I + E E+++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 356 HRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
H +++LY + E L V Y NG + ++ LD + A L YLH
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR------------ 462
+ IIHRD+K NILLD + DFG AK+LD S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 463 -------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
GT +++PE L+ + + +D++ G ++ +++TG+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 307 ILGKGGFGIVYKGILQD---GTVVAVKRLK--DGNAIGGEIQFQT---EVEMISLAVHRN 358
LG G F Y+ +D GT++AVK++ + E + E+ +++ H +
Sbjct: 7 QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
++R+ G + L +M+ GSV+ L + RGL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 419 PKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTA------VRGTVGHIAPE 471
+IIHRDVK AN+L+D + + + DFG A L + T A + GT+ +APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQ 498
L Q DV+ G +++E+ T +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 29/271 (10%)
Query: 307 ILGKGGFG--IVYKGILQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
+LGKG FG +Y+ +D ++V K L + E+ ++SL H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAY 64
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL--GAARGLLYLHEQCDPK 420
Y M L+ Y + G++ ++ + + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
I+HRD+K NI L +GDFG++K+L + S T V GT +++PE + +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
K+D++ G +L EL+T +R + A N L+ V KI Q +V Y
Sbjct: 181 KSDIWALGCVLYELLTLKRTFD---ATNP----LNLVVKIVQ-GNYTPVVSV-----YS- 226
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
E++ + Q P RP EV+
Sbjct: 227 ---SELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI-SLAVHRN 358
F ++G+G +G VYK + G +VA+K + + I E + + E ++ + H N
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 359 LLRLYG--FCMTPT----ERLLVYPYMSNGSVASRLKGKPILDWSTRKR------IALGA 406
+ YG P + LV GSV +KG + R + I
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--LRKKGKRLKEEWIAYILRET 122
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
RGL YLHE K+IHRD+K NILL E + DFG++ LD T + GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPY 178
Query: 467 HIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 498
+APE ++ + + + DV+ GI +EL G+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 308 LGKGGFGIVYKGIL-QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLY 363
LG+G FG V +G L QD ++ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 364 GFCMTPTER------LLVYPYMSNGSVAS-----RLKGKPI-LDWSTRKRIALGAARGLL 411
G C+ E +++ P+M +G + S RL P L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-RGTVGHIAP 470
YL + IHRD+ A N +L++ V DFGL+K + + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 471 EYLSTGQSSEKTDVFGFGILLLELIT-GQ 498
E L+ + K+DV+ FG+ + E+ T GQ
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 307 ILGKGGFGIVYKGILQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
+GKG FG V G + G VAVK +K D A F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 366 CMTPTERL-LVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ L +V YM+ GS+ R +G+ +L + +L + YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRD+ A N+L+ + A V DFGL K + S + V APE L + S K+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 483 DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
DV+ FGILL E+ + +G+ + + D V ++ + K++
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 219
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 64/308 (20%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGIL--QDGTV----VAVKRLKDGNAIGGEIQFQTEVE 349
+V + + LG G FG VY+G+ +DG VAVK L + + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKR------I 402
++S H+N++RL G R ++ M+ G + S L+ +P + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE-----AVVGDFGLAKLLDHQDSHV 457
A A+G YL E IHRD+ A N LL C+ A + DFG+A+ D +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR-----DIYR 171
Query: 458 TTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG 511
+ R + + PE G + KTDV+ FG+LL E+ + L Y +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMPYPGR-- 225
Query: 512 AMLDWVKKIHQEKKLEMLVD-------KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKM 564
++ +E + K RI M C Q+ P RP
Sbjct: 226 ---------TNQEVMEFVTGGGRLDPPKGCPGPVYRI----MTD----CWQHTPEDRPNF 268
Query: 565 SEVVRMLE 572
+ ++ ++
Sbjct: 269 ATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 5e-16
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL---AVHR 357
+ LG+G +G+VYK + G +VA+K+++ N G I T + ISL H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IP-STALREISLLKELKHP 58
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQ 416
N+++L T + LV+ Y + L +P L + K I RGL Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----RGTVGHIAPE 471
+I+HRD+K NIL++ + DFGLA+ T V R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 472 YL--STGQSSEKTDVFGFGILLLELITGQ 498
L S S+ D++ G + E+ITG+
Sbjct: 169 ILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 48/301 (15%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE 349
+ HN K LG+G FG V+ QD +VAVK LKD + F E E
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAE 59
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-----------GKPI--LDW 396
+++ H ++++ YG C+ ++V+ YM +G + L+ G L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 397 STRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-- 454
S IA A G++YL Q +HRD+ N L+ + +GDFG+++ + D
Sbjct: 120 SQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 455 ---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG 511
H +R + PE + + + ++DV+ G++L E+ T YGK +
Sbjct: 177 RVGGHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT------YGKQPWYQL 226
Query: 512 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
+ + ++ I Q + L+ R +E+ + L C Q P R + E+ +L
Sbjct: 227 SNNEVIECITQGRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
Query: 572 E 572
+
Sbjct: 277 Q 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-16
Identities = 44/105 (41%), Positives = 63/105 (60%), Gaps = 1/105 (0%)
Query: 83 QN-LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
QN LSG + PSI +L L + L +N+++G IP + +L L+ L L +N FTG+IP +L
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
L LQ ++ +N SG P +L L LDLS NNL+G +P
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 308 LGKGGFGIVYK----GILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 358
LG+G FG V GI +D VAVK LKD +E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWS-----------TRKRI--- 402
++ L G C ++ Y S G++ L+ + P +D+S T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461
A ARG+ YL Q K IHRD+ A N+L+ + + DFGLA+ + + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 306 NILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+ LG+G G V K L G + A+K + + Q E+E+ +++ YG
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 365 FCMTPTERLL--VYPYMSNGSVAS----------RLKGKPILDWSTRKRIALGAARGLLY 412
+ + + Y GS+ S R+ K + +IA +GL Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESVLKGLSY 120
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA-KLLDHQDSHVTTAVRGTVGHIAPE 471
LH + KIIHRD+K +NILL + + DFG++ +L++ T GT ++APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE 173
Query: 472 YLSTGQSSEKTDVFGFGILLLEL 494
+ S +DV+ G+ LLE+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 308 LGKGGFGIVYK-GILQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLYG 364
+G+G GIV+K + G VA+K++ GG I Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHPYVVKLLD 66
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ +LV YM ++ L+ +P+ + K +G+ Y+H I+
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV-KSYMRMLLKGVAYMHAN---GIM 121
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEK 481
HRD+K AN+L+ + DFGLA+L ++ + + T + APE L +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 482 TDVFGFGILLLELITGQ 498
D++ G + EL+ G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 308 LGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG VYKG L T VA+K LK+ + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRL----------------KGKPILDWSTRKRIALG 405
L G C +++ Y+++G + L K LD S IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-----SHVTTA 460
A G+ YL +HRD+ A N L+ + + DFGL++ + D S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 494
VR + PE + G+ + ++D++ FG++L E+
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 43/126 (34%), Positives = 61/126 (48%), Gaps = 24/126 (19%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG------ 135
S N +G + ++ +L LQ++ L +N +G IP +G+ L LDLS N TG
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 136 ------------------EIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177
EIP SLG RSL+ +R +NS SG P+ + + FLD+S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 178 YNNLSG 183
NNL G
Sbjct: 437 NNNLQG 442
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 308 LGKGGFGIVYKGIL------QDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G FG K L DGT +VAVK LK ++ E+ ++ H N+
Sbjct: 12 LGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++ G C + L+ Y+ GS+ L K L+ + A G+ YLH Q
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLST 475
IHRD+ A N+LLD+ +GDFGLAK + H+ V V A E L
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 476 GQSSEKTDVFGFGILLLELIT 496
+ S +DV+ FG+ L EL+T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 307 ILGKGGFGIVY----KGILQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
LG+G FG V+ KGI ++G T+V VK L+ + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 361 RLYGFCMTPTERLLVYPY----------MSNGSVASRLKGKPILDWSTRKRIALGA--AR 408
RL G C ++ Y + S +LK P+ ST++++AL A
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL---STKQKVALCTQIAL 128
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
G+ +L + +HRD+ A N L+ E V L+K + + + + + +
Sbjct: 129 GMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528
APE + S K+DV+ FG+L+ E+ T Q L + +++ + + ++ Q KLE+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-----EVLNRL-QAGKLEL 238
Query: 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
V + + ++ C P RP SE+V L
Sbjct: 239 PVPEGCPSRLYKLMTR--------CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 355
N+ +LG+G FG VY D G +A K+++ + E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 356 HRNLLRLYGFCMTPTERLLV--YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
H +++ YG E+ L YM GSV +LK L S ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH--QDSHVTTAVRGTVGHIAPE 471
H I+HRD+K ANIL D +GDFG +K L +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 472 YLSTGQSSEKTDVFGFGILLLELIT 496
+S K DV+ G ++E++T
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 43/280 (15%)
Query: 301 NFSSKNILGKGGFGIVYK-GILQDGTVVAVKRLKDGNAIGGEIQFQ-TEVEMISLAVHRN 358
+F LGKG +G VYK L D A+K + G+ E + E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVA-----SRLKGKPI---LDWSTRKRIALGAARGL 410
++ + + +V Y G ++ + K K I W RI + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
LHEQ KI+HRD+K+ANILL +GD G++K+L ++ GT ++AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAP 170
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
E S K+D++ G LL E+ T E + ++ L
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--------------------ARSMQDLR 210
Query: 531 DKDLKNNYDRIEL---EEMVQVALLCTQYLPAHRPKMSEV 567
K + Y I +++ Q P RP ++
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 70/299 (23%), Positives = 133/299 (44%), Gaps = 58/299 (19%)
Query: 308 LGKGGFGIVYK----GIL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+G+G FG V++ G+L + T+VAVK LK+ + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 362 LYGFCMTPTERLLVYPYM--------------------SNGSVASRLKGKPILDWSTRKR 401
L G C L++ YM S+ + ++R G L S ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 402 --IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
IA A G+ YL E+ K +HRD+ N L+ + + DFGL+ ++ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-----RNIYSAD 184
Query: 460 AVRGT------VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM 513
+ + + + PE + + + ++DV+ +G++L E+ + YG A
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA------- 237
Query: 514 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
E+ + + D ++ + D L E+ + LC LP+ RP + + R+L+
Sbjct: 238 --------HEEVIYYVRDGNVLSCPDNCPL-ELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVHR 357
+F ++GKG FG V +D + A+K + + G ++ E ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 358 NLLRL-YGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
L+ L Y F E + LV + G + L K K L YLH
Sbjct: 61 FLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+ IIHRD+K NILLD+ + DF +A + +TT+ GT G++APE L
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLCR 173
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEY 503
S D + G+ E + G+R
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 71/291 (24%), Positives = 133/291 (45%), Gaps = 38/291 (13%)
Query: 296 QVATHNFSSKNILGKGGFGIVY----KGILQDG--TVVAVKRLKDGNAIGGEIQFQTEVE 349
+VA + LG+G FG+VY KG+++D T VA+K + + ++ I+F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-------GKPILDWSTRKRI 402
++ +++RL G L++ M+ G + S L+ P+ + K++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 403 ALGA---ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
A A G+ YL+ K +HRD+ A N ++ + +GDFG+ + + D +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRK 177
Query: 460 AVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517
+G V ++PE L G + +DV+ FG++L E+ T A Q
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP------Y 222
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV 568
+ + E+ L +++ L + D + + ++ +C QY P RP E++
Sbjct: 223 QGMSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 32/242 (13%)
Query: 308 LGKGGFGIVY----KGIL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG V+ +L QD +VAVK LK+ + FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVR 71
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRL-------------KGKPI--LDWSTRKRIALGA 406
YG C L+V+ YM +G + L + L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTV 465
A G++YL +HRD+ N L+ +GDFG+++ + D + V +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
+ PE + + + ++D++ FG++L E+ T YGK + + + ++ I Q ++
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT------YGKQPWYQLSNTEAIECITQGRE 242
Query: 526 LE 527
LE
Sbjct: 243 LE 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 37/166 (22%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRL-----KDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG VYK ++ G VVA+K++ KDG I E++++ H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA----LREIKILKKLKHPNVVP 71
Query: 362 LYGFCMTPTERL--------LVYPYM--------SNGSVASRLKGKPILDWSTRKRIALG 405
L + ++ +V PYM N SV L S K L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--------LTESQIKCYMLQ 123
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451
G+ YLHE I+HRD+KAANIL+D+ + DFGLA+ D
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 76/293 (25%), Positives = 138/293 (47%), Gaps = 47/293 (16%)
Query: 305 KNILGKGGFGIVYKG-ILQDGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 360
++++G+G FG V K I +DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILD--------------WSTRKRIALGA 406
L G C L Y +G++ L+ +L+ S+++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 407 --ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRG 463
ARG+ YL ++ + IHRD+ A NIL+ + A + DFGL++ Q+ +V T R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523
V +A E L+ + +DV+ +G+LL E+++ G + +K+ Q
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQG 239
Query: 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV----RMLE 572
+LE ++ D +E+ + C + P RP ++++ RMLE
Sbjct: 240 YRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 308 LGKGGFGIVYK----GILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 358
LG+G FG V GI +D VAVK LKD +E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWS-----------TRKRI--- 402
++ L G C ++ Y S G++ L+ + P +++S T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461
ARG+ YL Q K IHRD+ A N+L+ + + DFGLA+ +++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
R V +APE L + ++DV+ FG+L+ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 43/113 (38%), Positives = 64/113 (56%)
Query: 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT 134
+I L + +LSG + + L NL+I+ L +NN TG IP + L +LQ L L +N F+
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 135 GEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
GEIP +LG +L + + N+L+G P L S L L L N+L G +P+
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 323 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL-YGF------CMT-PTERLL 374
V VK + G G EI ++ IS HR ++ L + + CM P +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434
++ Y+ R P+ T +R L A L YLH + IIHRDVK NI LD
Sbjct: 172 LFTYVD------RSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219
Query: 435 DCCEAVVGDFGLA-KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 493
+ AV+GDFG A KL H D+ GT+ +PE L+ KTD++ G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 494 LITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
+ L +GK + L + + Q LE +
Sbjct: 280 MSVKNVTL-FGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316
|
Length = 392 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYG 364
+LGKG +GIVY L +A+K + + ++ +Q E+ + S HRN+++ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGK--PILD-WSTRKRIALGAARGLLYLHEQCDPKI 421
+ + GS+++ L+ K P+ D T GL YLH+ +I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 422 IHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-- 478
+HRD+K N+L++ V + DFG +K L + T GT+ ++APE + G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGY 188
Query: 479 SEKTDVFGFGILLLELITGQ 498
D++ G ++E+ TG+
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 48/220 (21%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLA 354
+G G +G+V + + G VA+K++ N F E++++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLLRHL 56
Query: 355 VHRNLLRLYGFCMTPTERL------LVYPYMSN--GSVASRLKGKPILDWSTRKRIALGA 406
H N++ L + P +V M V +K L +
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMETDLHKV---IKSPQPLTDDHIQYFLYQI 112
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH--------VT 458
RGL YLH +IHRD+K +NIL++ C+ + DFGLA+ +D + VT
Sbjct: 113 LRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 459 TAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 497
R APE LS+ + ++ D++ G + EL+T
Sbjct: 170 RWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 356
F +LG G FG VYKG+ + +G VA+K L++ + + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSV-------ASRLKGKPILDWSTRKRIALGAARG 409
++ RL G C+T T +L + M G + + + +L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGH 467
+ YL E+ +++HRD+ A N+L+ + DFGLAKLL D ++ H + +
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELIT 496
+A E + + ++DV+ +G+ + EL+T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 22/271 (8%)
Query: 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+ + ILG G G VYK L ++AVK + + + Q +E+E++
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSV-ASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++ YG + +M GS+ R + +L RIA+ +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWSL- 114
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
KI+HRDVK +N+L++ + + DFG++ L +S T V GT ++APE +S Q
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
+DV+ GI +EL G+ Y + +G+++ + L+ +VD+D
Sbjct: 170 YGIHSDVWSLGISFMELALGR--FPYPQIQKNQGSLMPL-------QLLQCIVDEDPPVL 220
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVV 568
E+ V C + P RP ++
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 47/283 (16%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 358
+ ++G+G FGIV+ D +V +K++ + + Q E +++ L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVA--------SRLKGKPILDWSTRKRIALGAARGL 410
++ Y + ++V Y G++A S L IL + + +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH----- 115
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
++H + I+HRD+K NILLD V +GDFG++K+L + T V GT +I+
Sbjct: 116 -HVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169
Query: 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529
PE ++K+D++ G +L EL + +RA E AAN L L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE---AAN-----------------LPAL 209
Query: 530 VDKDLKNNY----DRIELEEMVQVALLCTQYLPAHRPKMSEVV 568
V K + + DR ++ Q+ L P+ RP++S+++
Sbjct: 210 VLKIMSGTFAPISDRYS-PDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 307 ILGKGGFGIVYKGI-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+LG G FG VYKGI + DG VA+K L++ + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 362 LYGFCMTPTERLLVYPYMSNGSV-------ASRLKGKPILDWSTRKRIALGAARGLLYLH 414
L G C+T T +L V M G + R+ + +L+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD-HQDSHVTTAVRGTVGHIAPEYL 473
E +++HRD+ A N+L+ + DFGLA+LLD + + + + +A E +
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 474 STGQSSEKTDVFGFGILLLELIT 496
+ + ++DV+ +G+ + EL+T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 308 LGKGGFGIVYK----GILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 358
LG+G FG V G+ ++ T VAVK LK +E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--------------PILDWSTRKRI-- 402
++ L G C ++ Y S G++ L+ + P S + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461
A ARG+ YL + K IHRD+ A N+L+ + + DFGLA+ + H D + TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 39/283 (13%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMIS 352
NF + +GKG F +VYK I L DG VVA+K+++ D A ++ E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL-----KGKPILDWSTRKRIALGAA 407
H N+++ + E +V G + SR+ K K ++ T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG- 466
L ++H + +I+HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169
Query: 467 --HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
+++PE + + K+D++ G LL E+ Q YG N + KKI +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCKKIEKCD 224
Query: 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
L ++ EL ++V C P RP +S V
Sbjct: 225 Y------PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 307 ILGKGGFGIVYKGI-LQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAV--HRN 358
+LG G FG V+KGI + +G VA+K ++D + G FQ + M+++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-------KPILDWSTRKRIALGAARGLL 411
++RL G C + +L V GS+ ++ + +L+W + A+G+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-SHVTTAVRGTVGHIAP 470
YL E ++HR++ A NILL + DFG+A LL D + + + + +A
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 471 EYLSTGQSSEKTDVFGFGILLLELIT 496
E + G+ + ++DV+ +G+ + E+++
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 308 LGKGGFGIVYK----GILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 358
LG+G FG V + GI + VAVK LKD +E+E++ L H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWS---TRK-----------RI 402
++ L G C ++ Y + G++ L+ + P D++ T+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461
A ARG+ YL + + IHRD+ A N+L+ + + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
R V +APE L + ++DV+ FGIL+ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 65/197 (32%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRL----KDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
+G G FG VY ++ VVA+K++ K N +I EV + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQLRHPNTIEY 80
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
G + LV Y GS + L+ KP+ + I GA +GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA-ICHGALQGLAYLHSHE--- 135
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY---LSTGQ 477
IHRD+KA NILL + + DFG A L+ +S V GT +APE + GQ
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQ 190
Query: 478 SSEKTDVFGFGILLLEL 494
K DV+ GI +EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 302 FSSKNILGKGGFGIVYKGIL--QDGTV--VAVKRLK-DGNAIGGEIQFQTEVEMISLAVH 356
F+ +LGKG FG V + L +DG+ VAVK LK D + +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 357 RNLLRLYGFCM--TPTERL----LVYPYMSNGSV-----ASRLKGKPI-LDWSTRKRIAL 404
N+++L G + RL ++ P+M +G + SR+ +P L T R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT-TAVRG 463
A G+ YL + IHRD+ A N +L++ V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQ 498
V +A E L+ + +DV+ FG+ + E++T GQ
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 308 LGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG V KG+ + VA+K LK+ N + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL---GAARGLLYLHEQCDPKI 421
C +LV S G + L GK D T + + G+ YL +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTVGHIAPEYLSTGQSS 479
+HRD+ A N+LL + A + DFGL+K L DS+ +A + + APE ++ + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
++DV+ +GI + E A YG+ +K + + I Q K+L+
Sbjct: 177 SRSDVWSYGITMWE------AFSYGQKPYKKMKGPEVMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 301 NFSSKNILGKGGFGIVYKG-ILQDGTVVAVKRL-----KDGNAIGG--------EIQFQT 346
F N +G+G +GIVY+ G +VA+K++ +DG I ++
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 347 EVEMISLAVHRNLLRLY---GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
VE+ + V ++L ++ +C LL M S++K +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKC-----------LM 114
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
L RGL YLHE IIHRD+K +N+LL D + DFGLA+ +T V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 464 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
T+ + APE L T + D++ G +L EL+ +
Sbjct: 171 TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 41/106 (38%), Positives = 57/106 (53%), Gaps = 1/106 (0%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S +L G + S+G +L+ V LQ+N+ +G +P+E +L + LD+SNN G I S
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
+ SLQ + N G P S S +L LDLS N SG VPR
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493
|
Length = 968 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM---ISLAVHR--NLLR 361
LG+G +G+V K + GT++AVKR++ Q Q + M IS+ +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR----ATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 362 LYG---------FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLY 412
YG CM + L Y + + IL +IA+ + L Y
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIP-EDIL-----GKIAVSIVKALEY 118
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
LH + +IHRDVK +N+L++ + + DFG++ L DS T G ++APE
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPER 174
Query: 473 LSTGQSSE----KTDVFGFGILLLELITG 497
++ + + K+DV+ GI ++EL TG
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 307 ILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAV-HRNLLR 361
+LGKG FG V L + G + AVK LK + I + + TE ++SLA H L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 362 LYGFCMTPTERLL-VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
LY C +RL V +++ G + ++ D + + A L++LH++
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
II+RD+K N+LLD + DFG+ K + T+ GT +IAPE L
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 481 KTDVFGFGILLLELITGQRALE 502
D + G+LL E++ G E
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG VYK + G A K ++ + F E++++S H N++ LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE---DFMVEIDILSECKHPNIVGLYE 69
Query: 365 -------------FC--------MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
FC M ER L P + R + +L+
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQI-------RYVCRQMLE-------- 114
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
L +LH K+IHRD+KA NILL + + DFG++ T + G
Sbjct: 115 -----ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-G 165
Query: 464 TVGHIAPEYLSTGQSSE-----KTDVFGFGILLLEL 494
T +APE ++ + K D++ GI L+EL
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 357
T + +GKG +G VYK +DG++ AVK L + + EI+ + + + SL H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-LQSLPNHP 79
Query: 358 NLLRLYGFC-----MTPTERLLVYPYMSNGSVASRLKGKPI----LDWSTRKRIALGAAR 408
N+++ YG + + LV + GSV +KG I LD + I GA
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
GL +LH +IIHRDVK NILL + DFG++ L T+V GT +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195
Query: 469 APEYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 501
APE ++ Q + + DV+ GI +EL G L
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 308 LGKGGFGIVYKG-ILQDGTVVAVKRL-KDGNAIGGE-IQFQTEVEMISLAVHR--NLLRL 362
+G G G VYK + G V+AVK++ + GN + I +V + S H +++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKC 79
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCDP 419
YG+ +T ++ + MS + +L PI + K + + + L YL E+
Sbjct: 80 YGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGK-MTVAIVKALHYLKEK--H 134
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+IHRDVK +NILLD + DFG++ L DS T G ++APE + +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 480 EK----TDVFGFGILLLELITGQ 498
K DV+ GI L+EL TGQ
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 301 NFSSKNILGKGGFGIVYK----GILQDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMIS- 352
N S LG G FG V + G+ + V VAVK LK A E + +E++++S
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP-TAHSSEREALMSELKIMSH 94
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGL 410
L H N++ L G C L++ Y G + + L+ K L + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 411 LYL-HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT----V 465
+L + C IHRD+ A N+LL + DFGLA+ + + ++V V+G V
Sbjct: 155 AFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
+APE + + ++DV+ +GILL E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 308 LGKGGFGIVYKGILQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G FG V G G A VK L+ ++ F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPIL-----DWSTRKRIALGAARGLLYLHEQCDP 419
C+ LLV + G + + L+ + +R+A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT-VGHIAPEYLSTGQS 478
IH D+ N L +GD+GLA +D ++T + +APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 479 -------SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
++K++++ G+ + EL T Y ++++ +L V + Q+ KL
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAA-DQPYPDLSDEQ--VLKQVVR-EQDIKLP---- 231
Query: 532 KDLKNNYDRIELEEMVQVALLCTQYL-PAHRPKMSEVVRML 571
K D + +V C +L P RP EV +L
Sbjct: 232 ---KPQLDLKYSDRWYEVMQFC--WLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEMISLAVHRNLLRLY 363
+G+G +G+V K + G +VA+K+ K+ + E +T EV+++ H N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKII 422
LV+ Y+ ++ L+ P L + + + Y H II
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NII 122
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQ-DSHVTTAVRGTVGHIAPEYL-STGQSSE 480
HRD+K NIL+ + + DFG A+ L + S +T V T + APE L +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGK 181
Query: 481 KTDVFGFGILLLELITGQ 498
DV+ G ++ EL+ G+
Sbjct: 182 PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 305 KNILGKGGFGIVYKGILQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 360
++++G+G FG V + +++ DG + A+K LK+ + F E+E++ L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILD--------------WSTRK--RIAL 404
L G C + Y G++ L+ +L+ ++++ + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRG 463
A G+ YL E+ + IHRD+ A N+L+ + + + DFGL++ ++ +V T R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
V +A E L+ + K+DV+ FG+LL E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 307 ILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI----------S 352
+LG+G FG V YK G + A+K LK G+ I + EVE + +
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARD-----EVESLMCEKRIFETAN 57
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR---G 409
H L+ L+ T V Y + G + + D + R AA G
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLG 113
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL-LDHQDSHVTTAVRGTVGHI 468
L YLHE KI++RD+K N+LLD + DFGL K + D T+ GT +
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFL 168
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQ 498
APE L+ + D +G G+L+ E++ G+
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 308 LGKGGFGIVY---KGILQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLR 361
+ KG +G V+ K D + A+K +K + I + Q TE +++S A +++
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVK 57
Query: 362 LYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
LY + + L LV Y+ G +AS L+ LD + L YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---G 113
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKL--------LDHQDSHVTTAVRGTVGHIAPEY 472
IIHRD+K NIL+D + DFGL+K+ L+ + V GT +IAPE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEV 172
Query: 473 LSTGQSSEKT-DVFGFGILLLELITG 497
+ GQ KT D + G +L E + G
Sbjct: 173 I-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 357
FS +G G FG VY +++ VVA+K++ E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 358 NLLRLYGFCMTPTERLLVYPY-MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
N ++ G + LV Y + + S + KP+ + + GA +GL YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHSH 134
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY---L 473
+IHRDVKA NILL + +GDFG A ++ + V GT +APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 474 STGQSSEKTDVFGFGILLLEL 494
GQ K DV+ GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 8e-13
Identities = 75/292 (25%), Positives = 136/292 (46%), Gaps = 47/292 (16%)
Query: 306 NILGKGGFGIVYKGILQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLR 361
+++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILD--------------WSTRK--RIALG 405
L G C L Y +G++ L+ +L+ S+++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGT 464
ARG+ YL ++ + IHRD+ A NIL+ + A + DFGL++ Q+ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
V +A E L+ + +DV+ +G+LL E+++ G + +K+ Q
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQGY 228
Query: 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV----RMLE 572
+LE ++ D +E+ + C + P RP ++++ RMLE
Sbjct: 229 RLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 9/195 (4%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
+G+G +G+VYK G +VA+K++K + G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 366 CMTPTERLLVYPYM-SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ LV+ +M ++ + + + L S K +GL + H I+HR
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH---GILHR 122
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTD 483
D+K N+L++ + DFGLA+ T V T + APE L S D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPVD 181
Query: 484 VFGFGILLLELITGQ 498
++ G + EL++ +
Sbjct: 182 IWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISLA 354
NF + +G+G F VY+ L DG VA+K+ L D A I+ E++++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQL 59
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL----KGKPILDWSTRKRIALGAARGL 410
H N+++ Y + E +V G ++ + K K ++ T + + L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG---H 467
++H + +++HRD+K AN+ + +GD GL + S TTA VG +
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYY 172
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
++PE + + K+D++ G LL E+ Q YG N + KKI Q
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCKKIEQCDYPP 227
Query: 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+ D +Y EE+ Q+ +C P RP ++ V +
Sbjct: 228 LPSD-----HYS----EELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-12
Identities = 20/41 (48%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 31 NYEVQALMGVKHSL-HDPHGVLENWDEDAVDPCSWTMVTCS 70
N + AL+ K SL DP G L +W+ + DPCSWT VTC
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHR 357
+G+G +G VYK L G VA+K+++ + G EI ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 358 NLLRLYGFCMTP-TER----LLVYP--------YMSNGSVASRLKGKPILDWSTRKRIAL 404
N++RL C P T+R LV+ Y+S KP L T K +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-------KPGLPPETIKDLMR 114
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
RG+ +LH I+HRD+K NIL+ + + DFGLA++ + + T+V T
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVT 169
Query: 465 VGHIAPEYLSTGQSSEKT--DVFGFGILLLEL 494
+ + APE L QSS T D++ G + EL
Sbjct: 170 LWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 43/131 (32%), Positives = 65/131 (49%), Gaps = 14/131 (10%)
Query: 366 CMT-PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
CM P +Y Y++ R + PI ++ L GL YLH Q +IIHR
Sbjct: 133 CMVLPHYSSDLYTYLTK-----RSRPLPIDQALIIEKQIL---EGLRYLHAQ---RIIHR 181
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
DVK NI ++D + +GD G A+ + + A GTV APE L+ + + K D+
Sbjct: 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVETNAPEVLARDKYNSKADI 239
Query: 485 FGFGILLLELI 495
+ GI+L E++
Sbjct: 240 WSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQT---------EV 348
T+ + +G G FG+V Q G VA+K++ F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK--------PFSTPVLAKRTYREL 60
Query: 349 EMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR 408
+++ H N++ L ++P E + + + L +P L+ + R
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILR 119
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
GL Y+H ++HRD+K +NIL+++ C+ + DFGLA++ QD +T V T +
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYR 172
Query: 469 APEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
APE + T Q + D++ G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 43/282 (15%)
Query: 305 KNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+G+G FG VY+G+ VAVK K+ + +F E ++ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 361 RLYGFCMTPTERLL--VYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQC 417
+L G ++ + P G + S L K LD ++ + + L YL +
Sbjct: 71 KLIGVITENPVWIVMELAPL---GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK- 126
Query: 418 DPKIIHRDVKAANILL--DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+ +HRD+ A N+L+ DC + +GDFGL++ L+ + + + + + +APE ++
Sbjct: 127 --RFVHRDIAARNVLVSSPDCVK--LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ + +DV+ FG+ + E+ L G Q VK ++E
Sbjct: 183 RRFTSASDVWMFGVCMWEI------LMLGVKPFQ------GVKNNDVIGRIE-------- 222
Query: 536 NNYDRIELEEMVQVAL-----LCTQYLPAHRPKMSEVVRMLE 572
N +R+ + L C Y P+ RP+ +E+ L
Sbjct: 223 -NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 307 ILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN---L 359
+LGKG FG V KG + AVK LK + + T E LA+ L
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 360 LRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
+L+ C +RL V Y++ G + ++ D + A GL +LHE+
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-- 115
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAK--LLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
II+RD+K N+LLD + DFG+ K +L T+ GT +IAPE LS
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPDYIAPEILSYQ 171
Query: 477 QSSEKTDVFGFGILLLELITGQ 498
D + G+LL E++ GQ
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 308 LGKGGFGIVY------KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG V +G G VAVK LK + + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 362 LYGFCMTPTER--LLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCD 418
G C L+ ++ +GS+ L + K ++ + + A+ +G+ YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA--VRGTVGHIAPEYLSTG 476
+ +HRD+ A N+L++ + +GDFGL K ++ + T + V APE L
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 477 QSSEKTDVFGFGILLLELIT 496
+ +DV+ FG+ L EL+T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 307 ILGKGGFGIVY---KGILQD-GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 361
+LG+G FG V+ K D G + A+K LK + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
L+ T + L+ ++ G + +RL + + K A L +LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GI 119
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
I+RD+K NILLD+ + DFGL+K + + GTV ++APE ++ ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 482 TDVFGFGILLLELITG 497
D + FG+L+ E++TG
Sbjct: 179 ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 63/201 (31%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYG 364
+G G FG VY VVAVK++ G + Q EV+ + H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 365 FCMTPTERLLVYPY-MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ LV Y + + S + KP+ + I GA +GL YLH +IH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN---MIH 144
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY---LSTGQSSE 480
RD+KA NILL + + + DFG A +S V GT +APE + GQ
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDG 199
Query: 481 KTDVFGFGILLLELITGQRAL 501
K DV+ GI +EL + L
Sbjct: 200 KVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 302 FSSKNILGKGGFGIVYK-GILQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 358
F +LGKGGFG V + G + A KRL K GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAAR---GLLYL 413
++ L T LV M+ G + + G P + +R AA GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAAEILCGLEDL 118
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H + ++RD+K NILLDD + D GLA + +S GTVG++APE L
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173
Query: 474 STGQSSEKTDVFGFGILLLELITGQ 498
+ + + D +G G L+ E+I GQ
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLL-RL 362
+LGKG FG V L+ G AVK LK D I +++ E +++LA L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
Y T V +++ G + ++ K D A GL +LH + II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K N++LD + DFG+ K D+ +T GT +IAPE L + +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 483 DVFGFGILLLELITGQ 498
D + FG+LL E++ GQ
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTV-----VAVKRLKDGNAIGGEIQ---FQTEVEMISL 353
+ ++L +G FG ++ GIL D V VK +KD + EIQ E ++
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQESCLLYG 64
Query: 354 AVHRNLLRLYGFCMTPTERLLV-YPYMSNGSVASRLKGKPILDW------STRKRIALGA 406
H+N+L + C+ E V YPYM+ G++ L+ + + ST++ + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 407 --ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRG 463
A G+ YLH++ +IH+D+ A N ++D+ + + D L++ L D H +
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
V +A E L + S +DV+ FG+LL EL+T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 8/196 (4%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE--MISLA-VHRNLLRL 362
+LGKG FG V+ L+ A+K LK + + T VE ++SLA H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
Y T V Y++ G + ++ D A GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K NILLD + DFG+ K D+ T GT +IAPE L + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177
Query: 483 DVFGFGILLLELITGQ 498
D + FG+LL E++ GQ
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
N +G G G VYK I + G + A+K + + Q E+E++ H N+++ +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
E ++ +M GS L+G I D +A G+ YLH + I+HR
Sbjct: 140 MFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQILSGIAYLHRR---HIVHR 192
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK--- 481
D+K +N+L++ + DFG++++L ++V GT+ +++PE ++T +
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDG 251
Query: 482 --TDVFGFGILLLELITGQRALEYGK 505
D++ G+ +LE G+ G+
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 301 NFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISL-A 354
NF +LG G +G V+ G G + A+K LK + + T E L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 355 VHRN--LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR---- 408
V R L+ L+ T T+ L+ Y++ G + + L R+ R
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL--------YQREHFTESEVRVYIA 112
Query: 409 ----GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
L +LH+ II+RD+K NILLD V+ DFGL+K ++ + GT
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 465 VGHIAPEYLSTGQS--SEKTDVFGFGILLLELITG 497
+ ++APE + G + D + G+L EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVH 356
LG+G + +VYK + G +VA+K++K G EI+ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR------KRIALGAARGL 410
N++ L + LV+ +M + L+ K I D S K L RGL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-----TDLE-KVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
YLH I+HRD+K N+L+ + DFGLA+ + +T V T + AP
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171
Query: 471 EYL------STGQSSEKTDVFGFGILLLELI 495
E L G D++ G + EL+
Sbjct: 172 ELLFGARHYGVG-----VDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN 358
F ++G G +G VYKG ++ G + A+K + + G E + + E+ M+ + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 359 LLRLYGFCMTPT------ERLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGL 410
+ YG + + LV + GSV +K L I RGL
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
+LH+ K+IHRD+K N+LL + E + DFG++ LD T + GT +AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
Query: 471 EYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 501
E ++ ++ + K+D++ GI +E+ G L
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 302 FSSKNILGKGGFGIVYK-GILQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 358
F +LGKGGFG V + G + A K+L K GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAAR---GLLYL 413
++ L T LV M+ G + + G P D +R AA GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLEDL 118
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR---GTVGHIAP 470
+ +I++RD+K NILLDD + D GLA + ++ VR GTVG++AP
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQ 498
E ++ + + D +G G L+ E+I GQ
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 302 FSSKNILGKGGFGIVY-KGILQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 357
F+ +G G FG VY ++ VVA+K++ E ++Q EV+ + H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHP 85
Query: 358 NLLRLYGFCMTPTERLLVYPY-MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
N + G + LV Y + + S + KP+ + I GA +GL YLH
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-ITHGALQGLAYLHSH 144
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY---L 473
+IHRD+KA NILL + + + DFG A + +S V GT +APE +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 474 STGQSSEKTDVFGFGILLLEL 494
GQ K DV+ GI +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF- 365
+GKG +G V+K + ++G+ AVK L + I EI+ + + + +L+ H N+++ YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84
Query: 366 ----CMTPTERLLVYPYMSNGSVASRLKG---------KPILDWSTRKRIALGAARGLLY 412
+ LV + GSV +KG +PI+ + I A GL +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQH 139
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
LH K IHRDVK NILL + DFG++ L T+V GT +APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 195
Query: 473 LSTGQS-----SEKTDVFGFGILLLELITGQRAL 501
++ Q + DV+ GI +EL G L
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 18/231 (7%)
Query: 302 FSSKNILGKGGFGIVYK-GILQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 358
F +LGKGGFG V + G + A K+L K GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAAR---GLLYL 413
++ L T LV M+ G + + G+ + R AA GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLEDL 118
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR-GTVGHIAPEY 472
H++ +I++RD+K NILLDD + D GLA H T R GTVG++APE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEV 172
Query: 473 LSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523
+ + + D + G LL E+I GQ + K ++ + VK++ +E
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 307 ILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
ILG G FG + +G L+ VA+ L+ G + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G ++V YMSNG++ S L K + L + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GY 128
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
+H+ + A +L++ + F + + + T + + V APE + S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 482 TDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
+DV+ FGI++ E+++ G+R Y + Q D +K + E + ++ N +
Sbjct: 189 SDVWSFGIVMWEVMSYGERP--YWDMSGQ-----DVIKAV--EDGFRLPAPRNCPNLLHQ 239
Query: 541 IELEEMVQVALLCTQYLPAHRPKMSEV 567
+ L+ C Q RP+ S++
Sbjct: 240 LMLD--------CWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+G+G +G+V+K ++ G +VA+K+ +D I +I + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALR-EIRMLKQLKHPNLVNLI 66
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ LV+ Y + +V + L+ P + K+I + + + H+ I
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCI 122
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL-STGQSSEK 481
HRDVK NIL+ + + DFG A++L T V T + APE L Q
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPP 181
Query: 482 TDVFGFGILLLELITGQ 498
DV+ G + EL+TGQ
Sbjct: 182 VDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 307 ILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRN---- 358
I+G+GGFG VY D G + A+K L D I GE E M+SL +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
+ Y F TP + + M+ G + L + + + A GL ++H +
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
+++RD+K ANILLD+ + D GLA + H + GT G++APE L G +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 172
Query: 479 SEKT-DVFGFGILLLELITGQ 498
+ + D F G +L +L+ G
Sbjct: 173 YDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 307 ILGKGGFGIVYKGILQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN----L 359
I+G+GGFG VY D G + A+K L K GE E M+SL + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
Y F TP + + M+ G + L + + A GL ++H +
Sbjct: 61 CMTYAF-HTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+++RD+K ANILLD+ + D GLA + H + GT G++APE L G +
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAY 173
Query: 480 EKT-DVFGFGILLLELITGQRALEYGKAANQ 509
+ + D F G +L +L+ G K ++
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 308 LGKGGFGIVYK-GILQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRL-Y 363
LGKGGFG V + G + A K+L K GE E E++ ++ L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
F + T LV M+ G + + G+ L+ + G+L+LH I
Sbjct: 61 AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DI 116
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
++RD+K N+LLDD + D GLA ++ +D T GT G++APE L S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 482 TDVFGFGILLLELITGQ 498
D F G + E++ G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNL 359
F ++G G +G VYKG ++ G + A+K + EI+ E+ M+ + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNI 75
Query: 360 LRLYGFCMTPT------ERLLVYPYMSNGSVA---SRLKGKPIL-DWSTRKRIALGAARG 409
YG + + + LV + GSV KG + DW I RG
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRG 133
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
L +LH K+IHRD+K N+LL + E + DFG++ LD T + GT +A
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189
Query: 470 PEYLSTGQSSEKT-----DVFGFGILLLELITG 497
PE ++ ++ + T D++ GI +E+ G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 17/194 (8%)
Query: 322 QDGTVVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHRNLLRLYGFCMTPTERLL-VYP 377
G VA+K L+ +A E Q F+ E + + H N++ L P L V+
Sbjct: 1 MTGHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---D 434
Y+ ++ L L R+ L L H Q I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 435 DCCEAVVGDFGLAKLL-DHQDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFG 488
A V DFG+ LL +D+ V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 489 ILLLELITGQRALE 502
++ LE +TGQR ++
Sbjct: 177 LIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 307 ILGKGGFGIVYKGILQDGT--VVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAV- 355
+LGKG FG V L+ GT V A+K LK ++ Q TE +++LA
Sbjct: 2 VLGKGSFGKVMLAELK-GTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAK 54
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
H L L+ T V Y++ G + +++ D + A L++LH
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+I+RD+K NILLD + DFG+ K + TT GT +IAPE L
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQE 170
Query: 476 GQSSEKTDVFGFGILLLELITGQRALE 502
+ D + G+L+ E++ GQ E
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 330 KRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL--------YGFCMTPTERLLVYPYMSN 381
KR+K G+ IQ + E+ + H N+L++ + +T +Y +M +
Sbjct: 198 KRVKAGSRAA--IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV 441
A K +P+L TR I + Y+H D K+IHRD+K NI L+ + V+
Sbjct: 256 E--AFDWKDRPLL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308
Query: 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
GDFG A + + GTV +PE L+ E TD++ G++LL++++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 46/278 (16%)
Query: 307 ILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLR 361
++GKG +G V ++ DG +K+L NA E + + E +++S H N++
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV- 62
Query: 362 LYGFCMTPTERLL--VYPYMSNGSVASRLK---GK-----PILDWSTRKRIALGAARGLL 411
Y + LL V + G + +LK GK +++W + A L
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQ 116
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
YLHE+ I+HRD+K N+ L VGD G+A++L++Q +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
S + K+DV+ G + E+ T + A N K M V +I + K M D
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAF------NAKD-MNSLVYRIIEGKLPPMPKD 225
Query: 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
Y EL E++ +L + P RP + ++R
Sbjct: 226 ------YSP-ELGELIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQF-----------QTEVE 349
+ +G+G FG +Y +A + + + EI + EV
Sbjct: 1 RYEIIKKIGEGSFGKIY---------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI 51
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--------PILDWSTRKR 401
+++ H N++ + +V Y G + R+ + IL W +
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-- 109
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTA 460
I+LG L ++H D KI+HRD+K+ NI L + A +GDFG+A+ L+ T
Sbjct: 110 ISLG----LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
V GT +++PE + KTD++ G +L EL T + E
Sbjct: 163 V-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 18/174 (10%)
Query: 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
+IA+ GL YL+ +I+HRD+K +NIL++ + + DFG++ L +S T
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF 162
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR--ALEYGKAANQKGAM--LDW 516
V GT +++PE + G+ + K+DV+ GI ++EL G+ A Q M LD
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+++I QE + + +L + V LL P RP ++ M
Sbjct: 222 LQQIVQEPPPRLPSSDFPE------DLRDFVDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 42/283 (14%)
Query: 308 LGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
LG+ FG +YKG L +VA+K LKD N +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 363 YGFCMTPTERLLVYPYMSNGSV---------------ASRLKG--KPILDWSTRKRIALG 405
G +++ Y++ G + +S G K LD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGT 464
A G+ YL +H+D+ A NIL+ + + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
+ + PE + G+ S +D++ FG++L E+ + YG ++
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG---------------FSNQE 234
Query: 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+EM+ + L + M + C Q P+ RP+ ++
Sbjct: 235 VIEMVRKRQLLPCSEDCP-PRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 307 ILGKGGFGIVYKGILQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRL 362
+LGKG FG V L+ A+K LK + + T VE LA+ H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ T V Y++ G + ++ D + + A GL +LH++ II
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GII 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K N+LLD + DFG+ K + + +T GT +IAPE L + +E
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNESV 177
Query: 483 DVFGFGILLLELITGQ 498
D + FG+LL E++ GQ
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 302 FSSKNILGKGGFGIVYK-GILQDGTVVAVKRL-------KDGNAIG-GEIQFQTEVE--- 349
F +LGKGGFG V + G + A K+L + G A+ E Q +V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAA 407
++SLA Y + T LV M+ G + + G P D +R AA
Sbjct: 62 VVSLA--------YAY-ETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAA 109
Query: 408 R---GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
GL LH + +I++RD+K NILLDD + D GLA ++ + GT
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGT 164
Query: 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
VG++APE + + + D +G G L+ E+I G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG VYK ++ V+A ++ D + + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 368 TPTERLLVYPYMSNGSV-ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
++ + + G+V A L+ + L + + L YLHE KIIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 427 KAANILLDDCCEAVVGDFGLA----KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 480
KA NIL + + DFG++ + + +DS + GT +APE + S +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184
Query: 481 ---KTDVFGFGILLLEL 494
K DV+ GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 6/196 (3%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G + VYKG + +G +VA+K ++ G E ++ H N++ L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
T LV+ Y+ K L K RGL Y+H++ I+HRD+
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDL 129
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 485
K N+L+ D E + DFGLA+ SH + T+ + P+ L + + S D++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188
Query: 486 GFGILLLELITGQRAL 501
G G + +E+I G A
Sbjct: 189 GVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 5/120 (4%)
Query: 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437
+M GS+ LK + + +I++ RGL YL E+ KI+HRDVK +NIL++
Sbjct: 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRG 137
Query: 438 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
E + DFG++ L DS + V GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 138 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 26/266 (9%)
Query: 308 LGKGGFGIVYKGILQ---DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
LG G FG V KG+ + VAVK LK D N + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
G C + +LV G + L+ + + + G+ YL E +H
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVH 118
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT--VGHIAPEYLSTGQSSEK 481
RD+ A N+LL A + DFGL+K L +++ G V APE ++ + S K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541
+DV+ FG+L+ E A YG+ + + + I +++E
Sbjct: 179 SDVWSFGVLMWE------AFSYGQKPYKGMKGNEVTQMIESGERMECPQRCP-------- 224
Query: 542 ELEEMVQVALLCTQYLPAHRPKMSEV 567
EM + LC Y RP + V
Sbjct: 225 --PEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 32/112 (28%), Positives = 57/112 (50%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
L + + NL+G + + + NL ++L +N++ G IP +G L+ + L +N F+GE+
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
PS L + ++ +NN+L G + M L L L+ N G +P
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 37/232 (15%)
Query: 308 LGKGGFGIVYKG--ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---------- 355
+G+G +G V+K + G VA+KR ++ QT E + L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR----------VRVQTGEEGMPLSTIREVAVLRHL 58
Query: 356 ----HRNLLRLYGFC-MTPTER----LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALG 405
H N++RL+ C ++ T+R LV+ ++ K +P + T K +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTV 465
RGL +LH +++HRD+K NIL+ + + DFGLA++ Q T+V T+
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTL 173
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517
+ APE L + D++ G + E+ + +Q G +LD +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEI------QFQTEVEMISLAVHRNLLR 361
LG G G+V K + ++ ++L I EI Q E++++ ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKL-----IHLEIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
YG + E + +M GS+ LK + ++++ RGL YL E+ +I
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQI 125
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L S +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 482 TDVFGFGILLLELITGQ 498
+D++ G+ L+EL G+
Sbjct: 183 SDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEI------QFQTEVEMISLA 354
+F + LG G G+V+K + ++ ++L I EI Q E++++
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKL-----IHLEIKPAIRNQIIRELQVLHEC 60
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
++ YG + E + +M GS+ LK + ++++ +GL YL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
E+ KI+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQ 175
Query: 475 TGQSSEKTDVFGFGILLLELITGQ 498
S ++D++ G+ L+E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 37/278 (13%)
Query: 308 LGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G F ++KGI ++ T V +K L + E F M+S H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHKHL 61
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCD 418
+ YG C+ E ++V Y+ GS+ + LK K +++ S + +A A L +L ++
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYLST 475
+ H +V A N+LL + G+ KL D S + I PE +
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 476 GQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-QEKKLEMLVDKD 533
Q+ S D + FG L E+ +G ++ + LD KK+ E + ++ K
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALDSQKKLQFYEDRHQLPAPK- 228
Query: 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
EL ++ C Y P RP ++R L
Sbjct: 229 ------WTELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 393 ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452
ILDW + +AL ++H D KI+HRD+K+ NI L +GDFG+A++L+
Sbjct: 103 ILDWFVQICLALK------HVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153
Query: 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512
T + GT +++PE + K+D++ G +L E+ T + A E A N K
Sbjct: 154 TVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNL 209
Query: 513 MLDWVK------KIHQEKKLEMLVDKDLKNNY-DR 540
+L ++ H L LV + K N DR
Sbjct: 210 VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL-----DHQDSHVTTAVR 462
RGL Y+H +IHRD+K +N+L+++ CE +GDFG+A+ L +H+ +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172
Query: 463 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALEYGK 505
T + APE LS + + D++ G + E++ G+R L GK
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 68/205 (33%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 308 LGKGGFGIVY------KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VH-RNL 359
LGKGGFG V G L + KRLK G + VE LA VH R +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-----VEKRILAKVHSRFI 55
Query: 360 LRL-YGFCMTPTERLLVYPYMSNGSVASRL----KGKPILDWSTRKRIALGAAR---GLL 411
+ L Y F T T+ LV M+ G + + + P R A+ GL
Sbjct: 56 VSLAYAF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLE 111
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA-KLLDHQDSHVTTAVRGTVGHIAP 470
+LH++ +II+RD+K N+LLD+ + D GLA +L D Q T GT G +AP
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP 166
Query: 471 EYLSTGQSSEKTDVFGFGILLLELI 495
E L + D F G+ L E+I
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 33/301 (10%)
Query: 286 NLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQ 345
L QF E+ + ++ K +VAVK L+ + F
Sbjct: 12 KLGEGQFGEVHLCE-ADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFL 67
Query: 346 TEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-----------GKPIL 394
EV+++S N+ RL G C ++ YM NG + L+ L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 395 DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
+ST +A A G+ YL +HRD+ N L+ + DFG+++ L D
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 455 SHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK 510
+ V+G I A E + G+ + K+DV+ FG+ L E++T R Y +Q+
Sbjct: 185 YY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+++ ++ ++ + + +++ ++ L C + RP E+
Sbjct: 242 --VIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293
Query: 571 L 571
L
Sbjct: 294 L 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 34/170 (20%)
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLLDHQDS-HVTTAVRGTVG 466
LL +H +IHRD+K+ANILL C +V GDFG +K+ S V GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILL--CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 467 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526
++APE S+K D+F G+LL EL+T +R + G +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------GE------------NM 250
Query: 527 EMLVDKDLKNNYDRI------ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
E ++ K L YD + E++E+V ALL + P RP S+++ M
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVT-ALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 307 ILGKGGFGIVYKGILQD-GTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLY 363
++G+G +G+V K ++ G +VA+K+ + + + +I + E+ M+ H NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKII 422
LV+ ++ + +V L+ P LD S ++ RG+ + H II
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK- 481
HRD+K NIL+ + DFG A+ L T V T + APE L +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRA 181
Query: 482 TDVFGFGILLLELITGQ 498
D++ G L+ E++TG+
Sbjct: 182 VDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 39/213 (18%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVE----MISL-A 354
LGKG +GIV+K I + VVA+K++ D NA EI F E+ ++ L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 355 VHR--NLLRLYGFCMTPTERLLVYPYM-SNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
V + N +Y LV+ YM ++ R IL+ ++ I + L
Sbjct: 75 VIKAENDKDIY----------LVFEYMETDLHAVIR---ANILEDVHKRYIMYQLLKALK 121
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR----GTVGH 467
Y+H +IHRD+K +NILL+ C + DFGLA+ L + + V T +
Sbjct: 122 YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 468 IAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
APE L ST + ++ D++ G +L E++ G+
Sbjct: 179 RAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
NF LG+G + VYKG + G +VA+K + G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLK------GKP-ILDWSTRKRIALGAARGLLY 412
+RL+ T + +LV+ YM LK G LD +T K +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
HE +++HRD+K N+L++ E + DFGLA+ + + V T+ + AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 473 LSTGQS-SEKTDVFGFGILLLELITG 497
L ++ S D++ G ++ E+ITG
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 346 TEVEMISLAVHRNLLRLYGF-------CMT-PTERLLVYPYMSNGSVASRLKGKPILDWS 397
TE ++ H ++++L G C+ P + +Y Y++ + I D
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK------RNIAICDIL 185
Query: 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457
+R L R + YLHE +IIHRD+KA NI ++ + +GDFG A +++
Sbjct: 186 AIERSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 501
GT+ APE L+ D++ GI+L E+ T +L
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN- 358
+F+ +LGKG FG V + + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 359 --LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
L +L+ C +RL V Y++ G + ++ A + GL +LH
Sbjct: 61 PFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR-GTVGHIAPEYLS 474
+ II+RD+K N++LD + DFG+ K +H VTT GT +IAPE ++
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 475 TGQSSEKTDVFGFGILLLELITGQ 498
+ D + +G+LL E++ GQ
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 357
+G G +G V G VA+K+L FQ+ E+ ++ H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR--------PFQSAIHAKRTYRELRLLKHMDHE 74
Query: 358 NLLRLYGFCMTPTERL-------LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
N++ L TP L LV M + + +K + + D + + RGL
Sbjct: 75 NVIGLLD-VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSD-DHIQFLVYQILRGL 131
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
Y+H IIHRD+K +NI +++ CE + DFGLA+ D + +T V T + AP
Sbjct: 132 KYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYV-ATRWYRAP 184
Query: 471 E-YLSTGQSSEKTDVFGFGILLLELITGQ 498
E L+ ++ D++ G ++ EL+TG+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 358
+ N + +G +G+VY+ + G +VA+K+LK + G I E+ ++ H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 359 LLRLYGFCM--TPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAARGLL 411
++ + + + +V Y+ + LK K S K + L G+
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
+LH+ I+HRD+K +N+LL++ + DFGLA+ T V T+ + APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 472 -YLSTGQSSEKTDVFGFGILLLELITG 497
L + S D++ G + EL+T
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+F+ +LGKG FG V + GT + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 359 ---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
L +L+ C +RL V Y++ G + +++ A A GL +LH
Sbjct: 60 PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
+ II+RD+K N++LD + DFG+ K + D T GT +IAPE ++
Sbjct: 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 475 TGQSSEKTDVFGFGILLLELITGQRALE 502
+ D + FG+LL E++ GQ E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N L + NL+NL + L N I+ +P EI L+ L+ LDLSNN E+ SSL
Sbjct: 171 SFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL 228
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+L++L + +NN L P S+ +++ L LDLS N +S
Sbjct: 229 SNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 14/196 (7%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLYG 364
LG GGFG V ++ A+K +K + + Q +E E++ H +++LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 365 FCMTPTERLLVY---PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
T ++ +Y Y G + + L+ + + D T + YLH + I
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
I+RD+K N+LLD + DFG AK L + T GT ++APE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 482 TDVFGFGILLLELITG 497
D + GILL EL+TG
Sbjct: 173 VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 308 LGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G FG V G + G V VK L+ ++ +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPIL-----DWSTRKRIALGAARGLLYLHEQCDP 419
C T LLV + G + L+ D +T +R+A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT-VGHIAPEYLSTGQS 478
IH D+ N LL +GD+GL+ +D +VT + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 479 -------SEKTDVFGFGILLLEL 494
+++++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 8/194 (4%)
Query: 308 LGKGGFGIVYKG--ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
LG+G + VYKG L D +VA+K ++ + G EV ++ H N++ L+
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 366 CMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
T LV+ Y+ ++ K RGL Y H + K++HRD
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD 129
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDV 484
+K N+L+++ E + DFGLA+ + V T+ + P+ L + S + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDM 188
Query: 485 FGFGILLLELITGQ 498
+G G + E+ TG+
Sbjct: 189 WGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT--------EVE-MISLAVHR 357
LG G FG VY + G +VA+K++K +F + EV+ + L H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 358 NLLRLYGFCMTPTERLLVYPYMSN---GSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
N+++L E V+ YM + R KGKP S + I +GL ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
+ HRD+K N+L+ E V + DFGLA+ + + + T V T + APE L
Sbjct: 117 KH---GFFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEIL 170
Query: 474 --STGQSSEKTDVFGFGILLLELITGQ 498
ST SS D++ G ++ EL T +
Sbjct: 171 LRSTSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 18/131 (13%)
Query: 374 LVYPYMSNGSVASRLK---GK-----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
+V Y G + ++K GK IL W + + LG ++HE+ +++HRD
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ----HIHEK---RVLHRD 125
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 485
+K+ NI L + +GDFG A+LL ++ T V GT ++ PE + K+D++
Sbjct: 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIW 184
Query: 486 GFGILLLELIT 496
G +L EL T
Sbjct: 185 SLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 301 NFSSKNILGKGGFGIVY---KGILQD-GTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAV 355
NF +LG G +G V+ K D G + A+K L+ + T E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 356 HRN---LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLY 412
R L+ L+ T + L+ Y+S G + + L + D + + + +L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILA 117
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
L I++RD+K NILLD V+ DFGL+K ++ T + GT+ ++APE
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 473 L-STGQSSEKTDVFGFGILLLELITG 497
+ G + D + GIL+ EL+TG
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 6/193 (3%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G + V+KG + +VA+K ++ + G EV ++ H N++ L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
T LV+ Y+ + ++ K RGL Y H++ KI+HRD+
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDL 129
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 485
K N+L+++ E + DFGLA+ + V T+ + P+ L + + S D++
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 486 GFGILLLELITGQ 498
G G +L E+ TG+
Sbjct: 189 GVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 38/216 (17%)
Query: 308 LGKGGFGIVYKGILQDG--TVVAVKRLKDGNAIGGEIQFQ---------TEVEMISLAV- 355
LG G FG VYK ++ ++A+K + N G+ + + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILD-WSTRK------------RI 402
H N++R Y +RL + V ++G P+ + +++ K I
Sbjct: 68 HPNIVRYYK-TFLENDRLYI--------VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462
+ L YLH++ +I+HRD+ NI+L + + + DFGLAK Q T+V
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVV 174
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
GT+ + PE + EK DV+ FG +L ++ T Q
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+F+ +LGKG FG V + GT + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 359 ---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLK--GK---PILDWSTRKRIALGAARG 409
L +L+ C +RL V Y++ G + ++ GK P + A A G
Sbjct: 60 PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIG 113
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR-GTVGHI 468
L +LH + II+RD+K N++LD + DFG+ K ++ TT GT +I
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYI 168
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQ 498
APE ++ + D + FG+LL E++ GQ
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
LGKG +G VYK + + G +A+K ++ D + I E++++ AV ++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKG---KPILDWSTRKRIALGAARGLLYLHEQCDPK 420
G + YM GS+ G + +RI +GL +L E+ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG---HIAPEYLSTGQ 477
IIHRDVK N+L++ + + DFG++ L V + + +G ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 478 SSE------KTDVFGFGILLLELITG 497
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 66/237 (27%), Positives = 112/237 (47%), Gaps = 30/237 (12%)
Query: 302 FSSKNILGKGGFGIVYKGILQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 359
F +G+G +G VYK +D G +VA+K+++ D G I E++++ HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 360 LRLYGFCMTPTERL----------LVYPYMSN---GSVASRLKGKPILDWSTR--KRIAL 404
+ L + L LV+ YM + G + S L + +S K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMK 123
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
GL Y H++ +HRD+K +NILL++ + + DFGLA+L + ++S T T
Sbjct: 124 QLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 465 VGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520
+ + PE L + DV+ G +L EL T + + ANQ+ A L+ + ++
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ----ANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G G+V+ + D VAVK+ L D ++ ++ E+++I H N++++Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR---EIKIIRRLDHDNIVKVYE 69
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA-------------RGLL 411
+ P+ L S + S + ++ + G RGL
Sbjct: 70 -VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVV---GDFGLAKLLDHQDSHVTTAVRGTVG-- 466
Y+H ++HRD+K AN+ ++ E +V GDFGLA+++D SH G V
Sbjct: 129 YIHSA---NVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 467 HIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
+ +P LS ++ D++ G + E++TG+ Q +L+ V + +E +
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 526 LEML 529
E+L
Sbjct: 244 NELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 362
++GKG FG V DG AVK L+ + + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ T + V Y++ G + L+ + + A A L YLH II
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NII 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K NILLD V+ DFGL K + S T+ GT ++APE L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 483 DVFGFGILLLELITG 497
D + G +L E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 301 NFSSKNILGKGGFGIVY---KGILQD-GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV 355
NF +LG G +G V+ K D G + A+K LK + + T E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 356 HRN---LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLY 412
R L+ L+ T T+ L+ Y++ G + + L + + + + + +L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVLA 117
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
L II+RD+K NILLD V+ DFGL+K + + GT+ ++AP+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 473 LSTGQS--SEKTDVFGFGILLLELITG 497
+ G + D + G+L+ EL+TG
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVH 356
H++ +G G +G VYK L G + AVK +L+ G+ Q E+ M+ H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQEIFMVKECKH 65
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
N++ +G ++ + + Y GS+ L + +GL YLH +
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR----GTVGHIAPEY 472
+HRD+K ANILL D + + DFG+A + T A R GT +APE
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEV 177
Query: 473 LS---TGQSSEKTDVFGFGILLLEL 494
+ G ++ D++ GI +EL
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 357
+G G +G V + + G VA+K+L FQ+ E+ ++ H
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHMKHE 74
Query: 358 NLLRLYGFCMTPTERL-------LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
N++ L TP L LV P+M G+ +L L + + +GL
Sbjct: 75 NVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
Y+H IIHRD+K N+ +++ CE + DFGLA+ DS +T V T + AP
Sbjct: 132 KYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAP 184
Query: 471 EY-LSTGQSSEKTDVFGFGILLLELITGQ 498
E L+ ++ D++ G ++ E++TG+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 305 KNILGKGGFGIVYKGILQDGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+LGKGG+G V++ G + A+K LK + + + + RN+L
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV------RNQKDTAHTKAERNIL 54
Query: 361 R----------LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
+Y F T + L+ Y+S G + L+ + I T + L
Sbjct: 55 EAVKHPFIVDLIYAF-QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
+LH+Q II+RD+K NILLD + DFGL K H+ + VT GT+ ++AP
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAP 169
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQ 498
E L + D + G L+ +++TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 362
++GKG FG V + DG+ AVK L+ + + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ T + V Y++ G + L+ + + A A + YLH II
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NII 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K NILLD V+ DFGL K + T+ GT ++APE L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 483 DVFGFGILLLELITG 497
D + G +L E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 308 LGKGGFGIV-YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G+G GIV + G +VAVK++ E+ F EV ++ H N++ +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 367 MTPTERLLVYPYMSNGSVA-----SRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ E +V ++ G++ +R+ + I + L + L LH Q +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------AAVCLAVLKALSVLHAQ---GV 137
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
IHRD+K+ +ILL + DFG + + + V GT +APE +S +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPE 196
Query: 482 TDVFGFGILLLELITGQ 498
D++ GI+++E++ G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 6/193 (3%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G + V+KG + +VA+K ++ + G EV ++ H N++ L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
T LV+ Y+ I+ K RGL Y H + K++HRD+
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDL 130
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 485
K N+L+++ E + DFGLA+ + V T+ + P+ L + + S + D++
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMW 189
Query: 486 GFGILLLELITGQ 498
G G + E+ +G+
Sbjct: 190 GVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 308 LGKGGFGIVYKGILQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGF 365
+GKG FG V + +D + A+K ++ + + T E LA V+ + F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 366 CMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
E+L LV +++ G + L+ + D +R R A L L +I+R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNVIYR 117
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D+K NILLD + DFGL K L+ +D T GT ++APE L ++ D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 485 FGFGILLLELITG 497
+ G+LL E++TG
Sbjct: 177 WTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV---HRNLLRL 362
+G G +G VYK G VA+K ++ N G + EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 363 YGFCMT-----PTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
C T T+ LV+ ++ K P L T K + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
C I+HRD+K NIL+ + + DFGLA++ Q T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQS 182
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515
+ D++ G + E+ + A+Q G + D
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 6e-09
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 122 KLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
L++LDLSNN T + L +L+ + + N+L+ P + + + L LDLS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 301 NFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA 354
+F LG G FG V +K G A+K L + E ++
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLL- 411
H L+ LYG + LV Y+ G + S L+ G+ + AA+ +L
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLA 113
Query: 412 --YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
YLH I++RD+K N+LLD + DFG AK + + T + GT ++A
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLA 166
Query: 470 PEYLST---GQSSEKTDVFGFGILLLELITG 497
PE + + G++ D + GIL+ E++ G
Sbjct: 167 PEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G + VYKG + G +VA+K ++ + G E ++ H N++ L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
T LV+ Y+ + + L + RGL Y H++ +++HRD
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRD 128
Query: 426 VKAANILLDDCCEAVVGDFGLAK---LLDHQDSH--VTTAVRGTVGHIAPEYL--STGQS 478
+K N+L+ + E + DFGLA+ + S+ VT R P+ L ST S
Sbjct: 129 LKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGSTEYS 182
Query: 479 SEKTDVFGFGILLLELITGQ 498
+ D++G G + E+ TG+
Sbjct: 183 TS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 27/160 (16%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLY 363
+G+G FG V+K + +VA+K++ N G I E++++ L H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 364 GFCMTPTERLLVYPYMSNGSVAS-------------RLKGKPILDWS--TRKRIALGAAR 408
C T N S L + ++ K++
Sbjct: 78 EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448
GL Y+H KI+HRD+KAANIL+ + DFGLA+
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
LG G FG VYK ++ +A ++ + + + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 368 TPTERLLVYPYMSNGSV-ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+ ++ + G+V A L+ L + I L YLH KIIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 427 KAANILLDDCCEAVVGDFGLA----KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 480
KA N+LL + + DFG++ K L +DS + GT +APE + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191
Query: 481 ---KTDVFGFGILLLEL 494
K D++ GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 9/145 (6%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
+G+G +G V+K ++ +VA+KR++ D + G E+ ++ H+N++RLY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 366 CMTPTERLLVYPYMSNG--SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ + LV+ Y G D K +GL + H ++H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSH---NVLH 122
Query: 424 RDVKAANILLDDCCEAVVGDFGLAK 448
RD+K N+L++ E + DFGLA+
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 307 ILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLL 360
++GKGG G VY D VA+K++++ + + +F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 361 RLYGFCMTPTERLLVY---PYMSNGSVASRLKG--------KPILDWSTRK---RIALGA 406
+Y C ++ VY PY+ ++ S LK K + + ++ I
Sbjct: 66 PVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK--------LLD------- 451
+ Y+H + ++HRD+K NILL E V+ D+G A LLD
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 452 --HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
+ + + GT ++APE L +SE TD++ G++L +++T
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 3/100 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N +L + NL NL+ + L N+++ +P + L+ L LDLS N + ++P +
Sbjct: 148 SDNKIESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
L +L+ + +NNS+ +SL+++ L L+LS N L
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G+G GIV + G VAVK++ E+ F EV ++ H N++ +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 367 MTPTERLLVYPYMSNGSVA-----SRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ E +V ++ G++ +R+ + I + L R L YLH Q +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLSVLRALSYLHNQ---GV 139
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
IHRD+K+ +ILL + DFG + + + V GT +APE +S +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTE 198
Query: 482 TDVFGFGILLLELITGQ 498
D++ GI+++E+I G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 38/216 (17%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-GE------IQFQTEVEMISLAVHRNLL 360
LGKG FG VY +++D VA +RLK I GE +Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 361 RLYG-------FCMTPTE----RLL---VYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406
+ + FC+ TE R L + G S + +W + +
Sbjct: 66 KFHASFLERDAFCII-TEYCEGRDLDCKLEELKHTGKTLSE---NQVCEWFIQLLL---- 117
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
G+ Y+H++ +I+HRD+KA NI L + +GDFG+++LL + T GT
Sbjct: 118 --GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPY 170
Query: 467 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
+++PE L K+D++ G +L E+ A E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEV-------EMISL 353
++S +G G +G V I + G VA+K+L FQ+E+ E+ L
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR--------PFQSEIFAKRAYRELTLL 68
Query: 354 A--VHRNLLRLYG-FCMTPTER-----LLVYPYMSNGSVASRLKGKPILDWSTRKRIALG 405
H N++ L F + LV PYM ++ G P+ + + +
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSE-DKVQYLVYQ 125
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTV 465
GL Y+H IIHRD+K N+ +++ CE + DFGLA+ H D+ +T V T
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178
Query: 466 GHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 498
+ APE L+ ++ D++ G ++ E++TG+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 8/194 (4%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G + VYKGI + +G +VA+K + G E ++ H N++ L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
T V+ YM ++ L + RGL Y+H Q I+HRD+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDL 129
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDV 484
K N+L+ E + DFGLA+ S ++ T+ + P+ L +T SS D+
Sbjct: 130 KPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA-LDI 187
Query: 485 FGFGILLLELITGQ 498
+G G + +E++ GQ
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 359
+G+G G VY I + G VA+K++ +Q Q + E+I + V R N+
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKNPNI 78
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+ + E +V Y++ GS+ + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
++IHRD+K+ NILL + DFG + + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 480 EKTDVFGFGILLLELITGQ 498
K D++ GI+ +E++ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 18/200 (9%)
Query: 310 KGGFGIVY--KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLYG 364
KG FG VY K G A+K LK + I + E + + + +LY
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ LV Y++ G AS +K G DW+ ++ IA G+ LH++ II
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA-KQYIA-EVVLGVEDLHQR---GII 119
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
HRD+K N+L+D + DFGL++ GT ++APE + + +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 483 DVFGFGILLLELITGQRALE 502
D + G ++ E + G
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 39/105 (37%), Positives = 60/105 (57%), Gaps = 4/105 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N L P I L+ L+ + L NN+I + + + L L L+LSNN ++P S+
Sbjct: 194 SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
G+L +L+ + +NN +S +SL S+T L LDLS N+LS +P
Sbjct: 252 GNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 305 KNILGKGGFGIVY----KGIL---------QDG--TVVAVKRLKDGNAIGGEIQFQTEVE 349
K LG+G FG V+ +G+ DG +VAVK L+ F E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR-KRIALGAAR 408
++S + N++RL G C++ ++ YM NG + L + I T I +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 409 GLLYLHEQCDP--------KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
LLY+ Q +HRD+ N L+ + + DFG+++ L D +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY---R 186
Query: 461 VRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
++G + +A E + G+ + +DV+ FG+ L E+ T
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-------HRNL 359
+G+G G VY I + G VA+K++ +Q Q + E+I + H N+
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKHPNI 78
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+ + E +V Y++ GS+ + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN--- 134
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
++IHRD+K+ NILL + DFG + + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 480 EKTDVFGFGILLLELITGQ 498
K D++ GI+ +E++ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 81 PSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
PS S S ++ NL L + L N + I E+ LT L +LDL NN T +IP
Sbjct: 77 PSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPL 134
Query: 141 LGHLRS-LQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+G L+S L+ + ++N + + P+ L ++ L LDLS+N+LS
Sbjct: 135 IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 10/196 (5%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 362
++GKG FG V + DG AVK L+ + + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 363 YGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ + TE+L V +++ G + L+ + + A A L YLH I
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NI 117
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
++RD+K NILLD V+ DFGL K Q S TT GT ++APE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 482 TDVFGFGILLLELITG 497
D + G +L E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 291 QFRE-LQVAT------HNFSSKNILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGG 340
QFR LQ+ + +G+G GIV I D G VAVK++
Sbjct: 3 QFRAALQLVVDPGDPRSYLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRR 60
Query: 341 EIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILD 395
E+ F EV ++ H N++ +Y + E +V ++ G++ +R+ + I
Sbjct: 61 ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-- 117
Query: 396 WSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
+T L A L +LH Q +IHRD+K+ +ILL + DFG Q S
Sbjct: 118 -ATVCLAVLKA---LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA----QVS 166
Query: 456 HVTTAVRGTVGH---IAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
+ VG +APE +S + D++ GI+++E++ G+
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 358
NF +G+G +G+VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GL 410
+++L T + LV+ ++ K +D S I L + GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
+ H +++HRD+K N+L++ + DFGLA+ T V T+ + AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 471 E-YLSTGQSSEKTDVFGFGILLLELITGQRAL 501
E L S D++ G + E++T +RAL
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 28/235 (11%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLA 354
NF + +G+G F VY+ L D VA+K+++ D A ++ E++++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL----KGKPILDWSTRKRIALGAARGL 410
H N+++ + E +V G ++ + K K ++ T + + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG---H 467
++H + +++HRD+K AN+ + +GD GL + S TTA VG +
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYY 172
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522
++PE + + K+D++ G LL E+ Q YG N + +KI Q
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLY 363
+G+G +G+VYKG + G +VA+K+++ + G T + ISL H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65
Query: 364 GFCMTPTERLLVYPYMSNG--SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
M + L++ ++S L +D K +G+L+ H + ++
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SE 480
+HRD+K N+L+D+ + DFGLA+ V T T+ + APE L S
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 481 KTDVFGFGILLLELIT 496
D++ G + E+ T
Sbjct: 182 PVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE 415
+ N ++LY T +L+ Y+ +G + LK + L + K+I L LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 416 QCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
IIH D+K N+L D + + + D+GL K++ + GT+ + +PE +
Sbjct: 128 H---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIK 179
Query: 475 TGQSSEKTDVFGFGILLLELITGQ 498
D + G+L EL+TG+
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
RGL Y+H IIHRD+K +N+ +++ CE + DFGLA+ H D +T V T +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 468 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 498
APE L+ ++ D++ G ++ EL+TG+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 22/160 (13%)
Query: 309 GKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA---VHRNLLRL 362
G+G +G VYK + DG A+K+ K I Q+ I+L H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67
Query: 363 YGFCMTPTERL--LVYPYMSNGSVA-----SRLKGKPILDWSTRKRIALGAARGLLYLHE 415
+ ++ L++ Y + + K I S K + G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPP-SMVKSLLWQILNGVHYLHS 126
Query: 416 QCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLD 451
++HRD+K ANIL+ + +GD GLA+L +
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
RGL YLH I+HRD+K N+L++ C + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 468 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
APE L + + D++ G + EL+ +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-----PILDWSTR 399
++E+ ++ H +++ + + + LL+ Y S G + ++K + P ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY--- 169
Query: 400 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS---H 456
+ L + +L L E K++HRD+K+ANI L +GDFG +K + DS
Sbjct: 170 -EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLD 226
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499
V ++ GT ++APE + S+K D++ G++L EL+T R
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 359
+G+G G VY + + G VA++++ +Q Q + E+I + V R N+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+ + E +V Y++ GS+ + + +D + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
++IHRD+K+ NILL + DFG + + S +T V GT +APE ++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 480 EKTDVFGFGILLLELITGQ 498
K D++ GI+ +E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 307 ILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLL 360
+LGKG FG K IL G A+K LK I + TE ++ H L
Sbjct: 2 LLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 361 RL-YGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGA--ARGLLYLHEQ 416
L Y F +RL V Y + G + L + + R R GA L YLH
Sbjct: 59 ALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARF-YGAEIVSALGYLHSC 114
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
+++RD+K N++LD + DFGL K D GT ++APE L
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 477 QSSEKTDVFGFGILLLELITGQ 498
D +G G+++ E++ G+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVK 427
T ++ LV YMS G + L+ + K L +LH+ I++RD+K
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLK 123
Query: 428 AANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFG 486
NILLD + DFGL+K + D+ T GT ++APE L + K D +
Sbjct: 124 PENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182
Query: 487 FGILLLELITG 497
G+L+ E+ G
Sbjct: 183 LGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/102 (34%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH---VTTAVRGT 464
RGL Y+H ++HRD+K +N+LL+ C+ + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 465 VGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALEYGK 505
+ APE L++ ++ D++ G +L E+++ R L GK
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 7/192 (3%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G+G G V+ I + G VA+K++ E+ + M L + N++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSF 85
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+ E +V Y++ GS+ + + +D + + + L +LH ++IHRD+
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDI 141
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 486
K+ N+LL + DFG + + S +T V GT +APE ++ K D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 487 FGILLLELITGQ 498
GI+ +E++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAI--GGEIQF 344
+ R+LQ+ ++ ++G+G FG V +K V A+K L I F
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRI 402
E ++++ A +++L FC ++ L V YM G + + + + K
Sbjct: 91 WEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWA 144
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAV 461
A +L L +IHRDVK N+LLD + DFG +D TAV
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 462 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 497
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 6/186 (3%)
Query: 345 QTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
QTE + A H L+ L+ T + V Y++ G + ++ + L + +
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
+ L YLHE+ II+RD+K N+LLD + D+G+ K + T+ G
Sbjct: 103 AEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCG 158
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE-YGKAANQKGAMLDWVKKIHQ 522
T +IAPE L D + G+L+ E++ G+ + G + N D++ ++
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218
Query: 523 EKKLEM 528
EK++ +
Sbjct: 219 EKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 305 KNILGKGGFGIVY----KGILQ-------------DGTVVAVKRLKDGNAIGGEIQFQTE 347
K LG+G FG V+ +G+ + +VAVK L++ F E
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 348 VEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV-----------ASRLKGKPILDW 396
++++S N++RL C+T ++ YM NG + A+ + +
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 397 STRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
ST +A A G+ YL +HRD+ N L+ + DFG+++ L D +
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 457 VTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
++G + ++ E + G+ + +DV+ FG+ L E++T
Sbjct: 187 ---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 394 LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453
LD R + A+G+ +L + IHRDV A N+LL D A + DFGLA+ + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 454 DSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512
++V R V +APE + + ++DV+ +GILL E+ + ++ G N K
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-- 323
Query: 513 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
VK+ +Q + + E+ + +C P RP S++ ++++
Sbjct: 324 FYKMVKRGYQMSRPDF-------------APPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 44/234 (18%)
Query: 301 NFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLA 354
+F ++G+G FG V+ L G V A+K L+ + I +I + E ++++ A
Sbjct: 2 DFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 355 VHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
+++LY + E L LV YM G + + L K + T + L +
Sbjct: 59 DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK-----------------------LL 450
H+ IHRD+K NIL+D + DFGL K +L
Sbjct: 118 HKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 451 DHQDSHVTTAVR-----GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
+ H VR GT +IAPE L G + D + G++L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 7/195 (3%)
Query: 307 ILGKGGFG-IVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLYG 364
+LGKG FG ++ G A+K LK I + T E L R+ L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 365 FCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ +RL V Y++ G + L + + + L YLH KI++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVY 118
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RD+K N++LD + DFGL K D+ GT ++APE L D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 484 VFGFGILLLELITGQ 498
+G G+++ E++ G+
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 47/242 (19%)
Query: 308 LGKGGFGIVYKGIL-QDGTVVAVKRLKD--------GNAIGGEIQFQTEVEMISLAVHRN 358
LG+G F +YKG+L + V ++ G+ + F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL-GAARGLLYLHEQC 417
L++LYG C+ E ++V Y+ G + L + K A L YL ++
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK- 120
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGL-AKLLDHQDSHVTTAVRGTVGH--------- 467
K++H +V NIL+ + + KL D + TV
Sbjct: 121 --KLVHGNVCGKNILV--ARYGLNEGYVPFIKLSD-------PGIPITVLSREERVERIP 169
Query: 468 -IAPEYLSTGQSS--EKTDVFGFGILLLEL----------ITGQRALEYGKAANQKGAML 514
IAPE + GQ+S D + FG LLE+ ++ + + ++ M
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL-PMP 228
Query: 515 DW 516
D
Sbjct: 229 DC 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE------------IQFQT--EVEM 350
LG+G +G V K G +VA+K++K I + I F T E+++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
++ H N++ L + LV M+ + + K L S K I L GL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK------LLDHQDSHVTTAVRG- 463
LH+ +HRD+ ANI ++ + DFGLA+ D T R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 464 ------TVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 498
T+ + APE L + D++ G + EL+TG+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLK-----DG---NAIGGEIQFQTEVEMISLAVHRN 358
+G+G +G+VYK G +VA+K+++ +G AI EI E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELN------HPN 59
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA----------R 408
++RL + + LV+ ++ L K +D + L +
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLD-------LDLKKYMD--SSPLTGLDPPLIKSYLYQLLQ 110
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448
G+ Y H +++HRD+K N+L+D + DFGLA+
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G +G VYK + G + A+K +L+ G Q E+ M+ H N++ +G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---VVQQEIIMMKDCKHSNIVAYFG 73
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ + + + GS+ L S ++ +GL YLH + +HR
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR----GTVGHIAPEYLST---GQ 477
D+K ANILL D + DFG++ + T A R GT +APE + G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 478 SSEKTDVFGFGILLLEL 494
++ D++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAV 355
+F K+++G+G FG V ++++ G + A+K +K + E F+ E +++S++
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 356 HRNLLRL-YGFCMTPTERL-LVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLY 412
+ +L Y F + L LV Y G + S L + + D + L A +L
Sbjct: 60 SPWIPQLQYAF--QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYL--AELVLA 114
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
+H +HRD+K N+L+D + DFG A L + GT +IAPE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 473 LSTGQSSEKT------DVFGFGILLLELITGQRALEYGKAA 507
L+T K D + G++ E+I G+ G +A
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
RGL Y+H ++HRD+K +N+LL+ C+ + DFGLA+ + +T V T +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 468 IAPEYLSTGQSSEKT---DVFGFGILLLELITGQ 498
APE L SE T DV+ G + EL+ +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
YLH D II+RD+K N+LLD+ V DFG AK + + T + GT ++APE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185
Query: 472 YLSTGQSSEKTDVFGFGILLLELITG 497
+ + + D + G+LL E I G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLY 363
++GKG FG V + + AVK L+ + E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 364 GFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
F ++L V Y++ G + L+ + + A A L YLH I+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIV 118
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+RD+K NILLD V+ DFGL K + + + T+ GT ++APE L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 483 DVFGFGILLLELITG 497
D + G +L E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDG-------NAIGGEIQFQTEVEMISLAVHRNL 359
+G+G F V K + G A+K +K N + EIQ + L+ H N+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQ-----ALRRLSPHPNI 60
Query: 360 LRLYGFCM-TPTERL-LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
LRL T RL LV+ M + ++ +KG K L K + L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-YLST 475
I HRD+K NIL+ D + DFG + + + + T T + APE L+
Sbjct: 120 ---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTD 173
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521
G K D++ G + E+++ L G N+ LD + KIH
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS-LFPLFPGT--NE----LDQIAKIH 212
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 326 VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVA 385
+VAVK L+ F EV+++S N++RL G C+ ++ YM NG +
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 386 SRLKGK-------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
L P + +S+ +AL A G+ YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG----TVGHIAPEYLSTGQSSEKT 482
N L+ + + DFG+++ L D + ++G + +A E + G+ + +
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 483 DVFGFGILLLELITGQRALEYGKAANQK 510
DV+ FG+ L E++ + YG+ +++
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT-AVRGTV 465
ARG+ +L + K IHRD+ A NILL + + DFGLA+ + +V + R +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
+APE + + ++DV+ FG+LL E+ + + G N+ ++ +++ +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTR 295
Query: 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAER 579
+ E+ ++ L C Q P RP S +V +L GD L E
Sbjct: 296 MRA----------PENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 98 NLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
NL+ + L NN +T IP L L+ LDLS N T P + L SL+ + + N+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 157 L 157
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/192 (25%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G+G GIV + G VAVK + E+ F EV ++ H+N++ +Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+ E ++ ++ G++ + + + L+ + + L YLH Q +IHRD+
Sbjct: 88 LVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDI 143
Query: 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 486
K+ +ILL + DFG + +D ++ GT +APE +S + D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 487 FGILLLELITGQ 498
GI+++E++ G+
Sbjct: 203 LGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
QTE + A L C T RL LV Y++ G + ++ + L + A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA 102
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL-LDHQDSHVTTAVR 462
L +LHE+ II+RD+K N+LLD + D+G+ K L D+ T+
Sbjct: 103 AEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
GT +IAPE L + D + G+L+ E++ G+ +
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 294 ELQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTE 347
E+ ++T F + LG+ FG VYKG L + VA+K LKD +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 348 VEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN----------------GSVASRLKGK 391
M S H N++ L G +++ Y S+ GS K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 392 PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451
L+ + I A G+ +L ++H+D+ N+L+ D + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 452 HQDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
D + + G + ++PE + G+ S +D++ +G++L E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
RGL Y+H IIHRD+K +N+ +++ CE + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 468 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 498
APE L+ ++ D++ G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 310 KGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLYGFC 366
+G FG VY G + + + AVK +K + I + Q + E +LA+ ++ ++ LY
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+ LV Y+ G V S L D + A L YLH IIHRD+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDL 130
Query: 427 KAANILLDDCCEAVVGDFGLAKL 449
K N+L+ + + DFGL+K+
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV 355
+ +G G FG V+ ++D A+K + I E E ++
Sbjct: 2 DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 356 HRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
H ++RL+ +R L + Y+ G + S L+ ST A L YL
Sbjct: 60 HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H + +I++RD+K NILLD + DFG AK L + T + GT ++APE +
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVI 170
Query: 474 STGQSSEKTDVFGFGILLLELITG 497
+ ++ D + GIL+ E++ G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-VRGTV 465
ARG+ +L + K IHRD+ A NILL + + DFGLA+ + +V R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
+APE + + ++DV+ FG+LL E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 308 LGKGGFGIVYKGILQD---GTVVAVKRLK--------DGNAIGGEIQFQTEVEMISLAVH 356
+G+G +G+VYK +D +A+K+++ AI EI E++ H
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ------H 60
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR--KRIALGAARGLLYLH 414
N++RL + LV+ Y+ + + + P + R K RG+ Y H
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE-Y 472
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 473 LSTGQSSEKTDVFGFGILLLELITGQRAL 501
L + S D++ G + E++ Q+ L
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTV--VAVKRLKDGNAIGGEIQFQ----- 345
R+ ++ +F+ LG G FG V ++ VA+KR + I Q Q
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVF 79
Query: 346 TEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRI--- 402
+E ++++ H + LYG + LV ++ G + L+ KR
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--------RNKRFPND 131
Query: 403 --ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
AA+ +L I++RD+K N+LLD + DFG AK++D + T
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYT 187
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
+ GT +IAPE L + D + GI + E++ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 308 LGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV----HRNL 359
LG+G +GIV + VA+K++ N +I + + + L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 360 LRLYGF-CMTPTERLLVYPYMS--NGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHE 415
LY + P +Y Y + ++ G+P+ D + I GL Y+H
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIHS 123
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD----HQDSHVTTAVRGTVGHIAPE 471
++HRD+K N+L++ CE + DFGLA+ +T V T + APE
Sbjct: 124 A---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRAPE 179
Query: 472 YLSTGQSSEKT-DVFGFGILLLELITGQ 498
+ + QS K DV+ G +L EL+ +
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-VRGTV 465
A+G+ +L + K IHRD+ A NILL + + DFGLA+ + +V R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--WVKKIHQE 523
+APE + + ++DV+ FG+LL E+ + A+ G +D + +++ +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEG 298
Query: 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
++ +Y EM Q L C P+ RP SE+V L
Sbjct: 299 TRMR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/200 (25%), Positives = 76/200 (38%), Gaps = 42/200 (21%)
Query: 324 GTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLYGFCMTPTERL-LVYPYMSN 381
T+VAVK++ + +++ Q E+ H N+L Y L +V P M+
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIVDSELYVVSPLMAY 83
Query: 382 GSVASRLK-----GKPILDWSTRKRIAL---GAARGLLYLHEQCDPKIIHRDVKAANILL 433
GS LK G P L IA L Y+H + IHR VKA++ILL
Sbjct: 84 GSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK---GFIHRSVKASHILL 134
Query: 434 D-----------DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS---- 478
+ + D S V + ++PE L Q+
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK-----NLPWLSPEVLQ--QNLQGY 187
Query: 479 SEKTDVFGFGILLLELITGQ 498
+EK+D++ GI EL G
Sbjct: 188 NEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
+G+G +G VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 368 TPTER--LLVYPYMSNG-------SVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQC 417
+ ++R L++ Y + AS+ KP+ L S K + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 418 DPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTVGHIAPE 471
++HRD+K ANIL+ + + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 472 YLSTGQSSEKT-DVFGFGILLLELITGQ 498
L + K D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
++GKG +G+V I G VA+K++ D + + E++++ L H +++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 365 FCMTPTER-----LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+ P+ R +V+ M + + +K L + R L Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA--- 122
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAK--LLDHQDSHVTTAVRGTVGHIAPEYLST-- 475
+ HRD+K NIL + C+ + DFGLA+ D + T T + APE +
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182
Query: 476 GQSSEKTDVFGFGILLLELITGQ 498
+ + D++ G + E++TG+
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 41/193 (21%), Positives = 83/193 (43%), Gaps = 19/193 (9%)
Query: 315 IVYKGILQDGTVVAVKRLK-DGNAIGGEI-QFQTEVEMISLAVHRNLLRLYGFCMTPTER 372
+YKGI + V ++ K I + E++ + N+L++YGF + +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 373 L----LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKA 428
L L+ Y + G + L + L + T+ +A+ +GL L++ ++++ +
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTS 151
Query: 429 ANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAV---RGTVGHIAPEYLSTGQSSEKTDV 484
+ L+ + + + GL K+L +V V + I EY K D+
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT------IKDDI 205
Query: 485 FGFGILLLELITG 497
+ G++L E+ TG
Sbjct: 206 YSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 307 ILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLR 361
+LGKG FG K IL G A+K L+ I + T E L R+ L
Sbjct: 2 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 362 LYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ +RL V Y + G + L + + + L YLH +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---D 115
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
+++RD+K N++LD + DFGL K + + T GT ++APE L
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 174
Query: 481 KTDVFGFGILLLELITGQ 498
D +G G+++ E++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 30/194 (15%)
Query: 324 GTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382
GT+V V+ N ++ Q EV + H N++ + T + ++ P+M+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 383 SVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440
S S LK + + I GA RGL YLH+ IHR++KA++IL+
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILIS------ 135
Query: 441 VGDFGLAKL--LDHQDSHVTTAVRGTVGHIAPEYLSTGQ---SSE-----------KTDV 484
GD GL L L H S V + V + P++ ++ S E K+D+
Sbjct: 136 -GD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI 193
Query: 485 FGFGILLLELITGQ 498
+ GI EL TG+
Sbjct: 194 YSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 60/248 (24%), Positives = 100/248 (40%), Gaps = 40/248 (16%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAI--GGEIQF 344
+ +L++ +F ++G+G FG V +K Q V A+K L I F
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ---VYAMKLLSKFEMIKRSDSAFF 90
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPIL-DWS---- 397
E ++++ A +++L ++ L V YM G + + + I W+
Sbjct: 91 WEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYT 148
Query: 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-H 456
+AL A + + IHRDVK N+LLD + DFG +D
Sbjct: 149 AEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 457 VTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRAL-------EYGK 505
TAV GT +I+PE L + G + D + G+ L E++ G Y K
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 506 AANQKGAM 513
+ K ++
Sbjct: 259 IMDHKNSL 266
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 12/198 (6%)
Query: 307 ILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLR 361
+LGKG FG K IL G A+K LK + + T E L R+ L
Sbjct: 2 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 362 LYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ +RL V Y + G + L + + + L YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KN 116
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
+++RD+K N++LD + DFGL K +D GT ++APE L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 481 KTDVFGFGILLLELITGQ 498
D +G G+++ E++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 5/155 (3%)
Query: 345 QTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
QTE + A H L+ L+ T + V ++S G + ++ + L + +
Sbjct: 43 QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS 102
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
+ L +LHE+ II+RD+K N+LLD + D+G+ K + T+ G
Sbjct: 103 AEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCG 158
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
T +IAPE L D + G+L+ E++ G+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 20/238 (8%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQDGT--VVAVKRLKDGNAI--GGEIQFQT 346
+ R+L++ ++ ++G+G FG V + + T V A+K L I F
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 347 EVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406
E ++++ A +++L+ +V YM G + + + + + R
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR----FYT 148
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
A +L L IHRDVK N+LLD + DFG ++ + GT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 467 HIAPEYLST----GQSSEKTDVFGFGILLLELITGQRAL-------EYGKAANQKGAM 513
+I+PE L + G + D + G+ L E++ G Y K N K ++
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 308 LGKGGFGIVYKGILQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G FG V + T VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR-------KRIALGAARGLLYLHEQC 417
C+ LLV+ Y G + S L + W R +R+A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT------AVRGTVGHIAPE 471
+H D+ N L VGD+G+ +++ ++ T +R APE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL----APE 171
Query: 472 YLSTGQ----SSEKT---DVFGFGILLLEL 494
+ ++E+T +V+ G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-VRGTV 465
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V R V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
+APE + + ++DV+ +GILL E+ + + G + K
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--------------- 325
Query: 526 LEMLVDKDLKNNYDRIELE----EMVQVALLCTQYLPAHRPKMSEVVRMLE 572
K +K Y + E EM + C P RP ++V+++E
Sbjct: 326 ----FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367
+G+G +G VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 368 TPTER--LLVYPYMSNG-------SVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQC 417
+ +R L++ Y + AS+ KP+ L K + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 418 DPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTVGHIAPE 471
++HRD+K ANIL+ + + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 472 YLSTGQSSEKT-DVFGFGILLLELITGQ 498
L + K D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRLY 363
LGKG G V+ L+ G + A+K L D + + TE E+++ H L LY
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYLHE 415
T T LV Y G + L+ +P K ++ AR L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLHL 121
Query: 416 QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR------------- 462
I++RD+K NILL + ++ DF L+K D + V+ A+R
Sbjct: 122 L---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 463 ---------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT +IAPE +S D + GILL E++ G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT-- 464
ARG+ +L + +HRD+ A N+LL + DFGLA+ + H ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 465 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496
V +APE + + +DV+ +GILL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 6e-05
Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 2/38 (5%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT 134
TNL+ + L NN IT +P + L L+TLDLS N T
Sbjct: 1 TNLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 30/203 (14%)
Query: 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVHRN 358
+G+GG+G V+ +D G +VA+KR+K + F+ TE ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 359 LLRL-YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
L++L Y F L Y+ G + L +L + + LHE
Sbjct: 63 LVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL- 120
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG---HIAPEYLS 474
IHRD+K N L+D + DFGL+K + T VG ++APE L
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLR 171
Query: 475 TGQSSEKTDVFGFGILLLELITG 497
D + G +L E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 14/102 (13%)
Query: 422 IHRDVKAANILLDDCCEAVVGDFG-LAKLLDHQDSHVTTAVRGTVGHIAPEYL-----ST 475
+HRD+K N+LLD + DFG +LL AV GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMEDGK 182
Query: 476 GQSSEKTDVFGFGILLLELITGQ------RALE-YGKAANQK 510
G+ + D + G+ + E++ G+ +E YGK N K
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 407 ARGLL----YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD-HQDSHVTTAV 461
AR LL Y+H + IIHRD+K N+L++ + +GDFG A + +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 493
GTV APE L+ + D++ G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 301 NFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV 355
+F + ++ G +G VY K Q A+K++ N I +IQ Q VE L
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQ-QVFVERDILTF 57
Query: 356 HRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
N + FC T+R L V Y+ G A+ LK L + L YL
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYL 117
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK---------LLDHQDSHVT-----T 459
H I+HRD+K N+L+ + DFGL+K L + T
Sbjct: 118 HNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
V GT +IAPE + + D + GI+L E + G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 40/230 (17%)
Query: 291 QFRELQVATHNFS------SKNILGKGGFGIV---YKGILQDGTVVAVKRLKDGNAIGGE 341
QF +QVA F+ +G G GIV + +L G VAVK+L
Sbjct: 6 QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSR------P 57
Query: 342 IQFQT-------EVEMISLAVHRNLLRLYGFCMTPTERL-------LVYPYMSNGSVASR 387
Q QT E+ ++ H+N++ L TP + L LV M + ++
Sbjct: 58 FQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELM-DANLCQV 115
Query: 388 LKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447
+ + LD + G+ +LH IIHRD+K +NI++ C + DFGLA
Sbjct: 116 IHME--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
+ + + T T + APE + E D++ G ++ EL+ G
Sbjct: 171 RTA--CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 14/102 (13%)
Query: 422 IHRDVKAANILLDDCCEAVVGDFG-LAKLLDHQDSHVTTAVRGTVGHIAPEYLST----- 475
+HRD+K NIL+D + DFG KL++ + AV GT +I+PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGK 182
Query: 476 GQSSEKTDVFGFGILLLELITGQRAL-------EYGKAANQK 510
G+ + D + G+ + E++ G+ YGK N K
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
G+ +LH IIHRD+K +NI++ C + DFGLA+ S + T T +
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 184
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQ 498
APE + E D++ G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 14/117 (11%)
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR-GTV 465
A +L +H +HRD+K N+LLD + DFG + L +QD V ++V GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 466 GHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRAL-------EYGKAANQK 510
+I+PE L G+ + D + G+ + E++ G+ YGK N +
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 32/137 (23%), Positives = 63/137 (45%), Gaps = 17/137 (12%)
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426
+P ++ + + + P L + + A G+ +L + +HRD+
Sbjct: 210 ESPYDQY-LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265
Query: 427 KAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGT----VGHIAPEYLSTGQSS 479
A N+L+ CE + DFGLA+ + ++++ +G+ + +APE + +
Sbjct: 266 AARNVLI---CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYT 319
Query: 480 EKTDVFGFGILLLELIT 496
+DV+ FGILL E+ T
Sbjct: 320 TLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 306 NILGKGGFGIVYKGILQDGT-VVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
NI+G G FG+VY+ I D + VA+K+ L+D E+ + I++ ++ Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYY--Y 129
Query: 364 GFCMTPTERLL------------VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
C E+ + V+ YM + A P+ K + R L
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKH--YARNNHALPLF---LVKLYSYQLCRALA 184
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAK-LLDHQDSHVTTAVRGTVGHIA 469
Y+H + I HRD+K N+L+D + + DFG AK LL Q S R + A
Sbjct: 185 YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRA 238
Query: 470 PEYLSTGQSSEKT--DVFGFGILLLELITG 497
PE L G ++ T D++ G ++ E+I G
Sbjct: 239 PE-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 300 HNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVH 356
+ F ++G+G +G+V K ++ +VA+K+ KD E++ T E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLH 414
N++ L + LV+ Y+ ++ L+ P + R I + + + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH 117
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
+ I+HRD+K N+L+ + DFG A+ L + T T + +PE L
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 475 TGQSSEKTDVFGFGILLLELITGQ 498
+ D++ G +L EL GQ
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 21/137 (15%)
Query: 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNL----TNLQIVLLQNNNITGP-IP-- 114
+ + E LV+G L G ++ +L+ + L NN I I
Sbjct: 130 KGLKDLPPALEKLVLG----RNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRAL 185
Query: 115 AEIGR-LTKLQTLDLSNNFFTGE----IPSSLGHLRSLQYMRFNNNSLSGAFPTSLAS-- 167
AE + L+ LDL+NN T E + +L L+SL+ + +N+L+ A +LAS
Sbjct: 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASAL 245
Query: 168 ---MTQLIFLDLSYNNL 181
L+ L LS N++
Sbjct: 246 LSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRN 358
+G+G +G VYK G +VA+K+ + G EI ++M+S +++
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL---LQMLSESIY-- 62
Query: 359 LLRLYGFCMTPTER-------LLVYPYM---------SNGSVASRLKGKPILDWSTRKRI 402
++RL + E LV+ Y+ SNG R G+P L T K
Sbjct: 63 IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNG----RGPGRP-LPAKTIKSF 115
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAV 461
+G+ + H+ ++HRD+K N+L+D + + D GL + T +
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 462 RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 498
T+ + APE L + S D++ G + E+ Q
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
G+ +LH IIHRD+K +NI++ C + DFGLA+ S + T T +
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 192
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQ 498
APE + E D++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 308 LGKGGFGIVYK----GILQDGT--VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 360
LG+G FG V + GI + + VAVK LK+G TE++ +I + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 361 RLYGFCMTPTERLLV-YPYMSNGSVASRLKGK-----PILDWSTRKRI 402
L G C P L+V Y G++++ L+ K P + STRKR
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
G+ +LH IIHRD+K +NI++ C + DFGLA+ S + T T +
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 185
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELI 495
APE + E D++ G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 622 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.2 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.18 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.09 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.07 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.06 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.75 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.69 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.65 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.64 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.64 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.5 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.48 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.38 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.16 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.15 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-60 Score=558.90 Aligned_cols=460 Identities=27% Similarity=0.512 Sum_probs=342.6
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++++.+|..|.++++|+.|+|++|++.+.+|..+.++++|++|+|++|.++|.+|..|.++++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 46778888888888888888888889999999999888888888888899999999999988888888888889999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc----cccccccccccccCCC---CCCCcccccCCCccCcCCCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATGS---EPDCYGTQLMPMSMNLNSSQ 226 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N~~~c~~~~---~~~c~~~~~~p~s~~~~~s~ 226 (622)
+|+++|.+|..+..+++|+.|++++|+++|.+|.... ....+.||+.+|+... .+.|.
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~--------------- 620 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK--------------- 620 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCc---------------
Confidence 9999888888888888899999999999888886422 2345678888886431 11111
Q ss_pred CCCCCCCCCcceeEEeeeehhhHHHHHHHHHHHhhhhhhccchhhhhhhccccccccc-----CcccccCHHHHHHHHhC
Q 036225 227 TASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSL-----GNLRRFQFRELQVATHN 301 (622)
Q Consensus 227 ~~s~~~~~~~~l~~vi~~~~~~~~l~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 301 (622)
.........+++++++++++++++++++++++|+|+..+... . +........ .....+++.+ ....
T Consensus 621 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 691 (968)
T PLN00113 621 ----RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR-V-ENEDGTWELQFFDSKVSKSITIND---ILSS 691 (968)
T ss_pred ----cccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccc-c-ccccccccccccccccchhhhHHH---HHhh
Confidence 001111222333333343333333333333333333221110 0 000000000 0011122333 3456
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|...++||+|+||.||+|.. .++..||||+++..... ...|++.+++++|||||+++|+|...+..++||||++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 77889999999999999997 57899999998754321 2356888999999999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+|+|.++++. ++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++..++. ||........ ..
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CC
Confidence 9999999963 8999999999999999999997777799999999999999999888875 6655432211 12
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC--C
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN--Y 538 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--~ 538 (622)
..+|..|+|||++.+..++.++|||||||++|||+||+.||+... .....+.+|.+..........++|+.+... .
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 357899999999999999999999999999999999999985322 233457778776655555666677666432 3
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+..++.+++.+|++.+|++||+|+|+++.|+.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 45566788999999999999999999999999975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=457.27 Aligned_cols=286 Identities=52% Similarity=0.878 Sum_probs=253.3
Q ss_pred cccccCHHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeee
Q 036225 286 NLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365 (622)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 365 (622)
..+.|++.++..+|++|...++||+|+||.||+|..++|+.||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999887655433 5569999999999999999999999
Q ss_pred eeCCC-ceeEEeeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 036225 366 CMTPT-ERLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442 (622)
Q Consensus 366 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 442 (622)
|.+.+ +.+||||||++|+|.++|+... .++|..|.+||.++|+||+|||+.+.+.||||||||+|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99999 4999999999999999998655 89999999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|||+|+..............||.+|+|||++..+..++|+|||||||+++||+||+.|.+... ......+.+|+.....
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHH
Confidence 999997654311111111179999999999999999999999999999999999998887654 2333448899988888
Q ss_pred hhhhhhhccccCC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 523 EKKLEMLVDKDLK-NNYDR-IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 523 ~~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+.+++|+.+. ..+.. .+...+.+++.+|++.+|.+||+|.||+++|+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 8899999999987 66664 678889999999999999999999999999954
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=399.18 Aligned_cols=255 Identities=35% Similarity=0.514 Sum_probs=212.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCC-ceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-ERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~ 376 (622)
..++...+.||+|+||+||+|.++....||||++....... ....|.+|+.++.+++|||||+++|+|..+. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 33444556799999999999999855559999998654322 2558999999999999999999999999988 799999
Q ss_pred eeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeeecCCC-ceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANILLDDCC-EAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~ 452 (622)
||+++|+|.++++. +..+++..+.+|+.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999987 67899999999999999999999998 6 99999999999999997 999999999987654
Q ss_pred CCCceeeeecCcccccCccccc--cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||...... +- ...++
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~---------~~~v~ 259 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QV---------ASAVV 259 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HH---------HHHHH
Confidence 32 2233467999999999999 568999999999999999999999999854421 00 11112
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..++..+..++.+||..||.+||++.+++..|+.
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 2223333444467889999999999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.65 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=214.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC-ceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-ERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e 377 (622)
.+++..+.||+|..|+|||+.++ +++.+|+|.+.........+++.+|+++++..+||+||++||.|..+. +..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34556789999999999999976 689999999976666666778999999999999999999999999998 5999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||++|+|.+.++..+.+++...-+|+.+|++||.|||+ . +||||||||+|||++..|++||||||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999999987889999999999999999999996 5 9999999999999999999999999999877543
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
....++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .....+.+.+.. +++... .
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~---------Iv~~pp-P 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCA---------IVDEPP-P 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHH---------HhcCCC-C
Confidence 4566789999999999999999999999999999999999999987541 111222222222 222111 1
Q ss_pred CCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDR-IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+. ...+++..++..|+++||.+||+++|++++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222 356789999999999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=387.53 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=217.0
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+++..+.+...+.||+|.||+||.|.++....||+|.++.... ....|.+|+++|++++|+|||+++|+|..++..+|
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 3444455566789999999999999999888999999987632 34578899999999999999999999999999999
Q ss_pred EeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|||||+.|+|.++|+. ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999985 56799999999999999999999999 999999999999999999999999999996554
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..+.....-.-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.... ..+.+..+.+.
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~G-------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERG-------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhcc--------
Confidence 44444444455789999999999999999999999999999999 666655322 22333333333
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+-..+..|+.++.+++..||+.+|++|||++.+...|+.
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 3333456688999999999999999999999998888874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.01 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=208.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc------hhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.+.|.+.+.||+|+||.|-+|+. ++|+.||||++++..... .....++|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45577889999999999999995 579999999998654332 22346799999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcccccce
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC---CEAVVGDFGLAK 448 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~ 448 (622)
.|+||||++||+|.+.+-.+..+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999888899999999999999999999999 99999999999999755 789999999999
Q ss_pred ecCCCCCceeeeecCcccccCccccccCC---CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
+.+ ........+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||........ +.+ ++.
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~e---QI~---- 395 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKE---QIL---- 395 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHH---HHh----
Confidence 876 344566788999999999997654 33488999999999999999999975443221 111 111
Q ss_pred hhhhccccCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 LEMLVDKDLK--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ~~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..++. +.......++..++|.+||..||++||++.|++++
T Consensus 396 -----~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 -----KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111 11233455789999999999999999999998864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.74 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=181.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.+|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+++|+.++|||||.+++++..++..++|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56778888999999999999975 68999999997664 33344567899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC------CceEEcccccceecC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC------CEAVVGDFGLAKLLD 451 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~Dfgla~~~~ 451 (622)
||.||+|.++++....+++.+.+.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999999998999999999999999999999999 99999999999999864 568999999999886
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccch
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGK 505 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~ 505 (622)
. .......+|++.|||||++..++|+.|+|+||+|+++|++++|+.||+...
T Consensus 167 ~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 P--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred c--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 3 334556789999999999999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=381.88 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=214.0
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..|...+.||+|||+.+|.+.. .+|+.||+|++.+.. .......+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 789999999997642 2334556889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+|++++|..+++....+++++++.++.||+.||.|||+. +|+|||||-.|+|++++.++||+|||+|..+.... .
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence 9999999999999888999999999999999999999999 99999999999999999999999999999887543 3
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....+||+.|.|||++....++..+||||+||+||-|++|++||+.....+. ...+... + .
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~---~--------Y 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLN---E--------Y 235 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhc---C--------c
Confidence 45567899999999999999999999999999999999999999985432211 1111111 0 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++..-..+..+||.++|+.+|.+|||+++|+..
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222334668899999999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=351.54 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=213.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+.|+..-++|+|+||+|||++.+ +|+.||||++...... ...+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34667789999999999999976 5999999999876542 233457899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
||+..-|.++=+....++.....++++|+++|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+.. ....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 999855554444445688999999999999999999999 999999999999999999999999999998875 3344
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh--------hhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH--------QEKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 528 (622)
.+.++.|..|+|||.+.+ .+|+..+||||.||++.||+||.+.|....+.++...|...+..+. ..+....
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 567789999999999988 6899999999999999999999999988777666555554443321 1111111
Q ss_pred hccccC------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDL------KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.-+.. ...++ .....+.+++..|++.||.+|++.+|++..
T Consensus 238 v~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 11111 123468899999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=348.69 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=205.5
Q ss_pred hCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeee-eeeCCCc-eeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYG-FCMTPTE-RLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 375 (622)
.+|.+.++||+|.||+||++. ..+|..||.|.++-..... .......|+.+|++++|||||++++ .+.+..+ ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 446677899999999999998 5689999999998443222 2335789999999999999999999 4444455 7899
Q ss_pred eeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeeecCCCceEEcccccceec
Q 036225 376 YPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 376 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
||||+.|+|...++ .+..+++..+++++.|++.||.++|++...+ |+||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999885 4567999999999999999999999954322 889999999999999999999999999998
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..... .....+|||.||+||.+.+..|+.||||||+||++|||..-++||.... +...-+.+.+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qg------- 243 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQG------- 243 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcC-------
Confidence 75443 3456789999999999999999999999999999999999999998542 22222222211
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
+...-.....+..+.+||..|+..||+.||+.-.+++.+
T Consensus 244 --d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 --DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 111112245668899999999999999999855444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=355.14 Aligned_cols=245 Identities=27% Similarity=0.320 Sum_probs=208.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
...++|++.++||+|+||+||.++.+ +++.+|+|++++..... +......|..+|.+++||.||+++-.|++++..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34578999999999999999999954 68999999998765333 3456889999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+|+||+.||.|..+|+++..++++.+..++.+|+.||.|||++ +||||||||+|||+|++|+++|+|||+++..-.
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999999999999999999999999999999999 999999999999999999999999999985432
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
....+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+. ..+...+...+
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGK--------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCc---------
Confidence 33345568899999999999999999999999999999999999999985442 22223322221
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRP 562 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 562 (622)
+ ...+..-..+..+++.+.++.||++|-
T Consensus 242 ~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 112222346788999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=388.67 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=219.5
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 366 (622)
.-.++...+....+.||+|+||+||+|... +...||||.+++....+...+|++|+++++.++|||||+++|.|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334455666777889999999999999843 35689999999988777788999999999999999999999999
Q ss_pred eCCCceeEEeeeccCCCccccccC--------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKG--------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIL 432 (622)
..++..++|+|||..|+|.++|.. .+.|+..+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 999999999999999999999851 12388899999999999999999999 9999999999999
Q ss_pred ecCCCceEEcccccceecCCCCCceee-eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcccc
Q 036225 433 LDDCCEAVVGDFGLAKLLDHQDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQK 510 (622)
Q Consensus 433 l~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~ 510 (622)
|.++..|||+|||+++..-..+++... ...-..+|||||.|..+++|++||||||||+|||++| |+.|++.....
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--- 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--- 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence 999999999999999877655554432 2234679999999999999999999999999999998 77887644321
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+-++.+-+..+ -..++.++.++++|+..||+..|++||+++||-..|+.
T Consensus 713 -------------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 713 -------------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred -------------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 11222222233 23567788999999999999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=363.02 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=216.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCC-ceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPT-ERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~l 374 (622)
..++|...+.||.|+||+||+|+. .+|+.||||+++.....-++..-.+|++.|++++ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356788889999999999999994 5799999999987654444445678999999998 999999999999888 8999
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|||||+. +|+++++. ...+++..++.|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+|+.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999965 99999975 45799999999999999999999999 9999999999999999999999999999977643
Q ss_pred CCceeeeecCcccccCccccc-cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh-----hhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK-----KLE 527 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 527 (622)
. ..+.++.|..|+|||++. .+.|+.+.||||+||+++|+++-++.|.+..+.|+...+-+.++...... .+.
T Consensus 164 p--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 P--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3 346678999999999874 56799999999999999999999999988777666544444332221111 111
Q ss_pred hhccccCCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNN-------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+.-+++.. .-.....+..+++.+|+.+||.+|||++|.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 2222222111 112256788999999999999999999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=358.68 Aligned_cols=267 Identities=23% Similarity=0.310 Sum_probs=214.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 374 (622)
.+.|+..++||+|+||.||+|.. .+|+.||+|+++-.+. .....-..+||.+|++++||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34566778999999999999994 5799999999986553 33344567999999999999999999998876 78999
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|+|||++ +|.-++.. .-.++..++..++.|++.||+|||++ +|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999988 88887765 44799999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh-hhhcc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL-EMLVD 531 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d 531 (622)
.....+..+-|..|+|||.+.+. .|+..+|+||.||||.||++|++.|....+.++...|........+..+. ..+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66666777789999999999875 69999999999999999999999998777666555554443332222221 01110
Q ss_pred c---cCCCCCCHH-------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 532 K---DLKNNYDRI-------ELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 532 ~---~~~~~~~~~-------~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
. .....+.+. -+...++|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 001112211 1356788999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=355.61 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=211.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchh--HHHHHHHHHHhcc-ccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA-VHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 373 (622)
..++|..++.||+|+|++|++|.. .+++.||||++.+.....+. ..+..|-++|.++ .||.|++|+--|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 456788999999999999999995 46899999998765433222 2466788889988 8999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+|+||+++|+|.++++..+.+++...+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999988532
Q ss_pred CCc----------e--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 454 DSH----------V--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 454 ~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
... . ...++||-.|.+||++.....+..+|+|+|||++|+|+.|++||...++... .+.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-------Fqk-- 298 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-------FQK-- 298 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-------HHH--
Confidence 211 1 1458899999999999999999999999999999999999999986542111 111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
+.. ++-.+...++ +.+.+|+.+.|..||.+|+|..+|-++.
T Consensus 299 ----I~~-l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 ----IQA-LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----HHH-hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111 1122233333 6788999999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=347.61 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=204.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC--ceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--ERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 376 (622)
.++...+.||+|+||+||++... +|+..|||.+....... ...+.+|+++|.+++|||||+.+|...... .+.++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34667899999999999999975 48999999987653322 446889999999999999999999855554 588999
Q ss_pred eeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccccceecCC--
Q 036225 377 PYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKLLDH-- 452 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~-- 452 (622)
||+++|+|.+++.... .++++.+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998655 799999999999999999999999 9999999999999999 79999999999987653
Q ss_pred CCCceeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........||+.|||||++.++. ...++|||||||++.||+||++||... .....++-.+.....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~------ 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDS------ 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCC------
Confidence 2222344578999999999998643 345999999999999999999998742 011112222111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
....+...+.+..+++.+|++.+|++|||++++++...
T Consensus 241 ---~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 ---LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11233334577899999999999999999999998654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.09 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=211.5
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
..++++..+++.+.+.||+|.||+||+|.|.. .||||+++...... ..+.|++|+.++++-+|.||+-+.|||..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 46777888888899999999999999999862 49999998655333 3457999999999999999999999999988
Q ss_pred ceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 371 ERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
. .+|+.+|+|-+|+.+++- +..++..+.+.|+.|||+||.|||.+ +|||||||..||++.+++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 7 999999999999999984 45689999999999999999999999 999999999999999999999999999975
Q ss_pred cCCC-CCceeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 450 LDHQ-DSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 450 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
...- .........|...|||||+++. .+|++.+||||||+++|||+||..||. ....++ ++- .+.+..-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq---Iif---mVGrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ---IIF---MVGRGYL 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh---eEE---Eeccccc
Confidence 4321 1111222347889999999964 368999999999999999999999987 222221 110 0111100
Q ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
..+. ......++.++.+|+..||..++++||.+.+|+..|+..
T Consensus 611 ~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 611 MPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred Cccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0000 112234567899999999999999999999999988753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=323.85 Aligned_cols=265 Identities=24% Similarity=0.340 Sum_probs=211.5
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCch-hHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.+|...++||+|.||.||+|.. ++|+.||||+++..+..++ .....+|++.|+.++|+||+.+++.|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567788999999999999995 5799999999987654433 3467899999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|++. +|...++.+ ..+.-.++..++.++.+|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 899988754 4688899999999999999999999 9999999999999999999999999999998765544
Q ss_pred eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh----------
Q 036225 457 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK---------- 525 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 525 (622)
.... +-|..|+|||.+.+. .|+..+||||.||++.||+-|.+-|.+..+.++...+...+.......+
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3333 679999999998875 5999999999999999999998777666555554444333222111111
Q ss_pred -hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 -LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 -~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.....+.+.. .-..+.....+++.+++..+|.+|+++.|++++
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111111 222344567999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.23 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=204.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
++..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 35567899999999999999999974 235689999997654444455789999999999 89999999998876
Q ss_pred CC-ceeEEeeeccCCCccccccCC--------------------------------------------------------
Q 036225 369 PT-ERLLVYPYMSNGSVASRLKGK-------------------------------------------------------- 391 (622)
Q Consensus 369 ~~-~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 391 (622)
.+ ..++||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999998887531
Q ss_pred ------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce-eeeecCc
Q 036225 392 ------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGT 464 (622)
Q Consensus 392 ------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt 464 (622)
..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 2477888999999999999999998 99999999999999999999999999998654322211 2233466
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHH
Q 036225 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543 (622)
Q Consensus 465 ~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 543 (622)
..|+|||++.+..++.++|||||||++|||++ |..||....... .....+..... ...+...+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~----------~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR----------MRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC----------CCCCCCCC
Confidence 88999999999999999999999999999997 999986432111 11111111100 01122334
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 544 EEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 544 ~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=353.89 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=209.1
Q ss_pred hCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
..|...+.||+|+.|.||.|. ..+++.||||++...... ..+-+.+|+.+++..+|+|||+++..|...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 346677899999999999998 457889999999765433 344578999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
|++|+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 352 m~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred cCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999999887554 89999999999999999999999 999999999999999999999999999988765444 45
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...+||+.|||||++....|++|+||||||++++||+-|++||...++.. -+..+...+ .+.+ ..
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng------~P~l--k~ 491 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNG------TPKL--KN 491 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcC------CCCc--CC
Confidence 56679999999999999999999999999999999999999997533211 111111111 1111 12
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+.+++.+||+.|+++||+++|+|++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23344779999999999999999999999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=366.10 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=216.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
...+.++||.|.||+||+|.++ ....||||.+|.........+|+.|..++.++.||||++|.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999975 246799999999888888889999999999999999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||++|+|..+|+. ...+++.++.-++++||.||.||-+. ++|||||..+|||++.+..+|++|||+++.+.....
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999974 45699999999999999999999999 999999999999999999999999999998865443
Q ss_pred ceeeeecC--cccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 456 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 456 ~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
...+...| ..+|.|||.+....+|..||||||||+|||.++ |.+|+....+.+ -++. +..
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIka----------Ie~ 849 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKA----------IEQ 849 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHH----------HHh
Confidence 33333323 579999999999999999999999999999886 888876443221 2222 223
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.++-..+.+++..|.+|++.||++|-.+||++.+++..|..
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 33334566788999999999999999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=346.19 Aligned_cols=250 Identities=29% Similarity=0.405 Sum_probs=216.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
..|...+.||+|.||.||+|.. ..++.||+|++.-....++...+++|+.++..++++||.++||.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4567778999999999999995 468999999999887777777899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
|.+|++.+.++....+++..+.-|+.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||.+-.+.......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999999999888889999999999999999999999 99999999999999999999999999998876544433
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
..++||+.|||||++....|+.|+||||||++.+||.+|.+|+..-.+. +..-++.+..+...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEeccCCCCCcc
Confidence 6778999999999999889999999999999999999999998743321 11222233333333
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+.+++..|+.++|+.||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33445678999999999999999999999963
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=353.08 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=209.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.-+.....+-||.|+-|.||.|.++ ++.||||+++.-+ ..+++-|++++||||+.+.|+|.....+++|||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 3334445678999999999999998 6789999886432 256778999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
||..|-|.+.|+....+.-.....|..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++..... ..
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 999999999999999999999999999999999999999 9999999999999999999999999999876543 33
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
...+.||..|||||++.+.+.++|+|||||||+||||+||..|+..-+... |+ -.+-...+.-.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----II------------wGVGsNsL~Lp 331 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----II------------WGVGSNSLHLP 331 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eE------------EeccCCccccc
Confidence 456789999999999999999999999999999999999999986332110 00 00111122233
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.+..+++-+.-|++.||+..|..||++.+++.+|+-.
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 5666778899999999999999999999999998743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=335.38 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=208.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..++|...++||.|..++||+|.. ..++.||||++.-+........+.+|+..++.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788899999999999999994 5689999999987776666778999999999999999999999999999999999
Q ss_pred eeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
.||.+|++.+.++. ...+++..+..|+++++.||.|||++ |.||||||+.||||+.+|.+||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999974 23489999999999999999999999 99999999999999999999999999876664433
Q ss_pred Ccee---eeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 455 SHVT---TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 455 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.... ...+||+.|||||++.. ..|+.|+||||||++..||.+|..||..-.+ +...+..+........
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~~- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPPTLL- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCCCcc-
Confidence 2221 34579999999999644 4599999999999999999999999963221 1111112211111000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+..+........+.+++..|++.||.+|||+.++++
T Consensus 254 -t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 -TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 011111111222357889999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=339.82 Aligned_cols=262 Identities=17% Similarity=0.258 Sum_probs=206.9
Q ss_pred cCcccccCHHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCch--hHHHHHHHHHHhcccccccee
Q 036225 284 LGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~ 361 (622)
+.+++.+...++ +......||+|++|.||+|.+ +|+.||||+++....... ...+.+|++++.+++||||++
T Consensus 9 ~~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 9 INDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred cCcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 344455555555 223346899999999999998 588999999976533221 346789999999999999999
Q ss_pred eeeeeeC----CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 036225 362 LYGFCMT----PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 362 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
++|++.+ ....++||||+++|+|.+++.....+++.....++.|++.||.|||+.. +++||||||+|||+++++
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY 160 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence 9999876 3567899999999999999988888999999999999999999999732 788999999999999999
Q ss_pred ceEEcccccceecCCCCCceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 438 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 438 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||+||+.||...... +
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~ 229 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E 229 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H
Confidence 99999999998654321 22358899999999976 67899999999999999999999999743211 1
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+.. ...+...+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 230 ~~~~i~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 230 IYDLIIN---------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHh---------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111110 111111222345679999999999999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=347.53 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=214.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|.+.+.||+|.||.||||..+ +.+.||+|.+.+... ..+.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999965 689999999976543 3345568999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+.| +|..++.....++++....|+.+++.||.|||+. +|+|||+||.|||+++.+.+|+||||+|+.+.. ....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 9987 9999999999999999999999999999999999 999999999999999999999999999998765 4456
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.+...||+.|||||++.+++|+..+|+||+||++||+++|++||... .+.+.++.+..+. . .
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~--------v---~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDP--------V---K 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCC--------C---C
Confidence 67788999999999999999999999999999999999999999743 2444444443221 1 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+......+..++...+.+||.+|.+-.+++.+
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 222445678899999999999999999998864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=321.86 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=204.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
-++|+..+.||.|+||.|..++.+ +|..+|+|++.+.... .+.+...+|.++|+.+.||.++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356788899999999999999965 6889999999765432 2333577899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||++||.|.++++..+.++...++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999999976532
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
+-..+||+.|+|||++....|+..+|.|||||++|||+.|.+||...... +.. +.++...+
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY---------~KI~~~~v- 258 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIY---------EKILEGKV- 258 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHH---------HHHHhCcc-
Confidence 56678999999999999999999999999999999999999999855431 111 11222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCC
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHR 561 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~R 561 (622)
.+++.-..++.+|+.+.++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1344444678899999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.48 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=213.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
+...++|+..++||+|+||.||.|+-+ +|+.+|+|++++.... .+.+.++.|-.+|....+|.||+++..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456788999999999999999999954 6999999999876432 2334578899999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||||||++||++..+|.....|++...+.++.+++.|++.+|+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999843311
Q ss_pred ----------------------CCCc-----e-------------------eeeecCcccccCccccccCCCCcccceee
Q 036225 453 ----------------------QDSH-----V-------------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFG 486 (622)
Q Consensus 453 ----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvws 486 (622)
.+.. . ....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0 11245999999999999999999999999
Q ss_pred hhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---
Q 036225 487 FGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK--- 563 (622)
Q Consensus 487 lGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt--- 563 (622)
||||+|||+.|.+||....+...-..+..|...+...... ....+..+||.+|+. ||++|-.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999998777666555666666544322111 122678899999999 9999986
Q ss_pred HHHHHH
Q 036225 564 MSEVVR 569 (622)
Q Consensus 564 ~~evl~ 569 (622)
+.||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 444443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=353.87 Aligned_cols=260 Identities=30% Similarity=0.429 Sum_probs=211.5
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECC--C--eE-EEEEEccCC--CCCchhHHHHHHHHHHhccccccceeeeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQD--G--TV-VAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 365 (622)
..++...++....++||+|+||.||+|.+.. + .. ||||..+.. .......+|.+|.+++++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4455566667777999999999999999652 2 23 899998852 334455689999999999999999999999
Q ss_pred eeCCCceeEEeeeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 366 CMTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 366 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
+......++|||+|.||+|.++|+..+ .++..++..++.+.|+||+|||++ +++||||..+|+|++.++.+||+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999998766 599999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceee-eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhh
Q 036225 445 GLAKLLDHQDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 445 gla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|+++.-. ...... ...-+..|+|||.+..+.|++++|||||||++||+++ |..|+......+ ...++
T Consensus 307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI----- 375 (474)
T KOG0194|consen 307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKI----- 375 (474)
T ss_pred ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----HHHHH-----
Confidence 9987543 111111 2235689999999999999999999999999999999 788887544321 11111
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.-...+...+...+.++..++.+|+..+|++||+|.++.+.|+.
T Consensus 376 -------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 376 -------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred -------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 11122222334556788999999999999999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.83 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=205.8
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+....++|+..+.||+|+||.||+|.+ .++..||||+++..........+.+|++++..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344566788999999999999999973 246689999997654444455788999999999 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC--------------------------------------------------------
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK-------------------------------------------------------- 391 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 391 (622)
..+..++||||+++|+|.++++..
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999998887431
Q ss_pred -------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 392 -------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 392 -------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
..+++..+.+++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1478889999999999999999998 999999999999999999999999999986643
Q ss_pred CCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..... .....++..|+|||++.+..++.++|||||||++|||+| |..||...... .....++. ..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~---~~------- 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIK---EG------- 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHH---hC-------
Confidence 32211 122335678999999999999999999999999999998 78887532211 11111111 11
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+.++.+++.+|++.||++||+++|+++.|+.
T Consensus 334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0001111224678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=347.28 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=207.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCC----chhHHHHHHHHHHhccc-cccceeeeeeeeCCCc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTE 371 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 371 (622)
....|...+.||+|+||+|+.|.. .+|+.||+|++...... .....+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788999999999999999985 47899999977654111 23445778999999999 9999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~ 450 (622)
.++||||+.+|+|.+++.....+.+....+++.|++.|++|||++ +|+||||||+|||+|.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999888899999999999999999999999 99999999999999999 99999999999977
Q ss_pred CCCCCceeeeecCcccccCccccccCC-CC-cccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ......+...
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki~~~----- 238 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKIRKG----- 238 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHHhcC-----
Confidence 4 2233445678999999999999877 75 789999999999999999999986321 1111111111
Q ss_pred hccccCCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 529 LVDKDLKNNYDRIE-LEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 529 ~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+ .++... ..++..++.+|+..+|.+|+++.++++
T Consensus 239 ----~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 ----EF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----Cc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 00 111111 477899999999999999999999983
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=374.83 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=213.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC--Ce----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD--GT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
..+....+.||+|.||.||.|...+ |. .||||.++.........+|.+|..++++++|||||+++|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556677899999999999999653 43 49999999888788888999999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 373 LLVYPYMSNGSVASRLKGK-------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
++++|||++|+|..+|++. ..++....+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999754 4588899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeee-cCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhh
Q 036225 446 LAKLLDHQDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 446 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
+|+.+...+++..... .-...|||||.+..+.+|.|+|||||||++||++| |..|+...++.+ .+..+...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhC
Confidence 9996544444333322 23479999999999999999999999999999999 666665333211 11111111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
+ +-+.++.|++.+.+++..||+.+|++||++..+++.+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1 2234667889999999999999999999999999977643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=335.74 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=206.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
...+|++.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++.+++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3467888999999999999999853 367899999987654444557889999999999999999999999999999
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999875 35689999999999999999999998 999999999999999999999999998765422
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........++..|+|||++.+..++.++|||||||++||+++ |+.||...... .....+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~-------- 224 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDG-------- 224 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCC--------
Confidence 21111122335678999999999999999999999999999875 99998643211 111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.13 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=202.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-----------------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccccee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 361 (622)
.++|...+.||+|+||.||+|.+++ +..||+|.++..........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578888999999999999998532 34799999876544444557899999999999999999
Q ss_pred eeeeeeCCCceeEEeeeccCCCccccccCC-------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCee
Q 036225 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGK-------------------PILDWSTRKRIALGAARGLLYLHEQCDPKII 422 (622)
Q Consensus 362 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 422 (622)
+++++...+..++||||+++|+|.+++... ..++|....+++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 999999999999999999999999887432 2468889999999999999999998 999
Q ss_pred ecCCCCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhc--CC
Q 036225 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG--QR 499 (622)
Q Consensus 423 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg--~~ 499 (622)
||||||+|||+++++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 12233457899999999888999999999999999999974 45
Q ss_pred ccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 500 ALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 500 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
||...... .....+............ ...+..++..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 241 p~~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE----QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH----HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55432211 112222221111100000 0011223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.39 Aligned_cols=267 Identities=19% Similarity=0.231 Sum_probs=204.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|.+.+.||+|+||+||+|..+ +++.||+|+++..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 6889999998754322 233467889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999887766655556789999999999999999999998 99999999999999999999999999998764333323
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH--------HHHHhhhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW--------VKKIHQEKKLEML 529 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 529 (622)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 33456899999999999888999999999999999999999999754332211111111 0100000000000
Q ss_pred ccccCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKN------NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+.... .+....+..+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 001113456899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.94 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=205.2
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+....++|++.+.||+|+||.||+|... ++..||+|+++..........+.+|+++++.+ +|+||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3455668899999999999999998842 34579999998655444455688999999999 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC--------------------------------------------------------
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK-------------------------------------------------------- 391 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 391 (622)
..+..++||||+++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999998877421
Q ss_pred --------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc-
Q 036225 392 --------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH- 456 (622)
Q Consensus 392 --------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~- 456 (622)
..+++..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 2478888999999999999999998 9999999999999999999999999999865432221
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+.. ... . ...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~---~~~-~---------~~~ 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYK---MVK-R---------GYQ 333 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHH---HHH-c---------ccC
Confidence 1122335678999999988899999999999999999997 999986432111 0111 110 0 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01111123678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=327.16 Aligned_cols=286 Identities=20% Similarity=0.346 Sum_probs=225.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|++.+.||+|.||.|-+|+. ..|+.||||.+++....+ +...+.+|+++++.++||||+.+|++|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35677788999999999999995 679999999998765433 333688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||..+|.|++++.....|++.+.++++.||..|+.|+|++ +++|||||.+|||+|+++++||+|||++..+.. .
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--K 206 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--c
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999987643 3
Q ss_pred ceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
..-+.++|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||+..+. ...++++.... .
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~Ga---------Y 270 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGA---------Y 270 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhccc---------c
Confidence 33456789999999999999988 6889999999999999999999985431 12233332211 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHHHHhhhhhccCCCCCC-CCCCCCCCCCCCCcchhh
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHE-FSSSDRYSDLTDDSSLLV 613 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~ 613 (622)
+ .+..+....-||++|+..+|++|.|+.+|..+ +.-.|......-...+.... ...++++.|-++.|...+
T Consensus 271 r---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH-----WWvNwgy~~~V~~~ea~h~~~~P~~~~m~dw~~Rs~~~~ 342 (668)
T KOG0611|consen 271 R---EPETPSDASGLIRWMLMVNPERRATIEDIASH-----WWVNWGYNMPVIQEEAQHIDHTPGSDSMADWTERSETMI 342 (668)
T ss_pred c---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh-----heeecccccccccccccccCCCCcchhhhHHhhccccch
Confidence 1 11122446689999999999999999999865 22334443332222222221 122555666665555443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=328.51 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=196.9
Q ss_pred CCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHh--ccccccceeeeeeeeCCC----ceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS--LAVHRNLLRLYGFCMTPT----ERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~l 374 (622)
.....++||+|.||.||||.++ ++.||||++... +...|+.|-++++ .++|+||++++++-...+ +++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999999999997 589999998743 3457888888877 558999999999987666 8899
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ------CDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
|+||.+.|+|.++|+.. .++|....+|+..+++||+|||+. .+|+|+|||||++|||+..|+++.|+|||+|.
T Consensus 286 Vt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999999865 589999999999999999999964 47899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeecCcccccCccccccCCC-C-----cccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 449 LLDHQDSH-VTTAVRGTVGHIAPEYLSTGQS-S-----EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 449 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~-----~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
.+...... .....+||.+|||||++.+... . .+.||||+|.++|||++.-..++.+...+....+-.-++.-.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 88643322 2234689999999999976432 2 367999999999999986544432221111111111111111
Q ss_pred hhhhhhh-hccccCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 522 QEKKLEM-LVDKDLKNNYDR-----IELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 522 ~~~~~~~-~~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.-+.+.+ ++.++.+..++. ..+..+.+.+..||..||+.|-|+.=|-+.+.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 1111111 111122221111 23456889999999999999999987766654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=319.95 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=209.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC--CCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~l 374 (622)
.++|+..+.|++|+||.||+|+++ +++.||+|+++-... .+-...-.+|+.+|.+++|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356778899999999999999965 789999999985432 2223356799999999999999999998764 467899
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|||||++ +|.+.+..- +.+...+..-++.|+++|++|||.. .|+|||||++|+|+++.|.+||+|||+|+.++.+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999988 888888753 4788899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh--hh--
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL--EM-- 528 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 528 (622)
.. ..+..+-|..|+|||.+.+. .|++..|+||+|||+.||+++++.|.+....++...+.+.+....+..+. .+
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 33 34556679999999999875 58999999999999999999999998777666655554433322111110 00
Q ss_pred hcc-c--------cCCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVD-K--------DLKNNYDRI-ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d-~--------~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+. - .++..+... -.+.-++++...+..||.+|-|+.|.++.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 0 011111111 23567899999999999999999998863
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=334.14 Aligned_cols=248 Identities=30% Similarity=0.509 Sum_probs=195.8
Q ss_pred cCCeeeecCCceEEEEEEC-----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 304 SKNILGKGGFGIVYKGILQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
..+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 36789999997655444567899999999999999999999999988889999999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++|+|.+++... ..+++..+..|+.||++||.|||++ +++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999865 6799999999999999999999998 9999999999999999999999999999876332222
Q ss_pred -eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 457 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
..........|+|||.+.+..++.++||||||+++|||+| |+.|+..... .++...+......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~~~~~~~-------- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKLKQGQRL-------- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHHHTTEET--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccc--------
Confidence 2223346789999999999899999999999999999999 6777653321 1222222222111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
..+...+..+.+++..||..+|++||++.++++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222346788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.57 Aligned_cols=246 Identities=23% Similarity=0.252 Sum_probs=202.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 689999999864321 223446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999865432
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+... ..
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~---------~~-- 215 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAG---------KL-- 215 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---------Cc--
Confidence 22346899999999999888999999999999999999999999743321 111111111 00
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
.++......+.+++.+|++.||.+||+ +.|+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111222457889999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=327.76 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=203.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-------------CchhHHHHHHHHHHhccccccceee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-------------IGGEIQFQTEVEMISLAVHRNLLRL 362 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~H~niv~l 362 (622)
..-++|.+.+.||+|.||.|-+|+.. +++.||||++.+... ....+...+|+.++++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34567899999999999999999954 799999999964321 1112367899999999999999999
Q ss_pred eeeeeCC--CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 363 YGFCMTP--TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 363 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
+++..++ +..|||+|||..|.+...--..+.++..++++|+.++..||+|||.+ +||||||||+|+|++++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9998764 67899999999988766555555599999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCC----ceeeeecCcccccCccccccCC----CCcccceeehhHHHHHHHhcCCccccchhcccccc
Q 036225 441 VGDFGLAKLLDHQDS----HVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512 (622)
Q Consensus 441 l~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~ 512 (622)
|+|||.+........ ..-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----- 325 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----- 325 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-----
Confidence 999999987632211 1122367999999999987632 356789999999999999999999754321
Q ss_pred HHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 513 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
... +.+++..+.-.-..+..+.+.+||+++|.+||++|.+..+|..+.
T Consensus 326 --~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 --ELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --HHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 222222232222223457889999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.99 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=201.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||+||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999987654444445678999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++ +|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 975 88888754 34578999999999999999999998 999999999999999999999999999976543222 1
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH--------hhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI--------HQEKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 528 (622)
.....+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+....+....... ........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233457999999999865 568999999999999999999999997543322211111111000 00000000
Q ss_pred hccccCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNY----DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...... ......+..+++.+|++.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0001000000 00123567899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=331.71 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=206.0
Q ss_pred hCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++|+..+.||+|+||.||+|.... ...||+|.++..........+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 25799999876554444557899999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 036225 374 LVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999988542 4578899999999999999999999 999999999999999999
Q ss_pred ceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHH
Q 036225 438 EAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 438 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 515 (622)
.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||+| |..||...... .+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 999999999986543222 12223346788999999988899999999999999999998 99998643221 1111
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+. .......+...+.++.+++.+||+.+|.+||+++||++.|+.
T Consensus 238 ---~i~----------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIR----------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHH----------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 111111223345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.19 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=207.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|+..+.||+|+||.||++... +|..||+|.++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999975 6889999998765433344578999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence 9999999999987778999999999999999999999852 6999999999999999999999999999765322 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-h--------------
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-Q-------------- 522 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~-------------- 522 (622)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||......+ +...+.... .
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCcccc
Confidence 234468999999999999899999999999999999999999996433211 000000000 0
Q ss_pred -------------------hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 -------------------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 -------------------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+...............++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000111234678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=332.45 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=200.0
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|+..+.||+|+||+||+|.. .+|+.||+|.+..... ......+.+|++++.+++|+|++++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999996 4789999999864322 22334578899999999999999999999999999999999
Q ss_pred ccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 999999887743 34689999999999999999999999 99999999999999999999999999998754322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~---------~~--~~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVK---------ED--QE 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhh---------cc--cc
Confidence 2234468999999999999999999999999999999999999997543211100 0001000 00 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
.+.......+.+++.+||+.||++||+ ++++++.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 112223357889999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.59 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=206.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..++|+..+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4567888999999999999999988788999999875432 24568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999987543 689999999999999999999998 999999999999999999999999999987653222
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
........+..|+|||++.+..++.++||||||+++|||+| |+.||...... .... .+... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~---~~~~~----------~ 221 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQ---QVDQG----------Y 221 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH---HHHcC----------C
Confidence 21222223458999999998899999999999999999999 88888532211 1111 11110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+|++.+|.+||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111122234678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.29 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=205.6
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+|.+.+.||+|+||.||+|... +++.||+|+++.... ......+..|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888999999999999999976 588999999875421 2234468889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999999998777899999999999999999999999 999999999999999999999999999976543 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|.. .........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------~~~~~~~~~ 224 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE----------TLQRPVYDD 224 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc----------cccCCCCCc
Confidence 2345689999999999998999999999999999999999999975432211111111100 000000000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......++.+++.+|+..+|.+||++++++++
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.57 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=203.5
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|+..+.||+|+||.||++.++++..+|+|.++... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4678889999999999999999888899999886443 22456889999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++|+|.++++. ...+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999864 34689999999999999999999998 999999999999999999999999999976543322222
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+..+...... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~---~------- 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRL---Y------- 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC---C-------
Confidence 23345678999999988889999999999999999999 8888864321 1112222111110 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.+...+..+.+++.+|++.+|++||+++++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.96 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=202.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||.||+|... +++.||+|.++... .......+.+|+.++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 68999999987532 1223346889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999998877899999999999999999999999 99999999999999999999999999998664322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. ...
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~---------~~~-- 232 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILA---------GRL-- 232 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhc---------CCc--
Confidence 2346999999999999999999999999999999999999999643211 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
.++......+.+++.+||+.||.+||+ +++++.+
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112356889999999999999997 5666643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.96 Aligned_cols=243 Identities=23% Similarity=0.262 Sum_probs=198.4
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 689999999875422 223345778999999999999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 9999998878899999999999999999999999 99999999999999999999999999987532221 2233456
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .....+... +.. ++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~-------~~~----~p~~~ 218 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME-------EIR----FPRTL 218 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcC-------CCC----CCCCC
Confidence 999999999999999999999999999999999999999643211 111111100 011 12223
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 543 LEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
..++.+++.+|++.||++|| ++.+++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 46788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.20 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=198.7
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||.||+|... +++.||+|.++... .......+..|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 58899999986532 222344678899999999999999999999999999999999999999
Q ss_pred cccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCc
Q 036225 385 ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464 (622)
Q Consensus 385 ~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 464 (622)
.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 99998777899999999999999999999998 99999999999999999999999999997543222 223345699
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHH
Q 036225 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 544 (622)
Q Consensus 465 ~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 544 (622)
+.|+|||++.+..++.++|||||||++|||+||+.||..... .......... .. .++.....
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~---------~~--~~~~~~~~ 218 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQE---------PL--RFPDGFDR 218 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcC---------CC--CCCCcCCH
Confidence 999999999999999999999999999999999999974321 1111111111 00 11222336
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 545 EMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 545 ~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
.+.+++.+||+.||.+||++.++.+.|....+
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 78899999999999999876555555544433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=339.02 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=209.0
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|..++.||+|+-|.|-.|++ .+|+.+|||++.+.. .......+.+|+-+|+.+.|||++++|+++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56788999999999999995 579999999997652 222233578999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++|.|.+++-.++.+.+.+..+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..-. ....-
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL 168 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence 99999999999999999999999999999999999999 99999999999999999999999999998643 33344
Q ss_pred eeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
...+|++.|.+||++.+..| +.++||||.|||||.|+||+.||+.++ +...+.++.++. . +
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~-f----------~ 230 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGV-F----------E 230 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCc-c----------c
Confidence 56689999999999999988 678999999999999999999998432 233333322211 1 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.+...+.+..+|+.+|+..||..|.|++||+++-
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 2233346789999999999999999999999853
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.08 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=209.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+-++|++++.||+|-||.||.|..+ ++..||+|++.+... ...+.++.+|+++-+.++||||+++|+++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567899999999999999999964 688999999876542 2234478999999999999999999999999999999
Q ss_pred EeeeccCCCcccccc--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||..+|++...|+ ....++......++.|+|.|+.|+|.+ +|+||||||+|+|++.++..||+|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999998 555789999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+.....+. ..-+.. .++
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----YkrI~k-------~~~--- 239 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----YKRIRK-------VDL--- 239 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----HHHHHH-------ccc---
Confidence 4445677899999999999999999999999999999999999999985431111 110110 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++........++|.+|+..+|.+|.+..|++..
T Consensus 240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223344678899999999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.33 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=206.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..++|++.+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4567889999999999999999988888999998865332 34578899999999999999999999999999999999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.++++. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999864 34688999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+ ....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~---~~~~---------- 221 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSAL---QRGY---------- 221 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHH---HcCC----------
Confidence 22223345678999999988889999999999999999998 88888643211 111111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+.++.+++.+|+..+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000111234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=340.44 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=207.7
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhcc-ccccceeeeeeeeCCC
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPT 370 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 370 (622)
.....++|...++||+|.||+|+++..+ +++.+|||++++.... ++.+..+.|.+++... +||.+++++..|..++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456678999999999999999999976 6889999999987533 3344678888888777 5999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
+.+.||||+.||++. +++....+++..+..++..|+.||+|||++ +|||||||-+|||||.+|.+||+|||+++.-
T Consensus 443 ~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999999944 344456799999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
-. ....+..++||+.|||||++.+..|+..+|.|||||+||||+.|+.||...+..+....| +
T Consensus 519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----------------~ 581 (694)
T KOG0694|consen 519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----------------V 581 (694)
T ss_pred CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------------h
Confidence 32 233567789999999999999999999999999999999999999999866543322211 1
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.. ...|+...+.+..+++.+.+..+|++|--+
T Consensus 582 ~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 ND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 122555566788999999999999999876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.10 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=202.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..+|+..+.||+|+||.||+|.+. +++ .||+|.++.........++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356889999999999999999863 333 48999987654444556788999999999999999999999865 567
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+++||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999875 34688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
...... ....++..|+|||++.+..++.++|||||||++|||+| |+.||....... +.... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~---~~~------- 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL---EKG------- 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH---hCC-------
Confidence 332221 12234678999999999999999999999999999998 998886432111 11111 100
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.....+..+...+.+++.+||+.+|.+||++.+++..+...
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00011122345688999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.81 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=205.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||+||+|... +|+.||+|+++.... ......+..|++++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999975 689999999875421 233456889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC--
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-- 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~-- 454 (622)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999998664332
Q ss_pred --------------------------CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 455 --------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 455 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234568999999999999999999999999999999999999997543211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK-MSEVVRM 570 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~ 570 (622)
. ...+.... ..+........+..+.+++.+|+. +|.+||+ ++++++.
T Consensus 238 ~-------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 T-------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111100 000000001134678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.26 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=200.6
Q ss_pred CCCcCCeeeecCCceEEEEEE----CCCeEEEEEEccCCC---CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 301 NFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGN---AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
+|++.+.||+|+||.||++.. .+++.||+|+++... .......+..|++++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999885 358899999986432 122234577899999999 599999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........||..|+|||++.+. .++.++|||||||++|||+||+.||......... ......+.. .+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~-------~~ 227 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK-------CD 227 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc-------CC
Confidence 333334456799999999999765 4788999999999999999999999643221111 111111110 11
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
+.+ +......+.+++.+|++.||++|| +++++++.
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 112335688999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=335.48 Aligned_cols=271 Identities=24% Similarity=0.396 Sum_probs=226.3
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECC---C--eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQD---G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
+.+++..+.....++||+|-||.||+|.+.+ | -.||||.-+.....+..+.|..|..+++.++||||++++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3455566667778899999999999999642 3 3589999888777777888999999999999999999999997
Q ss_pred CCCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 368 TPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
+. ..|+|||.++-|.|..+|+. +..++......++.||+.||.|||++ ++|||||..+|||+.....+||+|||+
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 65 57999999999999999974 55789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
++.+.....+......-...|||||.+.-.+++.+||||.|||.+||++. |..||..-.+.+-.+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~------------- 604 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH------------- 604 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------------
Confidence 99988766665554455678999999999999999999999999999986 9999986554433221
Q ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHHHHhh
Q 036225 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQ 584 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~ 584 (622)
+...-+-..++.|+..+..|+.+||..+|.+||+++|+...|......++...++
T Consensus 605 ----iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~E 659 (974)
T KOG4257|consen 605 ----IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSE 659 (974)
T ss_pred ----ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHH
Confidence 1122223356778899999999999999999999999999887655444433333
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=323.64 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=206.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|...+.||+|+||+||+|.+.. ...||||.++..........|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999999742 457999998765544455678899999999999999999999999999999
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999865 34689999999999999999999998 9999999999999999999999999999877522
Q ss_pred CCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 454 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 454 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+ .+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~---~~~~~-------- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIK---AVEDG-------- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHH---HHHcC--------
Confidence 222 2222335678999999998899999999999999999998 98888532211 1111 11110
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus 225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0001112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.67 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=203.6
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
+.+++|+..+.||+|+||.||+|.+. ++..||+|.++.........++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 356799999865443344556889999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccCC----------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 371 ERLLVYPYMSNGSVASRLKGK----------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999988532 2357888999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHH
Q 036225 441 VGDFGLAKLLDHQDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 518 (622)
|+|||++........... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence 999999876543222111 12235778999999998889999999999999999999 67777533211 1111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...... . ...+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 233 ~~~~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGG---------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCC---------c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111110 0 01112234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=320.41 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=207.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhcccccc-ceeeeeeeeCCC-----
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRN-LLRLYGFCMTPT----- 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~----- 370 (622)
...|...++||+|+||+||+|.. .+|+.||+|+++.... .+......+|+.+++.++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566677899999999999995 4789999999986544 233335679999999999999 999999998877
Q ss_pred -ceeEEeeeccCCCccccccCCC----CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 371 -ERLLVYPYMSNGSVASRLKGKP----ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 371 -~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
..++||||++. +|..++...+ .++...++.++.||++||+|||++ +|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999976 8888886533 577788999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
+|+...-+.. ..+..++|..|+|||++.+. .|+...||||+||+++||++++..|......++...+...+.......
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9996653322 24455689999999999886 689999999999999999999988887766554444444333322222
Q ss_pred hhhhhccccCCCCCC---------HHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLVDKDLKNNYD---------RIE---LEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~---------~~~---~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.....-++....+. ... .....+++.+|++.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222111111111111 111 1367899999999999999999999876
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.19 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=205.7
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~ 367 (622)
+....++|.+.+.||+|+||.||+|... .+..||||+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678889999999999999999853 235799999976554444557899999999996 999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC--------------------------------------------------------
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK-------------------------------------------------------- 391 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 391 (622)
..+..++||||+++|+|.+++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999998876421
Q ss_pred ----------------------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 392 ----------------------------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 392 ----------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
..+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 2477888899999999999999998 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 9999999999999999866432221 1223346788999999998899999999999999999997 888886432110
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+. ...... .....+...+..+.+++.+||+.+|++||++.+|.++|+.
T Consensus 348 --~~~---~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 --TFY---NKIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --HHH---HHHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 011 111100 0111122334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=320.68 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=200.3
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC-----ceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-----ERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~l 374 (622)
.|...+++|.|+||.||+|... +++.||||+....... -.+|+++|++++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999965 5789999998654432 136899999999999999999886432 2358
Q ss_pred EeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEccccccee
Q 036225 375 VYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKL 449 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~ 449 (622)
|||||+. +|.+.++. +..++.-.++-+..||.+||.|||+. +|+||||||+|+|+|. .|.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 88888763 56788888899999999999999998 9999999999999995 59999999999999
Q ss_pred cCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
+...... ..+.-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+..++...+.+.++....+ .+..
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e-~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE-DIKS 252 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH-HHhh
Confidence 8755443 44557899999999877 469999999999999999999999998766555544444433221111 1111
Q ss_pred -------hccccCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 -------LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 -------~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.-.+.+... +......+..+++.++++.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111111 223445788999999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.13 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=195.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|+..+.||+|+||+||+|... +++.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4456788999999999999965 689999999876544444557889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
++|+|.+.. ..++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 155 ~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 155 DGGSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred CCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 999987543 356677889999999999999998 999999999999999999999999999987643221 223
Q ss_pred eecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 460 AVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
...||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ........... .
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~----------~ 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCAICMS----------Q 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhcc----------C
Confidence 4569999999998743 234568999999999999999999997332111 11111111000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........++.+++.+||+.||++||++.|++++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122234678999999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=319.12 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=207.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCC-CCCchhHHHHHHHHHHhccccccceeeeeeeeC-----CCce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-----PTER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~ 372 (622)
..|...+.||+|+||.|+.+... +|+.||||++... ......++..+|+++++.++|+||+.+.+.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 44555789999999999999964 7899999998733 223344567899999999999999999998765 3567
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|+|+|+| +.+|...++.++.++......+++|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 459999999988899999999999999999999999 999999999999999999999999999998754
Q ss_pred C-CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-------hh
Q 036225 453 Q-DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-------QE 523 (622)
Q Consensus 453 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 523 (622)
. .....+.++.|..|+|||++.. ..||...||||.|||+.||++|++.|.+.+..++...+...+.... ..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 1222356678999999998754 6799999999999999999999999987766555444443322110 00
Q ss_pred hhhhhhcccc---CCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDKD---LKNNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~~---~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.....+... .+..+. +.......+|+.+|+..||.+|+|++|.++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111100 000110 1233567899999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=321.89 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=203.2
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|...+.||+|+||+||+|.+.++..+|+|.++.... ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46778899999999999999988777899999875432 2356889999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
.+|+|.+++.. ...+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999999865 34689999999999999999999998 999999999999999999999999999986643322222
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+..... ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~----------~~ 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLR----------LY 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCC----------CC
Confidence 22335678999999988889999999999999999999 888886432111 1111111110 00
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11122467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=340.97 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=198.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.|...+.||+|+||+||+|... +++.||+|+++.... ......+.+|++++.+++|+||+++++++...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 688999999975432 2233468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC--
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-- 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-- 455 (622)
|+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998777899999999999999999999998 999999999999999999999999999754311000
Q ss_pred --------------------------------------------ceeeeecCcccccCccccccCCCCcccceeehhHHH
Q 036225 456 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 491 (622)
Q Consensus 456 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l 491 (622)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234699999999999988899999999999999
Q ss_pred HHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 036225 492 LELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL--CTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 492 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~evl~ 569 (622)
|||+||+.||...........+..|. .. ..... ......++.+++.+ |+..+|..||++.|+++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~------~~------~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWE------NT------LHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccc------cc------cCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999997543211110010000 00 00000 01123567778877 55666667999999987
Q ss_pred H
Q 036225 570 M 570 (622)
Q Consensus 570 ~ 570 (622)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=332.63 Aligned_cols=267 Identities=21% Similarity=0.332 Sum_probs=218.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+.+...+.++++||+|-||+|..+....+..||||.++.........+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44556678889999999999999999888999999999887777778999999999999999999999999999999999
Q ss_pred eeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 376 YPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+|||++|+|.+++... +.+.......|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999754 4456677788999999999999998 9999999999999999999999999999976555
Q ss_pred CCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh--cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
+++.. ...+-..+|||||.+..+.++.++|||+||+++||+++ ...|+...... .+++-...+........
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven~~~~~~~~~~~~-- 764 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVENAGEFFRDQGRQV-- 764 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHhhhhhcCCCCcce--
Confidence 54433 34456789999999999999999999999999999875 56676533211 11111111111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDG 575 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 575 (622)
--..++.++..+.+++.+||..+-++||+++++...|+++.
T Consensus 765 ----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 ----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11234567789999999999999999999999999987543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.22 Aligned_cols=243 Identities=23% Similarity=0.270 Sum_probs=197.4
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||.||++... +|+.||+|.++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999964 689999999875421 223345778999999999999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 9999988777899999999999999999999999 99999999999999999999999999987532221 1223456
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ +.. ++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~-------~~~----~p~~~ 218 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILME-------EIR----FPRTL 218 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcC-------CCC----CCCCC
Confidence 9999999999999999999999999999999999999996433211 01111000 011 11223
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 543 LEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
...+.+++.+|++.||++|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 46788999999999999998 78887753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.49 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=205.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..........+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567788999999999999998643 4789999998665444556899999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC--------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 373 LLVYPYMSNGSVASRLKGK--------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999988632 3478899999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH
Confidence 999999999765332221 1223345788999999999999999999999999999999 999986433211 1111
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
. .. . . ....+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ~---~~-~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 I---TQ-G--------R-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---Hc-C--------C-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 10 0 0 01111223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.82 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=204.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|+..+.||+|+||.||+|... +++.||+|.++... .....+.+|+++++.++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345778899999999999999965 58899999987532 234568899999999999999999999999999999999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998864 34589999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......++..|+|||++.+..++.++|||||||++|||+| |..||...... +....+... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~----------~ 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKG----------Y 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC----------C
Confidence 22222234668999999988899999999999999999998 88887643211 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+.++.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111222234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.20 Aligned_cols=248 Identities=22% Similarity=0.242 Sum_probs=202.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC--CeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD--GTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..++|...+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+++++.++||||+++++++...+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34568889999999999999998643 3689999986432 1223346788999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999998877899999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. ..
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~---------~~ 244 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILE---------GI 244 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhc---------CC
Confidence 23456999999999999888999999999999999999999999743321 11111111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
. .++......+.+++.+|++.+|++|+ +++++++.
T Consensus 245 ~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 01112235678999999999999995 78888764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.62 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=178.1
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..++|++.+.||+|+||.||++... +++.+|+|.++..........+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999976 688999998876543344457889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++.....++.|++.||.|||+.. +|+|+||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999999987777899999999999999999999742 6999999999999999999999999998755322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccc
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346899999999999888999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.22 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=202.5
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP 369 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 369 (622)
++.++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|+.++.++ +|+||++++++|...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44567889999999999999999742 35789999997654444445678899999999 899999999988654
Q ss_pred -CceeEEeeeccCCCccccccCC---------------------------------------------------------
Q 036225 370 -TERLLVYPYMSNGSVASRLKGK--------------------------------------------------------- 391 (622)
Q Consensus 370 -~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------- 391 (622)
...+++|||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999999998887421
Q ss_pred ----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce-eeeecCccc
Q 036225 392 ----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVG 466 (622)
Q Consensus 392 ----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~ 466 (622)
..++|..+.+++.||+.||+|||+. +|+||||||+|||+++++.++|+|||++..+....... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578999999999999999999998 99999999999999999999999999998764332222 223345678
Q ss_pred ccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHH
Q 036225 467 HIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEE 545 (622)
Q Consensus 467 y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 545 (622)
|+|||++.+..++.++|||||||++|||++ |..||......+ .....+... .....+.....+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEG----------TRMRAPEYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhcc----------CCCCCCccCCHH
Confidence 999999999999999999999999999998 988886422111 011111100 000111223467
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 546 MVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 546 l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+.+++.+|++.+|++||++.|++++|+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.72 Aligned_cols=243 Identities=23% Similarity=0.267 Sum_probs=198.5
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999975432 223446788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccccc
Confidence 9999998777899999999999999999999999 9999999999999999999999999998754322 12223456
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .....+.. .+..+ +...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~-------~~~~~----p~~~ 218 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM-------EDIKF----PRTL 218 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhcc-------CCccC----CCCC
Confidence 999999999999889999999999999999999999999643211 11111110 00111 1122
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 543 LEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
..++.+++.+|++.||++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 35688999999999999997 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.93 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=198.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||+||+|... +++.||+|+++..........+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999975 6899999998765444444467889999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|++ ++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 577776653 45688999999999999999999999 99999999999999999999999999997543222 1
Q ss_pred eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh------hh-
Q 036225 457 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL------EM- 528 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~- 528 (622)
......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ....+......... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhCCCChhhccchhhc
Confidence 2233458999999999865 4578899999999999999999999974322110 01111000000000 00
Q ss_pred -hccc-cCC----CCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 529 -LVDK-DLK----NNYDR-----IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 529 -~~d~-~~~----~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..++ ... ..... .....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000 00000 01245779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.36 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=200.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|.+.+.||+|+||.||++... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 457999999999999999999964 688999997532 246789999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++. ++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 995 68888887777799999999999999999999998 99999999999999999999999999997543322223
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccc----cHHHHHHHHhh---------hh
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG----AMLDWVKKIHQ---------EK 524 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~---------~~ 524 (622)
.....||+.|+|||++.+..++.++|||||||++|||+||+.|+......+... .+...+..... ..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 344579999999999998899999999999999999999998876433211110 11111110000 00
Q ss_pred hhhhhc---------cccCCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLV---------DKDLKNNY--DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~---------d~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...... .+..+... ....+.++.+++.+||+.||.+|||++|+++.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000000 01234578899999999999999999999863
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=326.67 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=206.5
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+.+..++|+..+.||+|+||.||++... +...+|+|.++..........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4455677888999999999999999864 24689999987654444445688999999999 7999999999999
Q ss_pred CCCceeEEeeeccCCCccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 368 TPTERLLVYPYMSNGSVASRLKG----------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
..+..+++|||+++|+|.++++. ...+++..+.+++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 99999999999999999988842 34688999999999999999999998 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 99999999999999998765432211 122235678999999988899999999999999999998 88887532211
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+........ .....+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 242 -----~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 242 -----ELFKLLKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred -----HHHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 111111111 1111122234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.11 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=203.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||+|+||+||++... +|+.||+|+++.... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999965 689999999975432 223446888999999999999999999999999999999
Q ss_pred eeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999764 6799999999999999999999999 999999999999999999999999999987754443
Q ss_pred ceeeeecCcccccCccccc------cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 456 HVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||...... .....+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~- 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLK- 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccC-
Confidence 3334456999999999986 456789999999999999999999999754321 11111111110000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ........+.+++.+|++ +|.+||++.++++.
T Consensus 230 ----~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 ----FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 011123568899999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.28 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=197.9
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 78999999887654444455789999999999999999999999999999999999999999
Q ss_pred cccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee-eeec
Q 036225 385 ASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT-TAVR 462 (622)
Q Consensus 385 ~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~ 462 (622)
.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999864 34689999999999999999999998 999999999999999999999999999875432211111 1112
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.+..|+|||.+.++.++.++||||||+++|||++ |..||....... .... +........+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~----------~~~~~~~~~~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREA----------IEQGVRLPCPEL 220 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHH----------HHcCCCCCCccc
Confidence 3457999999999899999999999999999998 887775322110 0001 111111112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.+..+.+++.+|++.+|++||++.+++++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.88 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=204.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..++|++.+.||+|+||.||+|...++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3467888999999999999999988888899999875432 2346889999999999999999999875 456889999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.++++. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999864 34589999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......++..|+|||++.+..++.++||||||+++|||++ |..||..... .+....+... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~----------~ 220 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERG----------Y 220 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC----------C
Confidence 22223345678999999988889999999999999999999 8888854221 1111111110 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+|+..+|++|||++++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111122334679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=320.12 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=201.7
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
.+|+..+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45778899999999999999988778899999865432 2346888999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999864 34689999999999999999999999 999999999999999999999999999976543222111
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ . ....... ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~---~~~~~~~----------~~~~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----V---VESVSAG----------YRLY 221 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----H---HHHHHcC----------CcCC
Confidence 22224467999999998899999999999999999999 788886432211 1 1111110 0111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.+...+.++.+++.+|+..+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122456799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=324.68 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=202.6
Q ss_pred hCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++|++.+.||+|+||.||+|.. .++..||+|.++..........+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 24678999999765444444578899999999999999999999999999999
Q ss_pred EeeeccCCCccccccC-----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 036225 375 VYPYMSNGSVASRLKG-----------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
||||+++++|.+++.. ...+++.....++.|++.||+|||++ +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999988742 12478889999999999999999998 999999999999999999
Q ss_pred ceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHH
Q 036225 438 EAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 438 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 515 (622)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 999999999986543222 12223345678999999988889999999999999999999 8888753221 11
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+.... ....+...+..+.+++.+|++.+|.+||++.++++.|..
T Consensus 235 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 001122234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=331.59 Aligned_cols=243 Identities=27% Similarity=0.338 Sum_probs=197.2
Q ss_pred CeeeecCCceEEEEEE----CCCeEEEEEEccCCCC---CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 306 NILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.||+|+||.||++.. .+++.||+|+++.... ......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 3578999999875321 22234577899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++|+|.+++.....+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999999998777888999999999999999999998 999999999999999999999999999875432222 22
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~---------~~~--~~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILK---------GKL--NL 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHc---------CCC--CC
Confidence 3456999999999999888999999999999999999999999743311 11111111 110 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
+......+.+++.+|++.+|++|| ++.++++.
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112235688999999999999999 78877663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.62 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=195.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC--CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhcc---ccccceeeeeeee-----C
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ--DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLYGFCM-----T 368 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~ 368 (622)
++|+..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 47889999987543222 223456677776655 6999999999885 3
Q ss_pred CCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 369 PTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
....++||||++ ++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456789999996 588888854 34589999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
+...... .......||..|+|||.+.+..++.++|||||||++|||++|++||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9866433 22334568999999999988899999999999999999999999997554332222222111100000000
Q ss_pred h------hhccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 527 E------MLVDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 527 ~------~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
. ..+.+..... ........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 00112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.53 Aligned_cols=266 Identities=25% Similarity=0.342 Sum_probs=202.8
Q ss_pred CCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeE
Q 036225 302 FSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLL 374 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 374 (622)
|...+.||+|+||+||++.. .+++.||+|.++..........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 357889999987654434455788999999999999999999988653 45789
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+|||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|||++.......
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999998754 489999999999999999999998 99999999999999999999999999998664322
Q ss_pred Cce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 455 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 455 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... .....++..|+|||.+.+..++.++||||||+++|||+||..|+....... .....+..............+.
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhhhhc
Confidence 211 122235677999999988889999999999999999999999976432110 0000000000000111111222
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 21112223345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.87 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=210.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCc-eeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE-RLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 376 (622)
++|..++++|+|+||.++.+..+ +++.+++|.+.-..... .....++|+.++++++|||||.+.+.++.++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999999865 67889999987554333 33367899999999999999999999999988 89999
Q ss_pred eeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+|++||++.+.+... ..++++.+..|+.|++.|+.|||++ .|+|||||++||++++++.|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999998743 4688999999999999999999988 99999999999999999999999999999987654
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
. ....++||+.||.||.+.+.+|+.|+|||||||++|||.+-+++|...+.. ..+.++.+. .+
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------~Li~ki~~~-----~~---- 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------ELILKINRG-----LY---- 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-------HHHHHHhhc-----cC----
Confidence 3 345677999999999999999999999999999999999999999754321 222222111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+.....++..++..|++.+|..||++.+++.+
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12334455789999999999999999999999976
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.40 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=202.1
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
++....++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999975 58899999986432 1223345788999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999998754 478899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeecCcccccCccccccC----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
............||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+......
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~ 265 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNS 265 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcc
Confidence 54333233455699999999998654 3788999999999999999999999743321 111111110000
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRM 570 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 570 (622)
..+.. .......+.+++.+|+..++.+ ||++.|++++
T Consensus 266 -----~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 -----LNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----cCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00011 1112356778899999855543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=322.13 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=208.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+..+|+..+.||+|+||.||+|...+++.+|+|.++.... .....+..|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4567888999999999999999988899999999876542 234468899999999999999999999999999999999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999874 34689999999999999999999998 999999999999999999999999999976643221
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... . ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~---~----------~~~ 221 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQI---T----------AGY 221 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHH---H----------hCC
Confidence 1223346778999999988899999999999999999998 88888643211 111111 1 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+|++.+|.+|||++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111222344678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.34 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=200.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||+||+|... +|+.||||+++.... ......+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 689999999975321 223345788999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999998777899999999999999999999999 9999999999999999999999999998764321100
Q ss_pred -------------------------------------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCC
Q 036225 457 -------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499 (622)
Q Consensus 457 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~ 499 (622)
......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112458999999999998899999999999999999999999
Q ss_pred ccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 036225 500 ALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK---MSEVVRM 570 (622)
Q Consensus 500 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 570 (622)
||........ ...+.... ..+...........+.+++.+|+. +|.+|++ ++|+++.
T Consensus 238 Pf~~~~~~~~-------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQET-------YRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHH-------HHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9975432111 11111000 000000000123567889999996 9999998 7777663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.57 Aligned_cols=247 Identities=30% Similarity=0.440 Sum_probs=199.9
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCcc
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVA 385 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 385 (622)
++||+|+||.||+|...+++.+|+|.++..........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999876554444456889999999999999999999999999999999999999999
Q ss_pred ccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCc
Q 036225 386 SRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464 (622)
Q Consensus 386 ~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 464 (622)
+++.. ...+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 98864 34689999999999999999999998 999999999999999999999999999975443222222222346
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHH
Q 036225 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543 (622)
Q Consensus 465 ~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 543 (622)
..|+|||++.++.++.++||||||+++||+++ |..||....... ......... ....+...+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~----------~~~~~~~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY----------RMSCPQKCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC----------CCCCCCCCC
Confidence 78999999998899999999999999999998 888886432111 111111110 011112234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 544 EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 544 ~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..+.+++.+|+..+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=324.01 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=202.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+...........+..|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567889999999999999999975 3578999988755444445578999999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEE
Q 036225 372 RLLVYPYMSNGSVASRLKGK-------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC---EAVV 441 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl 441 (622)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999988643 2589999999999999999999998 999999999999998654 5999
Q ss_pred cccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHH
Q 036225 442 GDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKK 519 (622)
Q Consensus 442 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 519 (622)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 9999998663222111 111223568999999998899999999999999999997 88888643221 11111
Q ss_pred HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 520 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 520 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
+... .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 111112223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.96 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=203.4
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..++|.+.+.||+|+||.||+|.+.++..||+|.++.... ....+.+|+++++.++|+||+++++++. ....++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3466889999999999999999987777899999875432 2346889999999999999999999875 456799999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999874 34579999999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......++..|+|||+..+..++.++||||||+++|||+| |..||...... ........ ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~----------~~ 220 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVER----------GY 220 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhc----------CC
Confidence 22233446778999999988899999999999999999999 77777533211 00111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=339.94 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=198.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||+|+||+||++... +++.||||++..... ......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 689999999864321 223346788999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999998777899999999999999999999999 9999999999999999999999999999643210000
Q ss_pred ----------------------------------------------eeeeecCcccccCccccccCCCCcccceeehhHH
Q 036225 457 ----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 490 (622)
Q Consensus 457 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~ 490 (622)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999998899999999999999
Q ss_pred HHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHH
Q 036225 491 LLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR---PKMSEV 567 (622)
Q Consensus 491 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev 567 (622)
+|||+||+.||......+. ...+.... ..+ .+.. ......++.+++.+|+. +|.+| +++.|+
T Consensus 238 l~elltG~~Pf~~~~~~~~-------~~~i~~~~--~~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSHET-------YRKIINWR--ETL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHHHH-------HHHHHccC--Ccc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999964332111 11111000 000 0000 00123567899999997 67665 588888
Q ss_pred HHH
Q 036225 568 VRM 570 (622)
Q Consensus 568 l~~ 570 (622)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.82 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=193.0
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhc-cccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|... +++.||+|.++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 578999999875421 2223345566666664 4899999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999997653322 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ...++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~-----------~~~~~~~ 218 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDSILND-----------RPHFPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-----------CCCCCCC
Confidence 6999999999999889999999999999999999999999743321 111111100 0112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS-EVVR 569 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~-evl~ 569 (622)
...++.+++.+|++.+|++||++. ++++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 345688999999999999999976 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.38 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=202.7
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
...++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44678899999999999999999965 68899999986432 1222335778999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999988654 478888999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeeeecCcccccCccccccC----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.........||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+......
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~--- 265 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKNS--- 265 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCCc---
Confidence 32223345699999999998653 4789999999999999999999999754321 111111110000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 570 (622)
..+.. ....+.++.+++.+|++.+|.+ ||++.|+++.
T Consensus 266 --~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00011 1112467889999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.19 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=198.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++|...+.||+|+||+||+|.+. +++ .+++|.+..........++..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999964 344 4788887544333333467788888999999999999998764 45788
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
++||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999964 45689999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 454 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 454 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... ......++..|+|||++.++.++.++|||||||++|||+| |+.||...... .+.+++. ...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~----~~~------ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLE----KGE------ 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH----CCC------
Confidence 221 2233456789999999998899999999999999999998 99888643211 1111111 000
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+..+...+.+++.+|+..+|.+||++.|+++.|..
T Consensus 229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 ---RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 000111133567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=333.67 Aligned_cols=266 Identities=21% Similarity=0.353 Sum_probs=198.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCC-----cee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-----ERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 373 (622)
+|++.+.||+|+||.||+|... +|+.||||+++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 68999999987532 2223446889999999999999999999886432 479
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+. ++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999888777899999999999999999999999 9999999999999999999999999999765322
Q ss_pred CC--ceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHHh
Q 036225 454 DS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKIH 521 (622)
Q Consensus 454 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~ 521 (622)
.. .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+.+ +...+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 11234568999999999865 5789999999999999999999999965432111000000 000000
Q ss_pred hhh--hhhhhccccCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEK--KLEMLVDKDLKNNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~--~~~~~~d~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... .....+.+....... ......+.+++.+|++.+|++||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000000000000 0123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.57 Aligned_cols=243 Identities=27% Similarity=0.330 Sum_probs=195.9
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
++||+|+||.||+|... +++.||+|+++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 578999999875421 22334567788888765 799999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|...+.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 99999988777899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.... . .++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~---------~--~~p~~ 218 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDD---------V--LYPVW 218 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC---------C--CCCCC
Confidence 6899999999999889999999999999999999999999754321 1111111110 0 01111
Q ss_pred HHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRP-------KMSEVVRM 570 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RP-------t~~evl~~ 570 (622)
...++.+++.+|++.||++|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 235688999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=336.62 Aligned_cols=202 Identities=22% Similarity=0.327 Sum_probs=176.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||+||++... +++.||+|+++.... ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999865 689999999875321 222345788999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS- 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 455 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999998878899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 456 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 456 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cc
Q 036225 503 YG 504 (622)
Q Consensus 503 ~~ 504 (622)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.37 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=197.3
Q ss_pred eeeecCCceEEEEEEC---CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 307 ILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
.||+|+||.||+|.++ ++..+|+|+++.... ......+..|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899999875432 223456889999999999999999999885 45678999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee--e
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT--A 460 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~--~ 460 (622)
+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++............ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777899999999999999999999998 9999999999999999999999999999876543332211 1
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
..++..|+|||.+....++.++|||||||++|||+| |+.||...... .+...+.... ....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~----------~~~~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGE----------RMECP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCC----------CCCCC
Confidence 224578999999988889999999999999999998 99998643211 1111111111 11112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+.++.+++.+|++.+|++||++.+|.+.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.48 Aligned_cols=245 Identities=23% Similarity=0.283 Sum_probs=193.5
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|... +++.||+|+++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 688999999975422 22334577888888766 799999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|..++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 99999888777899999999999999999999999 99999999999999999999999999987532221 122345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc-cccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
.||..|+|||++.+..++.++|||||||++|||+||+.||........ ......++......... ..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p~ 226 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCCC
Confidence 689999999999999999999999999999999999999963221111 11111222211111110 1222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.....+.+++.+|++.||++||++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 234668899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.62 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=205.3
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45677889999999999999999988899999999875432 2447889999999999999999999864 56789999
Q ss_pred eeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999998864 34689999999999999999999998 99999999999999999999999999998765332
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...... +........
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------- 219 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERG---------- 219 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcC----------
Confidence 222223346778999999988889999999999999999999 99998643311 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.........+.++.+++.+|+..+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.93 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=195.3
Q ss_pred CeeeecCCceEEEEEE----CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 306 NILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
+.||+|+||.||++.. .+|+.||+|+++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3588999999875432 2233457789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++....... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998777899999999999999999999998 99999999999999999999999999997654322 22334
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..||..|+|||.+.+..++.++|||||||++|||+||+.||...... .....+... .. ..+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~---------~~--~~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKA---------KL--GMPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcC---------CC--CCCC
Confidence 56999999999998888999999999999999999999999743211 111111110 00 1112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~e 566 (622)
.....+.+++.+|++.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22356889999999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.06 Aligned_cols=243 Identities=23% Similarity=0.271 Sum_probs=197.2
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||.||++... +|+.||+|.++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999875421 223345778999999999999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
+|.+++.....+++..+..++.||+.||.|||+ . +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 999999877789999999999999999999997 6 999999999999999999999999999875432221 22345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+... ... ++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~-------~~~----~p~~ 218 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME-------EIR----FPRT 218 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcC-------CCC----CCCC
Confidence 6999999999999999999999999999999999999999643211 111111000 001 1122
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
...++.+++.+|++.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 235688999999999999996 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.28 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=207.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECC-----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC-CC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PT 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~ 370 (622)
+..++|...+.||+|+||.||+|.+.+ +..|++|+++..........+.+|+.++++++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456788899999999999999999765 788999998765544455678899999999999999999998776 57
Q ss_pred ceeEEeeeccCCCccccccCC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 036225 371 ERLLVYPYMSNGSVASRLKGK--------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 442 (622)
..++++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999988532 4588999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHH
Q 036225 443 DFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 443 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... ++....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EMAAYL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------HHHHHH
Confidence 999998654333221 122346778999999988889999999999999999999 99998643211 111111
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ........+..+.+++.+|+..+|++|||+.++++.|+.
T Consensus 233 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 233 KDGY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred HcCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1111 000111234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=298.62 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=206.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-----C
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----T 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~ 370 (622)
+..++|.+.+.+|+|||+-||.++ ..+++.+|+|++.... .++.+..++|++..++++|||+++++++...+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999999 5678999999997665 45566788999999999999999999988654 3
Q ss_pred ceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 371 ERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
+.|++++|...|+|.+.+. ++..+++.+.++|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 4899999999999999875 345799999999999999999999998 34699999999999999999999999999
Q ss_pred ceecCCCCCc--------eeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 447 AKLLDHQDSH--------VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 447 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
+....-.-.. ......-|..|+|||.+. +...++++|||||||++|+|+.|..||+........ +
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--l-- 251 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--L-- 251 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--E--
Confidence 8755321110 112233688999999984 345789999999999999999999999854321110 0
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+....+.-.-....++.+.+++.+|++.||.+||++.+++..++.
T Consensus 252 ----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 ----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 011111111111111245789999999999999999999999988764
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.45 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=197.2
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
++||+|+||.||++... +++.||+|+++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 688999999975432 22234577899999888 799999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence 99999887777899999999999999999999999 9999999999999999999999999998743221 1223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc-cccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
.||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .....++........ .. ..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~p~ 226 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QI--RIPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CC--CCCC
Confidence 699999999999999999999999999999999999999974322111 111112222211111 11 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPK------MSEVVR 569 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt------~~evl~ 569 (622)
....++.+++.+|++.||.+||+ +.++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22356889999999999999998 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.27 Aligned_cols=246 Identities=27% Similarity=0.384 Sum_probs=196.9
Q ss_pred eeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 307 ILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
.||+|+||.||+|.+. ++..||+|++...........+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876554444557899999999999999999999886 457899999999999
Q ss_pred ccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee--
Q 036225 384 VASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-- 460 (622)
Q Consensus 384 L~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~-- 460 (622)
|.+++.. ...+++..+.+++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.............
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999864 45689999999999999999999998 99999999999999999999999999998654333222211
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
..++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ++...+... .....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~----------~~~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQG----------KRLDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCC----------CCCCCC
Confidence 223578999999988889999999999999999996 99998643221 111111111 111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+.++.+++.+||..+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 3345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.86 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=201.7
Q ss_pred CCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+|++.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999853 2357999988765544444578899999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 036225 375 VYPYMSNGSVASRLKGK------------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 430 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 430 (622)
++||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999876421 2478899999999999999999998 99999999999
Q ss_pred eeecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcc
Q 036225 431 ILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAAN 508 (622)
Q Consensus 431 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~ 508 (622)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999997654332221 122345678999999988889999999999999999999 88888533211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+..+.. .......+......+.+++.+|++.+|++||+++|+++.|+.
T Consensus 237 ---~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 237 ---RLFNLLK-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ---HHHHHHh-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1111111 111111122234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.00 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=206.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
....++|...+.||+|+||.||++... .+..||+|.++..........+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345567899999999999999999742 35579999987654444445788999999999 79999999999999
Q ss_pred CCceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 369 PTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
.+..++||||+.+|+|.++++.. ..+++.++..++.|++.||+|||++ +|+|+||||+|||+++++.++++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999998643 2389999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhh
Q 036225 447 AKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 447 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||........ ... ...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~---~~~--- 258 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYK---LIK--- 258 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHH---HHH---
Confidence 9866433221 1222345778999999998899999999999999999998 8888864321110 111 110
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.......+...+.++.+++.+|+..+|++||++.|+++.|+.
T Consensus 259 -------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 -------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 001111111223678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.78 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=206.3
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeee
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFC 366 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~ 366 (622)
++.+..++|.+.+.||+|+||.||+|.+. .+..||+|+++..........+.+|++++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35566778888999999999999999863 346899999986544444456889999999997 99999999999
Q ss_pred eCCCceeEEeeeccCCCccccccCC-------------------------------------------------------
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKGK------------------------------------------------------- 391 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 391 (622)
...+..++||||+++|+|.++++..
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999998887431
Q ss_pred -------------------------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 036225 392 -------------------------------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKA 428 (622)
Q Consensus 392 -------------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 428 (622)
..+++.....++.|++.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 2367788899999999999999998 999999999
Q ss_pred CCeeecCCCceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchh
Q 036225 429 ANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKA 506 (622)
Q Consensus 429 ~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~ 506 (622)
+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533221 11222346788999999988889999999999999999998 8888753221
Q ss_pred ccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 507 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+. ....+. ...+...+.....++.+++.+||..+|.+||+++|+++.|+.
T Consensus 348 ~~~------~~~~~~----------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 NEQ------FYNAIK----------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred hHH------HHHHHH----------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 001111 111111122234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=316.68 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=204.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc----hhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++|...+.||+|++|.||++... +++.||+|.++...... ....+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999964 68999999986543211 22357889999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|+||+++++|.+.+.....+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998777789999999999999999999998 99999999999999999999999999997654322
Q ss_pred Ccee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 455 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 455 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ..... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~---------~~ 222 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------A-IFKIA---------TQ 222 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------H-HHHHh---------cc
Confidence 2111 23457889999999999889999999999999999999999986432110 0 00100 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+......+.+++.+|+..+|.+||++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111222344678899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.72 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=199.4
Q ss_pred hCCCcCCeeeecCCceEEEEEECC-Ce--EEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
++|++.+.||+|+||.||+|..++ +. .+++|.++..........+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998753 33 47888887544334455788999999999 799999999999999999999
Q ss_pred eeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 376 YPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999988542 2478899999999999999999998 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHH
Q 036225 440 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 518 (622)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||+| |..||...... +...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence 99999998643211 11111223567999999988889999999999999999998 99998643211 1111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ......+...+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 230 ~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 230 KLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred HHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 11111122234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.45 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=204.4
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
+.++....++|++.+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999975 68899999986422 12223457789999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999998754 478888999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccC----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~ 263 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHK 263 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC
Confidence 7654333333455699999999998653 3789999999999999999999999743321 1111111111
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRMLE 572 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L~ 572 (622)
.... +. ........+.+++.+|+...+.+ ||++.|++++.-
T Consensus 264 ~~~~-----~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 264 NSLT-----FP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred Cccc-----CC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0000 00 01122356788999999844433 778998887653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=326.73 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=198.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||+||++... +++.||+|.+.... .......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 67889999986432 1222335788999999999999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999975 45789999999999999999999998 999999999999999999999999999987654433
Q ss_pred ceeeeecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 456 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.......||+.|+|||++.+ +.++.++|||||||++|||+||+.||...... .....+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~---- 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEER---- 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCc----
Confidence 33334569999999999865 46788999999999999999999999643321 111111110000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 570 (622)
..+... ....+.++.+++.+|+..++++ |+++++++++
T Consensus 227 -~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -FQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -ccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 0112367888999998865544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.56 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=218.0
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
++++....+....++||-|.||.||.|+|+. .-.||||.++.... ...+|..|..+++.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5566666677788999999999999999874 56799999987653 34579999999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 372 RLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+|+|+|||..|+|.+||.. +..++--..+.++.||+.||+||..+ ++|||||..+|+|+.++..+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999974 34567777889999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
+....+.......-...|.|||-+....++.|+|||+|||+|||+.| |..|+..-+- ..+-.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----------------SqVY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYG 477 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----------------HHHHH
Confidence 87655544444445678999999999999999999999999999998 6667653221 11223
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
++.+.++-+.++.|++.+++|++.||+++|.+||+++|+-+.+|
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 34445555567778899999999999999999999999988766
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.14 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=205.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-----------------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccccee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 361 (622)
..+|++.+.||+|+||.||+|...+ +..||+|.+...........+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999988642 24689999886654445567889999999999999999
Q ss_pred eeeeeeCCCceeEEeeeccCCCccccccCCC-----------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 036225 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKP-----------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 430 (622)
Q Consensus 362 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 430 (622)
+++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999886544 689999999999999999999998 99999999999
Q ss_pred eeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh--cCCccccchhc
Q 036225 431 ILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALEYGKAA 507 (622)
Q Consensus 431 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t--g~~p~~~~~~~ 507 (622)
|++++++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999999865433221 2233446788999999988889999999999999999998 56666432211
Q ss_pred cccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 508 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
................ .....+...+.++.+++.+|++.+|.+||++.|+++.|+
T Consensus 241 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ----QVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----HHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111110000 000111223467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.10 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=202.0
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCC-----cee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-----ERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 373 (622)
+|+..+.||+|+||.||++.. .+|+.||+|.+.... .......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986532 2223456889999999999999999999998776 789
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 57888887777899999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-------hhhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-------QEKK 525 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~ 525 (622)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||......+....+.+...... ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 33333344678999999998774 478999999999999999999999975443222111111100000 0000
Q ss_pred hhhhccccCC-C------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 LEMLVDKDLK-N------NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ~~~~~d~~~~-~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...... . .......+++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0 0111124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.71 Aligned_cols=242 Identities=25% Similarity=0.310 Sum_probs=195.6
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcccc-ccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH-RNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 376 (622)
+|+..+.||+|+||.||+|... +++.||+|+++... .......+..|.+++..+.| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 57899999987542 12234467789999988876 56888999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++....... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999987532221 2
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+.. .. .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~---------~~--~ 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIME---------HN--V 218 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHc---------CC--C
Confidence 2344569999999999999999999999999999999999999997433211 1111110 00 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.++.....++.+++.+|+..+|.+|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1112233568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.85 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=204.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
+..++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 245899999876554444556888999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 371 ERLLVYPYMSNGSVASRLKG----------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
..++||||+++|+|.+++.. ....++..+..++.|++.||.|||++ +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999853 23456778899999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHH
Q 036225 441 VGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 518 (622)
|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||...... +...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 99999997654322211 122235678999999998899999999999999999999 67777532211 1111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.+.... .. ..+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 233 ~~~~~~---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGG---------YL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCC---------CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111110 00 01112346799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.53 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=205.3
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
+..++|.+.+.||+|+||.||+|...+ +..||+|.+...........+.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345678899999999999999998642 46899999876544444557889999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccCC----------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 371 ERLLVYPYMSNGSVASRLKGK----------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999988532 2478889999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHH
Q 036225 441 VGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 518 (622)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++||++| |..||...... ....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFV- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHH-
Confidence 9999999765433221 1223346789999999988889999999999999999998 88887532211 111111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.... ....+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 235 --~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 --IDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1100 00111122467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.24 Aligned_cols=238 Identities=28% Similarity=0.373 Sum_probs=192.9
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|..+ +++.||+|+++... .......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 58899999987532 122334567788888766 699999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999987543222 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.... . ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~---------~--~~~~~ 218 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE---------V--VYPTW 218 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCC---------C--CCCCC
Confidence 6999999999999889999999999999999999999999754321 1111111110 0 01112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
...++.+++.+|++.||++||++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCC
Confidence 335788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.67 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=199.6
Q ss_pred CeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|.+.. +..+|+|.++..........+.+|+++++.+.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 36899999986654445567899999999999999999999876 4567999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee-
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA- 460 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~- 460 (622)
|+|.+++.....+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999998765433222211
Q ss_pred -ecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 461 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 461 -~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+..++. ..... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~---~~~~~----------~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLE---SGERL----------PR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHH---cCCcC----------CC
Confidence 223568999999988899999999999999999998 89998643211 1112211 11100 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
+...+..+.+++.+|+..+|++||++.++++.|++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 122346788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.36 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=200.7
Q ss_pred CCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+|.+.+.||+|+||.||+|... +++.||+|+++..........+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666789999999999999863 2578999999865433334568899999999999999999999999999999
Q ss_pred EeeeccCCCccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 375 VYPYMSNGSVASRLKG----------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999888742 23478888999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||+| |..||..... .++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 999999998865432221 1223345789999999988889999999999999999998 7777753221 112
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
...+.... . ...+...+..+.+++.+|++.+|++||+++++++.|+
T Consensus 236 ~~~i~~~~---------~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 IEMIRNRQ---------V-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHcCC---------c-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 22221111 0 0112234467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.21 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=202.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|.+.+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++.+++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46788899999999999999984 235679999887543 23345688999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC-------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 373 LLVYPYMSNGSVASRLKGK-------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 9999999999999888532 2489999999999999999999998 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHH
Q 036225 440 VVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 517 (622)
||+|||++......... ......++..|+|||++.+..++.++|||||||++|||+| |..||....... . .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~---~ 232 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----V---I 232 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----H---H
Confidence 99999999765432211 1122335778999999988889999999999999999999 888876432111 1 1
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+.... . .. .+...+.++.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 233 ~~i~~~~-~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 233 ECITQGR-V-----LQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred HHHHcCC-c-----CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1111110 0 00 111233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.98 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=195.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.|...+.||+|+||+||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++.+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999964 688999999875321 2233468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC---
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD--- 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~--- 454 (622)
|+++|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998777789999999999999999999999 99999999999999999999999999975321000
Q ss_pred -------------------------------------------CceeeeecCcccccCccccccCCCCcccceeehhHHH
Q 036225 455 -------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 491 (622)
Q Consensus 455 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l 491 (622)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001224689999999999999999999999999999
Q ss_pred HHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 036225 492 LELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK---MSEVV 568 (622)
Q Consensus 492 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl 568 (622)
|||+||+.||........ ...+... ..............+..+++.+++ .+|.+|++ +.|++
T Consensus 239 ~elltG~~Pf~~~~~~~~-------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET-------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCHHHH-------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999975432111 1111000 000000001112345677777765 49999997 77666
Q ss_pred H
Q 036225 569 R 569 (622)
Q Consensus 569 ~ 569 (622)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.87 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=197.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+|++.+.||+|+||.||+|... +++.||||++..... ......+.+|++++..++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999965 689999999864321 1223457889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC---
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD--- 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~--- 454 (622)
|+++|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998877889999999999999999999999 99999999999999999999999999975321000
Q ss_pred ---------------------------------------CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHH
Q 036225 455 ---------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495 (622)
Q Consensus 455 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~ 495 (622)
........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00012346999999999999999999999999999999999
Q ss_pred hcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 036225 496 TGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRP---KMSEVVRM 570 (622)
Q Consensus 496 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~~ 570 (622)
||+.||......+. ...+.... ..............+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~~~~-------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAET-------QLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHH-------HHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999975432211 11111000 00000000112345677787766 4999999 88888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.67 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=203.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.+|...+.||+|+||.||+|... ++..+++|.++... ......+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45778899999999999999842 35679999886543 223346889999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 036225 374 LVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
+||||+++++|.+++... ..+++..+.+++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 999999999999988532 2488999999999999999999999 999999999999999999
Q ss_pred ceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHH
Q 036225 438 EAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 438 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 515 (622)
.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||....... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~-- 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----V-- 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----H--
Confidence 9999999999765432211 1223446788999999998899999999999999999999 999886433211 1
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...... . .. .......+..+.+++.+|++.+|++||++.+|+++|+..
T Consensus 235 -~~~~~~-~--------~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 -IECITQ-G--------RV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -HHHHhC-C--------CC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111110 0 00 011122346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.53 Aligned_cols=239 Identities=26% Similarity=0.288 Sum_probs=191.1
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHH-HHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 689999999864321 122234455554 46788999999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 99999998877899999999999999999999999 9999999999999999999999999998753221 1223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~-------~~~~~~---- 218 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNILNKP-------LRLKPN---- 218 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCC-------CCCCCC----
Confidence 6899999999999999999999999999999999999999743211 1111111100 011111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~e 566 (622)
.+..+.+++.+|++.||.+||++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 2467889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.27 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=195.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+|...+.||+|+||.||+|... +++.||+|.++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 578999999875432 22233466777777766 5899999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999997543222 2
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+.. ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~---------~~~-- 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIME---------HNV-- 218 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHh---------CCC--
Confidence 2334569999999999999999999999999999999999999997433211 1111111 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.++.....++.+++.+|++.+|.+|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122234678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.83 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=193.9
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHH---hccccccceeeeeeeeCCCceeEE
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMI---SLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
|.+.+.||+|+||.||+|... +++.||||+++.... ......+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999965 689999999975321 12233566666654 567899999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988865 4689999999999999999999998 99999999999999999999999999987533221
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~-------~~-- 219 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDE-------VR-- 219 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------CC--
Confidence 2233456999999999999989999999999999999999999999743321 1111111100 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
++...+..+.+++.+|++.||.+||+ +.++++
T Consensus 220 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 --YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11223466889999999999999994 556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.25 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=199.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe--EEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 374 (622)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457788899999999999999964 454 46888776544444455788999999999 89999999999999999999
Q ss_pred EeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 375 VYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
||||+++++|.++++.. ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 99999999999988532 2578999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 517 (622)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 233 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHH
Confidence 999999998632211 11111224668999999988889999999999999999998 99998643211 111
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...... .........+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 0000111123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.81 Aligned_cols=252 Identities=29% Similarity=0.420 Sum_probs=202.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.++|.+.+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++|+|++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 356888899999999999999988777899998865432 2346889999999999999999999875 4567899999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.++++.. ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999998643 3478999999999999999999998 9999999999999999999999999999876433322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......++..|+|||+..+..++.++||||||+++|||+| |+.||...... ....+. ... ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~---~~~----------~~ 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQV---ERG----------YR 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---HcC----------CC
Confidence 2223346778999999988889999999999999999999 88887643211 111111 110 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=315.93 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=206.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||.||+|... +++.||||.++.... ......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999964 789999998764322 223346889999999999999999999999999999999
Q ss_pred eeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+++|+|.+++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988774 234578899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ......|+..|+|||.+.+..++.++||||||+++|||+||+.||..... ....+...+....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCD-------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCC--------
Confidence 221 12234588899999999888899999999999999999999999864321 1112222211110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
............+.+++.+||..+|++||++.++++.++.
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 1111122344678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.82 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=207.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|.+.+.||+|+||.||+|..++++.||||.+..... ....+.+|+.++++++|+|++++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 34578899999999999999999988888899999875432 3456889999999999999999999999989999999
Q ss_pred eeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++++|.+++... ..+++..+..++.|++.|+.|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999998753 3689999999999999999999999 99999999999999999999999999998765322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~---~~~~~~---------- 220 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVL---EQVERG---------- 220 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH---HHHHcC----------
Confidence 222223335678999999998889999999999999999999 88888532211 111 111100
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001111124678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=315.33 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=204.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|.+.+.||+|+||.||+|... .+..+|+|.++..........+.+|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888999999999999999863 2347999998765444445578999999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++++|.+++... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999998653 4689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeee--ecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
....... ..++..|+|||++.+..++.++||||||+++||+++ |..||......+ ....+ ....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~---~~~~------ 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAI---EEGY------ 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHH---hCCC------
Confidence 3222221 123568999999998899999999999999999886 999986432211 11111 1110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 001111234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.78 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=200.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC---------------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD---------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 363 (622)
..+|++.+.||+|+||.||++...+ ...||+|.++..........+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999987532 2358999987654444455789999999999999999999
Q ss_pred eeeeCCCceeEEeeeccCCCccccccCC------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 364 GFCMTPTERLLVYPYMSNGSVASRLKGK------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 364 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 9999999999999999999999887532 2468899999999999999999998 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh--cCCccccchhcc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALEYGKAAN 508 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t--g~~p~~~~~~~~ 508 (622)
++++++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765332211 1122335678999999988899999999999999999998 455665322111
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
............... .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ----VIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ----HHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111100000 000011123467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.55 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=205.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CC---eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++..........+..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999965 23 37999998765444445578899999999999999999999999999999
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999864 35689999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCceee--eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||..... .++...+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~------ 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGF------ 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCC------
Confidence 222111 1123457999999988889999999999999999998 9999864321 11222221110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.40 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=202.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|+..+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888999999999999999853 444 48999987655555556788999999999999999999998754 567
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+++||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999875 45689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..... .....++..|+|||...+..++.++|||||||++|||+| |..||...... .+..++.. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~---~~------ 228 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLEK---GE------ 228 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHC---CC------
Confidence 32221 112234678999999988899999999999999999998 88887643211 11111111 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+|++.||++||++.++++.|+.
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001112234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.53 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=205.1
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+..++|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45677888999999999999999741 34579999987554344455788999999999 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
.....++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999988532 3478889999999999999999998 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999998765433221 222345678999999988889999999999999999998 677764321
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..++...+..... ...+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 245 ---~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 245 ---VEELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---HHHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1122222211111 01122344678999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.18 Aligned_cols=242 Identities=27% Similarity=0.353 Sum_probs=194.0
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhc-cccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +++.||+|+++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999875421 2223346677777775 4899999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 99999998777799999999999999999999998 99999999999999999999999999987543222 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .+. ++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~-------~~~----~~~~ 218 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMD-------NPC----YPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------CCC----CCcc
Confidence 6999999999999889999999999999999999999999743321 111111100 011 1112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS-EVVR 569 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~-evl~ 569 (622)
...++.+++.+|++.+|++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 335688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=324.84 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=203.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
..++|.+.+.||+|+||.||++... ++..+|+|.++..........+..|++++..+ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467899999999999999999852 23579999998654344445688899999999 79999999999999
Q ss_pred CCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 036225 369 PTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIL 432 (622)
.+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 99999999999999999998642 2488999999999999999999998 9999999999999
Q ss_pred ecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcccc
Q 036225 433 LDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQK 510 (622)
Q Consensus 433 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~ 510 (622)
+++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 9999999999999997654322111 111224568999999988889999999999999999998 7777753221
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+....+... .....+.....++.+++.+|++.+|++||++.++++.|+.
T Consensus 249 ---~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 249 ---EELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred ---HHHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1111111111 1111122234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.81 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=205.1
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cc-----cceeeeeeeeCCCcee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HR-----NLLRLYGFCMTPTERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~ 373 (622)
+|.+.++||+|+||.|.+|.. ++++.||||+++..... ..+-..|+.+|..++ |. |+|+++++|...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 788899999999999999995 46999999999875432 334567999999887 43 7999999999999999
Q ss_pred EEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEccccccee
Q 036225 374 LVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--CCEAVVGDFGLAKL 449 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~ 449 (622)
||+|.++. +|+++++.+ ..++...++.|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|++
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999965 999999853 4688999999999999999999998 9999999999999974 45799999999997
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH-----Hhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK-----IHQEK 524 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 524 (622)
....- . .+..+..|+|||++.+.+|+.+.||||||||++||+||.+.|.+.+..++...|.+.... +....
T Consensus 341 ~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 64322 2 556899999999999999999999999999999999998888777766665555443221 00111
Q ss_pred hhhhhccc---------------------------------cCC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 525 KLEMLVDK---------------------------------DLK-------NNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 525 ~~~~~~d~---------------------------------~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
+....++. ... ..........+.+++++|+.+||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 11111111 000 00111234568999999999999999999
Q ss_pred HHHHHH
Q 036225 565 SEVVRM 570 (622)
Q Consensus 565 ~evl~~ 570 (622)
.|++++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=319.52 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=200.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+|+..++||+|+||+||++... +++.||+|.+..... ......+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677899999999999999964 689999999865322 1223457789999999999999999999999999999999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999988753 34689999999999999999999998 999999999999999999999999999987543221
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||......... ......+ .. ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~----------~~-~~ 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRV----------KE-DQ 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHh----------hh-cc
Confidence 22346899999999999888999999999999999999999999743221110 0100110 00 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
..++...+..+.+++.+|+..||.+|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112223346788999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.47 Aligned_cols=243 Identities=28% Similarity=0.342 Sum_probs=196.5
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +++.||+|+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999987542 122334567888888877 799999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 99999998777899999999999999999999998 99999999999999999999999999987532222 222345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.|+..|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. ... .++..
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~---------~~~--~~~~~ 218 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILE---------DEV--RYPRW 218 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHc---------CCC--CCCCc
Confidence 6899999999999999999999999999999999999999643311 11111111 000 11222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKM-----SEVVRM 570 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~-----~evl~~ 570 (622)
.+..+.+++.+||+.||.+||++ .++++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 34678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.89 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=204.1
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCC-eEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeee-eeeC------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYG-FCMT------ 368 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~------ 368 (622)
...++++.++|.+|||+.||.|....+ ..||+|++-.. ........++|++++++++ |+|||.+++ ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 345567889999999999999997765 99999998765 3455667899999999997 999999999 3321
Q ss_pred CCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 369 PTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
.-+.+|.||||.+|+|.+++.. ...|++.++++|+.|+++|+.+||.. +++|||||||.+||||+.+++.||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2467899999999999999873 34599999999999999999999985 77899999999999999999999999999
Q ss_pred ceecCCCC-Ccee-------eeecCcccccCcccc---ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 447 AKLLDHQD-SHVT-------TAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 447 a~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
|.-.-... .... .....|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 86432211 1110 112368999999976 567899999999999999999999999985422
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+++..+.-.........+.+||..||+.+|.+||++.+|++.+..
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 12233333222224566889999999999999999999999987753
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.07 Aligned_cols=241 Identities=26% Similarity=0.334 Sum_probs=193.5
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhc-cccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
++||+|+||.||+|... +|+.||+|.++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 688999999875421 2233356677777765 4899999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 99999998777899999999999999999999999 9999999999999999999999999998753221 1223445
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .+. ++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~-------~~~----~~~~ 218 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVD-------TPH----YPRW 218 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------CCC----CCCC
Confidence 6999999999999999999999999999999999999999743321 111111100 111 1112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS-EVV 568 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~-evl 568 (622)
...++.+++.+|++.||++||++. +++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 335688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=311.82 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=204.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.++|+..+.||+|+||.||+|... |+.||+|.++.... ...++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888999999999999999876 78899999976543 456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999987554 689999999999999999999999 999999999999999999999999999986532211
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
....+..|+|||++.++.++.++||||||+++|||++ |..||......+ +. ..... ...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~---~~~~~----------~~~ 217 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VV---PHVEK----------GYR 217 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HH---HHHhc----------CCC
Confidence 2235678999999988889999999999999999997 888875332111 11 11110 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=316.67 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=200.5
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|+..++||+|+||.||+|.. .+++.||+|.+...........+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999985 478899999987554344455788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 81 MDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 9999986543 367888999999999999999998 9999999999999999999999999999765432 22
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....|+..|+|||++.+..++.++||||||+++|+|+||+.||..............+.... .+.......
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---------VDEDPPVLP 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---------hccCCCCCC
Confidence 33468999999999998899999999999999999999999997533222111111111111 111100001
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.06 Aligned_cols=248 Identities=20% Similarity=0.256 Sum_probs=200.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-C-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-D-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.|...+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999854 3 6788888765432 23334678899999999999999999999999999999999
Q ss_pred ccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 379 MSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 379 ~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+++|+|.++++ ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999988764 344688999999999999999999998 99999999999999999999999999998765332
Q ss_pred C-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .......... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~---------~ 287 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYG---------K 287 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------C
Confidence 2 123445699999999999999999999999999999999999999864321 1111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.. ..+......+.+++.+|++.+|++||++.+++.
T Consensus 288 ~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 111223367899999999999999999999875
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.05 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=203.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeee
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFC 366 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 366 (622)
....++|.+.+.||+|+||.||+|... .+..+|+|.++..........+..|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 24679999988654444455688999999999 699999999999
Q ss_pred eCCCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 430 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 430 (622)
...+..+++|||+++|+|.+++... ..+++.++.+++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 9999999999999999999988532 3488999999999999999999998 99999999999
Q ss_pred eeecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcc
Q 036225 431 ILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAAN 508 (622)
Q Consensus 431 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~ 508 (622)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998654322211 111224567999999988889999999999999999999 78887532211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.......... ....+...+.++.+++.+|++.+|++||++.|+++.|+.
T Consensus 244 ------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 244 ------ELFKLLREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ------HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111110 001122234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.28 Aligned_cols=238 Identities=24% Similarity=0.274 Sum_probs=189.9
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHH-HHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
++||+|+||.||+|... +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 688999999865321 122334555554 57889999999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|...+.....+++.....++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 99999888777789999999999999999999998 99999999999999999999999999987532221 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......+.. ... ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~---------~~~--~~~~~ 218 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILH---------KPL--QLPGG 218 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhc---------CCC--CCCCC
Confidence 689999999999988999999999999999999999999974321 111111111 111 11112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
....+.+++.+|++.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 335688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.05 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=198.6
Q ss_pred CCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCc-----
Q 036225 302 FSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE----- 371 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 371 (622)
|.+.+.||+|+||.||+|.... +..||+|+++..... .....+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4678899999999999998642 367999998754322 234568899999999999999999998876554
Q ss_pred -eeEEeeeccCCCccccccC------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 372 -RLLVYPYMSNGSVASRLKG------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 372 -~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
.++++||+++|+|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999888742 23688999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhh
Q 036225 445 GLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 445 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.+++ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~---~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYL---RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---Hc
Confidence 9998764433221 112235678999999988889999999999999999999 88887543211 111111 11
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.. ....+...+.++.+++.+|++.||++||++.|+++.|+.
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10 011122344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.74 Aligned_cols=249 Identities=25% Similarity=0.294 Sum_probs=195.5
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||+||++..+ +|+.||+|.+..... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 689999999864321 12233456799999999999999999999999999999999999999
Q ss_pred cccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 385 ASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 385 ~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 888753 33588999999999999999999998 99999999999999999999999999998764322 223446
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... ...... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~---------~~~~~~-~~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTL---------EDEVKF-EHQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhh---------cccccc-ccccC
Confidence 89999999999988899999999999999999999999864321111 111111111 111100 00122
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
..++.+++.+|++.+|++||+++|+++.+...
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 35689999999999999999998877655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.26 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=207.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||.||+|... +|+.||+|.++.... ......+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 789999998864322 223457889999999999999999999999999999999
Q ss_pred eeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999988742 34589999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+........
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--------- 223 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKC--------- 223 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcC---------
Confidence 3221 2334588999999999888899999999999999999999999864321 111222111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.............+.+++.+|+..+|++||++.+++++|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 01111112344678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.56 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=204.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
..++|+..+.||+|+||.||+|... ++..||+|.++..........+.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567889999999999999999863 4678999998765444445578899999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCC----------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 036225 372 RLLVYPYMSNGSVASRLKGK----------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 429 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~ 429 (622)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 99999999999999888521 2478888999999999999999998 9999999999
Q ss_pred CeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhc
Q 036225 430 NILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAA 507 (622)
Q Consensus 430 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~ 507 (622)
||++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765432211 1122234678999999988899999999999999999998 77787532211
Q ss_pred cccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 508 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+....+... ... ..+...+.++.+++.+|++.+|.+||++.|+++.|+.
T Consensus 240 -------~~~~~~~~~---------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -------EVIYYVRDG---------NVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHHhcC---------CCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112211111 110 0111234678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.96 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=194.1
Q ss_pred CeeeecCCceEEEEEECC-Ce--EEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|..++ +. .+++|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 57889887544444455788999999999 799999999999999999999999999
Q ss_pred CCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 382 GSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 382 gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999988532 2478999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
++...... ........+..|+|||++....++.++|||||||++|||+| |..||...... +....+....
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhCCC
Confidence 98632211 11111224567999999988889999999999999999997 99998643211 1111111110
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...........+.+++.+|+..+|.+||++.++++.|+.
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 001111233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=317.79 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=201.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
..+|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 356778899999999999999742 36689999887543 33445789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC---------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 036225 373 LLVYPYMSNGSVASRLKGK---------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 9999999999999888643 2488999999999999999999998 999999999999999999
Q ss_pred ceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHH
Q 036225 438 EAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 438 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 515 (622)
.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------- 232 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------- 232 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------
Confidence 9999999999765432211 1122335678999999999999999999999999999998 888875332211
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
......... ....+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus 233 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111000 00111223466889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.74 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=195.3
Q ss_pred CCcCCeeeecCCceEEEEEECC-Ce--EEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC------Cc
Q 036225 302 FSSKNILGKGGFGIVYKGILQD-GT--VVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TE 371 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 371 (622)
|.+.+.||+|+||.||+|.+.+ ++ .||+|.++.... ......+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 32 699998875432 22345688899999999999999999987532 24
Q ss_pred eeEEeeeccCCCcccccc------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 372 RLLVYPYMSNGSVASRLK------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
.+++|||+++|+|.+++. ....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988763 223588999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhh
Q 036225 446 LAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 446 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
+++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcC
Confidence 998764332211 122235678999999998899999999999999999999 78887542211 111111111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... ......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 0111234568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=325.72 Aligned_cols=245 Identities=24% Similarity=0.259 Sum_probs=193.2
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHH-HHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +++.||+|++..... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999975 578899999865321 122233444444 56788999999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+.+.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 99999998777788899999999999999999999 99999999999999999999999999997543222 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .. .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~---------~~--~~~~~ 218 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNK---------PL--QLKPN 218 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC---------Cc--CCCCC
Confidence 6999999999999999999999999999999999999999743321 111111110 00 01112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
....+.+++.+|++.+|.+||++.+.+..+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 2356889999999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.05 Aligned_cols=266 Identities=21% Similarity=0.312 Sum_probs=200.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||+||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999965 67889999987654444445678899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++ +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 975 77777654 44588999999999999999999998 999999999999999999999999999976533221 1
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH--------HHhhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK--------KIHQEKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 528 (622)
.....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+....+..... ..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223457899999998865 4588999999999999999999999975443222111111000 0000000000
Q ss_pred hccccCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNN----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.-.+..... .......++.+++.+|++.||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000 001123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=318.39 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=193.3
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||+||++... +++.||+|.+...... .....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 6889999998653221 1224577899999999999999999999999999999999999999
Q ss_pred ccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 385 ASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 385 ~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 87763 345689999999999999999999998 999999999999999999999999999986643322 2234
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ .... ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~---------~~~~--~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRI---------LNDS--VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhh---------cccC--CCCcc
Confidence 5689999999999999999999999999999999999999974322111 00111110 1110 01122
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRP-----KMSEVVR 569 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 569 (622)
..+..+.+++.+|++.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2346788999999999999999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.47 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=204.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 68889999987554333345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|.++++....+++..+..++.|++.||.|||+.+ +++|+||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 999999999987778999999999999999999999732 8999999999999999999999999998754322 12
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh---------------
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--------------- 523 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 523 (622)
....|+..|+|||++.+..++.++||||||+++|||+||+.||....... ...+.......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCC
Confidence 33468899999999988889999999999999999999999986433111 11111000000
Q ss_pred ---------hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 ---------KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ---------~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+...............++.+++.+|+..+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000001134568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.67 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=203.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|++|.||+|..+ +++.|++|.+.... .......+.+|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 68999999986432 233445788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999998653 5688999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....|+..|+|||++.+..++.++||||||+++|||+||+.||...... ........ .. ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~---------~~-~~ 219 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIR---------GV-FP 219 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHc---------CC-CC
Confidence 23345889999999999989999999999999999999999998644311 11111110 00 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222334678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.94 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=204.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|...+.||+|+||.||+|...++..+|+|.++... .....+.+|++++++++|+|++++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3456788999999999999999998778889999887532 234468899999999999999999999887 7789999
Q ss_pred eeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999864 34578999999999999999999998 99999999999999999999999999998664332
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
........++..|+|||++....++.++|||||||++|+++| |..||...... ....+.. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~---~~---------- 219 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALE---RG---------- 219 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHh---CC----------
Confidence 222223345678999999988889999999999999999999 88888643211 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.........+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=323.75 Aligned_cols=244 Identities=25% Similarity=0.257 Sum_probs=193.4
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHH-HHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 689999999865321 222334555655 46778999999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccc
Confidence 99999988777899999999999999999999998 9999999999999999999999999998753221 1223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||..|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~~-------~~~~~----~ 218 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHKP-------LVLRP----G 218 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcCC-------ccCCC----C
Confidence 6999999999999999999999999999999999999999743311 1111111100 00111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
....+.+++.+|++.+|.+||++.+.++.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 235678999999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.53 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=202.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CC---eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.+|...+.||+|+||.||+|... ++ ..||||.++..........|..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34678899999999999999964 23 369999987654444456799999999999999999999999999999999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999998864 45689999999999999999999998 99999999999999999999999999987664322
Q ss_pred Ccee--eeec--CcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 455 SHVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 455 ~~~~--~~~~--gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.... .... .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~---~~------ 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE---QD------ 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH---cC------
Confidence 2111 1111 2457999999998899999999999999999887 99998643211 1112111 10
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.........+..+.+++.+|++.+|.+||++.+++..|+.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0001112234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.22 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=201.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-----------------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccccee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-----------------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 361 (622)
.++|++.+.||+|+||.||++... ++..||+|+++..........+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999998532 245699999876544444557899999999999999999
Q ss_pred eeeeeeCCCceeEEeeeccCCCccccccCC-----------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 036225 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGK-----------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 430 (622)
Q Consensus 362 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 430 (622)
+++++...+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999988542 2467889999999999999999999 99999999999
Q ss_pred eeecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh--cCCccccchhc
Q 036225 431 ILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALEYGKAA 507 (622)
Q Consensus 431 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t--g~~p~~~~~~~ 507 (622)
||+++++.++|+|||++..+....... .....++..|+|||...++.++.++|||||||++|||+| |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999997654322211 122334678999999888889999999999999999998 66777532211
Q ss_pred cccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 508 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
. +............... .. ..+..++..+.+++.+|++.||++||++.||++.|+
T Consensus 241 ~----~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q----VIENTGEFFRDQGRQV-YL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H----HHHHHHHHHhhccccc-cC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1111111110000000 00 011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=342.71 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=203.1
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC---
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--- 370 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--- 370 (622)
....++|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+..+..++|+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999985 4789999999865432 233446888999999999999999988765432
Q ss_pred -----ceeEEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 036225 371 -----ERLLVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV 441 (622)
Q Consensus 371 -----~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 441 (622)
..++||||+++|+|.++++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 35799999999999998853 34688999999999999999999998 9999999999999999999999
Q ss_pred cccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 442 GDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 442 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 99999987643221 223345699999999999999999999999999999999999999964321 1122211
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... . ...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 258 ~~~~-----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR-----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC-----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 0 01122234678999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=301.78 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=205.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.+++|++.+.||+|.|+.||+... .+|+.+|+|.+.... ...+.+.+.+|+++-+.++||||+++...+......++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999985 478999999886432 233556789999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~ 452 (622)
+|+|+|++|..-+-.+...++...-.++.||+++|.|+|.+ +|||||+||+|+++. ...-+||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999977665556678888889999999999999999 999999999999995 44568999999999887
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
+.......+||++|||||++...+|+..+|||+-||+||-|+.|..||...+... +.+ ++... .+|
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----lye---~I~~g-----~yd- 230 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYE---QIKAG-----AYD- 230 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----HHH---HHhcc-----ccC-
Confidence 4455566789999999999999999999999999999999999999998543221 111 11110 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+.+-....++..+|+++|+..||.+|.|+.|.++
T Consensus 231 -~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 -YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111122223467889999999999999999998874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.65 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=198.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||+||++... +++.||+|+++... .......+..|++++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 68999999986432 1223346788999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS- 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 455 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999998878899999999999999999999999 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 456 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 456 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 503 YGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...... ....+..... .. .+.... ....++.+++.+++. +|.+|++...+-+.++..
T Consensus 238 ~~~~~~-------~~~~i~~~~~--~~---~~p~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 238 SETPQE-------TYRKVMNWKE--TL---VFPPEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCHHH-------HHHHHHcCCC--ce---ecCCCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 543211 1111111000 00 000000 122567778888764 999999644343444433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=309.86 Aligned_cols=247 Identities=31% Similarity=0.477 Sum_probs=203.7
Q ss_pred CeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|.... +..|++|.++..........+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999753 7889999998665444456789999999999999999999999999999999999999
Q ss_pred CCccccccCC---------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 382 GSVASRLKGK---------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 382 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++|.+++... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764 7799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
... .......++..|+|||.+....++.++||||||+++|||++ |..||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-------
Confidence 321 12233457889999999988889999999999999999999 58888654211 111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.....+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112223567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.69 Aligned_cols=245 Identities=23% Similarity=0.271 Sum_probs=193.9
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|... +++.||+|+++..... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999999764322 2234577899988887 699999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 99999888777899999999999999999999999 99999999999999999999999999997532222 223345
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.||+.|+|||++.+..++.++|||||||++|||+||+.||......... ....+........ .. ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~--------~~--~~p~~ 225 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEK--------PI--RIPRF 225 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhC--------CC--CCCCC
Confidence 6999999999999999999999999999999999999999643221111 1111111111110 00 11222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
.+..+.+++.+|++.||++||++.
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 235678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.57 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=199.4
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC-
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP- 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 369 (622)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456789999999999999999974 347889999997654444445688999999999 689999999988654
Q ss_pred CceeEEeeeccCCCccccccCC----------------------------------------------------------
Q 036225 370 TERLLVYPYMSNGSVASRLKGK---------------------------------------------------------- 391 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------- 391 (622)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999999998887531
Q ss_pred ---------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc-eeeee
Q 036225 392 ---------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAV 461 (622)
Q Consensus 392 ---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~ 461 (622)
..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2367888899999999999999998 9999999999999999999999999999765322211 11223
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
.++..|+|||.+.+..++.++||||||+++|||++ |..||....... .......... ....+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~----------~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT----------RMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccC----------CCCCCC
Confidence 35678999999988899999999999999999997 888875422110 0111111100 000111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....++.+++.+||+.+|++||++.|+++.|+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.66 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=205.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||+|+||.||+|.. .+++.+|||.+..... ......+.+|+++++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677889999999999999995 4789999998865332 223346889999999999999999999999999999999
Q ss_pred eeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999998875 245689999999999999999999998 999999999999999999999999999876643
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ......++..|+|||++.+..++.++||||||+++|||++|..||...... ...+.+.+. ....+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~------~~~~~ 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIE------QCDYP 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhh------cCCCC
Confidence 322 123345889999999998888999999999999999999999998643211 111111111 10111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.. ........+.+++.+|+..+|.+|||+.+|++.+++
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 112244678999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.99 Aligned_cols=249 Identities=19% Similarity=0.281 Sum_probs=203.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|++.+.||+|+||.||++... +++.+|+|.++..........+.+|+.+++.++|+|++++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 688999999875444444557889999999999999999999999999999999999
Q ss_pred cCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 380 SNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 380 ~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++|+|.+++.. ...+++.....++.|++.||.|||+. +|+|+||||+||++++++.++++|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999988753 34578999999999999999999998 999999999999999999999999999986643222 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.... ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~----------~~~ 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-------NLILKVCQGS----------YKP 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-------HHHHHHhcCC----------CCC
Confidence 23456889999999998888999999999999999999999998643211 1111111100 001
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.62 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=203.0
Q ss_pred hCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--Cce
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 372 (622)
..|.+.+.||+|+||.||.+.+ .++..||+|.++..........+.+|+++++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 257889999987654444455789999999999999999999998775 567
Q ss_pred eEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 LLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999998643 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhc--------cccccHHHHHHHHh
Q 036225 452 HQDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAA--------NQKGAMLDWVKKIH 521 (622)
Q Consensus 452 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~ 521 (622)
..... ......++..|+|||++.+..++.++||||||+++|||+|++.|....... ........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 43221 112345677899999998888999999999999999999987664321100 00001111111111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... ........+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 241 EGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred cCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 110 011112234679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.90 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=203.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|+..+.||+|+||+||+|..+ +.+.|++|.+...........+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 367888999999999999999964 24679999886544332345789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCC---------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 373 LLVYPYMSNGSVASRLKGKP---------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999987544 689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhh
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHc
Confidence 99987543322222233346778999999988889999999999999999999 7777753221 111111110
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.. .........+..+.+++.+|++.+|.+||++.|+++.|.
T Consensus 234 -~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000111123467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.00 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=202.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++.+++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45788999999999999999996 4688999999875432 233457889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.++++....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........ .
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999999998777889999999999999999999998 999999999999999999999999999986643221 1
Q ss_pred eeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 458 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||...........+ .. .....+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~----~~~~~~~~ 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK----SNFQPPKL 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec----CCCCCCCC
Confidence 23345889999999884 345788999999999999999999998643211110000 00 00000001
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.. ....+..+.+++.+|++.+|++||+++++++.|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 111236788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.09 Aligned_cols=250 Identities=26% Similarity=0.471 Sum_probs=202.3
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
.+|+..+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46778899999999999999987788999999875432 2346889999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++++|.+++... ..++++.+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999998653 4689999999999999999999998 999999999999999999999999999986543322222
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
....++.+|+|||.+.++.++.++||||||+++|||++ |+.||..... ......+.... ....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~---~~~~------ 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF---RLYK------ 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC---CCCC------
Confidence 22335678999999988889999999999999999998 8888863221 11111111110 0011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
+...+..+.+++.+|++.+|++||++.|+++.|
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111236799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.97 Aligned_cols=259 Identities=27% Similarity=0.370 Sum_probs=199.8
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHh--ccccccceeeeeeeeCC----C
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS--LAVHRNLLRLYGFCMTP----T 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~----~ 370 (622)
....+....+.||+|.||+||+|.|+ |+.||||+|... ++..+.+|.++++ .++|+||+.+++.-..+ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 33456778899999999999999998 899999999753 3557778888876 56999999999986554 4
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-----cCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-----QCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
+.|||++|.+.|||+|+|.. ..++.+..++++..+|.||+|||. +.+|.|.|||||+.|||+.+++.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 67999999999999999987 568999999999999999999994 468899999999999999999999999999
Q ss_pred cceecCCCCCce---eeeecCcccccCccccccCC------CCcccceeehhHHHHHHHhc----------CCccccchh
Q 036225 446 LAKLLDHQDSHV---TTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITG----------QRALEYGKA 506 (622)
Q Consensus 446 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~el~tg----------~~p~~~~~~ 506 (622)
+|.......... ....+||.+|||||++...- --..+||||||.++||+.-. +.||..-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-- 439 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-- 439 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC--
Confidence 998776543222 23457999999999996532 13468999999999999742 2344321
Q ss_pred ccccccHHHHHHHHhhhhhh-hhhccccCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 507 ANQKGAMLDWVKKIHQEKKL-EMLVDKDLKNNY-----DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+..-...+.+ ..+..++++... .......+.++++.||..+|.-|-|+-.+.+.|.+
T Consensus 440 ----------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 440 ----------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred ----------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 1111111111 112223333222 23456778999999999999999999988888764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.09 Aligned_cols=254 Identities=22% Similarity=0.373 Sum_probs=202.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|...+.||+|+||.||+|.+.+ ...||+|.............+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567888999999999999998643 346999988765434445578999999999999999999999875 45789
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999753 4589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.........++..|+|||.+....++.++||||||+++|||++ |..||....... ...+ +......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~---~~~~~~~------ 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VIGR---IENGERL------ 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHH---HHcCCcC------
Confidence 3222222334568999999988889999999999999999996 999986443211 1111 1111100
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...+..+.+++.+|+..+|.+|||+.++++.|+.
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=313.74 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=201.8
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhH-HHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|+..+.||+|+||+||++... +++.||+|.+.......... ...+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 57799999998765333222 3356999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999998667789999999999999999999999 99999999999999999999999999998642 2223344
Q ss_pred eecCcccccCccccc-cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 460 AVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...++..|+|||++. +..++.++||||+|+++|+|++|..||......+... ............. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~-- 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE----IIEKILKRPLPSS-----SQQ-- 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH----HHHHHHHTHHHHH-----TTS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhh----hhhhccccccccc-----ccc--
Confidence 566899999999998 7889999999999999999999999987542111111 1111110000000 000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012679999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.73 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=203.7
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+...+|.+.+.||+|+||.||+|... .+..||+|.++..........+.+|++++.++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34456888999999999999999742 13479999887654444455788999999999 7999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
..+..+++|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 999999999999999999988532 2478899999999999999999998 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999998664322211 122234567999999999899999999999999999998 7787753221
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.++...+.... ....+......+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 243 ----~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 243 ----EELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred ----HHHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11222211110 1111122346788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.80 Aligned_cols=255 Identities=19% Similarity=0.221 Sum_probs=197.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||+|+||+||++..+ +++.||+|++.+.. .......+..|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 57889999986422 1222335788999999999999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999975 45689999999999999999999998 999999999999999999999999999976543333
Q ss_pred ceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 456 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~---- 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKER---- 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcc----
Confidence 3333456999999999986 34578999999999999999999999974321 1111211111000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 570 (622)
..+.. ........+.+++.+|+..++.+ |+++.|+++.
T Consensus 227 -~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 -FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 01122466788899988654444 6888888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.41 Aligned_cols=247 Identities=32% Similarity=0.453 Sum_probs=199.1
Q ss_pred CeeeecCCceEEEEEECC--C--eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQD--G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|++|.||+|.+.+ + ..||+|.+...........+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 36999999876543445678999999999999999999999988 889999999999
Q ss_pred CCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce--
Q 036225 382 GSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-- 457 (622)
Q Consensus 382 gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-- 457 (622)
++|.+++... ..+++.....++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999998754 3689999999999999999999998 99999999999999999999999999998765432221
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||...... +......... . ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~-------~--~~ 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEG-------E--RL 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcC-------C--cC
Confidence 122446789999999988899999999999999999999 99998633211 1111111100 0 00
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.72 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=192.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-------- 369 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 369 (622)
..+|...++||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457899999999999999999964 68899999885432 1345799999999999999999876432
Q ss_pred CceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEccc
Q 036225 370 TERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDF 444 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Df 444 (622)
...++||||+++ ++.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999975 6665553 456789999999999999999999999 999999999999999654 7999999
Q ss_pred ccceecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 445 GLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||+||.+||......+....+........ .
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~-~ 292 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT-E 292 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-H
Confidence 99986643222 2345689999999998664 689999999999999999999999975443222111111110000 0
Q ss_pred hhhh-------h-----hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLE-------M-----LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~-------~-----~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+... . +....+...++...+.++.+++.+||+.||.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 0 000001111112234678999999999999999999998854
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.67 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=207.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|++.+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456778899999999999999965 6889999988765444455678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.....+++.....++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++...... .
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I 158 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---c
Confidence 9999999999887777999999999999999999999732 8999999999999999999999999998654321 1
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc----cccHHHHHHHHhhhhhhhhhcccc
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ----KGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ...+..+........ .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 2234689999999999888899999999999999999999999975433211 111122222211110 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
+ .....+..+.+++.+|++.||++||++.|++++.
T Consensus 233 ~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1 1112346788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.28 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=199.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee-CCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM-TPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e 377 (622)
.++|...+.||+|+||.||++... |..||+|.++... ....+.+|+.++++++|+|++++++++. ..+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357888899999999999999876 7889999986432 2446889999999999999999999764 5567899999
Q ss_pred eccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.++++.. ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999998643 3488999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~----------~ 216 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKG----------Y 216 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcC----------C
Confidence 22335678999999988889999999999999999998 8888763221 1111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111122334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=323.20 Aligned_cols=243 Identities=23% Similarity=0.306 Sum_probs=195.2
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 376 (622)
+|+..+.||+|+||+||+|... +|+.||+|+++... .......+..|.+++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999965 68999999987532 1223345778888888775 577888999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999987543221 2
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. .. .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~---------~~--~ 218 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIME---------HN--V 218 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh---------CC--C
Confidence 233456899999999999889999999999999999999999999743321 11111111 00 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
.++.....++.+++.+|++.+|.+|++..
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11222335678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=307.09 Aligned_cols=247 Identities=29% Similarity=0.441 Sum_probs=199.0
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCcc
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVA 385 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 385 (622)
++||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876544334557899999999999999999999999999999999999999999
Q ss_pred ccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee-eeecC
Q 036225 386 SRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT-TAVRG 463 (622)
Q Consensus 386 ~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~g 463 (622)
+++.. ...+++.....++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99854 34688999999999999999999999 999999999999999999999999999976542211111 11223
Q ss_pred cccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 464 t~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
+..|+|||.+.++.++.++||||||+++|||+| |..||...... ....... .......+...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~----------~~~~~~~~~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIE----------SGYRMPAPQLC 220 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHh----------cCCCCCCCccC
Confidence 567999999988899999999999999999999 77777543211 1111110 00011112233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 543 LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
+..+.+++.+|+..+|.+||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.79 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=209.5
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+...++||+|+||+||+|.+ .+|+ +||+|++.........+++.+|+-++.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44678999999999999995 3443 689999988877777789999999999999999999999998876 88999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+|++.|+|.++++. +..+.....+.|..|||+||.|||++ +++||||..+|||+..-..+||.|||+++.......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999974 55688889999999999999999999 999999999999999999999999999998876544
Q ss_pred ceee-eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 456 HVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 456 ~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.... .-.-.+.|||=|.+....|+.++|||||||++||++| |..|++..... .+.+++...
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle~g 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLEKG 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHhcc
Confidence 3332 2234678999999999999999999999999999998 88887643321 122222222
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.+-..++.+..++..++.+||..|+..||+++++...+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 223345677888999999999999999999999987654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=308.22 Aligned_cols=252 Identities=24% Similarity=0.272 Sum_probs=203.1
Q ss_pred hCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||.|.-|+||++...+ +..+|+|++.+..... ...+.+.|-+||+.++||.++.+|+.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 445667899999999999999764 5899999997654322 2336778999999999999999999999999999999
Q ss_pred eeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC--
Q 036225 377 PYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH-- 452 (622)
Q Consensus 377 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~-- 452 (622)
|||+||+|...++.+ ..+++..++.++.+|+.||+|||.. |||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999998754 4699999999999999999999999 999999999999999999999999998743310
Q ss_pred -------------------------------CCC----------------------ceeeeecCcccccCccccccCCCC
Q 036225 453 -------------------------------QDS----------------------HVTTAVRGTVGHIAPEYLSTGQSS 479 (622)
Q Consensus 453 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 479 (622)
... .....++||-.|+|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235699999999999999999
Q ss_pred cccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCC
Q 036225 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPA 559 (622)
Q Consensus 480 ~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~ 559 (622)
.++|.|+|||++|||+.|..||........ +.. ++.+.+.-.-....+..+.+||++.|.+||.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T---l~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET---LRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh---HHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999976543222 222 1222221111123446789999999999999
Q ss_pred CCCC----HHHHHHH
Q 036225 560 HRPK----MSEVVRM 570 (622)
Q Consensus 560 ~RPt----~~evl~~ 570 (622)
+|-. ++||.++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 7777653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.15 Aligned_cols=263 Identities=27% Similarity=0.391 Sum_probs=200.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--CCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 371 (622)
.++|.+.+.||+|+||+||++..+ +++.||+|.++... ......+.+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 346788899999999999999742 57899999987543 2334578899999999999999999998754 346
Q ss_pred eeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 7899999999999999865 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh-----
Q 036225 451 DHQDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE----- 523 (622)
Q Consensus 451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 523 (622)
........ ....++..|+|||++.+..++.++|||||||++|||++|..++...... +.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 43322211 1122345699999998888999999999999999999987765322110 00000000
Q ss_pred --hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 524 --KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 524 --~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+.+.+............+..+.+++.+||+.+|++|||++|+++.|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 00001111111111122234679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.99 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=191.7
Q ss_pred CeeeecCCceEEEEEECC---CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 46799999876554444557889999999999999999999999999999999999999
Q ss_pred CccccccCC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 383 SVASRLKGK-----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 383 sL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+|.+++... ...++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999988632 2456778889999999999999998 99999999999999999999999999997543322211
Q ss_pred e-eeecCcccccCccccccC-------CCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 458 T-TAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 458 ~-~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
. ....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ... .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~--~~--~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LTY--TV--REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HHH--Hh--hcccCC
Confidence 1 233467889999998542 35789999999999999996 9999864332111 110 00 000011
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..++.+. ......+.+++.+|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 112345778999998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.10 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=196.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||+||++... +++.||+|+++... .......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 58999999986422 1223345788999999999999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999865 45689999999999999999999999 999999999999999999999999999976654333
Q ss_pred ceeeeecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 456 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +....+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-- 228 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQ-- 228 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCccc--
Confidence 33333469999999999863 45788999999999999999999999643221 11111111110000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLP--AHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p--~~RPt~~evl~~ 570 (622)
+... ....+..+.+++.+|+..++ ..||++.++++.
T Consensus 229 ---~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ---FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 11133567888888775533 337888888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.18 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=193.9
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhcc---ccccceeeeeeeeC-----CC
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLYGFCMT-----PT 370 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~ 370 (622)
+|+..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 68999999987543222 223456677776655 79999999998764 34
Q ss_pred ceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 371 ERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
..+++|||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 888877643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......||..|+|||++.+..++.++|||||||++|||++|++||......+....+..+............
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 664322 123345899999999999889999999999999999999999998654332221112111110000000000
Q ss_pred ------hccccCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 529 ------LVDKDLKN---NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 529 ------~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.+.... .........+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 001122356789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.25 Aligned_cols=193 Identities=26% Similarity=0.364 Sum_probs=166.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44568999999999999999999975 5788999975432 234689999999999999999999999999999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+||+. ++|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 99995 588887753 45689999999999999999999999 9999999999999999999999999999754322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
.......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234568999999999999999999999999999999999766654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.25 Aligned_cols=243 Identities=25% Similarity=0.371 Sum_probs=200.6
Q ss_pred eeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCcc
Q 036225 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVA 385 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 385 (622)
+||+|.||+||.|.+. +...+|||-+...... ...-++.|+.+-+.++|.|||+++|.+..++..-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999965 5678999998765533 2335889999999999999999999999999999999999999999
Q ss_pred ccccC-CCCC--ChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCCCCceeeee
Q 036225 386 SRLKG-KPIL--DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 386 ~~l~~-~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
++|.+ .+++ ++.+.-.+..||++||.|||++ .|||||||-.|||++ ..|.+||+|||-++.+.. -...+..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 99974 3555 6788889999999999999999 999999999999997 689999999999988753 34456677
Q ss_pred cCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 462 RGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
.||..|||||++..++ |+..+|||||||++.||.||++||..-..+.. -+-++. ++ ......+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVG-------my--KvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVG-------MY--KVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhc-------ce--ecCCCCc
Confidence 8999999999998764 89999999999999999999999974332211 000000 00 1123345
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.....+...+|.+|+..||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 566678899999999999999999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=308.03 Aligned_cols=248 Identities=30% Similarity=0.439 Sum_probs=191.7
Q ss_pred CeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee-CCCceeEEeeecc
Q 036225 306 NILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM-TPTERLLVYPYMS 380 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~ 380 (622)
+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++|||++++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 246799999865433334457889999999999999999999876 4556789999999
Q ss_pred CCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce--
Q 036225 381 NGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-- 457 (622)
Q Consensus 381 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-- 457 (622)
+|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998653 3467888899999999999999998 99999999999999999999999999997653322111
Q ss_pred -eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCc-cccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 458 -TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA-LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 458 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....++..|+|||++.+..++.++|||||||++|||++|+.| |.... ..+......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~----------~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGR----------R 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCC----------C
Confidence 1123457789999999888999999999999999999996544 43221 111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00111223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.04 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.0
Q ss_pred CCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+|...+.||+|+||+||+|...+++.+|+|.++..... .....+.+|+++++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46788999999999999999888999999988754321 1223588899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC-
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD- 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~- 454 (622)
|||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998767789999999999999999999998 99999999999999999999999999987643211
Q ss_pred ----CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 455 ----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 455 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
........|+..|+|||++.+..++.++||||||+++|+|+||+.||...+.... .. ...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~----~~~~~~----~~ 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MF----YIGAHR----GL 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HH----Hhhhcc----CC
Confidence 1112334588999999999988899999999999999999999999964321110 00 000000 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.+ +.....++.+++.+|++.+|.+||++.|+++
T Consensus 227 ~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 1123467899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.02 Aligned_cols=269 Identities=25% Similarity=0.358 Sum_probs=205.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--CCce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 372 (622)
++|...+.||+|+||.||+|.+. +++.||||.++..........+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677799999999999999854 3688999998765433345679999999999999999999999887 5678
Q ss_pred eEEeeeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 LLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997543 689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 452 HQDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 452 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
....... ....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... +..-.........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHHHHHH
Confidence 3222111 1223566799999998888999999999999999999999987643211100 00000000000001111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+........+...+.++.+++.+|++.+|++||++.|++++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11111111122334679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.80 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=210.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 374 (622)
...|...+.||+|.||.||++..+ +|+.+|+|.+.+..... ....+.+|+.+|+++. |||||.+++.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456778899999999999999976 49999999997765433 2357899999999998 9999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC----CCceEEcccccceec
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD----CCEAVVGDFGLAKLL 450 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfgla~~~ 450 (622)
|||++.||.|.+.+... .+++.....++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998765 489999999999999999999998 9999999999999963 357999999999987
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+...
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~------- 253 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG------- 253 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC-------
Confidence 65 445667789999999999999999999999999999999999999998654322111 11111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+..+...........+.+++.+++..||.+|+|+.+++++
T Consensus 254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0122222333345778999999999999999999999984
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.20 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=201.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
..+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 457899999999999999999753 35789999876432 356899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||++. ++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||+++.......
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99995 68888887777899999999999999999999998 999999999999999999999999999976543322
Q ss_pred -ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh---------
Q 036225 456 -HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK--------- 525 (622)
Q Consensus 456 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 525 (622)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...........+...++.+.....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2223456999999999999999999999999999999999999999754432221112111111100000
Q ss_pred h-hh--hccccCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 L-EM--LVDKDLKNNYD-------RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ~-~~--~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+ .. -+....+..+. .....++.+++.+|+..||++||++.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 00000000000 0123467889999999999999999999875
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.00 Aligned_cols=249 Identities=29% Similarity=0.389 Sum_probs=204.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+|++++++++......++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778899999999999999965 689999999876554444557889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999998865 789999999999999999999998 999999999999999999999999999987754322 223
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
...++..|+|||++.+..++.++||||||+++|+|+||+.||...... .....+... ..+.+...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~------~~~~~~~~-- 221 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKN------NPPSLEGN-- 221 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhc------CCCCCccc--
Confidence 345888999999999888999999999999999999999998643211 111111100 01111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+..+.+++.+|+..+|++||+++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 034568899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.49 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999864 588999999875544444557889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
++++|.+++.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 99999998865 4589999999999999999999998 999999999999999999999999999976643221 122
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
...++..|+|||++.+..++.++|||||||++|||+||+.|+....... . .... .........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~---~~~~----------~~~~~~~~~ 222 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----V---LFLI----------PKNSPPTLE 222 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----H---Hhhh----------hcCCCCCCC
Confidence 3457889999999998889999999999999999999999986332111 0 1111 001111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+..+.+++.+|++.+|.+||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2334678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=293.15 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=203.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC----ch---hHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI----GG---EIQFQTEVEMISLA-VHRNLLRLYGFCMTP 369 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 369 (622)
-+.|...++||.|..++|.++..+ +|..+|+|++...... .. .+.-.+|+++|+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777889999999999998865 6888999988543211 11 12356799999988 599999999999999
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...++|+|.|+.|.|.++|.+.-.+++...++|+.|+.+|++|||.+ +||||||||+|||+|++.++||+|||+++.
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeeeecCcccccCcccccc------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
+... ..-...+||++|+|||.+.. ..|+..+|+|+.||+||-|+.|.+||..-+. + -.++.+.+.
T Consensus 173 l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------m-lMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------M-LMLRMIMEG 243 (411)
T ss_pred cCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------H-HHHHHHHhc
Confidence 7643 33456789999999998843 3578899999999999999999999974321 1 111111111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+ . .+...--.+......+||.+|++.||.+|.|++|++++
T Consensus 244 k-y------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 K-Y------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred c-c------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1 0 01111112334668899999999999999999999864
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.20 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=202.4
Q ss_pred CCcCCeeeecCCceEEEEEECC-----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 302 FSSKNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
|++.+.||+|+||.||++...+ +..||+|.++..........+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 48899999976554435667899999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGKPI--LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999975443 89999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
........++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ............
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYR-------- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCC--------
Confidence 222222336789999999988889999999999999999999 7777653211 111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.......+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111122446789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.98 Aligned_cols=247 Identities=29% Similarity=0.477 Sum_probs=197.2
Q ss_pred CeeeecCCceEEEEEECC-------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 306 NILGKGGFGIVYKGILQD-------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.||+|+||.||+|...+ ++.+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 3579999887654344456788999999999999999999999999999999999
Q ss_pred ccCCCccccccC-------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-----ceEEccccc
Q 036225 379 MSNGSVASRLKG-------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-----EAVVGDFGL 446 (622)
Q Consensus 379 ~~~gsL~~~l~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~Dfgl 446 (622)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999998853 23478999999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhh
Q 036225 447 AKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 447 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
+......... ......++..|+|||++.++.++.++|||||||++|||+| |+.||...... +....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHHhcCC
Confidence 9765432211 1122235688999999999999999999999999999998 99888643211 1111111100
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
........+..+.+++.+|++.+|.+||+++++++.|+
T Consensus 231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11112234567899999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=309.04 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=205.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
..|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999975 58899999987654444455788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++|+|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 84 LGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 9999999988754 588999999999999999999998 999999999999999999999999999977644322 22
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....++..|+|||++.+..++.++|||||||++|||+||+.||........ ... .........
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~----------~~~~~~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFL----------IPKNNPPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhh----------hhcCCCCCC
Confidence 334578899999999888899999999999999999999999864322110 000 011111223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....+..+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 34456778999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.46 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=199.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|...+.||+|+||.||+|.+. +|+ .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999863 443 57999887654444444688999999999999999999998764 467
Q ss_pred EEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+++||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 899999999999998653 3588999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+++.. ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~~~---~~~----- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLLEK---GER----- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHC---CCC-----
Confidence 22211 122335678999999988899999999999999999998 88888542211 11111111 000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. ..+..+...+.+++.+|+..+|++||+++++++.|+.
T Consensus 230 ---~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 230 ---L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 0111233578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.80 Aligned_cols=267 Identities=20% Similarity=0.300 Sum_probs=205.2
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999976 588999999875432 22345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++++.+..+......+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99877777666666789999999999999999999998 999999999999999999999999999987655433233
Q ss_pred eeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh--------hhhhh--
Q 036225 459 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ--------EKKLE-- 527 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-- 527 (622)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+......... .....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 445688999999999887 7899999999999999999999998644322111111110000000 00000
Q ss_pred hhcccc----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKD----LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+.. ....++...+.++.+++.+|+..+|++||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 0001122235778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.79 Aligned_cols=267 Identities=22% Similarity=0.258 Sum_probs=203.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|+..+.||+|+||.||+|..+ +|+.||+|++..... ......+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999976 589999999865432 2233467899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|++++.|..++.....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 999998888877666799999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh--------hhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ--------EKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 528 (622)
.....++..|+|||++.+ ..++.++||||||+++|||+||+.||......+....+......... ......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223457889999999876 45789999999999999999999999754432221111111100000 000000
Q ss_pred hccccCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+......+ ......+.+++.+|++.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000 1123668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.40 Aligned_cols=250 Identities=19% Similarity=0.295 Sum_probs=201.9
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++|+|++++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4678889999999999999996 46889999998754432 345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 9999999998653 578999999999999999999999 999999999999999999999999999876543221 12
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.. .... .......
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~-~~~~--------~~~~~~~ 238 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYL-IATN--------GTPELQN 238 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHH-HhcC--------CCCCCCC
Confidence 23458899999999988889999999999999999999999996433211 0110 0000 0000011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+......+.+++.+|+..+|++||++.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12233568899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.40 Aligned_cols=264 Identities=21% Similarity=0.284 Sum_probs=196.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------ 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 370 (622)
.++|...+.||+|+||.||++... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999964 689999999875432 233446789999999999999999999986543
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 46899999975 56655543 478889999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHH--------HHHHH---
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML--------DWVKK--- 519 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~--- 519 (622)
... .......||..|+|||++.+..++.++|||||||++|||+||+.||...+..+....+. .+...
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 321 22234568999999999999999999999999999999999999997543211100000 00000
Q ss_pred ----Hhhhh------hhhhhcccc-CC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 520 ----IHQEK------KLEMLVDKD-LK--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 520 ----~~~~~------~~~~~~d~~-~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... ...+..... .. ..........+.+++.+|++.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000000000 00 00111223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.98 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=197.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP------ 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------ 369 (622)
++..|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5667888899999999999999965 68899999986543 2344678899999988 699999999998753
Q ss_pred CceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccc
Q 036225 370 TERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 447 (622)
...+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 457899999999999998875 34689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .... ...
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~~-~~~ 230 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFL-IPR 230 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHH-Hhc
Confidence 86543221 223456899999999986 3457889999999999999999999986332111 1100 000
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ..... .....+..+.+++.+|+..+|.+||++.|+++.
T Consensus 231 ~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 N------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C------CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00111 111233578899999999999999999998753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.02 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=204.5
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccc-cccceeeeeeeeCCCce
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTER 372 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 372 (622)
+.+....|++.+.||+||.+.||++...+.+.+|+|++...... .....|.+|+..|.+++ |.+||++++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34556678899999999999999999888889999887654332 23346999999999995 99999999999999999
Q ss_pred eEEeeeccCCCccccccCCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 373 LLVYPYMSNGSVASRLKGKPI--LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
|+||||-+ .+|..+|+.+.. .+| .++.+..|+++|+.++|+. ||||.||||.|+|+-+ |.+||+|||+|..+
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99999874 499999975432 334 7888999999999999999 9999999999999976 89999999999988
Q ss_pred CCCCCc-eeeeecCcccccCccccccCC-----------CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH
Q 036225 451 DHQDSH-VTTAVRGTVGHIAPEYLSTGQ-----------SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 518 (622)
...... .....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.. +..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n--- 577 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IIN--- 577 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHH---
Confidence 655433 445678999999999885332 46789999999999999999999862 111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHH-HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIEL-EEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~-~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...++..+.|+.-.-+|+.... .++.++++.||..||++||+..|+|++
T Consensus 578 ---~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ---QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223455556644333332222 339999999999999999999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.23 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=202.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..+|+..+.||+|+||.||+|.++ +|+ .+|+|.+...........+.+|+.++++++|+|++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999864 333 6899988765544445578899999999999999999999987 7889
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999875 34689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
...... ....++..|+|||.+....++.++||||||+++||++| |+.||...... ++...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~------ 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLEKGE------ 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhCCC------
Confidence 322211 11223568999999988889999999999999999999 99998643211 1111111100
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+..+...+.+++.+||..+|.+||++.++++.|+.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001112233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.60 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=198.0
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|+..+.||+|+||+||++... +++.||+|.+....... ....+..|+.+++.++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999986543222 233577899999999999999999999999999999999
Q ss_pred ccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 999999988853 33588999999999999999999998 999999999999999999999999999976542221
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.................. .. .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~~--------~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VQ--------E 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------hh--------h
Confidence 12346899999999999999999999999999999999999999743211100000000000 00 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
.+.......+.+++.+|++.||++||+ ++|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111222356889999999999999999 7777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.85 Aligned_cols=267 Identities=18% Similarity=0.248 Sum_probs=194.4
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc------ccceeeeeee
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH------RNLLRLYGFC 366 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~ 366 (622)
++...+++|.+.+.||+|+||+||+|... +++.||||+++.... ....+..|+++++.++| .+++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455688999999999999999999964 588999999864321 22345566766666654 4588999988
Q ss_pred eCC-CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--------
Q 036225 367 MTP-TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-------- 437 (622)
Q Consensus 367 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-------- 437 (622)
... ...++|||++ +++|.+++.....+++..+..|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccc
Confidence 764 5678899988 7789888877778999999999999999999999732 899999999999998765
Q ss_pred --------ceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc
Q 036225 438 --------EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509 (622)
Q Consensus 438 --------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~ 509 (622)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864322 23345799999999999999999999999999999999999999975443221
Q ss_pred cccHHH--------HHHHHhhhhhhhhhcccc--CCCC---------------CCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 510 KGAMLD--------WVKKIHQEKKLEMLVDKD--LKNN---------------YDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 510 ~~~~~~--------~~~~~~~~~~~~~~~d~~--~~~~---------------~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
...+.. |...... .....+++.. +... ........+.+|+.+||+.||++|||+
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGT-EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccc-hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 111111 1100000 0000000000 0000 001123557899999999999999999
Q ss_pred HHHHHH
Q 036225 565 SEVVRM 570 (622)
Q Consensus 565 ~evl~~ 570 (622)
+|++++
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.55 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=199.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999965 68899999987554444445677899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 588887754 45688999999999999999999998 999999999999999999999999999975432221 1
Q ss_pred eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc-----
Q 036225 458 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD----- 531 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 531 (622)
.....++..|+|||.+.+. .++.++|||||||++|||+||+.||...+..+....+........ ......+.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhcccccc
Confidence 2233478899999988654 578899999999999999999999975443221111111000000 000000000
Q ss_pred ----ccCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 ----KDLKNN----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ----~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+..... ........+.+++.+|++.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.18 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=196.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC----chhHHHHHHHHHHhccccccceeeeeeeeC--CCce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 372 (622)
.+|...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 5889999988643211 223458889999999999999999998865 3567
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++++||+++++|.+++.....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999998777789999999999999999999998 999999999999999999999999999976542
Q ss_pred CC--CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. ........++..|+|||++.+..++.++|||||||++|||+||+.||...... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~--------- 222 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIA--------- 222 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHh---------
Confidence 11 11112345889999999999888999999999999999999999998632210 0011100
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+......+.+++ .|+..+|++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00011122223335566666 6888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.10 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=202.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999976 5899999998654322 234468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.++......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 999999988776666689999999999999999999998 999999999999999999999999999987644332 2
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh--------hhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--------KKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 528 (622)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..+....... .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 233457899999999865 447889999999999999999998886443221111111111100000 00000
Q ss_pred hccccCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNY-----DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...... ....+..+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0001000000 01124678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.24 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=201.9
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCch--------hHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGG--------EIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
+|.....||+|+||.||+|... +++.||+|.+........ ...+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999864 588999998865432211 1357889999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++++|.+++.....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999998777789999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCc-----eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 452 HQDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 452 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
..... ......|+..|+|||.+.+..++.++||||||+++|+|+||+.||....... -+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~------ 224 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFKI------ 224 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHHH------
Confidence 22111 1123457889999999988889999999999999999999999997432110 01110
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+ ..+...+..+.+++.+|++.+|.+||++.|+++.
T Consensus 225 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011111 1222334678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.38 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=197.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456888999999999999999975 578899996432 235689999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
++. ++|.+++.. ...++|..+..|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 688887754 34699999999999999999999999 9999999999999999999999999999876432221
Q ss_pred -eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccc----cHHHHHHHHhhh--hh----
Q 036225 457 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG----AMLDWVKKIHQE--KK---- 525 (622)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~--~~---- 525 (622)
......||..|+|||++.+..++.++|||||||++|||++|..++.......... .+...+...... ..
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234569999999999999999999999999999999999987765433221111 111212111000 00
Q ss_pred ---h-hhhcc---ccCCCCCC-----H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 ---L-EMLVD---KDLKNNYD-----R--IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ---~-~~~~d---~~~~~~~~-----~--~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+ ..... ........ . .....+.+++.+||+.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000 00000000 0 112367899999999999999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=305.28 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=204.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|+..+.||+|+||.||+|...+ ++.+++|.+..... ...+.+|++++++++|+|++++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3578889999999999999999764 78999999865432 5578999999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999999864 45789999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......++..|+|||++.+..++.++||||||+++|+|+||+.||......... . ... ......+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~----~~~------~~~~~~~-- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---F----MIP------NKPPPTL-- 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---h----hhc------cCCCCCC--
Confidence 223345789999999998889999999999999999999999998743221110 0 000 0000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+......+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1112233578999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.96 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=188.3
Q ss_pred CeeeecCCceEEEEEECC---CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||+||+|...+ ...+|+|.+...........+.+|+++++.++|+||+++++.+...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 45788898765544444556889999999999999999999999999999999999999
Q ss_pred CccccccCC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 383 SVASRLKGK-----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 383 sL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+|.+++... ...++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999988643 2346788899999999999999999 99999999999999999999999999986543222111
Q ss_pred -eeeecCcccccCcccccc-------CCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 458 -TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 458 -~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+ ......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~-~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQ-DIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhcc-Ccc
Confidence 122345678999998743 356889999999999999999 677775332111 011111110 011
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
+.++. .....+..+.+++..|+ .||++||+++||++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12223356677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=342.43 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=199.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.++||+|+||.||+|... +|+.||+|+++..... ....++.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999975 5899999998754322 22446889999999999999999999999999999999
Q ss_pred eeccCCCccccccC-----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 377 PYMSNGSVASRLKG-----------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 377 e~~~~gsL~~~l~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
||+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999988752 12356778889999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----------------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 446 LAKLLDHQDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 446 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01112469999999999999999999999999999999999999996422110
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRP-KMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~ 573 (622)
. .+.... .++.... .....+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 239 i-----~~~~~i---------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I-----SYRDVI---------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h-----hhhhhc---------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 000000 0000000 0112335688999999999999996 55666666653
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=307.48 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=201.1
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++.+++++.....||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456677777789999999999999954 678899998875432 33457889999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCC-CCC--ChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEccccccee
Q 036225 374 LVYPYMSNGSVASRLKGK-PIL--DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKL 449 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~ 449 (622)
+|+||+++++|.+++... ..+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999998753 345 7888899999999999999998 9999999999999986 67999999999976
Q ss_pred cCCCCCceeeeecCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
...... ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+.....
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~~------ 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGMF------ 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhhh------
Confidence 543222 222345889999999986643 78899999999999999999999863221110 01100000
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+.....++.+++.+|++.+|.+||++.|+++.
T Consensus 228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222334678899999999999999999998864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.42 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=204.3
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|+||.||.+.. .+++.+++|.+.... .......+.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999985 468899999886543 233445688999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998754 4689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~---------~~~~ 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQG---------NYTP 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcC---------CCCC
Confidence 23345689999999999888899999999999999999999999864321 1111111111 1110
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.....+.++.+++.+|++.+|.+||+++++++.+
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122346788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.32 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=197.1
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|+++++.++|+|++++.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999964 6889999998654322 2233577899999999999999999999999999999999
Q ss_pred ccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999888753 34689999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......|+..|+|||++.+..++.++|||||||++|||+||..||........ ...+....... . .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~---~--------~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET---E--------E 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc---c--------c
Confidence 12334689999999999988999999999999999999999999974332111 01111111100 0 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
.+.......+.+++.+|++.+|++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111222356789999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=310.72 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=197.2
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|++|.||+|... +++.||+|.++..... .....+.+|+.++..++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 6899999998754322 2234678899999999999999999999999999999999
Q ss_pred ccCCCccccccC---CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKG---KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588877753 24689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH--------Hhhhhhh
Q 036225 456 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK--------IHQEKKL 526 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 526 (622)
.......++..|+|||++.+. .++.++|||||||++|||+||+.||......+........... .......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 112233568899999988654 4788999999999999999999998754322211111100000 0000000
Q ss_pred hhhccccCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 EMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 ~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......... ........++.+++.+|+..||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0001123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=307.71 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=200.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777889999999999999964 688999999875432 223457889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.....+++.+...++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 999999999998777899999999999999999999999 99999999999999999999999999987654322 22
Q ss_pred eeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 458 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||........ . ....... ...+..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~----~~~~~~~----~~~~~~ 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---L----FLMTKSN----FQPPKL 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---H----HhhhccC----CCCCcc
Confidence 23446899999999874 45688999999999999999999999864321110 0 0000000 000000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ....+..+.+++.+|++.+|++||++++++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 00123468899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.09 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=186.8
Q ss_pred CeeeecCCceEEEEEECC-------------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 306 NILGKGGFGIVYKGILQD-------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
+.||+|+||.||+|+..+ ...|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2358889876543 23344688899999999999999999999999999
Q ss_pred eEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-------eEEccc
Q 036225 373 LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE-------AVVGDF 444 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~Df 444 (622)
++||||+++|+|..++.. ...+++..+.+++.||+.||+|||++ +|+||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999888864 45689999999999999999999998 9999999999999987664 899999
Q ss_pred ccceecCCCCCceeeeecCcccccCccccc-cCCCCcccceeehhHHHHHHH-hcCCccccchhccccccHHHHHHHHhh
Q 036225 445 GLAKLLDHQDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-TGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+...... .. ....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~-~~~~- 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK-ERFY- 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH-HHHH-
Confidence 998654321 2235788999999886 466899999999999999998 577776532111 00 0000
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..... ........+.+++.+||+.||.+||++.++++.++
T Consensus 223 --------~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 --------EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --------hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 00112356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.62 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=202.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC----CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+|+..+.||+|+||.||+|... +++.|++|.+..... ......+.+|+++++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667889999999999999976 789999999864331 12334688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999998777789999999999999999999998 99999999999999999999999999998664332
Q ss_pred ceeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~-------- 220 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKEL-------- 220 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccC--------
Confidence 223455889999999987766 89999999999999999999999864321 1111111110000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+......+.+++.+|++.+|.+||++.++++.
T Consensus 221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11112234678899999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.32 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=200.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||.||++... +++.||+|.++..........+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999976 78999999987543333345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999998888653 36899999999999999999999632 8999999999999999999999999998765322
Q ss_pred ceeeeecCcccccCccccccCC------CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||....... ....... +
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~---------~ 222 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSA---------I 222 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHH---------H
Confidence 222345788999999985543 4889999999999999999999986432111 1111111 1
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.. ....+.....++.+++.+|++.+|++||++.+++..
T Consensus 223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111 111222345778899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.99 Aligned_cols=264 Identities=20% Similarity=0.271 Sum_probs=197.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC------C
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------T 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 370 (622)
.++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999964 588999999875432 22344677899999999999999999987543 3
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 56999999975 67666643 478899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHHhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKIHQ 522 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~ 522 (622)
... .......||..|+|||++.+..++.++|||||||++|||+||+.||...+..+....+.. +...+..
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 432 222345689999999999999999999999999999999999999975443221111110 0000000
Q ss_pred -------h-hh-----hhhhccccC-C--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 -------E-KK-----LEMLVDKDL-K--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 -------~-~~-----~~~~~d~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. .. ......... . ..........+.+++.+|++.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00 000000000 0 00011123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.35 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=196.7
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999975 57889999886433 2334568889999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 381 NGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 381 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
+++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999887753 45689999999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred eecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 460 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
...++..|+|||++. +..++.++|||||||++|||++|+.||....... .+........ +..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~~------~~~ 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEP------PTL 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-------HHHHHhhcCC------CCC
Confidence 345899999999984 3457889999999999999999999986432111 1111111000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.41 Aligned_cols=193 Identities=23% Similarity=0.357 Sum_probs=158.6
Q ss_pred CCeeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--CCceeEEeeec
Q 036225 305 KNILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTERLLVYPYM 379 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 379 (622)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999964 467899999865432 2356789999999999999999998854 45678999998
Q ss_pred cCCCccccccC---------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEccccc
Q 036225 380 SNGSVASRLKG---------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGL 446 (622)
Q Consensus 380 ~~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl 446 (622)
.+ +|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 77666531 22588899999999999999999999 99999999999999 4668899999999
Q ss_pred ceecCCCCCc--eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccc
Q 036225 447 AKLLDHQDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 447 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
++........ ......||+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876433221 12345689999999998774 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.60 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=199.3
Q ss_pred CCCcCCeeeecCCceEEEEEECC--CeEEEEEEccCCCC---------CchhHHHHHHHHHHhc-cccccceeeeeeeeC
Q 036225 301 NFSSKNILGKGGFGIVYKGILQD--GTVVAVKRLKDGNA---------IGGEIQFQTEVEMISL-AVHRNLLRLYGFCMT 368 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 368 (622)
+|+..+.||+|+||.||+|.... ++.+|+|.+..... ......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 78899998853321 1122346778887764 799999999999999
Q ss_pred CCceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 369 PTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
.+..+++|||+++++|.+++. ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999988763 34568899999999999999999996 4 899999999999999999999999
Q ss_pred cccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLATKIVE- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHHHHHhh-
Confidence 99998765432 233456889999999999888999999999999999999999998643211 11111111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..............+.+++.+|++.||++||++.|+..+++
T Consensus 228 --------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 --------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110011122367899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.34 Aligned_cols=237 Identities=24% Similarity=0.268 Sum_probs=185.0
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhcc---ccccceeeeeeeeCCCceeEEeeeccC
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA---VHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
||+|+||+||+|... +++.||+|++...... .....+..|..++... +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 6899999998643211 1222345566666554 699999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 99999998878899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 462 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
.||..|+|||++.+. .++.++|||||||++|||+||+.||...... ...+.+.... ..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~-------~~~~~---~ 219 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGK-------VRFPK---N 219 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCC-------CCCCC---c
Confidence 699999999998764 4799999999999999999999999643211 1111111100 01110 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
.....+.+++.+|++.+|.+||++.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1235678999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.34 Aligned_cols=244 Identities=30% Similarity=0.401 Sum_probs=199.3
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchh--HHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.|...+.||.|+||.||.|.. .+.+.||||++.-......+ .++..|++.|.+++|||.+.+-|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355667899999999999995 57899999998755433332 368899999999999999999999999999999999
Q ss_pred eccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||-| +-.|++. .+.++.+..+..|+.+.++||.|||+. +.||||||..|||+++.|.|||+|||.|....+..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence 9954 7777764 345688899999999999999999999 99999999999999999999999999998765443
Q ss_pred eeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.++||+.|||||++. .+.|+-|+|||||||+-.||.-.++|.+..+.- .-+..+.+++ .+.
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNe------sPt 244 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE------SPT 244 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcC------CCC
Confidence 467999999999984 578999999999999999999999998743311 1111121111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+. .....+.+.+++..|+++-|.+|||.+++++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 21 3345577899999999999999999999885
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.82 Aligned_cols=237 Identities=24% Similarity=0.407 Sum_probs=189.1
Q ss_pred CeeeecCCceEEEEEECCCe-----------EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 306 NILGKGGFGIVYKGILQDGT-----------VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976432 5788877654322 5678899999999999999999999988 78899
Q ss_pred EeeeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-------ceEEccccc
Q 036225 375 VYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-------EAVVGDFGL 446 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~Dfgl 446 (622)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999997655 789999999999999999999998 999999999999999887 799999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccC--CCCcccceeehhHHHHHHHhc-CCccccchhccccccHHHHHHHHhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITG-QRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
+..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .+.......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-------~~~~~~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-------EKERFYQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-------hHHHHHhcC
Confidence 986543 2233467889999999776 789999999999999999995 6666433211 111111000
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..... .....+.+++.+|+..+|.+||++.++++.|+
T Consensus 223 --------~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --------HRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 01167889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.37 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=197.2
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++..++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 57789999986532 234688999999999999999999998764 478999999
Q ss_pred cCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 380 SNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 380 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999998643 3578999999999999999999998 99999999999999999999999999987543211
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....+..|+|||.+.++.++.++||||||+++|||++ |+.||...... ........ ....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~----------~~~~ 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEK----------GYRM 216 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhC----------CCCC
Confidence 12234578999999988899999999999999999998 88888643211 11111111 1111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......+..+.+++.+|++.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.67 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=200.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC-CCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 377 (622)
+|++.+.||+|++|.||++... +++.||+|.+..... ......+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 578899999865432 2234468889999999999999999998764 445789999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++++|.+++.. ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999998864 34589999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+. ..+....... . +
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~-~--------~- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIEG-K--------L- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhc-C--------C-
Confidence 22344588999999999999999999999999999999999999864321 1111111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11222344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.41 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=204.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||.||+|... +++.+++|.+...... ....+.+|++++++++||||+++++++...+..+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888999999999999999964 5788999998765432 44578899999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999988765 6799999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred eeeeecCcccccCccccccC---CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 VTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||........ . ...... ......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~----~~~~~~----~~~~~~ 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---L----FLISKS----NFPPPK 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhc----cCCCcc
Confidence 22334688899999999776 789999999999999999999999864321111 0 000000 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ......+.++.+++.+|+..+|.+||++.+++.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 1122334678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.59 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=205.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||.||++... +++.|++|.+..... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 578999999875432 222346778999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC--
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD-- 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~-- 454 (622)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999986421100
Q ss_pred ------------CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 455 ------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 455 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
........++..|+|||.+.+..++.++||||||+++|||++|+.||..... .++......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence 0011123578899999999888899999999999999999999999864321 111111111
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
.. ...+.. ....+..+.+++.+|++.+|++||++.++.+.|+...+
T Consensus 231 ~~----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 231 DD----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred cc----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 00 000110 01234668999999999999999998888888877554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.48 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=199.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc---------hhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG---------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
+|...+.||+|+||.||+|... +|+.||+|.++...... ..+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667889999999999999864 68999999886422111 1235778999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999998777899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc-eeeeecCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 451 DHQDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
...... ......|+..|+|||.+.... ++.++||||||+++||+++|+.||...... .... ...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~-~~ 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMF-KLGNKR-SA 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHH-Hhhccc-cC
Confidence 432211 123345889999999987654 789999999999999999999998532211 0111 100000 00
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...........+..+.+++.+|+..+|++||+++++++.
T Consensus 231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 ----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 011111112234678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.94 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=197.4
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------ 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 369 (622)
..++|...+.||+|+||.||++... .++.||||.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999864 688999999875432 22334677899999999999999999988643
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...++||||+++ ++.+.+.. .+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 346899999975 66666643 478899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHH--
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKK-- 519 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~-- 519 (622)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....... +...
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 5322 222345689999999999988999999999999999999999999975432211110000 0000
Q ss_pred -----Hhh-hhhhhhhc------cccCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 520 -----IHQ-EKKLEMLV------DKDLK--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 520 -----~~~-~~~~~~~~------d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ........ +.... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00000000 00000 00111123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.23 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=208.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC--CC--eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ--DG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++....+.||+|.||.|++|.|. +| -.||||.++.........+|.+|+.++.+++|||++++||...+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 344456688999999999999986 34 36999999877655566689999999999999999999999887 67789
Q ss_pred EeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|||.++.|+|.+.|+. +..|-......++.|||.||.||..+ +.|||||..+|+|+-....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999975 45677888899999999999999999 999999999999999999999999999998876
Q ss_pred CCCceee--eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 453 QDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 453 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.+.+... ...-...|+|||.+....++.++|||+|||++|||+| |+.||..-.. ..+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHh
Confidence 5544321 2334678999999999999999999999999999998 5677754321 112223
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
+|..-+-.-+..|++.++++++.||...|.+|||+..+.+.+
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 333333334567889999999999999999999999997443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.24 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=188.4
Q ss_pred CeeeecCCceEEEEEECCC---eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.||+|+||+||+|...++ ..+++|.++..........+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 3566777665444444567899999999999999999999999999999999999999
Q ss_pred CccccccCC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-ce
Q 036225 383 SVASRLKGK----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HV 457 (622)
Q Consensus 383 sL~~~l~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 457 (622)
+|.++++.. ...++.....++.||+.||+|||+. +++||||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999988642 3456677889999999999999998 999999999999999999999999999864322111 11
Q ss_pred eeeecCcccccCcccccc-------CCCCcccceeehhHHHHHHHhc-CCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITG-QRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .......... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-ccccc
Confidence 223457889999998743 2457899999999999999975 556643221 1111111111 11222
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.++.+...+ ...+.+++..|+ .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333333222 256778899999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=306.34 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=205.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|+..+.||+|+||.||++... +++.||+|.+...........+.+|+++++.++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999976 689999999876654445567889999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 380 SNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 380 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++++|.+++... ..+++.....++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999998754 678999999999999999999999 7 9999999999999999999999999998765322211
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.+....... ....
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~---------~~~~ 224 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP---------PPRL 224 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC---------CCCC
Confidence 256889999999998889999999999999999999999998644221 111222222221110 0000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+.+++.+|+..+|++|||+.+++..
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111144678999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.14 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=209.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|+..+.||+|++|.||+|... +++.|++|++...........+.+|++.+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 58999999987655434456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++++|.+++.....+++..+..++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999999877789999999999999999999999 8 9999999999999999999999999999876543322
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ....+....+.. ... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~---------~~~-~~ 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICD---------GPP-PS 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhc---------CCC-CC
Confidence 2234588999999999988899999999999999999999999865432 011111111111 000 11
Q ss_pred CCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRI-ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... .+..+.+++.+|+..+|++||++.|+++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1222 34679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=301.89 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=203.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|+||.||+|... +++.|++|.++..... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 6899999998765432 2455789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998777789999999999999999999998 999999999999999999999999999987654333222
Q ss_pred e---eecCcccccCccccccCC---CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 459 T---AVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 459 ~---~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. ...++..|+|||++.+.. ++.++||||||+++||+++|+.||...... . ........ . ..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~---~~~~~~~~-~-----~~~ 225 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---F---QIMFHVGA-G-----HKP 225 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---H---HHHHHHhc-C-----CCC
Confidence 1 345788999999998766 889999999999999999999999643211 0 01111000 0 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.. .......+.+++.+|++.+|.+||++.|++.
T Consensus 226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1112466789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.11 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=205.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|+..+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 68899999987655444556789999999999999999999999999999999999
Q ss_pred ccCCCccccccCC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998643 4589999999999999999999998 999999999999999999999999999876654332
Q ss_pred c---eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 456 H---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 456 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||....... ....... . ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~----~------~~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQ----N------DP 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhc----C------CC
Confidence 2 22334688999999998777 78999999999999999999999986432211 1111111 0 00
Q ss_pred ccCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNY-DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.+.... ....+..+.+++.+|++.+|++||+++++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 11234678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.84 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=185.6
Q ss_pred eeeecCCceEEEEEECC-------------------------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccccee
Q 036225 307 ILGKGGFGIVYKGILQD-------------------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 361 (622)
.||+|+||.||+|.+.. ...|++|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 68999999999997421 13588998865432 23346788999999999999999
Q ss_pred eeeeeeCCCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---
Q 036225 362 LYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC--- 437 (622)
Q Consensus 362 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~--- 437 (622)
+++++......++||||+++|+|..++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988864 55789999999999999999999998 999999999999998644
Q ss_pred ----ceEEcccccceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHH-hcCCccccchhccccc
Q 036225 438 ----EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELI-TGQRALEYGKAANQKG 511 (622)
Q Consensus 438 ----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~-tg~~p~~~~~~~~~~~ 511 (622)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3899999998643221 12347888999998865 56899999999999999995 6888886432111
Q ss_pred cHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 512 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
...+... ....... ....+.+++.+||+.+|++||+++++++.|.
T Consensus 230 -~~~~~~~-----------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERFYEK-----------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHHh-----------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0111100 0001111 1246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.92 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=203.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788899999999999999996 4789999999875433 334568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 9999999998864 3578999999999999999999998 9999999999999999999999999999865433221
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....+++.|+|||.+.+..++.++|||||||++|+|+||+.||.......... . .. ........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~----~~--------~~~~~~~~ 236 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L----IA--------TNGTPELQ 236 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---e----ec--------cCCCCCCC
Confidence 223458899999999998889999999999999999999999996433211100 0 00 00000001
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+......+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122233567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.42 Aligned_cols=250 Identities=19% Similarity=0.315 Sum_probs=202.5
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.+|+..+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4588889999999999999985 4789999999865432 3345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|.+++... .+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999999988654 589999999999999999999999 999999999999999999999999999876543322 12
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....++..|+|||.+.+..++.++|||||||++|+|+||+.||........ ........ . +.+ ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~~~~~~-~-----~~~--~~ 237 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNG-T-----PEL--QN 237 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcC-C-----ccc--CC
Confidence 234588999999999888899999999999999999999999965432111 11110000 0 000 01
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+......+.+++.+||..+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11233568899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.36 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=197.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC----CchhHHHHHHHHHHhccccccceeeeeeeeCC--Cce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 372 (622)
++|.+.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 589999998853321 11234678899999999999999999988764 457
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+++|||+++++|.+++.....+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 79999999999999997766789999999999999999999998 999999999999999999999999999976542
Q ss_pred CCC--ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... . .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~-~~~~~--------- 222 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------A-IFKIA--------- 222 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------H-HHHHh---------
Confidence 211 11223458899999999988889999999999999999999999986322110 0 00000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+......+.+++.+|+. +|++||+++|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0001112233444677889999985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.15 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=198.9
Q ss_pred cCCeeeecCCceEEEEEEC-CCeEEEEEEccC---CCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc--eeEEee
Q 036225 304 SKNILGKGGFGIVYKGILQ-DGTVVAVKRLKD---GNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE--RLLVYP 377 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e 377 (622)
...+||+|+|-+||+|.+. +|-.||--.++. ........+|..|+.+|+.++||||+++|.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999975 577777544432 2333444689999999999999999999999987665 678999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
.+..|+|..|++....++.....+|+.||+.||.|||++ +|+|||||||-.||+|+ ..|.|||+|.|+|.......
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999999888899999999999999999999998 78999999999999998 57999999999998775332
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
...+.|||.|||||.+. ..|++.+||||||+.++||+|+..|+.....+.+ | .+.+..+.+. .
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---I---YKKV~SGiKP---------~ 263 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---I---YKKVTSGIKP---------A 263 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---H---HHHHHcCCCH---------H
Confidence 23378999999999986 7899999999999999999999999874433221 2 2222211111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+......++.++|.+|+.. .++|||+.|+|+
T Consensus 264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12222346799999999999 999999999996
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.18 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=202.6
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... .....+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 56899999998643311 123468899999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 453 (622)
||||+++++|.+++.....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999998777899999999999999999999999 999999999999998765 5999999999766432
Q ss_pred CC---ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. .......++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~--------- 224 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIA--------- 224 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHh---------
Confidence 11 112234578999999999888899999999999999999999999864322111 11111100
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
........+.....++.+++.+|+..+|.+||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112233334567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=303.55 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=199.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.+.|++.+.||+|+||.||+|... +++.|++|.+.... ......+.+|+++++.++|+|++++++.+...+..++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888999999999999999975 58899999987543 2334568889999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999999887653 45689999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 457 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
......++..|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~------ 232 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEP------ 232 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCC------
Confidence 223445889999999984 345688999999999999999999998643211 11111111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.. ..+.....++.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0111223568899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.53 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=202.3
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|+||.+|++... +|+.||+|.+.... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999964 68899999986532 223345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+++++|.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988643 3578999999999999999999998 999999999999999999999999999986643322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......|+..|+|||++.+..++.++|||||||++|+|+||+.||...... ..+...... .. .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~---------~~-~ 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------NLVLKIIRG---------SY-P 219 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------HHHHHHhcC---------CC-C
Confidence 122345888999999998888999999999999999999999998643221 111111111 00 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+......+.+++.+|++.+|.+||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.67 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=201.2
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc---cccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 376 (622)
.|+..+.||+|+||.||+|.. .+++.||+|.++..........+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 4789999999876544444557889999999886 999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++++|.+++... .+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999999988654 689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... .+..... ....+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~------~~~~~~~~ 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMMLIP------KSKPPRLE 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhccc------cCCCCCCC
Confidence 23344689999999998654 4689999999999999999999998643211 1111100 00011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ..+.++.+++.+|++.+|++||++.|+++.
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 133578899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.27 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=200.7
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee--
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM-- 367 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~-- 367 (622)
++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++..+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3445567889999999999999999999964 58899999876432 2234678899999998 6999999999874
Q ss_pred ---CCCceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 368 ---TPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 368 ---~~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
..+..++||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 3456899999999999988764 345688999999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCceeeeecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 441 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+........
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------ 237 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------ 237 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------
Confidence 999999987643222 2233458999999998753 4478899999999999999999999864332111
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
.. ...... .....+ +......+.+++.+|++.+|++||++.|+++..
T Consensus 238 ~~-~~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LF-KIPRNP-PPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hh-hccccC-CCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 000000 000001 111235688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=301.90 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=201.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC--CCceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 376 (622)
+|+..+.||+|+||.||++... +++.||+|.++.... ......+..|++++++++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 688999999875432 2334468889999999999999999998764 45578999
Q ss_pred eeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 377 PYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 377 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
||+++++|.+++.. ...+++..+..++.|++.||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999988853 457899999999999999999999322 229999999999999999999999999999876
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~--------- 223 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIK--------- 223 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHh---------
Confidence 543321 23346899999999999888999999999999999999999998753311 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+...+..+.+++.+|++.+|++||++++|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 -EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011112233344678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.47 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=195.4
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------ 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 369 (622)
..++|...+.||+|+||.||+|.. .+++.||||.+..... ......+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 357799999999999999999996 4688999999875432 12334577899999999999999999987543
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3468999988 7788887764 4589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH--------HHH
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV--------KKI 520 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~ 520 (622)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.... ..+
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 5432 233468999999999876 568999999999999999999999996543221111111100 000
Q ss_pred hhhhhhhhhccccCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQEKKLEMLVDKDLKNNYD-------RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ...... ..+..... ......+.+++.+|++.||.+|||+.|++++
T Consensus 244 ~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSE-HARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chh-hHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000 00000000 0112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.73 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=193.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHH-HhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM-ISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|++.+.||+|+||.||+|... +|+.||+|+++..........+..|+.. ++..+|||++++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999975 6999999998765444444556667665 566789999999999999999999999
Q ss_pred eccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 378 YMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 378 ~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|++ |+|.+++. ....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 57766653 3456899999999999999999999753 7999999999999999999999999999765322
Q ss_pred CCceeeeecCcccccCcccccc----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~------ 223 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEE------ 223 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHHhc------
Confidence 1 1223458889999998864 45688999999999999999999998632211 0111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+.+. ....+.++.+++.+|+..+|++||++.++++
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111 1112467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.71 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=196.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++++++|+|++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999975 6899999998754322 2234577899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++ +|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 974 77777653 45689999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred eeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh------hhhhhhc
Q 036225 458 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE------KKLEMLV 530 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 530 (622)
.....++..|+|||++.+.. ++.++|||||||++|||+||+.|+........ ........... .......
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHHHhCCCChHHhHHhhhcc
Confidence 22345788999999987654 68999999999999999999998754332111 00000000000 0000000
Q ss_pred ccc----CCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKD----LKN-----NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~----~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.. ... ........++.+++.+|++.||.+|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 100 000 0011224678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=305.79 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=187.0
Q ss_pred CeeeecCCceEEEEEECC--------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 306 NILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+.||+|+||.||+|.... ...||+|.+.... ......+..|+.+++.++|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998642 2348888875432 2233467889999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--------eEEcccccce
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--------AVVGDFGLAK 448 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~Dfgla~ 448 (622)
|+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++. ++++|||++.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999975 34689999999999999999999998 9999999999999987765 5999999986
Q ss_pred ecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCC-ccccchhccccccHHHHHHHHhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQR-ALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
.... .....++..|+|||++.+. .++.++||||||+++|||++|.. |+...... .......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~----- 219 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQFYE----- 219 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHHHHH-----
Confidence 5432 1234578899999999764 57999999999999999999954 44321110 0000000
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.. ...+.....++.+++.+|++.+|++|||++++++.|+
T Consensus 220 -----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -----DR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0111122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.96 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=193.2
Q ss_pred cCCeeeec--CCceEEEEEE-CCCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 304 SKNILGKG--GFGIVYKGIL-QDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 304 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+.++||+| +|++||++.. .+|+.||+|+++...... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999986 478999999987654322 3345778999999999999999999999999999999999
Q ss_pred cCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc-
Q 036225 380 SNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH- 456 (622)
Q Consensus 380 ~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~- 456 (622)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999854 34589999999999999999999998 9999999999999999999999999875433211110
Q ss_pred -----eeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH-Hh---hhh-
Q 036225 457 -----VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK-IH---QEK- 524 (622)
Q Consensus 457 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~---~~~- 524 (622)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....... .. ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccccc
Confidence 0112346778999999976 4589999999999999999999999964321110 0000000 00 000
Q ss_pred -hhhhh--------ccc-----------------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 -KLEML--------VDK-----------------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 -~~~~~--------~d~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..++. .+. .............+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 000 00001112234578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.79 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=200.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||.||+|... +++.||+|.+....... ....+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999975 48999999997654332 3446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+.+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998643 5689999999999999999999998 99999999999999999999999999987553221
Q ss_pred Cc----------------------------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchh
Q 036225 455 SH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506 (622)
Q Consensus 455 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~ 506 (622)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11 01123578899999999988899999999999999999999999864332
Q ss_pred ccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 036225 507 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK----MSEVVR 569 (622)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 569 (622)
... +. .+.+...........+..+.+++.+|+..+|++||+ ++|++.
T Consensus 238 ~~~------~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET------FS----------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH------HH----------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 110 11 111111111111113577999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.90 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=202.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
-|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999864 688999999865544444557889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
++++|.+++... .+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 999999988654 589999999999999999999998 999999999999999999999999999976643221 222
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
...++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..+....... ......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~----------~~~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIPKN----------NPPTLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHhcC----------CCCCCC
Confidence 34578899999999888899999999999999999999999863221 1111111110 011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+..+.+++.+|++.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2234678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.24 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=199.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC----chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+|+..+.||+|+||.||+|... +|+.||+|.++..... .....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999965 6899999999755422 1233567899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+ +|+|.+++.... .+++..+..++.||++||.|||++ +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999997765 799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh-----hhhhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ-----EKKLEM 528 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 528 (622)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+....+......... ......
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 21 222346788999998855 45789999999999999999997776543221111001000000000 000000
Q ss_pred hccccCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......... ........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 011224678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=338.16 Aligned_cols=255 Identities=19% Similarity=0.297 Sum_probs=198.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC--CCc
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTE 371 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 371 (622)
....++|.+.+.||+|+||+||+|... +++.||+|.+..... ......+..|+.++.+++|||||++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999965 578899999875432 2234568899999999999999999998854 456
Q ss_pred eeEEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeeecC--------
Q 036225 372 RLLVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCD----PKIIHRDVKAANILLDD-------- 435 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlk~~NILl~~-------- 435 (622)
.++||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+... .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8899999999999998863 3568999999999999999999998521 25999999999999964
Q ss_pred ---------CCceEEcccccceecCCCCCceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccc
Q 036225 436 ---------CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 436 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3458999999998654321 2234569999999999854 45889999999999999999999999643
Q ss_pred hhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 505 KAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.. ....+..+.... .+. ....+.++.+++..||..+|.+||++.|++.
T Consensus 247 ~~------~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN------FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc------HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111222211111 110 0112366889999999999999999999984
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.54 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=196.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 68999999987554333334567899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+.+ +|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 985 89888754 34688999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccc-cccHHHHHHHHhhhh-----hhhhhc
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQ-KGAMLDWVKKIHQEK-----KLEMLV 530 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~ 530 (622)
.....++..|+|||++.+ ..++.++||||+|+++|||++|+.||........ ...+.+.+....... ......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346889999999865 4578999999999999999999999864331110 000000000000000 000000
Q ss_pred c--------ccCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 531 D--------KDLKNNYDR-IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 531 d--------~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
. ..+...... .....+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000000 01156789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=304.42 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=196.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+.+|...+.||+|+||.||+|... +|+.||+|++...........+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999864 6889999998765444444467889999999999999999999999999999999
Q ss_pred eccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+. +++.+.+. ....+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 996 57766654 344578888999999999999999998 999999999999999999999999999975433221
Q ss_pred eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH-----------hhh-
Q 036225 457 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI-----------HQE- 523 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~- 523 (622)
......++..|+|||.+.+. .++.++|||||||++|||+||+.||........ .+.+..... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233478899999998764 578899999999999999999999874332110 000000000 000
Q ss_pred hhhhhhccccCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
................ ......+.+++.+|+..||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 001356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.22 Aligned_cols=259 Identities=24% Similarity=0.288 Sum_probs=201.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 376 (622)
++|...+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999975 68999999987654444556789999999999999999999988653 4679999
Q ss_pred eeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+++++|.+++. ....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988764 244588899999999999999999998 999999999999999999999999999875432
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.. .....++..|+|||.+.+..++.++||||||+++|+|+||+.||...... .....+......... ...+ ..
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-~~~~-~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMP-NPEL-KD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCC-chhh-cc
Confidence 21 12345788999999999889999999999999999999999999754321 111112222111100 0000 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ........+.+++.+|++.+|.+|||+.|+++.
T Consensus 231 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 001234678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.41 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=197.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|++|.||+|... +|+.||||.++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 6899999998754322 2234688999999999999999999999999999999999
Q ss_pred ccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 588887753 35689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh--------hhhhhh
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH--------QEKKLE 527 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 527 (622)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+....+..+..... ......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 122234688999999886644 58899999999999999999999875433221111111110000 000000
Q ss_pred hhccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+....... ........+.+++.+|++.||++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 001123567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.18 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=200.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 689999999876543 23345788999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+ +++|.+++.. ...+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999998853 45689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh-----hhh---hhh
Q 036225 458 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ-----EKK---LEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~---~~~ 528 (622)
.....++..|+|||.+.+. .++.++||||+|+++|||+||.+||...........+......... ... ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3344689999999998654 4689999999999999999997777543221110000000000000 000 000
Q ss_pred hccccCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLK----NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+..+... ..........+.+++.+|++.+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00001223778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.96 Aligned_cols=193 Identities=24% Similarity=0.360 Sum_probs=158.1
Q ss_pred CCeeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--CCceeEEeeec
Q 036225 305 KNILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTERLLVYPYM 379 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 379 (622)
..+||+|+||+||+|... ++..||+|.++... ....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 468999999999999965 35789999986543 22357789999999999999999998854 55678999998
Q ss_pred cCCCcccccc---------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEccccc
Q 036225 380 SNGSVASRLK---------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGL 446 (622)
Q Consensus 380 ~~gsL~~~l~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl 446 (622)
.+ +|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 6666553 122478899999999999999999998 99999999999999 5678999999999
Q ss_pred ceecCCCCCc--eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccc
Q 036225 447 AKLLDHQDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 447 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
++........ ......||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876543221 12334689999999998764 5799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=303.86 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=200.0
Q ss_pred CHHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
++.++..+...|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 44555567788999999999999999999964 68899999875432 2334678899998888 69999999999853
Q ss_pred ------CCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 369 ------PTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 369 ------~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
....+++|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 4567999999999999998864 34578888999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 441 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||+||+.||.........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875532221 123345899999999875 345788999999999999999999998643211110
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.... ....... .....+..+.+++.+||+.+|.+||++.|+++
T Consensus 236 --~~~~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 --FLIP------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hhHh------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0000111 11123467899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.62 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=208.0
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
-|+..+.||+|.|+.|-.|.+ -+|+.||||++.+..... ....+.+|++.++.++|||||++|++.......|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 477788999999999999984 479999999997654332 233578999999999999999999999999999999999
Q ss_pred ccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCceEEcccccceecCCCCCc
Q 036225 379 MSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
-++|+|++++- ....+.++...+++.||..|+.|+|+. .+|||||||+||.+ .+-|-+||.|||++..+.+. .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 99999999974 556799999999999999999999999 99999999999876 57899999999999765432 2
Q ss_pred eeeeecCcccccCccccccCCCC-cccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.-...+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+..+..+. +..++|..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmImDCK-- 235 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIMDCK-- 235 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhhccc--
Confidence 33456799999999999999886 577999999999999999999986654322 33344443
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+.....++.+||..|+..||++|.+.+||+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3356667788999999999999999999999873
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.89 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=200.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|++.+.||+|+||.||+|... +++.||+|.++... ......+..|++++++++|+|++++++++..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888899999999999999974 68999999986542 2234468899999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999998865 35689999999999999999999999 999999999999999999999999999875533222
Q ss_pred eeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 457 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------ 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEP------ 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCC------
Confidence 223456899999999874 345678999999999999999999998643211 11111111000
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.+ ..+......+.+++.+|++.+|.+||++.++++.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111233568899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=300.61 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=195.0
Q ss_pred CCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC------
Q 036225 302 FSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------ 370 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 370 (622)
|.+.+.||+|+||.||+|.+. +++.||||+++.... .....++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999853 368899999875432 233456889999999999999999999886542
Q ss_pred ceeEEeeeccCCCccccccC------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 371 ERLLVYPYMSNGSVASRLKG------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
..++++||+.+|+|.+++.. ...+++....+++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23688999999999877632 12478889999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhh
Q 036225 445 GLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 445 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||...... .+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~~---~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYLI---K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHHH---c
Confidence 999865432211 1122345678999999988889999999999999999999 77887533211 1111111 1
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... . .....+..+.+++.+|++.+|++||++.++++.|++
T Consensus 231 ~~~~--------~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRL--------K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcC--------C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1100 0 111233679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=304.63 Aligned_cols=258 Identities=27% Similarity=0.345 Sum_probs=200.1
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP 369 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 369 (622)
..++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3444556788999999999999999999964 68899999986532 2234677899999888 799999999998754
Q ss_pred -----CceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 370 -----TERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 370 -----~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
+..++||||+++++|.++++ ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 35799999999999998875 345689999999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCceeeeecCcccccCccccccCC-----CCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 441 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ-----SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
|+|||++........ ......|+..|+|||++.... ++.++|||||||++|||++|+.||........ +..
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFK 244 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHH
Confidence 999999876543221 122345889999999985433 68899999999999999999999864321111 111
Q ss_pred HHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 516 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... . +.+. ........+.+++.+|++.+|++||++.|+++.
T Consensus 245 ----~~~~~-~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ----IPRNP-P-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HhcCC-C-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10000 0 0000 011223568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.19 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|+..+.||+|++|.||+|... +|+.||||.++..........+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 689999999986554444456778999999999999999999999999999999999
Q ss_pred cCCCccccccCC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 380 SNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 380 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
++ +|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888777532 4589999999999999999999998 999999999999999999999999999975543211
Q ss_pred eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc-ccC
Q 036225 457 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD-KDL 534 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~ 534 (622)
......++..|++||.+.+. .++.++|||||||++|+|++|+.||......+....+........ ......+.+ +.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT-ESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-hhhHHHHhcCchh
Confidence 12233478899999988664 468899999999999999999999875433221111111100000 000000000 000
Q ss_pred CCC-----------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNN-----------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~-----------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ........+.+++.+|++.+|.+||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 011224568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.13 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=197.4
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999965 7999999998754322 22346788999999999999999999999999999999999
Q ss_pred cCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 380 SNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 380 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+ ++|.+++.... .+++..+..++.|+++||+|||++ +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999887654 689999999999999999999998 9999999999999999999999999999765432211
Q ss_pred eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh--------hhhhh
Q 036225 458 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--------KKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 528 (622)
.....++..|+|||++.+. .++.++||||||+++|||+||+.||...........+..+....... .....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1223468899999988664 57889999999999999999999987543322111111110000000 00000
Q ss_pred hccccCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLK---NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+..... ..........+.+++.+|++.+|.+||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00011122568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.67 Aligned_cols=266 Identities=21% Similarity=0.306 Sum_probs=199.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCC--CceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 375 (622)
++|+..+.||+|+||.||+|... +++.+|+|.++..... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 5889999998754322 2233567899999999999999999998877 889999
Q ss_pred eeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 888887643 3589999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH-----------HHhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK-----------KIHQ 522 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~ 522 (622)
.. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+..... .+..
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 21 2233478899999998764 468999999999999999999999874432211111111000 0000
Q ss_pred h--hhhhhhccccCCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 E--KKLEMLVDKDLKNNYDRI-ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~--~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ..........+...++.. ....+.+++.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000001111112221 24668899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.62 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=201.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|+..+.||+|+||.||++... +++.||+|.++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999965 689999999865322 223446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999998778899999999999999999999998 9999999999999999999999999999876433
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ....... ....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~---------~~~~-- 215 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKIL---------EGKV-- 215 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHh---------cCCc--
Confidence 23345889999999998888899999999999999999999998643310 0011111 0000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
..+......+.+++.+|+..+|.+|| +++|+++.
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11112246788999999999999999 67777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.63 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=198.2
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|.....||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+|++++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 334567999999999999964 68899999986533 2334468899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.++|+|||++........ ....
T Consensus 103 ~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 103 GGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred CCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 99999988543 589999999999999999999998 999999999999999999999999999876543222 2233
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..... .......... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~------~~~~~~~~~~--~~ 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRI------RDNLPPRVKD--SH 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH------HhcCCCcccc--cc
Confidence 458999999999988889999999999999999999999986432211 01111 0111111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+.+++.+|+..+|.+|||++|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=297.25 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=199.9
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 68899999986543 223345788999999999999999999999999999999999
Q ss_pred ccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~ 455 (622)
+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999865 34589999999999999999999998 99999999999999854 4689999999987653321
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~~~----------~ 218 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMSGT----------F 218 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHhcC----------C
Confidence 22345889999999998888999999999999999999999998643211 1111111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........+.+++.+|++.+|.+|||+.|+++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.34 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=197.9
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||.||++... +++.||+|.+...... .....+.+|+.+++.++||||+++++++..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 4889999998754322 3345789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCc
Q 036225 385 ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464 (622)
Q Consensus 385 ~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 464 (622)
.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 99998777789999999999999999999998 99999999999999999999999999998765432 22334688
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHH
Q 036225 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 544 (622)
Q Consensus 465 ~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 544 (622)
..|++||.+.+..++.++|+||||+++|+|++|..||...... ........ .+......++.....
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~~~ 221 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDI---------LKGNGKLEFPNYIDK 221 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHH---------hccCCCCCCCcccCH
Confidence 9999999998888999999999999999999999999754320 11111111 111111112222357
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 545 EMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 545 ~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
.+.+++.+|++.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=299.75 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=203.1
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
+|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 589999999875432 2334578899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+.+++|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999999999998777899999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+....... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----------~~~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET----------ADVL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc----------cccc
Confidence 23455888999999998888999999999999999999999998754321 11111111100 0111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKM--SEVV 568 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl 568 (622)
.+...+..+.+++.+|++.+|.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 222234778899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.71 Aligned_cols=252 Identities=29% Similarity=0.383 Sum_probs=198.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCC-----
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPT----- 370 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~----- 370 (622)
++++|++.+.||+|+||.||+|... +++.+++|++..... ....+.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 578999999875432 345688999999998 6999999999997644
Q ss_pred -ceeEEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 371 -ERLLVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 371 -~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999988753 35789999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeeeecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
++....... .......|+..|+|||++.. ..++.++|||||||++|+|+||+.||....... .+ ...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~ 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---AL----FKI 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HH----HHh
Confidence 997654322 22233458899999998753 346789999999999999999999986322110 01 111
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ..+... ........+.+++.+|+..||++|||+.|+++.
T Consensus 231 ~~~------~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRN------PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hcc------CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 001111 112234678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.77 Aligned_cols=246 Identities=29% Similarity=0.372 Sum_probs=196.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+.|...+.||+|+||+||+|... +++.||+|.+...... .....+.+|+++++.++|||++++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999965 6899999998644322 22346889999999999999999999999999999999
Q ss_pred eeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||++ |++.+.+. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 46666654 345689999999999999999999998 9999999999999999999999999999765432
Q ss_pred ceeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 456 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
....++..|+|||++. ...++.++||||||+++|||+||+.||....... ........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~~~~--------- 229 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQN--------- 229 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHHhcC---------
Confidence 2345788999999874 4568899999999999999999999986432111 11111100
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.............+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111122244678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.93 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=204.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++.|+..+.||+|+||.||+|..+ +++.|++|++..... ....+.+|+++++.++|+|++++++++...+..++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556778889999999999999976 688999999875543 4557889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999998765 799999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........ ... ..
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~-----~~- 236 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFLITTK-GIP-----PL- 236 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhc-CCC-----CC-
Confidence 1223347889999999988889999999999999999999999986432211 01111000 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+..+.+++.+|++.+|.+||++.++++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111234678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.90 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=199.7
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeEEee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLVYP 377 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 377 (622)
|++.+.||+|+||.||+|... +++.+|+|.++... .......+.+|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 58999999998653 222334678899999999999999999999988 88999999
Q ss_pred eccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888887654 5789999999999999999999998 9999999999999999999999999999877544322
Q ss_pred eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhhh-----
Q 036225 457 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLEM----- 528 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----- 528 (622)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+........... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2333456889999998765 4578999999999999999999999875443221111111100000000 0000
Q ss_pred ------hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 ------LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+...+...++..+.+++.+|++.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000111125678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.35 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=198.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------ 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 369 (622)
..++|+..+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999964 68999999986432 223334677899999999999999999988643
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 346899999964 888877644 88999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHH--------HHHHHHh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML--------DWVKKIH 521 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~~ 521 (622)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+. .+.....
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 643221 233457899999999999999999999999999999999999997543221111110 0000000
Q ss_pred --------hhh-----hhhhhccccCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 --------QEK-----KLEMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 --------~~~-----~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ........... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00011100000 00011234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=293.98 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=204.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
-|+++.+||+|+||.||+|.++ .|+.+|||.+.... +..++.+|+.++.+.+.|++|++||.|.....+|+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3667889999999999999975 69999999986543 3457889999999999999999999999999999999999
Q ss_pred cCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
.-|++.+.+. .+.++.+.++..++...+.||+|||.. .-+|||||..|||++-+|.+||+|||.|-.+.... ...
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hhh
Confidence 9999999986 456799999999999999999999998 78999999999999999999999999997664321 223
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC-
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN- 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~- 537 (622)
..+.||+.|||||++..-.|+.++||||||++..||..|++|+..-.+-.. +-. +....+..
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFM-IPT~PPPTF 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFM-IPTKPPPTF 249 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEe-ccCCCCCCC
Confidence 456799999999999999999999999999999999999999863221100 000 11111111
Q ss_pred -CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 -YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 -~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++....++-++++.|+-+.|++|-|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 234455778999999999999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.57 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=194.2
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCC--CceeEEee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTP--TERLLVYP 377 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 377 (622)
|...+.||+|+||.||+|... +++.||+|.++............+|+.++.++. |+|++++++++... +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999964 689999999876543333334557888888885 99999999999987 88999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|++ |++.+.+.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 477777764 45689999999999999999999998 9999999999999999 9999999999986643222
Q ss_pred eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHHhhhhhhh
Q 036225 457 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKIHQEKKLE 527 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 527 (622)
.....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+....+.. |...........
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 123457899999997644 5578899999999999999999999975433221111111 100000000000
Q ss_pred hhccccCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKN---NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......... ......+..+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=292.23 Aligned_cols=249 Identities=30% Similarity=0.417 Sum_probs=203.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677899999999999999975 688999999876543 34557889999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998765 5789999999999999999999998 999999999999999999999999999987654332 3
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ..... ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~-----~~~-- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIAT-NGPPG-----LRN-- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHh-cCCCC-----cCc--
Confidence 3456889999999998888999999999999999999999998643211 11111100 00000 000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11114678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.81 Aligned_cols=266 Identities=20% Similarity=0.315 Sum_probs=197.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC-----ce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-----ER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~ 372 (622)
+++|.+.+.||+|+||.||+|... +|+.||+|.++..........+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999864 689999999875433334456788999999999999999999876543 47
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++|+||+++ +|.+.+.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999975 78777754 3589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCc--eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 453 QDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 453 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.... ......|+..|+|||.+.+ ..++.++|||||||++|+|+||+.||...+.......+...... ...+....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CCHHHHHHh
Confidence 2211 1123468899999998754 46889999999999999999999999654321110000000000 000001110
Q ss_pred cccc-------CC--CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 VDKD-------LK--NNY-----DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~-------~~--~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.. .. ... ......++.+++.+|++.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1000 00 000 01123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.56 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=194.9
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999965 689999999876544444557889999999986 99999999999999999999999
Q ss_pred ccCCCccccc-----cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 379 MSNGSVASRL-----KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 379 ~~~gsL~~~l-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+.. ++.++. .....+++.....++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 544432 12356899999999999999999999742 8999999999999999999999999999765432
Q ss_pred CCceeeeecCcccccCccccccC---CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... .....+...... .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~------~ 227 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKG------D 227 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCC------C
Confidence 2 12233588999999998776 68999999999999999999999986432 111111111100 0
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.+........+.++.+++.+|++.+|++||+++++++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111222345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.71 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=197.2
Q ss_pred cCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 304 SKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
....||+|+||.||++... +++.||+|.+..... .....+.+|+.++..++|||++++++++..++..++++||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3457999999999999964 689999999865432 33456889999999999999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
+|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .......
T Consensus 104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 178 (297)
T cd06659 104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV 178 (297)
T ss_pred CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccccee
Confidence 99987754 4589999999999999999999998 99999999999999999999999999987554322 1223356
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.... ..... .....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~------~~~~~--~~~~~ 243 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSP------PPKLK--NAHKI 243 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccC------CCCcc--ccCCC
Confidence 8999999999988889999999999999999999999987432211 111111100 00000 01112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 543 LEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+.+++.+|++.+|.+||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.78 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=214.2
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC----C----CeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeee
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ----D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYG 364 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~ 364 (622)
.+++..+++.+.+.+|+|.||.|++|... . ...||||.++......+...+..|++++..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56677777778889999999999999843 1 4579999999877666777899999999987 6999999999
Q ss_pred eeeCCCceeEEeeeccCCCccccccCCC----------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 036225 365 FCMTPTERLLVYPYMSNGSVASRLKGKP----------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKA 428 (622)
Q Consensus 365 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 428 (622)
+|...+..++|+||+..|+|.++++... .+.......++.|||.|++||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999997544 488889999999999999999999 999999999
Q ss_pred CCeeecCCCceEEcccccceecCCCCCceeeeecC--cccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccch
Q 036225 429 ANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGK 505 (622)
Q Consensus 429 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~ 505 (622)
+|||+.++..+||+|||+|+...+...+....-.| ...|||||.+....|+.|+|||||||++|||+| |..|+..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765555444333333 456999999999999999999999999999999 566664311
Q ss_pred hccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 506 AANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. ..+..+.+ .+..+-..+..+..++.++++.||+.+|++||++.++++.++.
T Consensus 527 ~------~~~l~~~l----------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 P------TEELLEFL----------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred c------HHHHHHHH----------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0 11111111 1222223455567889999999999999999999999999986
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.29 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=202.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 367888999999999999999854 67899999986433 2234568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++........ .
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999999988754 478999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....++..|+|||.+.+..++.++||||||+++|++++|+.||...........+ ... ......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~--------~~~~~~ 236 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATN--------GTPELQ 236 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcC--------CCCCCC
Confidence 23345888999999998888999999999999999999999999754322111000 000 000000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+.+++.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.98 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=189.7
Q ss_pred eeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHH---hccccccceeeeeeeeCCCceeEEeeecc
Q 036225 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMI---SLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
+||+|+||.||++... +++.+|+|.+...... .....+.+|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6899999988654322 1222344454433 34479999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+|+|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 999999988777899999999999999999999998 99999999999999999999999999987554322 223
Q ss_pred ecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 461 VRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
..|+..|+|||.+.+ ..++.++|||||||++|||+||..||........ ....... ..... ..+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~------~~~~~----~~~ 219 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT------LTVNV----ELP 219 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHh------hcCCc----CCc
Confidence 458999999999864 5588999999999999999999999964322111 0111100 00111 122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRP-----KMSEVVRML 571 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 571 (622)
...+.++.+++.+|+..+|.+|| +++|++++-
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 22346788999999999999999 599888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.95 Aligned_cols=240 Identities=26% Similarity=0.306 Sum_probs=189.9
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||+||++... +|+.||+|.+.... .......+..|+++++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999986432 122334567899999999999999999999999999999999999999
Q ss_pred cccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 385 ASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 385 ~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99886544 689999999999999999999998 9999999999999999999999999998765432 1223345
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHH
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 542 (622)
++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... ... .....+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~---------~~~--~~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRR---------TLE--MAVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhc---------ccc--ccccCCccC
Confidence 7889999999988889999999999999999999999986433211100 00000 000 011122223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHH
Q 036225 543 LEEMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 543 ~~~l~~li~~cl~~~p~~RPt~~e 566 (622)
...+.+++.+|++.+|.+||+..+
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 467899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=290.74 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=206.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeEEe
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLVY 376 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 376 (622)
+|...+.||+|++|.||+|... +++.|++|++..... ......+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 689999999875432 23345788999999999999999999999988 8899999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998777899999999999999999999998 9999999999999999999999999999877544321
Q ss_pred -eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......++..|+|||.+.+...+.++||||||+++|+|++|+.||..... ......... .....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~---------~~~~~ 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIG---------SSGEP 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhcc---------ccCCC
Confidence 12334588999999999888899999999999999999999999875431 111111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11222335789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=295.50 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=199.3
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|...+.||+|++|.||++.. .+++.+++|+++... ......+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 44567999999999999996 468899999886433 2234468899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++....... .....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 9999999876 5689999999999999999999998 99999999999999999999999999887554322 22233
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.... .+.... ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~------~~~~~~--~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNL------PPKLKN--LH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcC------CCCCcc--cc
Confidence 4589999999999888899999999999999999999999864321 11122111110 011110 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+..+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 13367899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=293.55 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=198.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC----CCchhHHHHHHHHHHhccccccceeeeeeeeCC--Cce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 372 (622)
.+|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 68999999875321 122334688999999999999999999998764 457
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++++||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999988766789999999999999999999998 999999999999999999999999999986532
Q ss_pred CC--CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||....... . +.+. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~---------~ 222 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------A-IFKI---------A 222 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------H-HHHH---------H
Confidence 11 111223458899999999988889999999999999999999999986322110 0 1111 1
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+......+.+++.+|++ +|..||+..+++.+
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111112233344678999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.89 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=198.6
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|.+.+.||+|++|+||+|... +++.|+||++.............+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578999999876543333334567899999999 999999999999999999999999
Q ss_pred cCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 380 SNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 380 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+|+|.+++.... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789998887543 789999999999999999999998 999999999999999999999999999986643222
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH---------HHHHHhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD---------WVKKIHQEKKLE 527 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 527 (622)
.....++..|+|||++.+ ..++.++||||||++++||++|+.||......+....+.. |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 4578999999999999999999999865433222111111 111111011111
Q ss_pred hhccccCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKN---NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+...... .........+.+++.+|++.+|++||+++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 0001113678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.21 Aligned_cols=255 Identities=28% Similarity=0.358 Sum_probs=206.1
Q ss_pred HhCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+-++.....||.|.||.||-|. ..+|+..|+|-++..... .....+.+|+.++..++|||+|++||+-...+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3356677899999999999999 567999999988754322 22335789999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|||++|+|.+.+......++.....+..|++.|+.|||++ |||||||||.||+++.+|.+|++|||.|..+.+....
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999888888888889999999999999999 9999999999999999999999999999887654211
Q ss_pred ---eeeeecCcccccCccccccC---CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 457 ---VTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 457 ---~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.-....||+.|||||++.+. ....+.||||+||++.||+||++||..-+. ...|.-.+..
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~----------- 1456 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAA----------- 1456 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhc-----------
Confidence 12345699999999999654 356788999999999999999999974332 1111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.-.+..+.....+-.+++..|++.||++|.++.|+++.--
T Consensus 1457 --gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1457 --GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred --cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 1112234445566789999999999999999998887643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.51 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=198.9
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC----
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT---- 370 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 370 (622)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|+++++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 588999999875432 223346778999999999999999999987654
Q ss_pred ------ceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 371 ------ERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 371 ------~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
..++|+||+++ ++.+.+.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 66666654 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998765433222222346788999998865 35789999999999999999999998744322111111111000000
Q ss_pred hhhhhhhc--------cc------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 EKKLEMLV--------DK------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~~~~~~~~--------d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+. +. ....... ..+..+.+++.+|++.+|.+||++.++++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 -AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred -hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 00 0000001 124678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.13 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=204.9
Q ss_pred CCCcCCeeeecCCceEEEEEE----CCCeEEEEEEccCCCC---CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 301 NFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
+|+..+.||+|+||.||++.. .+++.||||.++.... ......+..|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999984 2578899999875322 22334678899999999 599999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++|+|.+++.....+++.....++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999988777789999999999999999999998 999999999999999999999999999876654
Q ss_pred CCCceeeeecCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..........|+..|+|||.+.+.. .+.++||||||+++|||+||+.||....... ......+.....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc-------
Confidence 3333333456889999999987655 7889999999999999999999986322111 111111111100
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
.. ..+......+.+++.+|++.+|++|||+.++.+.|+...+
T Consensus 228 ~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 01 1122233568899999999999999999999888887654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.52 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=200.2
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||.||++... +|+.+++|.+..... ......+.+|++++.+++|+|++++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865432 13344688899999999999999999999999999999999999999
Q ss_pred cccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-------ce
Q 036225 385 ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-------HV 457 (622)
Q Consensus 385 ~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-------~~ 457 (622)
.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998766899999999999999999999998 999999999999999999999999999876533211 12
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....++..|+|||...+...+.++||||||+++|||+||+.||...... ........ ....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~---------~~~~-- 219 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILN---------GKIE-- 219 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc---------CCcC--
Confidence 23345788999999998888999999999999999999999998643311 11111111 0000
Q ss_pred CCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 538 YDRI--ELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 538 ~~~~--~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
.+.. .+..+.+++.+|++.+|++|||+.++.+.|+...+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 1111 24678999999999999999999777777765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.99 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=199.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|+||.||+|... +|..||+|.+..... ......+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999975 588999999865422 22345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~ 455 (622)
+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999988643 3579999999999999999999998 999999999999999875 469999999976653322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..++........ ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-----~~---- 220 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGY-----FA---- 220 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhccc-----CC----
Confidence 2223458899999999988889999999999999999999999986332 112222211110 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.........+.+++.+|+..+|++|||+.|+++.
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=300.57 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=194.4
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|...+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++|+|++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999964 6889999998654322 2234688899999999999999999999999999999999
Q ss_pred ccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+.+ ++.+.+. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 7777664 355689999999999999999999998 9999999999999999999999999998754322
Q ss_pred eeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 458 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ......... ..
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~---------~~ 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN---------ES 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhc---------cC
Confidence 2345888999999974 456889999999999999999999998642211 001111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
...........+.+++.+|++.+|.+||++.++++.+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 1111122345689999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=298.86 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=198.6
Q ss_pred CCCcCCeeeecCCceEEEEEE----CCCeEEEEEEccCCCC---CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 301 NFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
+|++.+.||+|+||.||++.. .+|+.||+|+++.... ......+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999986 3689999999875321 22334678899999999 599999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++++|.+++.....+++.....++.|++.||.|||+. +++||||+|+|||+++++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999998777889999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCceeeeecCcccccCccccccC--CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
..........|+..|+|||.+.+. .++.++||||||+++|+|+||+.||...... .....+.......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~------- 227 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKS------- 227 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhcc-------
Confidence 332223345688999999998653 4678999999999999999999998632211 1111222111110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVR 569 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 569 (622)
.+ .++......+.+++.+|++.+|++|| ++.+++.
T Consensus 228 ~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 11222346788999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.14 Aligned_cols=269 Identities=19% Similarity=0.258 Sum_probs=188.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC--CeEEEEEEcc--------------CC--CCCchhHHHHHHHHHHhccccccc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD--GTVVAVKRLK--------------DG--NAIGGEIQFQTEVEMISLAVHRNL 359 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~--------------~~--~~~~~~~~~~~e~~~l~~l~H~ni 359 (622)
..++|.+.+.||+|+||+||++..+. +..+++|.+. +. ........+.+|++++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987542 2222222111 00 111223457899999999999999
Q ss_pred eeeeeeeeCCCceeEEeeeccCCCccccccCC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 036225 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434 (622)
Q Consensus 360 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~ 434 (622)
+++++++...+..++|+|++. ++|.+++... ..........|+.||+.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 4666665422 2233556778999999999999998 999999999999999
Q ss_pred CCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHH
Q 036225 435 DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML 514 (622)
Q Consensus 435 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~ 514 (622)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998775443333344679999999999999999999999999999999999886543322111111111
Q ss_pred HHHHHHhh--h------hhhhhhccc-cC---CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 515 DWVKKIHQ--E------KKLEMLVDK-DL---KNNYDR-----IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 515 ~~~~~~~~--~------~~~~~~~d~-~~---~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.+..+.. . ......++. .+ ...... .....+.+++.+|++.||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111100 0 000000000 00 000000 012456778999999999999999999874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.11 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=203.1
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhH--HHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
..++|+..++||+|.||.|-.+.-+ +|+.+|+|++++.......+ .-..|-++|...+||.+..+--.|...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999855 79999999999876544333 34578899999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||||..||.|.-+|.....++++..+.+...|+.||.|||++ +||+||||.+|.|+|++|++||+|||+++.-- ..
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KY 321 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-cc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999997432 23
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......++||+.|+|||++....|+..+|.|.+||++|||++|+.||...+... +.. -+.-.++
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----LFe------------LIl~ed~ 385 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----LFE------------LILMEDL 385 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----HHH------------HHHhhhc
Confidence 344567899999999999999999999999999999999999999997543211 111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRP 562 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RP 562 (622)
.+++.-..+...|+.-.+..||.+|.
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 13344446677888999999999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=286.02 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=196.7
Q ss_pred cCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhc-cccccceeeeeeeeCCCceeEEeeeccC
Q 036225 304 SKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
....||.|+||+|+|-.++ .|+..|||+++..+...+++++..|.+...+ -+.||||++||.+..++..|+.||.|+-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 4467999999999998865 6999999999988877778889999987554 4799999999999999999999999954
Q ss_pred CCcccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 382 GSVASRLK-----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 382 gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+..+.+ .+..+++...-+|......||.||-+.. .|||||+||+|||+|..|.+||||||++-.+. ++.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~Si 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSI 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH--HHH
Confidence 6655443 3456888888899999999999998764 89999999999999999999999999987553 233
Q ss_pred eeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 457 VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
..+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..-+. +.+.+.++..........+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~~~~- 295 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLFDKE- 295 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecCccc-
Confidence 3445568999999999954 3489999999999999999999999863221 223333332221111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+...+..|+.+|-.+||+..+++++
T Consensus 296 ----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 ----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11234678899999999999999999998864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=290.31 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=204.6
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...+.||+|+||.||++... +++.|++|++..... ......+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 688999999875433 23445688999999999999999999999999999999999
Q ss_pred ccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 379 MSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 379 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999998865 36799999999999999999999998 99999999999999999999999999998765433
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......|+..|+|||...+..++.++||||+|+++++|++|+.||..... ...........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~---------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQ---------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCC----------
Confidence 233345688999999999888899999999999999999999999864331 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....+......+.+++.+|+..+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011122234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.82 Aligned_cols=266 Identities=19% Similarity=0.272 Sum_probs=194.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|+..+.||+|++|+||+|..+ +|+.||+|.++..... .....+.+|+++++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 6899999998654322 223467889999999999999999999999999999999
Q ss_pred eccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~ 454 (622)
|++ ++|.+++.... .+++.....++.||+.||+|||++ +++|+||+|+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 47777765433 357788889999999999999998 9999999999999985 5679999999997654321
Q ss_pred CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh-----hhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK-----KLEM 528 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 528 (622)
. ......++..|+|||++.+. .++.++|||||||++|+|+||+.||......+....+..+........ ....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 12233578899999988664 578999999999999999999999975432211111111000000000 0000
Q ss_pred hcc--ccCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVD--KDLKNN----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d--~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... +..... .......++.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 001123568899999999999999999999863
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=292.13 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=202.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|++.+.||+|+||.||++... +++.+|+|.+..... ......+.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 688999999875432 23344677899999999999999999999999999999999
Q ss_pred ccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 379 MSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 379 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998854 45689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... + ..... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~---~~~~~----------~~~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----L---RYKVQ----------RGK 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHh----------cCC
Confidence 2223457899999999998889999999999999999999999986433210 1 11110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111223445779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.49 Aligned_cols=267 Identities=19% Similarity=0.309 Sum_probs=200.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC----CCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT----PTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~ 372 (622)
.++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999965 689999999875432 2234467789999999999999999998763 3467
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 89999995 68999988777799999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc---eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHH
Q 036225 453 QDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKI 520 (622)
Q Consensus 453 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~ 520 (622)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 1223468899999999865 4689999999999999999999999965432211100000 00000
Q ss_pred hhhhhhhhhccc-cCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQEKKLEMLVDK-DLKNNY-----DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~~~~~~~~~d~-~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....+....+. ...... .+..+.++.+++.+|++.+|++||++++++..
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 -GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001110000 000001 11235778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.06 Aligned_cols=267 Identities=26% Similarity=0.327 Sum_probs=196.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCC--CceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 374 (622)
.++|+..+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 68999999987543222 223466899999999999999999998765 56799
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 78777654 35689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh--------h
Q 036225 454 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--------K 524 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 524 (622)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++....... .
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 221 222345788999999865 457899999999999999999999997543322211111111000000 0
Q ss_pred hhhhh-ccccCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEML-VDKDLKNNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~-~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... ......... .......+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000000000 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.09 Aligned_cols=265 Identities=20% Similarity=0.227 Sum_probs=194.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccc-cccceeeeeeeeCCCc-----
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTE----- 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~----- 371 (622)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999965 6899999988654322 22346788999999995 6999999999887665
Q ss_pred eeEEeeeccCCCccccccC-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccc
Q 036225 372 RLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFG 445 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfg 445 (622)
.++||||+++ +|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777642 23579999999999999999999998 9999999999999998 8999999999
Q ss_pred cceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|+||..||...........+....... ...
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP-TEQ 234 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC-Chh
Confidence 99765432211 122346888999998865 457899999999999999999999987543222111111100000 000
Q ss_pred hhhhhc---c----ccCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLV---D----KDLKN----NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~---d----~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...... + +.... ........++.+++.+|+..+|.+||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 0 00000 0001134668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.22 Aligned_cols=259 Identities=17% Similarity=0.202 Sum_probs=185.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCch-hH---------HHHHHHHHHhccccccceeee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGG-EI---------QFQTEVEMISLAVHRNLLRLY 363 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~~---------~~~~e~~~l~~l~H~niv~l~ 363 (622)
...+|.+.++||+|+||+||+|...+ +..+|+|.......... +. ....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678899999999999999999654 34567775433221110 00 112233445667899999999
Q ss_pred eeeeCCC----ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 364 GFCMTPT----ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 364 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
+.+.... ..++++|++.. ++.+.++.....++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 9766543 33567777643 5555555444467888999999999999999998 99999999999999999999
Q ss_pred EEcccccceecCCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccccc-
Q 036225 440 VVGDFGLAKLLDHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA- 512 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~- 512 (622)
+|+|||+++.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||...........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 11234699999999999999999999999999999999999999975422111000
Q ss_pred -HHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 513 -MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 513 -~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
..++...+... ... ...++..+.+++..|++.+|++||+++++++.++
T Consensus 246 ~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHEG---------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhhh---------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 01122222111 110 1112467899999999999999999999998763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.44 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=188.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------- 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 369 (622)
-..+|+..++||+||||.||+++.+ ||+.||||++........-..+.+|+..+++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888899999999999999976 89999999998665333444688999999999999999997654110
Q ss_pred --------------------------------------------------------------------------------
Q 036225 370 -------------------------------------------------------------------------------- 369 (622)
Q Consensus 370 -------------------------------------------------------------------------------- 369 (622)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceeEEeeeccCCCccccccCCCCC-ChhHHHHHHHHHHHHHHHHHhc
Q 036225 370 --------------------------------TERLLVYPYMSNGSVASRLKGKPIL-DWSTRKRIALGAARGLLYLHEQ 416 (622)
Q Consensus 370 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~~L~~LH~~ 416 (622)
...|+-||||+...+.+++..+... .....++++.+|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0135678888877777766654433 4677889999999999999999
Q ss_pred CCCCeeecCCCCCCeeecCCCceEEcccccceecC-----------------CCCCceeeeecCcccccCccccccC---
Q 036225 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD-----------------HQDSHVTTAVRGTVGHIAPEYLSTG--- 476 (622)
Q Consensus 417 ~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~--- 476 (622)
|||||||||.||++|++..|||+|||+|+... .......+..+||.-|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998721 0111123456799999999999765
Q ss_pred CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCC
Q 036225 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 556 (622)
Q Consensus 477 ~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~ 556 (622)
.|+.|+|+||+||+++||+. ||..... ...++ ..+. .+.+..- ..+.......=..+|.++++.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~iL---~~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSME---RASIL---TNLR-KGSIPEP------ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHH---HHHHH---Hhcc-cCCCCCC------cccccccchHHHHHHHHHhcC
Confidence 49999999999999999984 5543221 11111 1111 1111110 112223334556899999999
Q ss_pred CCCCCCCHHHHHH
Q 036225 557 LPAHRPKMSEVVR 569 (622)
Q Consensus 557 ~p~~RPt~~evl~ 569 (622)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.06 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=194.9
Q ss_pred CcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeeecc
Q 036225 303 SSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
.....||.|+.|.|+++..+ +|...|||.+.......+.+++...++++.+.+ .|.||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999976 589999999987665556667788888776664 8999999999999999999999985
Q ss_pred CCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 381 NGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 381 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
. .+..+++ -..++++..+-++...+..||.||.++. +|+|||+||+|||+|+.|++|+||||++-++-. +...+
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAht 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAHT 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--ccccc
Confidence 3 3444443 2345788888899999999999998764 999999999999999999999999999977653 34445
Q ss_pred eecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 460 AVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
...|-+.|||||.+.- ..|+.++||||||+.++||.||+.||...+..- +.+..+..++ .+.+++
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF------e~ltkvln~e------PP~L~~ 317 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF------EVLTKVLNEE------PPLLPG 317 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH------HHHHHHHhcC------CCCCCc
Confidence 5679999999999853 468999999999999999999999998643221 1122222111 122222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... -...+.+++..|+++|+.+||...+++++
T Consensus 318 ~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 23568899999999999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=293.02 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=192.7
Q ss_pred CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHH-HhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||.||+|... +|+.||+|.++..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 6899999998654321 112234445444 3455899999999999999999999999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
++|.++++....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 99999998777899999999999999999999998 999999999999999999999999999875432 2234
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHH
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 541 (622)
.++..|+|||.+.+..++.++||||||+++|||+||..||...... ......... . ..........
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-~------~~~~~~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSR-R------INWPEEVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhc-c------cCCCCccccc
Confidence 5888999999998888999999999999999999999998643211 111111100 0 0011111122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 542 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+..+.+++.+|++.+|++||++.++.+.|..
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 34678999999999999999988777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.90 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=194.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 376 (622)
-++|+..+.||+|+||.||+|..++ ++.||||.++..........+..|+.++.+.. |+||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4567888999999999999999864 89999999976544444445667777666664 999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+.+ ++.+.+.. ...+++..+..++.|++.||.|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99854 66665543 346899999999999999999999732 899999999999999999999999999876543221
Q ss_pred ceeeeecCcccccCccccccCC----CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+..........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~------ 236 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEP------ 236 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCC------
Confidence 12234788999999987553 788999999999999999999998642211 111111111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+... .......++.+++.+|+..+|.+||++.+++++
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001134678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.08 Aligned_cols=267 Identities=24% Similarity=0.359 Sum_probs=198.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC--Ccee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP--TERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~ 373 (622)
.++|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.++.++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999975 68899999886432 122334577899999999 999999999998654 3579
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||++ ++|.+++... .+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5898888765 789999999999999999999998 9999999999999999999999999999866433
Q ss_pred CC----ceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH-------h
Q 036225 454 DS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI-------H 521 (622)
Q Consensus 454 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~ 521 (622)
.. .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||......+....+....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22 12234568999999998755 457899999999999999999999986443322111111110000 0
Q ss_pred hhhhhhhhcc----ccCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEKKLEMLVD----KDLK--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~~~d----~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+++ .... .......+.++.+++.+|++.+|++||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111 0000 00001134678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.78 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=203.6
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|+..+.||+|++|.||++... +++.|++|.+...... .....+.+|++++.+++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 5789999999765432 2344688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 99999999998777899999999999999999999998 9999999999999999999999999999876543322 2
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ..... .... . ....
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~------~----~~~~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFR-IVQD------D----HPPL 219 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-Hhcc------C----CCCC
Confidence 3345889999999998888899999999999999999999998643211 00000 0000 0 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+......+.+++.+|+..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2223467889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=295.97 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=200.6
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|...+.||+|++|.||+|... +++.+++|.++..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999965 6899999998765432 33456888999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++ ++.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 88877765 35789999999999999999999998 99999999999999999999999999998775443 122
Q ss_pred eeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc------
Q 036225 459 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD------ 531 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------ 531 (622)
....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+........ ........+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD-PEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc-hHhcccchhhhhhhh
Confidence 334578899999998776 789999999999999999999999865443221111110000000 000000000
Q ss_pred -----ccCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 -----KDLK--NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 -----~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... .........++.+++.+|++.||.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00112345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.75 Aligned_cols=266 Identities=21% Similarity=0.312 Sum_probs=202.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC-----cee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-----ERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 373 (622)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 589999999875432 333456889999999999999999999988775 789
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
++|||++ ++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 48988888777899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC--ceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-------hh
Q 036225 454 DS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-------QE 523 (622)
Q Consensus 454 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 523 (622)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 21 112334578899999999887 789999999999999999999999975443221111111000000 00
Q ss_pred hhhhhhccc-cCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDK-DLKNN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~-~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+.. ..... .....+..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 00000 011124668899999999999999999998864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.42 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=200.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
..+.|..-++||+|+||.||-+... +|+.+|.|.+.+.. ...++.-..+|-.+|.+++.+.||.+--.|+.++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456788899999999999999854 69999998875432 12234456789999999999999999999999999999
Q ss_pred EeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|+..|.||+|.-++.+ .+.+++.....++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999988854 56899999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ....+||.+|||||++.++.|+...|.|||||++|||+.|+.||...+...... -+|.
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-----------------Evdr 400 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-----------------EVDR 400 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-----------------HHHH
Confidence 433 233479999999999999999999999999999999999999997433221110 0111
Q ss_pred cC---CCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 533 DL---KNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 533 ~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
+. ...++..-.++...+-...++.||.+|-..
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11 122334445677888888999999999744
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=305.39 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=194.8
Q ss_pred CCcCCeeeecCCceEEEEEECCC-eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGILQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
+.++..||.|+||.||+|..++. -..|.|++... .......|.-|+++|....||+||++++.|...+.++++.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 44556799999999999997754 34556666432 23445578999999999999999999999999999999999999
Q ss_pred CCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 381 NGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 381 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
||-....+- -...|..+++.-+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+..... ......
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 999988764 356799999999999999999999999 999999999999999999999999999753321 223345
Q ss_pred eecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 460 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.+.||++|||||+.. ..+|+.++||||||++|.||..+.+|-..-. .+.-.++. ...+ .+.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKi-aKSe------PPTL 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKI-AKSE------PPTL 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHH-hhcC------CCcc
Confidence 678999999999874 5679999999999999999999988854221 11111111 1110 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. .+......+.+++.+|+..+|..||++++++++
T Consensus 256 l--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 L--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 122334568899999999999999999999863
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.06 Aligned_cols=266 Identities=19% Similarity=0.295 Sum_probs=198.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC-----Cc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 371 (622)
..+|...+.||+|+||+||+|... +++.||||.++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 346888999999999999999964 68999999987532 222334577899999999999999999988654 34
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+. ++|.+++.....+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999996 68988888777899999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-------hh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH-------QE 523 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 523 (622)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+........ ..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 22233457889999998865 4688999999999999999999999864322111000111000000 00
Q ss_pred hhhhhhc-------cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLV-------DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~-------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+ +..... .......++.+++.+|++.+|++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 000000 011234668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=288.56 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=191.9
Q ss_pred HHHHhCCCcCCee--eecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCc
Q 036225 296 QVATHNFSSKNIL--GKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 296 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 371 (622)
....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +|+|++++++.+...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344566666666 99999999999964 68889999986543211 122222222 69999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~ 450 (622)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999998777899999999999999999999999 999999999999999988 9999999999765
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.....
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~--------- 224 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQQ--------- 224 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhhc---------
Confidence 4322 2358899999999998899999999999999999999999997332211 11112221110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK-MSEVVR 569 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 569 (622)
.. ..........+.+++.+|++.+|.+||+ ++|+++
T Consensus 225 -~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0111234467899999999999999996 688874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=291.47 Aligned_cols=243 Identities=25% Similarity=0.327 Sum_probs=189.1
Q ss_pred eeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHH---HHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 307 ILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVE---MISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
+||+|+||.||+|... +++.||+|.+...... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6889999998654322 11222344443 3445579999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 999999998777899999999999999999999998 99999999999999999999999999987553222 123
Q ss_pred ecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 461 VRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
..|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ .. ..... ......+ +
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~-~~~~~------~~~~~~~----~ 219 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMT------LTMAVEL----P 219 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HH-HHHHh------hccCCCC----C
Confidence 4589999999998754 689999999999999999999999975422111 00 00000 0011111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
...+..+.+++.+|+..+|.+|| ++.++++.
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12246789999999999999999 99998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=292.30 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=193.9
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhcc---ccccceeeeeeeeCCCc-----
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLYGFCMTPTE----- 371 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~----- 371 (622)
|++.+.||+|+||.||+|..+ +++.||+|+++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999986 48999999997543322 223466777766555 69999999999988776
Q ss_pred eeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 372 RLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.+++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 788877643 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh-
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM- 528 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 528 (622)
...... .....++..|+|||++.+..++.++|||||||++|||+||..||......+....+.+.............
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 643322 12234788999999999889999999999999999999999888743322211111111000000000000
Q ss_pred -----hccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 -----LVDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 -----~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......... ........+.+++.+|++.||.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 011224667899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.95 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=191.2
Q ss_pred Ceeeec--CCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKG--GFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
..||+| +||+||++... +|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 7999999998754322 2335688899999999999999999999999999999999999
Q ss_pred CCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce--
Q 036225 382 GSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-- 457 (622)
Q Consensus 382 gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-- 457 (622)
+++.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988643 3588899999999999999999998 99999999999999999999999998654332111110
Q ss_pred ----eeeecCcccccCccccccC--CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH-----------
Q 036225 458 ----TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI----------- 520 (622)
Q Consensus 458 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 520 (622)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccccc
Confidence 0112346679999999764 478999999999999999999999864322110 00000000
Q ss_pred ---------------------hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 ---------------------HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ---------------------~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........+..+...........+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000000111111111223355778999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=294.63 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=203.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 375 (622)
++|...+.||+|+||.||+|... +|+.||+|++..... ......+..|.+++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 689999999875322 223446788999999998 99999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998877899999999999999999999998 999999999999999999999999999987654322
Q ss_pred -------------------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH
Q 036225 456 -------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 456 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 516 (622)
.......++..|+|||...+..++.++||||||++++++++|+.||...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~ 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------LT 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------HH
Confidence 1222345789999999998888999999999999999999999998744311 00
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKM----SEVVR 569 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~ 569 (622)
..... . .....+...+..+.+++.+|++.+|.+||++ .++++
T Consensus 231 ~~~~~---------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKIL---------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH---------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 0011112224678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.78 Aligned_cols=268 Identities=24% Similarity=0.317 Sum_probs=193.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCc-----
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE----- 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 371 (622)
-++|...+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999965 689999998864432 2223356789999999999999999999876543
Q ss_pred ---eeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccc
Q 036225 372 ---RLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447 (622)
Q Consensus 372 ---~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 447 (622)
.++||||+.+ +|.+.+... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4999999965 777777543 3689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCc---eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 448 KLLDHQDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 448 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
......... ......++..|+|||.+.+. .++.++||||||+++|||+||..||...........+..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 766432221 11233478899999988664 36889999999999999999999886543221111111100000000
Q ss_pred ----hhhhhhccc-cCCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 ----KKLEMLVDK-DLKNNY---------DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ----~~~~~~~d~-~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+. ...... .......+.+++.+|+..+|.+|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000 000000 00112456799999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=305.61 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=195.3
Q ss_pred CcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC------CceeEE
Q 036225 303 SSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TERLLV 375 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv 375 (622)
...+.||+|+||.||+|.. .+|+.||||.++........+...+|++++++++|+|||++++.-+.. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3457899999999999995 479999999998766666667788999999999999999999986654 356899
Q ss_pred eeeccCCCccccccC---CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCc--eEEcccccce
Q 036225 376 YPYMSNGSVASRLKG---KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCE--AVVGDFGLAK 448 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~--~kl~Dfgla~ 448 (622)
||||.+|||+..|.+ ...|++.+.+.++.+++.||.|||++ +|+||||||.||++- .+|+ -||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999974 34699999999999999999999998 999999999999984 3333 6999999999
Q ss_pred ecCCCCCceeeeecCcccccCccccc-cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
.++.+ .....++||..|++||.+. .+.|+..+|.|||||++||.+||..||.....+..... ..|.........+.
T Consensus 173 el~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 173 ELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSGVA 249 (732)
T ss_pred cCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCcee
Confidence 87643 3667788999999999998 48899999999999999999999999986544322111 12221111111111
Q ss_pred hhccccCC------------CCCCHHHHHHHHHHHHHccCCCCCCCC
Q 036225 528 MLVDKDLK------------NNYDRIELEEMVQVALLCTQYLPAHRP 562 (622)
Q Consensus 528 ~~~d~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~RP 562 (622)
....+... ....+.....+-..+..++..+|++|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11111111 111233334566677778888888888
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.51 Aligned_cols=246 Identities=29% Similarity=0.369 Sum_probs=193.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.|+..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 68899999886432 22233467889999999999999999999999999999999
Q ss_pred eccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+. |++.+.+. ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 57777664 345689999999999999999999998 9999999999999999999999999998765432
Q ss_pred eeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~--------- 230 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE--------- 230 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcC---------
Confidence 2235788999999974 356788999999999999999999998643211 1111111000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
............+.+++.+||+.+|.+||++.++++.-
T Consensus 231 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00001122346688999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.81 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=194.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC---CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCC--Ccee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 373 (622)
.|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 478999999876331 12234577899999999999999999999988 8899
Q ss_pred EEeeeccCCCcccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC----CCceEEccc
Q 036225 374 LVYPYMSNGSVASRLK-----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD----CCEAVVGDF 444 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Df 444 (622)
+||||+++ ++.+.+. ....++...+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6665543 123688899999999999999999999 9999999999999999 999999999
Q ss_pred ccceecCCCCC--ceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccc------cHHH
Q 036225 445 GLAKLLDHQDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKG------AMLD 515 (622)
Q Consensus 445 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~------~~~~ 515 (622)
|++........ .......++..|+|||++.+. .++.++|||||||++|||++|+.||.......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112234578899999988664 57899999999999999999999997543322100 0111
Q ss_pred HHHHHhh-----------hhhhhhhccccCCCCCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 516 WVKKIHQ-----------EKKLEMLVDKDLKNNYD---------R--IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 516 ~~~~~~~-----------~~~~~~~~d~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+..+.. ........+......+. . ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000 00000000000000011 0 223568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.14 Aligned_cols=263 Identities=21% Similarity=0.243 Sum_probs=195.8
Q ss_pred cCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-------------hhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 304 SKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-------------GEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
..+.||+|+||+||+|... +++.||||.++...... ....+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999965 68999999986543221 012467899999999999999999999999
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+..++||||++ |+|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 99999999997 58999988777799999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCC-------------CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHH
Q 036225 450 LDHQD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515 (622)
Q Consensus 450 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~ 515 (622)
..... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||......+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 1111223467889999998764 468999999999999999999999875443222111111
Q ss_pred HHHHHhhhhhhhhh-------ccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 516 WVKKIHQEKKLEML-------VDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 516 ~~~~~~~~~~~~~~-------~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.............. ........ ........+.+++.+|++.+|++||+++|++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11100000000000 00000000 001124668899999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.93 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=213.6
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
..+++...++|.+.++||+|+||.|..+..+ +++.||+|++++... ......|..|-++|...+.+-|+.+.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 5677788899999999999999999999975 688999999976322 2334468899999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+.++|+||||++||+|..++.....++++-++.++..|..||.-||+. |+|||||||.|||+|..|++||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999999877899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccc----c-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLS----T-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
.+...+.-.....+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||+...-.+..+ .+...
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~-------KIm~h 296 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG-------KIMNH 296 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH-------HHhch
Confidence 88766665666778999999999984 2 578999999999999999999999998544322222 22222
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK---MSEVVRML 571 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~L 571 (622)
+..-.+ +. ....+++..+||.+.+. +|+.|-. +.++-.+-
T Consensus 297 k~~l~F-----P~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 297 KESLSF-----PD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhcCC-----Cc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 111111 10 11234667788877665 6777776 88887654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=300.14 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=207.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCch-hHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
...|.+...||+|.|+.|..|++. ++..||||.+.+...... ...+.+|++++..++|||||+++.+.+....+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788999999999999999964 689999999987643322 234789999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+.+|.+.+++.............++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++.++. ...
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGL 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--ccc
Confidence 9999999999998877777788999999999999999999 99999999999999999999999999999876 334
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...-.... +..+-..++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------~rvl~gk~r 273 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------------PRVLRGKYR 273 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------------chheeeeec
Confidence 4567789999999999998776 68999999999999999999999854422111 011111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.....++.+++++++-.+|.+|++++++.+.
T Consensus 274 --Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 --IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 112223567789999999999999999998753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.67 Aligned_cols=267 Identities=25% Similarity=0.311 Sum_probs=193.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCC------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------ 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 370 (622)
.++|++.+.||+|+||.||+|... +++.+|+|++....... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999965 68899999986543222 2335678999999999999999999875443
Q ss_pred --ceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccc
Q 036225 371 --ERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447 (622)
Q Consensus 371 --~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 447 (622)
..++|+||+.+ ++...+.. ...+++..+..++.|+++||.|||++ +|+|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 45899999975 66666543 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc----------eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH
Q 036225 448 KLLDHQDSH----------VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 448 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 516 (622)
......... ......++..|+|||.+.+. .++.++|||||||++|||++|++||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211 11234568889999987654 5789999999999999999999998644332211111111
Q ss_pred HHHHhh-----hhhhhhhcc----ccCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 517 VKKIHQ-----EKKLEMLVD----KDLKNNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 517 ~~~~~~-----~~~~~~~~d----~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...... ........+ ........ ......+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 000000000 00000000 011256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=292.95 Aligned_cols=244 Identities=30% Similarity=0.385 Sum_probs=192.1
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
|...+.||+|+||+||+|... +++.|++|.+...... .....+.+|+++++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 6889999998654322 2234678899999999999999999999999999999999
Q ss_pred ccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+. |++.+.+. ....+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 47776664 345689999999999999999999998 999999999999999999999999999864322
Q ss_pred eeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 458 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.....|+..|+|||++. ...++.++|||||||++|||++|..||...... .......... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~---------~ 237 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQND---------S 237 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcC---------C
Confidence 12345889999999984 456888999999999999999999998643211 1111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...........+.+++.+|++.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111123568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=289.36 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=196.4
Q ss_pred CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 305 KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
...||+|+||.||++..+ +++.||+|.+.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 357999999999999874 78999999886433 2344568899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecC
Q 036225 384 VASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463 (622)
Q Consensus 384 L~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 463 (622)
|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .......|
T Consensus 104 L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 104 LTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 99887543 579999999999999999999998 99999999999999999999999999987654322 22234568
Q ss_pred cccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHH
Q 036225 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543 (622)
Q Consensus 464 t~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 543 (622)
+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........ .....+.. ....+
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~------~~~~~~~~--~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRD------NLPPKLKN--LHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh------hCCcccCC--cccCC
Confidence 89999999998888999999999999999999999998643211 11111110 01111110 11123
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 544 EEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 544 ~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+.+++.+|++.+|.+||++.++++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 568899999999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=291.13 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=199.0
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|+..+.||+|+||.||+|... +++.||+|.++... .......+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999976 58999999987653 2223346778999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++......... .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 8 5899998765 5799999999999999999999999 9999999999999999999999999999866443221 2
Q ss_pred eeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhhhh--cccc
Q 036225 459 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLEML--VDKD 533 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~d~~ 533 (622)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........... ..... .+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223457789999998776 789999999999999999999988865432211111111100000000 00000 0000
Q ss_pred CCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNN-------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... ........+.+++.+|++.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 000114578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.40 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=198.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC-CCcee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PTERL 373 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~ 373 (622)
..+++|+..+.||+|+||.||+|... +++.||+|.+..... ......+..|++++..++|||++++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45778999999999999999999965 789999998865322 2234567789999999999999999998865 56788
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+++||+ +++|.++++.. .+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999998 56888887644 478888899999999999999999 9999999999999999999999999998754321
Q ss_pred CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHHhhhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKIHQEK 524 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 524 (622)
.....++..|+|||++.+ ..++.++||||||+++|+|+||+.||...........+.+ +........
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 123457889999998866 5689999999999999999999999865432111111111 111111111
Q ss_pred hhhhhccccCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLVDKDLKNNYDR-----IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......-......+. .....+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110000000111111 123678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.12 Aligned_cols=259 Identities=23% Similarity=0.253 Sum_probs=189.7
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCC-CCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
.+.+|.|+++.||++.. +++.||||+++.. ........+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34444555555555544 6899999998765 233344578999999999999999999999999999999999999999
Q ss_pred ccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC------
Q 036225 384 VASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS------ 455 (622)
Q Consensus 384 L~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~------ 455 (622)
|.+++.. ...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9998864 34588899999999999999999999 999999999999999999999999999875532211
Q ss_pred ceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh----hhh-----
Q 036225 456 HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH----QEK----- 524 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~----- 524 (622)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+...... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchhhh
Confidence 11123347788999999866 3588999999999999999999999975332110 111000000 000
Q ss_pred --hhhh----hcccc----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 --KLEM----LVDKD----LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 --~~~~----~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... ..+.. ...........++.+++.+||+.+|++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=275.71 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=197.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-----CeEEEEEEccCCCCCch-hHHHHHHHHHHhccccccceeeeeeeeC-CCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLYGFCMT-PTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~ 371 (622)
-..|+....||+|+||.||+|.-.+ ...+|+|.++......+ .....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999997432 23699999986643322 3357799999999999999999999887 778
Q ss_pred eeEEeeeccCCCcccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC----CceEEc
Q 036225 372 RLLVYPYMSNGSVASRLK-----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC----CEAVVG 442 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~ 442 (622)
.++++||.+. +|...++ ....++......|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999988 8887775 234688889999999999999999999 89999999999999876 999999
Q ss_pred ccccceecCCCCCce--eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccc--cHHHHH
Q 036225 443 DFGLAKLLDHQDSHV--TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKG--AMLDWV 517 (622)
Q Consensus 443 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~--~~~~~~ 517 (622)
|||+++.+...-... ...++-|..|+|||.+.+. .||++.|||+.|||+.||+|-++.|......-... ...+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999886543322 3456789999999999885 58999999999999999999987776433211111 111111
Q ss_pred HHH---hhhhhhhhhccc-----------cCC-CCCCHH-----------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 KKI---HQEKKLEMLVDK-----------DLK-NNYDRI-----------ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 ~~~---~~~~~~~~~~d~-----------~~~-~~~~~~-----------~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++ ...+....+.+- .++ ..+... .....++|+.+++..||.+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111 111111111100 000 000100 11236789999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.55 Aligned_cols=287 Identities=21% Similarity=0.279 Sum_probs=202.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-C--CeEEEEEEccCCCCC-chhHHHHHHHHHHhcc-ccccceeeeeeeeCC----Cc
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-D--GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP----TE 371 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~ 371 (622)
+|...+.||+|+||.||++... + +..||+|.+...... .....+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999965 3 778999998753222 2244678899999998 599999999975432 45
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++++||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678888886 68999888777899999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc---eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHH
Q 036225 452 HQDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKK 519 (622)
Q Consensus 452 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~ 519 (622)
..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. +...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32211 1223468999999998765 4689999999999999999999999875432111111111 0111
Q ss_pred Hhhhhh--hhhhccccCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHHHHhhhhhccCCCCC
Q 036225 520 IHQEKK--LEMLVDKDLKNNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPH 594 (622)
Q Consensus 520 ~~~~~~--~~~~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~ 594 (622)
+..... ............+ .......+.+++.+|++.+|.+|||+.|+++. .+-.+|+.+.. .+.+..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~----~~~~~~~~~~~-~~~~~~~~ 311 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH----PYLAIWHDPDD-EPVCQKPF 311 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC----hhhhhhcCccc-cccccccc
Confidence 000000 0000000000000 01123578899999999999999999998643 33455544222 22344444
Q ss_pred CC
Q 036225 595 EF 596 (622)
Q Consensus 595 ~~ 596 (622)
++
T Consensus 312 ~~ 313 (332)
T cd07857 312 DF 313 (332)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.07 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=191.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC------c
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------E 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 371 (622)
.+|...+.||+|+||.||+|... +|+.||+|+++.... ......+.+|+++++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888999999999999999964 689999999875432 222345788999999999999999999987543 4
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++|+||+.. +|.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5899999964 6666553 3588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH--------HHHHhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW--------VKKIHQ 522 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 522 (622)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... ......
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 169 AE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 22 123457889999999876 46889999999999999999999999754321111101000 000000
Q ss_pred hhhhhhhcc--ccC-CCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 EKKLEMLVD--KDL-KNNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~~~~~~~~d--~~~-~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........ +.. +.... ......+.+++.+|++.||.+||++++++..
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 245 -KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred -cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000 00000 0123567899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=284.62 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=194.6
Q ss_pred CCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCC----CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+|.+.+.||+|+||.||++.... +..+++|.++... .......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998653 4456666554321 222334577899999999999999999999999999999
Q ss_pred eeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999988774 345689999999999999999999998 9999999999999985 569999999997764
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... .......|+..|+|||...+..++.++||||||+++|+|++|..||.... ...........
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~-------- 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEG-------- 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcC--------
Confidence 322 22234458889999999988888999999999999999999999986322 11111111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+...+.++.+++.+|++.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111233445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=296.50 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=198.9
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
..++...+++|...+.||+|+||.||+|.. .+++.||+|+++... .......+.+|++++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566778999999999999999999985 478999999987542 222344677899999999999999999987543
Q ss_pred ------CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 370 ------TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 370 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3457788876 77898877654 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH-----
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV----- 517 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~----- 517 (622)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998754321 233457899999998866 468899999999999999999999986433221111111100
Q ss_pred ---HHHhhhh--hhhhhccccCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 ---KKIHQEK--KLEMLVDKDLKNNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 ---~~~~~~~--~~~~~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+.... .............+ .......+.+++.+|++.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000000000000 00123568899999999999999999988864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=253.56 Aligned_cols=265 Identities=20% Similarity=0.280 Sum_probs=198.8
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+|...++||+|.||+||+|.. ++++.||+|+++-... .+......+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999995 4689999999975433 33344678999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+. +|..+..+ +..++.+..+.++.|+++||.++|++ ++.|||+||.|.|++.+|+.|++|||+++.++-+.. .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-c 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence 965 77777653 45688899999999999999999999 999999999999999999999999999997764332 3
Q ss_pred eeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCc-cccchhccccccHHHHHHHHhhhhh--hhhhcccc
Q 036225 458 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRA-LEYGKAANQKGAMLDWVKKIHQEKK--LEMLVDKD 533 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~ 533 (622)
....+-|..|++|.++.+.. |+...|+||-||++.|+.....| |...+..++...+...+....++.+ +..+.|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 34455799999999998765 78889999999999999875555 4444444443333333322222222 22222222
Q ss_pred CCCCCCHHH---------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIE---------LEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~---------~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.-.-++... ...=.+++.+.+.-+|.+|.++++.++.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 222222111 1223567777888899999998877654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.31 Aligned_cols=237 Identities=28% Similarity=0.301 Sum_probs=194.9
Q ss_pred eeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCc
Q 036225 308 LGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSV 384 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 384 (622)
||+|+||.||++... +++.+|+|.+...... .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 5899999998765322 2344688999999999999999999999999999999999999999
Q ss_pred cccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCc
Q 036225 385 ASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464 (622)
Q Consensus 385 ~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 464 (622)
.+++.....+++.....++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 99998777899999999999999999999998 99999999999999999999999999998764432 123345588
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHH
Q 036225 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 544 (622)
Q Consensus 465 ~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 544 (622)
..|+|||...+...+.++|+||||+++|+|++|+.||..... ......... .. ...+...+.
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~---------~~--~~~~~~~~~ 218 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK---------DP--LRFPEFLSP 218 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc---------CC--CCCCCCCCH
Confidence 999999999888889999999999999999999999864332 111111111 00 111222246
Q ss_pred HHHHHHHHccCCCCCCCCCHHH
Q 036225 545 EMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 545 ~l~~li~~cl~~~p~~RPt~~e 566 (622)
.+.+++.+|+..||++||++++
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.12 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=192.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC---------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--------- 369 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------- 369 (622)
.+|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 689999999865543 3345688999999999999999999876543
Q ss_pred -----CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcc
Q 036225 370 -----TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGD 443 (622)
Q Consensus 370 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~D 443 (622)
...++||||++ ++|.+++... .+++.....++.||+.||.|||+. +|+||||||+||+++ +++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 35689999997 5888877643 588999999999999999999998 999999999999997 566789999
Q ss_pred cccceecCCCCCce--eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 444 FGLAKLLDHQDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 444 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
||++.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~---~~~~ 235 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI---LESV 235 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhc
Confidence 99998664322111 122357889999998754 56788999999999999999999999754332111111 0000
Q ss_pred hh--h---h----hhhhhcc-ccCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQ--E---K----KLEMLVD-KDLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~--~---~----~~~~~~d-~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. . . ....... .......+ .....++.+++.+|++.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0 0 0000000 00000000 1123568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=269.63 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=193.7
Q ss_pred HhCCCc-CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHh-ccccccceeeeeeeeC----CCc
Q 036225 299 THNFSS-KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLYGFCMT----PTE 371 (622)
Q Consensus 299 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~ 371 (622)
+++|.+ .++||-|-.|.|-.+..+ +|+.+|+|++.+.. ..++|+++-- .-.|||||.++++|.+ ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 445543 378999999999999865 79999999987643 3457887643 3469999999998864 456
Q ss_pred eeEEeeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEccccc
Q 036225 372 RLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGL 446 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl 446 (622)
+++|||.|+||.|.+.++++. .+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999997654 599999999999999999999999 999999999999996 467799999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
|+.... .......+-|+.|.|||++-...|+...|+||+||++|-|++|.+||...........+.. ++... .
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~---rI~~g-q- 283 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR---RIRTG-Q- 283 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh---Hhhcc-C-
Confidence 986443 2223445679999999999888899999999999999999999999985443222111111 11100 0
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
-.++..--...++...++|+..++.+|.+|-|+.+++.
T Consensus 284 -----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 -----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 00111111234567889999999999999999999984
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.16 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=197.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCc----
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE---- 371 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 371 (622)
..++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999975 588999999865321 2233457789999999999999999998776554
Q ss_pred --eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 372 --RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 372 --~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 5699888875 3589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HHHHH
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WVKKI 520 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~ 520 (622)
.... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...........+.+ +....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5432 223457889999999865 3678999999999999999999999975432211111111 00000
Q ss_pred hhhhhhhhhcc---ccCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 521 HQEKKLEMLVD---KDLKNNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 521 ~~~~~~~~~~d---~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... .....+. ...+..+. .....++.+++.+|+..+|++|||+.|+++.
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 0000000 00000010 1124678999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.38 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=195.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC-----
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT----- 370 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 370 (622)
..++|+..+.||+|+||.||+|... +|+.||||+++.... ......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3567889999999999999999854 789999999864322 222346789999999999999999999887553
Q ss_pred -ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 371 -ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 371 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 6788887764 4589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHH--------HHHHHH
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML--------DWVKKI 520 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~ 520 (622)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+. .+...+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 5322 123457889999999876 458899999999999999999999987443211100000 111111
Q ss_pred hhhhhhhhhcc--ccCC-CC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 521 HQEKKLEMLVD--KDLK-NN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 521 ~~~~~~~~~~d--~~~~-~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.... ...... +... .. ........+.+++.+|++.||++|||+.++++
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000 0000 00 00112346889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=277.50 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=213.8
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeee
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 365 (622)
..++.+..++++...++-+|.||.||.|.|.+ .+.|-+|.++....+-+...+..|.-.+..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45677788889989999999999999997643 456788888876655555568888888888999999999999
Q ss_pred eeC-CCceeEEeeeccCCCcccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 036225 366 CMT-PTERLLVYPYMSNGSVASRLK--------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC 436 (622)
Q Consensus 366 ~~~-~~~~~lv~e~~~~gsL~~~l~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~ 436 (622)
+.+ ....+.+|.++.-|+|..+|. ..+.++..+...++.|++.|++|||++ +|||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 466789999999999999986 123577778889999999999999999 99999999999999999
Q ss_pred CceEEcccccceecCCCCCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHH
Q 036225 437 CEAVVGDFGLAKLLDHQDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAML 514 (622)
Q Consensus 437 ~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~ 514 (622)
-++||+|=.+++.+-+.+++.- .....+..||+||.+.+..|+..+|||||||++|||+| |+.|+..-++.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------- 505 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------- 505 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------
Confidence 9999999999998876666543 33446789999999999999999999999999999998 77776532211
Q ss_pred HHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 515 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 515 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+....+-..+.+++++++.++.-||..+|++||+++|++.-|.+
T Consensus 506 ----------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 ----------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111222222355688999999999999999999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=314.28 Aligned_cols=146 Identities=30% Similarity=0.409 Sum_probs=132.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||+||+|... +++.||||+++..... .....+..|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999976 6899999999754322 22346888999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
||+.+++|.+++.....+++..++.|+.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998777789999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=271.42 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=197.1
Q ss_pred CeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
++||+|+|+.|--++ ..+|..+|||++.+. ......++.+|++++... .|+||+.++++|+++...|||||-|.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 679999999999988 678999999999765 334455788999999888 49999999999999999999999999999
Q ss_pred ccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEcccccceecCCCC------
Q 036225 384 VASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFGLAKLLDHQD------ 454 (622)
Q Consensus 384 L~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~~------ 454 (622)
|..+++....+++.++.++..+|+.||.|||.+ ||.||||||+|||-.+... +|||||.+..-.....
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999999999999999999999999999999 9999999999999976544 7999999875432111
Q ss_pred CceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhcccc---c-cHHHHHHHHhhhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK---G-AMLDWVKKIHQEKK 525 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~---~-~~~~~~~~~~~~~~ 525 (622)
...-...+|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||...-..+.. + .-.. -+..-
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~-----CQ~~L 314 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV-----CQNKL 314 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH-----HHHHH
Confidence 11223456889999999863 345889999999999999999999999854332221 0 0000 11111
Q ss_pred hhhhccccCCCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 526 LEMLVDKDLKNNYDRI----ELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~----~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.+.+... .++.. ...+..+++...+..++.+|-++.+++.
T Consensus 315 FesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122222211 12322 2356778899999999999999998876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=274.46 Aligned_cols=220 Identities=20% Similarity=0.199 Sum_probs=177.5
Q ss_pred cCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCcccccc
Q 036225 311 GGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK 389 (622)
Q Consensus 311 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 389 (622)
|.||.||++... +++.||+|+++... .+..|...+....|||++++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 68999999987543 23345555556679999999999999999999999999999999987
Q ss_pred CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccC
Q 036225 390 GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469 (622)
Q Consensus 390 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 469 (622)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 777799999999999999999999998 9999999999999999999999999988655432 122345778999
Q ss_pred ccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHH
Q 036225 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQV 549 (622)
Q Consensus 470 PE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 549 (622)
||.+.+..++.++||||+|+++|||++|+.|+........ ......+ +......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~~~~~----~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THTTLNI----PEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------cccccCC----cccCCHHHHHH
Confidence 9999888899999999999999999999987653211000 0000011 11223568899
Q ss_pred HHHccCCCCCCCCCHH
Q 036225 550 ALLCTQYLPAHRPKMS 565 (622)
Q Consensus 550 i~~cl~~~p~~RPt~~ 565 (622)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=274.78 Aligned_cols=264 Identities=21% Similarity=0.260 Sum_probs=199.9
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-c-cc----ceeeeeeeeCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-H-RN----LLRLYGFCMTP 369 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H-~n----iv~l~~~~~~~ 369 (622)
..+.+|.+...+|+|.||.|-++.++ .+..||||+++.-.. ..+..+-|++++.++. + |+ +|.+.+++.-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 44778999999999999999999965 478999999975432 2334667999999984 2 22 78888999999
Q ss_pred CceeEEeeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-------------
Q 036225 370 TERLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD------------- 434 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~------------- 434 (622)
++.++|+|.+ |-|+.+++..+. +++..+++.++.|++++++|||+. +++|-||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999998 569999998644 578899999999999999999999 999999999999983
Q ss_pred -------CCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhc
Q 036225 435 -------DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAA 507 (622)
Q Consensus 435 -------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~ 507 (622)
++..++|+|||.|.+-... ....+.|..|+|||++.+-.++.++||||+||||+|++||...|+..++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1345899999999865432 25567899999999999999999999999999999999999999876643
Q ss_pred cccccHHHHHHHHhhh----hhhhh-----hcc---ccCCC----------------CCCHHHHHHHHHHHHHccCCCCC
Q 036225 508 NQKGAMLDWVKKIHQE----KKLEM-----LVD---KDLKN----------------NYDRIELEEMVQVALLCTQYLPA 559 (622)
Q Consensus 508 ~~~~~~~~~~~~~~~~----~~~~~-----~~d---~~~~~----------------~~~~~~~~~l~~li~~cl~~~p~ 559 (622)
+....+...++++... ...++ -+| ....+ .....+..++++|+.+|+..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3321111111110000 00000 000 00000 01123446799999999999999
Q ss_pred CCCCHHHHHHH
Q 036225 560 HRPKMSEVVRM 570 (622)
Q Consensus 560 ~RPt~~evl~~ 570 (622)
+|+|+.|++..
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=291.45 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=195.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+++|.....+|.|+|+.|-.+... +++..++|++.+... +-.+|+.++... .|||++++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 566777788999999999999854 688899999976522 223566555544 7999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|.+.++-+.+.+...+... ..+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999988887666555 77788999999999999998 99999999999999 58999999999999876543
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
....+-|..|.|||++....|++.+|+||||++||+|++|+.||...... .+....+ ..
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i-------------~~ 528 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRI-------------QM 528 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhh-------------cC
Confidence 22234588999999999999999999999999999999999999754422 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.+....+....+|+.+||+.||.+||+|.++...
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22234445778899999999999999999998754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.50 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=195.0
Q ss_pred CCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCC
Q 036225 305 KNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
.++||+|.||+||-|++ ++|+.||||++.+... ..++.++++|+.+|..++||.||.+...|+.++..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999996 4799999999976543 344567999999999999999999999999999999999999654
Q ss_pred Ccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccceecCCCCCcee
Q 036225 383 SVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 383 sL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
=|.-.|. ++..+++.....++.||+.||.|||.+ +|+|+||||+|||+.. -.++||||||+|+++++. ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--hhh
Confidence 3444443 456788888889999999999999999 9999999999999964 457999999999998743 345
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
..++||+.|+|||++.+..|+..-|+||.||++|--++|..||..+.+.. +.+.. ..-++ +...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn------dQIQN------AaFMy----Pp~P 787 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN------DQIQN------AAFMY----PPNP 787 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh------HHhhc------ccccc----CCCc
Confidence 67889999999999999999999999999999999999999997433211 11110 00011 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
-.+......++|...++..-.+|-+.+.-+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2233456788999999999999988876653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=275.23 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=201.9
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchh--HHHHHHHHHHhcc-ccccceeeeeeeeCCCc
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA-VHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 371 (622)
++...+|....+||+|+||.|.+|..+ +.+.+|||++++....++. +--+.|-++|+.. +-|.++.+...+...+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455567888999999999999999865 4678999999877543322 2234677777766 46789999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
+|+||||+.||+|--.+++-..+.++.+..++.+||-||-+||++ +|++||||..|||+|.+|++||+|||+++.--
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999999999888899999999999999999999999 99999999999999999999999999997422
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
-+...+..++||+.|+|||++...+|+..+|.|||||+||||+.|++||+..+..+.... +.+
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----------------I~e 564 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----------------IME 564 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------------HHH
Confidence 233445678999999999999999999999999999999999999999987654322111 111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPK 563 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 563 (622)
.. -.|+..-+.+...+....+...|.+|..
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 1244444567788888899999999963
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.21 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=200.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchh------HHHHHHHHHHhccccccceeeeeeee-
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLYGFCM- 367 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~H~niv~l~~~~~- 367 (622)
....++|-..++||+|+|++||+|.+ ...+.||||+-.......++ +...+|.++-+.+.||.||++|+|+.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34455677788999999999999994 56788999987544333222 23568999999999999999999986
Q ss_pred CCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEccc
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDF 444 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Df 444 (622)
+.+.++-|.|||+|.+|.-+|+....+++.+++.|+.||+.||.||.+. +++|||-||||.|||+. ..|.+||.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 4567789999999999999999988999999999999999999999987 77999999999999995 5688999999
Q ss_pred ccceecCCCCCc------eeeeecCcccccCccccccC----CCCcccceeehhHHHHHHHhcCCccccchhccccccHH
Q 036225 445 GLAKLLDHQDSH------VTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML 514 (622)
Q Consensus 445 gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~ 514 (622)
|+++.+...... .+....||..|++||.+.-+ ..+.|+||||.||++|..+.|+.||....... .++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dIL 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DIL 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHH
Confidence 999988643222 24456799999999987533 46889999999999999999999997432211 111
Q ss_pred HHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 515 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 515 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+...+...- ...-...+....+...+|++|+++..++|....++..
T Consensus 695 -------qeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 -------QENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------hhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111100 0011111223456788999999999999988777653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-34 Score=264.57 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=196.4
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccC-CCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--------C
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKD-GNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--------T 370 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~ 370 (622)
.|....+||+|.||+||+|..+ +|+.||+|++-- ....+-.....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999965 577889886532 22233334567899999999999999999988642 3
Q ss_pred ceeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 371 ERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
..++||++|+. +|.-+|... ..++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 47899999987 888888754 5789999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCCCc---eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 450 LDHQDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 450 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
+...+.. ..++.+-|..|++||.+.+. .|+++.|||.-||++.||+||.+.+.......+...+......+..+-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6533221 23445569999999998875 5899999999999999999999888765544332222222221111100
Q ss_pred --------hhhhccccCC-CCCCH--------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 --------LEMLVDKDLK-NNYDR--------IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 --------~~~~~d~~~~-~~~~~--------~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.+-.+.+. +.+.. ....+..+|+.+++..||.+|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0000000010 11110 012367799999999999999999998853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=292.07 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=205.0
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee--
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM-- 367 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~-- 367 (622)
++.+...++-|.+.++||+|.+|.||+++. ++++.+|+|+....... ++++..|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 444455677889999999999999999994 57999999987755433 34566788888876 6999999999986
Q ss_pred ---CCCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 036225 368 ---TPTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG 442 (622)
Q Consensus 368 ---~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 442 (622)
.++++|||||||.+||..|++++ ...+.|+.+..|+..+++|+.+||.. .++|||||-.|||++.++.+|+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 35789999999999999999874 45789999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCceeeeecCcccccCccccccC-----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
|||.+..+..... ......||+.|||||++... .|+.++|+||||++..||--|.+|+....+... +
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------L 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------L 237 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------h
Confidence 9999987754332 33455699999999998543 467899999999999999999999864332111 1
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
-.+.+ ++...-.-+.....++.+.|..|+..|-++||++.++++
T Consensus 238 F~IpR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01111 111111123455678999999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=250.06 Aligned_cols=205 Identities=25% Similarity=0.365 Sum_probs=173.1
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHh-ccccccceeeeeeeeCCCce
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~ 372 (622)
+++..+++.....||+|+||.|-+-.+ ++|+..|+|+++.....+.+.+...|+++.. ...+|.+|.+||.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455566667778899999999988874 5899999999987766666778888998755 45799999999999999999
Q ss_pred eEEeeeccCCCccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRL----KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
++.||.|+. ||..+. +....+++..+-+|+..+..||.|||++. .++|||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999964 776543 46677899999999999999999999985 89999999999999999999999999997
Q ss_pred ecCCCCCceeeeecCcccccCcccccc----CCCCcccceeehhHHHHHHHhcCCccccc
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
.+.+ +-..+.-.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++..
T Consensus 198 ~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 7643 222333458889999998853 36899999999999999999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=295.25 Aligned_cols=259 Identities=18% Similarity=0.232 Sum_probs=170.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-C----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeee------e
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF------C 366 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~ 366 (622)
..++|...+.||+|+||.||+|.+. + +..||+|+++.... ...+..| .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999975 4 68999998764321 1111111 1122222222222221 2
Q ss_pred eCCCceeEEeeeccCCCccccccCCCC--------------------CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKGKPI--------------------LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 426 (622)
......++||||+.+++|.++++.... .....+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 456778999999999999988864321 11234567999999999999998 9999999
Q ss_pred CCCCeeecC-CCceEEcccccceecCCCCCceeeeecCcccccCccccccC----------------------CCCcccc
Q 036225 427 KAANILLDD-CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD 483 (622)
Q Consensus 427 k~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 483 (622)
||+|||+++ ++.+||+|||+|+.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 68999999999987654444444556789999999965322 2345679
Q ss_pred eeehhHHHHHHHhcCCccccchhc------cccccHHHHHHHHhhhhhhhhhccccCCCCCC--HHHHHHHHHHHHHccC
Q 036225 484 VFGFGILLLELITGQRALEYGKAA------NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD--RIELEEMVQVALLCTQ 555 (622)
Q Consensus 484 vwslGv~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~ 555 (622)
||||||++|||+++..++...... ........|....... ..+.+...+. ........+|+.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999976554321000 0000111222111100 0000000000 0011235589999999
Q ss_pred CCCCCCCCHHHHHHH
Q 036225 556 YLPAHRPKMSEVVRM 570 (622)
Q Consensus 556 ~~p~~RPt~~evl~~ 570 (622)
.||++|||++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.70 Aligned_cols=239 Identities=28% Similarity=0.347 Sum_probs=194.4
Q ss_pred CCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCccccccC
Q 036225 312 GFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG 390 (622)
Q Consensus 312 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 390 (622)
+||.||+|... +|+.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997665443256789999999999999999999999999999999999999999999876
Q ss_pred CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCc
Q 036225 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470 (622)
Q Consensus 391 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 470 (622)
...+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 66689999999999999999999998 99999999999999999999999999998765432 23345588899999
Q ss_pred cccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHH
Q 036225 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 550 (622)
Q Consensus 471 E~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 550 (622)
|...+..++.++||||||+++++|++|..||...... ..+.++... .... . .........++.+++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~---~~~~-----~---~~~~~~~~~~~~~~i 221 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGK---PKPP-----F---PPPEWKISPEAKDLI 221 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhc---cCCC-----C---ccccccCCHHHHHHH
Confidence 9998888999999999999999999999998642111 111111111 0000 0 000000336788999
Q ss_pred HHccCCCCCCCCCHHHHHH
Q 036225 551 LLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 551 ~~cl~~~p~~RPt~~evl~ 569 (622)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=281.69 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=207.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCe-EEEEEEccCCCCC--chhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGT-VVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.-.++..+..||-|+||.|-.+..+... .+|+|.+++.... .+++.+..|-+++...+.|.||++|.-|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3445666778999999999999876433 4899988765432 334457789999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+||-|-||.|...|..++.++..+...++..+.+|++|||++ +||+|||||+|.++|.+|.+||.|||+|+.+...
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 999999999999999999999999999999999999999999 9999999999999999999999999999987643
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
..+-.++||+.|.|||++.+..++..+|.||||+++|||+||.+||...++-.....++.-+..
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------------- 637 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------------- 637 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------------
Confidence 3345678999999999999999999999999999999999999999865542222212111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
-.+++.......+++++.+..+|.+|.. +.++-++
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1133334456789999999999999975 5555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=258.72 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=204.9
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
...++|+..++||+|+|+.|..+.+. +.+.+|+|++++....+ +..-.+.|-.+..+. +||.+|.+...+..+...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34568899999999999999999964 67899999998753222 222356777777765 799999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++|.||++||+|--+++....++++.++.+...|..||.|||+. |||+||||..|||+|..|++|+.|+|+++.--
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-
Confidence 99999999999999999999999999999999999999999999 99999999999999999999999999997532
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.....+..++||+.|.|||++.+..|...+|.|++||+++||+.|+.||+.-...+.....-+++-++.-++.+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 23344667889999999999999999999999999999999999999998544333333333444433322221
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRP 562 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 562 (622)
+ .++........+++.-+.+||++|.
T Consensus 477 --r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 2223334566788889999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=284.16 Aligned_cols=261 Identities=20% Similarity=0.218 Sum_probs=181.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEE-----------------CCCeEEEEEEccCCCCCc-------------hhHHHHH
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGIL-----------------QDGTVVAVKRLKDGNAIG-------------GEIQFQT 346 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~ 346 (622)
...++|++.++||+|+||+||+|.. .+++.||||+++...... .......
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3577899999999999999999964 235689999986432111 1112345
Q ss_pred HHHHHhccccccc-----eeeeeeeeC--------CCceeEEeeeccCCCccccccCC----------------------
Q 036225 347 EVEMISLAVHRNL-----LRLYGFCMT--------PTERLLVYPYMSNGSVASRLKGK---------------------- 391 (622)
Q Consensus 347 e~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~---------------------- 391 (622)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++..
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766654 677888753 35679999999999998887531
Q ss_pred --CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccC
Q 036225 392 --PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469 (622)
Q Consensus 392 --~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 469 (622)
..++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1346788899999999999999998 99999999999999999999999999997654322211122234789999
Q ss_pred ccccccCC--------------------C--CcccceeehhHHHHHHHhcCC-ccccchhccc-----cccHHHHHHHHh
Q 036225 470 PEYLSTGQ--------------------S--SEKTDVFGFGILLLELITGQR-ALEYGKAANQ-----KGAMLDWVKKIH 521 (622)
Q Consensus 470 PE~~~~~~--------------------~--~~~sDvwslGv~l~el~tg~~-p~~~~~~~~~-----~~~~~~~~~~~~ 521 (622)
||.+.... + ..+.||||+||++|||++|.. |+......+. ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 134799999999999999875 5542111100 011112211100
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLP---AHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~ 570 (622)
.. .+- ...........+++.+++..+| .+|+|++|++++
T Consensus 459 ~~------~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK------YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC------CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 000 0111224668899999999766 689999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=253.82 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=202.8
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC-----CceeE
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TERLL 374 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~l 374 (622)
.+-.+.||-|+||.||.+.+ ++|+.||.|++..-. .-...+.+-+|++++..++|.|++..+++..-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34567899999999999996 489999999875321 122344678999999999999999988876543 34578
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
++|.|.. +|.+.+-+...++-+...-+.+||++||+|||+. +|.||||||.|.|++.+...||||||+++.....+
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8898854 8888888888899999999999999999999999 99999999999999999999999999999877666
Q ss_pred CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH--------Hhhhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK--------IHQEKK 525 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 525 (622)
....+..+-|..|+|||++++. .|+...||||.||++.||+..+..|....+..+...+.+.+.. .-+..+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 6556666789999999999885 5899999999999999999888888765554444433333221 111111
Q ss_pred hhhhccccCCCCCC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 526 LEMLVDKDLKNNYD--------RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 526 ~~~~~d~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.+.+-.+.-...++ .....+...+..+++..||++|.+.++.+..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111110011111 112245667888899999999999999987664
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=273.22 Aligned_cols=218 Identities=23% Similarity=0.346 Sum_probs=184.1
Q ss_pred hCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.-|..++.||-|+||+|.++. .++...+|.|.+++..... .....+.|-+||.....+-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347788999999999999998 4557789999987643221 2224678999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC-----
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD----- 451 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~----- 451 (622)
+|++||++-.+|-..+.++++.++.++.++..|+++.|.. |+|||||||.|||||.+|++||.|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999984331
Q ss_pred ----CCC-----C---------------------------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHH
Q 036225 452 ----HQD-----S---------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495 (622)
Q Consensus 452 ----~~~-----~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~ 495 (622)
..+ + ......+||+.|+|||++....|+.-+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000 0 0011345999999999999999999999999999999999
Q ss_pred hcCCccccchhccccccHHHHHHHH
Q 036225 496 TGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 496 tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
.|+.||-.....+....+..|-..+
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l 890 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFL 890 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhcc
Confidence 9999998777666666666775543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-31 Score=278.14 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=186.7
Q ss_pred CCcCCeeeecCCce-EEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeec
Q 036225 302 FSSKNILGKGGFGI-VYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 302 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
|...+++|.|+.|+ ||+|.++ |+.||||++-... ....++|+..|..- +|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44567889999985 8999997 7899999986432 22467899998877 5999999999999999999999999
Q ss_pred cCCCccccccCC-C---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceEEcccccceec
Q 036225 380 SNGSVASRLKGK-P---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-----CCEAVVGDFGLAKLL 450 (622)
Q Consensus 380 ~~gsL~~~l~~~-~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~ 450 (622)
. .+|.+++... . ...-...+.+..|++.||+|||+. +||||||||.||||+. ...++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 4999998763 1 111134467889999999999997 9999999999999975 257899999999988
Q ss_pred CCCCCcee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHhc-CCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 451 DHQDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
....+... ....||-+|+|||.+....-+..+||||+||++|..+|| .+||...... ...++ .....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl------~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANIL------TGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhh------cCcccee
Confidence 76554433 355699999999999998888899999999999999997 8898643211 11111 0111110
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. +... .+ .+..+||.+|+..+|..||++.+|+.+
T Consensus 734 ~-----L~~~--~d--~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 H-----LEPL--PD--CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e-----eccC--ch--HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 1111 11 167899999999999999999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=234.62 Aligned_cols=258 Identities=18% Similarity=0.300 Sum_probs=195.0
Q ss_pred HhCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCC--CceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTP--TERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~l 374 (622)
.++|++.+.+|+|.|++||.|. ..+.+.++||+++.- ..+.+.+|+.+|..+. ||||+++++...++ ....|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678889999999999999999 457889999998743 3456889999999997 99999999998775 45679
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~ 453 (622)
|+||+.+.+...+. +.++.-.+..++.+++.||.|+|++ ||.|||+||.|+++| +.-.++|+|+|+|.++...
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999987766554 3567778889999999999999999 999999999999999 4567999999999987654
Q ss_pred CCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh-----------
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH----------- 521 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 521 (622)
... .-.+.+..|..||.+..- .|+-.-|+|||||++..|+..+.||..+... ..+++..++-+.
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN--~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC--HHHHHHHHHHhChHHHHHHHHHH
Confidence 332 223467889999998654 5777889999999999999999999865532 122222222111
Q ss_pred ---hhhhhhhhccccCCCCCC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 ---QEKKLEMLVDKDLKNNYD--------RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ---~~~~~~~~~d~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
-......++....+.... ....++..+++.+.+..|..+|||++|...+
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111112222211111100 1123678899999999999999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=236.71 Aligned_cols=210 Identities=36% Similarity=0.527 Sum_probs=184.2
Q ss_pred eeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCccc
Q 036225 308 LGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 386 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 386 (622)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998865433234578899999999999999999999999999999999999999999
Q ss_pred cccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccccceecCCCCCceeeeecCc
Q 036225 387 RLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464 (622)
Q Consensus 387 ~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 464 (622)
++... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98765 4689999999999999999999999 9999999999999999 89999999999987654321 12334578
Q ss_pred ccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHH
Q 036225 465 VGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543 (622)
Q Consensus 465 ~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 543 (622)
..|++||..... .++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999877 788999999999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 544 EEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 544 ~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=261.44 Aligned_cols=196 Identities=24% Similarity=0.335 Sum_probs=170.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchh-------HHHHHHHHHHhccc---cccceeeeeeeeCC
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGE-------IQFQTEVEMISLAV---HRNLLRLYGFCMTP 369 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-------~~~~~e~~~l~~l~---H~niv~l~~~~~~~ 369 (622)
+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-.+. -.+-.|+++|..++ |+||++++.+|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788999999999999999976 4678999998765321111 02456999999887 99999999999999
Q ss_pred CceeEEeeec-cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 370 TERLLVYPYM-SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 370 ~~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+.++++||-. ++.+|.+++.-++.+++.....|+.||+.|+++||++ +|||||||-+||.++.+|.+||+|||.|.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence 9999999975 5778999999999999999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccc
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
.... .....++||..|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 719 ~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6543 23345679999999999988877 566799999999999999888875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=249.30 Aligned_cols=131 Identities=24% Similarity=0.312 Sum_probs=110.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-----cc---cceeeeeeee--
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HR---NLLRLYGFCM-- 367 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H~---niv~l~~~~~-- 367 (622)
..+|.+.++||.|.|++||++.+ ++.+.||+|+.+... ...+....||++|++++ |+ .||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 36788999999999999999995 578899999987643 33445678999998874 33 5999999986
Q ss_pred --CCCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 036225 368 --TPTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434 (622)
Q Consensus 368 --~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~ 434 (622)
.+.+.+||+|++ |.+|..++.. ...++....++|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 456889999999 6688888863 456899999999999999999999999 999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=263.15 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=202.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..++|...+.+|.|+||.|||+++ ..++..|+|+++-... ++...+++|+-+++..+|+||+.++|.+...+..+++|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 356788999999999999999995 4789999999986543 22335678999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|||.+|+|.+..+...++++.++..+++...+|++|||++ +-+|||||-.|||+++.|.+|++|||.+-.+... -.
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 9999999999999888999999999999999999999999 8899999999999999999999999998765432 22
Q ss_pred eeeeecCcccccCcccc---ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 VTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
....+.||+.|||||+. ..+.|+.++|||+.|+...|+---++|.+...+... +.-..+...+. ..+-|+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---l~LmTkS~~qp---p~lkDk- 240 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---LFLMTKSGFQP---PTLKDK- 240 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---HHHhhccCCCC---CcccCC-
Confidence 34567799999999976 567799999999999999999877777553221100 00000000000 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
....+.+-++++.|+..+|++||+++.+++
T Consensus 241 ------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 ------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112356778999999999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=240.29 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=195.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCC------Cc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 371 (622)
.+|...+.+|.|.- .|..+.+. .+++||+|...... .....++..+|...+..+.|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34666777888887 66666643 58899999875432 122344677899999999999999999998533 45
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++|||+|+. +|...+. -.++-.+...|..|++.|++|||+. +|+||||||+||++..++.+||.|||+|+...
T Consensus 96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 6899999964 8887776 3478889999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH--------HHHhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV--------KKIHQE 523 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 523 (622)
. ....+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+..++-..+.+.. .++...
T Consensus 170 ~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 T--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred c--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 2 245677889999999999999889999999999999999999998887544333322222111 111000
Q ss_pred h--------------hhhhhccccCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 K--------------KLEMLVDKDLKNN--YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~--------------~~~~~~d~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. .-+.+.|..++.. .++.......+++.+||..+|++|-++++++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0011111111111 112234567899999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=231.13 Aligned_cols=270 Identities=19% Similarity=0.291 Sum_probs=198.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHH-Hhccccccceeeeee-eeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM-ISLAVHRNLLRLYGF-CMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~-~~~~~~~~lv 375 (622)
.+.|.+.+.+|+|.||.+-++.++ +.+.+++|.+.... ....+|.+|... +..-.|.||+.-|+. |+..+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 456888999999999999999975 57889999887653 335678899875 444479999988775 6677888899
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEcccccceecCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~ 453 (622)
+||++.|+|.+.+...+ +.+....+++.|++.|++|+|++ ++||||||.+|||+- +..++|+||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999999887643 67888899999999999999999 999999999999993 4568999999998754321
Q ss_pred CCceeeeecCcccccCccccccC-----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
-....-+..|.+||..... ...+.+|||.||+++|.++||+.||+.... .......|.....+..
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~--~d~~Y~~~~~w~~rk~---- 246 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI--MDKPYWEWEQWLKRKN---- 246 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--cCchHHHHHHHhcccC----
Confidence 1223356789999976432 246788999999999999999999983322 2234445544332211
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHHHHhhhhhc
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEA 588 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~ 588 (622)
+.++..+.+ -.+.+.++.++-+..+|++|-...++.++....+......-+++.+.
T Consensus 247 ---~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee 302 (378)
T KOG1345|consen 247 ---PALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEE 302 (378)
T ss_pred ---ccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhh
Confidence 111111221 12567889999999999999777777776654444333333333333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=234.89 Aligned_cols=199 Identities=31% Similarity=0.454 Sum_probs=173.5
Q ss_pred CCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 889999999765433245578899999999999999999999999999999999999
Q ss_pred CCCccccccCCCC-CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 381 NGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 381 ~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
+++|.+++..... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999986655 89999999999999999999998 9999999999999999999999999999877544311223
Q ss_pred eecCcccccCcccc-ccCCCCcccceeehhHHHHHHHhcCCcccc
Q 036225 460 AVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRALEY 503 (622)
Q Consensus 460 ~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~el~tg~~p~~~ 503 (622)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 44578899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=247.78 Aligned_cols=205 Identities=22% Similarity=0.237 Sum_probs=171.0
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc------cccceeeee
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV------HRNLLRLYG 364 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~ 364 (622)
+.-.+.....|.+.-..|+|-|++|..|..+ -|+.||||++...... .+.=+.|+++|+++. --++++++.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3334456778888899999999999999965 4789999999865432 223457999999985 247999999
Q ss_pred eeeCCCceeEEeeeccCCCccccccC---CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceE
Q 036225 365 FCMTPTERLLVYPYMSNGSVASRLKG---KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAV 440 (622)
Q Consensus 365 ~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~k 440 (622)
.|...+++|||||-+. .+|.+.|+. +-.|.......++.|+..||..|-.. +|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence 9999999999999884 489999874 33588889999999999999999887 99999999999999864 5679
Q ss_pred EcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccch
Q 036225 441 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGK 505 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~ 505 (622)
|||||.|.....+. .+.+.-+..|.|||++.+.+|+...|+||.||.||||+||+..|.+..
T Consensus 578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99999998765432 334456788999999999999999999999999999999999987544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=236.40 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=196.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPT 370 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 370 (622)
....+.|..+++||+|.|++||++.+. .++.||+|.+.....+ ..+..|+++|..+ .+.||+++.+.+..++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 344566888999999999999999854 3678999998765433 3578999999888 5999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEccccccee
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKL 449 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~ 449 (622)
...+|+||+++....+++.+ ++...+..++..+..||.++|++ |||||||||+|+|.+ ..+.-.|.|||+|..
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999888888764 56888999999999999999999 999999999999998 567789999999962
Q ss_pred cCC---------------------------------C----------CCceeeeecCcccccCcccccc-CCCCccccee
Q 036225 450 LDH---------------------------------Q----------DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVF 485 (622)
Q Consensus 450 ~~~---------------------------------~----------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvw 485 (622)
... . .........||++|+|||++.. ...++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 100 0 0001123459999999999865 4568899999
Q ss_pred ehhHHHHHHHhcCCccccchhccccccHHHHHHHHh---------hhhh---------------------hh-hhccc-c
Q 036225 486 GFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH---------QEKK---------------------LE-MLVDK-D 533 (622)
Q Consensus 486 slGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~---------------------~~-~~~d~-~ 533 (622)
|.||+++-+++++.||...... ...+.+.+.... ..+. +. +.+.+ +
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eccceeehhhccccccccCccc--cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999854432 222222111100 0000 00 00000 0
Q ss_pred ---C-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 036225 534 ---L-KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 534 ---~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 571 (622)
. ........+..+++++.+|+..+|.+|.|++|.|++-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 0001111234688999999999999999999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=267.65 Aligned_cols=194 Identities=15% Similarity=0.149 Sum_probs=139.2
Q ss_pred cccc-ccceeeeeee-------eCCCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeee
Q 036225 353 LAVH-RNLLRLYGFC-------MTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423 (622)
Q Consensus 353 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 423 (622)
.++| +||+++++++ ......+.++||+ +++|.+++.. ...+++.++..++.||++||.|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4455 6888888877 2234567788887 5599999964 45689999999999999999999998 9999
Q ss_pred cCCCCCCeeecC-------------------CCceEEcccccceecCCCC---------------CceeeeecCcccccC
Q 036225 424 RDVKAANILLDD-------------------CCEAVVGDFGLAKLLDHQD---------------SHVTTAVRGTVGHIA 469 (622)
Q Consensus 424 ~Dlk~~NILl~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y~a 469 (622)
|||||+||||+. ++.+|++|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 4556677777765421100 000112357889999
Q ss_pred ccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHH
Q 036225 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQV 549 (622)
Q Consensus 470 PE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 549 (622)
||++.+..++.++|||||||++|||++|..|+.... .....+.. ....+.. ........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~-----~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRH-----RVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHH-----hhcChhh-----hhcCHHHHHH
Confidence 999999999999999999999999999988764211 01111100 0011100 0112345678
Q ss_pred HHHccCCCCCCCCCHHHHHH
Q 036225 550 ALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 550 i~~cl~~~p~~RPt~~evl~ 569 (622)
+.+||+.+|.+||++.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 89999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=208.29 Aligned_cols=165 Identities=19% Similarity=0.187 Sum_probs=124.9
Q ss_pred CCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 382 GSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 382 gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
|+|.++++. ...+++..+..|+.||+.||.|||++ + ||+|||+++++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 688888875 45699999999999999999999998 5 999999999999999 99998764322
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+..+....... ++... ....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~~~~-~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD-------DPRDR-SNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC-------Ccccc-ccHH
Confidence 258999999999999999999999999999999999999986432111 1111111111100 00000 0111
Q ss_pred HHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 541 IEL--EEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 541 ~~~--~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... ..+.+++.+|+..+|.+||++.|+++++..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 122 268999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=220.34 Aligned_cols=177 Identities=20% Similarity=0.212 Sum_probs=135.8
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC--CCeEEEEEEccCCC----CCchhHHHHHHHHHHhcccccccee-eeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ--DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLR-LYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~ 367 (622)
.....++|...+.||+|+||+||+|.+. +++.||||++.... .......+.+|++++++++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455678999999999999999999864 57888999875331 1122446899999999999999985 4432
Q ss_pred CCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeecCCCceEEccccc
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgl 446 (622)
+..++||||+++++|... .... ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 467999999999999632 2111 246789999999999998 9999999 99999999999999999999
Q ss_pred ceecCCCCCcee-------eeecCcccccCccccccCC------CCccccee
Q 036225 447 AKLLDHQDSHVT-------TAVRGTVGHIAPEYLSTGQ------SSEKTDVF 485 (622)
Q Consensus 447 a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~sDvw 485 (622)
|+.+........ ....+++.|+|||++...+ .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 987754321111 3456788999999985433 23446777
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.63 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=190.8
Q ss_pred CCCcCCeeeecCCceEEEEEECCC--eEEEEEEccCCCCCchhHHHHHHHHHHhcccc----ccceeeeeee-eCCCcee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH----RNLLRLYGFC-MTPTERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~ 373 (622)
+|.+.+.||+|+||.||++...+. ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997643 57999987765433333 57788888887763 5788888888 5777889
Q ss_pred EEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-----CceEEccccc
Q 036225 374 LVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-----CEAVVGDFGL 446 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~Dfgl 446 (622)
+||+.+ |.+|.++... ...++..+...|+.|++.+|+++|+. |++||||||.|+++... ..++|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999988 7799997743 35799999999999999999999999 99999999999999854 4689999999
Q ss_pred ceecC--CCCC----ce---eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 447 AKLLD--HQDS----HV---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 447 a~~~~--~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
++... .... .. .....||..|.++....+.+.+.+.|+||++.++.|++.|..||........... +
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~----~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK----F 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH----H
Confidence 98322 1111 01 2235699999999999999999999999999999999999999864433222111 1
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......... .. .....+.++.++...+-..+..++|....+...++.
T Consensus 250 ~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 250 EKDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 111111000 00 111123456666666666899999999999888654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-24 Score=199.90 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=185.8
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
....+|.+...|+.|+|.++ |..+++|+++... .....+.|..|.-.++.+.||||+.++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34567889999999999998 5556677776432 223344788999999999999999999999999999999999999
Q ss_pred CCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 382 GSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 382 gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
|+|+..+++.. ..+..+..+++.+||+|++|||+. .+-|.---|.+..|++|++.+++|+- +-+++ +....
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~ 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEV 344 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eeecc
Confidence 99999998654 477889999999999999999986 33444556899999999999988742 11111 11111
Q ss_pred eecCcccccCccccccCCC---CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~---~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
...-.+.||+||.++..+. -..+|+|||.+++|||.|..-||..-.+-+... .+.-..++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------kialeglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------KIALEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------hhhhccccc
Confidence 1123689999999977654 346899999999999999999997433221110 011112233
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..++.....+.+++.-|+..||.+||.+..++-.||.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 3333444668899999999999999999999988874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=224.94 Aligned_cols=160 Identities=39% Similarity=0.657 Sum_probs=129.9
Q ss_pred CCCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC-----CccceEEcCC-----CcEEEEecCCCCCccccCCcccCC
Q 036225 27 AKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPC-----SWTMVTCSPE-----SLVIGLGIPSQNLSGTLSPSIGNL 96 (622)
Q Consensus 27 ~~~~~~~~~aLl~~k~~~~~~~~~l~~W~~~~~~~C-----~w~gv~C~~~-----~~v~~L~l~~n~l~~~~~~~~~~l 96 (622)
..+.+.|+.||+.+|+++.+|.. .+|.+ ||| .|.||+|+.. ..|+.|+|++|++.|.+|+.|++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34567899999999999987642 48975 455 7999999632 248899999999999999999999
Q ss_pred CcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccccccccccccccc-ceeEEe
Q 036225 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMT-QLIFLD 175 (622)
Q Consensus 97 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~l~ 175 (622)
++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+..+. ++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~---- 517 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR---- 517 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccC----
Confidence 9999999999999999998999999999999999999999999999999999999999999988888775431 12
Q ss_pred CCCCcCCCcCCCCCccccccccccccccCCCCCCC
Q 036225 176 LSYNNLSGPVPRFSAKTFNIVGNPLICATGSEPDC 210 (622)
Q Consensus 176 l~~N~l~g~~p~~~~~~~~l~~N~~~c~~~~~~~c 210 (622)
..+++.+|+.+|+.+....|
T Consensus 518 ---------------~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 518 ---------------ASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred ---------------ceEEecCCccccCCCCCCCC
Confidence 23456778888876555555
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=202.65 Aligned_cols=259 Identities=29% Similarity=0.365 Sum_probs=198.7
Q ss_pred CCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccc-cceeeeeeeeCCCceeEEeee
Q 036225 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHR-NLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 378 (622)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.++..+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 789999997665444 366799999999999988 799999999777778999999
Q ss_pred ccCCCccccccCCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCCC
Q 036225 379 MSNGSVASRLKGKP---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 379 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~ 454 (622)
+.++++.+++.... .+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 688999999999999999999999 899999999999999888 79999999998665433
Q ss_pred Cc-----eeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 455 SH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 455 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
.. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...............+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2355679999999999987 578899999999999999999999965433210001111111111100
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.................+.+++..++..+|..|.+..+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567899999999999999999887764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=240.97 Aligned_cols=157 Identities=39% Similarity=0.700 Sum_probs=120.3
Q ss_pred ChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCC
Q 036225 30 VNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNI 109 (622)
Q Consensus 30 ~~~~~~aLl~~k~~~~~~~~~l~~W~~~~~~~C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 109 (622)
.+.|+.||++||+++.+|.+.+.+|+.. .|||.|.||+|++.++|+.|+|++|++.|.+++.|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 5689999999999999898889999754 589999999999878999999999999999999999999999999999999
Q ss_pred CCCCCCccC-CCCcccEEEecCccccCCC----------------------CchhccccCccceeccccccccccccccc
Q 036225 110 TGPIPAEIG-RLTKLQTLDLSNNFFTGEI----------------------PSSLGHLRSLQYMRFNNNSLSGAFPTSLA 166 (622)
Q Consensus 110 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~----------------------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 166 (622)
+|.+|..+. ++++|++|+|++|+++|.+ |..++++++|++|+|++|.+.+.+|..+.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 988887655 6777777777766665544 44455555555555555555555555555
Q ss_pred cccceeEEeCCCCcCCCcCCC
Q 036225 167 SMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 167 ~l~~L~~l~l~~N~l~g~~p~ 187 (622)
++++|++|+|++|++++.+|.
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~ 206 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPR 206 (968)
T ss_pred hCcCCCeeeccCCCCcCcCCh
Confidence 555555555555555555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=227.43 Aligned_cols=251 Identities=20% Similarity=0.228 Sum_probs=188.7
Q ss_pred CcCCeeeecCCceEEEEEEC-CCeEEEEEEccC----CCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 303 SSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKD----GNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
....++|.|++|.|+..... ..+..+.|.++. ... ......+..|+-+-..++|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877643 344444444331 111 111112555666777889999998888887777776679
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS- 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 455 (622)
|||++ +|..++.....+.-..+..++.|+..|+.|+|+. ||.|||+|++|++++.+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 9999998877788889999999999999999999 999999999999999999999999999987754433
Q ss_pred --ceeeeecCcccccCccccccCCCCcc-cceeehhHHHHHHHhcCCccccchhcccccc---HHHHHHHHhhhhhhhhh
Q 036225 456 --HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALEYGKAANQKGA---MLDWVKKIHQEKKLEML 529 (622)
Q Consensus 456 --~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 529 (622)
.......|+..|+|||++.+..|.+. .||||.|+++..|++|+.||......+.... ...|......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~------- 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG------- 549 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC-------
Confidence 34556789999999999999999765 5999999999999999999986655443210 0011100000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
........+.....++.++++.+|.+|-|+++|++
T Consensus 550 -----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 -----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 01112233456788999999999999999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-23 Score=223.19 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=192.1
Q ss_pred CCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHH--HhccccccceeeeeeeeCCCceeEEeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++...+.+|++.|=.|.+|++++|. |+||++-+....-....|.++++- ...++|||.+++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667889999999999999999888 889998665533334444444433 5566899999998888888888999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec--CCCCCc
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSH 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~--~~~~~~ 456 (622)
..+ +|+|.+..++.+...+.+.|+.|++.||..+|.. +|+|||||.+|||++.-.-+.|+||-.-+.. .+++..
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 976 9999999999999999999999999999999999 9999999999999999999999999765432 222211
Q ss_pred eee----eecCcccccCccccccC----------C-CCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHH-
Q 036225 457 VTT----AVRGTVGHIAPEYLSTG----------Q-SSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKK- 519 (622)
Q Consensus 457 ~~~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~- 519 (622)
... .-..-..|+|||.+... . .+++-||||+||+++||++ |+++|.... +..+-..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aYr~~~ 251 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAYRSGN 251 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhHhccC
Confidence 111 12234579999987541 1 4678899999999999998 466665322 1111110
Q ss_pred -HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHH
Q 036225 520 -IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERW 580 (622)
Q Consensus 520 -~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 580 (622)
...+.-++++-| ..+.+++..|++.||++|-++++.++.-.+..+++-.
T Consensus 252 ~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yF 301 (1431)
T KOG1240|consen 252 ADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYF 301 (1431)
T ss_pred ccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHH
Confidence 001111122222 3578999999999999999999999998887776443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=185.36 Aligned_cols=141 Identities=16% Similarity=0.179 Sum_probs=110.7
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc-h-------hHH-----------------HHHHHHHHhccccccc
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-G-------EIQ-----------------FQTEVEMISLAVHRNL 359 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------~~~e~~~l~~l~H~ni 359 (622)
...||+|+||.||+|...+|+.||||+++...... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998889999999997542211 0 011 2348999999988877
Q ss_pred eeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeeecCCCc
Q 036225 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 360 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
.....+.. ...++||||++++++.........++......++.|++.+|.|+ |+. +|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 54443322 23489999999887765543345688999999999999999999 677 999999999999998 478
Q ss_pred eEEcccccceecC
Q 036225 439 AVVGDFGLAKLLD 451 (622)
Q Consensus 439 ~kl~Dfgla~~~~ 451 (622)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=184.44 Aligned_cols=203 Identities=21% Similarity=0.290 Sum_probs=171.2
Q ss_pred hCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 377 (622)
-+|.++++||+|.||+++.|+ +-+++.||||.-..... .-+++.|.+.++.+. .++|..+|-|...+.+-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 368899999999999999999 55799999998543321 226788999888875 6899999999899999999999
Q ss_pred eccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceEEcccccceecC
Q 036225 378 YMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-----CCEAVVGDFGLAKLLD 451 (622)
Q Consensus 378 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~ 451 (622)
.+ |.||.|++. -...++..+...||.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 98 779988876 355689999999999999999999999 9999999999999963 4458999999999886
Q ss_pred CCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc
Q 036225 452 HQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509 (622)
Q Consensus 452 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~ 509 (622)
..... ......||.+||+=-...+.+-+.+.|+-|||-++...+-|..||..-+.+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 54432 33456799999999888899999999999999999999999999987654433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=180.08 Aligned_cols=201 Identities=21% Similarity=0.270 Sum_probs=167.6
Q ss_pred HhCCCcCCeeeecCCceEEEEE-ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc-ccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 376 (622)
...|..++.||.|+||.+|.|. ..+|+.||||+-...... -++..|.++.+.++| ..|..+..|..+...-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4578889999999999999999 578999999986554322 256778889998875 67888888999999999999
Q ss_pred eeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~ 452 (622)
+.+ |.+|.+++. -...++..+.+-.+-|++.-++|+|.+ +++||||||+|+|.. ....+.++|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 779988875 345688889999999999999999999 999999999999996 456789999999987754
Q ss_pred CCC------ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchh
Q 036225 453 QDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506 (622)
Q Consensus 453 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~ 506 (622)
... .......||.+|.+=-...+.+.+.+.|+-|+|.++..+--|..||+.-..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 322 223456799999998777777778899999999999999999999986543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-22 Score=206.06 Aligned_cols=234 Identities=24% Similarity=0.249 Sum_probs=187.8
Q ss_pred eeeecCCceEEEEE----ECCCeEEEEEEccCCCCCch-hHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeeecc
Q 036225 307 ILGKGGFGIVYKGI----LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
++|+|.||.|+.+. .+.|..+|.|+.++...... ......|..++...+ ||.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 34578899998876542221 114556778888887 9999999999999999999999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeee
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
+|.|...+.....++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999999988899988999999999999999999 9999999999999999999999999999865432221
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
+||..|||||++. .+...+|.||||++++||+||-.||.. +.++.+.. ..-.+++
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~-----------~~~~~p~ 208 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILK-----------AELEMPR 208 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhh-----------hccCCch
Confidence 7999999999997 567889999999999999999999874 11112111 1122455
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHh
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKM--SEVVRMLE 572 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~--~evl~~L~ 572 (622)
.-.....+++..++..+|..|--. ..+.+..+
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 556778889999999999999755 34444433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=184.14 Aligned_cols=173 Identities=10% Similarity=0.071 Sum_probs=134.7
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhH--H------HHHHHHHHhccccccceeeeeeeeC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEI--Q------FQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--~------~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
+...+|...+++|.|+||.||.+.. ++..+|||.++......... . +.+|++.+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578899999999999999999766 57789999997654332221 1 6789999999999999999988654
Q ss_pred C--------CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 036225 369 P--------TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440 (622)
Q Consensus 369 ~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 440 (622)
. ...+++|||++|.+|.+... ++. ....+++.++..+|+. +++|||+||+||+++.++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 3 35789999999999977632 222 3466999999999999 999999999999999988 99
Q ss_pred EcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHH
Q 036225 441 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~ 495 (622)
|+|||........... ..+.....++.++|+|+||+.+..+.
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988644211110 11334455678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=177.17 Aligned_cols=142 Identities=17% Similarity=0.138 Sum_probs=112.4
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCch-------------------------hHHHHHHHHHHhccccccc
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG-------------------------EIQFQTEVEMISLAVHRNL 359 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~e~~~l~~l~H~ni 359 (622)
...||+|+||.||+|...+|+.||||+++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999999875421100 1124578899999999987
Q ss_pred eeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCc
Q 036225 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 360 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
.....+... ..++||||++++++.........++......++.|++.++.++|+ . +|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence 555444333 348999999988654432233457788899999999999999999 8 999999999999999 799
Q ss_pred eEEcccccceecCC
Q 036225 439 AVVGDFGLAKLLDH 452 (622)
Q Consensus 439 ~kl~Dfgla~~~~~ 452 (622)
++|+|||++....+
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=195.16 Aligned_cols=212 Identities=23% Similarity=0.362 Sum_probs=161.7
Q ss_pred HhccccccceeeeeeeeCCCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCe-eecCCCC
Q 036225 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKI-IHRDVKA 428 (622)
Q Consensus 351 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~Dlk~ 428 (622)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ...++|.....+..+|+.||+|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3568899999999999999999999999999999999976 55799999999999999999999987 45 8999999
Q ss_pred CCeeecCCCceEEcccccceecCCC-CCceeeeecCcccccCccccccCC-------CCcccceeehhHHHHHHHhcCCc
Q 036225 429 ANILLDDCCEAVVGDFGLAKLLDHQ-DSHVTTAVRGTVGHIAPEYLSTGQ-------SSEKTDVFGFGILLLELITGQRA 500 (622)
Q Consensus 429 ~NILl~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslGv~l~el~tg~~p 500 (622)
+|.++|....+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998766421 111111222346799999986631 46779999999999999999999
Q ss_pred cccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
|...........++.+++.. -...+-+.+.... ...+++..++..||..+|.+||+++++-..++
T Consensus 158 ~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred cccccccCChHHHHHHHHhc-----CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 98654433333333333330 1111111111100 22347899999999999999999999987665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=170.48 Aligned_cols=186 Identities=17% Similarity=0.065 Sum_probs=138.8
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc---hhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeee
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG---GEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.....|++|+||+||.+.. .+..++.+.+....... ....+.+|+++++++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997665 57778877766443211 1224789999999995 5889999886 456999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeecCCCceEEcccccceecCCCCCc-
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDDCCEAVVGDFGLAKLLDHQDSH- 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgla~~~~~~~~~- 456 (622)
++|.+|...+... ...++.|++++|+++|+. ||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998887544211 235788999999999999 9999999 799999999999999999999865432210
Q ss_pred ---e--------eeeecCcccccCccccccC-CCC-cccceeehhHHHHHHHhcCCcccc
Q 036225 457 ---V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELITGQRALEY 503 (622)
Q Consensus 457 ---~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslGv~l~el~tg~~p~~~ 503 (622)
. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 1112257778888754321 223 566889999999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-19 Score=174.51 Aligned_cols=230 Identities=23% Similarity=0.273 Sum_probs=145.3
Q ss_pred CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccc----------cccceeeeeeee-
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV----------HRNLLRLYGFCM- 367 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~----------H~niv~l~~~~~- 367 (622)
+...+.||.|+++.||.+.+. +|+.+|+|++..... ....+++++|.-....+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345688999999999999986 589999998864432 223445666665544432 212222222221
Q ss_pred --------CC---C-----ceeEEeeeccCCCcccccc---CC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 036225 368 --------TP---T-----ERLLVYPYMSNGSVASRLK---GK----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424 (622)
Q Consensus 368 --------~~---~-----~~~lv~e~~~~gsL~~~l~---~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 424 (622)
.. . ..+++|+-+ .++|.+.+. .. ..+....+..+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 225667766 447766643 11 1234456667789999999999999 99999
Q ss_pred CCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCcccccc--------CCCCcccceeehhHHHHHHHh
Q 036225 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELIT 496 (622)
Q Consensus 425 Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGv~l~el~t 496 (622)
||+|+|++++.+|.++|+||+.....+. .... ...+..|.+||.... -.++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999998875432 1111 345688999997643 246889999999999999999
Q ss_pred cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 036225 497 GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR 561 (622)
Q Consensus 497 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 561 (622)
|..||........... .+ .... ..++.+..||..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999985433221100 11 1122 456889999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9e-19 Score=172.32 Aligned_cols=197 Identities=21% Similarity=0.238 Sum_probs=135.9
Q ss_pred cccccceeeeeeeeCC---------------------------CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHH
Q 036225 354 AVHRNLLRLYGFCMTP---------------------------TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406 (622)
Q Consensus 354 l~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i 406 (622)
-+|||||++.++|.+. ...|+||.-.+. +|.+++-.+. .+.....-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence 3699999999987432 234778877654 7888886554 3445566788999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCCeeec--CCC--ceEEcccccceecCCCC-----CceeeeecCcccccCccccccCC
Q 036225 407 ARGLLYLHEQCDPKIIHRDVKAANILLD--DCC--EAVVGDFGLAKLLDHQD-----SHVTTAVRGTVGHIAPEYLSTGQ 477 (622)
Q Consensus 407 a~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 477 (622)
++|+.|||++ +|.|||+|++|||+. +|+ ...|+|||++-.-.... ....-...|.-.-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 999999999999994 443 46789999874322111 11112334778899999985432
Q ss_pred ------CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHH
Q 036225 478 ------SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVAL 551 (622)
Q Consensus 478 ------~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 551 (622)
...|+|.|+.|-+.||+++...||...... .++. +. .++-. ....+..++..+.+++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----~L~~-r~------Yqe~q----LPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----LLDT-RT------YQESQ----LPALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----eech-hh------hhhhh----CCCCcccCChHHHHHHH
Confidence 246899999999999999999999742110 0000 00 01111 11233445577899999
Q ss_pred HccCCCCCCCCCHHHHHHHH
Q 036225 552 LCTQYLPAHRPKMSEVVRML 571 (622)
Q Consensus 552 ~cl~~~p~~RPt~~evl~~L 571 (622)
..++.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=164.65 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=106.0
Q ss_pred CCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-----ccccceeeeeeeeCCC---ce-
Q 036225 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-----VHRNLLRLYGFCMTPT---ER- 372 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~- 372 (622)
+...+.||+|+||.||. .-+++.. +||++..... .....+.+|+++++.+ .||||++++|++.++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 44568999999999996 2234444 6898865432 2345789999999999 5799999999998864 32
Q ss_pred eEEeee--ccCCCccccccCCCCCChhHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeeecC----CCceEEcccc
Q 036225 373 LLVYPY--MSNGSVASRLKGKPILDWSTRKRIALGAARGL-LYLHEQCDPKIIHRDVKAANILLDD----CCEAVVGDFG 445 (622)
Q Consensus 373 ~lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfg 445 (622)
.+|+|| +++|+|.++++.. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+||+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 378999 5579999999764 35555 35678888777 999999 9999999999999974 3479999954
Q ss_pred cc
Q 036225 446 LA 447 (622)
Q Consensus 446 la 447 (622)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=194.03 Aligned_cols=200 Identities=22% Similarity=0.259 Sum_probs=164.1
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc---cccceeeeeeeeCC
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLYGFCMTP 369 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~ 369 (622)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+..+... |.-=.+++.+++ -+-|.++...+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 45666677888999999999999999998889999999976654332 211122333333 34566666777778
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-------CCCceEEc
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-------DCCEAVVG 442 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-------~~~~~kl~ 442 (622)
+.-++|+||.+.|+|.+++......+|.....++.|+++-+++||.. +||||||||+|+||. +...++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 88899999999999999999988999999999999999999999999 999999999999994 34568999
Q ss_pred ccccceecCC-CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCC
Q 036225 443 DFGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499 (622)
Q Consensus 443 Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~ 499 (622)
|||.+..+.- .+.......++|-.+--+|...+..++..+|.|.+.-+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999966532 22234556678999999999999999999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=167.33 Aligned_cols=143 Identities=15% Similarity=0.125 Sum_probs=112.7
Q ss_pred CCCcCCeeeecCCceEEEEE--ECCCeEEEEEEccCCCCCc-----------------------hhHHHHHHHHHHhccc
Q 036225 301 NFSSKNILGKGGFGIVYKGI--LQDGTVVAVKRLKDGNAIG-----------------------GEIQFQTEVEMISLAV 355 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 355 (622)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36778999999999999998 5689999999987543110 0123568999999997
Q ss_pred ccc--ceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCee
Q 036225 356 HRN--LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANIL 432 (622)
Q Consensus 356 H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NIL 432 (622)
+.. +.+++++ ...++||||+++++|.........+.......++.|++.++.+||+. + |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 633 3444443 23589999999988877664444566666789999999999999999 8 999999999999
Q ss_pred ecCCCceEEcccccceecC
Q 036225 433 LDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 433 l~~~~~~kl~Dfgla~~~~ 451 (622)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=160.16 Aligned_cols=135 Identities=19% Similarity=0.256 Sum_probs=114.0
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCc-------hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.||+|++|.||+|.. +|..|++|+........ ....+.+|++++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57789999865432111 123477899999999999998888888778888999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
++|++|.+.+.... + .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7889999999999999999 999999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=157.37 Aligned_cols=141 Identities=19% Similarity=0.136 Sum_probs=110.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC---------------------chhHHHHHHHHHHhcccc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI---------------------GGEIQFQTEVEMISLAVH 356 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~H 356 (622)
....|...+.||+|+||.||++...+|+.||||+++..... .....+..|..++.++.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33347778999999999999999888999999987643210 001135678888888888
Q ss_pred cc--ceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 036225 357 RN--LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434 (622)
Q Consensus 357 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~ 434 (622)
++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 74 444443 2456899999999998765431 34567899999999999998 999999999999999
Q ss_pred CCCceEEcccccceecC
Q 036225 435 DCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 435 ~~~~~kl~Dfgla~~~~ 451 (622)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=156.29 Aligned_cols=131 Identities=20% Similarity=0.270 Sum_probs=107.6
Q ss_pred eeeecCCceEEEEEECCCeEEEEEEccCCCCCc-------hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 307 ILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
.||+|+||.||+|.+ +|..|++|......... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 47789999865432111 1235778999999999988766666666777789999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+|++|.+.+..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887754321 7899999999999999 999999999999999 79999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-18 Score=176.11 Aligned_cols=171 Identities=25% Similarity=0.348 Sum_probs=127.6
Q ss_pred ceeEEeeeccCCCccccccCC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccc
Q 036225 371 ERLLVYPYMSNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 447 (622)
..++.|++|...+|.+++... ...++.....++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999743 346788899999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC-----CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHh
Q 036225 448 KLLDHQD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 448 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
....... ....+...||..||+||.+.+..|+.|+||||||++++|+++ =..+++.... ...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~- 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDI- 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhh-
Confidence 8765443 223455679999999999999999999999999999999987 2222221100 0000
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 567 (622)
+ ...+++....+++ +=..++.+++...|.+||++.++
T Consensus 473 r----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 R----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred h----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 0 1111111112222 23468889999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-18 Score=186.39 Aligned_cols=212 Identities=23% Similarity=0.276 Sum_probs=147.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|+.++.|..|+||.||.+.++ ..+++|+|+ .+.+.. .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc---cccccCCccee-----------------
Confidence 467889999999999999999876 467788843 332211 111 22222233322
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC----
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ---- 453 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~---- 453 (622)
|+-...++.-+.++. +++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ----gDc~tllk~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444555555444443 237889999999 9999999999999999999999999998653210
Q ss_pred ----------CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 454 ----------DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 454 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
.......++||+.|+|||++....|+..+|.|++|+++||.+-|..||+.....+-.+..+....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-----
Confidence 11123456799999999999999999999999999999999999999987654433222221000
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 566 (622)
.+.+. ....+.+..+++.+.++.+|.+|--...
T Consensus 276 ~wpE~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 276 EWPEE----------DEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred ccccc----------CcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 00111 1122367889999999999999964333
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.1e-17 Score=177.35 Aligned_cols=139 Identities=19% Similarity=0.259 Sum_probs=112.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEE-ccCCCCC------chhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKR-LKDGNAI------GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
...|...+.||+|+||+||+|.+.+.. +++|+ +.+.... .....+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566889999999999999876444 33333 2221111 112357899999999999999988888888888
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999988775 4578999999999999998 99999999999999 5789999999999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=145.81 Aligned_cols=137 Identities=20% Similarity=0.207 Sum_probs=98.6
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCch-hHH----------------------HHHHHHHHhcccccc--c
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG-EIQ----------------------FQTEVEMISLAVHRN--L 359 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~e~~~l~~l~H~n--i 359 (622)
.+.||+|+||.||+|...+++.||||+++....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999988899999999875322111 101 134555555554432 3
Q ss_pred eeeeeeeeCCCceeEEeeeccCCCcccc-ccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCC
Q 036225 360 LRLYGFCMTPTERLLVYPYMSNGSVASR-LKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCC 437 (622)
Q Consensus 360 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~ 437 (622)
.+.++. ...++||||++++.+... +... ... .....++.+++.++.++|. . +|+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence 344433 246899999998654322 2111 111 6678899999999999998 7 999999999999999 89
Q ss_pred ceEEcccccceecC
Q 036225 438 EAVVGDFGLAKLLD 451 (622)
Q Consensus 438 ~~kl~Dfgla~~~~ 451 (622)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-15 Score=136.14 Aligned_cols=135 Identities=19% Similarity=0.131 Sum_probs=115.6
Q ss_pred cCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc--ccceeeeeeeeCCCceeEEeeeccC
Q 036225 304 SKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++.+++++....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35789999999999999864 7899999865433 4468899999999977 5899999998888899999999998
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+.+..+ +......++.++++++.++|....++++|+|++|+||++++++.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 5667788899999999999986445799999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-16 Score=171.85 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=189.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC--CeEEEEEEccCCC-CCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD--GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 374 (622)
...|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++++++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677789999999999887543 4456667665442 2222333445666666665 9999999999999999999
Q ss_pred EeeeccCCCccccc-cCCC-CCChhHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeeecCCC-ceEEcccccceec
Q 036225 375 VYPYMSNGSVASRL-KGKP-ILDWSTRKRIALGAARGLLYLH-EQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLL 450 (622)
Q Consensus 375 v~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~ 450 (622)
+.+|.+++++.+.+ +... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999998 5443 5677788899999999999999 77 999999999999999999 9999999999877
Q ss_pred CC-CC-CceeeeecC-cccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 451 DH-QD-SHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 451 ~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
.. .. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+. ....|...-.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~~----- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNKG----- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeeccccc-----
Confidence 65 22 223344568 9999999999874 457788999999999999999999886554332 1122222110
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.........-.....++..+++..+|..|.+.+++..
T Consensus 249 ------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 ------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000111112245677888899999999999887653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=142.00 Aligned_cols=136 Identities=16% Similarity=0.159 Sum_probs=105.7
Q ss_pred CCeee-ecCCceEEEEEECCCeEEEEEEccCCCC------------CchhHHHHHHHHHHhccccccc--eeeeeeeeCC
Q 036225 305 KNILG-KGGFGIVYKGILQDGTVVAVKRLKDGNA------------IGGEIQFQTEVEMISLAVHRNL--LRLYGFCMTP 369 (622)
Q Consensus 305 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~ 369 (622)
..+|| .|+.|+||++... +..++||.+..... ......+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999886 67789998853211 1122357889999999998875 6777765432
Q ss_pred Cc----eeEEeeeccC-CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 370 TE----RLLVYPYMSN-GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 370 ~~----~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
.. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|||++.++.++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 22 2599999997 6888887653 34432 367899999999999 9999999999999999899999999
Q ss_pred cccee
Q 036225 445 GLAKL 449 (622)
Q Consensus 445 gla~~ 449 (622)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 99874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.7e-13 Score=142.75 Aligned_cols=141 Identities=23% Similarity=0.224 Sum_probs=100.5
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc---------------------------------------hhHHHH
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG---------------------------------------GEIQFQ 345 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~ 345 (622)
.+.||.|++|.||+|++++|+.||||+.+...... .+.+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999986432100 011244
Q ss_pred HHHHHHhccc----cccceeeeeee-eCCCceeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHH-HHHHHHhcCC
Q 036225 346 TEVEMISLAV----HRNLLRLYGFC-MTPTERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAAR-GLLYLHEQCD 418 (622)
Q Consensus 346 ~e~~~l~~l~----H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-~L~~LH~~~~ 418 (622)
+|.+.+.+++ |.+-+.+-..+ ......++||||++|++|.+..... ... .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 5555544442 32223332322 2345679999999999998876421 112 34567777766 46788988
Q ss_pred CCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 419 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|++|+|+||.||++++++.++++|||++..+.
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.8e-14 Score=125.50 Aligned_cols=108 Identities=29% Similarity=0.481 Sum_probs=88.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
+.++.|.|++|.++ .+|+.+..|.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 45788999999988 57888999999999999999998 88888888888888888888888 88888888888888888
Q ss_pred cccccc-cccccccccccceeEEeCCCCcCCC
Q 036225 153 NNNSLS-GAFPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 153 ~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
.+|++. ..+|..|.-|..|+.|+|+.|.|.-
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~ 141 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEI 141 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCccc
Confidence 888875 3566667777777777777777763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.2e-13 Score=139.21 Aligned_cols=249 Identities=20% Similarity=0.164 Sum_probs=182.6
Q ss_pred HhCCCcCCeeee--cCCceEEEEEE---CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccc-cccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGK--GGFGIVYKGIL---QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 371 (622)
...|...+.+|+ |.+|.||.+.. .++..+|+|.-+.... ......=.+|+....+++ |+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345667788999 99999999986 3678899998543322 112223345666666664 9999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCC-CChhHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccc
Q 036225 372 RLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAAR----GLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFG 445 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfg 445 (622)
.++-+|++. .+|.++.+.... ++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ ...+++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 999999995 688877765433 677788888888888 99999998 99999999999999998 889999999
Q ss_pred cceecCCCCCc----eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 446 LAKLLDHQDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 446 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
+...+...... ......|...|++||.. ++-++..+|+|++|.++.+-.+|.++...+.... |... .
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~~~-r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WSQL-R 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------cccc-c
Confidence 99887654411 12233578899999987 4568889999999999999999988776542211 1110 0
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+.. ++.++-.....++...+..+++.+|..|++.+.+..
T Consensus 340 ~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 111111112244555888999999999999887764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-12 Score=145.68 Aligned_cols=93 Identities=39% Similarity=0.615 Sum_probs=90.0
Q ss_pred cccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCC
Q 036225 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177 (622)
Q Consensus 98 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 177 (622)
.++.|+|++|.++|.+|..+++|++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCcCCCCCc
Q 036225 178 YNNLSGPVPRFSA 190 (622)
Q Consensus 178 ~N~l~g~~p~~~~ 190 (622)
+|+|+|.+|..+.
T Consensus 499 ~N~l~g~iP~~l~ 511 (623)
T PLN03150 499 GNSLSGRVPAALG 511 (623)
T ss_pred CCcccccCChHHh
Confidence 9999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=127.15 Aligned_cols=201 Identities=21% Similarity=0.298 Sum_probs=137.2
Q ss_pred HHHHhccccccceeeeeeeeCC-----CceeEEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCC
Q 036225 348 VEMISLAVHRNLLRLYGFCMTP-----TERLLVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCD 418 (622)
Q Consensus 348 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 418 (622)
..-+-++.|-|||++..|+.+. .+..+++|||..|++..+|+. ...+......+|+-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445567799999999998654 446889999999999999973 3346677778999999999999998 58
Q ss_pred CCeeecCCCCCCeeecCCCceEEcccccceecC---CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHH
Q 036225 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD---HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495 (622)
Q Consensus 419 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~ 495 (622)
|+|+|+++..+-|++..++-+||.----..... ......+....+-++|.+||+-.....+..+|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999988874321111100 01111122234678999999887777888999999999999998
Q ss_pred hcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 496 TGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 496 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
-|..--....... .. ...+...+- .+.. ..-...+.+|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~----~~--------ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKV----EV--------EENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCccee----eh--------hhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence 7753211111000 00 000000000 0000 11135678899999999999998874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.6e-12 Score=117.34 Aligned_cols=130 Identities=22% Similarity=0.178 Sum_probs=97.4
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccce-eeeeeeeCCCceeEEeeeccCCC
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
.+.++.|.++.||++... +..|++|....... ....+..|++++..+.+.+++ +++.+. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 457899999999999876 77899999765432 123467899999888765544 444443 334589999999988
Q ss_pred ccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 384 VASRLKGKPILDWSTRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 384 L~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+.+.- .....++.+++++|..||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76531 112346789999999999872 12369999999999999 6789999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-13 Score=119.15 Aligned_cols=127 Identities=24% Similarity=0.430 Sum_probs=110.9
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcccc-CCCCchhccccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT-GEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~ 153 (622)
+..|++.+|++. .+|.+++.|+.|+.|+++-|++. .+|..|+.++.|+.|||++|+++ ..+|..|..++.|+.|+|+
T Consensus 58 levln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~ 135 (264)
T KOG0617|consen 58 LEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLG 135 (264)
T ss_pred hhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhc
Confidence 456788888887 68999999999999999999999 99999999999999999999997 4589999999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
.|.|+ .+|..++++++|+.|.+..|.+- ++|...+ +.+.+.||.....++
T Consensus 136 dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 136 DNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred CCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecCh
Confidence 99999 89999999999999999999987 5665443 567888998765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=5e-11 Score=111.87 Aligned_cols=138 Identities=17% Similarity=0.167 Sum_probs=100.2
Q ss_pred CeeeecCCceEEEEEECC-------CeEEEEEEccCCCC---------------------CchhHHH----HHHHHHHhc
Q 036225 306 NILGKGGFGIVYKGILQD-------GTVVAVKRLKDGNA---------------------IGGEIQF----QTEVEMISL 353 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~ 353 (622)
..||.|--+.||.|...+ +..+|||+.+.... ......+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 47899998753210 0011122 378888888
Q ss_pred ccc--ccceeeeeeeeCCCceeEEeeeccCCCccc-cccCCCCCChhHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCC
Q 036225 354 AVH--RNLLRLYGFCMTPTERLLVYPYMSNGSVAS-RLKGKPILDWSTRKRIALGAARGLLYL-HEQCDPKIIHRDVKAA 429 (622)
Q Consensus 354 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk~~ 429 (622)
+.. -++.+++++ ...++||||+.++.+.. .++ ...++......+..+++.+|..+ |+. +++||||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 854 456666654 56789999997754432 222 22344556677889999999999 777 9999999999
Q ss_pred CeeecCCCceEEcccccceecCC
Q 036225 430 NILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 430 NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|||+++ +.+.|+|||.+....+
T Consensus 155 NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEEC-CcEEEEECCCceeCCC
Confidence 999974 7899999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.3e-12 Score=136.19 Aligned_cols=145 Identities=21% Similarity=0.222 Sum_probs=92.9
Q ss_pred hCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCC--------------------------c-------------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI--------------------------G------------- 339 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~------------- 339 (622)
.+|+. +.||+|++|.||+|.+++ |+.||||+.+..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999987 999999998743210 0
Q ss_pred hhHHHHHHHHHHhccc----cccceeeeeeeeC-CCceeEEeeeccCCCcccc--ccCCCCCChhHHHHHHHHHHHH-HH
Q 036225 340 GEIQFQTEVEMISLAV----HRNLLRLYGFCMT-PTERLLVYPYMSNGSVASR--LKGKPILDWSTRKRIALGAARG-LL 411 (622)
Q Consensus 340 ~~~~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~l~~~~~~~i~~~ia~~-L~ 411 (622)
.+.++.+|...+.+++ +.+.+.+-..+.+ ....++||||++|+.+.+. +.... .+ +..++...++. +.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHHHHH
Confidence 0012344444443332 3333333333322 4567899999999999764 22221 12 11222222211 22
Q ss_pred HHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccceecCC
Q 036225 412 YLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAKLLDH 452 (622)
Q Consensus 412 ~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~ 452 (622)
.++.. |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 275 Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33345 999999999999999888 999999999987753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.5e-11 Score=125.21 Aligned_cols=166 Identities=19% Similarity=0.220 Sum_probs=122.9
Q ss_pred ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHH
Q 036225 321 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRK 400 (622)
Q Consensus 321 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~ 400 (622)
..++.+|.|...+.... .......+-++-++.++||||++++..++..+..|+|+|-+. -|..+++.. ......
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHH
Confidence 34678888888776554 223346677888999999999999999999999999999875 344444432 234555
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCc
Q 036225 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480 (622)
Q Consensus 401 ~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 480 (622)
..+.||+.||.|||..| +++|++|.-.-|+++..|+.||++|.++........ ......--..|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 67899999999999876 899999999999999999999999998865432221 111111223466666543221 2
Q ss_pred ccceeehhHHHHHHHhc
Q 036225 481 KTDVFGFGILLLELITG 497 (622)
Q Consensus 481 ~sDvwslGv~l~el~tg 497 (622)
..|.|-||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 35999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=113.26 Aligned_cols=143 Identities=21% Similarity=0.292 Sum_probs=112.7
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc--ccceeeeeeeeCCC---ceeEEeeecc
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLYGFCMTPT---ERLLVYPYMS 380 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 380 (622)
+.|+.|.++.||++...+|+.+++|.............+..|.+++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 578999999999999877789999997654332234467899999998875 44677777776543 6689999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC------------------------------------------- 417 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------- 417 (622)
+.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9988876642 35677888889999999999998521
Q ss_pred ----------CCCeeecCCCCCCeeecC--CCceEEccccccee
Q 036225 418 ----------DPKIIHRDVKAANILLDD--CCEAVVGDFGLAKL 449 (622)
Q Consensus 418 ----------~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~ 449 (622)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=105.22 Aligned_cols=132 Identities=20% Similarity=0.283 Sum_probs=102.5
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEE-ccCCCCCch------hHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKR-LKDGNAIGG------EIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
..+++|+-+.+|.+.+.+ ..+++|. +++...... ..+-.+|.+++.+++--.|.-.+=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999998763 3355553 333322211 11456899999998877777777788888999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888654 256777788888899999 999999999999998754 99999999974
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-12 Score=129.70 Aligned_cols=120 Identities=31% Similarity=0.459 Sum_probs=103.4
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhc-cccCccceecccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG-HLRSLQYMRFNNN 155 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N 155 (622)
.||..+| +.+++|+.++.+.+|..|||..|+|. .+| +|+++..|.+|+++.|+|+ .+|...+ ++++|..|||..|
T Consensus 187 ~ld~~~N-~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 187 HLDCNSN-LLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDN 262 (565)
T ss_pred hcccchh-hhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccc
Confidence 3444444 44578999999999999999999999 888 8999999999999999999 8888866 8999999999999
Q ss_pred ccccccccccccccceeEEeCCCCcCCCcCCCCCc---ccccccccccc
Q 036225 156 SLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA---KTFNIVGNPLI 201 (622)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~~~~l~~N~~~ 201 (622)
+++ ..|+.+.-+.+|.+||||+|.+++..+.... +.+.+.|||..
T Consensus 263 klk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 263 KLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 999 9999999999999999999999976665432 56788999974
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-12 Score=134.09 Aligned_cols=136 Identities=21% Similarity=0.251 Sum_probs=97.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCc---hhccccCccce
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS---SLGHLRSLQYM 150 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L 150 (622)
.+..|+|++|+|+..-+.+|..|..|++|+|++|.++..-...|..+++|++|||++|.|++.+.+ .|..|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 456677777777776667777777777777777777755555677777888888888887766654 36677888888
Q ss_pred eccccccccccccccccccceeEEeCCCCcCCCcCCCCCc----cccccccccccccCCCCCC
Q 036225 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATGSEPD 209 (622)
Q Consensus 151 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N~~~c~~~~~~~ 209 (622)
+|.+|+|....-.+|..+++|++|||.+|.|...-|..+. +.+-+..-.++|+|...+-
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl 460 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWL 460 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHH
Confidence 8888888733335788888888888888888766666554 4455666678899876543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-12 Score=132.33 Aligned_cols=126 Identities=25% Similarity=0.236 Sum_probs=103.3
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|+.|+++..-...+.+|+.|+.||||+|.|...-++.+.-+.+|++|+||+|+|+..-+.+|..|..|+.|+|++
T Consensus 271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~ 350 (873)
T KOG4194|consen 271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSH 350 (873)
T ss_pred cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccc
Confidence 56788888888887778888899999999999999877788888888999999999999866667788888999999999
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCC--------ccccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--------AKTFNIVGNPL 200 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--------~~~~~l~~N~~ 200 (622)
|+++..--..|..+++|+.|||++|.|++.|.+.. .+.+.|.||.+
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCcee
Confidence 98885555678888899999999999988776532 14567777776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.7e-11 Score=127.51 Aligned_cols=250 Identities=21% Similarity=0.194 Sum_probs=176.3
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC--CCeEEEEEEccCCCCCchh-HHHHHHHHHHhcc-ccccceeeeeeeeCCC
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ--DGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLA-VHRNLLRLYGFCMTPT 370 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 370 (622)
......+|..+..||.|.|+.|++...+ ++..|++|.+......... ..-..|+.+...+ .|.++++.+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445667888999999999999998744 5788999988755332222 2223455555444 5888888877777777
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEccccccee
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFGLAKL 449 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~ 449 (622)
..++--|||+++++.....-...++...++++..|++.++.++|++ .++|+|+||+||++..+ +.-+++|||.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 7789999999999887776566788889999999999999999998 99999999999999876 8889999999864
Q ss_pred cCCCCCceeeeecCccccc--CccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHI--APEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
+. ..... ..+.-+++ +|+......+..+.|++|||.-+.|..+|...-+.... |..
T Consensus 417 ~~---~~~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~~~--------- 474 (524)
T KOG0601|consen 417 LA---FSSGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------SLT--------- 474 (524)
T ss_pred cc---eeccc-ccccccccccchhhccccccccccccccccccccccccCcccCccccc---------cee---------
Confidence 21 11111 12333444 55555666788999999999999999988643322111 100
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
+...... .. ......+..+...+...++..||.+.++..+.+
T Consensus 475 -i~~~~~p-~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 -IRSGDTP-NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -eeccccc-CC-CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000000 00 111255677788888999999999888766543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.2e-12 Score=130.32 Aligned_cols=123 Identities=33% Similarity=0.455 Sum_probs=78.8
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCC-ccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPA-EIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
++.||||+|.+. ..|..+.+-+++-.|+||+|+|. .||. -|-+|+.|-+||||+|++. .+|+.+..|.+|++|+|+
T Consensus 105 Lt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls 181 (1255)
T KOG0444|consen 105 LTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLS 181 (1255)
T ss_pred ceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcC
Confidence 566777777776 45666666677777777777776 5554 3456677777777777776 666666666667777777
Q ss_pred ccccc-------------------------cccccccccccceeEEeCCCCcCCCcCCCCC-----cccccccccccc
Q 036225 154 NNSLS-------------------------GAFPTSLASMTQLIFLDLSYNNLSGPVPRFS-----AKTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~-------------------------~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-----~~~~~l~~N~~~ 201 (622)
+|.+. ..+|.++..|.+|..+|||.|+|. .+|++. .+.++|+||.+.
T Consensus 182 ~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 182 NNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred CChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 66543 135666666666777777777666 445432 145666676653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=6e-11 Score=109.16 Aligned_cols=104 Identities=32% Similarity=0.440 Sum_probs=39.4
Q ss_pred cEEEEecCCCCCccccCCccc-CCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchh-ccccCcccee
Q 036225 74 LVIGLGIPSQNLSGTLSPSIG-NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMR 151 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 151 (622)
....|+|++|.|+.+ +.++ .|.+|+.|||++|.|+ .++ .+..+++|+.|+|++|.|+ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 356788888888854 3455 5788888888888888 554 5788888888888888888 565544 4688888888
Q ss_pred cccccccccc-ccccccccceeEEeCCCCcCC
Q 036225 152 FNNNSLSGAF-PTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 152 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~ 182 (622)
|++|+|...- -..+..+++|+.|+|.+|+++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 8888887321 145677888888888888876
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-11 Score=123.11 Aligned_cols=134 Identities=25% Similarity=0.342 Sum_probs=117.6
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC-ccccCCCC-chhccccCcccee
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN-NFFTGEIP-SSLGHLRSLQYMR 151 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p-~~~~~l~~L~~L~ 151 (622)
..+.|+|..|+|+.+.|.+|+.+++|+.||||+|+|+..-|+.|.+|.+|..|-+.+ |+|+ .+| ..|.+|.+|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 378999999999998889999999999999999999988899999999998877766 9999 555 5699999999999
Q ss_pred ccccccccccccccccccceeEEeCCCCcCCCcCCC------CCccccccccccccccCCCCCC
Q 036225 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR------FSAKTFNIVGNPLICATGSEPD 209 (622)
Q Consensus 152 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~------~~~~~~~l~~N~~~c~~~~~~~ 209 (622)
+.-|++.-.....|..|++|..|.|-.|.+. .|+. ...+.+.+.-||+.|.|...+.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchh
Confidence 9999999777889999999999999999997 3332 2346788999999999976654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.9e-11 Score=133.56 Aligned_cols=252 Identities=17% Similarity=0.177 Sum_probs=176.0
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCch--hHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.+...+.+.+.+-+-+|.++.++.+.-. .|...++|+......... .+....+-.++-..+||-++...--+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4456677788888899999999987633 354455554433221111 1112222223333445666655555556677
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
..|+++|..+++|...++..+..+.+-.......+.++++|||.. .+.|+|++|.|.+...++..+++|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 899999999999999999888778777788888899999999997 79999999999999999999999998432211
Q ss_pred C---------------------C---------CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCcc
Q 036225 452 H---------------------Q---------DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 501 (622)
Q Consensus 452 ~---------------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~ 501 (622)
- . +........||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 001122345899999999999999999999999999999999999999
Q ss_pred ccchhccccccHHHHHHHHhhhhhhhhhccccCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 036225 502 EYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
.......... .+...... ...+........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~----------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFE----------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhh----------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7544322211 11111111 112233345677888889999999998776
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-11 Score=128.76 Aligned_cols=105 Identities=28% Similarity=0.423 Sum_probs=57.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..+|||.|++. .+|..+.++++|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|+.++.|+.|+.|++.+
T Consensus 224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence 445566666665 45666666666666666666665 44444444555555555555555 5555555555555555555
Q ss_pred cccc-cccccccccccceeEEeCCCCcCC
Q 036225 155 NSLS-GAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 155 N~l~-~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
|+++ .-||..++.|.+|+.+..++|+|.
T Consensus 301 NkL~FeGiPSGIGKL~~Levf~aanN~LE 329 (1255)
T KOG0444|consen 301 NKLTFEGIPSGIGKLIQLEVFHAANNKLE 329 (1255)
T ss_pred CcccccCCccchhhhhhhHHHHhhccccc
Confidence 5543 124455555555555555555444
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-10 Score=80.25 Aligned_cols=41 Identities=51% Similarity=1.011 Sum_probs=31.2
Q ss_pred ChHHHHHHHHHHHhCC-CCCCCCCCCCCCC-CCCCCccceEEc
Q 036225 30 VNYEVQALMGVKHSLH-DPHGVLENWDEDA-VDPCSWTMVTCS 70 (622)
Q Consensus 30 ~~~~~~aLl~~k~~~~-~~~~~l~~W~~~~-~~~C~w~gv~C~ 70 (622)
++.|++||++||+++. +|.+.+.+|+..+ .+||+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 3689999999999998 5778999999764 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=132.15 Aligned_cols=123 Identities=32% Similarity=0.532 Sum_probs=110.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCC-CccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP-AEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.+..|.|.+|.++...-+.|.++++|+.|+|++|+|. .+| ..+.++..|+.|+||+|.|+ .+|..+.+++.|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 3778999999999988899999999999999999999 566 46889999999999999999 99999999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCC-cCC----CCCccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVP----RFSAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p----~~~~~~~~l~~N~~ 200 (622)
.+|++. .+| .+..+++|+.+|||.|+|+- .+| .-..+.++++||.+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 888 89999999999999999983 333 33347899999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-11 Score=119.82 Aligned_cols=114 Identities=32% Similarity=0.523 Sum_probs=90.6
Q ss_pred CCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccccccccc
Q 036225 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPT 163 (622)
Q Consensus 84 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 163 (622)
+..+.+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||||+|+|. .+|..+..+..|+.+-.++|++....|.
T Consensus 422 n~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 422 NKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS 499 (565)
T ss_pred CccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence 344456667888999999999999998 89999999999999999999988 7888877777777777777888755555
Q ss_pred ccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 164 SLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 164 ~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
.+.+|.+|..|||.+|.+. .||...+ +.+.+.||||
T Consensus 500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred HhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCcc
Confidence 6888888888888888888 4554443 4567788887
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-09 Score=95.80 Aligned_cols=142 Identities=16% Similarity=0.206 Sum_probs=104.0
Q ss_pred cCCeeeecCCceEEEEEECCCeEEEEEE-ccCCCCCc------hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 304 SKNILGKGGFGIVYKGILQDGTVVAVKR-LKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
....|-+|+-+.|+++.+. |+...||. +.+..... ...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999987 66666663 33322211 1235678999999887666666666777777888999
Q ss_pred eeccC-CCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEccccccee
Q 036225 377 PYMSN-GSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC---EAVVGDFGLAKL 449 (622)
Q Consensus 377 e~~~~-gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~ 449 (622)
||+++ .++.+++.. ...........++..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 356666642 12222233367889999999999999 999999999999996443 358999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.8e-09 Score=97.17 Aligned_cols=127 Identities=24% Similarity=0.310 Sum_probs=83.8
Q ss_pred eEEEEEECCCeEEEEEEccCCCC------------Cc-------------hhHHHHHHHHHHhccccc--cceeeeeeee
Q 036225 315 IVYKGILQDGTVVAVKRLKDGNA------------IG-------------GEIQFQTEVEMISLAVHR--NLLRLYGFCM 367 (622)
Q Consensus 315 ~Vy~~~~~~~~~vavK~~~~~~~------------~~-------------~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 367 (622)
.||.|...+|..+|||+.+.... .. ......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998854210 00 011367899999988765 466666552
Q ss_pred CCCceeEEeeecc--CCCccccccCCCCCChhHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 368 TPTERLLVYPYMS--NGSVASRLKGKPILDWSTRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 368 ~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
...+||||++ |..+.. +.... ++.+....++.+++..+..+ |.. ||+||||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 444433 32211 12455677888888866665 566 99999999999999987 9999999
Q ss_pred ccceecC
Q 036225 445 GLAKLLD 451 (622)
Q Consensus 445 gla~~~~ 451 (622)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-10 Score=104.03 Aligned_cols=104 Identities=32% Similarity=0.478 Sum_probs=36.8
Q ss_pred cccCCCcccEEEccCCCCCCCCCCccC-CCCcccEEEecCccccCCCCchhccccCccceecccccccccccccc-cccc
Q 036225 92 SIGNLTNLQIVLLQNNNITGPIPAEIG-RLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSL-ASMT 169 (622)
Q Consensus 92 ~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~ 169 (622)
.+.+...+++|+|++|+|+ .+. .++ .+.+|+.||||+|.|+ .++ .+..++.|+.|+|++|+|+ .++..+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 4556678999999999999 564 566 6899999999999999 564 5888999999999999999 565555 4689
Q ss_pred ceeEEeCCCCcCCCc--CCCC----Cccccccccccc
Q 036225 170 QLIFLDLSYNNLSGP--VPRF----SAKTFNIVGNPL 200 (622)
Q Consensus 170 ~L~~l~l~~N~l~g~--~p~~----~~~~~~l~~N~~ 200 (622)
+|+.|+|++|+|... +-.. ..+.+++.|||+
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 999999999999742 1100 125678899998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-08 Score=101.48 Aligned_cols=140 Identities=14% Similarity=0.017 Sum_probs=100.0
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCC----------chhHHHHHHHHHHhcccccc--ceeeeeeeeC-----
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI----------GGEIQFQTEVEMISLAVHRN--LLRLYGFCMT----- 368 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~----- 368 (622)
+.+-+-....|++..+ +|+.|.||+....... .....+.+|.+.+.++...+ ...++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555555777766 4788999977432211 11114778999888875443 3444555543
Q ss_pred CCceeEEeeeccCC-CccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-------CCc
Q 036225 369 PTERLLVYPYMSNG-SVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-------CCE 438 (622)
Q Consensus 369 ~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-------~~~ 438 (622)
....++|||++++. +|.+++.. ....+...+..++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 78887743 23345567778999999999999999 9999999999999985 578
Q ss_pred eEEccccccee
Q 036225 439 AVVGDFGLAKL 449 (622)
Q Consensus 439 ~kl~Dfgla~~ 449 (622)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998863
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.2e-10 Score=109.71 Aligned_cols=118 Identities=26% Similarity=0.479 Sum_probs=86.9
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+++|||++|.|+ .+..+..-++.++.|+||+|.|. .+- .+..|++|+.||||+|.++ .+...-..|.+.+.|.|+.
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 567888888877 45667777888888888888888 444 3778888888888888888 6666666777888888888
Q ss_pred cccccccccccccccceeEEeCCCCcCC--------CcCCCCCccccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS--------GPVPRFSAKTFNIVGNPL 200 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~--------g~~p~~~~~~~~l~~N~~ 200 (622)
|.|+ .+ ..+..+-+|..||+++|++. |.+|-. ..+.+.+||.
T Consensus 362 N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCL--E~l~L~~NPl 411 (490)
T KOG1259|consen 362 NKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCL--ETLRLTGNPL 411 (490)
T ss_pred hhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHH--HHHhhcCCCc
Confidence 8886 22 45667777888888888885 444432 4566777776
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.6e-10 Score=83.18 Aligned_cols=59 Identities=39% Similarity=0.581 Sum_probs=26.9
Q ss_pred cccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 98 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
+|++|+|++|+|+...+..|.++++|++|+|++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444555554443323344444444444444444443333344444444444444443
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=104.55 Aligned_cols=165 Identities=20% Similarity=0.233 Sum_probs=125.6
Q ss_pred CCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC----CCceeEEeeeccC-CCcc
Q 036225 312 GFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT----PTERLLVYPYMSN-GSVA 385 (622)
Q Consensus 312 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 385 (622)
...+.||+.. .||..|++|+++........ .-..-+++++++.|.|+|++.+++.. ....++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3468899984 48999999999544322211 12245778999999999999998873 4567899999985 4565
Q ss_pred cccc---------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 386 SRLK---------------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 386 ~~l~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
++.. .....++..++.++.|+..||.++|+. |+..+-|.+++||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 5432 223567889999999999999999999 9999999999999999889999999988766
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcC
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~ 498 (622)
..+.. |-+. --.+-|.=.||.+++.|.||.
T Consensus 444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 54331 1111 123568888999999999995
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-09 Score=82.07 Aligned_cols=61 Identities=39% Similarity=0.605 Sum_probs=55.8
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcC
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL 181 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 181 (622)
++|++|+|++|+|+...+..|..+++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5899999999999955557899999999999999999977778999999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.3e-08 Score=94.98 Aligned_cols=135 Identities=20% Similarity=0.179 Sum_probs=98.0
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC---------------------CchhHHHHHHHHHHhccccc--cc
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA---------------------IGGEIQFQTEVEMISLAVHR--NL 359 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~H~--ni 359 (622)
.+++.||-|--+.||.|..++|..+|||.-+.... .-.....++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45789999999999999999999999997543210 00112367888888888644 56
Q ss_pred eeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 360 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
.+.+++ +...+||||++|--|...-- +-.....++..|++-+.-+-.. ||||+|+++-||+++++|.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence 665554 56689999999866654431 2333445555555555555555 99999999999999999999
Q ss_pred EEccccccee
Q 036225 440 VVGDFGLAKL 449 (622)
Q Consensus 440 kl~Dfgla~~ 449 (622)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.3e-07 Score=93.66 Aligned_cols=259 Identities=15% Similarity=0.115 Sum_probs=154.0
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeee------eCCCc-eeE
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFC------MTPTE-RLL 374 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~------~~~~~-~~l 374 (622)
.....||+|+-+.+|-.--- + ..+.|+++........ +.+..|... .||-+-.=+.+- -+... .-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-h-chhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 35678999999999964311 1 1345776654322111 223333333 465433211111 11122 456
Q ss_pred EeeeccCCC-cccc------ccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccc
Q 036225 375 VYPYMSNGS-VASR------LKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447 (622)
Q Consensus 375 v~e~~~~gs-L~~~------l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 447 (622)
+|..+++.. +..+ .++.+..+|+-..+++..+|.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 677665531 1122 23456789999999999999999999999 9999999999999999999999886544
Q ss_pred eecCCCCCceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhc-CCccccchhcccccc-HH-HHHHH
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITG-QRALEYGKAANQKGA-ML-DWVKK 519 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg-~~p~~~~~~~~~~~~-~~-~~~~~ 519 (622)
... .........+|...|.+||.-. +..-+...|-|.|||++++++.| ++||..-........ .- +....
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 332 2233344567899999999764 33457789999999999999987 899874222111100 00 00000
Q ss_pred -HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHh
Q 036225 520 -IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL--PAHRPKMSEVVRMLE 572 (622)
Q Consensus 520 -~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~--p~~RPt~~evl~~L~ 572 (622)
+...++...-..+.-....-..-+..+..+..+|+... +.-||+++..+..|.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 00000000000000000011222356778888888754 567999998887764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.5e-09 Score=114.22 Aligned_cols=153 Identities=16% Similarity=0.253 Sum_probs=106.0
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce--------eeeecCcccccCccccc
Q 036225 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV--------TTAVRGTVGHIAPEYLS 474 (622)
Q Consensus 403 ~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 474 (622)
+.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+++........+. ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999874 89999999999999999999999999886554322111 11122456799999999
Q ss_pred cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHcc
Q 036225 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCT 554 (622)
Q Consensus 475 ~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 554 (622)
....+.++|+||+|+++|.+..|+.+............ .....+..-...+...-+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 98889999999999999999955444332221111000 01111111111233445578889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 036225 555 QYLPAHRPKMSEVVRM 570 (622)
Q Consensus 555 ~~~p~~RPt~~evl~~ 570 (622)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988877643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=7e-09 Score=116.18 Aligned_cols=72 Identities=29% Similarity=0.412 Sum_probs=44.7
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccc
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNI 195 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l 195 (622)
.+|+.|+|++|.|+ .+|.. .++|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+|..+. ..+++
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 35677777777777 45543 246777777777777 456432 35667777777776 5564322 34667
Q ss_pred cccccc
Q 036225 196 VGNPLI 201 (622)
Q Consensus 196 ~~N~~~ 201 (622)
++|++.
T Consensus 453 s~N~Ls 458 (788)
T PRK15387 453 EGNPLS 458 (788)
T ss_pred CCCCCC
Confidence 777763
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-08 Score=111.55 Aligned_cols=115 Identities=26% Similarity=0.445 Sum_probs=79.4
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 47788888888884 565543 57888888888888 5676554 36888888888887 6777664 478888888
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~~ 201 (622)
+|+|+ .+|..+. ++|+.|+|++|+|++ +|... ...+++++|.+.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLT 317 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccc
Confidence 88887 5676554 478888888888874 33321 134555666553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.1e-08 Score=112.89 Aligned_cols=116 Identities=27% Similarity=0.423 Sum_probs=71.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|+++. +|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 221 nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 46788888888874 565443 36777777777777 6666554 46777777777777 5666553 467777777
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---ccccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPLIC 202 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~~c 202 (622)
+|+|+ .+|..+. ++|+.|+|++|+|++ +|... .+.+.+.+|.+.+
T Consensus 292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 292 DNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTS 339 (754)
T ss_pred CCccc-cCcccch--hhHHHHHhcCCcccc-CCccccccceeccccCCcccc
Confidence 77777 4554432 356666666666663 23211 1344555555544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.9e-09 Score=109.57 Aligned_cols=100 Identities=30% Similarity=0.516 Sum_probs=62.5
Q ss_pred EecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccc
Q 036225 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157 (622)
Q Consensus 78 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 157 (622)
|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.|.+|+.|++..|++. .+|..+..|+ |..||+|+|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 334444443 45555565566666666666665 55556666666666666666666 5566665443 66677777777
Q ss_pred ccccccccccccceeEEeCCCCcCC
Q 036225 158 SGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
+ .||..|.+|+.|++|-|.+|+|.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC
Confidence 6 67777777777777777777776
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.7e-09 Score=108.99 Aligned_cols=121 Identities=36% Similarity=0.549 Sum_probs=107.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|||+.|.++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 3678999999998 6788888876 999999999999 99999999999999999999999 899999999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
.|++. .+|..+..| .|..||+|+|+++ .||-.+. +.+.|.+||+.
T Consensus 198 Rn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 99999 888888855 5999999999999 7776553 45778999984
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=5e-08 Score=109.43 Aligned_cols=113 Identities=27% Similarity=0.358 Sum_probs=66.8
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCc---cCC-------------C-CcccEEEecCccccCCC
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE---IGR-------------L-TKLQTLDLSNNFFTGEI 137 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~-------------l-~~L~~L~Ls~N~l~~~~ 137 (622)
+..|+|++|+++. +|. .+++|+.|+|++|+|++ +|.. +.. + .+|+.|+|++|+|+ .+
T Consensus 284 L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~L 357 (788)
T PRK15387 284 LCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SL 357 (788)
T ss_pred cCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CC
Confidence 3445666666653 343 24678888888888774 3331 111 1 36888888888888 56
Q ss_pred CchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC--cccccccccccc
Q 036225 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--AKTFNIVGNPLI 201 (622)
Q Consensus 138 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~N~~~ 201 (622)
|... .+|+.|++++|+|+ .+|... .+|+.|+|++|+|++ +|... .+.+++++|.+.
T Consensus 358 P~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N~Ls 415 (788)
T PRK15387 358 PTLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPSELKELMVSGNRLT 415 (788)
T ss_pred CCCC---cccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCcccCCCEEEccCCcCC
Confidence 6532 45666677777776 455432 456777777777764 44322 244566666653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.2e-09 Score=100.44 Aligned_cols=117 Identities=23% Similarity=0.291 Sum_probs=96.5
Q ss_pred CccceEEcCC-----CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCC
Q 036225 63 SWTMVTCSPE-----SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137 (622)
Q Consensus 63 ~w~gv~C~~~-----~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 137 (622)
+..-++|-+. ..|..|++++|+|... ..+..|++|+.||||+|.++ .+-..-.+|-+.+.|.|+.|.|. .+
T Consensus 292 S~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L 367 (490)
T KOG1259|consen 292 SGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL 367 (490)
T ss_pred cccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh
Confidence 3445666543 2488999999999865 34889999999999999999 66667778899999999999998 33
Q ss_pred CchhccccCccceeccccccccccc--cccccccceeEEeCCCCcCCCcC
Q 036225 138 PSSLGHLRSLQYMRFNNNSLSGAFP--TSLASMTQLIFLDLSYNNLSGPV 185 (622)
Q Consensus 138 p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~g~~ 185 (622)
..++.|-+|..||+++|+|. .+. ..++++|.|+.|.|.+|+|++.+
T Consensus 368 -SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 368 -SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred -hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccc
Confidence 45788889999999999998 332 57899999999999999999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-07 Score=89.76 Aligned_cols=106 Identities=18% Similarity=0.155 Sum_probs=84.4
Q ss_pred HHHHHHHHHHhccccc--cceeeeeeeeCCC----ceeEEeeeccCC-CccccccCCCCCChhHHHHHHHHHHHHHHHHH
Q 036225 342 IQFQTEVEMISLAVHR--NLLRLYGFCMTPT----ERLLVYPYMSNG-SVASRLKGKPILDWSTRKRIALGAARGLLYLH 414 (622)
Q Consensus 342 ~~~~~e~~~l~~l~H~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH 414 (622)
....+|.+.+..+... ...+++++..... ..++|+|++++. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3577888887777533 3556666665432 347999999874 78888876444667778899999999999999
Q ss_pred hcCCCCeeecCCCCCCeeecCCC---ceEEcccccceec
Q 036225 415 EQCDPKIIHRDVKAANILLDDCC---EAVVGDFGLAKLL 450 (622)
Q Consensus 415 ~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~ 450 (622)
.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 136 ~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 999999999999999877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.4e-08 Score=98.47 Aligned_cols=91 Identities=23% Similarity=0.263 Sum_probs=66.1
Q ss_pred cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccce
Q 036225 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQL 171 (622)
Q Consensus 92 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 171 (622)
.|..|++|+.|+|++|+|++.-+..|.++..|++|+|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 36677777777777777777667777777777777777777774444557777777777777777776667777777777
Q ss_pred eEEeCCCCcCC
Q 036225 172 IFLDLSYNNLS 182 (622)
Q Consensus 172 ~~l~l~~N~l~ 182 (622)
..|+|-.|++.
T Consensus 349 ~~l~l~~Np~~ 359 (498)
T KOG4237|consen 349 STLNLLSNPFN 359 (498)
T ss_pred eeeehccCccc
Confidence 77777776664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.8e-09 Score=87.93 Aligned_cols=103 Identities=23% Similarity=0.330 Sum_probs=62.9
Q ss_pred EEEecCCCCCccccCC---cccCCCcccEEEccCCCCCCCCCCccCC-CCcccEEEecCccccCCCCchhccccCcccee
Q 036225 76 IGLGIPSQNLSGTLSP---SIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 76 ~~L~l~~n~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
-.++|+++.|- .+++ .+.....|+..+|++|.+. .+|..|.. .+.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34555555544 2222 2344455666677777776 44544443 346667777777776 6666677777777777
Q ss_pred ccccccccccccccccccceeEEeCCCCcCC
Q 036225 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 152 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
+++|.|. ..|..+..|.+|-.|+..+|.+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 7777776 55666666666667776666665
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.4e-07 Score=85.97 Aligned_cols=154 Identities=21% Similarity=0.235 Sum_probs=97.8
Q ss_pred CHHHHHHHHhCCCcCCe---eeecCCceEEEEEECCCeEEEEEEccCCCCCchh--------HH---------------H
Q 036225 291 QFRELQVATHNFSSKNI---LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGE--------IQ---------------F 344 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------~~---------------~ 344 (622)
+...+........+... |+.|--+.||+|...++..+|||+++.....-.. .. .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34445444555555444 4566667899999888999999998643211100 00 2
Q ss_pred HHHHHHHhccc--cccceeeeeeeeCCCceeEEeeeccCC-CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCe
Q 036225 345 QTEVEMISLAV--HRNLLRLYGFCMTPTERLLVYPYMSNG-SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421 (622)
Q Consensus 345 ~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 421 (622)
.+|+.-|.++. +-.+.+.+++ ..-.|||||+... .-.-.|+.-+ +.......+..++++.+.-|-..+ ++
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l~~~a--~L 188 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRLYKEA--GL 188 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence 33444444442 2233333333 2347999999653 2222333222 233356777888888888887643 99
Q ss_pred eecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 422 vH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccCC
Confidence 9999999999999 79999999999875543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3e-07 Score=98.93 Aligned_cols=141 Identities=23% Similarity=0.285 Sum_probs=94.4
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCC---------------------c------------------hhHHHH
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI---------------------G------------------GEIQFQ 345 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~------------------~~~~~~ 345 (622)
.+.|+.++-|.||+|++++|+.||||+.+..-.. . .+.++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 3689999999999999999999999987542110 0 011244
Q ss_pred HHHHHHhccc-----cccceeeeeeeeCCCceeEEeeeccCCCccccc--cCCCCCChhHHHHHHHHHHHHH-HHHHhcC
Q 036225 346 TEVEMISLAV-----HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAARGL-LYLHEQC 417 (622)
Q Consensus 346 ~e~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~ 417 (622)
+|..-+.+++ .+++.-..=|..-.+...|+|||++|-.+.+.. +. ..++ +..++..++++. ..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhc-
Confidence 4555444442 233322222333456779999999999888874 33 3344 333444333332 223234
Q ss_pred CCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 418 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
|++|.|.+|.||+++.+|++-+.|||+...++.
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.50 E-value=3e-07 Score=110.46 Aligned_cols=122 Identities=24% Similarity=0.306 Sum_probs=65.8
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.|+|++|++. .++..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..+.++++|+.|+|++
T Consensus 613 L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~ 690 (1153)
T PLN03210 613 LVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690 (1153)
T ss_pred CcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence 455556555554 345555556666666666554333555 355566666666666554445666666666666666665
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc--ccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA--KTFNIVGNP 199 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~~~~l~~N~ 199 (622)
|..-+.+|..+ ++++|+.|+|++|...+.+|.... +.+.+.+|.
T Consensus 691 c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 691 CENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETA 736 (1153)
T ss_pred CCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCc
Confidence 43333555544 456666666666554444443221 234444444
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-08 Score=104.90 Aligned_cols=111 Identities=24% Similarity=0.323 Sum_probs=82.0
Q ss_pred CcEEEEecCCCCCccccCCcccCCCc---ccEEEccCCCCCC----CCCCccCCC-CcccEEEecCccccCC----CCch
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTN---LQIVLLQNNNITG----PIPAEIGRL-TKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
..++.|+|++|.+.+..+..+..+.. |++|+|++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 46888999988888766666666655 9999999988873 233345566 8889999999988843 3345
Q ss_pred hccccCccceeccccccccc----cccccccccceeEEeCCCCcCCC
Q 036225 141 LGHLRSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 66677899999999988742 34455566789999999988874
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-09 Score=113.06 Aligned_cols=121 Identities=31% Similarity=0.440 Sum_probs=85.6
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCch-hccccCccceecccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS-LGHLRSLQYMRFNNN 155 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N 155 (622)
..+.+.|.|. .+..++.-++.|+.|||++|+++. .. .+-.|++|+.|||++|.|. .+|.. ...+. |+.|+|+||
T Consensus 168 ~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN 242 (1096)
T KOG1859|consen 168 TASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNN 242 (1096)
T ss_pred hhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeeccc
Confidence 4455555555 455677778888888888888883 33 6778888888888888888 66643 33344 888888888
Q ss_pred ccccccccccccccceeEEeCCCCcCCCcCCCC------CccccccccccccccC
Q 036225 156 SLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF------SAKTFNIVGNPLICAT 204 (622)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~------~~~~~~l~~N~~~c~~ 204 (622)
.++ .+ ..+.+|.+|..|||++|-|++--.-. ....++|.|||.-|.+
T Consensus 243 ~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 243 ALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred HHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 887 33 45778888888888888887532111 1156788888887763
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.9e-08 Score=110.11 Aligned_cols=101 Identities=27% Similarity=0.436 Sum_probs=86.8
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|||++|.+. ..|..+..+.+|+.|+++.|-|. .+|.+..++.+|++|+|.+|.+. .+|.++..+++|++|+++.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 678888877766 67888888999999999999998 88888889999999999999988 8899999999999999999
Q ss_pred cccccccccccccccceeEEeCCCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
|+|. .+|..+..+..+..+..++|
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcc
Confidence 9998 88888877777777777777
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.2e-09 Score=88.12 Aligned_cols=113 Identities=15% Similarity=0.209 Sum_probs=91.7
Q ss_pred CCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 72 ESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 72 ~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
..+++.++|++|.+....+..-..++.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|-.|+
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 456899999999999654444455679999999999999 89999999999999999999999 8888888899999999
Q ss_pred ccccccccccccccccccceeEEeCCCCcCCCcCCC
Q 036225 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 152 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
..+|.+. .+|..+.--.++-..++.+|++.+.-|.
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 9999998 7776543333344456677777766553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.7e-06 Score=81.85 Aligned_cols=133 Identities=15% Similarity=0.108 Sum_probs=85.5
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc--ceeeeeeeeCCCceeEEeeeccCC
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
-..||+|..+.||+.. |..+++|...... ......+|.+++..+..-. +.+++++....+...+|||+++|.
T Consensus 6 ~~~i~~G~t~~~y~~~---~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 6 WTQTGEGGNGESYTHK---TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred heeecCCCCcceeEec---CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 3578999999999842 4467888876533 2335678999998886433 467778877777788999999986
Q ss_pred C-ccccccCCCCCChhHHHHHHHHHHHHH---------------------------------------HHHHhc-CCCCe
Q 036225 383 S-VASRLKGKPILDWSTRKRIALGAARGL---------------------------------------LYLHEQ-CDPKI 421 (622)
Q Consensus 383 s-L~~~l~~~~~l~~~~~~~i~~~ia~~L---------------------------------------~~LH~~-~~~~i 421 (622)
. +...+.. +......++.++++.+ .+|... ..+.+
T Consensus 80 ~~~~~~~~~----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 80 RSFSRIISD----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cchhhhhcC----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 3 2111110 0011111112222222 222211 13457
Q ss_pred eecCCCCCCeeecCCCceEEcccccce
Q 036225 422 IHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 422 vH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+|+|+.|.||++++++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.6e-08 Score=100.20 Aligned_cols=111 Identities=26% Similarity=0.398 Sum_probs=87.7
Q ss_pred CcEEEEecCCCCCcc----ccCCcccCC-CcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCC----CCc
Q 036225 73 SLVIGLGIPSQNLSG----TLSPSIGNL-TNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPS 139 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 139 (622)
..+..|++++|++.+ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 348999999999884 334456677 8999999999999953 344567788999999999999853 334
Q ss_pred hhccccCccceeccccccccc----cccccccccceeEEeCCCCcCCC
Q 036225 140 SLGHLRSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 140 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
.+..+++|++|+|++|.+++. ++..+..+++|+.|++++|++++
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 456667999999999998743 44566778899999999999985
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.4e-07 Score=106.63 Aligned_cols=108 Identities=24% Similarity=0.294 Sum_probs=89.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|...+.+|.++++|++|+.|+|++|...+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 47788999998888899999999999999999876555888766 7899999999998655566653 3678999999
Q ss_pred ccccccccccccccccceeEEeCCC-CcCCCcCCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSY-NNLSGPVPR 187 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~g~~p~ 187 (622)
+|.++ .+|.++..+++|+.|+|++ |+|.+ +|.
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~ 887 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSL 887 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cCc
Confidence 99998 7899999999999999988 56654 543
|
syringae 6; Provisional |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-06 Score=79.67 Aligned_cols=138 Identities=13% Similarity=0.127 Sum_probs=91.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHH---------HHHHHHHHhccccc---cceeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ---------FQTEVEMISLAVHR---NLLRLYG 364 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~l~H~---niv~l~~ 364 (622)
+...+|...+++-......|.+-..+ |..+++|..+...... ++. ..+++..+.+++.. ....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45667777777777776666666554 7889999887654322 222 22333333344322 2223233
Q ss_pred eee-----CCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 365 FCM-----TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 365 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
... .....+++|||++|..|.+... ++. .++..+++++.-+|+. |++|+|..|.|++++++ .+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cE
Confidence 322 2244578999999988876543 222 3456778889999999 99999999999999964 49
Q ss_pred EEcccccce
Q 036225 440 VVGDFGLAK 448 (622)
Q Consensus 440 kl~Dfgla~ 448 (622)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3e-07 Score=97.93 Aligned_cols=102 Identities=31% Similarity=0.542 Sum_probs=64.7
Q ss_pred EEEEecCCCCCccccCCcccCCC-cccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLT-NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
+..|++.+|+++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 566666666666 3445555553 6666666666666 55556666666666666666666 566555566666666666
Q ss_pred ccccccccccccccccceeEEeCCCCc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNN 180 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~ 180 (622)
+|+++ .+|.....+..|+.|.+++|+
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 66666 566555455556666666664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.6e-06 Score=78.67 Aligned_cols=136 Identities=18% Similarity=0.104 Sum_probs=99.1
Q ss_pred eeecCCceEEEEEECCCeEEEEEEccCC--C--C-CchhHHHHHHHHHHhcccccc--ceeeeeeee-C--C--CceeEE
Q 036225 308 LGKGGFGIVYKGILQDGTVVAVKRLKDG--N--A-IGGEIQFQTEVEMISLAVHRN--LLRLYGFCM-T--P--TERLLV 375 (622)
Q Consensus 308 lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~--~-~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~-~--~--~~~~lv 375 (622)
-|+||-+-|+....+ |..+-+|+-... . . +-+...|.+|+..+.++...+ +.++. ++. . + -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366888889987776 446888875411 0 1 335567999999999886433 44444 332 1 1 234799
Q ss_pred eeeccC-CCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--eEEcccccce
Q 036225 376 YPYMSN-GSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--AVVGDFGLAK 448 (622)
Q Consensus 376 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~ 448 (622)
+|-+++ -+|.+++... ...+...+..++.+++..+.-||.. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998763 4777777543 2346677789999999999999999 9999999999999986666 9999998765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.7e-07 Score=97.77 Aligned_cols=180 Identities=18% Similarity=0.141 Sum_probs=132.0
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc-ceeeeeeeeCCCceeEEeeeccCC-C
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLYGFCMTPTERLLVYPYMSNG-S 383 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~g-s 383 (622)
+-.++|+++.+||.+..-.+....+.+... ....-++++|.+.+||| .+..++-+..++..+++++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 456899999999977432333335554322 34557889999999999 777778888888899999999887 2
Q ss_pred ccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeec
Q 036225 384 VASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462 (622)
Q Consensus 384 L~~~l-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 462 (622)
-.... ...-.+..-+...+...-.++++|+|+. .-+|+| ||+..+ +..+..||+....+.... ......
T Consensus 322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred ccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 22222 2222234444455667778899999986 458998 777766 788999999987665433 344556
Q ss_pred CcccccCccccccCCCCcccceeehhHHHHHHHhcCCcc
Q 036225 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 501 (622)
Q Consensus 463 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~ 501 (622)
+++.++|||+.....+..+.|+|++|+-..++--|-+|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999999777777666554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1e-05 Score=79.14 Aligned_cols=140 Identities=18% Similarity=0.151 Sum_probs=83.2
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccc--cceeeeeeeeC---CCceeEEeeec
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLYGFCMT---PTERLLVYPYM 379 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~---~~~~~lv~e~~ 379 (622)
++.++.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999999887 58999986543 2345677888888877543 34566664432 33468999999
Q ss_pred cCCCccc----------------cc---cCC----CCCChhHH---------HHH------------HHHHHH-HHHHHH
Q 036225 380 SNGSVAS----------------RL---KGK----PILDWSTR---------KRI------------ALGAAR-GLLYLH 414 (622)
Q Consensus 380 ~~gsL~~----------------~l---~~~----~~l~~~~~---------~~i------------~~~ia~-~L~~LH 414 (622)
++..+.. .+ +.. ....+... ... ...+.+ .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887766 01 010 11111110 000 111222 333333
Q ss_pred hc----CCCCeeecCCCCCCeeec-CCCceEEcccccce
Q 036225 415 EQ----CDPKIIHRDVKAANILLD-DCCEAVVGDFGLAK 448 (622)
Q Consensus 415 ~~----~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~ 448 (622)
+. ....++|+|+.+.|||++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234799999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.6e-07 Score=94.81 Aligned_cols=123 Identities=26% Similarity=0.437 Sum_probs=98.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|++++|.+. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|.++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 5888999999998 45678899999999999999999 88877779999999999999999 888887777789999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCc--CC-CC-Cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGP--VP-RF-SAKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~--~p-~~-~~~~~~l~~N~~ 200 (622)
+|.+. .++..+.++.++..+.+++|++... .. .. ..+.+++++|..
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccc
Confidence 99755 5677788888888888888887641 11 11 124556666665
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-06 Score=60.88 Aligned_cols=36 Identities=47% Similarity=0.672 Sum_probs=17.3
Q ss_pred cccEEEccCCCCCCCCCCccCCCCcccEEEecCcccc
Q 036225 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT 134 (622)
Q Consensus 98 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 134 (622)
+|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4455555555555 34444555555555555555554
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-06 Score=60.07 Aligned_cols=37 Identities=41% Similarity=0.685 Sum_probs=24.7
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccc
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLS 158 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 158 (622)
++|++|+|++|+|+ .+|..+.+|++|+.|++++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 36777777777777 56666777777777777777776
|
... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.3e-05 Score=88.77 Aligned_cols=80 Identities=11% Similarity=0.276 Sum_probs=58.6
Q ss_pred CCeeeecCCceEEEEEECCC---eEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccc--eeeeeeeeCC---CceeEE
Q 036225 305 KNILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNL--LRLYGFCMTP---TERLLV 375 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv 375 (622)
.+.++.|.+..+|+....++ ..+++|+............+.+|+++++.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 4677887654332223346889999999885 6664 7888888764 467899
Q ss_pred eeeccCCCc
Q 036225 376 YPYMSNGSV 384 (622)
Q Consensus 376 ~e~~~~gsL 384 (622)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 622 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-132 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-129 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 2r9u_A | 174 | Crystal Structure Of Lamprey Variable Lymphocyte Re | 8e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain Length = 174 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 586 bits (1513), Expect = 0.0
Identities = 232/325 (71%), Positives = 267/325 (82%), Gaps = 5/325 (1%)
Query: 271 FFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVK 330
FFDV EV LG L+RF RELQVA+ NFS+KNILG+GGFG VYKG L DGT+VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 331 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL-- 388
RLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMTPTERLLVYPYM+NGSVAS L
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 389 --KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446
+ +P LDW R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506
AKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQRA + +
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 507 ANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMS 565
AN ML DWVK + +EKKLE LVD DL+ NY E+E+++QVALLCTQ P RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 566 EVVRMLEGDGLAERWEASQRAEATK 590
EVVRMLEGDGLAERWE Q+ E +
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFR 325
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 428 bits (1104), Expect = e-148
Identities = 116/313 (37%), Positives = 175/313 (55%), Gaps = 23/313 (7%)
Query: 276 ERHHEEVSLGNLRRFQFRELQVATHNFSSK------NILGKGGFGIVYKGILQDGTVVAV 329
E EVS F F EL+ T+NF + N +G+GGFG+VYKG + + T VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 330 KRLKDGNAIG---GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVAS 386
K+L I + QF E+++++ H NL+ L GF + LVY YM NGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 387 RL---KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443
RL G P L W R +IA GAA G+ +LHE IHRD+K+ANILLD+ A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 444 FGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502
FGLA+ + + +T+ + GT ++APE L G+ + K+D++ FG++LLE+ITG A++
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 503 YGKAANQKGAMLDWVKKIHQEKK-LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR 561
+ + +LD ++I E+K +E +DK + N+ D +E M VA C R
Sbjct: 236 EHR---EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 562 PKMSEVVRMLEGD 574
P + +V ++L+
Sbjct: 292 PDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-133
Identities = 108/294 (36%), Positives = 164/294 (55%), Gaps = 10/294 (3%)
Query: 286 NLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQ 345
R +L+ AT+NF K ++G G FG VYKG+L+DG VA+KR ++ G E +F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFE 83
Query: 346 TEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP----ILDWSTRKR 401
TE+E +S H +L+ L GFC E +L+Y YM NG++ L G + W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL-LDHQDSHVTTA 460
I +GAARGL YLH + IIHRDVK+ NILLD+ + DFG++K + +H++T
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520
V+GT+G+I PEY G+ +EK+DV+ FG++L E++ + A+ + +W +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVES 259
Query: 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574
H +LE +VD +L + L + A+ C RP M +V+ LE
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 4e-79
Identities = 69/318 (21%), Positives = 120/318 (37%), Gaps = 28/318 (8%)
Query: 278 HHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA 337
H + L + + +G FG V+K L VAVK +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD- 59
Query: 338 IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP----TERLLVYPYMSNGSVASRLKGKPI 393
Q + EV + H N+L+ G + L+ + GS++ LK
Sbjct: 60 -KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 394 LDWSTRKRIALGAARGLLYLHE-------QCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446
+ W+ IA ARGL YLHE P I HRD+K+ N+LL + A + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 447 AKLLDH-QDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRA 500
A + + + T GT ++APE L + + D++ G++L EL + A
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD-----LKNNYDRIE-LEEMVQVALLCT 554
+ G + + + + ++ +V L++ + + + + + C
Sbjct: 238 AD-GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 555 QYLPAHRPKMSEVVRMLE 572
+ R V +
Sbjct: 297 DHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-63
Identities = 75/342 (21%), Positives = 128/342 (37%), Gaps = 46/342 (13%)
Query: 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVE 349
E + N ++G+G +G VYKG L D VAVK N F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKN 57
Query: 350 MISLAV--HRNLLRLYGFCMTP-----TERLLVYPYMSNGSVASRLKGKPILDWSTRKRI 402
+ + + H N+ R E LLV Y NGS+ L DW + R+
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRL 116
Query: 403 ALGAARGLLYLHE------QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH---- 452
A RGL YLH P I HRD+ + N+L+ + V+ DFGL+ L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 453 ---QDSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELITGQRALE 502
++ + + GT+ ++APE L + ++ D++ G++ E+ L
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 503 YGKAANQ-KGAMLDWVKKIHQEKKLEMLVDKD-----LKNNY--DRIELEEMVQVALLCT 554
G++ + + A V + +++LV ++ + + + + + + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 555 QYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEF 596
R + L WE R ++ H
Sbjct: 297 DQDAEARLTAQXAEERMA--ELMMIWE---RNKSVSPTAHHH 333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 36/288 (12%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEM 350
+ +L + K +G G FG V++ G+ VAVK L + + + F EV +
Sbjct: 36 WCDLNI-------KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL---KGKPILDWSTRKRIALGAA 407
+ H N++ G P +V Y+S GS+ L + LD R +A A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
+G+ YLH +P I+HR++K+ N+L+D V DFGL++L + + GT
Sbjct: 148 KGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEW 205
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQ---RALEYGKAANQKGAMLDWVKKIHQEK 524
+APE L S+EK+DV+ FG++L EL T Q L + G K
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-----------FK 254
Query: 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + ++L ++ + C P RP + ++ +L
Sbjct: 255 CKRLEIPRNL--------NPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 82/309 (26%), Positives = 140/309 (45%), Gaps = 44/309 (14%)
Query: 283 SLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGE 341
++G + R +A + + +GKGGFG+V+KG L D +VVA+K L G++ G
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 342 I------QFQTEVEMISLAVHRNLLRLYGFCMTP----TERLLVYPYMSNGSVASRLKGK 391
+FQ EV ++S H N+++LYG P E ++ G + RL K
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME------FVPCGDLYHRLLDK 115
Query: 392 PI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV-----VGDFG 445
+ WS + R+ L A G+ Y+ +P I+HRD+++ NI L E V DFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELITGQRALEY 503
L++ Q H + + G +APE + + +EK D + F ++L ++TG+ +
Sbjct: 175 LSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--F 228
Query: 504 GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK 563
+ + K ++ + + + + D + V LC P RP
Sbjct: 229 DEYSYGKIKFINMI--REEGLRPTIPEDCP----------PRLRNVIELCWSGDPKKRPH 276
Query: 564 MSEVVRMLE 572
S +V+ L
Sbjct: 277 FSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-57
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
++E++V + ++G+G FG+V K + VA+K+++ + F E+ +
Sbjct: 7 YKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK---AFIVELRQL 55
Query: 352 SLAVHRNLLRLYGFCMTP----TERLLVYPYMSNGSVASRL---KGKPILDWSTRKRIAL 404
S H N+++LYG C+ P E Y GS+ + L + P + L
Sbjct: 56 SRVNHPNIVKLYGACLNPVCLVME------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRG 463
++G+ YLH +IHRD+K N+LL + + DFG A + T +G
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKG 165
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523
+ +APE SEK DVF +GI+L E+IT ++ + G + +H
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--F---DEIGGPAFRIMWAVHNG 220
Query: 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ ++ + + + + C P+ RP M E+V+++
Sbjct: 221 TRPPLIKNLP----------KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-56
Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 45/295 (15%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEI---QFQTEV 348
F EL + + I+G GGFG VY+ G VAVK + + E
Sbjct: 6 FAELTL-------EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 349 EMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR 408
++ ++ H N++ L G C+ LV + G + L GK + A+ AR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIAR 116
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAV--------VGDFGLAKLLDHQDSHVTTA 460
G+ YLH++ IIHRD+K++NIL+ E + DFGLA+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMS 173
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ---RALEYGKAANQKGAMLDWV 517
G +APE + S+ +DV+ +G+LL EL+TG+ R ++ A
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------ 227
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
KL + + E ++ C P RP + ++ L
Sbjct: 228 -----MNKLALPIPSTC--------PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-56
Identities = 69/283 (24%), Positives = 106/283 (37%), Gaps = 34/283 (12%)
Query: 305 KNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+LGKG FG K + G V+ +K L + + F EV+++ H N+L+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKII 422
G + Y+ G++ +K WS R A A G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT-------------TAVRGTVGHIA 469
HRD+ + N L+ + VV DFGLA+L+ + + V G +A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529
PE ++ EK DVF FGI+L E+I A + L+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------VRGFLDRY 243
Query: 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + + C P RP ++ LE
Sbjct: 244 CPPNC--------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-53
Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 41/310 (13%)
Query: 289 RFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEV 348
R R++ + +GKG +G V++G Q G VAVK + E + E
Sbjct: 4 RTVARDITL-------LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRET 51
Query: 349 EMISLAV--HRNLLRLYGFCMT----PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRI 402
E+ + + H N+L MT T+ L+ Y GS+ L+ LD + RI
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRI 110
Query: 403 ALGAARGLLYLHE-----QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457
L A GL +LH Q P I HRD+K+ NIL+ + + D GLA + + +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 458 ---TTAVRGTVGHIAPE------YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508
GT ++APE + S ++ D++ FG++L E+ R + G +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVED 228
Query: 509 QKGAMLDWV-KKIHQEKKLEMLVDKDL-----KNNYDRIELEEMVQVALLCTQYLPAHRP 562
K D V E +++ + L + ++ C P+ R
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 563 KMSEVVRMLE 572
+ + L
Sbjct: 289 TALRIKKTLT 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEM 350
F +L++ ++GKG FG VY G G V A++ + +++ F+ EV
Sbjct: 32 FEQLEI-------GELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMA 82
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARG 409
H N++ G CM+P ++ ++ S + K +LD + ++IA +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH----QDSHVTTAVRGTV 465
+ YLH + I+H+D+K+ N+ D+ V+ DFGL + + G +
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 466 GHIAPEYLSTGQS---------SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516
H+APE + S+ +DVF G + EL + + Q + W
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPF---KTQPAEAIIW 253
Query: 517 VKKIHQEKKLEMLVDKDLKNNYDRIEL-EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ +K N +I + +E+ + L C + RP ++++ MLE
Sbjct: 254 Q------------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFC 366
+G G FG VYKG G V AVK L ++Q F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 367 MTP-----TERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
P T+ + S+ L + + IA ARG+ YLH +
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---S 140
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLSTGQS- 478
IIHRD+K+ NI L + +GDFGLA SH + G++ +APE + S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 479 --SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
S ++DV+ FGI+L EL+TGQ L + ++++ +EM+ L
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ---------------LPYSNINNRDQIIEMVGRGSLSP 245
Query: 537 NYDRIEL---EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ ++ + M ++ C + RP ++ +E
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 51/295 (17%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEM 350
F++L L + G ++KG Q G + VK LK + + + F E
Sbjct: 9 FKQLNF-------LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 351 ISLAVHRNLLRLYGFCMTPTERLL--VYPYMSNGSVASRL--KGKPILDWSTRKRIALGA 406
+ + H N+L + G C +P + +M GS+ + L ++D S + AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
ARG+ +LH +P I + + ++++D+ A + + S +
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 467 HIAPEYLSTGQS---SEKTDVFGFGILLLELITGQR------ALEYGKAANQKGAMLDWV 517
+APE L D++ F +LL EL+T + +E G +G
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
I + ++ +C PA RPK +V +LE
Sbjct: 234 PGIS----------------------PHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 68/296 (22%), Positives = 110/296 (37%), Gaps = 40/296 (13%)
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLY 363
+GKG +G V+ G + G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 364 GFCMTP----TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE---- 415
+ T+ L+ Y NGS+ LK LD + ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 416 -QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV---TTAVRGTVGHIAPE 471
Q P I HRD+K+ NIL+ + D GLA + V GT ++ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 472 ------YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
+ QS D++ FG++L E+ + + L + + +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG-----IVEEYQLPYHDLVPSDPS 271
Query: 526 LEMLVDKDLKNNY---------DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
E + + L +M ++ C + PA R V + L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 71/293 (24%), Positives = 114/293 (38%), Gaps = 34/293 (11%)
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLY 363
+GKG FG V++G + G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 364 GFCM----TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE---- 415
T T+ LV Y +GS+ L + ++AL A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 416 -QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT---TAVRGTVGHIAPE 471
Q P I HRD+K+ NIL+ + D GLA D + GT ++APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 472 YL------STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
L +S ++ D++ G++ E+ R G + + D V ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIAR--RCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 526 LEMLVDKD-----LKNNYDRIE-LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ +V + + N + E L M ++ C A R + + L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 33/187 (17%)
Query: 33 EVQALMGVKHSLHDPHGVLENWDEDA-VDPCSWTMVTCSPESL---VIGLGIPSQNLSGT 88
+ QAL+ +K L +P L +W +W V C ++ V L + NL
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 89 LS---------------------------PSIGNLTNLQIVLLQNNNITGPIPAEIGRLT 121
P+I LT L + + + N++G IP + ++
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 122 KLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLI-FLDLSYNN 180
L TLD S N +G +P S+ L +L + F+ N +SGA P S S ++L + +S N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 181 LSGPVPR 187
L+G +P
Sbjct: 186 LTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 6/134 (4%)
Query: 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF 132
L + I L+G + P+ NL NL V L N + G G Q + L+ N
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 133 FTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF---- 188
++ +G ++L + NN + G P L + L L++S+NNL G +P+
Sbjct: 233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 189 SAKTFNIVGNPLIC 202
N +C
Sbjct: 292 RFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+L+ L +G NL + L+NN I G +P + +L L +L++S N GEIP G+
Sbjct: 232 SLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GN 289
Query: 144 LRSLQYMRF-NNNSLSGA 160
L+ + NN L G+
Sbjct: 290 LQRFDVSAYANNKCLCGS 307
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 62/313 (19%)
Query: 273 DVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTV-VAVKR 331
D +HE++ LG +G+G FG V+ G L+ VAVK
Sbjct: 107 DKWVLNHEDLVLGE--------------------QIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 332 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG- 390
++ + +F E ++ H N++RL G C +V + G + L+
Sbjct: 147 CRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206
Query: 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
L T ++ AA G+ YL + IHRD+ A N L+ + + DFG+++
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263
Query: 451 DHQDSHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYG 504
+ V+ T APE L+ G+ S ++DV+ FGILL E + G Y
Sbjct: 264 ADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP--YP 317
Query: 505 KAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPA 559
+NQ+ + ++ R+ + + ++ C Y P
Sbjct: 318 NLSNQQ-------------------TREFVEKGG-RLPCPELCPDAVFRLMEQCWAYEPG 357
Query: 560 HRPKMSEVVRMLE 572
RP S + + L+
Sbjct: 358 QRPSFSTIYQELQ 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-40
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLYG 364
+G+G F VYKG+ + VA L+D E +F+ E EM+ H N++R Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 365 FCMTPTE---RLLVYP-YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ + +++ M++G++ + LK ++ + +GL +LH P
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 421 IIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
IIHRD+K NI + +V +GD GLA L + AV GT +APE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK-YD 207
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK---LEMLVDKDLKN 536
E DV+ FG+ +LE+ T + ++ +++ K + + ++K
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 260
Query: 537 NYDRIELEEMVQVALLCTQYLPAHRP 562
+ IE C + R
Sbjct: 261 --EIIE---------GCIRQNKDERY 275
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-39
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
LSGT+ S+G+L+ L+ + L N + G IP E+ + L+TL L N TGEIPS L +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAK-----TFNIVGN 198
+L ++ +NN L+G P + + L L LS N+ SG +P ++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 199 PLICATGSEPDCYGTQLMPMSMNLNS 224
G+ P Q ++ N +
Sbjct: 549 LF---NGTIPAAMFKQSGKIAANFIA 571
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-38
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
G SP+ N ++ + + N ++G IP EIG + L L+L +N +G IP +G
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR---FSAKTFN---IVG 197
LR L + ++N L G P +++++T L +DLS NNLSGP+P F TF +
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPAKFLN 736
Query: 198 NPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHK 237
NP +C G L S+ RSH
Sbjct: 737 NPGLC---------GYPLPR---CDPSNADGYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 35/193 (18%)
Query: 26 SAKGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNL 85
++ + E+ L+ K L D +L +W + +PC++ VTC + V + + S+ L
Sbjct: 6 PSQSLYREIHQLISFKDVLPDK-NLLPDWSSNK-NPCTFDGVTCRDDK-VTSIDLSSKPL 62
Query: 86 SGTLS--------------------------PSIGNLTNLQIVLLQNNNITGPIPA--EI 117
+ S +L + L N+++GP+ +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 118 GRLTKLQTLDLSNNFFTGEIPSSLG-HLRSLQYMRFNNNSLSGAFPTSLA---SMTQLIF 173
G + L+ L++S+N S G L SL+ + + NS+SGA +L
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 174 LDLSYNNLSGPVP 186
L +S N +SG V
Sbjct: 183 LAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 35/103 (33%), Positives = 62/103 (60%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+G + P++ N + L + L N ++G IP+ +G L+KL+ L L N GEIP L +
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+++L+ + + N L+G P+ L++ T L ++ LS N L+G +P
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 40/106 (37%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 84 NLSGTLSPSIGN--LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
N SG + P++ LQ + LQNN TG IP + ++L +L LS N+ +G IPSSL
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
G L L+ ++ N L G P L + L L L +N+L+G +P
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-33
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 84 NLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP-SSL 141
+G + + G L + L N+ G +P G + L++L LS+N F+GE+P +L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMT-QLIFLDLSYNNLSGPVP 186
+R L+ + + N SG P SL +++ L+ LDLS NN SGP+
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-33
Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+L+G + + N TNL + L NN +TG IP IGRL L L LSNN F+G IP+ LG
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188
RSL ++ N N +G P ++ + ++ N ++G +
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-33
Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
N S + P +G+ + LQ + + N ++G I T+L+ L++S+N F G IP
Sbjct: 211 NFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-- 267
Query: 144 LRSLQYMRFNNNSLSGAFPTSLA-SMTQLIFLDLSYNNLSGPVP 186
L+SLQY+ N +G P L+ + L LDLS N+ G VP
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 37/107 (34%), Positives = 61/107 (57%), Gaps = 4/107 (3%)
Query: 84 NLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGRLT-KLQTLDLSNNFFTGEIPSSL 141
N SG L ++ + L+++ L N +G +P + L+ L TLDLS+N F+G I +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 142 GH--LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+LQ + NN +G P +L++ ++L+ L LS+N LSG +P
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 84 NLSGTLSPSI---GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
++SG L+ + + N I+G + + R L+ LD+S+N F+ IP
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF- 218
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
LG +LQ++ + N LSG F ++++ T+L L++S N GP+P
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP 267
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-32
Identities = 36/155 (23%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
L I +SG + + NL+ + + +NN + IP +G + LQ LD+S N +G+
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA------K 191
++ L+ + ++N G P + L +L L+ N +G +P F +
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 192 TFNIVGNPLICATGSEPDCYG--TQLMPMSMNLNS 224
++ GN G+ P +G + L ++++ N+
Sbjct: 298 GLDLSGNHF---YGAVPPFFGSCSLLESLALSSNN 329
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 2/105 (1%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNN--NITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
++G I N + N G ++ RL+ ++++ + G +
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ S+ ++ + N LSG P + SM L L+L +N++SG +P
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 6/107 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ SG + +G+ +L + L N G IPA + + + ++ NF G+ + +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
Query: 144 LRSLQ--YMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188
+ + N G L ++ +++ G
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 14/50 (28%), Positives = 22/50 (44%)
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
+ S+ N A +SL S+T L L LS ++++G V F
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK 97
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 65/284 (22%), Positives = 118/284 (41%), Gaps = 27/284 (9%)
Query: 305 KNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G FG V G VAVK LK + + E+E++ H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
++ G C L+ ++ +GS+ L K ++ + + A+ +G+ YL +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYL 473
+ +HRD+ A N+L++ + +GDFGL K + D T + APE L
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 474 STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
+ +DV+ FG+ L EL+T Y + + A+ + + +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 534 LKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
LK R+ +E+ Q+ C ++ P++R ++ E
Sbjct: 256 LKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 77/284 (27%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 306 NILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 362 LYGFCMTPTE-RLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
L G C+ L+V PYM +G + + + L A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--- 147
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI-----APEYLS 474
K +HRD+ A N +LD+ V DFGLA+ + ++ + + T + A E L
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQ 205
Query: 475 TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
T + + K+DV+ FG+LL EL+T G Y +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFD-------------------ITVY 244
Query: 534 LKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L R+ + + +V L C RP SE+V +
Sbjct: 245 LLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 59/284 (20%), Positives = 113/284 (39%), Gaps = 47/284 (16%)
Query: 306 NILGKGGFGIVYKGILQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+LG G FG VYKG+ VA+K L++ + + E +++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
RL G C+T T L+ M G + + + K + + A+G+ YL ++
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLS 474
+++HRD+ A N+L+ + DFGLAKLL ++ ++ A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESIL 192
Query: 475 TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
+ ++DV+ +G+ + EL+T G + Y + +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASE-------------------ISSI 231
Query: 534 LKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L+ R+ ++ + C RPK E++
Sbjct: 232 LEKGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 305 KNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LGKG FG V G VVAVK+L+ F+ E+E++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
++ G C + R L+ Y+ GS+ L+ K +D + +G+ YL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYL 473
+ IHRD+ NIL+++ +GDFGL K+L D I APE L
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESL 189
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
+ + S +DV+ FG++L EL T +++ + + I + +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIE 243
Query: 533 DLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
LKNN R+ +E+ + C RP ++ ++
Sbjct: 244 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 305 KNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G FG V G +VAVK LK ++ E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++ G C LV Y+ GS+ L + + + A G+ YLH Q
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAPE 471
IHRD+ A N+LLD+ +GDFGLAK + + G APE
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APE 207
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
L + +DV+ FG+ L EL+T + ++ + I Q + + +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 532 KDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ L+ R+ E+ + C + + RP ++ +L+
Sbjct: 262 ELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 305 KNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LGKG FG V G VVAVK+L+ F+ E+E++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNI 104
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
++ G C + R L+ Y+ GS+ L+ K +D + +G+ YL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYL 473
+ IHRD+ NIL+++ +GDFGL K+L D I APE L
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESL 220
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
+ + S +DV+ FG++L EL T +++ + + I + +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIE 274
Query: 533 DLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
LKNN R+ +E+ + C RP ++ ++
Sbjct: 275 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 74/286 (25%), Positives = 114/286 (39%), Gaps = 46/286 (16%)
Query: 305 KNILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
++GKG FG+VY G D A+K L + F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 361 RLYGFCMTPTE--RLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQC 417
L G P E ++ PYM +G + ++ + L ARG+ YL EQ
Sbjct: 86 ALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI-----APEY 472
K +HRD+ A N +LD+ V DFGLA+ + ++ + + + A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALES 199
Query: 473 LSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
L T + + K+DV+ FG+LL EL+T G Y +
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFD-------------------LT 238
Query: 532 KDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L R+ + + QV C + PA RP +V +E
Sbjct: 239 HFLAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 81/320 (25%), Positives = 124/320 (38%), Gaps = 56/320 (17%)
Query: 261 WWRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI 320
+ + Q + D E E + L LG+G FG V+ G
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEV--------------------KLGQGCFGEVWMGT 204
Query: 321 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380
T VA+K LK G F E +++ H L++LY + +V YMS
Sbjct: 205 WNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS 261
Query: 381 NGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438
GS+ LK L +A A G+ Y+ +HRD++AANIL+ +
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV 318
Query: 439 AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 497
V DFGLA+L++ + + + APE G+ + K+DV+ FGILL EL T G
Sbjct: 319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 498 QRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALL 552
+ Y N++ V ++ Y R+ E + +
Sbjct: 379 RVP--YPGMVNRE-------------------VLDQVERGY-RMPCPPECPESLHDLMCQ 416
Query: 553 CTQYLPAHRPKMSEVVRMLE 572
C + P RP + LE
Sbjct: 417 CWRKEPEERPTFEYLQAFLE 436
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 77/285 (27%), Positives = 115/285 (40%), Gaps = 46/285 (16%)
Query: 306 NILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 362 LYGFCMTPTE--RLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCD 418
L G C +E L+V PYM +G + + + L A+G+ +L +
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 211
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI-----APEYL 473
K +HRD+ A N +LD+ V DFGLA+ + ++ T + A E L
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESL 268
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
T + + K+DV+ FG+LL EL+T G Y +
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFD-------------------ITV 307
Query: 533 DLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L R+ + + +V L C RP SE+V +
Sbjct: 308 YLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 76/315 (24%), Positives = 125/315 (39%), Gaps = 35/315 (11%)
Query: 305 KNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+ LGKG FG V G +VAVK+L+ + FQ E++++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFI 86
Query: 360 LRLYGFCMTPTER--LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQ 416
++ G P + LV Y+ +G + L+ + LD S + +G+ YL +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAP 470
+ +HRD+ A NIL++ + DFGLAKLL + G AP
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----AP 199
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
E LS S ++DV+ FG++L EL T Y + A + ++ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 531 DKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQR 585
+ L+ R+ E+ ++ LC P RP S + L+ R +
Sbjct: 254 LELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 586 -AEATKSKPHEFSSS 599
+ K H S S
Sbjct: 313 FTAHPEGKHHSLSFS 327
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 56/295 (18%)
Query: 305 KNILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 359
ILG+G FG V +G L+ VAVK +K N+ EI+ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 360 LRLYGFC-----MTPTERLLVYPYMSNGSVASRLK------GKPILDWSTRKRIALGAAR 408
+RL G C + +++ P+M G + + L G + T + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRG 463
G+ YL + +HRD+ A N +L D V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522
A E L+ + K+DV+ FG+ + E+ T G Y N
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNH------------- 256
Query: 523 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EM L + + R++ L+E+ ++ C + P RP S + LE
Sbjct: 257 ----EMY--DYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 63/324 (19%), Positives = 124/324 (38%), Gaps = 48/324 (14%)
Query: 306 NILGKGGFGIVYKGILQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+LG G FG VYKG+ VA+K L++ + + E +++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDP 419
RL G C+T T L+ M G + ++ K + + A+G+ YL ++
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLS 474
+++HRD+ A N+L+ + DFGLAKLL ++ ++ A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESIL 192
Query: 475 TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
+ ++DV+ +G+ + EL+T G + Y + +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASE-------------------ISSI 231
Query: 534 LKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEA 588
L+ R+ ++ + + C RPK E++ +
Sbjct: 232 LEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQGD 289
Query: 589 TKSKPHEFSSSDRYSDLTDDSSLL 612
+ + S+ Y L D+ +
Sbjct: 290 ERMHLPSPTDSNFYRALMDEEDMD 313
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-36
Identities = 82/318 (25%), Positives = 125/318 (39%), Gaps = 58/318 (18%)
Query: 264 QRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQD 323
+ + Q + D E E + L LG+G FG V+ G
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEV--------------------KLGQGCFGEVWMGTWNG 290
Query: 324 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER--LLVYPYMSN 381
T VA+K LK G F E +++ H L++LY +E +V YMS
Sbjct: 291 TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSK 345
Query: 382 GSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439
GS+ LK L +A A G+ Y+ +HRD++AANIL+ +
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVC 402
Query: 440 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499
V DFGLA+L++ + + + APE G+ + K+DV+ FGILL EL T R
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 500 ALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCT 554
+ Y N++ V ++ Y R+ E + + C
Sbjct: 463 -VPYPGMVNRE-------------------VLDQVERGY-RMPCPPECPESLHDLMCQCW 501
Query: 555 QYLPAHRPKMSEVVRMLE 572
+ P RP + LE
Sbjct: 502 RKEPEERPTFEYLQAFLE 519
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 46/284 (16%)
Query: 305 KNILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG G FG V +G+ + VA+K LK G + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPK 420
L G C +LV G + L G + + S + + G+ YL E+
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAPEYLS 474
+HRD+ A N+LL + A + DFGL+K L DS+ T G APE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186
Query: 475 TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
+ S ++DV+ +G+ + E ++ GQ+ Y K + V
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPE-------------------VMAF 225
Query: 534 LKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++ R+E E+ + C Y RP V + +
Sbjct: 226 IEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 65/300 (21%)
Query: 305 KNILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 359
+LGKG FG V + L+ VAVK LK +I+ F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 360 LRLYGFC------MTPTERLLVYPYMSNGSV-----ASRLKGKPI-LDWSTRKRIALGAA 407
+L G +++ P+M +G + ASR+ P L T R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VR 462
G+ YL + IHRD+ A N +L + V DFGL++ + D + V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA-----ANQKGAMLDWV 517
A E L+ + +DV+ FG+ + E++T G+ N +
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENAE------- 247
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ L R++ EE+ + C P RP + + LE
Sbjct: 248 ------------IYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 305 KNILGKGGFGIVYKGILQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+LG G FG V+KG+ V +K ++D + + I H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCD 418
+RL G C + LV Y+ GS+ ++ + L + A+G+ YL E
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-- 134
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYL 473
++HR++ A N+LL + V DFG+A LL D + + ++ A E +
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALESI 189
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
G+ + ++DV+ +G+ + EL+T G Y + V
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAE-------------------VPD 228
Query: 533 DLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L+ R+ ++ V + C RP E+
Sbjct: 229 LLEKGE-RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 15/244 (6%)
Query: 262 WRQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI- 320
W + + +E V L + E + H + + +G+G FG V++
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 321 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMS 380
Q G AVK+ + E+ E+ + ++ LYG + +
Sbjct: 80 KQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEA 439
GS+ +K L A GL YLH + +I+H DVKA N+LL D A
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 440 VVGDFGLAKLLDHQDSHVTTA----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495
+ DFG A L + + GT H+APE + K D++ ++L ++
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 496 TGQR 499
G
Sbjct: 251 NGCH 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-35
Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 306 NILGKGGFGIVYKGILQDGTV-VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLY 363
+ LG G +G VY+G+ + ++ VAVK LK+ +F E M + H NL++L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLL 282
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G C ++ +M+ G++ L+ + + +A + + YL ++
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
IHR++ A N L+ + V DFGL++L+ + + APE L+ + S K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541
+DV+ FG+LL E+ T Y + V + L+ +Y R+
Sbjct: 400 SDVWAFGVLLWEIATYGM-SPYPGIDLSQ-------------------VYELLEKDY-RM 438
Query: 542 EL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
E E++ ++ C Q+ P+ RP +E+ + E
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 86/301 (28%), Positives = 115/301 (38%), Gaps = 55/301 (18%)
Query: 307 ILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQ--FQTEVE-MISLAVHRNL 359
LG G FG+V +G VAVK LK E F EV M SL HRNL
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNL 83
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCD 418
+RLYG +TP +V GS+ RL+ + T R A+ A G+ YL +
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAPEY 472
+ IHRD+ A N+LL +GDFGL + L D H APE
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APES 195
Query: 473 LSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
L T S +D + FG+ L E+ T GQ + + KI
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGS-----QILHKI----------- 237
Query: 532 KDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRA 586
K R+ +++ V + C + P RP + L E RA
Sbjct: 238 --DKEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL-----EAQPTDMRA 289
Query: 587 E 587
E
Sbjct: 290 E 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 69/282 (24%), Positives = 109/282 (38%), Gaps = 46/282 (16%)
Query: 307 ILGKGGFGIVYKGILQDG---TVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRL 362
LG G FG V KG Q VAVK LK+ N + + E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
G C + +LV G + L+ + + + G+ YL E +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFV 139
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAPEYLSTG 476
HRD+ A N+LL A + DFGL+K L +++ G APE ++
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYY 195
Query: 477 QSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ S K+DV+ FG+L+ E + GQ+ Y + V L+
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE-------------------VTAMLE 234
Query: 536 NNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+ EM + LC Y +RP + V L
Sbjct: 235 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 51/286 (17%)
Query: 305 KNILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
ILG+G FG VY+G+ + VAVK K + + +F +E ++ H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 361 RLYGFCMT-PTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCD 418
+L G PT ++ G + L+ K L T +L + + YL
Sbjct: 77 KLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA------VRGTVGHIAPEY 472
+HRD+ NIL+ +GDFGL++ + +D A ++ +PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWM----SPES 185
Query: 473 LSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
++ + + +DV+ F + + E+++ G++ + N+ V
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKD-------------------VI 224
Query: 532 KDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
L+ R+ + + C Y P+ RP+ +E+V L
Sbjct: 225 GVLEKGD-RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-34
Identities = 66/280 (23%), Positives = 114/280 (40%), Gaps = 38/280 (13%)
Query: 305 KNILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG G FG V +G+ + VA+K LK G + E +++ + ++R
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPK 420
L G C +LV G + L G + + S + + G+ YL E+
Sbjct: 401 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT--VGHIAPEYLSTGQS 478
+HR++ A N+LL + A + DFGL+K L DS+ T G + APE ++ +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 479 SEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
S ++DV+ +G+ + E ++ GQ+ Y K + V ++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP--YKKMKGPE-------------------VMAFIEQG 555
Query: 538 YDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+E E+ + C Y RP V + +
Sbjct: 556 K-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 49/283 (17%)
Query: 307 ILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
+G+G FG V++GI VA+K K+ + +F E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G ++ + G + S L+ K LD ++ A + L YL + +
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG------TVGHIAPEYLST 475
+HRD+ A N+L+ +GDFGL++ + +DS A +G APE ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWM----APESINF 191
Query: 476 GQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534
+ + +DV+ FG+ + E++ G + + N V +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNND-------------------VIGRI 230
Query: 535 KNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+N R+ + + + C Y P+ RP+ +E+ L
Sbjct: 231 ENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 72/277 (25%), Positives = 113/277 (40%), Gaps = 42/277 (15%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+GKG FG V G + G VAVK +K+ F E +++ H NL++L G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 365 FCMTPTERL-LVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ L +V YM+ GS+ R +G+ +L + +L + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
+HRD+ A N+L+ + A V DFGL K V+ T APE L + S K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366
Query: 482 TDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
+DV+ FGILL E+ + G+ Y + + V ++ Y +
Sbjct: 367 SDVWSFGILLWEIYSFGRVP--YPRIPLKD-------------------VVPRVEKGY-K 404
Query: 541 IEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++ + V C A RP ++ LE
Sbjct: 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-34
Identities = 59/279 (21%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 307 ILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
+G+G FG V++GI VA+K K+ + +F E + H ++++L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G ++ + G + S L+ K LD ++ A + L YL + +
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RF 512
Query: 422 IHRDVKAANILL--DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+HRD+ A N+L+ +DC + +GDFGL++ ++ + + + + +APE ++ + +
Sbjct: 513 VHRDIAARNVLVSSNDCVK--LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 480 EKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538
+DV+ FG+ + E++ G + + N V ++N
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP--FQGVKNND-------------------VIGRIENGE 609
Query: 539 DRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+ + + + C Y P+ RP+ +E+ L
Sbjct: 610 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 44/280 (15%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G G FG+V+ G + VA+K +++G E F E E++ H L++LYG
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
C+ LV +M +G ++ L+ + + T + L G+ YL E +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLSTGQS 478
RD+ A N L+ + V DFG+ + + D + ++ V+ +PE S +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFSFSRY 182
Query: 479 SEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
S K+DV+ FG+L+ E+ + G+ Y +N + V +D+
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE-------------------VVEDISTG 221
Query: 538 YDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ R+ + Q+ C + P RP S ++R L
Sbjct: 222 F-RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 36/275 (13%)
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
LG G FG V+ T VAVK +K G+ F E ++ H L++L+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 366 CMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
T ++ +M+ GS+ + + A G+ ++ ++ IH
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RD++AANIL+ + DFGLA++++ + + + APE ++ G + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 484 VFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 542
V+ FGILL+E++T G+ Y +N + V + L+ Y R+
Sbjct: 368 VWSFGILLMEIVTYGRIP--YPGMSNPE-------------------VIRALERGY-RMP 405
Query: 543 L-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EE+ + + C + P RP + +L+
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 42/279 (15%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG+V G + VAVK +K+G+ E +F E + + H L++ YG
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
C +V Y+SNG + + L+ L+ S + G+ +L + IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA----VRGTVGHIAPEYLSTGQSS 479
RD+ A N L+D V DFG+ + + + V+ + APE + S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYS 183
Query: 480 EKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538
K+DV+ FGIL+ E+ + G+ Y N + V + +
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP--YDLYTNSE-------------------VVLKVSQGH 222
Query: 539 DRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+ + + Q+ C LP RP +++ +E
Sbjct: 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 46/285 (16%)
Query: 305 KNILGKGGFGIVYKGILQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+ I+G G G V G L+ VA+K LK G F +E ++ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDP 419
RL G ++V YM NGS+ + L+ + G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLL-DHQDSHVTTA-----VRGTVGHIAPEYL 473
+HRD+ A N+L+D V DFGL+++L D D+ TT +R T APE +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAI 226
Query: 474 STGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532
+ S +DV+ FG+++ E++ G+R Y N+ V
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRD-------------------VIS 265
Query: 533 DLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++ Y R+ + Q+ L C A RP+ S++V +L+
Sbjct: 266 SVEEGY-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 87/362 (24%), Positives = 143/362 (39%), Gaps = 68/362 (18%)
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQ---- 322
Q + KE +S+ ++G G FG V G L+
Sbjct: 32 TQTVHEFAKELDATNISIDK--------------------VVGAGEFGEVCSGRLKLPSK 71
Query: 323 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNG 382
VA+K LK G F E ++ H N++RL G ++V YM NG
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 383 SVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV 441
S+ S L K + G A G+ YL + +HRD+ A NIL++ V
Sbjct: 132 SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKV 188
Query: 442 GDFGLAKLL-DHQDSHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 495
DFGL ++L D ++ TT +R T +PE ++ + + +DV+ +GI+L E++
Sbjct: 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 496 T-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQV 549
+ G+R Y + +NQ V K + Y R+ + Q+
Sbjct: 245 SYGERP--YWEMSNQD-------------------VIKAVDEGY-RLPPPMDCPAALYQL 282
Query: 550 ALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLTDDS 609
L C Q +RPK ++V +L D L + + + ++P D+T
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSIL--DKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 610 SL 611
+
Sbjct: 341 TT 342
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 86/281 (30%), Positives = 128/281 (45%), Gaps = 46/281 (16%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG V+ G T VAVK LK G+ F E ++ H+ L+RLY
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 365 FCMTPTER--LLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
T+ ++ YM NGS+ LK L + +A A G+ ++ E+
Sbjct: 76 VV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYLSTGQ 477
IHRD++AANIL+ D + DFGLA+L++ + TA G I APE ++ G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 478 SSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
+ K+DV+ FGILL E++T G+ Y N + V ++L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPE-------------------VIQNLER 225
Query: 537 NYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
Y R+ EE+ Q+ LC + P RP + +LE
Sbjct: 226 GY-RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G FG VY+G + VAVK L + + E+ F E +IS H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-------KPILDWSTRKRIALGAARGLL 411
++R G + R ++ M+ G + S L+ L +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVV---GDFGLAKLLDHQDSHVTTAVRGTVGHI 468
YL E IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAML 207
Query: 469 -----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522
PE G + KTD + FG+LL E+ + G Y +NQ+
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE------------ 253
Query: 523 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
V + + + R++ + ++ C Q+ P RP + ++ +E
Sbjct: 254 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 40/278 (14%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG G FG+V G + VA+K +K+G+ E +F E +++ H L++LYG
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 365 FCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
C ++ YM+NG + + L+ + + + YL + + +H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI---APEYLSTGQSSE 480
RD+ A N L++D V DFGL++ + + T+ G+ + PE L + S
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 481 KTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
K+D++ FG+L+ E+ + G+ Y + N + + +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP--YERFTNSE-------------------TAEHIAQGL- 238
Query: 540 RIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+ E++ + C RP ++ +
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 82/324 (25%), Positives = 139/324 (42%), Gaps = 67/324 (20%)
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTV 326
NQ + E H V+ ++G G FG VYKG+L+ +
Sbjct: 31 NQAVLKFTTEIHPSCVTRQK--------------------VIGAGEFGEVYKGMLKTSSG 70
Query: 327 -----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381
VA+K LK G + F E ++ H N++RL G +++ YM N
Sbjct: 71 KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130
Query: 382 GSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440
G++ L+ + G A G+ YL +HRD+ A NIL++
Sbjct: 131 GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCK 187
Query: 441 VGDFGLAKLL-DHQDSHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 494
V DFGL+++L D ++ TT+ +R T APE +S + + +DV+ FGI++ E+
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEV 243
Query: 495 IT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQ 548
+T G+R Y + +N + V K + + + R+ + Q
Sbjct: 244 MTYGERP--YWELSNHE-------------------VMKAINDGF-RLPTPMDCPSAIYQ 281
Query: 549 VALLCTQYLPAHRPKMSEVVRMLE 572
+ + C Q A RPK +++V +L+
Sbjct: 282 LMMQCWQQERARRPKFADIVSILD 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 73/308 (23%), Positives = 116/308 (37%), Gaps = 73/308 (23%)
Query: 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAV 355
LG+G FG V VAVK LKD +E+E M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGS-----VASRLKGKPILDWSTRK---------- 400
H+N++ L G C ++ Y S G+ A R G R
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 401 -RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
ARG+ YL Q K IHRD+ A N+L+ + + DFGLA+ +++ D + T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 460 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA-----ANQ 509
V+ APE L + ++DV+ FG+L+ E+ T G + +
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 312
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKM 564
+ + K LK + R++ E+ + C +P+ RP
Sbjct: 313 E-------------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 565 SEVVRMLE 572
++V L+
Sbjct: 353 KQLVEDLD 360
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 69/302 (22%), Positives = 116/302 (38%), Gaps = 61/302 (20%)
Query: 305 KNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHR 357
LG+G FG V + VAVK LK+G +E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 358 NLLRLYGFCMTPTE-RLLVYPYMSNGSV-----ASRLKGKPILDWSTRKR---------- 401
N++ L G C P +++ + G++ + R + P
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 402 -IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
+ A+G+ +L + K IHRD+ A NILL + + DFGLA+ + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 461 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515
++ APE + + ++DV+ FG+LL E+ + + G +++
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 259
Query: 516 WVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+ LK R+ EM Q L C P+ RP SE+V
Sbjct: 260 --------------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 571 LE 572
L
Sbjct: 305 LG 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 52/282 (18%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+GKG FG V G + G VAVK +K+ F E +++ H NL++L G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 365 FCMTPTERL-LVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ L +V YM+ GS+ R +G+ +L + +L + YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLSTG 476
+HRD+ A N+L+ + A V DFGL K ++ T V+ T APE L
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT----APEALREK 189
Query: 477 QSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ S K+DV+ FGILL E+ + G+ Y + + V ++
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKD-------------------VVPRVE 228
Query: 536 NNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
Y +++ + +V C A RP ++ LE
Sbjct: 229 KGY-KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 64/295 (21%), Positives = 127/295 (43%), Gaps = 56/295 (18%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG+G FG+VY+G+ + T VA+K + + ++ I+F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-------PILDWSTRKR---IALGAAR 408
++RL G L++ M+ G + S L+ P+L + + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
G+ YL+ K +HRD+ A N ++ + +GDFG+ + + D +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLL 202
Query: 469 -----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522
+PE L G + +DV+ FG++L E+ T ++ Y +N++
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQ------------ 248
Query: 523 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
V + + ++ + + ++ +C QY P RP E++ ++
Sbjct: 249 -------VLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 73/308 (23%)
Query: 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAV 355
LG+G FG V VAVK LKD +E+E M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRK---------- 400
H+N++ L G C ++ Y S G++ A R G R
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 401 -RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
ARG+ YL Q K IHRD+ A N+L+ + + DFGLA+ +++ D + T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 460 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA-----ANQ 509
V+ APE L + ++DV+ FG+L+ E+ T G + +
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 266
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKM 564
+ + K LK + R++ E+ + C +P+ RP
Sbjct: 267 E-------------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 565 SEVVRMLE 572
++V L+
Sbjct: 307 KQLVEDLD 314
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 46/282 (16%)
Query: 305 KNILGKGGFGIVYKGILQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
K+ LG G +G VY+G+ + ++ VAVK LK+ +F E ++ H NL++L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 364 GFCMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
G C ++ +M+ G++ R + + +A + + YL ++
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-----VRGTVGHIAPEYLSTG 476
IHRD+ A N L+ + V DFGL++L+ D++ A ++ T APE L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 477 QSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ S K+DV+ FG+LL E+ T G Y + V + L+
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQ-------------------VYELLE 226
Query: 536 NNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+Y R+E E++ ++ C Q+ P+ RP +E+ + E
Sbjct: 227 KDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 68/303 (22%), Positives = 120/303 (39%), Gaps = 41/303 (13%)
Query: 278 HHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGN 336
HH F+ ++ + +G+G FG +DG +K +
Sbjct: 6 HHSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 337 AIGGEIQF-QTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK---GKP 392
E + + EV +++ H N+++ +V Y G + R+ G
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 393 -----ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLA 447
ILDW + I L L ++H++ KI+HRD+K+ NI L +GDFG+A
Sbjct: 122 FQEDQILDWFVQ--ICLA----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIA 172
Query: 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAA 507
++L+ + GT +++PE + K+D++ G +L EL T + A E A
Sbjct: 173 RVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AG 228
Query: 508 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+ K V KI + +Y +L +V L P RP ++ +
Sbjct: 229 SMKNL----VLKIISGSF------PPVSLHYSY-DLRSLVS-QLFKRN--PRDRPSVNSI 274
Query: 568 VRM 570
+
Sbjct: 275 LEK 277
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 70/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G FG VY+G + VAVK L + + E+ F E +IS H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRK--RIALGAARGLL 411
++R G + R ++ M+ G + +R + + +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVV---GDFGLAKLLDHQDSHVTTAVRGTVGHI 468
YL E IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAML 248
Query: 469 -----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQ 522
PE G + KTD + FG+LL E+ + G Y +NQ+
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE------------ 294
Query: 523 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
V + + + R++ + ++ C Q+ P RP + ++ +E
Sbjct: 295 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+LGKG +GIVY G L + +A+K +D E+ + H+N+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYL 85
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
G + + GS+++ L+ G + T GL YLH+ +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 421 IIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS- 478
I+HRD+K N+L++ + + DFG +K L + T GT+ ++APE + G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 479 -SEKTDVFGFGILLLELITGQR 499
+ D++ G ++E+ TG+
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 74/308 (24%), Positives = 117/308 (37%), Gaps = 73/308 (23%)
Query: 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAV 355
LG+G FG V T VAVK LK +E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRK---------- 400
H+N++ L G C ++ Y S G++ A R G +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 401 -RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
A ARG+ YL + K IHRD+ A N+L+ + + DFGLA+ + H D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 460 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA-----ANQ 509
V+ APE L + ++DV+ FG+LL E+ T G + +
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 300
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKM 564
+ + K LK + R++ E+ + C +P+ RP
Sbjct: 301 E-------------------LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340
Query: 565 SEVVRMLE 572
++V L+
Sbjct: 341 KQLVEDLD 348
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 63/299 (21%)
Query: 305 KNILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 360
++++G+G FG V K ++ A+KR+K+ + F E+E + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 361 RLYGFCMTPTERLLVYPYMSNGS----------------VASRLKGKPILDWSTRKRIAL 404
L G C L Y +G+ A L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
ARG+ YL ++ + IHRD+ A NIL+ + A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 465 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518
+G + A E L+ + +DV+ +G+LL E+++ G Y +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAE-------- 249
Query: 519 KIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + L Y R+E +E+ + C + P RP ++++ L
Sbjct: 250 -----------LYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 61/283 (21%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHR 357
NF + +G+G F VY+ L DG VA+K+++ + + + E++++ H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-----GKP-----ILDWSTRKRIALGAA 407
N+++ Y + E +V G ++ +K + + + + +
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ--LCSA-- 148
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
L ++H + +++HRD+K AN+ + +GD GL + + + + V GT +
Sbjct: 149 --LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 202
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
++PE + + K+D++ G LL E+ Q YG N + KKI Q
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCKKIEQCD--- 254
Query: 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
++Y EL ++V +C P RP ++ V +
Sbjct: 255 --YPPLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 58/299 (19%)
Query: 305 KNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHR 357
LG G FG V + VAVK LK + +E++ M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-PILDWSTRK-------------RIA 403
N++ L G C L++ Y G + + L+ K +L+ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA--- 460
A+G+ +L + IHRDV A N+LL + A +GDFGLA+ + + +++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 461 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK 518
V+ APE + + ++DV+ +GILL E+ + G N K
Sbjct: 228 LPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------- 275
Query: 519 KIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
K +K+ Y ++ + + + C P HRP ++ L+
Sbjct: 276 -----------FYKLVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 51/289 (17%)
Query: 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 356
LG+G F ++KG+ ++ T V +K L F M+S H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSH 71
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHE 415
++L+ YG C+ E +LV ++ GS+ + LK K ++ + +A A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 416 QCDPKIIHRDVKAANILLDDCCEAV--------VGDFGLAKLLDHQDSHVTTAVRGTVGH 467
+IH +V A NILL + + D G++ + +D +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL-QERIPWV--- 184
Query: 468 IAPEYLSTGQS-SEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKK 525
PE + ++ + TD + FG L E+ + G + +Q+
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQR--------------- 226
Query: 526 LEMLVDKDLKNNY--DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ ++ + + E+ + C Y P HRP ++R L
Sbjct: 227 ----KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 62/303 (20%)
Query: 305 KNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHR 357
LG G FG V + VAVK LK + +E++ + L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRKR----------- 401
N++ L G C L++ Y G + R
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 402 --IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
+ A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 460 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML 514
V+ APE + + ++DV+ +GI L EL + + G + K
Sbjct: 205 GNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256
Query: 515 DWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVR 569
K +K + R+ EM + C P RP ++V+
Sbjct: 257 ---------------FYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 570 MLE 572
++E
Sbjct: 301 LIE 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
F+ +GKG FG V+KGI + VVA+K + A Q E+ ++S +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL---GAARGLLYLHEQC 417
+ YG + T+ ++ Y+ GS L+ P+ +IA +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL----DETQIATILREILKGLDYLHSE- 138
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
K IHRD+KAAN+LL + E + DFG+A L T V GT +APE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195
Query: 478 SSEKTDVFGFGILLLELITGQ 498
K D++ GI +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/242 (23%), Positives = 101/242 (41%), Gaps = 26/242 (10%)
Query: 276 ERHHEEVSLGNLRR--FQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLK 333
HH S +L F+ + V +S +G GG V++ + + + A+K +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 334 DGNAIGGEIQ-FQTEVEMISLAVHRNL--LRLYGFCMTPTERLLVYPYMSNGSVASRLKG 390
A + ++ E+ ++ + +RLY + +T +V N + S LK
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120
Query: 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAK 448
K +D RK + +H+ I+H D+K AN L+ D ++ DFG+A
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD---GMLKLIDFGIAN 174
Query: 449 LL-DHQDSHVTTAVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELIT 496
+ S V + GTV ++ PE + S + S K+DV+ G +L +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 497 GQ 498
G+
Sbjct: 235 GK 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 71/305 (23%)
Query: 305 KNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
K LG+G FG V+ +D +VAVK LKD + FQ E E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEH 78
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGS-----VASRLKGKPILDWSTRKR-----------I 402
+++ YG C ++V+ YM +G A ++D R+ I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-- 460
A A G++YL Q +HRD+ N L+ +GDFG+++ + D +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 461 ---VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA-----ANQKGA 512
+R PE + + + ++DV+ FG++L E+ T YGK +N +
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTE-- 243
Query: 513 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEV 567
V + + +E +E+ V L C Q P R + E+
Sbjct: 244 -----------------VIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285
Query: 568 VRMLE 572
++L
Sbjct: 286 YKILH 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 54/217 (24%), Positives = 79/217 (36%), Gaps = 19/217 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---H 356
+F + LG G +G V+K +DG + AVKR + + E+ S H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQH 116
Query: 357 RNLLRLYGFCMTPTERLLVYPYM--SNGSVASRLK--GKPILDWSTRKRIALGAARGLLY 412
+RL +Y S+ + G L + L +
Sbjct: 117 PCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAH 172
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 472
LH Q ++H DVK ANI L +GDFGL L + G ++APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPEL 227
Query: 473 LSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509
L G DVF G+ +LE+ G+ Q
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 74/327 (22%), Positives = 115/327 (35%), Gaps = 60/327 (18%)
Query: 277 RHHEEVSLG-NLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKD 334
HH S G FQ + + ++ LG+GGF V L DG A+KR+
Sbjct: 5 HHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC 64
Query: 335 GNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER----LLVYPYMSNGSVA----S 386
E + Q E +M L H N+LRL +C+ L+ P+ G++
Sbjct: 65 HEQQDRE-EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 387 RLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446
L + LG RGL +H HRD+K NILL D + V+ D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 447 AKLLDHQDSHVTTAVR--------GTVGHIAPEYLST---GQSSEKTDVFGFGILLLELI 495
A+ T+ + APE S E+TDV+ G +L ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 496 TGQRALEYGKAANQKGAMLDWVKKIHQE----------KKLEMLVDKDLKNNYDRIELEE 545
G+ + QKG + + + L L++ + +
Sbjct: 241 FGEGPYD---MVFQKGDSV--ALAVQNQLSIPQSPRHSSALWQLLNSMMTVD-------- 287
Query: 546 MVQVALLCTQYLPAHRPKMSEVVRMLE 572
P RP + ++ LE
Sbjct: 288 ------------PHQRPHIPLLLSQLE 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 62/301 (20%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG+ FG VYKG L VA+K LKD +F+ E + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKG----------------KPILDWSTRKRI 402
++ L G +++ Y S+G + L K L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 403 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-- 460
A G+ YL ++H+D+ N+L+ D + D GL + + D +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 461 ---VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516
+R APE + G+ S +D++ +G++L E+ + G + Y +NQ
Sbjct: 191 LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQD------ 238
Query: 517 VKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRML 571
V + ++N + + + + C P+ RP+ ++ L
Sbjct: 239 -------------VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 572 E 572
Sbjct: 285 R 285
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 67/308 (21%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHR 357
+LG G FG V VAVK LK+ +E++ M L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRKR----------- 401
N++ L G C L++ Y G + + R K ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 402 -------IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
A A+G+ +L + +HRD+ A N+L+ + DFGLA+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 455 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509
++V V+ APE L G + K+DV+ +GILL E+ + G +
Sbjct: 227 NYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKM 564
K ++N + +++ EE+ + C + RP
Sbjct: 283 N-------------------FYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322
Query: 565 SEVVRMLE 572
+ L
Sbjct: 323 PNLTSFLG 330
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 64/290 (22%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+F ++G GGFG V+K DG +KR+K N + + EV+ ++ H N+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNI 66
Query: 360 LRLYGFCMTPTERLLVYP----------------YMSNGSVASRLK--GKPILDWSTRKR 401
+ G + G++ ++ LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
+ +G+ Y+H + K+I+RD+K +NI L D + +GDFGL L + +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521
GT+ +++PE +S+ ++ D++ G++L EL+
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------------- 225
Query: 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
K L D + + +D+ + + ++Q LL + P RP SE++R L
Sbjct: 226 --KFFTDLRDGIISDIFDK-KEKTLLQ-KLLSKK--PEDRPNTSEILRTL 269
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 62/300 (20%), Positives = 116/300 (38%), Gaps = 62/300 (20%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
K LG+G FG V+ + +VAVK LK+ + FQ E E++++ H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQH 104
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGS-----VASRLKGKPILDWSTRKR----------IA 403
++R +G C L+V+ YM +G + K + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
A G++YL +HRD+ N L+ +GDFG+++ + D G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVG 217
Query: 464 TVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWV 517
+ PE + + + ++DV+ FG++L E+ T G++ + + +N +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTE------- 268
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ +E E+ + C Q P R + +V L+
Sbjct: 269 ------------AIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LGKGGF ++ V A K L + + E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
+GF +V S+ K RK + AR G YL
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHK--------RRKALTEPEARYYLRQIVLGCQYL 157
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H ++IHRD+K N+ L++ E +GDFGLA +++ GT +IAPE L
Sbjct: 158 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVL 213
Query: 474 STGQSSEKTDVFGFGILLLELITG 497
S S + DV+ G ++ L+ G
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LGKGGF ++ V A K L + + E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
+GF +V S+ K RK + AR G YL
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHK--------RRKALTEPEARYYLRQIVLGCQYL 131
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H ++IHRD+K N+ L++ E +GDFGLA +++ GT +IAPE L
Sbjct: 132 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVL 187
Query: 474 STGQSSEKTDVFGFGILLLELITG 497
S S + DV+ G ++ L+ G
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 63/292 (21%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 295 LQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 353
+ V +S +G GG V++ + + + A+K + A + ++ E+ ++
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 354 AVHRNL--LRLYGFCMTPTERLLVYPYM--SNGSVASRLKGKPILDWSTRKRIALGAARG 409
+ +RLY + +T +Y M N + S LK K +D RK
Sbjct: 64 LQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLL-DHQDSHVTTAVRGTVG 466
+ +H+ I+H D+K AN L+ D ++ DFG+A + S V + GTV
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 467 HIAPEYL-----------STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD 515
++ PE + S + S K+DV+ G +L + G+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------------TP 219
Query: 516 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+ + I+Q KL ++D + + + I +++ V C + P R + E+
Sbjct: 220 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 52/292 (17%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRN 358
++ +G G +G K DG ++ K L G+ E Q +EV ++ H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 359 LLRLYGFCMTPTERLL--VYPYMSNGSVASRLK-----GKP-----ILDWSTRKRIALGA 406
++R Y + T L V Y G +AS + + +L T+ + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ--LTLA- 123
Query: 407 ARGLLYLHEQCDP--KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
L H + D ++HRD+K AN+ LD +GDFGLA++L+H S T V GT
Sbjct: 124 ---LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179
Query: 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
+++PE ++ +EK+D++ G LL EL A +QK
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKE------------- 223
Query: 525 KLEMLVDKDLKNNYDRI------ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
L K + + RI EL E++ +L + HRP + E++
Sbjct: 224 ----LAGKIREGKFRRIPYRYSDELNEIIT-RMLNLK--DYHRPSVEEILEN 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 78/313 (24%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG+G FG V K T VAVK LK+ + +E ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSV-----ASRLKGKPILDWSTRK------------- 400
+++LYG C LL+ Y GS+ SR G L +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 401 ------RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
A ++G+ YL E K++HRD+ A NIL+ + + + DFGL++ + +D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 455 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA--- 506
S+V + V+ A E L + ++DV+ FG+LL E++T G
Sbjct: 205 SYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYP 254
Query: 507 --ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPA 559
+ + LK + R+E EEM ++ L C + P
Sbjct: 255 GIPPE-----------------RLF--NLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 560 HRPKMSEVVRMLE 572
RP +++ + LE
Sbjct: 295 KRPVFADISKDLE 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 24/225 (10%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE 349
+ V +S +G GG V++ + + + A+K + A + ++ E+
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 350 MISLAVHRNL--LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA 407
++ + +RLY + +T +V N + S LK K +D RK
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLL-DHQDSHVTTAVRGT 464
+ +H+ I+H D+K AN L+ D ++ DFG+A + S V + G
Sbjct: 166 EAVHTIHQH---GIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 465 VGHIAPEYLS-----------TGQSSEKTDVFGFGILLLELITGQ 498
V ++ PE + + S K+DV+ G +L + G+
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHR 357
++ + ++G G +V VA+KR L+ E+ E++ +S H
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHHP 73
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKR-----IAL---GAARG 409
N++ Y + E LV +S GSV +K IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT-VGH- 467
L YLH+ IHRDVKA NILL + + DFG++ L VR T VG
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 468 --IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
+APE + + K D++ FGI +EL TG
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 49/296 (16%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+F LG+GGFG+V++ D A+KR++ N + EV+ ++ H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 360 LRLYGFCMTPTERLLVYP------------YMSNGSVASRLK---GKPILDWSTRKRIAL 404
+R + + + P ++ + + S I L
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR-- 462
A + +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 463 ---------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM 513
GT +++PE + S K D+F G++L EL+ + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQMER 233
Query: 514 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+ + + K Y MVQ P RP+ ++
Sbjct: 234 VRTLTDVRNLK-----FPPLFTQKYP--CEYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 36/229 (15%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 357
+F +LG+G FG V K D A+K+++ + +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 358 NLLRLYGFCMTPTERLLVYP-------------YMSNGSVASRL-KGKPILDWSTRKRIA 403
++R Y + + Y NG++ + R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH----------- 452
L Y+H Q IIHRD+K NI +D+ +GDFGLAK +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 453 ---QDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITG 497
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 41/229 (17%), Positives = 78/229 (34%), Gaps = 27/229 (11%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGI------LQDGTVVAVKRLKDGNAIGGEIQFQT 346
E Q+ + ++LG+G F VY+ ++ +K K N I Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116
Query: 347 EVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDW-----STRKR 401
+E + ++ ++ Y + +LV S G++ + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG-----------DFGLAKLL 450
A+ + +H+ +IIH D+K N +L + D G + +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 451 D-HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
+ TA T G E LS + + D FG + ++ G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 16/198 (8%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LGKG F VY+ + G VA+K + + Q EV++ H ++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILE 75
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDP 419
LY + LV NG + LK KP + R + G+LYLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSH--- 131
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
I+HRD+ +N+LL + DFGLA L T GT +I+PE +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHG 190
Query: 480 EKTDVFGFGILLLELITG 497
++DV+ G + L+ G
Sbjct: 191 LESDVWSLGCMFYTLLIG 208
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 70/309 (22%)
Query: 305 KNILGKGGFGIVYKGILQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+G+G FG V++ T+VAVK LK+ + + FQ E +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGS-----VASRLKGKPILDWSTRK------------- 400
+++L G C L++ YM+ G + L S
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 401 ------RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
IA A G+ YL E+ K +HRD+ N L+ + + DFGL++ + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 455 SHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAAN 508
I PE + + + ++DV+ +G++L E+ + G + Y A+
Sbjct: 229 ----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAH 282
Query: 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPK 563
++ V +++ + E+ + LC LPA RP
Sbjct: 283 EE-------------------VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 564 MSEVVRMLE 572
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKR-LKDGNAIGGEIQFQTEVE-MISLAVHRN 358
+F K++LG G G + + D VAVKR L + + EV+ + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPN 79
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR-KRIALGAARGLLYLHEQC 417
++R + + + + ++ ++ K + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 418 DPKIIHRDVKAANILL-----DDCCEAVVGDFGLAKLLDHQDS--HVTTAVRGTVGHIAP 470
I+HRD+K NIL+ +A++ DFGL K L + V GT G IAP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 471 EYLSTGQS---SEKTDVFGFGILLLELITG 497
E LS + D+F G + +I+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 50/237 (21%), Positives = 84/237 (35%), Gaps = 19/237 (8%)
Query: 277 RHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKG--GFGIVYKGI-LQDGTVVAVKRLK 333
HH + NL + ++GKG V G V V+R+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 334 DGNAIGGEIQF-QTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP 392
+ F Q E+ + L H N++ + E +V +M+ GS +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH- 120
Query: 393 ILDWSTRKRIAL---GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG-LAK 448
+D IA G + L Y+H +HR VKA++IL+ + +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 449 LLDHQDSH--VTTAVRGTVGHI---APEYLSTGQS--SEKTDVFGFGILLLELITGQ 498
++ H V + +V + +PE L K+D++ GI EL G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 6/207 (2%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
+ ++ +F + LG G G+V+K G V+A K + Q E++++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 352 SLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
++ YG + E + +M GS+ LK + ++++ +GL
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471
YL E+ KI+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPE 200
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQ 498
L S ++D++ G+ L+E+ G+
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 60/193 (31%), Positives = 85/193 (44%), Gaps = 9/193 (4%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LGKG FG VY Q ++A+K L G E Q + EVE+ S H N+LRLYG
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ T L+ Y G+V L+ D A L Y H + ++IHR
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 133
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D+K N+LL E + DFG + GT+ ++ PE + EK D+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEMIEGRMHDEKVDL 190
Query: 485 FGFGILLLELITG 497
+ G+L E + G
Sbjct: 191 WSLGVLCYEFLVG 203
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 47/226 (20%), Positives = 81/226 (35%), Gaps = 37/226 (16%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---H 356
F +G G FG V+K + DG + A+KR K A + Q E+ + AV H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLGQH 70
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLY 412
+++R + L+ Y + GS+A + + K + L RGL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 413 LHEQCDPKIIHRDVKAANILLD-----------------DCCEAVV--GDFGLAKLLDHQ 453
+H ++H D+K +NI + + + GD G +
Sbjct: 131 IHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 454 DSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
G +A E L + K D+F + ++ +
Sbjct: 188 QVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 26/155 (16%), Positives = 50/155 (32%), Gaps = 16/155 (10%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLG 142
+ + L++L+++ + N+ +I L L LDLS P++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF------SAKTFNIV 196
L SLQ + ++N+ + L LD S N++ + S N+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 197 GNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG 231
N C C + + +
Sbjct: 552 QNDFAC------TC---EHQSFLQWIKDQRQLLVE 577
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-26
Identities = 21/100 (21%), Positives = 37/100 (37%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L S S + LQ++ L I L+ L TL L+ N +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L SLQ + +L+ + + L L++++N +
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 28/108 (25%), Positives = 42/108 (38%), Gaps = 2/108 (1%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSS 140
S N T+S + L L+ + Q++N+ + L L LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 141 LGHLRSLQYMRFNNNSLSGAF-PTSLASMTQLIFLDLSYNNLSGPVPR 187
L SL+ ++ NS F P + L FLDLS L P
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 24/107 (22%), Positives = 44/107 (41%), Gaps = 2/107 (1%)
Query: 84 NLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI-PSSL 141
NL S+ +L NL + + + + L+ L+ L ++ N F P
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188
LR+L ++ + L PT+ S++ L L++S+NN
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 23/108 (21%), Positives = 51/108 (47%), Gaps = 5/108 (4%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSSLG 142
+ + L++LQ ++ N+ IG L L+ L++++N ++P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQL----IFLDLSYNNLSGPVP 186
+L +L+++ ++N + + T L + Q+ + LDLS N ++ P
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 26/107 (24%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNIT--GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ G + S +L +L+ + L N ++ G T L+ LDLS N + S+
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 142 GHLRSLQYMRFNNNSLSGAFPTS-LASMTQLIFLDLSYNNLSGPVPR 187
L L+++ F +++L S S+ LI+LD+S+ +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 15/90 (16%), Positives = 28/90 (31%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
+ + + L N + +LQ LDLS + L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ + + ++ L L NL+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 25/103 (24%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 86 SGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQ----TLDLSNNFFTGEIPSSL 141
S L NLTNL+ + L +N I ++ L ++ +LDLS N P +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 142 GHLRSLQYMRFNNNSLSGAFP-TSLASMTQLIFLDLSYNNLSG 183
+R L + NN S T + + L L
Sbjct: 198 KEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 29/142 (20%), Positives = 43/142 (30%), Gaps = 27/142 (19%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT--------- 134
+ LTN+ L + I Q L+L N F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 135 ----------GEIPSSLGHLRSLQYMRFNNNSLS--GAFPTSLASMTQLIFLDLSYNNLS 182
G S L SL+++ + N LS G S T L +LDLS+N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 183 GPVPRFSA----KTFNIVGNPL 200
F + + + L
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 18/115 (15%), Positives = 29/115 (25%), Gaps = 10/115 (8%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFTGEI--- 137
S N + P L + L+NN + + I L L+ L F E
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 138 PSSLGHLRSLQYMRFNNNSLS------GAFPTSLASMTQLIFLDLSYNNLSGPVP 186
L L + L+ +T + L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 31/132 (23%), Positives = 44/132 (33%), Gaps = 24/132 (18%)
Query: 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQ---NNNITGPIPAEIGRLTKLQTLDLS 129
LV+G NL ++ L NL I + + I LT + + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 130 NNFFTGEIPSSL-------------------GHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170
+ S L+SL+ + F +N AF S +
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPS 348
Query: 171 LIFLDLSYNNLS 182
L FLDLS N LS
Sbjct: 349 LEFLDLSRNGLS 360
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 25/128 (19%), Positives = 44/128 (34%), Gaps = 9/128 (7%)
Query: 71 PESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130
T NL +L V + N +P + L ++Q ++++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 131 NFFT--------GEIPSSLGHLRSLQYMRFNNNSL-SGAFPTSLASMTQLIFLDLSYNNL 181
N + + +Q + N+L + TSL M +L L+ YN L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342
Query: 182 SGPVPRFS 189
G +P F
Sbjct: 343 EGKLPAFG 350
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 14/159 (8%)
Query: 79 GIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI--GRLTKLQTLDLSNNFFTGE 136
IP N + + N L + L+ N +T + + L L +DLS N F+
Sbjct: 471 EIPK-NSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK- 527
Query: 137 IPSSLGHLRSLQYMRFNN------NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-- 188
P+ + +L+ N N +P + L L + N++ +
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP 587
Query: 189 SAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQT 227
+ +I NP I S C + + + +Q
Sbjct: 588 NISVLDIKDNPNISIDLSYV-CPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 22/114 (19%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 79 GIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG--- 135
+ +N L P+ N+ + L NN I+ + L +++L N T
Sbjct: 416 SVDGKNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 136 ----EIPSSLGHLRSLQYMRFNNNSLSGAFPTSLA--SMTQLIFLDLSYNNLSG 183
+ + + L + N L+ ++ L+ +DLSYN+ S
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 24/130 (18%), Positives = 45/130 (34%), Gaps = 20/130 (15%)
Query: 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF 132
S +I I S ++ S + +NNIT + + RLTKL+ + N+
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217
Query: 133 FTGE-------------------IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIF 173
F E +L+ L + N PT L ++ ++
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 174 LDLSYNNLSG 183
++++ N
Sbjct: 278 INVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 20/133 (15%), Positives = 40/133 (30%), Gaps = 28/133 (21%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGP-------------------IPAEIGRLTK 122
N +S ++ LT L+ + N+ + L
Sbjct: 191 LSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250
Query: 123 LQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL--------SGAFPTSLASMTQLIFL 174
L +++ N ++P+ L L +Q + N ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 175 DLSYNNL-SGPVP 186
+ YNNL + PV
Sbjct: 311 YIGYNNLKTFPVE 323
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL-- 141
L G L P+ G+ L + L N IT G +++ L ++N IP+
Sbjct: 341 QLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398
Query: 142 GHLRSLQYMRFNNNSLSG-------AFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ + + F+ N + + + ++LS N +S
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 20/173 (11%), Positives = 47/173 (27%), Gaps = 30/173 (17%)
Query: 33 EVQALMGVKHSLHDPHGVLENW------------DEDAVDPCSWTMVTCSPESLVIGLGI 80
V + + L+ +W + G+
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK-ELDMWGAQPGV 75
Query: 81 PSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG----E 136
S+ + + + L+ +G +P IG+LT+L+ L L ++
Sbjct: 76 -----------SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSLA--SMTQLIFLDLSYNNLSGPVPR 187
P + S + + F + LI ++ + + +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 20/181 (11%), Positives = 49/181 (27%), Gaps = 35/181 (19%)
Query: 53 NWDEDAVDPCSWTM---VTCSPESLVIGLGIPSQNLSGTLSPSIGNL------------- 96
NW+ + + W V+ + V GL + SG + +IG L
Sbjct: 59 NWNFNK-ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 97 ---------------TNLQIVLLQNNNITGPIPAEIGRL--TKLQTLDLSNNFFTGEIPS 139
+ + + R + L ++++ I
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNP 199
S + +N+++ ++ +T+L + + + + N
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236
Query: 200 L 200
Sbjct: 237 Q 237
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 11/124 (8%), Positives = 31/124 (25%), Gaps = 22/124 (17%)
Query: 84 NLSGTLSPSIG--NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ T + ++L + ++ I K + +N T + ++
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV 202
Query: 142 GHLRSLQYMRFNNNSLSG-------------------AFPTSLASMTQLIFLDLSYNNLS 182
L L+ N+ ++ L +++
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 183 GPVP 186
+P
Sbjct: 263 TKLP 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 308 LGKGGFGIVYKGILQDGTVVAVKRLK----------------DGNAIGGEIQFQTEVEMI 351
L +G F + +D A+K+ + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 352 SLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--- 408
+ + L G E ++Y YM N S+ + +LD + I + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 409 -----GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
Y+H + + I HRDVK +NIL+D + DFG ++ + D + + G
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGSR-G 212
Query: 464 TVGHIAPEYLST--GQSSEKTDVFGFGILLLELITG 497
T + PE+ S + K D++ GI L +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
++ +G+G G VY + + G VA++++ E+ E+ ++ + N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL---GAARGLLYLHEQC 417
+ E +V Y++ GS+ + + +IA + L +LH
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSN- 135
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
++IHRD+K+ NILL + DFG + + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 478 SSEKTDVFGFGILLLELITGQ 498
K D++ GI+ +E+I G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN 358
F ++G G +G VYKG ++ G + A+K + + G E + + E+ M+ + HRN
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 359 LLRLYG-----FCMTPTERL-LVYPYMSNGSVA---SRLKGKPILDWSTRKRIAL---GA 406
+ YG ++L LV + GSV KG + + IA
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
RGL +LH+ K+IHRD+K N+LL + E + DFG++ LD T + GT
Sbjct: 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 194
Query: 467 HIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQ 498
+APE ++ ++ + K+D++ GI +E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 28/232 (12%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-M 350
+ +++ + +L +GGF VY+ + G A+KRL N EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 351 ISLAVHRNLLRLYGFCMTPTER-------LLVYPYMSNGSVAS---RLKGKPILDWSTRK 400
L+ H N+++ E L+ + G + +++ + L T
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
+I R + ++H Q P IIHRD+K N+LL + + DFG A + H + +A
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 461 -----------VRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQ 498
T + PE + + EK D++ G +L L Q
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
S +G+G GIV G VAVK + E+ EV ++ H N++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVV 105
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL---GAARGLLYLHEQC 417
+Y + E ++ ++ G++ + + ++IA + L YLH Q
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL----NEEQIATVCEAVLQALAYLHAQ- 160
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+IHRD+K+ +ILL + DFG + + V GT +APE +S
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 478 SSEKTDVFGFGILLLELITGQ 498
+ + D++ GI+++E++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 358
F LG+G +G VYK I + G +VA+K++ + ++Q E+ ++ +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPH 85
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQC 417
+++ YG T+ +V Y GSV+ ++ + L I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+ IHRD+KA NILL+ A + DFG+A L + T + GT +APE +
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 478 SSEKTDVFGFGILLLELITGQ 498
+ D++ GI +E+ G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 45/221 (20%), Positives = 87/221 (39%), Gaps = 23/221 (10%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 354
+ H + +ILG+G V++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 355 VHRNLLRLYGFCMTPTERL--LVYPYMSNGSVASRLKGK---PILDWSTRKRIALGAARG 409
H+N+++L+ T R L+ + GS+ + L+ L S + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAV----VGDFGLAKLLDHQDSHVTTAVRGTV 465
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTE 179
Query: 466 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 498
++ P+ D++ G+ TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 54/227 (23%), Positives = 85/227 (37%), Gaps = 39/227 (17%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 360
S+ ILG G G V G VAVKR+ E++ + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVI 72
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR-------GLLYL 413
R Y T + N ++ ++ K + D + + + G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 414 HEQCDPKIIHRDVKAANILLD-------------DCCEAVVGDFGLAKLLDHQDSHVTTA 460
H KIIHRD+K NIL+ + ++ DFGL K LD S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 461 VR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELITG 497
+ GT G APE L + + D+F G + +++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 9/193 (4%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
LGKG FG VY Q+ ++A+K L G E Q + E+E+ S H N+LR+Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
+ L+ + G + L+ D A L Y HE+ K+IHR
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHR 138
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D+K N+L+ E + DFG + H S + GT+ ++ PE + EK D+
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDL 195
Query: 485 FGFGILLLELITG 497
+ G+L E + G
Sbjct: 196 WCAGVLCYEFLVG 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRN 358
+ LG G FG VYK + G + A K K + + E+E+++ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPY 77
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIAL---GAARGLLYL 413
+++L G + ++ + G+V + + + T +I + L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFL 133
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H + +IIHRD+KA N+L+ + + DFG++ + + GT +APE +
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189
Query: 474 STGQSSE-----KTDVFGFGILLLELITGQ 498
+ K D++ GI L+E+ +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 45/221 (20%), Positives = 87/221 (39%), Gaps = 23/221 (10%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 354
+ H + +ILG+G V++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 355 VHRNLLRLYGFCMTPTERL--LVYPYMSNGSVASRLKGK---PILDWSTRKRIALGAARG 409
H+N+++L+ T R L+ + GS+ + L+ L S + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAV----VGDFGLAKLLDHQDSHVTTAVRGTV 465
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTE 179
Query: 466 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 498
++ P+ D++ G+ TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 18/228 (7%)
Query: 283 SLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIG 339
S G L+ + + +G+G +G V K + G ++AVK R
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 340 GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR 399
++ +V M + +++ YG + + M + S K +
Sbjct: 65 KQLLMDLDVVM-RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVI 122
Query: 400 K-----RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
+I L + L +L E KIIHRD+K +NILLD + DFG++ L
Sbjct: 123 PEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180
Query: 455 SHVTTAVRGTVGHIAPEYLSTGQS----SEKTDVFGFGILLLELITGQ 498
+ A G ++APE + S ++DV+ GI L EL TG+
Sbjct: 181 AKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+ K LG GGFG V + I G VA+K+ + + ++ E++++ H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 360 LRLYGFCMTPTE------RLLVYPYMSNGSVASRLKGK---PILDWSTRKRIALGAARGL 410
+ + LL Y G + L L + + + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVRGTVGH 467
YLHE +IIHRD+K NI+L + + + D G AK LD Q T V GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQY 189
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499
+APE L + + D + FG L E ITG R
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 23/229 (10%), Positives = 55/229 (24%), Gaps = 44/229 (19%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
L G +V+ ++ A+K + N+ + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 364 GFC--------------------------MTPTERLLVYPYMS------NGSVASRLKGK 391
LL+ P S ++ +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 392 PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451
+ R L + ++H N+ + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241
Query: 452 HQDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
+ A V + E+L ST + + + G+ + +
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 40/201 (19%), Positives = 73/201 (36%), Gaps = 23/201 (11%)
Query: 308 LGKGGFGIVYKG---ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+ GG G +Y + +G V +K L + E + ++ VH ++++++
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 365 FCMTPTERLLVYPYM-----SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
F Y+ S+ K L + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSI--- 201
Query: 420 KIIHRDVKAANILLDDCCEAV-VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
+++ D+K NI+L + E + + D G ++ + GT G APE +
Sbjct: 202 GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRTGP 253
Query: 479 SEKTDVFGFGILLLELITGQR 499
+ TD++ G L L
Sbjct: 254 TVATDIYTVGRTLAALTLDLP 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRN 358
FS +G G FG VY +++ VVA+K+ + EV + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVAS--RLKGKPILDWSTRKRIAL---GAARGLLYL 413
++ G + LV Y GS + + KP+ IA GA +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYL 170
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H +IHRDVKA NILL + +GDFG A ++ +S V GT +APE +
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222
Query: 474 STGQSSE---KTDVFGFGILLLELITGQ 498
+ K DV+ GI +EL +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 29/238 (12%), Positives = 65/238 (27%), Gaps = 55/238 (23%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVK---------------------------RLKDGNAI 338
+LG+ + + G V +K+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 339 GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--ERLLVYPYMSN------GSVASRLKG 390
++F +++ + ++R+ R +YP M + + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
L R ++ L R L LH ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELITG 497
+ G PE + + + D + G+++ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 28/233 (12%), Positives = 60/233 (25%), Gaps = 44/233 (18%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVK---------------------------RLKDGNAI 338
+LG+ + + G V +K+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 339 GGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLVYPYMSN------GSVASRLKG 390
++F +++ + ++R+ R +YP M + + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
L R ++ L R L LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 451 DHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQ 498
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVE 349
+ Q ++ + +G G G V+K + G V+AVK R I +V
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARG 409
+ S +++ +G +T T+ + M + + + + + ++ + +
Sbjct: 78 LKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
L YL E+ +IHRDVK +NILLD+ + + DFG++ L + +A G ++A
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMA 192
Query: 470 PEYLSTGQSSE-----KTDVFGFGILLLELITGQ 498
PE + ++ + DV+ GI L+EL TGQ
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 295 LQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-S 352
++V + LG+G +G+V K + G ++AVKR++ + + ++++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK-----GKPILDWSTRKRIALGAA 407
+ YG + + M + S+ K G+ I + K IA+
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK-IAVSIV 119
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
+ L +LH + +IHRDVK +N+L++ + + DFG++ L D G +
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 468 IAPEYLSTGQS----SEKTDVFGFGILLLELITGQ 498
+APE ++ + S K+D++ GI ++EL +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 25/126 (19%), Positives = 40/126 (31%), Gaps = 12/126 (9%)
Query: 70 SPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLS 129
+ S NL +L V L N +P + L +LQ+L+++
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 130 NNFFTG---------EIPSSLGHLRSLQYMRFNNNSLSGAFPTS--LASMTQLIFLDLSY 178
N + +Q N+L FP S L M +L LD +
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVH 582
Query: 179 NNLSGP 184
N +
Sbjct: 583 NKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-22
Identities = 30/158 (18%), Positives = 56/158 (35%), Gaps = 16/158 (10%)
Query: 80 IPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI--GRLTKLQTLDLSNNFFTGEI 137
IP N + N L + L+ N +T + + L L +D+S N F+
Sbjct: 712 IPE-NSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SF 768
Query: 138 PSSLGHLRSLQ--YMRFN----NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA 190
P+ + L+ +R N + +PT + + LI L + N++
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ 828
Query: 191 -KTFNIVGNPLICATGSEPD-CYGTQLMPMSMNLNSSQ 226
+I NP I + C + + + +Q
Sbjct: 829 LYILDIADNPNI--SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-21
Identities = 24/130 (18%), Positives = 37/130 (28%), Gaps = 28/130 (21%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGP-------------------IPAEIGRLTK 122
N +S +I LT LQI+ N+ T L
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492
Query: 123 LQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSG---------AFPTSLASMTQLIF 173
L ++L N ++P L L LQ + N + ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 174 LDLSYNNLSG 183
+ YNNL
Sbjct: 553 FYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 9/128 (7%)
Query: 80 IPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIP 138
+ L+ +QI + NN+ P A + ++ KL LD +N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HL 588
Query: 139 SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA------KT 192
+ G L ++ + N + A Q+ L S+N L F+A +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGS 648
Query: 193 FNIVGNPL 200
+ N +
Sbjct: 649 VDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 25/137 (18%), Positives = 41/137 (29%), Gaps = 20/137 (14%)
Query: 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT 134
++ I + + N IT I I RLTKLQ + +N+ FT
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT 461
Query: 135 G-------------------EIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLD 175
S +L+ L + N P L + +L L+
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 176 LSYNNLSGPVPRFSAKT 192
++ N + T
Sbjct: 522 IACNRGISAAQLKADWT 538
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG-HLRSLQ 148
S S+ + L ++ +N + + G KL L L N EIP ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 149 YMRFNNNSLSGAFP--TSLASMTQLIFLDLSYNNLSG 183
+ F++N L P + S+ + +D SYN +
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS 658
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 14/104 (13%), Positives = 31/104 (29%), Gaps = 12/104 (11%)
Query: 92 SIGNLTNLQIVLLQNNNITG-----PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRS 146
+ ++ + V N I + + T+ LS N
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 147 LQYMRFNNNSLS-------GAFPTSLASMTQLIFLDLSYNNLSG 183
+ + +NN ++ + + L +DL +N L+
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 7e-18
Identities = 21/103 (20%), Positives = 32/103 (31%), Gaps = 10/103 (9%)
Query: 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT-------GEIPSSLG 142
S N V L N I + + T+ LSNN T +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLA--SMTQLIFLDLSYNNLSG 183
+ L + N L+ ++ L +D+SYN S
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEIPS--SLGHLRSL 147
+ G L + L N I IP + +++ L S+N IP+ + + +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646
Query: 148 QYMRFNNNSLSGAFPTSLASM-----TQLIFLDLSYNNLSGPVP 186
+ F+ N + SM + LSYN +
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 13/110 (11%), Positives = 35/110 (31%), Gaps = 11/110 (10%)
Query: 84 NLSG----TLSPSIG-NLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTG-- 135
L + ++ + +N + P + + ++D S N
Sbjct: 601 KLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660
Query: 136 -EIPSSLGHLR--SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
I S+ + + + + N + A+ + + + LS N ++
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 18/142 (12%), Positives = 38/142 (26%), Gaps = 23/142 (16%)
Query: 43 SLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIV 102
+ NW+ + + W + N + +
Sbjct: 291 GTINNTIHSLNWNFNK-ELDMWGDQPGV---------------------DLDNNGRVTGL 328
Query: 103 LLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAF- 161
L G +P IG+LT+L+ L + T + + + +
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 162 PTSLASMTQLIFLDLSYNNLSG 183
L +L DL + ++
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 18/122 (14%), Positives = 36/122 (29%), Gaps = 21/122 (17%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ + LQ + +N + PI + K + N T I ++
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQR 446
Query: 144 LRSLQYMRFNNNSLSG-------------------AFPTSLASMTQLIFLDLSYNNLSGP 184
L LQ + F N+ + S +++ L ++L
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 185 VP 186
+P
Sbjct: 507 LP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 11/111 (9%), Positives = 33/111 (29%), Gaps = 1/111 (0%)
Query: 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE 136
L + + + N + + ++ ++ L L+ G
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
+P ++G L L+ + F +S + + + + + +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 22/104 (21%), Positives = 39/104 (37%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L + + + L + + N I+ P +L L+ L+L +N + +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
+L + +NS+ LI LDLS+N LS
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 4/116 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+S L L+++ LQ+N ++ T L L L +N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNP 199
++L + ++N LS + + L L LS N + ++ +I N
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA----LKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 26/133 (19%), Positives = 50/133 (37%), Gaps = 14/133 (10%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNIT--------GPIPAEIGRLTKLQTLDLSNNFFTG 135
N++ + L L+I+ LQ+NN+ G + L+ L L+L +N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 136 EIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF------S 189
L L+ + N+L+ + + L L+L N ++ + +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 190 AKTFNIVGNPLIC 202
++ NP C
Sbjct: 611 LTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-22
Identities = 25/108 (23%), Positives = 44/108 (40%), Gaps = 3/108 (2%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPA-EIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+S S + L +L+++ L N I + E L + + LS N + +S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 143 HLRSLQYMRFNNNSLSG--AFPTSLASMTQLIFLDLSYNNLSGPVPRF 188
+ SLQ + +L + P+ + L LDLS NN++
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-21
Identities = 24/102 (23%), Positives = 39/102 (38%), Gaps = 3/102 (2%)
Query: 84 NLSGTLSPS-IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG--EIPSS 140
+ L+ L N+ + L N + LQ L L PS
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
LR+L + +NN+++ L + +L LDL +NNL+
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-21
Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 5/109 (4%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG---RLTKLQTLDLSNNFFTGEIPSS 140
+ + L + L N + + ++ T ++ L LSN+ + ++
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 141 LGHLR--SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
L+ +L + + N+L+ S A + QL + L YNN+
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 5/108 (4%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG--RLTKLQTLDLSNNFFTGEIPSSL 141
LS T + L NLQ +LL NN I E+ + L+ L+LS+N P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLA---SMTQLIFLDLSYNNLSGPVP 186
+ L + NN L + L + T + L LS + LS
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 1/105 (0%)
Query: 80 IPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ G + L++L I+ L++N L +L+ +DL N S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLA-SMTQLIFLDLSYNNLSG 183
+ SL+ + N ++ + L LD+ +N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-20
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 9/109 (8%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI------ 137
NL+ + S L L+ L+ NNI + L ++ L+L +F I
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 138 ---PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
S L+ L+++ +N + G + L +L LS + S
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-20
Identities = 22/91 (24%), Positives = 38/91 (41%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
TN+ ++ L +N + A R ++L +LD+ N + P L L+ + +N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 156 SLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
LS + A T L L L N++
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 21/108 (19%), Positives = 35/108 (32%), Gaps = 6/108 (5%)
Query: 82 SQNLSGTLSPSIGNL-----TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE 136
S + + + + + L I+ L N I+ L L+ LDL N E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 137 IP-SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ L ++ + + N S A + L L L L
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-19
Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITG--PIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S + +LQ ++L+ + P+ L L LDLSNN L
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 142 GHLRSLQYMRFNNNSLS--------GAFPTSLASMTQLIFLDLSYNNLSG 183
L L+ + +N+L+ G L ++ L L+L N
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 28/115 (24%), Positives = 44/115 (38%), Gaps = 6/115 (5%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF---- 133
I +L S L L+ + +++N+I G L L+ L LSN+F
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 134 -TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
T E SL H L + N +S + + + L LDL N + +
Sbjct: 370 LTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 5/102 (4%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG---HLRSLQ 148
I ++L+ + L +N I P + +L L L+N + L S++
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 149 YMRFNNNSLSGAFPTSLASM--TQLIFLDLSYNNLSGPVPRF 188
+ +N+ LS T+ + T L LDLSYNNL+
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 84 NLSGTLSPSIGNL--TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
LS T + + L TNL ++ L NN+ L +L+ L N SL
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 142 GHLRSLQYMRFNNN---------SLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
L +++Y+ + SL S + L L++ N++ G
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 22/105 (20%), Positives = 41/105 (39%), Gaps = 5/105 (4%)
Query: 84 NLSGTLSPSIG---NLTNLQIVLLQNNNITGPIPAEIG--RLTKLQTLDLSNNFFTGEIP 138
L +L+ + T+++ + L N+ ++ + T L LDLS N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 139 SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
S L L+Y N++ F SL + + +L+L +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 22/113 (19%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNN---------NITGPIPAEIGRLTKLQTLDLSNNFFT 134
N+ S S+ L N++ + L+ + ++ L L+ L++ +N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 135 GEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLA----SMTQLIFLDLSYNNLSG 183
G + L +L+Y+ +N+ S T+ + + L L+L+ N +S
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-17
Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 5/105 (4%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNIT-GPIPAEIGR---LTKLQTLDLSNNFFTGEIPS 139
++ G S L NL+ + L N+ + + E + L L+L+ N +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 140 SLGHLRSLQYMRFNNNSLSGAFP-TSLASMTQLIFLDLSYNNLSG 183
+ L L+ + N + + + + LSYN
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 16/90 (17%), Positives = 36/90 (40%), Gaps = 3/90 (3%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
+ ++ + +T +P ++ T + L+L++N ++ L + N+
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+S P + L L+L +N LS
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSD 90
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 6/195 (3%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLYG 364
LG GG VY VA+K + E F+ EV S H+N++ +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 365 FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
LV Y+ +++ ++ L T G+ + H+ +I+HR
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHR 135
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 484
D+K NIL+D + DFG+AK L T V GTV + +PE + E TD+
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195
Query: 485 FGFGILLLELITGQR 499
+ GI+L E++ G+
Sbjct: 196 YSIGIVLYEMLVGEP 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLY- 363
LG GG V+ L+D VAVK L+ A F+ E + + H ++ +Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 364 -GFCMTPTERL--LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
G TP L +V Y+ ++ + + + + A + L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---G 136
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT--AVRGTVGHIAPEYLSTGQS 478
IIHRDVK ANI++ V DFG+A+ + + VT AV GT +++PE
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 479 SEKTDVFGFGILLLELITGQR 499
++DV+ G +L E++TG+
Sbjct: 197 DARSDVYSLGCVLYEVLTGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 308 LGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRL 362
+G+GG G VY+ +D +VA+K + + + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ F + + ++ +A+ L+ + L I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT--AVRGTVGHIAPEYLSTGQSSE 480
HRDVK NIL+ A + DFG+A D +T GT+ ++APE S ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 481 KTDVFGFGILLLELITGQR 499
+ D++ +L E +TG
Sbjct: 215 RADIYALTCVLYECLTGSP 233
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-22
Identities = 27/154 (17%), Positives = 46/154 (29%), Gaps = 15/154 (9%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLG 142
N LT+L + + N+ + + T L LDLS
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-----SAKTFNIVG 197
L LQ + ++N+L + + L LD S+N + S FN+
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 198 NPLICATGSEPDCYGTQLMPMSMNLNSSQTASPG 231
N + C C + + +
Sbjct: 555 NSVAC------IC---EHQKFLQWVKEQKQFLVN 579
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 22/100 (22%), Positives = 35/100 (35%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L S S N + LQ + L I L L L L+ N P S
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L SL+ + L+ + + L L++++N +
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 23/100 (23%), Positives = 38/100 (38%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
TLS N TNL + L + L +LQ L++S+N S
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L SL + + N + + L F +L+ N+++
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 2/102 (1%)
Query: 84 NLSGTLSPS-IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS-L 141
L S +L L + + N LT L TL ++ N F S+
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ +L ++ + L ++ +L L++S+NNL
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 17/87 (19%), Positives = 30/87 (34%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
++ + + L N + ++LQ LDLS + L L + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 157 LSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ P S + +T L L L+
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLAS 118
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 2/98 (2%)
Query: 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP-SSLGHLRSLQ 148
S S +L+ + L N + A L +LQ LD ++ S+ L L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 149 YMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
Y+ + + F +T L L ++ N+
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
L+ S IG L L+ + + +N I +PA LT L +DLS N+ + L
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 143 HLRSLQYMRF----NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
LR + + N + + + +L L L N S + +
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMK 222
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNIT--GPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ N G++S L +L + L N ++ G L+ LDLS N + +
Sbjct: 336 TMN-KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSA 393
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTS-LASMTQLIFLDLSYNNLSG 183
+ L LQ++ F +++L S S+ +L++LD+SY N
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 5/98 (5%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHL--RSLQY 149
+L L+ + L N + L L LDLS N + S L SL++
Sbjct: 323 PTLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
+ + N + + +L LD ++ L
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 19/131 (14%), Positives = 37/131 (28%), Gaps = 12/131 (9%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEI--- 137
S N + L + L+ N + I + L L L F E
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 138 ---PSSLGHLRSLQY--MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP---RFS 189
PS + L + R + + + + L+ ++ F
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
Query: 190 AKTFNIVGNPL 200
++ +I+ L
Sbjct: 309 WQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 21/103 (20%), Positives = 39/103 (37%), Gaps = 8/103 (7%)
Query: 82 SQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
+ + L N+ + L +I ++ + K Q+L + + P+
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK-QFPTL 325
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L L+ + N S +F ++ L +LDLS N LS
Sbjct: 326 --DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSF 364
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 10/111 (9%)
Query: 84 NLSG---TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
+L+G + Q + + + P L L++L L+ N G I
Sbjct: 291 SLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMN--KGSISFK 345
Query: 141 LGHLRSLQYMRFNNNSLS--GAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
L SL Y+ + N+LS G S L LDLS+N F
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFM 396
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 14/109 (12%), Positives = 30/109 (27%), Gaps = 10/109 (9%)
Query: 83 QNLSGTLSPSIGNLTNLQI------VLLQNNNITGPIPAEIGRLTKLQT--LDLSNNFFT 134
N S + + NL L + N+ P+ + L + L+
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 135 GEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ L ++ M S+ + + + L + L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 55/246 (22%), Positives = 104/246 (42%), Gaps = 31/246 (12%)
Query: 277 RHHEEVSLG--NLRRFQFRELQVATHNFSSKNI---------LGKGGFGIVYKGI-LQDG 324
++ E++L + F F +L V + K + LG G G V +
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 325 TVVAVK-------RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377
VA++ + + +TE+E++ H ++++ F + +V
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLE 219
Query: 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---D 434
M G + ++ G L +T K + YLHE IIHRD+K N+LL +
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276
Query: 435 DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILL 491
+ C + DFG +K+L ++ + + GT ++APE L + + + D + G++L
Sbjct: 277 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 492 LELITG 497
++G
Sbjct: 335 FICLSG 340
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISL----AVHR 357
LGKGGFG V+ G L D VA+K R+ + + + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRK-RIALGAAR-------- 408
++RL + T +LV + + D+ T K + G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA--------QDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
+ + H + ++HRD+K NIL+D A + DFG LL D T GT +
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVY 204
Query: 468 IAPEYLSTGQ-SSEKTDVFGFGILLLELITG 497
PE++S Q + V+ GILL +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 50/199 (25%), Positives = 76/199 (38%), Gaps = 19/199 (9%)
Query: 298 ATHNFSSK----NILGKGGFGIVYKGI-LQDGTVVAVK--------RLKDGNAIGGEIQF 344
+TH F ILG+G +V + I AVK
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 345 QTEVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
EV+ + ++ H N+++L T T LV+ M G + L K L ++I
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 404 LGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
+ LH+ I+HRD+K NILLDD + DFG + LD + G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVC-G 185
Query: 464 TVGHIAPEYLSTGQSSEKT 482
T ++APE + +
Sbjct: 186 TPSYLAPEIIECSMNDNHP 204
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 11/206 (5%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 356
+ + LG G +G V A+K ++ + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
N+++LY F LV G + + + + I G+ YLH+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 417 CDPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
I+HRD+K N+LL+ + + DFGL+ + ++Q GT +IAPE L
Sbjct: 156 ---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 474 STGQSSEKTDVFGFGILLLELITGQR 499
+ EK DV+ G++L L+ G
Sbjct: 211 R-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-20
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 293 RELQVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI--GGEIQFQTE-- 347
+ + ++FS I+G+GGFG VY D G + A+K L GE E
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 348 -VEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406
+ ++S ++ + TP + + M+ G + L + + + A
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
GL ++H + +++RD+K ANILLD+ + D GLA + H +V GT G
Sbjct: 302 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHG 355
Query: 467 HIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
++APE L G + + + D F G +L +L+ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 21/100 (21%), Positives = 37/100 (37%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L + + L NL + L I +L TL L+ N ++L
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
++L+++ F +S L + L L L N++S
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 2/101 (1%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
S + + LQ + L +++ +P+ + L+ L+ L LS N F S +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 144 LRSLQYMRFNNNSLSGA-FPTSLASMTQLIFLDLSYNNLSG 183
SL ++ N+ L ++ L LDLS++++
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 27/127 (21%), Positives = 54/127 (42%), Gaps = 9/127 (7%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG---RLTKLQTLDLSNNFFTGEIPSS 140
L + L LQ + LQ N+ + L +L+ L LS + +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-----SAKTFNI 195
L+ + ++ ++N L+ + +L+ + + L+L+ N++S +P +T N+
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINL 554
Query: 196 VGNPLIC 202
NPL C
Sbjct: 555 RQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 13/100 (13%), Positives = 31/100 (31%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ + + L ++L N + + L+ L + L +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
++L+ + +N +S +L LD N +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 15/88 (17%), Positives = 25/88 (28%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
+ + + N + RL L LDL+ + L + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 156 SLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L T+L+ L L +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS 119
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 1/99 (1%)
Query: 86 SGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSSLGHL 144
S + + NL++LQ + L N +L+ LDL+ + S +L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L+ + +++ L + + L L+L N+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 2/102 (1%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L ++ L+ + I+ + L++L L +N +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQL--IFLDLSYNNLSG 183
L+ + F NN++ ++S+ Q + L+L+ N+++G
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 4/104 (3%)
Query: 84 NLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI---PS 139
L + S NL L+++ L ++ + L LQ L+L N F +
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
SL L L+ + + LS + S+ + +DLS+N L+
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFT--GEIPSS 140
S N +L + ++ N + + L L+ LDLS++
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L +L LQ + + N + QL LDL++ L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 19/106 (17%), Positives = 41/106 (38%), Gaps = 2/106 (1%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
++S + + + +++ + LQ + + LQ LDL+ + E+PS L
Sbjct: 242 DISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
L +L+ + + N S ++ L L + N +
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+ + L+++ L + + L L+ L+LS++
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 143 HLRSLQYMRFNNNSLSGAF---PTSLASMTQLIFLDLSYNNLSG 183
L +LQ++ N SL ++ +L L LS+ +LS
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 23/101 (22%), Positives = 46/101 (45%), Gaps = 1/101 (0%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+ + S+ L L+I++L +++ L + +DLS+N T +L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
HL+ + Y+ +N +S P+ L ++Q ++L N L
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 20/105 (19%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-S 140
+ L + L+ L+ ++L N L L + N E+ +
Sbjct: 286 TATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 141 LGHLRSLQYMRFNNNSL--SGAFPTSLASMTQLIFLDLSYNNLSG 183
L +L +L+ + +++ + S L +++ L L+LSYN
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 14/112 (12%), Positives = 30/112 (26%), Gaps = 4/112 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG--RLTKLQTLDLSNNFFTGEIPS 139
+ N + P + Q + I + + L + P+
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 140 SLGHLR--SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS 189
L S++ + + + + L LDL+ +LS
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV 298
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 15/109 (13%), Positives = 31/109 (28%), Gaps = 7/109 (6%)
Query: 84 NLSGTLSPSIGNLTNLQIVLL--QNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ + +L + L N+I G I Q+L+ I L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 142 GH--LRSLQYMRFNNNSLSGAFPTSLASM--TQLIFLDLSYNNLSGPVP 186
+ ++SL F + P + + ++L +
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 17/201 (8%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHR--NL 359
LG GGFG VY GI + D VA+K R+ D + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 360 LRLYGFCMTPTERLLVYPYMSN-GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
+RL + P +L+ + + + L + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-- 168
Query: 419 PKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
++HRD+K NIL+D + E + DFG LL +D+ T GT + PE++ +
Sbjct: 169 -GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPEWIRYHR 224
Query: 478 -SSEKTDVFGFGILLLELITG 497
V+ GILL +++ G
Sbjct: 225 YHGRSAAVWSLGILLYDMVCG 245
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-20
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLR 361
+ +LGKG FG V G AVK + EV+++ H N+++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
LY F LV + G + + + RI G+ Y+H+ KI
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KI 147
Query: 422 IHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 478
+HRD+K N+LL+ + + DFGL+ + GT +IAPE L G
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLH-GTY 204
Query: 479 SEKTDVFGFGILLLELITG 497
EK DV+ G++L L++G
Sbjct: 205 DEKCDVWSTGVILYILLSG 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 47/230 (20%), Positives = 85/230 (36%), Gaps = 27/230 (11%)
Query: 277 RHHEEVSLGNLRRFQFRELQVATHNFS-----SKNILGKGGFGIVYKGI-LQDGTVVAVK 330
HH L F+ + + + SK +LG G G V + + G A+K
Sbjct: 2 AHHHHHHSSGLE-VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 331 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER----LLVYPYMSNGSVAS 386
L D E+ + +++ + L++ M G + S
Sbjct: 61 LLYDSPKARQEVDH-----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS 115
Query: 387 RLKGKPILDWSTRK--RIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVV 441
R++ + ++ R+ I + +LH I HRDVK N+L + +
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 491
DFG AK + T T ++APE L + + D++ G+++
Sbjct: 173 TDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 288 RRFQFRELQ---VATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI--GGE 341
R Q++ L+ + F +LG+GGFG V+ ++ G + A K+L G
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 342 IQFQTEVEMISLAVHRNLLRL-YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRK 400
E ++++ R ++ L Y F T T+ LV M+ G + +
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAF-ETKTDLCLVMTIMNGGDIRYHIYNVD----EDNP 284
Query: 401 RIALGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452
A GL +LH++ II+RD+K N+LLDD + D GLA L
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
+ GT G +APE L G+ + + D F G+ L E+I +
Sbjct: 342 GQTKTKGYA-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 21/223 (9%)
Query: 288 RRFQFRELQ---VATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAI--GGE 341
R Q++ L+ V + F +LGKGGFG V ++ G + A K+L+ GE
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 342 IQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTR 399
E +++ R ++ L T LV M+ G + + G+
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---E 285
Query: 400 KRIALGAAR---GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
R AA GL LH + +I++RD+K NILLDD + D GLA +
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQ 340
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
GTVG++APE + + + D + G LL E+I GQ
Sbjct: 341 TIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 15/112 (13%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ L ++ L+ + L N + +PA I L +L+ L + E+P
Sbjct: 110 TIDAAGLMELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168
Query: 140 SLG---------HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L L +LQ +R + + P S+A++ L L + + LS
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 5/101 (4%)
Query: 84 NLSGT----LSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
L T L SI NL NL+ + ++N+ ++ + I L KL+ LDL P
Sbjct: 189 RLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
G L+ + + S P + +TQL LDL
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 16/102 (15%), Positives = 36/102 (35%), Gaps = 2/102 (1%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN-NFFTGEIPSS 140
+ L P+I +L L+ + L+ P G L+ L L + + +P
Sbjct: 214 RNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLD 272
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ L L+ + P+ +A + + + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 2/101 (1%)
Query: 80 IPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+P S S L NLQ + L+ I +PA I L L++L + N+ + +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGP 223
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
++ HL L+ + + +P L L L +
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 5/101 (4%)
Query: 88 TLSPSIGNLT--NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLR 145
+ + + T + L++ + P + RL+ LQ + + E+P ++
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 146 SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
L+ + N L A P S+AS+ +L L + +P
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR---------LTKLQTLDLSN 130
L+ L SI +L L+ + ++ +P + L LQ+L L
Sbjct: 133 TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+P+S+ +L++L+ ++ N+ LS A ++ + +L LDL P
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 6/104 (5%)
Query: 82 SQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGRLT--KLQTLDLSNNFFTGEIP 138
+ + + S N N QI + + T L+L + + P
Sbjct: 40 NADRNRWHSAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFP 97
Query: 139 SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L LQ+M + L P ++ L L L+ N L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
L + P G L+ ++L++ + +P +I RLT+L+ LDL +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAF---PTSLASM 168
PS + L + + + + P + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 72/288 (25%), Positives = 110/288 (38%), Gaps = 63/288 (21%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-------------------------RLKDGNAIGGE 341
+GKG +G+V D T A+K G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 342 IQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKR 401
Q E+ ++ H N+++L P E L YM V + P+++ T K
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YM----VFELVNQGPVMEVPTLKP 133
Query: 402 IALGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453
++ AR G+ YLH Q KIIHRD+K +N+L+ + + DFG++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 454 DSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQ--------RALE 502
D+ ++ V GT +APE LS + S + DV+ G+ L + GQ L
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL- 248
Query: 503 YGKAANQKGAMLDWVKKIHQEKKL--EMLVDKDLKNNYDRIELEEMVQ 548
+ K +Q D K L ML KN RI + E+
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLD----KNPESRIVVPEIKL 292
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 32/196 (16%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-------RLKDGNAIGGEIQFQTEVE-MISLAV 355
K+++G+G +V + + G AVK RL + E + +A
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAAR----- 408
H +++ L + + LV+ M G + L K S ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKE-----TRSIMRSL 209
Query: 409 --GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
+ +LH I+HRD+K NILLDD + + DFG + L+ + GT G
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELC-GTPG 264
Query: 467 HIAPEYLSTGQSSEKT 482
++APE L
Sbjct: 265 YLAPEILKCSMDETHP 280
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 7e-19
Identities = 48/236 (20%), Positives = 89/236 (37%), Gaps = 32/236 (13%)
Query: 279 HEEVSLGNLRRFQFRELQVATHNFSSK----NILGKGGFGIVYKGI-LQDGTVVAVKRLK 333
++ +++ + +++ + LG G FG+V++ G A K +
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 334 DGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI 393
+ E + E++ +S+ H L+ L+ E +++Y +MS G +
Sbjct: 192 TPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG---------EL 241
Query: 394 LDWSTRKRIALG---AAR-------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV-- 441
+ + + A GL ++HE +H D+K NI+ +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298
Query: 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
DFGL LD V GT APE TD++ G+L L++G
Sbjct: 299 IDFGLTAHLDP-KQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 24/203 (11%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
++GKG F +V + I + G AVK + + E + E + + H +
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPH 87
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRK-----RIALGAARGLL 411
++ L + +V+ +M + + + +S R L A R
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR--- 144
Query: 412 YLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
Y H+ IIHRDVK +LL ++ +G FG+A L V GT +
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 469 APEYLSTGQSSEKTDVFGFGILL 491
APE + + DV+G G++L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 14/226 (6%)
Query: 277 RHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDG 335
HH S G + ++ +LGKG FG V K AVK +
Sbjct: 2 HHHHHHSSGRENLYFQGTF---AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 336 NAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPIL 394
+A + EVE++ H N+++L+ + +V + G + + +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 395 DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA---VVGDFGLAKLLD 451
RI G+ Y+H+ I+HRD+K NILL+ + + DFGL+
Sbjct: 119 SEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
Q++ + + GT +IAPE L G EK DV+ G++L L++G
Sbjct: 176 -QNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 21/92 (22%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
++ +LT L+++ + +N I+ + L++L +L L+NN E +G L +L +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N ++ P LAS++++ D + +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NL+ L + + N I+ + LTKL+ L++ +N + S L +L L +
Sbjct: 237 SPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
NNN L + +T L L LS N+++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
++ NLTNL+ + L +NI+ P + LTK+ +L+L N S L ++ L Y+
Sbjct: 104 SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYL 160
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ + P +A++T L L L+YN +
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 11/115 (9%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ N+T L + + NN IT P + L++L L++ N + +++ L L+ +
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR-FSA----KTFNIVGNPL 200
+N +S + L +++QL L L+ N L T + N +
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 29/114 (25%), Positives = 52/114 (45%), Gaps = 10/114 (8%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
I LTNL+ + L N IT P + L KL L + N T S+L +L +L+ +
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLREL 115
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPL 200
N +++S + LA++T++ L+L N+ + S + + +
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 6/102 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
N + + + N+T L + + + + P I LT L +L L+ N P L
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--L 195
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L SL Y N ++ T +A+MT+L L + N ++
Sbjct: 196 ASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 22/93 (23%), Positives = 43/93 (46%), Gaps = 6/93 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ L ++ +++ + I I LT L+ L+L+ N T P L +L L +
Sbjct: 38 VTQEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNL 93
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
N ++ ++L ++T L L L+ +N+S
Sbjct: 94 YIGTNKITD--ISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 15/95 (15%), Positives = 38/95 (40%), Gaps = 6/95 (6%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+L +LQ ++T + L + L ++ + +L +L+Y+
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
N N ++ + L+++ +L L + N ++
Sbjct: 73 LNGNQITD--ISPLSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 3e-04
Identities = 6/62 (9%), Positives = 15/62 (24%), Gaps = 8/62 (12%)
Query: 123 LQTLDLSNNFFTGEIP--SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
TL I L S++ + + + L ++
Sbjct: 2 AATLATLPA----PINQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK 55
Query: 181 LS 182
++
Sbjct: 56 VA 57
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLK------------DGNAIGGEIQFQTEVEMI 351
LG G +G V + A+K +K + N + E+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 352 SLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
H N+++L+ LV + G + ++ + D I G+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
YLH+ I+HRD+K NILL++ + DFGL+ +D + + GT +I
Sbjct: 161 YLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRL-GTAYYI 215
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITG 497
APE L + +EK DV+ G+++ L+ G
Sbjct: 216 APEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 49/240 (20%), Positives = 93/240 (38%), Gaps = 32/240 (13%)
Query: 275 KERHHEEVSLGNLRRFQFRELQVATHNFSSK----NILGKGGFGIVYKGI-LQDGTVVAV 329
K +++ +++ + ++V + LG G FG+V++ + G V
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 330 KRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK 389
K + + + E+ +++ H L+ L+ E +L+ ++S G
Sbjct: 82 KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG------- 133
Query: 390 GKPILDWSTRKRIALG---AAR-------GLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439
+ D + + GL ++HE I+H D+K NI+ + +
Sbjct: 134 --ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 188
Query: 440 VV--GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
V DFGLA L+ D V T APE + TD++ G+L L++G
Sbjct: 189 SVKIIDFGLATKLNP-DEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 63/274 (22%), Positives = 92/274 (33%), Gaps = 59/274 (21%)
Query: 278 HHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK-----R 331
HH S FQ L + K +G+G +G+V I Q + A+K +
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 332 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK 391
++ N E + +TEV ++ H N+ RLY LV G + +L
Sbjct: 64 IRQINPKDVE-RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 392 PILDWSTRKRIALG---------------------------------AAR-------GLL 411
+ + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLLD----HQDSHVTTAVRGTV 465
YLH Q I HRD+K N L + DFGL+K + +TT GT
Sbjct: 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTP 238
Query: 466 GHIAPEYLSTGQSS--EKTDVFGFGILLLELITG 497
+APE L+T S K D + G+LL L+ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK---RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
LG+G +G V + + + AVK + K GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 364 G--FCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
+ + +V Y G + +LD KR + A GL YL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-------MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH--QDSHVTTAVRGTVGHIAPE 471
H Q I+H+D+K N+LL + G+A+ L D T+ +G+ PE
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPE 181
Query: 472 YLSTGQ--SSEKTDVFGFGILLLELITG 497
+ S K D++ G+ L + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G +G V + VAVK + A+ + E+ + + H N+++ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYLHEQCD 418
+ L Y S G + R+ + A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMAGVVYLHGI-- 124
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH--QDSHVTTAVRGTVGHIAPEYLS-T 475
I HRD+K N+LLD+ + DFGLA + + ++ + GT+ ++APE L
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 476 GQSSEKTDVFGFGILLLELITG 497
+E DV+ GI+L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 31/144 (21%), Positives = 54/144 (37%), Gaps = 14/144 (9%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LT L + L N + P I L L L L N + P + L LQ +
Sbjct: 281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATGS 206
F NN +S +SLA++T + +L +N +S P + + T +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAW---TNA 390
Query: 207 EPDCYGTQLMPMSMNLNSSQTASP 230
+ +P ++ + +P
Sbjct: 391 PVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ L NL + NN +T P + LTKL + ++NN P L +L +L +
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
NN ++ L ++T L L+LS N +S
Sbjct: 118 TLFNNQITD--IDPLKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NLT L+ + + +N ++ + +LT L++L +NN + P LG L +L +
Sbjct: 171 KPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDEL 226
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
N N L +LAS+T L LDL+ N +S
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 6/93 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LTNL+ ++ NN I+ P +G LT L L L+ N +L L +L +
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
NN +S L+ +T+L L L N +S
Sbjct: 249 DLANNQISN--LAPLSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NLTNL + L NN IT P + LT L L+LS+N + S+L L SLQ +
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
F N LA++T L LD+S N +S
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 7/93 (7%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NLTNL + L +N I+ + LT LQ L N L +L +L+ +
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
++N +S + LA +T L L + N +S
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 6/99 (6%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
T + S +L + + I + L L ++ SNN T P L +L L
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKL 92
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ NNN ++ T LA++T L L L N ++ P
Sbjct: 93 VDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 20/109 (18%), Positives = 41/109 (37%), Gaps = 7/109 (6%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
I + L +L N+T + L ++ TL
Sbjct: 6 ATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--S 60
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ +L +L + F+NN L+ P L ++T+L+ + ++ N ++ P
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 18/94 (19%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
S+ NLTN+ + +N I+ P + LT++ L L++ +T + ++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184
+ +L P +++ D+++N S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 15/196 (7%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 362
+LGKG FG V K AVK + +A + EVE++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
+ + +V + G + + + RI G+ Y+H+ I+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 423 HRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
HRD+K NILL + C+ + DFGL+ Q++ + + GT +IAPE L G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIAPEVLR-GTYD 200
Query: 480 EKTDVFGFG----ILL 491
EK DV+ G ILL
Sbjct: 201 EKCDVWSAGVILYILL 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 14/207 (6%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 357
F K LG G FG V+ G +K + + Q + E+E++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR----GLLYL 413
N+++++ +V G + R+ + + + L Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
H Q ++H+D+K NIL D + DFGLA+L D H T A GT ++AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA-GTALYMAP 195
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITG 497
E + K D++ G+++ L+TG
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 292 FRELQVATHNFSS----KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT 346
++L + F+ K +G G + + + I AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----- 64
Query: 347 EVE-MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRK--R 401
E+E ++ H N++ L +V M G + ++ + +S R+
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASA 120
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHV 457
+ + + YLH Q ++HRD+K +NIL + + DFG AK L ++ +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 491
T T +APE L D++ G+LL
Sbjct: 178 MTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 43/217 (19%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G F IV K G A K + + + + EV ++ +H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 359 LLRLYGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIAL 404
++ L+ T+ +L+ +S G A+ K ILD
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-KQILD--------- 126
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVTTA 460
G+ YLH + KI H D+K NI+L + DFGLA ++
Sbjct: 127 ----GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT +APE ++ + D++ G++ L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 13/194 (6%)
Query: 303 SSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 360
LG+G F I K + + AVK + E Q E+ + H N++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIV 69
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+L+ LV ++ G + R+K K + I + ++H+
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126
Query: 421 IIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
++HRD+K N+L +D E + DFG A+L + + T T+ + APE L+
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 478 SSEKTDVFGFGILL 491
E D++ G++L
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 19/199 (9%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 362
LGKG F +V + + + G A + + Q + E + L H N++RL
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPIL---DWSTRKRIALGAARGLLYLHEQCDP 419
+ L++ ++ G + + + D S + L A +L+ H+
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA---VLHCHQM--- 129
Query: 420 KIIHRDVKAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
++HR++K N+LL + + DFGLA ++ + GT G+++PE L
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKD 188
Query: 477 QSSEKTDVFGFG----ILL 491
+ D++ G ILL
Sbjct: 189 PYGKPVDLWACGVILYILL 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 46/220 (20%)
Query: 299 THNFSSK----NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 352
+ FS LGKG F +V + + G A K + + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWST 398
H N++RL+ + LV+ ++ G + AS + IL+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE--- 116
Query: 399 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDS 455
+ Y H I+HR++K N+LL + + DFGLA ++ DS
Sbjct: 117 ----------SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DS 161
Query: 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 491
GT G+++PE L S+ D++ G ILL
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+LG G F V+ G + A+K +K + + + E+ ++ H N++ L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 364 GFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIALGAARG 409
+ T LV +S G AS + + +L
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-QQVLS-------------A 118
Query: 410 LLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 466
+ YLHE I+HRD+K N+L ++ + ++ DFGL+K+ + ++TA GT G
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPG 172
Query: 467 HIAPEYLSTGQSSEKTDVFGFG----ILL 491
++APE L+ S+ D + G ILL
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
S ILG G FG V+K G +A K +K E + + E+ +++ H NL
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANL 148
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALG---AAR-------G 409
++LY + + +LV Y+ G + D + L G
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGG---------ELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLLDHQDSHVTTAVRGTVGH 467
+ ++H+ I+H D+K NIL + + DFGLA+ ++ + GT
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEF 254
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITG 497
+APE ++ S TD++ G++ L++G
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 33/173 (19%)
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR------ 462
+ +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 463 -----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517
GT +++PE + S K D+F G++L EL+ ++ ++ V
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRIITDV 286
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570
+ + Y + MVQ +L P RP+ ++++
Sbjct: 287 RNLK--------FPLLFTQKYP--QEHMMVQ-DMLSPS--PTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 16/69 (23%), Positives = 33/69 (47%), Gaps = 1/69 (1%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+F +G+GGFG+V++ D A+KR++ N + EV+ ++ H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 360 LRLYGFCMT 368
+R + +
Sbjct: 67 VRYFNAWLE 75
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 39/215 (18%)
Query: 304 SKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE-MISLAVHRNLL 360
+ LG+G F +V + I G A K LK E+ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 361 RLYGFCMTPTERLLVYPYMSNG----SVASRLKG-----------KPILDWSTRKRIALG 405
L+ +E +L+ Y + G L K IL+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---------- 142
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVR 462
G+ YLH+ I+H D+K NILL + DFG+++ + + +
Sbjct: 143 ---GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM- 194
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT ++APE L+ + TD++ GI+ L+T
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 42/210 (20%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 362
K LGKG F +V + + G A K + + Q + E + H N++RL
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 363 YGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIALGAAR 408
+ + LV+ ++ G + AS + IL+
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE------------- 139
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGTV 465
+ Y H I+HR++K N+LL + + DFGLA ++ DS GT
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP 194
Query: 466 GHIAPEYLSTGQSSEKTDVFGFG----ILL 491
G+++PE L S+ D++ G ILL
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 299 THNFSSKNILGKGGFGIVYKGILQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 356
+++ ++G G FG+VY+ L D G +VA+K+ L+D E+Q +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 357 RNLLRLYGFCMTPTERL------LVYPYMS---NGSVASRLKGKPILDWSTRKRIALGAA 407
N++RL F + E+ LV Y+ + K L K
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAV----R 462
R L Y+H I HRD+K N+LLD D + DFG AK L + +V+ R
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 463 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
APE + + DV+ G +L EL+ GQ
Sbjct: 224 ------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 43/217 (19%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G F IV K G A K + + + + EV ++ +H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 359 LLRLYGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIAL 404
++ L+ T+ +L+ +S G A+ K ILD
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-KQILD--------- 126
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVTTA 460
G+ YLH + KI H D+K NI+L + DFGLA ++
Sbjct: 127 ----GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT +APE ++ + D++ G++ L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 20/89 (22%), Positives = 42/89 (47%), Gaps = 2/89 (2%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
I N++ + + N + T P I L+ L+ L + T + +L L SL +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
++++ + T + ++ ++ +DLSYN
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 18/102 (17%), Positives = 47/102 (46%), Gaps = 4/102 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ + +P I L+NL+ + + ++T + LT L LD+S++ I + +
Sbjct: 74 NNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 142 GHLRSLQYMRFN-NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + + + N +++ L ++ +L L++ ++ +
Sbjct: 133 NTLPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 19/100 (19%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+++ P++ LT+L ++ + ++ I +I L K+ ++DLS N +I L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L L+ + + + + +L L + G
Sbjct: 158 LPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 18/91 (19%), Positives = 40/91 (43%), Gaps = 4/91 (4%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ + +L + L N N+T I ++ L ++N T + + L +L+ +R
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
++ +L+ +T L LD+S++
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 12/88 (13%), Positives = 36/88 (40%), Gaps = 7/88 (7%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
LL ++ A+ + L + L+N T ++ + + + +++ + NN
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ P ++ ++ L L + +++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVT 101
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 14/83 (16%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNN-ITGPIPAEIGRLTKLQTLDLSNNFFTGE 136
L I ++ I L + + L N IT +P + L +L++L++ +
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHD- 173
Query: 137 IPSSLGHLRSLQYMRFNNNSLSG 159
+ L + + ++ G
Sbjct: 174 -YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 9/59 (15%), Positives = 20/59 (33%), Gaps = 3/59 (5%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE 136
+ + + P + L L+ + +Q + + I KL L + G+
Sbjct: 141 IDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G +G V + VAVK + A+ + E+ + + H N+++ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYLHEQCD 418
+ L Y S G + R+ + A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMAGVVYLHGI-- 124
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH--QDSHVTTAVRGTVGHIAPEYLS-T 475
I HRD+K N+LLD+ + DFGLA + + ++ + GT+ ++APE L
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 476 GQSSEKTDVFGFGILLLELITG 497
+E DV+ GI+L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 43/217 (19%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G F IV K G A K RL + + EV ++ H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 359 LLRLYGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIAL 404
++ L+ T+ +L+ +S G A++ K ILD
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL-KQILD--------- 119
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVTTA 460
G+ YLH + +I H D+K NI+L + DFG+A ++ +
Sbjct: 120 ----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNI 171
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT +APE ++ + D++ G++ L++G
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+++ ++G G FG+V++ L + VA+K+ L+D E+Q V+ H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNVV 95
Query: 361 RLYGFCMTPTERL------LVYPYMS---NGSVASRLKGKPILDWSTRKRIALGAARGLL 411
L F + ++ LV Y+ + K K + K R L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 412 YLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAV----RGTVG 466
Y+H I HRD+K N+LLD + DFG AK+L + +V+ R
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR---- 208
Query: 467 HIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
APE + + + D++ G ++ EL+ GQ
Sbjct: 209 --APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-------RLKDGNAIGGEIQFQTEVEMISLAVH 356
LG G G V + VA+K + + +TE+E++ H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
++++ F + +V M G + ++ G L +T K + YLHE
Sbjct: 75 PCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 417 CDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
IIHRD+K N+LL ++ C + DFG +K+L + S + T GT ++APE L
Sbjct: 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPEVL 188
Query: 474 STGQS---SEKTDVFGFGILL 491
+ + + D + G++L
Sbjct: 189 VSVGTAGYNRAVDCWSLGVIL 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 44/194 (22%), Positives = 71/194 (36%), Gaps = 25/194 (12%)
Query: 304 SKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 361
+++LG+G V I L AVK ++ + EVE + HRN+L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLE 75
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRK--RIALGAARGLLYLHEQC 417
L F LV+ M GS+ S + + ++ + + A L +LH +
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNK- 130
Query: 418 DPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHV-------TTAVRGTVGH 467
I HRD+K NIL + + DF L + T G+ +
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 468 IAPEYLSTGQSSEK 481
+APE +
Sbjct: 188 MAPEVVEAFSEEAS 201
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 300 HNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEI--QFQTEVEMI 351
+S+ + LG G FG V+ + + V VK ++ + I + E+ ++
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 352 SLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS-VASRLKGKPILDWSTRKRIALGAARGL 410
S H N++++ LV +G + + + P LD I +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
YL + IIHRD+K NI++ + + DFG A L + T GT+ + AP
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAP 198
Query: 471 EYLSTGQSSE--KTDVFGFGILLLELITG 497
E L G + +++ G+ L L+
Sbjct: 199 EVLM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 36/230 (15%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIG-GEI-QF 344
+ +E+++ +F ++G+G F V K G V A+K + + + GE+ F
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
+ E +++ R + +L+ F L LV Y G + + L +RI
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-------KFGERIP 160
Query: 404 LGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
AR + +H +HRD+K NILLD C + DFG L +
Sbjct: 161 AEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217
Query: 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG-------FGILLLELITGQ 498
+ GT +++PE L T +G G+ E+ GQ
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 34/228 (14%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIG-GEIQ-F 344
+ +++++ +F ++G+G FG V K V A+K L + E F
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACF 121
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIA 403
+ E +++ + + L+ + L LV Y G + + L R+
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS-------KFEDRLP 173
Query: 404 LGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
AR + +H+ +HRD+K NIL+D + DFG L +
Sbjct: 174 EEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 456 HVTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 498
++ GT +I+PE L + + D + G+ + E++ G+
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 34/206 (16%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
+GKG F V + G VA+K +L + + EV ++ + H N+++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVK 78
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
L+ T L+ Y S G V L R+ AR + Y
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYL--------VAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H++ I+HRD+KA N+LLD + DFG + + G + APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELF 185
Query: 474 STGQSSE--KTDVFGFGILLLELITG 497
G+ + + DV+ G++L L++G
Sbjct: 186 Q-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 33/226 (14%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIG-GEIQ-F 344
+ R+L++ ++ ++G+G FG V K V A+K L I + F
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIAL 404
E ++++ A +++L+ +V YM G + + + +
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---------NYDVPE 167
Query: 405 GAAR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
AR L +H IHRDVK N+LLD + DFG ++ +
Sbjct: 168 KWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFGILLLELITGQ 498
GT +I+PE L + D + G+ L E++ G
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 299 THNFSSKNILGKGGFGIVYKGILQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 356
F + + G+G FG V G + G VA+K+ ++D E+Q ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 357 RNLLRLYGFCMTPTER-------LLVYPYMS---NGSVASRLKGKPILDWSTRKRIALGA 406
N+++L + T ER +V Y+ + + + + K
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAV---- 461
R + LH + HRD+K N+L++ + DFG AK L + +V
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 462 RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 498
R APE + Q + D++ G + E++ G+
Sbjct: 198 R------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 18/90 (20%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
N +I + ++++ + + ++ LDLS N + + L L+ +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
++N L L S++ L LDL+ N +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 8/102 (7%)
Query: 82 SQNLSGTLSPSIG-NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
+ + S+ + N++ + L N ++ A++ TKL+ L+LS+N E
Sbjct: 18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-D 75
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L L +L+ + NNN + L + L + NN+S
Sbjct: 76 LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 5/102 (4%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSS 140
+ N +S S + + L NN IT + G +++Q LDL N
Sbjct: 107 ANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+L+++ N + +L LDLS N L+
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 20/102 (19%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 84 NLSG---TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
NLS + + +L+ L+ + L NN + E+ ++TL +NN + + S
Sbjct: 64 NLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + + NN ++ +++ +LDL N +
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 16/120 (13%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
L+ + L +N + + E + + L NN I +L ++L++
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 151 RFNNNSLS-GAFPTSLASMTQLIFLDLSYN-NLSGPVPRFSAKTFNIVGNPLICATGSEP 208
N G + ++ + L+G C P
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 14/70 (20%), Positives = 28/70 (40%)
Query: 113 IPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLI 172
I + + ++++ + S +++ + + N LS LA T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 173 FLDLSYNNLS 182
L+LS N L
Sbjct: 62 LLNLSSNVLY 71
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 43/217 (19%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
LG G F +V K G A K R K + EV ++ H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 359 LLRLYGFCMTPTERLLVYPYMSNG--------------SVASRLKGKPILDWSTRKRIAL 404
++ L+ T+ +L+ ++ G A+ K IL+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-KQILN--------- 125
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAKLLDHQDSHVTTA 460
G+ YLH +I H D+K NI+L + DFGLA +D +
Sbjct: 126 ----GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI 177
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
GT +APE ++ + D++ G++ L++G
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 46/167 (27%), Positives = 68/167 (40%), Gaps = 27/167 (16%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISL----- 353
+ +G G +G VYK G VA+K ++ N GG + V ++L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 354 -AVHRNLLRLYGFCMTPTERL-----LVYPYMSNGSVASRLKG------KPILDWSTRKR 401
H N++RL C T LV+ ++ L+ P L T K
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLPAETIKD 124
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448
+ RGL +LH I+HRD+K NIL+ + DFGLA+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 24/114 (21%), Positives = 47/114 (41%), Gaps = 6/114 (5%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFN 153
+L NL + + + + L+ L+ L ++ N F LR+L ++ +
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS----GPVPRFSA-KTFNIVGNPLIC 202
L PT+ S++ L L+++ N L G R ++ + + NP C
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 26/103 (25%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSS 140
S N T+S + L L+ + Q++N+ + L L LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 141 LGHLRSLQYMRFNNNSLSGAFPT-SLASMTQLIFLDLSYNNLS 182
L SL+ ++ NS F + L FLDLS L
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-16
Identities = 26/137 (18%), Positives = 45/137 (32%), Gaps = 14/137 (10%)
Query: 60 DPCSW----TMVTCSPESL-VIGLGIPSQ---------NLSGTLSPSIGNLTNLQIVLLQ 105
+PC C + I +P L S S + LQ++ L
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 106 NNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSL 165
I L+ L TL L+ N + L SLQ + +L+ +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 166 ASMTQLIFLDLSYNNLS 182
+ L L++++N +
Sbjct: 121 GHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 2/103 (1%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
S + I L++L+++ + N+ +I L L LDLS P+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ L SLQ + +N L +T L + L N
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 6/109 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNIT-GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
NL+ + IG+L L+ + + +N I +P LT L+ LDLS+N + L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 143 HLRSLQYMR----FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
L + + + N ++ P + + +L L L N S V +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 23/175 (13%), Positives = 51/175 (29%), Gaps = 20/175 (11%)
Query: 84 NLSGTLSPSIGNLTNLQIVL----LQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ + L + ++ L N + I + +L L L NNF + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 140 -SLGHLRSLQYMR------FNNNSLSGAFPTSLASMTQLIF--LDLSYNNLSGPVPR--- 187
+ L L+ R N +L ++L + L L+Y +
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 188 ---FSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLS 239
+ +F++V + + L ++ T + +
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 24/102 (23%), Positives = 40/102 (39%), Gaps = 7/102 (6%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+++ Q + L N P +L L+ L ++N S +
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGG-NAFSEVD 345
Query: 143 HLRSLQYMRFNNNSLS--GAFPTSLASMTQLIFLDLSYNNLS 182
L SL+++ + N LS G S T L +LDLS+N +
Sbjct: 346 -LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 18/111 (16%), Positives = 29/111 (26%), Gaps = 10/111 (9%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFTGE---I 137
S N + P L + L+NN + + I L L+ L F E
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 138 PSSLGHLRSLQYMRFNNNSLSG------AFPTSLASMTQLIFLDLSYNNLS 182
L L + L+ +T + L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 30/133 (22%), Positives = 44/133 (33%), Gaps = 26/133 (19%)
Query: 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLL---QNNNITGPIPAEIGRLTKLQTLDLS 129
LV+G NL ++ L NL I + I LT + + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 130 NNFFTGEIPSSLGH--------------------LRSLQYMRFNNNSLSGAFPTSLASMT 169
+ + + L+SL+ + F +N AF S +
Sbjct: 291 SVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLP 347
Query: 170 QLIFLDLSYNNLS 182
L FLDLS N LS
Sbjct: 348 SLEFLDLSRNGLS 360
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 20/197 (10%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+LG G G V + + A+K L+D E++ + +++R+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIV 121
Query: 364 GFCMTPTER----LLVYPYMSNGSVASRLKGKPILDWSTRK--RIALGAARGLLYLHEQC 417
L+V + G + SR++ + ++ R+ I + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 180
Query: 418 DPKIIHRDVKAANILLDDCCEAV---VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
I HRDVK N+L + DFG AK +S +TT T ++APE L
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLG 236
Query: 475 TGQSSEKTDVFGFGILL 491
+ + D++ G+++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 42/210 (20%), Positives = 79/210 (37%), Gaps = 37/210 (17%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK----RLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG+G FGIV++ + K + D + + E+ ++++A HRN+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV------KKEISILNIARHRNI 63
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALG---AAR-------G 409
L L+ + E ++++ ++S I + L
Sbjct: 64 LHLHESFESMEELVMIFEFISGL---------DIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVV--GDFGLAKLLDHQDSHVTTAVRGTVGH 467
L +LH I H D++ NI+ + + +FG A+ L + +
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLF-TAPEY 169
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITG 497
APE S TD++ G L+ L++G
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 18/90 (20%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
N +I + ++++ + + ++ LDLS N + + L L+ +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
++N L L S++ L LDL+ N +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 7/105 (6%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
+ +L L+ + N++ + L N ++ A++ TKL+ L+LS+N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L L +L+ + NNN + L + L + NN+S
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 20/102 (19%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 84 NLSG---TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
NLS + + +L+ L+ + L NN + E+ ++TL +NN + + S
Sbjct: 64 NLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + + NN ++ +++ +LDL N +
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 5/102 (4%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSS 140
+ N +S S + + L NN IT + G +++Q LDL N
Sbjct: 107 ANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+L+++ N + +L LDLS N L+
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 18/163 (11%), Positives = 45/163 (27%), Gaps = 6/163 (3%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
L+ + L +N + + E + + L NN I +L ++L++
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 151 RFNNNSLS-GAFPTSLASMTQLIFLDL-SYNNLSGPVPRFSAKTFNIVGNPLICATGSEP 208
N G + ++ + + L+G C P
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
Query: 209 DCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSL 251
+ +L+ + ++ + T + +
Sbjct: 303 --FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 13/64 (20%), Positives = 27/64 (42%)
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
+ + ++++ + S +++ + + N LS LA T+L L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 180 NLSG 183
L
Sbjct: 69 VLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 8/98 (8%), Positives = 24/98 (24%), Gaps = 4/98 (4%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
++ Q + + E + + +D + I ++ +
Sbjct: 311 KRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 155 NSLSGAFPTSLASMTQL---IFLDLSYNNLSGPVPRFS 189
+L + +L + + L S
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 9/116 (7%), Positives = 24/116 (20%), Gaps = 6/116 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEIPSS 140
+ + L N + + + ++ TL+ ++ +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRT-VIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 141 LGHLRSLQY---MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTF 193
L L A + + L + Y +
Sbjct: 380 RRAHAELDGTLQQAVGQIELQHATE-EQSPLQLLRAIVKRYEEMYVEQQSVQNNAI 434
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 48/200 (24%), Positives = 80/200 (40%), Gaps = 25/200 (12%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 358
+N +G+G +G V + A K ++D + + E+E++ H N
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF------KQEIEIMKSLDHPN 67
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
++RLY T+ LV + G + R+ K + S RI + Y H+
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-- 125
Query: 419 PKIIHRDVKAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
+ HRD+K N L + DFGLA + T V GT +++P+ L
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV-GTPYYVSPQVLE- 181
Query: 476 GQSSEKTDVFGFG----ILL 491
G + D + G +LL
Sbjct: 182 GLYGPECDEWSAGVMMYVLL 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 40/217 (18%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISL 353
+ +G+G +G+VYK G +VA+KR++ G EI E+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH---- 77
Query: 354 AVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAAR 408
H N++ L + LV+ +M LK K L S K R
Sbjct: 78 --HPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----RG 463
G+ + H+ +I+HRD+K N+L++ + DFGLA+ T V R
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR- 186
Query: 464 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
AP+ L S S+ D++ G + E+ITG+
Sbjct: 187 -----APDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 5e-16
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 352
+ +G+G +G V+K + +VA+KR++ + G EI E++
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAA 407
H+N++RL+ + + LV+ + LK LD K
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----R 462
+GL + H + ++HRD+K N+L++ E + +FGLA+ + V R
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 463 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQRAL 501
P+ L + S+ D++ G + EL R L
Sbjct: 169 ------PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 39/233 (16%)
Query: 288 RRFQFRELQVATH--NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG---- 340
AT + LG+G +G VYK I VA+KR++ + G
Sbjct: 20 GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT 79
Query: 341 ---EIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWS 397
E+ E++ HRN++ L L++ Y N + + P +
Sbjct: 80 AIREVSLLKELQ------HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR 132
Query: 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVG-----DFGLAKLLDH 452
K G+ + H + + +HRD+K N+LL + DFGLA+
Sbjct: 133 VIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 453 QDSHVTTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
T + R PE L S S+ D++ + E++
Sbjct: 190 PIRQFTHEIITLWYR------PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 14/134 (10%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQ----NLSG----TLSPSI-GNLTNLQIVLLQNNNIT- 110
CS T + C+ + L + GIPS L +L + LT L + L +N ++
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 111 GPIPAEIGR-LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSL-ASM 168
++ T L+ LDLS N + S+ L L+++ F +++L S+ S+
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 169 TQLIFLDLSYNNLS 182
LI+LD+S+ +
Sbjct: 126 RNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 27/149 (18%), Positives = 49/149 (32%), Gaps = 20/149 (13%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRF 152
L++L+++ + N+ +I L L LDLS ++ + L SLQ +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS-------GPVPRFSAKTFNIVGNPLICATG 205
++N+ + L LD S N++ P S N+ N C
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS-SLAFLNLTQNDFAC--- 262
Query: 206 SEPDCYGTQLMPMSMNLNSSQTASPGRTR 234
C + + + R
Sbjct: 263 ---TC---EHQSFLQWIKDQRQLLVEVER 285
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS- 139
S N T+S + L L+ + Q++N+ + L L LD+S+ +
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 140 SLGHLRSLQYMRFNNNSLSGAF-PTSLASMTQLIFLDLSYNNLS 182
L SL+ ++ NS F P + L FLDLS L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 17/89 (19%), Positives = 38/89 (42%), Gaps = 4/89 (4%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS--LGHLRSLQYMRF 152
T+L+ + L N + + + L +L+ LD ++ ++ LR+L Y+
Sbjct: 76 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 133
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
++ AF ++ L L ++ N+
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 25/234 (10%)
Query: 275 KERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK 333
HH F+ ++ + + ++G+G +G+V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 334 DGNAIGGEIQFQT--EVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK 391
+ + ++ E++++ H NL+ L C LV+ ++ + ++ L+
Sbjct: 60 ESDDDKM-VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117
Query: 392 PI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
P LD+ ++ G+ + H IIHRD+K NIL+ + DFG A+ L
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
Query: 451 DHQDSHVTTAV-----RGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 498
V R APE L + + DV+ G L+ E+ G+
Sbjct: 175 AAPGEVYDDEVATRWYR------APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 23/209 (11%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHR 357
+ +G+G +G+V+K G +VA+K+ + I+ E+ M+ H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALREIRMLKQLKHP 62
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQ 416
NL+ L LV+ Y + +V L + K I + + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----RGTVGHIAPE 471
IHRDVK NIL+ + DFG A+LL + V R +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------SPE 172
Query: 472 YL--STGQSSEKTDVFGFGILLLELITGQ 498
L T DV+ G + EL++G
Sbjct: 173 LLVGDTQYGPP-VDVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 301 NFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAI-GGEIQF-QTEVEMISLA 354
+F ILG+G F V A+K L+ + I ++ + E +++S
Sbjct: 31 DFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR------ 408
H ++LY + Y NG + ++ R
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTAEI 139
Query: 409 --GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA-VRGTV 465
L YLH + IIHRD+K NILL++ + DFG AK+L + GT
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
+++PE L+ + + +D++ G ++ +L+ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 7/98 (7%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS----LGHLRSLQYMR 151
L+++ + + ++ L TLDLS+N GE +LQ +
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 152 FNNN---SLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
N + SG A+ QL LDLS+N+L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 31/122 (25%), Positives = 44/122 (36%), Gaps = 15/122 (12%)
Query: 94 GNLTNLQIVLLQNNNIT---GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQY 149
LQ++ L+N + G A +LQ LDLS+N + L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATG 205
+ + L P L + +L LDLSYN L P ++ GNP
Sbjct: 258 LNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPF---LD 310
Query: 206 SE 207
SE
Sbjct: 311 SE 312
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 25/110 (22%), Positives = 37/110 (33%), Gaps = 9/110 (8%)
Query: 82 SQNLSGTLS-PSIGNLTNLQIVLLQNNNITGPIPAEI----GRLTKLQTLDLSNNFFT-- 134
+Q S S + L + L +N G + LQ L L N
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 135 -GEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLAS-MTQLIFLDLSYNNLS 182
G + LQ + ++NSL A +QL L+LS+ L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 18/113 (15%), Positives = 35/113 (30%), Gaps = 6/113 (5%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP-AEIGRLTKLQTLDLSNNFFTGEIPSSL 141
L G +L+ +L + + +I + L+ L + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 142 GHLRS---LQYMRFNNNSLSGAFPTSLASMT--QLIFLDLSYNNLSGPVPRFS 189
+ LQ + N ++G P L T L L+L + + +
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA 141
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG G FG V G G VAVK +++ + +G + + E++ + L H ++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIK 75
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
LY TPT+ +V Y+S G + + R+ AR + Y
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + APE +
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVI 182
Query: 474 S-TGQSSEKTDVFGFGILLLELITG 497
S + + D++ G++L L+ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 301 NFSSKNILGKGGFGIVYKG--ILQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMI 351
+ +G+G +G V+K + G VA+KR++ G E+ + +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV---LRHL 68
Query: 352 SLAVHRNLLRLYGFCMTPTERL-----LVYPYMSNGSVASRLKG------KPILDWSTRK 400
H N++RL+ C LV+ ++ L +P + T K
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIK 123
Query: 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD--SH-- 456
+ RGL +LH +++HRD+K NIL+ + + DFGLA++ Q +
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
VT R APE L + D++ G + E+ +
Sbjct: 181 VTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.1 bits (194), Expect = 2e-15
Identities = 67/405 (16%), Positives = 123/405 (30%), Gaps = 118/405 (29%)
Query: 259 FLW--WRQRRNQ-----QMFFDVKERHHEEVSL---GNLRRFQ-FRELQVATHNF-SSKN 306
FL + + Q +M+ + ++R + + + N+ R Q + +L+ A +KN
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 307 IL--GKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+L G G G K T VA+ + + ++ ++L
Sbjct: 153 VLIDGVLGSG---K------TWVALDVCLS---YKVQCKMDFKIFWLNL----------K 190
Query: 365 FCMTPTERL---------LVYPYMSNGSVASRLKGKPILDWSTRKRIALGA---ARGLLY 412
C +P L + + S +S +K I R L + LL
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK-LRIHSIQAELRRLLKSKPYENCLLV 249
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK-LLDHQDSHVTTAVRG-TVGHIAP 470
L + K A N+ C K LL + VT + T HI+
Sbjct: 250 LLNVQNAKAW----NAFNL---SC-----------KILLTTRFKQVTDFLSAATTTHISL 291
Query: 471 EYLSTGQSSEKT-DVFG--FGI--------------LLLELITGQRALEYGKAANQKGAM 513
++ S + ++ + L +I A + + +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII----------AESIRDGL 341
Query: 514 LDW-------VKKIHQ--EKKLEMLVDKDLKNNYDRIE-LEEMVQV--ALLCTQYLPAHR 561
W K+ E L +L + + +DR+ + LL + +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIK 401
Query: 562 PKMSEVVRMLEGDGLAERWEASQRAEATKSKPHEFSSSDRYSDLT 606
+ VV L L E+ K S Y +L
Sbjct: 402 SDVMVVVNKLHKYSLVEKQ----------PKESTISIPSIYLELK 436
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 40/207 (19%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLL 360
++ LG+G IVY+ A+K L D + +TE+ ++ H N++
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RTEIGVLLRLSHPNII 111
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAAR-------GLL 411
+L TPTE LV ++ G + R+ KG +S R AA +
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERD-----AADAVKQILEAVA 162
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEA---VVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
YLHE I+HRD+K N+L + DFGL+K+++HQ T GT G+
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 469 APEYLSTGQSSEKTDVFGFG----ILL 491
APE L + D++ G ILL
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILL 244
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISL 353
+ +G+G +G+VYK G A+K+++ G EI E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK---- 58
Query: 354 AVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAAR 408
H N+++LY T +LV+ ++ LK + L+ T K L
Sbjct: 59 --HSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----RG 463
G+ Y H++ +++HRD+K N+L++ E + DFGLA+ T + R
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR- 167
Query: 464 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
AP+ L S S+ D++ G + E++ G
Sbjct: 168 -----APDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 23/174 (13%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFTGE 136
L I T++P+ NL + + + N+T +P + L L+ L+LS N +
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA----K 191
S L L LQ ++ L+ P + + L L++S N L+ F + +
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 192 TFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSSQT-------ASPGRTRSHKL 238
T + NPL C DC +L+ + A+P + +
Sbjct: 324 TLILDSNPLAC------DC---RLLWVFRRRWRLNFNRQQPTCATPEFVQGKEF 368
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 25/103 (24%), Positives = 46/103 (44%), Gaps = 3/103 (2%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
++N+ + P NL NL+ + L++N + IP + L+ L LD+S N +
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L +L+ + +N L + + + L L L NL+
Sbjct: 123 MFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 21/89 (23%), Positives = 45/89 (50%), Gaps = 2/89 (2%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
+L L ++ L++ NI I RL +L+ L++S+ + + + + +L +
Sbjct: 174 HLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ +L+ ++ + L FL+LSYN +S
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 4/102 (3%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRF 152
+L NL+ + + +N++ I L L+ L L T IP+ +L HL L +R
Sbjct: 126 DLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFN 194
+ +++ S + +L L++S+ + N
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 24/123 (19%), Positives = 46/123 (37%), Gaps = 16/123 (13%)
Query: 62 CSW--TMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR 119
CS V C + + +P + + T +++ L N I E
Sbjct: 9 CSAQDRAVLCHRKRF---VAVP-EGIP----------TETRLLDLGKNRIKTLNQDEFAS 54
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
L+ L+L+ N + P + +L +L+ + +N L ++ L LD+S N
Sbjct: 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 180 NLS 182
+
Sbjct: 115 KIV 117
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 54/244 (22%), Positives = 96/244 (39%), Gaps = 33/244 (13%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIG-GEIQF-QTEVEMIS 352
V +F +GKG FG V D + A+K + + E++ E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 353 LAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--- 408
H L+ L+ + E + +V + G + L +
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--------QQNVHFKEETVKLFI 121
Query: 409 -----GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRG 463
L YL Q +IIHRD+K NILLD+ + DF +A +L + T A G
Sbjct: 122 CELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--G 176
Query: 464 TVGHIAPEYLSTGQSSEKT---DVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520
T ++APE S+ + + + D + G+ EL+ G+R + +++ + V
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSKEI---VHTF 232
Query: 521 HQEK 524
Sbjct: 233 ETTV 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 27/202 (13%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
+G G FG+ +VAVK ++ G AI +Q E+ H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVI 85
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYLHEQCD 418
+TPT ++ Y S G + R+ R + AR G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERI--------CNAGRFSEDEARFFFQQLLSGVSYCHSM-- 135
Query: 419 PKIIHRDVKAANILLDDCCEAV--VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS-T 475
+I HRD+K N LLD + DFG +K S + V GT +IAPE L
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVLLRQ 192
Query: 476 GQSSEKTDVFGFGILLLELITG 497
+ DV+ G+ L ++ G
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVG 214
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 24/122 (19%), Positives = 49/122 (40%), Gaps = 9/122 (7%)
Query: 68 TCSPESL-----VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLT 121
C +L + I Q L N +IV +N+ + +PA +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFR 69
Query: 122 KLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
+++ L+L++ EI + + + ++Q + N++ P ++ L L L N+
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 181 LS 182
LS
Sbjct: 129 LS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMR 151
+Q + + N I +P + + + L L L N + +P + + L +
Sbjct: 90 AYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+NN+L + + T L L LS N L+
Sbjct: 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 15/105 (14%)
Query: 84 NLSG----TLSPSI-GNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEI 137
L +L I N L + + NNN+ I + + T LQ L LS+N T +
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + SL + + N L ++LA + LD S+N+++
Sbjct: 181 D--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
N+S L ++ ++ + +N+I + + +L L L +N T + L +
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT-DTAW-LLN 246
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + + N L M +L L +S N L
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 8/122 (6%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
N L P + N+ L +++L+ N+++ +P I KL TL +SNN I
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIED 158
Query: 140 S-LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGN 198
SLQ ++ ++N L+ SL + L ++SYN LS + + + N
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDASHN 215
Query: 199 PL 200
+
Sbjct: 216 SI 217
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 13/103 (12%), Positives = 37/103 (35%), Gaps = 10/103 (9%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+S L+ + L+++ L +N++ + + +L+ L L +N +
Sbjct: 278 YISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK- 334
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L +L+ + ++N +L + + +
Sbjct: 335 -LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK----DG---NAIGGEIQFQTEVEMIS 352
F LG G + VYKG+ G VA+K +K +G AI EI E++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELK--- 61
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSN------GSVASRLKGKPILDWSTRKRIALGA 406
H N++RLY T + LV+ +M N S + L+ + K
Sbjct: 62 ---HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYFQWQL 117
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV----- 461
+GL + HE KI+HRD+K N+L++ + +GDFGLA+ + ++ V
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 462 RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
R AP+ L S S+ D++ G +L E+ITG+
Sbjct: 175 R------APDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 42/218 (19%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK----DG---NAIGGEIQFQTEVEMIS 352
+ + LG+G + VYKG +VA+K ++ +G AI E+ +++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLK--- 58
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIALGAA 407
H N++ L+ T LV+ Y+ LK I++ K
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----R 462
RGL Y H Q K++HRD+K N+L+++ E + DFGLA+ V R
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 463 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
P+ L ST S++ D++G G + E+ TG+
Sbjct: 168 ------PPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/230 (24%), Positives = 88/230 (38%), Gaps = 53/230 (23%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 352
+ +G+G FG V+K + G VA+K++ N G EI+ ++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--- 74
Query: 353 LAVHRNLLRLYGFCMTPTERL--------LVYPYMSNGSVASRLKG-----KPILDWSTR 399
H N++ L C T LV+ + + L G S
Sbjct: 75 ---HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEI 126
Query: 400 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL----LDHQDS 455
KR+ GL Y+H KI+HRD+KAAN+L+ + DFGLA+ + Q +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 456 HVTTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 498
T V R PE L D++G G ++ E+ T
Sbjct: 184 RYTNRVVTLWYR------PPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 6/115 (5%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQY 149
+ N L V L N + I ++ +L+ L +SNN + + +L+
Sbjct: 248 AWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-KTFNIVGNPLIC 202
+ ++N L + +L L L +N++ + K + N C
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 24/122 (19%), Positives = 49/122 (40%), Gaps = 9/122 (7%)
Query: 68 TCSPESL-----VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLT 121
C +L + I Q L N +IV +N+ + +PA +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFR 75
Query: 122 KLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
+++ L+L++ EI + + + ++Q + N++ P ++ L L L N+
Sbjct: 76 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 181 LS 182
LS
Sbjct: 135 LS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMR 151
+Q + + N I +P + + + L L L N + +P + + L +
Sbjct: 96 AYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 153
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+NN+L + + T L L LS N L+
Sbjct: 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 29/120 (24%), Positives = 52/120 (43%), Gaps = 21/120 (17%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
N L P + N+ L +++L+ N+++ +P I KL TL +SNN I
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIED 164
Query: 140 S-LGHLRSLQYMRFNNNSLS----GAFP------------TSLASMTQLIFLDLSYNNLS 182
SLQ ++ ++N L+ P ++LA + LD S+N+++
Sbjct: 165 DTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
N+S L ++ ++ + +N+I + + +L L L +N T + L +
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT-DTA-WLLN 252
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + + N L M +L L +S N L
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 17/91 (18%), Positives = 37/91 (40%), Gaps = 10/91 (10%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ + +L + N ++ + ++ LD S+N + + L ++
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 238
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N+L+ L + L+ +DLSYN L
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 13/77 (16%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N L+ + L+++ L +N++ + + +L+ L L +N + L
Sbjct: 286 SNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--L 341
Query: 142 GHLRSLQYMRFNNNSLS 158
+L+ + ++N
Sbjct: 342 STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 14/84 (16%), Positives = 30/84 (35%), Gaps = 5/84 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N + + L+ + L +N+I + + L+ L LS+N + +L
Sbjct: 309 SHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL 365
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSL 165
R++ ++ L
Sbjct: 366 --FRNVARPAVDDADQHCKIDYQL 387
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 39/240 (16%), Positives = 74/240 (30%), Gaps = 31/240 (12%)
Query: 82 SQNLSGTLSPS--IGNLTNLQIVLLQNNNITGPIPAEIGR-----LTKLQTLDLSNNFFT 134
+QN + S +L+ + L N + E+ L+ LQ L L++N+
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 135 GEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF--SAKT 192
P HL +L+ + N+N L+ L + L LD+S N L P P S
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSV 551
Query: 193 FNIVGNPLICATGSEP--DCYGTQLMPMSMNLNSSQTASPGRTRSHKLS----------- 239
+I N IC + + ++ P L
Sbjct: 552 LDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEE 611
Query: 240 -------LVFGLSVGCVSLIILVFGLFLWWRQRRNQQMFFDVKERHHEEVSLGNLRRFQF 292
+F + ++L ++ +R + + +++
Sbjct: 612 VLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKY 671
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 28/122 (22%), Positives = 47/122 (38%), Gaps = 1/122 (0%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
S +L+ + L +L+++ L N I L LQ L+LS N S+
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPL 200
L + Y+ N ++ + + +L LDL N L+ S + GN L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393
Query: 201 IC 202
+
Sbjct: 394 VT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 28/105 (26%), Positives = 41/105 (39%), Gaps = 4/105 (3%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
S N T++ S L LQ++ L + I E L L+ LDL ++ P
Sbjct: 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91
Query: 140 SLGHLRSLQYMRFNNNSLSGAF--PTSLASMTQLIFLDLSYNNLS 182
+ L L +R LS A ++ L LDLS N +
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 1/89 (1%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI-PSSLGHLRSLQYMRFN 153
L + +LL N I + L +LQ L+L + + I + +L +L+ +
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
++ + P + + L L L + LS
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 14/87 (16%), Positives = 39/87 (44%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
++++ + L + + L L+ L+L+ N + L +LQ + + N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 156 SLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + ++ + ++ ++DL N+++
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 8/111 (7%)
Query: 80 IPSQNLSGTLSPSIGNLT-NLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTG-E 136
IP LSG ++ + ++ L N + I + R+ LQ L L+ N F+
Sbjct: 383 IPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442
Query: 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSL-----ASMTQLIFLDLSYNNLS 182
+ SL+ + N L A+ T L ++ L L L++N L+
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 23/112 (20%), Positives = 38/112 (33%), Gaps = 9/112 (8%)
Query: 92 SIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLR--SLQ 148
NL L + L N I + G+L L+++D S+N L L+ +L
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 149 YMRFNNNSLSGAFPTSLASMTQ------LIFLDLSYNNLSGPVPRFSAKTFN 194
+ NSL L LD+S N + + + +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 20/107 (18%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTK------LQTLDLSNNFFTGEIPS---------- 139
L L N++ + + G+ L+ LD+S N +T +I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 140 --SLGHLRSLQYMRFNNNSLSGAFPTSLASM--TQLIFLDLSYNNLS 182
SL + F +++ + A + + + LDLS+ +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLR--SLQYMR 151
GN + I +N I+ + + + ++ L S++++
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
++ + ++ L L+L+YN ++
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 9/64 (14%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ T ++P L + + + + N + +S + QL L+L
Sbjct: 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 184 PVPR 187
+ +
Sbjct: 63 TIDK 66
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG----------EIQFQTEVE 349
+ + LG+G F VYK +VA+K++K G+ EI+ E+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 350 MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG-----KPILDWSTRKRIAL 404
H N++ L + LV+ +M + L+ +L S K L
Sbjct: 71 ------HPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYML 119
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448
+GL YLH+ I+HRD+K N+LLD+ + DFGLAK
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 288 RRFQFRELQVATHNFSSK----NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ 343
R+L H S + G +G V G+ +G VA+KR+ + + G +
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 344 -FQT---------EVEMISLAVHRNLLRLYGFCMTPTERL------LVYPYMSNGSVASR 387
E+ +++ H N+L L E LV M + ++
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM--RTDLAQ 122
Query: 388 L--KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445
+ + ++ + GL LHE ++HRD+ NILL D + + DF
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179
Query: 446 LAKLLDHQDSHVTTAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 498
LA+ D++ T V R APE + ++ D++ G ++ E+ +
Sbjct: 180 LAREDT-ADANKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 31/205 (15%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG G FG V G G VAVK +++ + +G + + E++ + L H ++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIK 80
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
LY TP++ +V Y+S G + + R+ +R G+ Y
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + APE +
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVI 187
Query: 474 S-TGQSSEKTDVFGFGILLLELITG 497
S + + D++ G++L L+ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 19/115 (16%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL-------------TKLQTLDL 128
S NL+ + N+ + + P G + L+L
Sbjct: 20 SSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELEL 78
Query: 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+N + +P HL SL + NSL+ P S+ L+ + + LS
Sbjct: 79 NNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALSD 128
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 21/116 (18%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPA---------------EIGRLTKLQTL 126
S N L +L +L + ++ P E+ + L+ +
Sbjct: 99 SCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII 158
Query: 127 DLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
D+ NN ++P L + NN L P L ++ L + N+L
Sbjct: 159 DVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 10/94 (10%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
P + N + L+I+ + NN++ +P L+ + NN E+P L +L L +
Sbjct: 147 PELQNSSFLKIIDVDNNSLKK-LPDLPP---SLEFIAAGNNQLE-ELPE-LQNLPFLTAI 200
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184
+NNSL P S L + N L
Sbjct: 201 YADNNSLK-KLPDLPLS---LESIVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 10/95 (10%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
L +L ++ NN + E+ L L T+ NN +P L +L
Sbjct: 209 KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N L+ P S+T L + ++ LS
Sbjct: 263 N---VRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 10/103 (9%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ 148
++P + T LQ L ++N+T +P E + + + + P G R +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 149 YMRFNNN--------SLSGAFPTSL-ASMTQLIFLDLSYNNLS 182
R + L+ +SL L L S N+L+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
P + NL L + NN + +P L+ L++ +N+ T ++P L L
Sbjct: 231 PELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 151 RFNNNSLSGAFPTSL--------------ASMTQLIFLDLSYNNLS 182
+ LS P +L L L++S N L
Sbjct: 286 ENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 20/103 (19%), Positives = 32/103 (31%), Gaps = 20/103 (19%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
N+S L L L N++ +P L+ L + N E P
Sbjct: 323 NVSNNKLIELPALPPRLERLI---ASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPD 374
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ L+ N+ L+ P + L L + N L
Sbjct: 375 IPESVEDLRM----NSHLA-EVPELPQN---LKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 23/114 (20%), Positives = 37/114 (32%), Gaps = 21/114 (18%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITG-------------PIPAEIGRLTKLQTLDL 128
N L +LT L + + ++ I + L+ L++
Sbjct: 265 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 324
Query: 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
SNN E+P+ L L + N L+ P L L + YN L
Sbjct: 325 SNNKLI-ELPALPPRLERL---IASFNHLA-EVPELP---QNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 16/117 (13%), Positives = 33/117 (28%), Gaps = 24/117 (20%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLT----------------KLQT 125
S N + NL L ++ N + P + L+
Sbjct: 345 SFNHLAEVPELPQNLKQLH---VEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQ 400
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + N E P + L R N+ + + + + +L +++
Sbjct: 401 LHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 23/160 (14%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
L LQ + LQ+N + +P + L L L L N + + L SL + +
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA----KTFNIVGNPLICATGSEP 208
N ++ P + + +L+ L L NNLS P + + + NP +C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC------ 239
Query: 209 DCYGTQLMPMSMNLNSSQT-------ASPGRTRSHKLSLV 241
DC + P+ L + + P R L +
Sbjct: 240 DC---RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRL 276
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRF 152
L L+ + L +N + L +L TL L E+ L +LQY+
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N+L + + L L L N +S
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 18/87 (20%), Positives = 29/87 (33%), Gaps = 1/87 (1%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR-FNNN 155
Q + L N I+ A L L L +N ++ L L+ + +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 156 SLSGAFPTSLASMTQLIFLDLSYNNLS 182
L P + + +L L L L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 16/79 (20%), Positives = 28/79 (35%), Gaps = 3/79 (3%)
Query: 102 VLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAF 161
+ +P I Q + L N + +S R+L + ++N L+
Sbjct: 16 TSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 162 PTSLASMTQLIFLDLSYNN 180
+ + L LDLS N
Sbjct: 73 AAAFTGLALLEQLDLSDNA 91
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 29/112 (25%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTG 135
L IP L LS L ++ + ++N+ + +P + L L+ LDLS N
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVE 348
Query: 136 EI---PSSLGHLRSLQYMRFNNNSLS--GAFPTSLASMTQLIFLDLSYNNLS 182
E + G SLQ + + N L L ++ L LD+S N
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 26/126 (20%), Positives = 43/126 (34%), Gaps = 14/126 (11%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S+N + S ++ + L + I + I L+ LD+SNN L
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLD-SFSLFL 450
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-----SAKTFNIV 196
L+ L + N L P + L+ + +S N L S + +
Sbjct: 451 PRLQEL---YISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 197 GNPLIC 202
NP C
Sbjct: 506 TNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 19/89 (21%), Positives = 37/89 (41%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
G ++ + L N IT ++ LQ L L ++ + L SL+++ +
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N LS + ++ L +L+L N
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 23/105 (21%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFTG-EIP 138
+ T+ +L +L+ + L +N+++ + + G L+ L+ L+L N + +
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 139 SSLGHLRSLQYMRF-NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
S +L +LQ +R N + S A +T L L++ +L
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 26/109 (23%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 82 SQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS 139
S N + + NLQ+++L+++ I I + L L+ LDLS+N + S
Sbjct: 34 SFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSS 92
Query: 140 SLGHLRSLQYMRFNNNSLSG-AFPTSLASMTQLIFLDLSYNNLSGPVPR 187
G L SL+Y+ N + ++T L L + + R
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 17/149 (11%), Positives = 45/149 (30%), Gaps = 1/149 (0%)
Query: 78 LGIPSQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE 136
L I + + LT+L + ++ ++ + + + L L +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIV 196
+ L S++Y+ + +L+ + L + S + ++
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 197 GNPLICATGSEPDCYGTQLMPMSMNLNSS 225
L + DC L + + +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDV 276
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 11/100 (11%), Positives = 31/100 (31%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+ + + T + + ++ L + + ++ +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L ++ + N+ + + + L FLDLS N +
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 15/91 (16%), Positives = 35/91 (38%), Gaps = 3/91 (3%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
++ + + + + L K++ + + N+ S HL+SL+++ +
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 155 NSLSGAF---PTSLASMTQLIFLDLSYNNLS 182
N + + + L L LS N+L
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTA 460
+ A+G+ +L + K IHRD+ A NILL + + DFGLA+ + +V
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520
R + +APE + + ++DV+ FG+LL E+ + + G +++
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------- 304
Query: 521 HQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ LK R+ EM Q L C P+ RP SE+V L
Sbjct: 305 ---------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 34/165 (20%), Positives = 57/165 (34%), Gaps = 15/165 (9%)
Query: 300 HNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MIS 352
LG+G FG V + VAVK LK+G +E++ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 353 LAVHRNLLRLYGFCMTPTERLLV-YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL 411
+ H N++ L G C P L+V + G++++ L S R +G
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGAR 134
Query: 412 YLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
+ + I D+K + + F K L +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 18/244 (7%)
Query: 264 QRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIV----YKG 319
+ ++ K + + + ++ +F+ +LGKG FG V KG
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG 364
Query: 320 ILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN---LLRLYGFCMTPTERL-LV 375
+ AVK LK I + T VE LA+ L +L+ C +RL V
Sbjct: 365 ---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFV 420
Query: 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD 435
Y++ G + ++ A A GL +L + II+RD+K N++LD
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDS 477
Query: 436 CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLEL 494
+ DFG+ K + D T GT +IAPE + Q K+ D + FG+LL E+
Sbjct: 478 EGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEM 535
Query: 495 ITGQ 498
+ GQ
Sbjct: 536 LAGQ 539
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 32/132 (24%), Positives = 52/132 (39%), Gaps = 15/132 (11%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQ----NLSG----TLSP-SIGNLTNLQIVLLQNNNITG 111
C +V CS L + I +L L L +L ++L NN I+
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170
I + L KLQ L +S N EIP +L SL +R ++N + + +
Sbjct: 93 -IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 171 LIFLDLSYNNLS 182
+ +++ N L
Sbjct: 149 MNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
+ L + L +N I I L L+ L L NN + +P+ L L+ LQ + +
Sbjct: 215 RYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 154 NNSLS----GAFP--TSLASMTQLIFLDLSYNNLS 182
N+++ F + L N +
Sbjct: 273 TNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
L + L +N I I E R +KL L L +N SL L +L+ +
Sbjct: 190 DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+NN LS P L + L + L NN++
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 95 NLTNLQIVLLQNNNIT-GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
L N+ + + N + KL L +S T IP L +L + +
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLD 201
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N + L ++L L L +N +
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 22/98 (22%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 86 SGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHL 144
+ P + L + + +TG IP ++ L L L +N I L
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRY 216
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L + +N + SL+ + L L L N LS
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 19/98 (19%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS-------LGHLRSL 147
L L+ + L NN ++ +PA + L LQ + L N T ++ +
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 148 QYMRFNNNSLS------GAFPTSLASMTQLIFLDLSYN 179
+ NN + F +T + +
Sbjct: 297 NGISLFNNPVPYWEVQPATF----RCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 14/85 (16%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITGPIPAEI-------GRLTKLQTLDLSNNF 132
+L + + +L LQ+V L NNIT + + + L NN
Sbjct: 247 HLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 133 FT-GEI-PSSLGHLRSLQYMRFNNN 155
E+ P++ + ++F N
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 16/136 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L NL+ + L NI +P + L L+ L++S N F P S L SL+ + N
Sbjct: 194 GLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA----KTFNIVGNPLICATGSEPD 209
+ +S + + L+ L+L++NNLS P F+ ++ NP C D
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC------D 305
Query: 210 CYGTQLMPMSMNLNSS 225
C ++ ++ L
Sbjct: 306 C---DILWLAWWLREY 318
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 40/182 (21%), Positives = 67/182 (36%), Gaps = 46/182 (25%)
Query: 62 CSW--TMVTCSPESL-VIGLGIPSQ----NLSG----TLSPSI-GNLTNLQIVLLQNNNI 109
CS + V C+ L + GIPS NL + +L +L+++ L N+I
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 110 TGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLS----GAF-- 161
I L L TL+L +N+ T IPS + +L L+ + NN + AF
Sbjct: 112 RQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 162 -------------------PTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGN 198
+ + L +L+L N+ +P + + + GN
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGN 228
Query: 199 PL 200
Sbjct: 229 HF 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAE-IGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
S L++L+ + + N+ ++ I L L L+L++N + LR L +
Sbjct: 237 SFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295
Query: 151 RFNNNSL 157
++N
Sbjct: 296 HLHHNPW 302
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 40/163 (24%), Positives = 57/163 (34%), Gaps = 24/163 (14%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
S N +L L L NN +T +PA L+ L +S N T +P
Sbjct: 189 SDNQLASLPTLPSELYKLW---AYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLP 240
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSL-ASMTQLIFLDLSYNNLSGPVPR-----FSAKTFNI 195
L+ L + N L TSL + L+ L + N L+ +P S T N+
Sbjct: 241 SELKEL---MVSGNRL-----TSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNL 291
Query: 196 VGNPLICATGSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKL 238
GNPL T + T S + A R +
Sbjct: 292 EGNPLSERT-LQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 29/131 (22%), Positives = 49/131 (37%), Gaps = 24/131 (18%)
Query: 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQT 125
M C + L + L+ TL + ++ +++ +NN+T +PA +L+T
Sbjct: 34 MRACLNNGNAV-LNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALPP---ELRT 85
Query: 126 LDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSL--------------ASMTQL 171
L++S N T +P L L L A P+ L L
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGL 143
Query: 172 IFLDLSYNNLS 182
L +S N L+
Sbjct: 144 QELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 4/91 (4%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
+L L +L + N +T +P + L+ T++L N + +L + S
Sbjct: 255 SLPMLPSGLLSLS---VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSY 178
A ++ L +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
L S+ +L++ V L+ N ++ + +T F S+ R+L
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
Query: 148 QYMRFNNNSLSGAFPTSLASMTQL 171
+ L A A +
Sbjct: 335 H--LAAADWLVPAREGEPAPADRW 356
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 46/255 (18%), Positives = 85/255 (33%), Gaps = 68/255 (26%)
Query: 295 LQVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEM 350
L+ ++ +S LG G FGIV + + G A+K++ + E+++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDI 53
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA---- 406
+ + H N+++L + T + P + K + + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 407 -------------------------------------ARGLLYLHEQCDPKIIHRDVKAA 429
R + ++H I HRD+K
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 430 NILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTD 483
N+L++ + DFG AK L + V R APE L + + D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSID 224
Query: 484 VFGFGILLLELITGQ 498
++ G + ELI G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 32/137 (23%), Positives = 59/137 (43%), Gaps = 16/137 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L+NL+ + L N+ IP + L KL LDLS N + P S L LQ +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA----KTFNIVGNPLICATGSEPD 209
+ + + ++ L+ ++L++NNL+ P F+ + ++ NP C +
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC------N 294
Query: 210 CYGTQLMPMSMNLNSSQ 226
C ++ +S +
Sbjct: 295 C---DILWLSWWIKDMA 308
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 33/133 (24%), Positives = 55/133 (41%), Gaps = 16/133 (12%)
Query: 62 CSW--TMVTCSPESL-VIGLGIPSQ----NLSG----TLSPSI-GNLTNLQIVLLQNNNI 109
CS + V C ++L + GI + NL + + +L +L+I+ L N+I
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 110 TGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLAS 167
I L L TL+L +N T IP+ + +L L+ + NN + +
Sbjct: 101 RT-IEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 168 MTQLIFLDLSYNN 180
+ L LDL
Sbjct: 159 IPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 10/113 (8%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMR- 151
L NL + L +N +T IP L+KL+ L L NN IPS + SL+ +
Sbjct: 110 GLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPL 200
LS + ++ L +L+L+ NL +P + ++ GN L
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 19/86 (22%), Positives = 33/86 (38%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
TN +++ L N I L L+ L LS N + L +L + +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 157 LSGAFPTSLASMTQLIFLDLSYNNLS 182
L+ + +++L L L N +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 3/85 (3%)
Query: 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157
V+ N+ +P I T + L+L N +S HLR L+ ++ + N +
Sbjct: 44 QFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 158 SGAFPTSLASMTQLIFLDLSYNNLS 182
+ + L L+L N L+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT 125
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 296 QVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
+V + F +LGKG FG V K G A+K LK + + T E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 352 SLAVHRN--LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR 408
L R+ L L + +RL V Y + G + L + + +
Sbjct: 201 VLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 409 GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHI 468
L YLH + + +++RD+K N++LD + DFGL K +D GT ++
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 469 APEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
APE L + D +G G+++ E++ G+
Sbjct: 317 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 296 QVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIG-GEIQFQTEVEM 350
+ F +LG+G FG V+ + A+K LK ++ + E ++
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 351 ISLAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR- 408
+ H +++L+ + +L L+ ++ G + +RL S +
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL--------SKEVMFTEEDVKF 130
Query: 409 -------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
L +LH II+RD+K NILLD+ + DFGL+K +
Sbjct: 131 YLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 462 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
GTV ++APE + + ++ D + FG+L+ E++TG
Sbjct: 187 CGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 296 QVATHNFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
++ +F +LGKG FG V +K A+K LK + + T VE
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 352 SLAVHRN---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA 407
L++ L ++ E L V Y++ G + ++ D S A
Sbjct: 70 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
GL +LH + I++RD+K NILLD + DFG+ K + T GT +
Sbjct: 129 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 468 IAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
IAPE L GQ + D + FG+LL E++ GQ
Sbjct: 185 IAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 300 HNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISL 353
F LG G FG V K G A+K L + +I+ E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 354 AVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
L++L + +V Y++ G + S L+ + A YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H +I+RD+K N+L+D V DFG AK + T + GT +APE +
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEII 210
Query: 474 STGQSSEKTDVFGFGILLLELITGQ 498
+ ++ D + G+L+ E+ G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 296 QVATHNFSSKNILGKGGFGIVY---KGILQD-GTVVAVKRL-KDGNAIGGEIQFQTEVEM 350
+V NF +LG G +G V+ K D G + A+K L K + T E
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 351 ISLAVHRN---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406
L R L+ L+ + +L L+ Y++ G + + L S R+R
Sbjct: 110 QVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL--------SQRERFTEHE 160
Query: 407 AR--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458
+ L +LH+ II+RD+K NILLD V+ DFGL+K ++
Sbjct: 161 VQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 459 TAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELITGQ 498
GT+ ++AP+ + G S V + G+L+ EL+TG
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 15/132 (11%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQ----NLSGTLSPSI-----GNLTNLQIVLLQNNNITG 111
C +V CS L + +P +L I NL NL ++L NN I+
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 112 PIPAEIGR-LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170
I L KL+ L LS N E+P + ++LQ +R + N ++ + + Q
Sbjct: 91 -ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 171 LIFLDLSYNNLS 182
+I ++L N L
Sbjct: 147 MIVVELGTNPLK 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
L NL + L N+I+ + L+ L L+NN ++P L + +Q + +
Sbjct: 214 GLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271
Query: 154 NNSLS----GAF--PTSLASMTQLIFLDLSYNNLS 182
NN++S F P + L N +
Sbjct: 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFN 153
+ L + + + NIT IP + L L L N T ++ + SL L +L + +
Sbjct: 169 GMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
NS+S SLA+ L L L+ N L
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 27/90 (30%), Positives = 37/90 (41%), Gaps = 3/90 (3%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
G +L + L N IT + A L L L LS N + SL + L+ +
Sbjct: 189 GLPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
NNN L P LA + + L NN+S
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 16/91 (17%), Positives = 36/91 (39%), Gaps = 7/91 (7%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFN 153
L L+ + L N + +P ++ LQ L + N T ++ L + +
Sbjct: 98 PLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELG 153
Query: 154 NNSLSGAF--PTSLASMTQLIFLDLSYNNLS 182
N L + + M +L ++ ++ N++
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 21/111 (18%), Positives = 42/111 (37%), Gaps = 25/111 (22%)
Query: 96 LTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEI--PSSLGHLRSLQYMRF 152
LQ + + N IT + + L ++ ++L N + ++ L Y+R
Sbjct: 120 PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 153 NNNSLS----GAFPT-----------------SLASMTQLIFLDLSYNNLS 182
+ +++ G P+ SL + L L LS+N++S
Sbjct: 179 ADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS-------LGHLRSL 147
N +L+ + L NN + +P + +Q + L NN + I S+ S
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 148 QYMRFNNNSLSGAF--PTSLASMTQLIFLDLSYN 179
+ +N + P++ + + L
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/84 (17%), Positives = 29/84 (34%), Gaps = 12/84 (14%)
Query: 84 NLSG----TLSPSIGNLTNLQIVLLQNNNITG------PIPAEIGRLTKLQTLDLSNNFF 133
+L+ + + + +Q+V L NNNI+ P + + L +N
Sbjct: 246 HLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
Query: 134 T-GEIPSSL-GHLRSLQYMRFNNN 155
EI S + ++ N
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 308 LGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN---LL 360
LGKG FG V K G + AVK LK + + T E L++ RN L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 361 RLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
+L+ C +RL V +++ G + ++ D + + A L++LH++
Sbjct: 88 QLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK--- 143
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
II+RD+K N+LLD + DFG+ K + T GT +IAPE L
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEIL-QEMLY 201
Query: 480 EKT-DVFGFGILLLELITGQ 498
D + G+LL E++ G
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 296 QVATHNFSSKNILGKGGFGIVY---KGILQD-GTVVAVKRLKDGNAI--GGEIQFQTEVE 349
++ F +LGKGG+G V+ K + G + A+K LK + + T+ E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAE 71
Query: 350 MISLAVHRN--LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKR----- 401
L ++ ++ L + +L L+ Y+S G + +L+ + I
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAE 129
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
I++ L +LH++ II+RD+K NI+L+ + DFGL K D VT
Sbjct: 130 ISM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181
Query: 462 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
GT+ ++APE L + D + G L+ +++TG
Sbjct: 182 CGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 283 SLGNLRRFQFRELQVATHNF------SSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDG 335
SL +R+ F + V + S +G G +G V I + G VA+K+L
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR- 59
Query: 336 NAIGGEIQFQT---------EVEMISLAVHRNLLRLYGFCMTPTERL-------LVYPYM 379
FQ+ E+ ++ H N++ L TP L LV P+M
Sbjct: 60 -------PFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM 111
Query: 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439
+ ++ G + + + +GL Y+H ++HRD+K N+ +++ CE
Sbjct: 112 --QTDLQKIMGLKFSE-EKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 165
Query: 440 VVGDFGLAKLLDHQDSHVTTAV-----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLE 493
+ DFGLA+ H D+ +T V R APE LS ++ D++ G ++ E
Sbjct: 166 KILDFGLAR---HADAEMTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAE 216
Query: 494 LITGQ 498
++TG+
Sbjct: 217 MLTGK 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 44/220 (20%)
Query: 308 LGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+G+G +G VYK +D A+K+++ G + E+ ++ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85
Query: 365 FCMTPTERL--LVYPYMS--------NGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
++ +R L++ Y + K L K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAV----VGDFGLA-------KLLDHQDSHVTTAVRG 463
++HRD+K ANIL+ + D G A K L D V T
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT---- 198
Query: 464 TVGHI---APEYL--STGQSSEKTDVFGFGILLLELITGQ 498
APE L + + D++ G + EL+T +
Sbjct: 199 ----FWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSE 233
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 34/131 (25%), Positives = 52/131 (39%), Gaps = 13/131 (9%)
Query: 62 CSWTMVTCSPESL-VIGLGIP--------SQNLSGTLSPSI-GNLTNLQIVLLQNNNITG 111
S V C +L + +P S+NL T S + T L + L +T
Sbjct: 10 ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69
Query: 112 PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQL 171
+ + G L L TLDLS+N +P L +L + + N L+ +L + +L
Sbjct: 70 -LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 172 IFLDLSYNNLS 182
L L N L
Sbjct: 127 QELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 18/127 (14%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLR 145
+L L L ++ + N +T +P L +LQ L L N +P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 146 SLQYMRFNNNSLS----GAFPTSLASMTQLIFLDLSYNNLSGPVPR--F---SAKTFNIV 196
L+ + NN+L+ G + L L L N+L +P+ F +
Sbjct: 149 KLEKLSLANNNLTELPAGLL----NGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 197 GNPLICA 203
GNP +C
Sbjct: 204 GNPWLCN 210
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 34/249 (13%)
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVY----KGILQ 322
N + EE N R + +F ++G+G + V K
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK--- 75
Query: 323 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN---LLRLYGFCMTPTERL-LVYPY 378
+ A++ +K E + E N L+ L+ C RL V Y
Sbjct: 76 TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEY 134
Query: 379 MSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAAN 430
++ G + + ++++ AR L YLHE+ II+RD+K N
Sbjct: 135 VNGGDLMFHM--------QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDN 183
Query: 431 ILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGI 489
+LLD + D+G+ K + T+ GT +IAPE L G+ + D + G+
Sbjct: 184 VLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGV 241
Query: 490 LLLELITGQ 498
L+ E++ G+
Sbjct: 242 LMFEMMAGR 250
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 33/219 (15%)
Query: 296 QVATHNFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
+V ++F +LGKG FG V K G A+K L+ I + T E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 352 SLAVHRN--LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR 408
L R+ L L + +RL V Y + G + L S + AR
Sbjct: 58 VLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL--------SRERVFTEERAR 108
Query: 409 --------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
L YLH + +++RD+K N++LD + DFGL K D
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT 164
Query: 461 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
GT ++APE L + D +G G+++ E++ G+
Sbjct: 165 FCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 34/206 (16%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
LG+G FG V + VA+K LK + + + E+ + L H ++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM---RVEREISYLKLLRHPHIIK 73
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAAR--------GLLYL 413
LY TPT+ ++V Y + G + + +KR+ R + Y
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
H KI+HRD+K N+LLDD + DFGL+ ++ + + T+ G+ + APE +
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVI 179
Query: 474 STGQSSE--KTDVFGFGILLLELITG 497
+ G+ + DV+ GI+L ++ G
Sbjct: 180 N-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 308 LGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN---LL 360
+GKG FG V K + AVK L+ + + + E L + L+
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 361 RLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKR-----IALGAARGLLYLH 414
L+ F ++L V Y++ G + L+ + R R IA L YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASA----LGYLH 156
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
I++RD+K NILLD V+ DFGL K + + + T+ GT ++APE L
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVL- 211
Query: 475 TGQSSEKT-DVFGFGILLLELITGQ 498
Q ++T D + G +L E++ G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 22/200 (11%), Positives = 50/200 (25%), Gaps = 40/200 (20%)
Query: 308 LGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRL 362
G ++ D VA+ + + ++ + +S + R+
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422
T L+V ++ GS+ P + R A H +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA---GVA 151
Query: 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 482
+ + + + V+ ++ +
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATM----------------------------PDANPQD 183
Query: 483 DVFGFGILLLELITGQRALE 502
D+ G G L L+ + L
Sbjct: 184 DIRGIGASLYALLVNRWPLP 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 34/157 (21%), Positives = 59/157 (37%), Gaps = 24/157 (15%)
Query: 305 KNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+LG G G V + + A+K L+D E++ + +++R+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIV 77
Query: 364 GFCMTPTER----LLVYPYMSNGSVASRLKGKPILDWSTRK-----RIALGAARGLLYLH 414
L+V + G + SR++ + ++ R+ + A + YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLH 134
Query: 415 EQCDPKIIHRDVKAANILLDDCCEA---VVGDFGLAK 448
I HRDVK N+L + DFG AK
Sbjct: 135 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 6/94 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ L + + L +N + +P + L L+ L S+N + + +L LQ +
Sbjct: 457 CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQEL 513
Query: 151 RFNNNSLSGAFPT--SLASMTQLIFLDLSYNNLS 182
NN L L S +L+ L+L N+L
Sbjct: 514 LLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSS 140
S N L P++ L L+++ +N + + + L +LQ L L NN
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQP 528
Query: 141 LGHLRSLQYMRFNNNSLS 158
L L + NSL
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 34/217 (15%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 348
+ + +G G GIV VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 349 EMISLAVHRNLLRLYGFCMTPTERL-------LVYPYMSNGSVASRLKGKPILDWSTRKR 401
++ H+N++ L TP + L LV M + ++ LD
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM--DANLCQVIQME-LDHERMSY 168
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
+ G+ +LH IIHRD+K +NI++ C + DFGLA+ S + T
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 223
Query: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
T + APE + E D++ G ++ E++ +
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 296 QVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
+ +F ++G+G + V K + A+K +K E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 352 SLAVHRN---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA 407
N L+ L+ C RL V Y++ G + + ++++ A
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM--------QRQRKLPEEHA 112
Query: 408 R--------GLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
R L YLHE+ II+RD+K N+LLD + D+G+ K + T+
Sbjct: 113 RFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS 168
Query: 460 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
GT +IAPE L G+ + D + G+L+ E++ G+
Sbjct: 169 TFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LTNLQ + + N ++ P + L+KL TL +N + +I S L L +L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEV 200
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
NN +S + LA+ + L + L+ ++
Sbjct: 201 HLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
T+ + L NL + L++N IT P + LTK+ L+LS N + S++
Sbjct: 49 FGTGVTTIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NV-SAI 103
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L+S++ + + ++ P LA ++ L L L N ++
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 20/88 (22%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L N + +N+T + L + TL T I + +L +L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182
N ++ P L ++T++ L+LS N L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ +L + + +T I + L L L+L +N T ++ + L +L + +
Sbjct: 35 VTQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQIT-DL-APLKNLTKITEL 90
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N L +A + + LDL+ ++
Sbjct: 91 ELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NL+ L + +N I+ I + L L + L NN + S L + +L +
Sbjct: 167 TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIV 222
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
N +++ L+ ++ P+
Sbjct: 223 TLTNQTITNQPVFYN---NNLVVPNVVKGPSGAPIA 255
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 296 QVATHNFSSKNILGKGGFGIV----YKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
++ +F+ +LGKG FG V KG + AVK LK I + T VE
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 352 SLAVHRN---LLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA 407
LA+ L +L+ C +RL V Y++ G + ++ A A
Sbjct: 73 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
GL +L + II+RD+K N++LD + DFG+ K + D T GT +
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 187
Query: 468 IAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 498
IAPE + Q K+ D + FG+LL E++ GQ
Sbjct: 188 IAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 36/218 (16%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 348
+ + +G G GIV VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 349 EMISLAVHRNLLRLYGFCMTPTERL-------LVYPYM-SNGSVASRLKGKPILDWSTRK 400
++ H+N++ L TP + L +V M +N +++ LD
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMS 130
Query: 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
+ G+ +LH IIHRD+K +NI++ C + DFGLA+ S + T
Sbjct: 131 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTP 185
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
T + APE + E D++ G ++ E+I G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 11/119 (9%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ T L + N IT ++ + L L+ N T ++ L
Sbjct: 157 LNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQ 210
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-KTFNIVGNPL 200
L ++ ++N L+ + +TQL + D S N L+ V S T + + L
Sbjct: 211 NIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 24/99 (24%), Positives = 45/99 (45%), Gaps = 8/99 (8%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ T + S L L + N++IT + I +LT L L ++N T + L
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT-TLD--LSQ 83
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+L Y+ ++N L+ + +T+L +L+ N L+
Sbjct: 84 NTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
I LT L ++ +NNIT ++ + T L L +N T + + L L Y+
Sbjct: 58 TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N L+ ++ L +L+ + N L+
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 23/148 (15%), Positives = 47/148 (31%), Gaps = 15/148 (10%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
+ + T L ++ Q IT + + + KL L L+N T E+ + H
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSH 337
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICA 203
L+ + N + +S+ + L + + + N L A
Sbjct: 338 NTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI------TMPKETLTNNSLTIA 389
Query: 204 TGSEP-DCYGTQLMPMSMNLNSSQTASP 230
+ D +G + + A+
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 8/91 (8%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ + T L + N + + T+L TLD S N T E+ + + L +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N+++ L QL FLD S N L+
Sbjct: 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 22/95 (23%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ TNL + +N +T + + LTKL L+ N T ++ + L Y+
Sbjct: 80 DLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLN 133
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
N+L+ ++ TQL LD N +
Sbjct: 134 CARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 21/91 (23%), Positives = 30/91 (32%), Gaps = 8/91 (8%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ LT L N +T + + L+KL TL EI L H L Y +
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQ 281
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ TQL LD ++
Sbjct: 282 AEGCRKIK--ELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 8/91 (8%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ + T L + + ++ T+L LD T E+ L L Y+
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
NN L+ ++ T+L L ++
Sbjct: 325 LNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 20/105 (19%), Positives = 37/105 (35%), Gaps = 7/105 (6%)
Query: 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157
N + + +L L +LD N+ T ++ + L L + +N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI 76
Query: 158 SGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-KTFNIVGNPL 200
+ L+ T L +L N L+ V + N N L
Sbjct: 77 TT---LDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 22/116 (18%), Positives = 48/116 (41%), Gaps = 11/116 (9%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
+ +LQ + + N+++ L +L++S+N T I L ++ + +
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF------SAKTFNIVGNPLICA 203
+N + + P + + L L+++ N L VP S + + NP C+
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 3/107 (2%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT--GEIPSSL 141
++ + NN +T + G LT+L+TL L N +I
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSL-ASMTQLIFLDLSYNNLSGPVPR 187
++SLQ + + NS+S + L+ L++S N L+ + R
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
+N+ I + +++ LD SNN T + + GHL L+ +
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 155 NSLSGAFPTSLA--SMTQLIFLDLSYNNLSGPVP 186
N L + M L LD+S N++S
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 31/129 (24%), Positives = 57/129 (44%), Gaps = 14/129 (10%)
Query: 65 TMVTCSPESLV-IGLGIP--------SQNLSGTLSPS-IGNLTNLQIVLLQNNNITGPIP 114
+V S L+ + + SQN L S I +L+ L+I+++ +N I
Sbjct: 3 FLVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 115 AEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL-SGAFPTSLASMTQLIF 173
+ +L+ LDLS+N +I +L+++ + N+ + +M+QL F
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 174 LDLSYNNLS 182
L LS +L
Sbjct: 120 LGLSTTHLE 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 12/93 (12%), Positives = 27/93 (29%), Gaps = 5/93 (5%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGR-----LTKLQTLDLSNNFFTGEIPSSLGHLRSLQY 149
T + + N + G + L L + ++ F ++
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
F + + ++ + LD S N L+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 10/90 (11%), Positives = 29/90 (32%), Gaps = 2/90 (2%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
GN++ L+ + L ++ I L + L + + + L+ +
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLH 169
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ + ++ +L +N+
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKC 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 37/200 (18%), Positives = 74/200 (37%), Gaps = 35/200 (17%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---EVEMISLAVH 356
+ ++++G G +G V + + VVA+K++ I + E+ +++ H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNH 111
Query: 357 RNLLRLYGFCMTPTERL-----LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA---- 407
+++++ + +V S K K R + L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFK-KLF-----RTPVYLTELHIKT 160
Query: 408 ------RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461
G+ Y+H I+HRD+K AN L++ C V DFGLA+ +D+ ++ +
Sbjct: 161 LLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 462 RGTVGHIAPEYLSTGQSSEK 481
+ K
Sbjct: 218 ISPREDDMNLVTFPHTKNLK 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 296 QVATHNFSSKNILGKGGFGIVY----KGILQDGTVVAVKRLKDGNAIGGEIQFQTEVE-- 349
+ + +F LG G FG V+ + +G A+K LK + +VE
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKE-----IVVRLKQVEHT 53
Query: 350 -----MISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRK---- 400
M+S+ H ++R++G + ++ Y+ G + S L+ K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 113
Query: 401 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTA 460
+ L L YLH + II+RD+K NILLD + DFG AK VT
Sbjct: 114 EVCLA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYT 162
Query: 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
+ GT +IAPE +ST ++ D + FGIL+ E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 46/214 (21%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 357
+G G +G V + + G VA+K+L FQ+ E+ ++ H
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHMRHE 84
Query: 358 NLLRLYGFCMTPTERL-------LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
N++ L TP E L LV P+M G+ +L L + + +GL
Sbjct: 85 NVIGLLD-VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-----RGTV 465
Y+H IIHRD+K N+ +++ CE + DFGLA+ DS +T V R
Sbjct: 142 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYR--- 192
Query: 466 GHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 498
APE L+ + ++ D++ G ++ E+ITG+
Sbjct: 193 ---APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 24/139 (17%)
Query: 62 CSWTM--VTCSPESL-VIGLGIP--------SQNLSGTLSPSI-GNLTNLQIVLLQNNNI 109
C+ V CS + L I IP N +L LT L+++ L +N +
Sbjct: 14 CNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 110 TGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLS----GAFPT 163
+PA I L L+TL +++N +P + L +L +R + N L F
Sbjct: 74 QT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVF-- 129
Query: 164 SLASMTQLIFLDLSYNNLS 182
S+T+L +L L YN L
Sbjct: 130 --DSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 36/120 (30%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRF 152
L NL + L N + +P + LTKL L L N +P + L SL+ +R
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 153 NNNSLS----GAFPTSLASMTQLIFLDLSYNNL-SGPVPRF----SAKTFNIVGNPLICA 203
NN L GAF +T+L L L N L P F K + NP C
Sbjct: 165 YNNQLKRVPEGAF----DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 55/234 (23%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 348
+ LG GG G+V+ + VA+K+ I E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK----------IVLTDPQSVKHALREI 59
Query: 349 EMISLAVHRNLLRLYGFCMTPTERL--------------LVYPYMSNGSVASRLKGKPIL 394
++I H N+++++ +L +V YM + + + + L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 395 DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQ 453
+ RGL Y+H ++HRD+K AN+ ++ + +GDFGLA+++D
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 454 DSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 498
SH VT R +P LS ++ D++ G + E++TG+
Sbjct: 175 YSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 45/163 (27%), Positives = 64/163 (39%), Gaps = 27/163 (16%)
Query: 62 CSWTMVTCSPESL-VIGLGIP--------SQNLSGTLSPSI-GNLTNLQIVLLQNNNITG 111
CS +V C + L I +P QN + P L+ + L NN I+
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE 70
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLS----GAFPTSL 165
+ + L L +L L N T E+P SL L SLQ + N N ++ AF
Sbjct: 71 -LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAF---- 124
Query: 166 ASMTQLIFLDLSYNNL-SGPVPRFSA----KTFNIVGNPLICA 203
+ L L L N L + FS +T ++ NP IC
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+ N + P + NL NL + L N I + L KL++L L +N + +I + L
Sbjct: 73 NGNKLTDIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DI-NGL 127
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
HL L+ + NN ++ T L+ +T+L L L N +S
Sbjct: 128 VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
S+ +L L+ + L++N I+ I + L +L++L L NN T +I + L L L +
Sbjct: 103 SSLKDLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTL 158
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N +S LA +T+L L LS N++S
Sbjct: 159 SLEDNQISDI--VPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ L ++ ++ N++I + I L + L L+ N T +I L +L++L ++
Sbjct: 37 VTQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWL 92
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N + +SL + +L L L +N +S
Sbjct: 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 14/88 (15%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L+ ++T + L + + +N+ + + +L ++ + N
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182
N L+ P L ++ L +L L N +
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
I L N+ + L N +T I + L L L L N ++ SSL L+ L+ +
Sbjct: 61 IQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N +S L + QL L L N ++
Sbjct: 117 EHNGISDI--NGLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LT L + L++N I+ I + LTKLQ L LS N + ++ +L L++L +
Sbjct: 147 TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVL 202
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFN 194
+ +++ + + +L P +
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 15/92 (16%), Positives = 34/92 (36%), Gaps = 4/92 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LT LQ + L N+I+ + L L L+L + + + +L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + SL P ++ ++ ++
Sbjct: 227 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 38/167 (22%), Positives = 56/167 (33%), Gaps = 19/167 (11%)
Query: 53 NWDEDAVDPCSWTMVTCSPESLVIGLGIPSQ---NLSG----TLSPSI-GNLTNLQIVLL 104
+ + T GL +LS L S+ + T+L+ + L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 105 QNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFP 162
N I I LT L L+LS NF I S +L L+ + + N +
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGD 364
Query: 163 TSLASMTQLIFLDLSYNNLSGPVPR--FSA----KTFNIVGNPLICA 203
S + L L L N L VP F + + NP C+
Sbjct: 365 QSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 24/125 (19%), Positives = 37/125 (29%), Gaps = 16/125 (12%)
Query: 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLT 121
C L P + ++ V L N+I RL
Sbjct: 10 VIGYNAICINRGL-------------HQVPEL--PAHVNYVDLSLNSIAELNETSFSRLQ 54
Query: 122 KLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
LQ L + I + + L SL ++ + N + + L L L+ N
Sbjct: 55 DLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCN 114
Query: 181 LSGPV 185
L G V
Sbjct: 115 LDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNN--------FFTGEIPSSLGHLR 145
LT+L++++L++NNI PA + + LDL+ N LR
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 146 --SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
S+ N L + T + LDLS N
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 15/103 (14%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ-----Y 149
L+++ + + + + T + TLDLS N F + +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 150 MRFNNNSLSGAFPTSLASMTQLIF----------LDLSYNNLS 182
+ + N S T+ F DLS + +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 18/120 (15%), Positives = 39/120 (32%), Gaps = 15/120 (12%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI---GRLTKLQTLDLSNNF-- 132
+ L + T++ + L N + TK+Q+L LSN++
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 133 --------FTGEIPSSLGHLR--SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
F + L ++ + + + + + T L L L+ N ++
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN 312
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 32/211 (15%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYG 364
LG+G + V++ I + + V VK LK I EI+ + +L N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI-----LENLRGGPNIITLAD 98
Query: 365 FCMTPTER--LLVYPYMSNGSVASRLKGKPILDWSTRKRIA------LGAARGLLYLHEQ 416
P R LV+ +++N K + T I L + L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEIL---KALDYCHSM 149
Query: 417 CDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 475
I+HRDVK N+++D + + + D+GLA+ H V + PE L
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRV-ASRYFKGPELLVD 204
Query: 476 GQS-SEKTDVFGFGILLLELITGQRALEYGK 505
Q D++ G +L +I + +G
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
S+ +L L+ + L++N I+ I + L +L++L L NN T +I + L L L +
Sbjct: 107 SLKDLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLS 162
Query: 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N +S LA +T+L L LS N++S
Sbjct: 163 LEDNQISDI--VPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ +L L+ + L NN IT + RLTKL TL L +N + +I L L LQ +
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNL 183
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N +S +LA + L L+L
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
I L N+ + L N +T P + L L L L N ++ SSL L+ L+ +
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSL 119
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+N +S L + QL L L N ++
Sbjct: 120 EHNGISDI--NGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ L ++ ++ N++I + I L + L L+ N T +I L +L++L ++
Sbjct: 40 VTQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWL 95
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ N + +SL + +L L L +N +S
Sbjct: 96 FLDENKVKDL--SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 15/88 (17%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L+ ++T + L + + +N+ + + +L ++ + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182
N L+ P LA++ L +L L N +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 21/94 (22%), Positives = 42/94 (44%), Gaps = 4/94 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ LT L + L++N I+ +P + LTKLQ L LS N + ++ +L L++L +
Sbjct: 150 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVL 205
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184
+ +++ + + +L P
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 47/249 (18%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 275 KERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK 333
HH + ++ +++ + +G+G +G+V + VA+K++
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 334 DGNAIGGEIQFQT---------EVEMISLAVHRNLLRLYGFCMTPTERL------LVYPY 378
F+ E++++ H N++ + + +V
Sbjct: 62 P---------FEHQTYCQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMKDVYIVQDL 111
Query: 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438
M + +L L RGL Y+H ++HRD+K +N+LL+ C+
Sbjct: 112 M--ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCD 166
Query: 439 AVVGDFGLAKLLDHQDSH--------VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGI 489
+ DFGLA++ D H T R APE L++ ++ D++ G
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYR------APEIMLNSKGYTKSIDIWSVGC 220
Query: 490 LLLELITGQ 498
+L E+++ +
Sbjct: 221 ILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 348
+ + + +G G +G V + G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 349 EMISLAVHRNLLRLYGFCMTPTERL-------LVYPYMSNGSVASRLKGKPILDWSTRKR 401
++ H N++ L TP L LV M + + +K + L +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQF 136
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ--DSHVTT 459
+ RGL Y+H IIHRD+K +N+ +++ CE + DFGLA+ + T
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 460 AVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 498
R APE L+ ++ D++ G ++ EL+TG+
Sbjct: 194 WYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 5e-11
Identities = 35/218 (16%), Positives = 58/218 (26%), Gaps = 49/218 (22%)
Query: 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRL-------------KDGN 336
F + T +G+G FG V++ I D T VA+K + K
Sbjct: 11 VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 337 AIGGEIQFQTEVEMISLAV---HRNLLRLYGFCM----TPTERLLVYPY----------- 378
I EI E+ ++S V + L P L + +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 379 --------------MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424
G + + +T K I L + HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVR 462
D+ N+LL + K + ++
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 71/248 (28%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEM 350
N+ K+++G+G +G VY VA+K++ F+ E+ +
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREITI 78
Query: 351 ISLAVHRNLLRLYGFCMTPTERL------LVYPYMSNGSVASRLKGKPILDWSTRKRIAL 404
++ ++RLY + P + L +V S LK K + I L
Sbjct: 79 LNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA-----DSDLK-KLF-----KTPIFL 126
Query: 405 GAA----------RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
G ++HE IIHRD+K AN LL+ C V DFGLA+ ++ +
Sbjct: 127 TEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 455 SHVTTAVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILLL 492
APE + ++ ++ D++ G +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 493 ELITGQRA 500
EL+ ++
Sbjct: 244 ELLNMLQS 251
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 22/105 (20%), Positives = 38/105 (36%), Gaps = 13/105 (12%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
N L +L L ++NN +T +P L L D+S N +P+
Sbjct: 148 DNNQLTMLPELPTSLEVL---SVRNNQLTF-LPELPESLEAL---DVSTNLLE-SLPAVP 199
Query: 142 GHLRSLQ----YMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + R N ++ P ++ S+ + L N LS
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 25/102 (24%), Positives = 38/102 (37%), Gaps = 17/102 (16%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
+QN +L +L L +N ++ +P L LD+ NN T +P
Sbjct: 88 TQNALISLPELPASLEYLD---ACDNRLST-LPELPASLKH---LDVDNNQLT-MLPELP 139
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSL-ASMTQLIFLDLSYNNLS 182
L + +NN L T L T L L + N L+
Sbjct: 140 ALLEYI---NADNNQL-----TMLPELPTSLEVLSVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 26/101 (25%), Positives = 38/101 (37%), Gaps = 15/101 (14%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL 141
N TL +L +L + NN +T +P L+ ++ NN T +P
Sbjct: 108 CDNRLSTLPELPASLKHLD---VDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELP 159
Query: 142 GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
L L NN L+ P S+ LD+S N L
Sbjct: 160 TSLEVL---SVRNNQLT-FLPELPESLEA---LDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 18/81 (22%), Positives = 26/81 (32%), Gaps = 5/81 (6%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVL----LQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
S NL +L + + + N IT IP I L T+ L +N + I
Sbjct: 188 STNLLESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI 246
Query: 138 PSSLGHLRSLQYMRFNNNSLS 158
SL + S
Sbjct: 247 RESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 14/100 (14%), Positives = 28/100 (28%), Gaps = 9/100 (9%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
+ + N + + + L L+ + +P +L
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLP 79
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + N+L + P L +LD N LS
Sbjct: 80 --PQITVLEITQNALI-SLPELP---ASLEYLDACDNRLS 113
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 26/127 (20%), Positives = 40/127 (31%), Gaps = 25/127 (19%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGR 119
C T V CS + L I IP + L NN T +
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIP---------------QYTAELRLNNNEFTVLEATGIFKK 55
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL----SGAFPTSLASMTQLIFLD 175
L +L+ ++ SNN T + + + +N L F + L L
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMF----KGLESLKTLM 111
Query: 176 LSYNNLS 182
L N ++
Sbjct: 112 LRSNRIT 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 9/82 (10%)
Query: 96 LTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFN 153
+ + +LL +N + + ++ L L+TL L +N T + + S L S++ +
Sbjct: 80 ASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 154 NNSLS----GAFPTSLASMTQL 171
+N ++ GAF +L S++ L
Sbjct: 138 DNQITTVAPGAF-DTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 16/62 (25%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
L +L+ ++L++N IT + + L+ ++ L L +N T P + L SL +
Sbjct: 103 GLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 154 NN 155
N
Sbjct: 162 AN 163
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 2e-10
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 14/118 (11%)
Query: 113 IPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQL 171
+ L L + N + L L L+ + + L P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 172 IFLDLSYNNLS----GPVPRFSAKTFNIVGNPLICATGSEPDCYGTQLMPMSMNLNSS 225
L+LS+N L V S + + GNPL C C L +
Sbjct: 83 SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC------SC---ALRWLQRWEEEG 131
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 4/82 (4%)
Query: 78 LGIPSQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGR-LTKLQTLDLSNNFFTG 135
L I +Q L + L L+ + + + + + + +L L+LS N
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE- 93
Query: 136 EIPSSLGHLRSLQYMRFNNNSL 157
+ SLQ + + N L
Sbjct: 94 SLSWKTVQGLSLQELVLSGNPL 115
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 48/236 (20%), Positives = 91/236 (38%), Gaps = 67/236 (28%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMI 351
F K++LG+G +G+V G +VA+K++ F E++++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI---EP------FDKPLFALRTLREIKIL 63
Query: 352 SLAVHRNLLRLYGFCMTPTERL------LVYPYMSNGSVASRLKGKP------------I 393
H N++ ++ P ++ M + + +
Sbjct: 64 KHFKHENIITIFN-IQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT 121
Query: 394 LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453
L R + LH +IHRD+K +N+L++ C+ V DFGLA+++D +
Sbjct: 122 L-------------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-E 164
Query: 454 DSHVTTAVRGTVGHI----------APEY-LSTGQSSEKTDVFGFGILLLELITGQ 498
+ + G + APE L++ + S DV+ G +L EL +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 7/90 (7%)
Query: 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
+ TNL+ + L +N I+ P + LTKL+ L ++ N + + + L +
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL-NGIPSA-CLSRLFL 113
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+NN L SL + L L + N L
Sbjct: 114 DNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 7/103 (6%)
Query: 80 IPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
I + P L N L ++T + L+ +Q + N+ + +
Sbjct: 3 IQRPTPINQVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ +L+ + ++N +S + L +T+L L ++ N L
Sbjct: 58 GMQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
S+ +L NL+I+ ++NN + I +G L+KL+ LDL N T L L+ + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
+ +L + +
Sbjct: 178 DLTGQKCV---NEPVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 15/92 (16%), Positives = 33/92 (35%), Gaps = 4/92 (4%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+G L+ L+++ L N IT + RL K+ +DL+ E L +
Sbjct: 144 VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 151 RFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + P +++ + + +
Sbjct: 202 KDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 19/123 (15%), Positives = 33/123 (26%), Gaps = 18/123 (14%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
C + I +P + + + L N +
Sbjct: 7 VPNITYQCMELNFYKIPDNLP---------------FSTKNLDLSFNPLRHLGSYSFFSF 51
Query: 121 TKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
+LQ LDLS I L L + N + + + ++ L L
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 180 NLS 182
NL+
Sbjct: 111 NLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 21/95 (22%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTG-EIPSSLGHLRSLQYMRF 152
L++LQ ++ N+ + G L L+ L++++N ++P +L +L+++
Sbjct: 98 GLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 153 NNNSLS----GAFPTSLASMTQLIF-LDLSYNNLS 182
++N + L M L LDLS N ++
Sbjct: 157 SSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 16/135 (11%)
Query: 82 SQNLSGTLSPSI-GNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ +L G+L L+ + + +N I +P LT L+ LDLS+N I
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
Query: 140 -SLGHLRSLQYMRF----NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR--F---- 188
L L + + + N ++ +L L L N L VP F
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLT 224
Query: 189 SAKTFNIVGNPLICA 203
S + + NP C+
Sbjct: 225 SLQKIWLHTNPWDCS 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 21/118 (17%), Positives = 46/118 (38%), Gaps = 11/118 (9%)
Query: 68 TCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTL 126
C E + +++ PS+ + Q + L ++ IP+ L + +
Sbjct: 9 ECHQEEDFR---VTCKDI--QRIPSL--PPSTQTLKLIETHLRT-IPSHAFSNLPNISRI 60
Query: 127 DLSNNFFTGEIPS-SLGHLRSLQYMR-FNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+S + ++ S S +L + ++ N +L+ P +L + L FL + L
Sbjct: 61 YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 25/140 (17%), Positives = 49/140 (35%), Gaps = 17/140 (12%)
Query: 62 CS-WTMVTCSPESLVIGLGIPSQ----NLSGTLSPSI-----GNLTNLQ-IVLLQNNNIT 110
C + + + +P L T +I NL N+ I + + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 111 GPIPAEI-GRLTKLQTLDLSNNFFTGEIPSS-LGHLRSLQYMRFNNNSLSGAFP--TSLA 166
+ + L+K+ +++ N I L L L+++ N L FP T +
Sbjct: 70 Q-LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 167 SMTQLIFLDLSYNNLSGPVP 186
S L+++ N +P
Sbjct: 128 STDIFFILEITDNPYMTSIP 147
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 17/93 (18%), Positives = 37/93 (39%), Gaps = 12/93 (12%)
Query: 95 NLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRS-LQYMR 151
L L+ + + N + P ++ L++++N + IP + L + ++
Sbjct: 103 ELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 152 FNNNSLS----GAFPTSLASMTQLIFLDLSYNN 180
NN + AF + T+L + L+ N
Sbjct: 163 LYNNGFTSVQGYAF-----NGTKLDAVYLNKNK 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 11/99 (11%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEI--GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ 148
+ + I+ + +N IP G + TL L NN FT + + L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 149 YMRFNNNSL-----SGAFPTSLASMTQLIFLDLSYNNLS 182
+ N N AF + S LD+S +++
Sbjct: 183 AVYLNKNKYLTVIDKDAF-GGVYS--GPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 95 NLTNLQIVL-LQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSL--GHLRSLQYMR 151
L N + L L NN T + TKL + L+ N + I G +
Sbjct: 153 GLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 152 FNNNSLSGAFPT-SLASMTQLIFLDL 176
+ S++ A P+ L + +LI +
Sbjct: 212 VSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 38/153 (24%), Positives = 56/153 (36%), Gaps = 32/153 (20%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
C T+V CS + L + GIP ++ + L N T +P E+
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIP---------------RDVTELYLDGNQFTL-VPKELSNY 53
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLS----GAFPTSLASMTQLIFLDL 176
L +DLSNN + S ++ L + + N L F + L L L
Sbjct: 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTF----DGLKSLRLLSL 109
Query: 177 SYNNLSGPVPR--F----SAKTFNIVGNPLICA 203
N++S VP F + I NPL C
Sbjct: 110 HGNDISV-VPEGAFNDLSALSHLAIGANPLYCD 141
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 28/121 (23%), Positives = 43/121 (35%), Gaps = 30/121 (24%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIP----SSLGHLRSLQY 149
+L L+++LL NN+I + + +LQ L LS N + P L L
Sbjct: 110 DLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLML 167
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICATGSEPD 209
+ ++N L T L + + L +N NPL C D
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN-----------------NPLEC------D 204
Query: 210 C 210
C
Sbjct: 205 C 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 29/124 (23%), Positives = 56/124 (45%), Gaps = 19/124 (15%)
Query: 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI--GR 119
C+ +++CS + L +P +L + ++ L +NN++ + AE R
Sbjct: 18 CASNILSCSKQQL---PNVPQ-SLP----------SYTALLDLSHNNLSR-LRAEWTPTR 62
Query: 120 LTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSY 178
LT L +L LS+N I S + + +L+Y+ ++N L + + L L L
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121
Query: 179 NNLS 182
N++
Sbjct: 122 NHIV 125
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNN 155
++ + L NN IT +++ R LQ L L++N I S L SL+++ + N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 156 SLSGAFPTSLASMTQLIFLDLSYNNLS 182
LS + ++ L FL+L N
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 19/102 (18%), Positives = 40/102 (39%), Gaps = 2/102 (1%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
+LT LQI+ + N + I + LT L+ L++ + P SL ++++ ++ +
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSAKTFN 194
+ + + L+L +L S N
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 35/154 (22%), Positives = 53/154 (34%), Gaps = 40/154 (25%)
Query: 67 VTCSPESL-VIGLGIPSQ----NLSG----TLSPSI-GNLTNLQIVLLQNNNITGPIPAE 116
S SL I G+ +LS +S S NLQ ++L +N I I +
Sbjct: 36 CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEED 94
Query: 117 I-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLS-----GAF-------- 161
L L+ LDLS N+ + + SS L SL ++ N F
Sbjct: 95 SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153
Query: 162 -------------PTSLASMTQLIFLDLSYNNLS 182
A +T L L++ ++L
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 9/105 (8%), Positives = 33/105 (31%), Gaps = 12/105 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRF 152
LT L+ + + +++ + + + L L + + S++ +
Sbjct: 172 GLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229
Query: 153 NNNSLSGAFPTSLAS--------MTQLIFLDLSYNNLSGPVPRFS 189
+ L + L++ + ++ +L + +
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 15/128 (11%), Positives = 43/128 (33%), Gaps = 15/128 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI--------GRLTKLQTLDLSNNFFTGEIPSSLGHLRS 146
++++ + L++ ++ +E+ + + + +++ ++ L +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 147 LQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS------GPVPRFSAKTFNIVGNPL 200
L + F+ N L +T L + L N + R+ K
Sbjct: 279 LLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA 338
Query: 201 ICATGSEP 208
C+ +P
Sbjct: 339 KCSGSGKP 346
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/79 (16%), Positives = 28/79 (35%), Gaps = 1/79 (1%)
Query: 79 GIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP 138
LS + S+ + V + + ++ + + +++ L L+ S N
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPD 294
Query: 139 SSLGHLRSLQYMRFNNNSL 157
L SLQ + + N
Sbjct: 295 GIFDRLTSLQKIWLHTNPW 313
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 54/246 (21%), Positives = 91/246 (36%), Gaps = 71/246 (28%)
Query: 299 THNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEM 350
+ LGKG +GIV+K I + G VVAVK++ D N+ EI +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI-----L 62
Query: 351 ISLAVHRNLLRLYGFCMTPTERL---LVYPYMSN--GSVASRLKGKP------------I 393
L+ H N++ L + LV+ YM +V ++ +
Sbjct: 63 TELSGHENIVNLLN-VLRADNDRDVYLVFDYMETDLHAV---IRANILEPVHKQYVVYQL 118
Query: 394 LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453
+ + + YLH ++HRD+K +NILL+ C V DFGL++ +
Sbjct: 119 I-------------KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 454 DSHVTTAVRGTVGHI--------------------APEYLSTGQS-SEKTDVFGFGILLL 492
+ APE L ++ D++ G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 493 ELITGQ 498
E++ G+
Sbjct: 223 EILCGK 228
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 24/131 (18%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQ----NLSGTLSPSIG-----NLTNLQIVLLQNNNITG 111
CS + C + I +P T I +L+ + + N++
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPSS-LGHLRSLQYMRFNNNSLSGAFPTSLASMT 169
I A++ L KL + + I +L +LQY+ +N +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 170 QLIFLDLSYNN 180
Q + LD+ N
Sbjct: 129 QKVLLDIQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 19/108 (17%), Positives = 33/108 (30%), Gaps = 4/108 (3%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLS-NNFFTGEIPS-SLGHLRSLQYMRFNN 154
I+ L N I I T+L L+LS NN E+P+ + +
Sbjct: 154 FESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLIC 202
+ L ++ +L + + A + P C
Sbjct: 212 TRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHC 259
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 2/90 (2%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI--GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152
+ ++ +Q+N I G + L L+ N S+ + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+NN+L + + LD+S +
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+ + T EIPS L R+ +RF L + + L +++S N++
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 184 PVPR 187
+
Sbjct: 69 VIEA 72
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 24/122 (19%), Positives = 47/122 (38%), Gaps = 3/122 (2%)
Query: 63 SWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTK 122
+T + +SL+I + +Q + + I +L ++ +
Sbjct: 296 EFTYSETALKSLMI-EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354
Query: 123 LQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTS--LASMTQLIFLDLSYNN 180
L+ + N FT + L+ LQ + N L F + +M+ L LD+S N+
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS 414
Query: 181 LS 182
L+
Sbjct: 415 LN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 16/120 (13%)
Query: 74 LVIGLGIPSQNLSGT--------LS--PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123
L++G P N + L+ P + + L N+I+ +I L++L
Sbjct: 20 LIVGSMTPFSNELESMVDYSNRNLTHVPK-DLPPRTKALSLSQNSISELRMPDISFLSEL 78
Query: 124 QTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ L LS+N + + + L+Y+ ++N L + L LDLS+N+
Sbjct: 79 RVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPM---ASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 12/125 (9%)
Query: 88 TLSPSIGNLTNLQIVLLQNNNIT----GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
N+ + + ++ + L+LS+N TG + L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-- 448
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL-SGPVPRF----SAKTFNIVGN 198
++ + +NN + + P + + L L+++ N L S P F S + + N
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
Query: 199 PLICA 203
P C
Sbjct: 508 PWDCT 512
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 40/227 (17%), Positives = 72/227 (31%), Gaps = 18/227 (7%)
Query: 92 SIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
S + +L+ + L N+ P+ E G LTKL L LS F + HL L +
Sbjct: 116 SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCI 174
Query: 151 RFNN--NSLSGAFPTSLASM-TQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICATGSE 207
+ + G SL T ++ L N+L S + I
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 208 PDCYGTQLMPMSMNLNSSQTASPGRTRSHK-----LSLVFGLSVGCVSLIILVFGLFLWW 262
T L ++ + K + V +++ L
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI------ 288
Query: 263 RQRRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHN-FSSKNIL 308
R + F E + + + +++ F + A ++ F+ NI
Sbjct: 289 -TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 7/95 (7%)
Query: 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS--SLGHLRSL 147
+ N + + L+ I I L + +D S+N EI LR L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRL 66
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ + NNN + ++ L L L+ N+L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 9/100 (9%)
Query: 84 NLSGTLSPSIGN---LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT--GEIP 138
+ S + L L+ +L+ NN I L L L L+NN G++
Sbjct: 48 DFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL- 106
Query: 139 SSLGHLRSLQYMRFNNNSLSGAF---PTSLASMTQLIFLD 175
L L+SL Y+ N ++ + + Q+ LD
Sbjct: 107 DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 23/124 (18%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGPIPAEI---GRLTKLQTLDLSNNFFT--GEIPSSLGH 143
+ ++ L + + L NNI +I + L+ L L N + +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIKKIENLDAVADT 94
Query: 144 LRSLQYMRFNN-NSLSGAFPTSLASMTQLIFLDLSYNNLS--GPVPRFSA----KTFNIV 196
L L ++ +N SLSG + + L L +S N ++ G + + +A + +
Sbjct: 95 LEEL-WISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148
Query: 197 GNPL 200
GNPL
Sbjct: 149 GNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 24/106 (22%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT--GEIPS 139
+NL + L+ + + N I + I +L L+ L +SNN T GEI
Sbjct: 78 GRNLIKKIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI-D 134
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTS----------LASMTQLIFLD 175
L L L+ + N L + + + + L LD
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 47/228 (20%), Positives = 82/228 (35%), Gaps = 57/228 (25%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-----------A 354
LG G F V+ + + T VA+K ++ + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 355 VHRNLLRLYGF-----------CMTPTERLLVYPYMSNGSVASRLKGKPILDWSTR--KR 401
++L+L M E L + ++ + + + I K+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMV-FEVL----GENLLALIKKYEHRGI---PLIYVKQ 135
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV------VGDFGLAKLLDHQDS 455
I+ GL Y+H +C IIH D+K N+L++ + D G A D
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--- 190
Query: 456 HVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
H T ++ R +PE L D++ L+ ELITG
Sbjct: 191 HYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 21/124 (16%), Positives = 38/124 (30%), Gaps = 23/124 (18%)
Query: 61 PCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
+S+ T + + L ++ ++ N++I + I L
Sbjct: 18 FAETIKANLKKKSV-------------TDAVTQNELNSIDQIIANNSDIKS-VQG-IQYL 62
Query: 121 TKLQTLDLSNNFFTGEIPSSLG---HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177
++ L L N + L +L Y+ N L +T L L L
Sbjct: 63 PNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117
Query: 178 YNNL 181
N L
Sbjct: 118 ENQL 121
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 11/97 (11%)
Query: 96 LTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
LTNL+ ++L N + +P + +LT L L+L++N L +L + +
Sbjct: 108 LTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166
Query: 155 NSL----SGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187
N L G F +TQL L L N L VP
Sbjct: 167 NQLQSLPEGVF----DKLTQLKDLRLYQNQLKS-VPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 13/91 (14%)
Query: 96 LTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFN 153
LTNL + L +N + +P + +LT L LDLS N +P + L L+ +R
Sbjct: 132 LTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189
Query: 154 NNSL----SGAFPTSLASMTQLIFLDLSYNN 180
N L G F L S+ I+L ++N
Sbjct: 190 QNQLKSVPDGVF-DRLTSLQY-IWL---HDN 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 45/215 (20%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVH-----RNL 359
++GKG FG V K + VA+K +++ Q E+ ++ L N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 360 LRLYGF-------CMTPTERLL--VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
+ + CMT E L +Y + + +G + ++ A + L
Sbjct: 162 IHMLENFTFRNHICMT-FELLSMNLYELIKKN----KFQGFSL---PLVRKFAHSILQCL 213
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAV--VGDFGLAKLLDHQDSHVTTAV-----RG 463
LH+ +IIH D+K NILL + V DFG + ++ V T + R
Sbjct: 214 DALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRFYR- 266
Query: 464 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
APE + + D++ G +L EL+TG
Sbjct: 267 -----APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.3 bits (124), Expect = 2e-07
Identities = 16/101 (15%), Positives = 31/101 (30%), Gaps = 13/101 (12%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI------GRLTKLQTLDLSNNFFTGEIPSSLGH---LR 145
NL L + + + R L+ L + + + L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 146 SLQYMRFNNNSLSG----AFPTSLASMTQLIFLDLSYNNLS 182
L+ M + L+ + + L F+++ YN LS
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 24/161 (14%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG----EIQF------QTEVEMISLAVH 356
+G GGFG++Y A +K G E++F + ++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 357 RNLL---RLYGFCMTPTE----RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARG 409
+ L YG +T + R +V + + ST ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 410 LLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAK 448
L Y+HE +H D+KAAN+LL + + + D+GL+
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 4/88 (4%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
++ L + ++N + +L+ L N T I ++L L L+ + ++
Sbjct: 18 DVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182
N +SG L L+LS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 7/101 (6%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNIT--GPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
S++ G L L+ + N +T +P +L KL+ L+LS+N +G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEV 82
Query: 140 SLGHLRSLQYMRFNNNSLSG-AFPTSLASMTQLIFLDLSYN 179
+L ++ + N + + L + L LDL
Sbjct: 83 LAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 7/99 (7%)
Query: 84 NLSGTLSPSIGNL---TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPS 139
+ SI NL L+ + L +N ++G + + L L+LS N
Sbjct: 48 STINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 140 SLGHLRSLQYMRFNNN---SLSGAFPTSLASMTQLIFLD 175
L L +L+ + N +L+ + QL +LD
Sbjct: 108 PLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 40/137 (29%), Positives = 55/137 (40%), Gaps = 22/137 (16%)
Query: 62 CSWTMVTCSPESLV-IGLGIPS--------QNLSGTLSPSI-GNLTNLQIVLLQNNNITG 111
V C +SL + GIP+ TLS + LT L + L N +
Sbjct: 14 EGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT 73
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSL----SGAFPTSL 165
+ A + LT+L TL L+NN +P + HL L + N L SG F L
Sbjct: 74 -LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF-DRL 130
Query: 166 ASMTQLIFLDLSYNNLS 182
T+L L L+ N L
Sbjct: 131 ---TKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRF 152
+LT L + L N + +P+ + RLTKL+ L L+ N IP+ L +LQ +
Sbjct: 105 HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 153 NNNSLS----GAFPTSLASMTQLIFLDLSYNN 180
+ N L GAF L + I L + N
Sbjct: 163 STNQLQSVPHGAF-DRLGKLQT-ITL---FGN 189
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 100 QIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSG 159
++VL + G I L+ L L N + S+L L L+ + + N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFG 85
Query: 160 AFPTSLASMTQLIFLDLSYNNLS 182
+ L L+LS N L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 7/101 (6%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNIT--GPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
++ G + NL+ + L N + +P +L KL+ L+LS N G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDM 89
Query: 140 SLGHLRSLQYMRFNNNSLSG-AFPTSLASMTQLIFLDLSYN 179
L +L ++ + N L + L + L LDL
Sbjct: 90 LAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/100 (24%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 84 NLSGTLSPSIGNL---TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT--GEIP 138
+L S+ NL L+ + L N I G + +L L L+LS N +
Sbjct: 55 SLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL- 113
Query: 139 SSLGHLRSLQYMRFNNN---SLSGAFPTSLASMTQLIFLD 175
L L L+ + N +L+ + + QL +LD
Sbjct: 114 EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 13/100 (13%)
Query: 96 LTNLQIVLLQNNNIT----GPIPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHL-RS 146
L Q+V L + +T I + + L L+L +N + L
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 147 LQYMRFNNNSLS----GAFPTSLASMTQLIFLDLSYNNLS 182
+Q + N L+ G ++L ++ L L LS N L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 13/99 (13%)
Query: 97 TNLQIVLLQNNNIT----GPIPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHLRS-L 147
+Q + LQN +T G + + + L LQ L LS+N + L + L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 148 QYMRFNNNSLS----GAFPTSLASMTQLIFLDLSYNNLS 182
+ ++ SLS + L + L +S N+++
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 14/101 (13%), Positives = 32/101 (31%), Gaps = 13/101 (12%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRL----TKLQTLDLSNNFFTGE----IPSSLGHLR- 145
L+ + L+ +++ + + + L +SNN + L
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199
Query: 146 SLQYMRFNNNSLSGAFPTSLASM----TQLIFLDLSYNNLS 182
L+ ++ + ++ L + L L L N L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 16/113 (14%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNIT----GPIPAEIGRLTKLQTLDLSNNFFTGE-- 136
+ L L S L L+ L++ +T + + L+ L L +N
Sbjct: 188 RVLCQGLKDSPCQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 137 ---IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASM----TQLIFLDLSYNNLS 182
P L L+ + ++ L + L L L+ N L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 121 TKLQTLDLSNNFFTGE-IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASM----TQLIFLD 175
+Q+LD+ + L L+ Q +R ++ L+ A ++S L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 176 LSYNNLS 182
L N L
Sbjct: 63 LRSNELG 69
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 14/108 (12%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL-----TKLQTLDLSNNFFTGE----IPS 139
+S ++ L + L++N + + + K+Q L L N TG + S
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASM-----TQLIFLDLSYNNLS 182
+L L +LQ + ++N L A L +L L L Y +LS
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 21/108 (19%), Positives = 39/108 (36%), Gaps = 14/108 (12%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGP-----IPAEIGRLTKLQTLDLSNNFFTGE----IPS 139
L + +L+ + L N + + +L++L + + FT S
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASM-----TQLIFLDLSYNNLS 182
L R L ++ +NN L A L + L L L+ ++S
Sbjct: 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 32/125 (25%), Positives = 41/125 (32%), Gaps = 24/125 (19%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
CS T V C + + GIP TN QI+ L +N IT P L
Sbjct: 19 CSGTTVDCRSKRHASVPAGIP---------------TNAQILYLHDNQITKLEPGVFDSL 63
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL----SGAFPTSLASMTQLIFLDL 176
L+ L L +N L L + N L S F + L L +
Sbjct: 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVF----DRLVHLKELFM 119
Query: 177 SYNNL 181
N L
Sbjct: 120 CCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 17/60 (28%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
L +L+ + + N +T +P I RLT L L L N + L SL + N
Sbjct: 111 LVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 15/109 (13%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGP-IPAEIGRL----TKLQTLDLSNNFFTGE----IPS 139
+ + + L V + N I I + +L+ LDL +N FT +
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 140 SLGHLRSLQYMRFNNNSLSGAFPTSLASM------TQLIFLDLSYNNLS 182
+L +L+ + N+ LS ++ L L L YN +
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 18/116 (15%), Positives = 33/116 (28%), Gaps = 22/116 (18%)
Query: 89 LSPSIGNLTNLQIVLLQNNNIT-------------GPIPAEIGRLTKLQTLDLSNNFFTG 135
L + T L+ + L NN + + + L+++ N
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 136 E----IPSSLGHLRSLQYMRFNNNSL-----SGAFPTSLASMTQLIFLDLSYNNLS 182
+ R L ++ N + LA +L LDL N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 20/113 (17%)
Query: 89 LSPSIGNLTNLQIVLLQNNNITGPIPAE-----IGRLTKLQTLDLSNNF---FTGEIPSS 140
+ + +++ ++L N I G A I L+ + S+ F EIP +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 82
Query: 141 LGHL-------RSLQYMRFNNNSLSG----AFPTSLASMTQLIFLDLSYNNLS 182
L L L +R ++N+ L+ T L L L N L
Sbjct: 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 15/108 (13%), Positives = 36/108 (33%), Gaps = 19/108 (17%)
Query: 93 IGNLTNLQIVLLQNNNITG----PIPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHL 144
+ + ++ L+ + IT + A + ++ + LS N E + ++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 145 RSLQYMRFNNNSLS----------GAFPTSLASMTQLIFLDLSYNNLS 182
+ L+ F++ +L +L + LS N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 37/152 (24%), Positives = 56/152 (36%), Gaps = 29/152 (19%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
CS T + C+ + L + GIP ++ + L++N + +L
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIP---------------SSATRLELESNKLQSLPHGVFDKL 51
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL----SGAFPTSLASMTQLIFLDL 176
T+L L LS N L L + + N L +G F +TQL L L
Sbjct: 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVF----DKLTQLKELAL 107
Query: 177 SYNNL-SGPVPRF----SAKTFNIVGNPLICA 203
N L S P F S + + NP C+
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 37/169 (21%)
Query: 308 LGKGGFGIVYKGILQDGT------VVAVKRLKDGNA-IGGEIQF----QTEVEMISLAVH 356
+G+GGFG +Y + VK N + E++F ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 357 RNLL-----RLYGFCMTPTERLLVYPYMSNGSVASRLKGKP---ILDWSTRK-------R 401
R L + +G + Y +M + R G I + + ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFM----IMDRF-GSDLQKIYEANAKRFSRKTVLQ 156
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAK 448
++L L Y+HE +H D+KA+N+LL+ + + + D+GLA
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 29/169 (17%), Positives = 54/169 (31%), Gaps = 37/169 (21%)
Query: 308 LGKGGFGIVYKGI---------LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHR 357
+ GI+Y+ ++K + E F Q + + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGS-----VASRLKGKP---ILDWSTRK--------R 401
L + PT + + V L G+ LD S + +
Sbjct: 110 KLYSTPLLAI-PT----CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ 163
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILL--DDCCEAVVGDFGLAK 448
+A L +LHE +H +V A NI + +D + + +G A
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 31/125 (24%), Positives = 42/125 (33%), Gaps = 24/125 (19%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
CS T V C + + GIP + L+ N++ L
Sbjct: 7 CSGTTVECYSQGRTSVPTGIP---------------AQTTYLDLETNSLKSLPNGVFDEL 51
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL----SGAFPTSLASMTQLIFLDL 176
T L L L N L SL Y+ + N L +G F +TQL L L
Sbjct: 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVF----DKLTQLKELAL 107
Query: 177 SYNNL 181
+ N L
Sbjct: 108 NTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 13/91 (14%)
Query: 96 LTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFN 153
LT+L + L N + +P + +LT+L+ L L+ N +P + L L+ +R
Sbjct: 75 LTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132
Query: 154 NNSL----SGAFPTSLASMTQLIFLDLSYNN 180
N L G F L S+ I+L ++N
Sbjct: 133 QNQLKSVPDGVF-DRLTSLQY-IWL---HDN 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL------AVHRN 358
+++GKG FG V K + VA+K +K+ A Q Q EV ++ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117
Query: 359 LLRLYGF-------CMTPTERLLV--YPYMSNGSVASRLKGKPILDWSTRKRIALGAARG 409
++ L C+ E L Y + N + +G + + ++ A
Sbjct: 118 IVHLKRHFMFRNHLCLV-FEMLSYNLYDLLRN----TNFRGVSL---NLTRKFAQQMCTA 169
Query: 410 LLYLHEQCDPKIIHRDVKAANILL--DDCCEAVVGDFGLAKLLDHQDSHVTTAV-----R 462
LL+L + IIH D+K NILL + DFG + + + R
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQSRFYR 225
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
+PE L D++ G +L+E+ TG+
Sbjct: 226 ------SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 32/170 (18%)
Query: 294 ELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS 352
EL+V + +G G FG +Y G + G VA+K Q E ++
Sbjct: 4 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 59
Query: 353 -LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP---ILDWSTRK-------R 401
+ + + ++V M L G + ++ +RK
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMV---ME-------LLGPSLEDLFNFCSRKFSLKTVLL 109
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAK 448
+A + Y+H + IHRDVK N L+ + DFGLAK
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 32/179 (17%)
Query: 294 ELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS 352
E +V F +G G FG +Y G +Q VA+K Q E ++
Sbjct: 2 EPRVGNK-FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYR 57
Query: 353 -LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP---ILDWSTRK-------R 401
L + + F + +LV M L G + ++ +RK
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLV---MD-------LLGPSLEDLFNFCSRKLSLKTVLM 107
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQDSHV 457
+A + ++H + +HRD+K N L+ + + DFGLAK +H
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 17/103 (16%), Positives = 37/103 (35%), Gaps = 18/103 (17%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRL----TKLQTLDLSNNFFTGE----IPSSLGHLRSLQ 148
T ++ + P+ + + L++L++ +NF +G + +L SL
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 149 YMRFNNNSLS----GAFPTSLASM----TQLIFLDLSYNNLSG 183
+R +N S +A+M T L+ +
Sbjct: 125 ELRIDNQSQPLGNNVE--MEIANMLEKNTTLLKFGYHFTQQGP 165
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 14/106 (13%)
Query: 62 CSWTMVTCSPESLV-IGLGIPS--QNLS------GTLSPSI-GNLTNLQIVLLQNNNITG 111
CS T V CS +SL + GIP+ Q L L P + LT L + L NN +T
Sbjct: 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV 68
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNN 155
+PA + +LT+L L L++N IP + +L+SL ++ NN
Sbjct: 69 -LPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 14/102 (13%), Positives = 37/102 (36%), Gaps = 16/102 (15%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRL-----TKLQTLDLSNNFFTGE----IPSSLGHLRSL 147
++ + L N + AE+ + + +L+L N G + L+ L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 148 QYMRFNNNSLSG-------AFPTSLASMTQLIFLDLSYNNLS 182
Q + + + + A + ++ ++I +D + +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/158 (22%), Positives = 60/158 (37%), Gaps = 33/158 (20%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLYGF 365
+G+G FG++++G L + VA+K + Q + E L + +Y F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 366 CMTPTERLLVYPYMSNGSVASRLKGKP---ILDWSTRK-------RIALGAARGLLYLHE 415
+LV + L G +LD RK A + +HE
Sbjct: 75 GQEGLHNVLV---ID-------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 416 QCDPKIIHRDVKAANILL-----DDCCEAVVGDFGLAK 448
+ +++RD+K N L+ + V DFG+ K
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 62 CSWTMVTCSPESLV-IGLGIPS--QNLS------GTLSPSI-GNLTNLQIVLLQNNNITG 111
C T+V C L + GIP+ Q L L P + +L NLQ + +N +T
Sbjct: 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA 71
Query: 112 PIPAEI-GRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNN 155
IP + +LT+L LDL++N IP + +L+SL ++ NN
Sbjct: 72 -IPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 21/100 (21%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 96 LTNLQIVLLQNNNITGPIPAEIGRL-----TKLQTLDLSNNFFTGE----IPSSLGHLRS 146
+ + LQ N++ ++ L ++ TL LSNN T + L S
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 147 LQYMRFNNNSLSGAFPTSLASM----TQLIFLDLSYNNLS 182
+ ++ + L LA+ QL L+++YN
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 45/255 (17%), Positives = 75/255 (29%), Gaps = 97/255 (38%)
Query: 400 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DDC--------------------- 436
K+I +GL YLH +C +IIH D+K NILL ++
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 437 --------------------------CEAVVGDFGLAKLLDHQDSHV--TTAVRGTVGHI 468
+ + D G A + + T R
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR------ 260
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQ------------------------------ 498
+ E L + D++ + EL TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320
Query: 499 RALEYGKAA----NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCT 554
+ + GK + +KG L + K+ E+LV+ K + + E L
Sbjct: 321 KLIVAGKYSKEFFTKKG-DLKHITKLKPWGLFEVLVE---KYEWSQEEAAGFTDFLLPML 376
Query: 555 QYLPAHRPKMSEVVR 569
+ +P R +E +R
Sbjct: 377 ELIPEKRATAAECLR 391
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 16/76 (21%), Positives = 26/76 (34%), Gaps = 20/76 (26%)
Query: 62 CSWTMVTCSPESLVIG---LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEI- 117
C+ T+V C L P + ++L NN+T +P +
Sbjct: 8 CAGTLVDCGRRGLTWASLPTAFP---------------VDTTELVLTGNNLTA-LPPGLL 51
Query: 118 GRLTKLQTLDLSNNFF 133
L L+T L N +
Sbjct: 52 DALPALRTAHLGANPW 67
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 38/172 (22%), Positives = 59/172 (34%), Gaps = 34/172 (19%)
Query: 294 ELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS 352
L V + F +G G FG + G L VA+K + Q E
Sbjct: 4 VLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP---QLHLEYRFYK 59
Query: 353 LAVH-RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP---ILDWSTRK-------R 401
+ ++Y F +V + L G + D R
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMV---LE-------LLGPSLEDLFDLCDRTFSLKTVLM 109
Query: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVV--GDFGLAK 448
IA+ + Y+H + +I+RDVK N L+ + + V+ DF LAK
Sbjct: 110 IAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 24/123 (19%), Positives = 35/123 (28%), Gaps = 41/123 (33%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGR 119
C T V C+ L I IP + +LL +N + GR
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIP---------------LHTTELLLNDNELGRISSDGLFGR 52
Query: 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179
L L L+L N L ++ AF + + L L N
Sbjct: 53 LPHLVKLELKRN-----------QLTGIE---------PNAF----EGASHIQELQLGEN 88
Query: 180 NLS 182
+
Sbjct: 89 KIK 91
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 18/62 (29%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
+++Q + L N I I ++ L +L+TL+L +N + +P S HL SL +
Sbjct: 76 GASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 154 NN 155
+N
Sbjct: 135 SN 136
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 16/102 (15%), Positives = 38/102 (37%), Gaps = 15/102 (14%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRL----TKLQTLDLSNNFFTGE----IPSSLGHLRSLQ 148
+++ L N I+ + L L+ L++ +NF T E + S +S+
Sbjct: 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIV 129
Query: 149 YMRFNN---NSLSGAFPTSLASM----TQLIFLDLSYNNLSG 183
+ +N + L + L+ + +S+ ++
Sbjct: 130 EFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASMEA 171
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 622 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.88 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.74 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.74 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.65 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.62 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.62 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.62 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.58 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.57 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.57 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.56 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.56 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.55 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.55 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.55 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.55 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.55 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.54 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.53 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.53 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.53 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.52 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.52 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.51 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.5 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.49 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.47 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.47 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.46 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.46 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.45 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.45 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.44 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.44 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.43 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.42 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.42 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.4 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.39 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.39 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.39 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.39 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.38 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.37 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.36 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.35 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.33 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.33 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.32 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.31 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.31 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.3 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.27 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.25 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.25 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.24 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.23 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.18 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.1 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.1 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.09 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.03 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.03 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.79 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.69 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.65 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.62 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.26 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.23 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.09 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.97 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.41 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.37 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.24 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.13 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.03 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.0 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.81 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.13 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.24 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.54 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.49 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.53 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=444.54 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=209.9
Q ss_pred CCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++...+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|..++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4456788999999999999863 4688999999876555556789999999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 375 VYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
|||||++|+|.++|... ..++|..+..|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 99999999999998532 3589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||+|+.....+.. ......||+.|||||++.++.|+.++|||||||++|||+| |+.||...... +.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DV 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------HH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence 999999999876443322 2344579999999999999999999999999999999999 88998743321 11
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+..+.... ....+..++..+.+++.+||+.||++||||+||++.|+.
T Consensus 257 ~~~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 257 VEMIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22221111 111233455789999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=441.49 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=209.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|.+.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356778899999999999999864 47889999997643 33456799999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccC-------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 373 LLVYPYMSNGSVASRLKG-------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
++|||||++|+|.++++. ...++|.++..|+.|||+||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 999999999999999863 24699999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHH
Q 036225 440 VVGDFGLAKLLDHQDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 517 (622)
||+|||+|+.......... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +.+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~ 240 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVI 240 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999987654333222 23568999999999999999999999999999999999 89999753321 112
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+..... ...+..++.++.+++.+||+.||++|||++||++.|+.
T Consensus 241 ~~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 241 ECITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22211111 11233345789999999999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=442.29 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=203.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++|...+.||+|+||+||+|.++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677889999999999999864 47899999997643 334567999999999999999999999999999999
Q ss_pred EEeeeccCCCccccccCC---------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 374 LVYPYMSNGSVASRLKGK---------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
+|||||++|+|.++++.. ..++|.++..|+.|||+||+|||++ +|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999998642 3589999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EA 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-------HH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence 999999999876543322 3345679999999999999999999999999999999999 89999753321 11
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+..+.... +...+..+++++.+|+.+||+.||++|||++||++.|+.
T Consensus 270 ~~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 270 IDCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 22221111 111233345789999999999999999999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=433.39 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=202.8
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+..+++...+.||+|+||+||+|.+++ .||||+++.... ......|.+|++++++++|||||+++|++.. +..++|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 445678889999999999999999763 599999975433 2334579999999999999999999999865 568999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||||++|+|.++++. ...++|..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999964 45799999999999999999999998 99999999999999999999999999998765332
Q ss_pred -CceeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 455 -SHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 455 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
........||+.|||||++.+ +.|+.++|||||||++|||+||+.||........ +.. .+... ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~---~~~~~-----~~ 255 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIF---MVGRG-----YA 255 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHH---HHHTT-----CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHH---HHhcC-----CC
Confidence 223445679999999999864 4689999999999999999999999974332111 111 11111 11
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.+.+ ......++.++.+++.+||+.||++||||+||++.|+
T Consensus 256 ~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 256 SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1111 1122334578999999999999999999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=437.50 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=218.3
Q ss_pred cCHHHHHHHHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccc-ccceee
Q 036225 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRL 362 (622)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l 362 (622)
+...++++..++|.+.+.||+|+||+||+|.+.. ++.||||+++..........|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556778888999999999999999999998642 468999999876655556679999999999965 899999
Q ss_pred eeeeeCC-CceeEEeeeccCCCccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 036225 363 YGFCMTP-TERLLVYPYMSNGSVASRLKG----------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425 (622)
Q Consensus 363 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 425 (622)
+|+|... +..++|||||++|+|.++|+. ...++|..+..|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999853 23589999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCcccc
Q 036225 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEY 503 (622)
Q Consensus 426 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~ 503 (622)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877544433 3345679999999999999999999999999999999998 8999974
Q ss_pred chhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 504 GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..... .+ ...+.... +...+..++.++.+++.+||+.||++|||++||+++|+.
T Consensus 291 ~~~~~---~~---~~~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDE---EF---CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSH---HH---HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH---HH---HHHHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 33211 11 11111111 111223345679999999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=428.35 Aligned_cols=249 Identities=22% Similarity=0.242 Sum_probs=204.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.|...++||+|+||+||+|.+. +|+.||||+++.... ..+|++++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999975 699999999975432 24799999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCCCCc-
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQDSH- 456 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~- 456 (622)
|++|+|.++++....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999998877899999999999999999999999 999999999999999887 6999999999987543221
Q ss_pred ---eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 ---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+..... ...... .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~---~~~~~~-----~ 277 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIAS---EPPPIR-----E 277 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHH---SCCGGG-----G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHc---CCCCch-----h
Confidence 1233579999999999999999999999999999999999999997533221 1111111 000000 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.+...+..+.+++.+||+.||++|||+.|+++.|.
T Consensus 278 ----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 278 ----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp ----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 12223467889999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=427.97 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=207.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.|+..+.||+|+||+||+|... +|+.||||+++.... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999975 699999999975432 2344688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
|++|+|.+++... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 9999999998754 589999999999999999999999 999999999999999999999999999997754332 34
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +....+... ..+.+. .
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~------~~~~~~--~ 292 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDN------LPPRLK--N 292 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS------SCCCCS--C
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcC------CCCCCC--c
Confidence 4567999999999999999999999999999999999999999743321 111221111 111111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....+.++.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11233678999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=431.29 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=201.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 6999999999765432 334578999999999999999999999999999999999
Q ss_pred eccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||++|+|.+++.. ...+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 9999999999953 34578899999999999999999999 9999999999999999999999999999866422 1
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.+..+..... +..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~------~~~- 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSF------PPV- 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCC------CCC-
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCC------CCC-
Confidence 123446799999999999999999999999999999999999999975432 122222221110 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 246 ---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ---SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123367899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=424.72 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=209.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|... +|+.||||++.+.. .......+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 69999999996532 1223456899999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS- 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 455 (622)
||+++|+|.+++.....+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999998877899999999999999999999999 999999999999999999999999999998754332
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+.. .....+.... ..+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~-------~~~p 254 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLE-------YDFP 254 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-------CCCC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC-------CCCC
Confidence 2345678999999999999999999999999999999999999999754321 1122221111 1112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV 568 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 568 (622)
.. .+.++.+++.+||+.||++|||++|++
T Consensus 255 ~~----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EK----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22 235688999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=416.95 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=198.7
Q ss_pred CcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC----CCceeEEe
Q 036225 303 SSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT----PTERLLVY 376 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 376 (622)
...+.||+|+||+||+|.+. +++.||+|++...... .....|.+|++++++++|||||++++++.. ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 6889999999754322 234569999999999999999999999865 34579999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||++|+|.++++....+++..+..|+.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 9999999999998878899999999999999999999998 12399999999999998 489999999999985432
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ......+..... .
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~-~-------- 248 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVK-P-------- 248 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCC-C--------
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCC-C--------
Confidence 23445689999999998864 6999999999999999999999999643221 111222211111 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...+.++.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123568899999999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=421.27 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=200.1
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC----ceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT----ERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 375 (622)
.+|.+.+.||+|+||+||+|.+. |+.||||+++... .....+..|+..+.+++|||||+++|+|..++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 34667889999999999999985 8999999986532 11223345666677889999999999998654 57899
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
||||++|+|.++++.. .++|+.+.+++.|+++||+|||+++ .++|+||||||+|||+++++++||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999754 5899999999999999999999762 458999999999999999999999999999887
Q ss_pred CCCCCce---eeeecCcccccCccccccC------CCCcccceeehhHHHHHHHhcCCccccchhccc--------cccH
Q 036225 451 DHQDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGQRALEYGKAANQ--------KGAM 513 (622)
Q Consensus 451 ~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~--------~~~~ 513 (622)
....... .....||+.|||||++.+. .++.++|||||||++|||+||+.|+........ ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5543322 2345799999999999754 467899999999999999999887753322111 0111
Q ss_pred HHHHHHHhhhhhhhhhccccCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 514 LDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 514 ~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+.+. ....++.++.. .....+..+.+|+.+||+.||++||||.||++.|+.
T Consensus 239 ~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 239 EEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11111111 11112222211 122455778999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=409.50 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=193.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|... +|+.||||+++.... ......+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 699999999975432 223456899999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+ +|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+..... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 999 679999998888899999999999999999999999 9999999999999999999999999999876432 2
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ....+.+.... ..+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~-------~~~- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGV-------YTL- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-------CCC-
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-------CCC-
Confidence 2345679999999999988776 5799999999999999999999974321 12222221111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 ---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 ---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12223678899999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=428.65 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=207.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|++++++++|||||++++++...+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56889999999999999999975 699999999975543 3345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
|++|+|.++++.. .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 9999999998754 589999999999999999999999 999999999999999999999999999997754332 33
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.+..+... ..+.+. .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~------~~~~~~--~ 369 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDN------LPPRLK--N 369 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS------CCCCCS--C
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcC------CCCCCc--c
Confidence 4567999999999999999999999999999999999999999743321 111221111 111111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
....+.++.+++.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122367889999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=417.10 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=196.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++|++.+.||+|+||+||+|... +++.||||+++.... ......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 478999999975432 2223468899999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||||++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999998878899999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.. +....+.... ..
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~-------~~- 244 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------ETMTMILKAK-------LG- 244 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------CC-
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------HHHHHHHcCC-------CC-
Confidence 2 234567999999999999999999999999999999999999999754321 1122211110 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
++...+.++.+++.+||+.||++|||+
T Consensus 245 ---~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 ---MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 122234678999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=413.52 Aligned_cols=307 Identities=73% Similarity=1.155 Sum_probs=262.5
Q ss_pred cccccccccCcccccCHHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc
Q 036225 276 ERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 355 (622)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~ 355 (622)
.........+..+.+++.++....++|...+.||+|+||.||+|...+|+.||||+++..........+.+|+++++.++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~ 85 (326)
T 3uim_A 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV 85 (326)
T ss_dssp ---------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred cccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence 33444556677888999999999999999999999999999999988899999999987654444557899999999999
Q ss_pred cccceeeeeeeeCCCceeEEeeeccCCCccccccCC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 356 H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
||||+++++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++.++|+||||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 999999999999999999999999999999998643 3499999999999999999999998778999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhc-ccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAA-NQK 510 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~-~~~ 510 (622)
|+++++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||+||+.||...... ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred EECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 9999999999999999987665555566667999999999998889999999999999999999999999754433 333
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChhhHHHH
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEA 582 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~ 582 (622)
....+|+.............+......+.......+.+++.+|++.||.+|||+.||+++|++....++|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~ 317 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence 456678877777777788888888888888999999999999999999999999999999999888776655
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=407.82 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=188.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC--------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-------- 370 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------- 370 (622)
++|+..+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999975 689999999976554445567899999999999999999999987544
Q ss_pred ----ceeEEeeeccCCCccccccCCCC---CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 371 ----ERLLVYPYMSNGSVASRLKGKPI---LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 371 ----~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
..++|||||++|+|.+++..... .++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 45566889999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCc-----------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccccc
Q 036225 444 FGLAKLLDHQDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512 (622)
Q Consensus 444 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~ 512 (622)
||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~------ 232 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME------ 232 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH------
Confidence 9999877543221 1234579999999999999999999999999999999996 6642211
Q ss_pred HHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 513 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
....+.... +...+. ..........+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~---------~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDVR---------NLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHH---------TTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHh---------cCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111111 111100 11122345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=401.04 Aligned_cols=267 Identities=17% Similarity=0.281 Sum_probs=203.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC------CCc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT------PTE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 371 (622)
++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++++.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999975 7999999999765432 234568899999999999999999998754 367
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.|+|||||+ |+|.+++.....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 68999998888999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC---CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh----
Q 036225 452 HQD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE---- 523 (622)
Q Consensus 452 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 523 (622)
... .......+||+.|||||++.+. .++.++||||+||++|||+||+.||...+..+....+..........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 321 2223456899999999998775 46999999999999999999999997654333222111111000000
Q ss_pred ---hhhhhh---ccccCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 ---KKLEML---VDKDLKNNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ---~~~~~~---~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...... ..+...... ......++.+|+.+||..||++|||++|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000000000 00113568899999999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=392.11 Aligned_cols=198 Identities=24% Similarity=0.384 Sum_probs=170.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 373 (622)
.+.|++.+.||+|+||+||+|..+ +++.||||.+.... ...++.+|++++..+ +|||||++++++...+..+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 567999999999999999999853 47889999986543 244678999999988 6999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.++++ .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999985 489999999999999999999999 99999999999999876 8999999999986543
Q ss_pred CCC---------------------------ceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccc
Q 036225 453 QDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYG 504 (622)
Q Consensus 453 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~ 504 (622)
... ......+||+.|||||++.+. .|+.++||||+||++|||+||+.||..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112345799999999999775 4899999999999999999999999754
Q ss_pred h
Q 036225 505 K 505 (622)
Q Consensus 505 ~ 505 (622)
.
T Consensus 251 ~ 251 (361)
T 4f9c_A 251 S 251 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.21 Aligned_cols=276 Identities=39% Similarity=0.681 Sum_probs=236.5
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++...+++|+..+.||+|+||+||+|.+++++.||||++.... ......+.+|+++++.++||||+++++++...+..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445678899999999999999999998889999999987653 33455789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCC----CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKP----ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999997543 589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCC-CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 449 LLDHQD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 449 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||...... .......|...........
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhccccccHH
Confidence 754322 22233456899999999999999999999999999999999999999754433 2334556665555566666
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+++.+........+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 7777777777788889999999999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=406.92 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=200.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHH---HHHHHHhccccccceeeeeeeeCCCcee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQ---TEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++|++.++||+|+||+||+|... +|+.||||++++... ......+. .++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999975 699999999964321 11122233 3456677889999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||++||+|.+++.....+++..+..|+.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999998878899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. ....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||......+. .......... ..
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~i~~~i~~~-------~~ 411 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTM-------AV 411 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HHHHHHHHHC-------CC
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhhcCC-------CC
Confidence 2 334679999999999965 5799999999999999999999999975432221 1111111100 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
. ++...+.++.+++.+||+.||.+|++ ++||++
T Consensus 412 ~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 12223367899999999999999998 566654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=406.27 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=207.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||+||+|..+ +|+.||+|+++... ......+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57899999999999999999975 69999999997654 23345688999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--CCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~ 455 (622)
|++|+|.+++.. ...+++..+..|+.||+.||+|||++ +|+||||||+|||++. .+.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999998864 45799999999999999999999999 9999999999999985 489999999999987543
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +....+.... ..+.
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~-------~~~~ 376 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCD-------WNMD 376 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTC-------CCCC
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCC-------CCCC
Confidence 2344567999999999999999999999999999999999999999754321 1112211110 0011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.........++.+|+.+||+.||.+|||+.|+++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112356889999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.65 Aligned_cols=279 Identities=39% Similarity=0.648 Sum_probs=229.7
Q ss_pred cccccCHHHHHHHHhCCCcC------CeeeecCCceEEEEEECCCeEEEEEEccCCCC---CchhHHHHHHHHHHhcccc
Q 036225 286 NLRRFQFRELQVATHNFSSK------NILGKGGFGIVYKGILQDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH 356 (622)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H 356 (622)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++..... ......+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999877 8999999999999987 488999999875432 2334578999999999999
Q ss_pred ccceeeeeeeeCCCceeEEeeeccCCCccccccC---CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 036225 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG---KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 433 (622)
Q Consensus 357 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl 433 (622)
|||+++++++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998863 45689999999999999999999999 99999999999999
Q ss_pred cCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccccc
Q 036225 434 DDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512 (622)
Q Consensus 434 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~ 512 (622)
++++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-- 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence 99999999999999876543322 2334569999999998864 5889999999999999999999999765433222
Q ss_pred HHHHHHHHhh-hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 513 MLDWVKKIHQ-EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 513 ~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...... ...+...+++.+. ......+..+.+++.+|++.+|.+|||++++++.|+.
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 222222222 2233444554443 3566778889999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=374.29 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=209.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP 369 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 369 (622)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 45689999998765444556789999999999 899999999999999
Q ss_pred CceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 036225 370 TERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 433 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl 433 (622)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999998642 3488999999999999999999999 99999999999999
Q ss_pred cCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccc
Q 036225 434 DDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKG 511 (622)
Q Consensus 434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~ 511 (622)
+.++.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 999999999999998765433221 223457889999999999999999999999999999999 99998643321
Q ss_pred cHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 512 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+.. .+... .....+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 313 ~~~~---~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 313 ELFK---LLKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp GHHH---HHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH---HHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 11111 1111222344679999999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=366.05 Aligned_cols=260 Identities=28% Similarity=0.411 Sum_probs=203.3
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.++.+..++|++.+.||+|+||+||+|.. +|+.||||++...... .....+.+|++++++++||||+++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567889999999999999999987 4889999998765432 223468899999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCC---CChhHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEEccccc
Q 036225 372 RLLVYPYMSNGSVASRLKGKPI---LDWSTRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
.++||||+++|+|.+++..... +++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999986543 89999999999999999999998 7 99999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......
T Consensus 186 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-------~~~~~~~---- 253 (309)
T 3p86_A 186 SRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------VVAAVGF---- 253 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHHHHH----
T ss_pred Ccccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh----
Confidence 9765432 222344569999999999999999999999999999999999999997433211 1111100
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.......+...+..+.+++.+||+.+|.+|||++|+++.|+.
T Consensus 254 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 254 -----KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp -----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001111222334678999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.09 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=208.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|.+.+.||+|+||+||+|.+. .+..||||+++..........+.+|++++++++||||+++++++...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999974 4567999999876555556679999999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++|+|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999643 5799999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... +....+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~------- 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEG------- 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT-------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcC-------
Confidence 222 2223346788999999998999999999999999999999 99998643321 111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111222334679999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=358.43 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=207.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 456888999999999999999975 68999999886532 3345578999999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++|+|.++++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999975 56799999999999999999999999 9999999999999999999999999999876433221
Q ss_pred e-------------eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccc--ccHHHHHHHHh
Q 036225 457 V-------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK--GAMLDWVKKIH 521 (622)
Q Consensus 457 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~ 521 (622)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--- 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence 1 11456999999999999999999999999999999999999988643322111 11111111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... +...+..+.+++.+|++.||++|||+.|+++.|+.
T Consensus 242 ----------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 242 ----------RYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp ----------HTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------ccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 11122468899999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=356.52 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=207.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999996 57899999998754432 34568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999999998754 589999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ......... +. ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~~~------~~--~~ 237 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGT------PE--LQ 237 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHHCS------CC--CS
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC------CC--CC
Confidence 3445699999999999999999999999999999999999999964332111 111111100 00 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+...+..+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112233668899999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.04 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=209.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.++|...+.||+|+||+||+|.+.+++.||+|+++.... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 467888999999999999999998899999999976542 345789999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999999999964 45689999999999999999999999 99999999999999999999999999998654332222
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~----------~~~ 226 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG----------FRL 226 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT----------CCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcC----------ccC
Confidence 333456788999999998999999999999999999999 89998643321 111111111 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...+..+.+++.+|++.+|++||+++|+++.|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1122234678999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=362.73 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=205.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999976 7899999999765544444578899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-c
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-H 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 456 (622)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999999888899999999999999999999999 999999999999999999999999999987643221 1
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ ....|... . ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~----~---------~~ 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEK----K---------TY 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTT----C---------TT
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcc----c---------cc
Confidence 2234579999999999987765 7899999999999999999999975432211 11111110 0 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011123667899999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=373.22 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=215.4
Q ss_pred ccCHHHHHHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-cccccee
Q 036225 289 RFQFRELQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLR 361 (622)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~ 361 (622)
.+...++++..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345667778889999999999999999999984 246899999998765555556799999999999 7999999
Q ss_pred eeeeeeCCCc-eeEEeeeccCCCccccccCCCC-----------------------------------------------
Q 036225 362 LYGFCMTPTE-RLLVYPYMSNGSVASRLKGKPI----------------------------------------------- 393 (622)
Q Consensus 362 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 393 (622)
+++++...+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999865432
Q ss_pred -------------------CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 394 -------------------LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 394 -------------------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 88999999999999999999999 99999999999999999999999999998764433
Q ss_pred C-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 455 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||........ ... .....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~---~~~~~--------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR---RLKEG--------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHH---HHHHT---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HHH---HHHcC---------
Confidence 2 23344568999999999999999999999999999999999 9999864332111 111 11110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+.++.+++.+||+.||.+|||+.|++++|+.
T Consensus 313 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 313 -TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0111122233678999999999999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.13 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=211.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..++|...+.||+|+||+||+|..+++..||+|+++.... ....+.+|++++.+++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3567888999999999999999999888999999976542 34568899999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999998754 3589999999999999999999999 9999999999999999999999999999877654433
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ......... .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~----------~ 223 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGH----------R 223 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC----------C
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCC----------C
Confidence 3344456788999999998899999999999999999999 999986433211 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...+...+..+.+++.+|++.+|.+|||++|+++.|+..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011112235789999999999999999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=375.26 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=210.1
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.+..++|...+.||+|+||+||+|.+. +++.||||.++..........+.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344577888999999999999999986 7899999999865443444568899999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999998753 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcee-eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 454 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 454 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..... ....++..|+|||++.++.++.++|||||||++|||+| |..||....... ... .+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----~~~---~~~~--------- 330 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TRE---FVEK--------- 330 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----HHH---HHHT---------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHHc---------
Confidence 11111 11235778999999998999999999999999999998 999986433211 111 1111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus 331 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 331 -GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111222344678999999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.50 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=198.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|.+.+.||+|+||.||+|... ++..||||+++..........|.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457889999999999999999864 5778999999866544455679999999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999754 4699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~------- 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEG------- 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTT-------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC-------
Confidence 2221 122235778999999999999999999999999999998 99998643221 111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+||+.||.+||++.|+++.|+.
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 1111122334678999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.73 Aligned_cols=272 Identities=17% Similarity=0.221 Sum_probs=215.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC--ceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--ERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 375 (622)
.++|.+.+.||+|+||+||+|... +++.||||+++..........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888999999999999999976 589999999986554444567889999999999999999999988765 67999
Q ss_pred eeeccCCCccccccCCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEcccccce
Q 036225 376 YPYMSNGSVASRLKGKP---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAK 448 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~ 448 (622)
|||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997543 389999999999999999999999 99999999999999 788889999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccc--------cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHH-HHHHH
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML-DWVKK 519 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~ 519 (622)
....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||............. .....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 23456999999999986 5678999999999999999999999997544332222222 11111
Q ss_pred Hhhhhhhhhh---------cccc--CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 520 IHQEKKLEML---------VDKD--LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 520 ~~~~~~~~~~---------~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
. .......+ .... ............+.+++.+||+.||++|||++|+++...++..
T Consensus 243 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 K-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp C-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred C-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1 00000000 0001 1123456777889999999999999999999999999876544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=380.54 Aligned_cols=264 Identities=18% Similarity=0.232 Sum_probs=213.1
Q ss_pred CHHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeee
Q 036225 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
.+.+++...++|+..++||+|+||+||+|... +++.||+|+++.... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35566677889999999999999999999976 588999999864221 112234889999999999999999999999
Q ss_pred CCCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 368 TPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999976 56799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
++..............||+.|+|||++. ...++.++|||||||++|||+||+.||......+. ...+.
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~ 294 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIM 294 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------HHhhh
Confidence 9877655444445567999999999987 56789999999999999999999999975432221 11111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 570 (622)
.... ...-+..... ...++.+++.+|+..+|++ ||+++|++++
T Consensus 295 ~~~~--~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKE--RFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHH--HCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccc--cccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1100 0000111111 2356889999999998888 9999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.98 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=206.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..+|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999997 5799999999975432 233446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998664332
Q ss_pred eeeeecCcccccCccccccCCCC-cccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..++ .++|||||||++|||+||+.||...... .....+... ..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~---------~~- 231 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRG---------KY- 231 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC---------CC-
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---------CC-
Confidence 23445699999999999888764 7999999999999999999999754321 111111111 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+...+..+.+++.+|++.||.+|||++|+++.
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111233668899999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.97 Aligned_cols=260 Identities=25% Similarity=0.309 Sum_probs=205.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999965 68999999986543322 234688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999998777899999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ...... .. ... .....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~-~~-~~~-~~~~~- 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ-DS-VPN-VTTDV- 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS-SC-CCC-HHHHS-
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh-cc-CCC-cchhc-
Confidence 334456799999999999999999999999999999999999999975432111 111110 00 000 00011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcC
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRP-KMSEVVRMLEGD 574 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~ 574 (622)
....+..+.+++.+|++.||.+|| +++++.+.|+..
T Consensus 237 ---~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 237 ---RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ---ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 112236789999999999999999 889999888753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=352.14 Aligned_cols=262 Identities=20% Similarity=0.285 Sum_probs=212.9
Q ss_pred cccCHHHHHHHHhC----------CCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc
Q 036225 288 RRFQFRELQVATHN----------FSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 356 (622)
Q Consensus 288 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H 356 (622)
..++++++..+++. |...+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 44677777777664 566779999999999999976 799999999875442 334568899999999999
Q ss_pred ccceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 036225 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC 436 (622)
Q Consensus 357 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~ 436 (622)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999998754 589999999999999999999999 99999999999999999
Q ss_pred CceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH
Q 036225 437 CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 437 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 516 (622)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~~ 249 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QA 249 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH
Confidence 9999999999987654322 234457999999999999999999999999999999999999999743321 11
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+... ..+.+. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRDS------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHS------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcC------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 111111 011123568899999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.95 Aligned_cols=271 Identities=25% Similarity=0.322 Sum_probs=206.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc----ee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE----RL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~ 373 (622)
..++|++.+.||+|+||+||+|.+. ++.||||+++... .....+..|+.++.+++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467889999999999999999986 7999999986532 223356678888999999999999999987543 69
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC-------CCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC-------DPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
+||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999999764 4899999999999999999999752 33899999999999999999999999999
Q ss_pred ceecCCCCCc-eeeeecCcccccCccccccC-----CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 447 AKLLDHQDSH-VTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 447 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||............ ......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~ 256 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE-EEIGQH 256 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH-HHHCSS
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh-hhhccC
Confidence 9876543322 22335699999999999763 4567899999999999999999999754332211110 000000
Q ss_pred hhhhhh-hhhccccCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 521 HQEKKL-EMLVDKDLKNN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 521 ~~~~~~-~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...... ........... .....+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000000 00111111111 112355779999999999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.49 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=211.6
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
+...++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++++++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34467788999999999999999986 245889999998665444556789999999999999999999999999
Q ss_pred CceeEEeeeccCCCccccccCCC------------------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 036225 370 TERLLVYPYMSNGSVASRLKGKP------------------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 425 (622)
+..++||||+++|+|.+++.... .+++..+..++.||++||.|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 99999999999999999986432 388999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCcccc
Q 036225 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEY 503 (622)
Q Consensus 426 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~ 503 (622)
|||+||++++++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765433322 223457889999999999899999999999999999999 9999864
Q ss_pred chhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 504 GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... .+...+. .. .....+...+..+.+++.+|++.||.+||++.|+++.|+.
T Consensus 256 ~~~~----~~~~~~~---~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 256 IPPE----RLFNLLK---TG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CCGG----GHHHHHH---TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHH----HHHHHhh---cC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3321 1111111 10 0111122234678999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=364.18 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=207.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-----hhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.+.|.+.+.||+|+||+||+|... +|+.||+|.++...... ....+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457889999999999999999975 68999999997654321 245789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~ 448 (622)
++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999998888899999999999999999999999 999999999999998776 79999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... .
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~~~---~ 235 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITAVS---Y 235 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTC---C
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcC---C
Confidence 765432 233456999999999999989999999999999999999999999753321 1111111100 0
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
-++.... ...+..+.+++.+||..||.+|||+.|+++
T Consensus 236 ~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 112356889999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=353.98 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=208.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|...+.||+|+||+||+|.+.++..||+|+++.... ....+.+|++++.+++||||+++++++...+..++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 44667888999999999999999999899999999986542 2456889999999999999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999976 45699999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... .
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~----------~ 238 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------L 238 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTT----------C
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcc----------c
Confidence 22233446788999999998899999999999999999998 99998743321 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+||+.+|.+|||++|+++.|+.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111122223678999999999999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=364.48 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=210.6
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+++..++|...+.||+|+||.||+|.. .++..||||+++..........+.+|++++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445678899999999999999999996 246789999998655444556789999999999 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCCC-----------------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGKP-----------------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 424 (622)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 9999999999999999999986532 379999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccc
Q 036225 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALE 502 (622)
Q Consensus 425 Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~ 502 (622)
||||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543332 2334557889999999999999999999999999999998 999986
Q ss_pred cchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 503 YGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...... .+...+. .......+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 277 ~~~~~~---~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIPVDA---NFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCCCSH---HHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCcHH---HHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 543211 1111111 1111111222346799999999999999999999999999853
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=364.93 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=212.5
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
+....++|...+.||+|+||.||+|... +++.||||+++..........+.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999974 3489999999866544455679999999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccCC------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 036225 369 PTERLLVYPYMSNGSVASRLKGK------------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHR 424 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 424 (622)
.+..++||||+++|+|.+++... ..+++..++.++.||++||.|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999988642 5689999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccc
Q 036225 425 DVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALE 502 (622)
Q Consensus 425 Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~ 502 (622)
||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976643222 22334568899999999999999999999999999999999 999986
Q ss_pred cchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 503 YGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
..... .....+.... . ...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 279 ~~~~~-------~~~~~~~~~~---------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 279 GMAHE-------EVIYYVRDGN---------I-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TSCHH-------HHHHHHHTTC---------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCChH-------HHHHHHhCCC---------c-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 43211 1111111111 0 011222346789999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.58 Aligned_cols=250 Identities=23% Similarity=0.274 Sum_probs=207.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|+..+.||+|+||+||+|... +|+.||+|+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999975 68999999997532 122344688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 99999999999998777899999999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ...
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~-------~~~-- 223 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILME-------EIR-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------CCC--
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-------CCC--
Confidence 2234567999999999999999999999999999999999999999743321 111111110 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
++...+.++.+++.+||+.||++|| +++|++++
T Consensus 224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1222346789999999999999999 88888764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=380.95 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=213.1
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
...+++..++|...+.||+|+||+||+|.++++..||||+++... .....|.+|++++++++||||+++++++. .+.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 344556678899999999999999999999889999999998643 23567999999999999999999999986 567
Q ss_pred eeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 372 RLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.++||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 89999999999999999753 3688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
.............+|..|+|||++....++.++|||||||++|||+| |+.||...... +....+...
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~----- 401 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERG----- 401 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHHT-----
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC-----
Confidence 64322222233446789999999998999999999999999999999 99998743321 111111111
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.....+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus 402 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 402 -----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11111223446799999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.22 Aligned_cols=256 Identities=28% Similarity=0.394 Sum_probs=210.6
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
..++|.+.+.||+|+||+||+|... ++..||||+++..........+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567888999999999999999852 34689999998765555556789999999999 89999999999999
Q ss_pred CCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 036225 369 PTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIL 432 (622)
.+..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 99999999999999999998643 3589999999999999999999999 9999999999999
Q ss_pred ecCCCceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcccc
Q 036225 433 LDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQK 510 (622)
Q Consensus 433 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~ 510 (622)
+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654332 22233457889999999999999999999999999999999 9999864321
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+....+.... ....+...+.++.+++.+||+.||++|||++|+++.|+.
T Consensus 300 ---~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 300 ---EELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp ---HHHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11112111111 111112234678999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=352.65 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=197.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..++|.+.+.||+|+||+||+|.+.. +..||+|.++..........+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 35678889999999999999999742 56799999876554444567899999999999999999999984 56789
Q ss_pred EEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999998743 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ... .+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~---~i~~~~------- 234 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG---RIENGE------- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH---HHHTTC-------
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHH---HHHcCC-------
Confidence 43333344457889999999998999999999999999999997 888987543221 111 111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
....+...+..+.+++.+|++.||++|||+.|+++.|+..
T Consensus 235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111223346789999999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=360.64 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=200.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|...+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456888999999999999999964 344 468888876555555668999999999999999999999998754 78
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+|+||+++|+|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999864 45799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||....... +...+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~------------ 233 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE------------ 233 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH------------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHH------------
Confidence 3322 2233457889999999999999999999999999999999 999987433211 111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.......+......+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 234 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 234 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111112223346789999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.00 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=207.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|.+.+.||+|+||+||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456888999999999999999953 46789999998665555566789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEc
Q 036225 373 LLVYPYMSNGSVASRLKGK-------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC---EAVVG 442 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 442 (622)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999998632 3589999999999999999999999 999999999999999555 59999
Q ss_pred ccccceecCCCC-CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHH
Q 036225 443 DFGLAKLLDHQD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 443 Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||...... .....+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH
Confidence 999997553221 122234457899999999999999999999999999999998 99998643321 111111
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ....+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 300 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 300 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 111122234678999999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.11 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=201.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|++.+.||+|+||+||+|...+|+.||+|+++..... .....+.+|++++++++||||+++++++......++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3578889999999999999999988999999999754322 233568899999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++ +|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 77777654 44699999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh-----hhhhhhc
Q 036225 457 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE-----KKLEMLV 530 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 530 (622)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+.......... .......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2334568999999999876 568999999999999999999999997544332211111111000000 0000000
Q ss_pred cccCC--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DKDLK--NNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~~~~--~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.... .... .....++.+++.+|++.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 0000 1123568899999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=357.17 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=207.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.+.|...+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999975 6899999998754322 1345789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~ 448 (622)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999999 999999999999999877 89999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+....
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~---- 233 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVN---- 233 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTC----
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcC----
Confidence 765332 2234569999999999998999999999999999999999999996433211 111111000
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 ---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000001123568899999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.33 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=196.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCce---
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER--- 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~--- 372 (622)
.++|.+.+.||+|+||.||+|.. .+++.||||+++...... ....+.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999996 578999999997654322 234688999999999999999999998765544
Q ss_pred -eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 -LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 -~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
++||||+++++|.++++....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999999998777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 452 HQDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 452 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
..... ......||+.|+|||++.+..++.++||||||+++|||+||+.||....... .............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPP- 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCCH-
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCCCCc-
Confidence 43222 2234568999999999999999999999999999999999999997543211 1111111100000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... ...+..+.+++.+||+.||.+||++.+++..
T Consensus 240 --~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 240 --SARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp --HHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --cccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 1123678899999999999999988877653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=377.78 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=212.7
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++..++|...+.||+|+||.||+|.+.. +..||||.++.... ....|.+|++++++++||||++++++|......++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3445678889999999999999999864 88999999976532 35579999999999999999999999999999999
Q ss_pred EeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999963 45689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+ .
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~-------------~ 433 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL-------------E 433 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH-------------H
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH-------------H
Confidence 33222233446789999999999999999999999999999999 88888643321 111111 1
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...+...+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111122233457789999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.85 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=201.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhc--cccccceeeeeeeeC----CCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLYGFCMT----PTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~----~~~~ 372 (622)
.++|.+.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46789999999999999999998 5899999998643 23455667776665 799999999998654 3457
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
++||||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 8999999999999999654 6899999999999999999999 76 9999999999999999999999999
Q ss_pred ccceecCCCCCce---eeeecCcccccCccccccC------CCCcccceeehhHHHHHHHhc----------CCccccch
Q 036225 445 GLAKLLDHQDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----------QRALEYGK 505 (622)
Q Consensus 445 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~el~tg----------~~p~~~~~ 505 (622)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765443332 1234699999999999876 456799999999999999999 77775432
Q ss_pred hccccccHHHHHHHHhhhhhhhhhccccCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 506 AANQKGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ............. ..+.+. .......+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 238 ~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDP--SFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSC--CHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCc--chhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2221 1111111111110 011111 11223456789999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.10 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=200.7
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||+||+|...+|+.||+|+++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999988999999999754322 2235688999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++ +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 88888764 35689999999999999999999999 999999999999999999999999999986643222 2
Q ss_pred eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh-----hhhh--h
Q 036225 458 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK-----KLEM--L 529 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~ 529 (622)
.....||+.|+|||++.+. .++.++|||||||++|||+||+.||......+.. ........... .... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhcccc
Confidence 2344689999999998764 5899999999999999999999999754332211 11111110000 0000 0
Q ss_pred ccccCC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 VDKDLK-------NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 ~d~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++.+. .......+.++.+++.+|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011110 00011224678899999999999999999998863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=347.72 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=196.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-------------------------hhHHHHHHHHHHhc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-------------------------GEIQFQTEVEMISL 353 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~~ 353 (622)
++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999964 68999999986543211 12468899999999
Q ss_pred cccccceeeeeeeeC--CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 354 AVHRNLLRLYGFCMT--PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 354 l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
++||||+++++++.. .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999999986 5678999999999999987654 4689999999999999999999999 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCceeeeecCcccccCccccccCC---CCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
|++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 999999999999999987654332 234457999999999997655 47889999999999999999999974321
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+...+... ..........+..+.+++.+||+.||++||++.|+++
T Consensus 246 -----~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -----MCLHSKIKSQ---------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHHHHHHHHC---------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHHHHHHhcc---------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111110 0000001112367899999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.12 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=206.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||+||+|... +++.||+|.++... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357888999999999999999975 68999999987542 334568899999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--CCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999764 4699999999999999999999999 9999999999999987 7899999999998775432
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......||+.|+|||++.+..++.++|||||||++|||+||..||...... .....+...... .+...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---~~~~~ 226 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYT---FDEEA 226 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC---CCHHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCC---CChhh
Confidence 334567999999999999888999999999999999999999999754321 111111111000 00000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ...+.++.+++.+|+..||.+|||+.|+++.
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0123678899999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.36 Aligned_cols=255 Identities=30% Similarity=0.467 Sum_probs=209.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
++..++|...+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++++++||||+++++++.. +..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 344577889999999999999999998888999999875432 34578999999999999999999999864 568999
Q ss_pred eeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 376 YPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999997643 689999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+...
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~--------- 226 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERG--------- 226 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT---------
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHHHHHhcc---------
Confidence 3333334456789999999988889999999999999999999 88888643221 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 0111112234678999999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=362.49 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=212.2
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeee
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFC 366 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 366 (622)
+++...++|...+.||+|+||+||+|.... +..||+|.++..........+.+|++++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999642 2479999998765445556789999999999 899999999999
Q ss_pred eCCCceeEEeeeccCCCccccccC--------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKG--------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 432 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIL 432 (622)
...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999998853 34579999999999999999999999 9999999999999
Q ss_pred ecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcccc
Q 036225 433 LDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQK 510 (622)
Q Consensus 433 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~ 510 (622)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999876543322 2233457889999999999999999999999999999999 888886432211
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.....+.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 275 -~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 -KFYKLVKD-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhc-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111 011111122246789999999999999999999999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=354.42 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=211.7
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT 368 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 368 (622)
+...++|...+.||+|+||+||+|.+ .+++.||||+++..........+.+|++++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456788999999999999999985 357899999998665444556799999999999 99999999999999
Q ss_pred CCceeEEeeeccCCCccccccCCC------------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKP------------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 430 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 430 (622)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 999999999999999999986432 489999999999999999999999 99999999999
Q ss_pred eeecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhcc
Q 036225 431 ILLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAAN 508 (622)
Q Consensus 431 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~ 508 (622)
|+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999999998765443322 233457889999999999999999999999999999999 999986433211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. ....+.. ......+...+..+.+++.+|++.||.+|||+.|+++.|+.
T Consensus 256 ~---~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 K---FYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp H---HHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHhcc-------------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1 1111111 01111112234678999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=348.81 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=202.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|+..+.||+|+||+||+|... +++.||+|+++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 6899999999755432 234568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|++++.+..+......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence 998644444444566799999999999999999999999 999999999999999999999999999987653322 2
Q ss_pred eeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh--h---hhhhhcc
Q 036225 458 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--K---KLEMLVD 531 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~d 531 (622)
.....||+.|+|||++.+.. ++.++|||||||++|||+||+.|+........ .+.......... . ......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccccc
Confidence 33456899999999997766 79999999999999999999988754332111 111111111000 0 0000000
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KD---------LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ............+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0001111234678899999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=354.82 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=191.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||+|... +|+.||+|+++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999965 6899999999765544445678899999999999999999999999999999999
Q ss_pred eccCCCccccccC------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 378 YMSNGSVASRLKG------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 378 ~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|++ |+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 589888753 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLEM 528 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 528 (622)
.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||......+....+.+......... ....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 22344689999999999764 689999999999999999999999975443222111111110000000 0000
Q ss_pred --hccccCC----CC--------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 --LVDKDLK----NN--------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 --~~d~~~~----~~--------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+... .. .......++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 00 000123578999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=367.14 Aligned_cols=255 Identities=18% Similarity=0.269 Sum_probs=207.1
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
..++|.+.+.||+|+||+||+|... +|+.||+|++...... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4577999999999999999999964 7899999999765432 2344688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~ 452 (622)
|||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999998778899999999999999999999999 999999999999998 568899999999987654
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... .
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~-----~-- 230 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGA-----Y-- 230 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTC-----C--
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCC-----C--
Confidence 322 233457999999999999989999999999999999999999999643321 1111111110 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........+.++.+++.+|++.||.+|||+.|+++.
T Consensus 231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00010111223678899999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=355.48 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=209.4
Q ss_pred CCcCCeeeecCCceEEEEEEC-----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--CceeE
Q 036225 302 FSSKNILGKGGFGIVYKGILQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLL 374 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 374 (622)
|...+.||+|+||+||++.+. +++.||||+++..........+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 68899999998765445556789999999999999999999999874 56789
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||||+++|+|.+++.... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 999999999999997654 89999999999999999999999 99999999999999999999999999998876543
Q ss_pred Cc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 455 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 455 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.. ......+|..|+|||++.+..++.++||||||+++|||+||+.||........ ....+.............+..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHHHHhc
Confidence 32 22344578899999999998999999999999999999999999874332100 000000000001111122222
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 22222333345789999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.84 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=203.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--CCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 371 (622)
.++|++.+.||+|+||+||+|.+ .+++.||||+++... ......+.+|++++++++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 46788899999999999999984 368999999987543 2334578899999999999999999999865 356
Q ss_pred eeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999754 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh----hhh
Q 036225 451 DHQDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH----QEK 524 (622)
Q Consensus 451 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 524 (622)
...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+....... ........ ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVF 239 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-----HHHHCTTCCTHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH-----HhhhcCccccchhHH
Confidence 543221 2233457788999999999999999999999999999999998876432110 00000000 000
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+........+...+.++.+++.+||+.||++|||++|+++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011111111112233345779999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=355.17 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=199.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC-------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------- 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------- 370 (622)
.++|+..+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999986 799999999986655555668999999999999999999999986543
Q ss_pred --------------------------------------------------ceeEEeeeccCCCccccccCCC---CCChh
Q 036225 371 --------------------------------------------------ERLLVYPYMSNGSVASRLKGKP---ILDWS 397 (622)
Q Consensus 371 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~---~l~~~ 397 (622)
..++||||+++|+|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2789999999999999997643 34566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-----------ceeeeecCccc
Q 036225 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-----------HVTTAVRGTVG 466 (622)
Q Consensus 398 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 466 (622)
.+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999999 999999999999999999999999999988754321 11233469999
Q ss_pred ccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHH
Q 036225 467 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEM 546 (622)
Q Consensus 467 y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 546 (622)
|+|||++.+..++.++|||||||++|||+||..|+.... ........ ... ..........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~---------~~~-~~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRN---------LKF-PLLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHT---------TCC-CHHHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhc---------cCC-CcccccCChhH
Confidence 999999999999999999999999999999987653211 00111100 000 00112233567
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 036225 547 VQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 547 ~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+++.+||+.||++|||++|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=371.84 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=205.3
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
+++..++|...+.||+|+||.||+|.++++..||||+++.... ....|.+|++++++++||||+++++++.. +..++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3345677888999999999999999998888999999986542 34578999999999999999999999876 67899
Q ss_pred EeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999974 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........++..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+...
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~-------- 397 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERG-------- 397 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT--------
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC--------
Confidence 33333334457889999999999999999999999999999999 89998643221 111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 398 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 398 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111222345678999999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.02 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=202.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|...+.||+|+||+||+|.+. +++ .||+|.+...........+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 356788899999999999999964 444 388888765544444456788999999999999999999986 46688
Q ss_pred EEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999998754 5789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... ......||..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+. ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~---~~~------ 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLE---KGE------ 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHHH---TTC------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHHH---cCC------
Confidence 3322 2344568889999999999999999999999999999999 99999753321 1111111 110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
....+...+..+.+++.+||+.||.+||++.|+++.|+..
T Consensus 235 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 235 ----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111112234578999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.41 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=207.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
..++|.+.+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999975 6899999999765432 2344688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcccccceecCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC---CEAVVGDFGLAKLLDH 452 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~ 452 (622)
|||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999998888899999999999999999999999 99999999999999864 4599999999987653
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.... .
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~-----~-- 247 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGA-----Y-- 247 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-----C--
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCC-----C--
Confidence 32 223457999999999999989999999999999999999999999753321 1111111110 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..........+.++.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000011223678899999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=343.66 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=195.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC---chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|...+.||+|+||.||+|.+. ++.||||+++..... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999986 889999998754322 2235688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--------CCceEEcccccc
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--------CCEAVVGDFGLA 447 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~Dfgla 447 (622)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++...+|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999864 46899999999999999999999982222999999999999986 778999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
....... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .....
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~------- 226 (271)
T 3dtc_A 164 REWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGV------- 226 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHHH-------
T ss_pred ccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHhh-------
Confidence 8654322 224569999999999999999999999999999999999999997433211 01111
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.........+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 --AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111111223334679999999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.02 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=210.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+..++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578899999999999999999863 46789999998665444556789999999999 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCCC----------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGKP----------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 9999999999999999999987543 389999999999999999999999 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
+++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 99999999999999998775433222 223457889999999988889999999999999999999 99998643211
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.....+.... ....+...+..+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 267 -----~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 -----ELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -----HHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 0111222346789999999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=362.76 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=201.1
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
...++|+..+.||+|+||+||+|... +|+.||||+++... .......+..|.+++..+ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999987532 122334577899999987 699999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999998777899999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+...
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~--------- 239 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILND--------- 239 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC---------
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC---------
Confidence 2 223445679999999999998889999999999999999999999997543211 11111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKM------SEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~ 569 (622)
.. .++......+.+++.+|++.||.+||++ .|+++
T Consensus 240 ~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 EV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 1122233668899999999999999998 66664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=357.54 Aligned_cols=271 Identities=25% Similarity=0.324 Sum_probs=211.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee--CCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM--TPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~ 371 (622)
.++|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+|++++++++||||+++++++. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788899999999999999984 368999999987643 233456899999999999999999999886 4566
Q ss_pred eeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 8899999999999999875 34689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 451 DHQDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 451 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
....... .....||..|+|||++.+..++.++||||||+++|+|+||+.||.......... ..+............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLE 255 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHH
Confidence 5443322 223457888999999999899999999999999999999999987433211000 000000000011111
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDG 575 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 575 (622)
.+........+...+..+.+++.+|++.||.+|||+.|+++.|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222222223334577999999999999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.00 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=206.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC--Cc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~ 371 (622)
.+.|...+.||+|+||.||+|.+ .+++.||+|+++..........+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34578889999999999999984 368999999998665555556789999999999999999999999876 66
Q ss_pred eeEEeeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 899999999999999994 445699999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhc--------cccccHHHHHHHH
Q 036225 451 DHQDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAA--------NQKGAMLDWVKKI 520 (622)
Q Consensus 451 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~ 520 (622)
...... ......||..|+|||++.+..++.++||||||+++|||+||..|+...... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT- 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-
Confidence 654332 223455888899999999999999999999999999999999986532210 000000111111
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+........+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 256 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 ---------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111111223344679999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.23 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=208.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
.++|...+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467888999999999999999998899999999986543 235789999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999998743 5689999999999999999999999 99999999999999999999999999998654322222
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....++..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~----------~~~ 224 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG----------FRL 224 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT----------CCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcC----------CcC
Confidence 223457789999999998899999999999999999999 89888643211 111111111 001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1112234678999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.22 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=202.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhcc-ccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 373 (622)
..++|...++||+|+||+||+|..+ +++.||+|+++..... .....+..|..++.++ +||||+++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467889999999999999999975 5889999999754322 2233578899999877 8999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999998777899999999999999999999999 9999999999999999999999999999853322
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccc-ccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK-GAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ......+.... ...
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~ 277 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEK 277 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------HHC
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------hcc
Confidence 22344567999999999999999999999999999999999999999643221111 00111111111 111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.. .++.....++.+++.+||+.||.+||++
T Consensus 278 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QI--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 1222234678899999999999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=368.61 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=204.9
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC-ceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT-ERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv 375 (622)
+..++|...+.||+|+||.||+|.+. |+.||||+++... ....|.+|++++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567888999999999999999986 7899999998643 3457899999999999999999999987665 78999
Q ss_pred eeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 376 YPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999999743 3479999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ... .+...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~---~i~~~--------- 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP---RVEKG--------- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHH---HHHTT---------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHHcC---------
Confidence 122357889999999999999999999999999999998 999987433211 111 11111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111223345789999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=351.50 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=205.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||+||+|... +|+.||+|+++... .......+.+|..+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999975 68999999987532 122344678899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999999998777899999999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~---------~~~- 220 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILN---------AEL- 220 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHH---------CCC-
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh---------CCC-
Confidence 23457999999999999999999999999999999999999999753321 11111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
.++.....++.+++.+|++.||.+|| +++|++++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11122236788999999999999999 88888753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.77 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=214.3
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++...++|...+.||+|+||+||+|.+. ++..||+|.++... .....+.+|++++++++||||+++++++...+..+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3345678889999999999999999976 48899999987543 34557889999999999999999999999999999
Q ss_pred EEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 374 LVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999864 44589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... .+...+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~------------ 226 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLE------------ 226 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHH------------
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHh------------
Confidence 554444445567889999999999999999999999999999999 88888643321 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.......+...+..+.+++.+|++.||.+|||++|+++.|+..
T Consensus 227 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 227 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111112222346789999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=359.37 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=205.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999975 58899999986432 122345688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 99999999999999888899999999999999999999999 9999999999999999999999999999876533
Q ss_pred ceeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 456 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .......+...
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~--------- 235 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETT--------- 235 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHC---------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhc---------
Confidence 22345679999999999864 458999999999999999999999997443221 11111111100
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPK-MSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 569 (622)
...++...+..+.+++.+||+.||.+||+ ++++++
T Consensus 236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01112223467899999999999999998 666654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.17 Aligned_cols=257 Identities=19% Similarity=0.192 Sum_probs=206.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788899999999999999996 5799999999875432 23578999999999 9999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-----eEEcccccceec
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE-----AVVGDFGLAKLL 450 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~~~ 450 (622)
||+ +++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 9999999874 46799999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 451 DHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 451 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~ 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT----LKERYQKIGDTK 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS----HHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc----HHHHHHHHHhhh
Confidence 543321 1235679999999999999999999999999999999999999997543221 221111111111
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ...+.. ..+ ++.+++.+|++.+|.+||+++++++.|+.
T Consensus 237 ~~~~--~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 237 RATP--IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHSC--HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccCC--HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0000 000000 112 78999999999999999999999998873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=353.94 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=214.5
Q ss_pred cCHHHHHHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceee
Q 036225 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRL 362 (622)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l 362 (622)
+...++....++|.+.+.||+|+||+||+|.+ .+++.||||+++..........+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556667788999999999999999999984 356899999998765444556789999999999 79999999
Q ss_pred eeeeeCCC-ceeEEeeeccCCCccccccCCCC----------------CChhHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 036225 363 YGFCMTPT-ERLLVYPYMSNGSVASRLKGKPI----------------LDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425 (622)
Q Consensus 363 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 425 (622)
++++...+ ..++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988755 48999999999999999975443 88999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCcccc
Q 036225 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEY 503 (622)
Q Consensus 426 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~ 503 (622)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543332 2334567899999999999999999999999999999998 9999864
Q ss_pred chhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 504 GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..... .+ ...+.... ... .+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 254 ~~~~~---~~---~~~~~~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDE---EF---CRRLKEGT------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCCSH---HH---HHHHHHTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhH---HH---HHHhccCc------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 33211 11 11111110 011 111233678999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=355.91 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=215.3
Q ss_pred cCHHHHHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeee
Q 036225 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363 (622)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 363 (622)
+...++++..++|.+.+.||+|+||.||+|.+. +++.||+|.++..........+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455667788999999999999999999864 37889999998665545556789999999999999999999
Q ss_pred eeeeCCCceeEEeeeccCCCccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 036225 364 GFCMTPTERLLVYPYMSNGSVASRLKG----------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 433 (622)
Q Consensus 364 ~~~~~~~~~~lv~e~~~~gsL~~~l~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl 433 (622)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 999999999999999999999998863 14578999999999999999999999 99999999999999
Q ss_pred cCCCceEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccc
Q 036225 434 DDCCEAVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKG 511 (622)
Q Consensus 434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~ 511 (622)
+.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||+| |..||......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---- 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence 999999999999998654322211 122346889999999999999999999999999999999 88888643211
Q ss_pred cHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 512 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
.....+.... . ...+...+..+.+++.+|++.||.+|||+.|+++.|+....
T Consensus 248 ---~~~~~~~~~~---------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 ---QVLRFVMEGG---------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---HHHHHHHTTC---------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHHHHHcCC---------c-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111111 0 01112234678999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.15 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=210.6
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
+.+++...++|...+.||+|+||+||+|... +++.||+|+++... .......+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455666789999999999999999999976 58999999986421 11223357899999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
.+..++||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999998754 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCC----CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||....... ....+....
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~ 289 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHK 289 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHHHHHhcc
Confidence 77654433344667999999999997655 7899999999999999999999997543221 111111111
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAH--RPKMSEVVRML 571 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 571 (622)
... .+.. ......++.+++.+|++.+|.+ ||+++|++++-
T Consensus 290 ~~~-----~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 290 NSL-----TFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHC-----CCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccc-----cCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 000 0000 0012367889999999999988 99999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=341.97 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCC--CceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTP--TERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 375 (622)
.++|...+.||+|+||+||+|.++ ++.||||+++..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999986 889999999865432 3345689999999999999999999999887 788999
Q ss_pred eeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999997654 589999999999999999999998 7 9999999999999999999999999876432
Q ss_pred CCCCceeeeecCcccccCccccccCCCCc---ccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
. ....||+.|+|||.+.+..++. ++||||||+++|||+||+.||....... ......
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~------- 224 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-------IGMKVA------- 224 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-------HHHHHH-------
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-------HHHHHH-------
Confidence 2 2235899999999998765544 7999999999999999999997433211 111111
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
........+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 225 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 225 --LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp --HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111111222334678999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.80 Aligned_cols=252 Identities=31% Similarity=0.536 Sum_probs=202.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchh------HHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.++|...+.||+|+||+||+|... +++.||+|++......... ..+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999974 7899999998754432221 46889999999999999999999987655
Q ss_pred eeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCc-----eEEcc
Q 036225 372 RLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDDCCE-----AVVGD 443 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NILl~~~~~-----~kl~D 443 (622)
++||||+++|+|.+.+.. ...+++..+..++.|++.||+|||++ + |+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999887754 45799999999999999999999998 7 999999999999988776 99999
Q ss_pred cccceecCCCCCceeeeecCcccccCcccc--ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... ........
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHHh
Confidence 999974432 23446699999999998 34567899999999999999999999996432211 11111111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. .......+...+..+.+++.+||+.||.+|||++|+++.|+.
T Consensus 244 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 E---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred c---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 111112223344679999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=346.13 Aligned_cols=256 Identities=22% Similarity=0.383 Sum_probs=204.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..++|...+.||+|+||+||+|.+.+ +..||+|.++..........+.+|++++++++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678889999999999999998642 346999999876545556679999999999999999999999865 4568
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999864 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........+|..|+|||++.+..++.++||||||+++|||+| |+.||......+ ....+.. ...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~~~~---~~~------ 232 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEK---GDR------ 232 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHHHHH---TCC------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHHHhc---CCC------
Confidence 43333344557889999999998899999999999999999998 999997433221 1111111 100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...+...+..+.+++.+|++.||++||++.|+++.|+..
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 011112346789999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.37 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=205.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCc
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 371 (622)
....++|...+.||+|+||.||+|..+ +|+.||+|+++.... ......+..|.+++..+ +||||+++++++...+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999975 689999999975321 22334577899998877 89999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999998777799999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~-------~ 234 (345)
T 1xjd_A 170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD-------N 234 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------C
T ss_pred cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC-------C
Confidence 222 2234567999999999999999999999999999999999999999753321 111111111 1
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMS-EVVR 569 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 569 (622)
.. ++.....++.+++.+|++.||.+||++. |+++
T Consensus 235 ~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 1122336788999999999999999997 6653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=352.94 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=183.4
Q ss_pred CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeeeccCC
Q 036225 305 KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++......++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 6899999998643 3446788999999997 999999999999999999999999999
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEcccccceecCCCCCceee
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC---EAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 9999998888899999999999999999999999 999999999999998665 899999999987654322 233
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 539 (622)
...||+.|+|||++.+..++.++|||||||++|||+||+.||..................+..... .......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------SFEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------CCCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------CCCcccc
Confidence 456899999999999999999999999999999999999999765433222233333333221110 0000000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 540 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+.++.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 123467899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.57 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=209.6
Q ss_pred CHHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeee
Q 036225 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
.+.+.+...++|+..+.||+|+||+||+|... +|+.||+|++++... ......+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556667789999999999999999999975 699999999864321 112235889999999999999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999753 4799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccc-------cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK 519 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 519 (622)
++..............||+.|+|||++. +..++.++|||||||++|||+||+.||........ ...
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~ 281 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-------YGK 281 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-------HHH
Confidence 9877654443344567999999999987 35689999999999999999999999975432211 111
Q ss_pred HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 036225 520 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR---PKMSEVVRM 570 (622)
Q Consensus 520 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~~ 570 (622)
+..... ....+.. ....+.++.+++.+|+. +|.+| |+++|++++
T Consensus 282 i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111100 0000111 11123678999999999 99998 588888753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=354.56 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|...+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999964 444 468888876655556678999999999999999999999998764 78
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+|+||+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999999864 45699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....... +...+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~------------ 233 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE------------ 233 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH------------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH------------
Confidence 3222 2233456889999999999999999999999999999999 999987533211 111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.......+...+..+.+++.+||+.||.+||++.|+++.|+..
T Consensus 234 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 234 -KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111112222346789999999999999999999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.67 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=203.1
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999997 578999999986432 1122346889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+ +|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 789999887777899999999999999999999999 99999999999999999999999999998654322
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.......... .+... .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~~--~ 224 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNSC--V 224 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCSS--C
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHcC--C
Confidence 2234569999999999988776 789999999999999999999997543221110 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+...+..+.+++.+|++.||.+|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11122234678899999999999999999999763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.43 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=206.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++......++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 357889999999999999999975 689999999875432 234468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999987543 689999999999999999999999 999999999999997 45789999999998775432
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.... ...+.
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~---~~~~~-- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCD---WEFDE-- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCC---CCCCS--
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC---CCCCc--
Confidence 234457999999999999999999999999999999999999999754321 1111111110 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111233678999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.08 Aligned_cols=258 Identities=18% Similarity=0.207 Sum_probs=207.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|++++..+ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45788999999999999999996 5799999999865432 23578899999998 7999999999999999999999
Q ss_pred eeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-----eEEcccccceec
Q 036225 377 PYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE-----AVVGDFGLAKLL 450 (622)
Q Consensus 377 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~~~ 450 (622)
||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999753 4599999999999999999999998 9999999999999987776 999999999877
Q ss_pred CCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 451 DHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 451 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||...........+.. +.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-HHhhccCc
Confidence 543321 23445699999999999999999999999999999999999999975432222111111 11111011
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..... .. ..+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 241 ~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 241 PLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 11111 11 123678999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=356.30 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=199.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhcccc--ccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVH--RNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||++...+++.||||+++..... .....+.+|++++.+++| +||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998755432 233568899999999976 9999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|| +.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99 56889999998888899999999999999999999999 999999999999997 57899999999987654322
Q ss_pred c-eeeeecCcccccCcccccc-----------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 456 H-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 456 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ....
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~------- 229 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISK------- 229 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHH-------
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHH-------
Confidence 2 2335579999999999865 6789999999999999999999999963211 1111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....+++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111222222222233334678899999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.70 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=196.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||++... +++.||||++...... ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999976 7899999999764432 3468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--eEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--AVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~~~~~~~ 455 (622)
|+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999999999998777799999999999999999999999 9999999999999987765 999999999743322
Q ss_pred ceeeeecCcccccCccccccCCCCcc-cceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ....+..+.... ..+
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~-------~~~ 241 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVK-------YSI 241 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTC-------CCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCC-------CCC
Confidence 22334569999999999988887655 8999999999999999999975443222 222222211110 000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 01123678899999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=355.34 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=192.5
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEECC-C---eEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQD-G---TVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
.+..++|.+.+.||+|+||+||+|.+.. + ..||||+++... .......+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999653 3 279999997653 2334557899999999999999999999998776
Q ss_pred ce------eEEeeeccCCCccccccCC------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 371 ER------LLVYPYMSNGSVASRLKGK------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 371 ~~------~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
.. ++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 65 9999999999999988522 2589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... +..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~- 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYN- 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH-
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHH-
Confidence 999999999876443222 2233457889999999999999999999999999999999 898887533221 111
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+.... ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 251 --~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 251 --YLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp --HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111110 011122234678999999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=354.98 Aligned_cols=246 Identities=21% Similarity=0.247 Sum_probs=205.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|...+.||+|+||.||+|... +|+.||+|+++... .......+.+|+++++.++||||+++++++......++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 68999999986432 1223446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999998767799999999999999999999999 9999999999999999999999999999876432
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~-------~~--- 256 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGK-------VR--- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------CC---
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCC-------CC---
Confidence 23456999999999999999999999999999999999999999753321 1111111110 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 570 (622)
++...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 257 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11223367899999999999999998 7777653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.91 Aligned_cols=247 Identities=23% Similarity=0.238 Sum_probs=194.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 374 (622)
..++|+..+.||+|+||+||+|... +|+.||||++...... .....+..|+..+.++ +||||+++++++...+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999976 7999999998654322 2233455666655555 89999999999999999999
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+ +++|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999 6688887764 44699999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ..+.... ..+.
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~-----~~~~ 272 (311)
T 3p1a_A 211 G--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGY-----LPPE 272 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTC-----CCHH
T ss_pred C--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccC-----CCcc
Confidence 2 2344569999999999875 7899999999999999999998776533211 0111000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+.++.+++.+|++.||++|||++|+++.
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 011123678999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=339.80 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=208.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999975 6899999999765544555678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-c
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-H 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 456 (622)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999999887899999999999999999999999 999999999999999999999999999986643221 1
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||..|+|||.+.+..+ +.++||||||+++|||+||+.||........ ....|.. .... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----~~~~---~----- 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKE----KKTY---L----- 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHT----TCTT---S-----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhh----cccc---c-----
Confidence 2234568999999999987665 7899999999999999999999975432111 1111111 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+..+.+++.+|++.||.+|||++|+++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011123568899999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.22 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=191.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||+||+|... +++.||||+++... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888999999999999999976 58899999997543 23467889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999999999998888899999999999999999999999 9999999999999975 899999999999865432
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .....+..... ..
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-------~~ 270 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-------YF 270 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-------CC
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-------cc
Confidence 22334569999999999999899999999999999999999999996433211 01111111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........+..+.+++.+|++.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111233678899999999999999999999873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.78 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=201.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
++|...+.||+|+||.||+|... +++.||+|+++...... ....+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 68999999997653222 234578899999887 899999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 99999999999998777899999999999999999999999 99999999999999999999999999998543222
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccc-cHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG-AMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .....+.... .....
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--------~~~~~ 236 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQI 236 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--------HHCCC
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--------HcCCC
Confidence 22345679999999999999999999999999999999999999996432211100 0011111110 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.++...+..+.+++.+||+.||.+||++
T Consensus 237 --~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122234678899999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.59 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=196.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEE----CCCeEEEEEEccCCCC---CchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.++|.+.+.||+|+||.||++.. .+|+.||+|+++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999997 4789999999976532 2233457889999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999998777799999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~-------~ 237 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKC-------K 237 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHT-------C
T ss_pred cCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhC-------C
Confidence 222 2233456999999999999989999999999999999999999999754321 111111111 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
.. .+......+.+++.+||+.||.+|| ++.|++++
T Consensus 238 ~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 LN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01 1122236789999999999999999 66777663
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=346.54 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=204.7
Q ss_pred HHhCCCcCC-eeeecCCceEEEEEEC---CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 298 ATHNFSSKN-ILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 298 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
..++|.+.+ .||+|+||+||+|.+. +++.||||+++...... ....+.+|+++++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 9999999999999642 47889999997654322 345789999999999999999999999 56678
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999998777899999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCcee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 453 QDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 453 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
...... ....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~----- 237 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE----- 237 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-----
Confidence 443322 22346789999999988889999999999999999999 99998753321 1111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111222334679999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.06 Aligned_cols=267 Identities=19% Similarity=0.232 Sum_probs=211.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC--ceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--ERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 375 (622)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++..........+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999976 589999999986554444567889999999999999999999998765 67999
Q ss_pred eeeccCCCccccccCCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEcccccce
Q 036225 376 YPYMSNGSVASRLKGKP---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVVGDFGLAK 448 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~ 448 (622)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997543 389999999999999999999999 99999999999999 788889999999998
Q ss_pred ecCCCCCceeeeecCcccccCcccccc--------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........... .+..+
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~---~~~~~ 239 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE---VMYKI 239 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH---HHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH---HHHHH
Confidence 765322 2234569999999999865 5678899999999999999999999975433222211 11121
Q ss_pred hhhhhh---hhh---------cccc--CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 521 HQEKKL---EML---------VDKD--LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 521 ~~~~~~---~~~---------~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...... ..+ .... ............+.+++.+||+.||++||+++|+++.++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111110 000 0001 1123446777889999999999999999999999988764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.80 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=202.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC----CCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.+.|.+.+.||+|+||+||+|... +|+.||||+++... .......+.+|+++++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457889999999999999999975 68999999985321 1123457899999999999999999999999999999
Q ss_pred EEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEccccc
Q 036225 374 LVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFGL 446 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgl 446 (622)
+||||+++|+|.+.+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999887742 34589999999999999999999999 9999999999999986655 99999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .....+.....
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~- 249 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKY- 249 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCC-
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCC-
Confidence 987754322 23345699999999999999999999999999999999999999975321 11111111100
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+.... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 250 --~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 --KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 12367889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=343.96 Aligned_cols=260 Identities=18% Similarity=0.184 Sum_probs=200.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +++.||+|+++...... ....+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467889999999999999999975 68999999997543322 235688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999998777799999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......|++.|+|||++.+..++.++||||||+++|||+||+.||...... .+ ...+.......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~~~~~~-------- 254 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQAIPRP-------- 254 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHSCCCCG--------
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhccCCCCc--------
Confidence 3334556999999999999999999999999999999999999999754321 01 01111000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCh
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRP-KMSEVVRMLEGDGL 576 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~ 576 (622)
.......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 001112235688999999999999999 99999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.10 Aligned_cols=267 Identities=19% Similarity=0.231 Sum_probs=202.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|...+.||+|+||+||+|... +|+.||+|++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999975 58999999986654322 23467899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 999999999988777899999999999999999999999 999999999999999999999999999987653322 2
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH--------HHhhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK--------KIHQEKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 528 (622)
.....||..|+|||++.+ ..++.++||||||+++|||+||+.||......+....+..... ..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 334568999999999876 5689999999999999999999999975543322111111110 0000000000
Q ss_pred hccccCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+....... ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 1123568899999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.21 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=206.2
Q ss_pred hCCCcCC-eeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKN-ILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
++|.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 57889999998765444556789999999999999999999999 45668999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999864 45699999999999999999999999 99999999999999999999999999998775443
Q ss_pred Ccee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 455 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 455 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... ....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... +....+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~------- 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGK------- 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTC-------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCC-------
Confidence 3222 22346889999999988889999999999999999999 99998643321 1111111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111222334679999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=377.18 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=201.7
Q ss_pred CCCcCC-eeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 301 NFSSKN-ILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 301 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999864 4678999999876555566789999999999999999999999976 5689999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999864 44699999999999999999999999 999999999999999999999999999987643332
Q ss_pred cee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 456 HVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 456 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||......+ + ...+....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~---~~~i~~~~-------- 556 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----V---MAFIEQGK-------- 556 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----H---HHHHHTTC--------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----H---HHHHHcCC--------
Confidence 222 22335689999999999999999999999999999998 999997543211 1 11111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+..++.++.+++.+||+.+|++||++.++++.|+.
T Consensus 557 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 557 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111223345789999999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.93 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=201.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.++|...+.||+|+||+||+|.... +..||||.++..........+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3456778999999999999998642 34699999986654445557899999999999999999999999999999
Q ss_pred EEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999864 35799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 453 QDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 453 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.... ......+|..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~----- 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGF----- 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTC-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCC-----
Confidence 3221 1222346789999999998999999999999999999999 99998643221 1111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111122234678999999999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.76 Aligned_cols=265 Identities=17% Similarity=0.191 Sum_probs=203.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCch----------hHHHHHHHHHHhcccccccee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~H~niv~ 361 (622)
..++|.+.+.||+|+||+||+|.+.+ ++.||||++........ ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578899999999999999999764 47899999875432100 012334555677788999999
Q ss_pred eeeeeeCC----CceeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--
Q 036225 362 LYGFCMTP----TERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-- 434 (622)
Q Consensus 362 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-- 434 (622)
+++++... ...++||||+ +++|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 99998764 4579999999 99999998754 5799999999999999999999999 999999999999999
Q ss_pred CCCceEEcccccceecCCCCCce------eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 435 DCCEAVVGDFGLAKLLDHQDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 435 ~~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998765322111 133459999999999999999999999999999999999999998532211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+... .....+..++++.+.. ...+.++.+++..|++.+|.+||++.++++.|+.
T Consensus 269 ---~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 269 ---KYVRDSKI-RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ---HHHHHHHH-HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ---HHHHHHHH-HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11111111 1122333344433321 1123678999999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.06 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=199.5
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccc--cccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV--HRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45889999999999999999988899999999875433 223457899999999996 599999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
| +.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56889999998777899999999999999999999999 999999999999996 589999999999876533222
Q ss_pred -eeeeecCcccccCcccccc-----------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 457 -VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~------ 278 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLH------ 278 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHH------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHH------
Confidence 2344579999999999865 3688999999999999999999999964221 111111
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.++++.....++......+.+++.+||+.||.+||++.|+++.
T Consensus 279 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1122222212222224678899999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=342.12 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=195.2
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|.+.+.||+|+||+||+|.+. ++.||||.+... .....+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56788899999999999999986 788999998643 345578999999999999999999999874 579999999
Q ss_pred cCCCccccccCCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-eEEcccccceecCCCCC
Q 036225 380 SNGSVASRLKGKP---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE-AVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 380 ~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~Dfgla~~~~~~~~ 455 (622)
++|+|.+++.... .+++..+..++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999997654 4788999999999999999999932239999999999999998886 799999999755322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||...... ............ .+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~------~~~~- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNGT------RPPL- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTTC------CCCC-
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcCC------CCCc-
Confidence 22345899999999999999999999999999999999999999643211 111111111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+..+.+++.+|++.||.+|||++|+++.|+.
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11223678899999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.27 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=207.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-----hhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|.+.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|++++.+++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 466889999999999999999975 68999999997543222 245689999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~ 448 (622)
++||||+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998888899999999999999999999999 999999999999999887 79999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... .....+.... .
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~---~ 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITSVS---Y 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTC---C
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcc---c
Confidence 765432 223456999999999999999999999999999999999999999743321 1111111100 0
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..++.... ..+..+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000001 123568899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.98 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=204.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCce
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 372 (622)
...++|...+.||+|+||.||+|... +|+.||+|+++... .......+..|.+++..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999976 48899999987532 122344678899999887 799999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999998767799999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~--------- 236 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEH--------- 236 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC---------
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhC---------
Confidence 2 22334567999999999999999999999999999999999999999753321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKM-----SEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 569 (622)
.. .++...+.++.+++.+||+.||.+||++ +|+++
T Consensus 237 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 1122234678999999999999999964 55554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.83 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=197.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|...+.||+|+||.||+|... +|+.||||+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999965 68999999987532 222334577899999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999999999877789999999999999999999998 7 9999999999999999999999999999754322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+... ...
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~-------~~~- 367 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME-------EIR- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------CCC-
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHHhC-------CCC-
Confidence 22234567999999999999999999999999999999999999999754321 111111110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
++...+.++.+++.+||+.||.+|| +++|++++
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1222336789999999999999999 99998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=342.29 Aligned_cols=254 Identities=28% Similarity=0.378 Sum_probs=203.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-C---CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce-eEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-D---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER-LLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv 375 (622)
.|...+.||+|+||+||+|.+. + +..||+|.++..........+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455689999999999999853 2 3379999998655545556789999999999999999999999876665 999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999975 45689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ---CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 455 ---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 455 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
........+|..|+|||.+.+..++.++||||||+++|||+||+.|+........ +...+.. .
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~---~-------- 244 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQ---G-------- 244 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHT---T--------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhc---C--------
Confidence 1122334578999999999999999999999999999999997766553322111 1111111 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+|++.||.+|||++++++.|+.
T Consensus 245 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 245 --RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0111122234678999999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.48 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=205.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc-------hhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
..++|...+.||+|+||+||+|.. .+++.||||+++...... ....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999996 468999999997653211 223577899999999999999999999999
Q ss_pred CceeEEeeeccCC-CccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 370 TERLLVYPYMSNG-SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 370 ~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+..++||||+.+| +|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 9999998888899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------- 236 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------- 236 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence 7754332 334569999999999988776 88999999999999999999999642210
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...... .+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 237 --~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123678999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=375.40 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=211.5
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
..+++..++|.+.+.||+|+||+||+|.+.++..||||+++.... ....|.+|++++++++||||+++++++.. +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 334556678889999999999999999998888999999986542 34578999999999999999999999876 678
Q ss_pred eEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 373 LLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
++||||+++|+|.++++. ...+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999999974 24689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
............++..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+...
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~------ 480 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERG------ 480 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTT------
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC------
Confidence 4321111223446789999999999999999999999999999999 89998643211 111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.+...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 481 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 481 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112223446789999999999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.18 Aligned_cols=263 Identities=24% Similarity=0.272 Sum_probs=202.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHH-HhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.++|...+.||+|+||.||+|..+ +++.||+|+++..... .....+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999976 5889999999764322 223346667766 577899999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 999999999999998777899999999999999999999999 9999999999999999999999999999854322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~-------~~~ 258 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKP-------LQL 258 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHHSC-------CCC
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcc-------cCC
Confidence 22334567999999999999999999999999999999999999999754321 1111111110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCChh--hHHHHh
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLA--ERWEAS 583 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~--~~~~~~ 583 (622)
... ....+.+++.+||+.||.+||++.+.++.+....+- ..|...
T Consensus 259 ~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 259 KPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp CSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred CCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 112 235688999999999999999997655555444332 235543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.77 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=193.2
Q ss_pred CCCcCCeeeecCCceEEEEEEC--CC--eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC-CCceeEE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ--DG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PTERLLV 375 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv 375 (622)
.|...+.||+|+||+||+|.+. ++ ..||||.++..........+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999863 22 46899998765555556679999999999999999999998754 5678999
Q ss_pred eeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999754 4588999999999999999999999 99999999999999999999999999998664322
Q ss_pred Cc---eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 455 SH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 455 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...... .+...+ .....
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~~~---~~~~~----- 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYL---LQGRR----- 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHHHH---HTTCC-----
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHHHH---HcCCC-----
Confidence 11 1233457889999999999999999999999999999999 56666533211 111111 11110
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus 315 -----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01112234678999999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=347.25 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=205.6
Q ss_pred CHHHHHHHHhCCCcC-CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhcc-ccccceeeeeee
Q 036225 291 QFRELQVATHNFSSK-NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLYGFC 366 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 366 (622)
.+...+...+.|.+. +.||+|+||.||+|... +++.||+|+++..... .....+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445566677776 89999999999999976 6899999998754322 2345788999999988 469999999999
Q ss_pred eCCCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEE
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVV 441 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl 441 (622)
...+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999864 36799999999999999999999999 9999999999999987 789999
Q ss_pred cccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||........ ...+.
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~ 246 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-------YLNIS 246 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------HHHHH
Confidence 9999998765322 22345699999999999999999999999999999999999999975432111 11111
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ............+..+.+++.+|++.||.+|||++|+++.
T Consensus 247 ~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 0011111112234678899999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=339.61 Aligned_cols=253 Identities=20% Similarity=0.294 Sum_probs=206.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 6899999998754422 23456889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEcccccceecCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFGLAKLLDHQ 453 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~ 453 (622)
||+++++|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888777899999999999999999999999 9999999999999986655 999999999876533
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.... ..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~-----~~-- 225 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGA-----YD-- 225 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-----CC--
T ss_pred c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcc-----cc--
Confidence 2 223456999999999999999999999999999999999999999653321 1111111110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.........+..+.+++.+|++.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000011223678899999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.29 Aligned_cols=266 Identities=19% Similarity=0.203 Sum_probs=199.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCc----------hhHHHHHHHHHHhccccccceeeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLRLYG 364 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~ 364 (622)
.++|.+.+.||+|+||+||+|... ++..||||++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888999999999999999975 57889999987543211 1123567888889999999999999
Q ss_pred eeeC----CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--c
Q 036225 365 FCMT----PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC--E 438 (622)
Q Consensus 365 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~--~ 438 (622)
++.. ....++||||+ +++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 9887 77889999999 999999998777899999999999999999999999 999999999999999877 9
Q ss_pred eEEcccccceecCCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccccc
Q 036225 439 AVVGDFGLAKLLDHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGA 512 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~ 512 (622)
+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||+||+.||........ .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence 999999999876432211 11345699999999999999999999999999999999999999964221111 1
Q ss_pred HHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 036225 513 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDG 575 (622)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 575 (622)
......... . ........... ....+.++.+++.+||+.||++||++.++++.|+...
T Consensus 270 ~~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLL-D-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH-H-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhc-c-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111110 0 01111100000 0012357899999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.31 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=206.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEE----CCCeEEEEEEccCCCC---CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPT 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 370 (622)
.++|.+.+.||+|+||+||+|.. .+++.||||+++.... ......+.+|++++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999997 3689999999875321 12234567899999999 6999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999998777899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...........
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~----- 281 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS----- 281 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC-----
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc-----
Confidence 5433333445679999999999975 3478999999999999999999999975432222 12222211110
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRMLE 572 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L~ 572 (622)
.+. ++......+.+++.+||+.||.+|| +++|+++..-
T Consensus 282 --~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 --EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred --CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111 1222336688999999999999999 8999887653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.54 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=202.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||+||+|... +++.||+|++..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999965 578999999864321 12244688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 99999999999998777799999999999999999999998 9999999999999999999999999998654322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+... ...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-------~~~-- 225 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRV-------EFT-- 225 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT-------CCC--
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhC-------CCC--
Confidence 234456899999999999999999999999999999999999999743321 111111110 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+...+..+.+++.+|++.||.+|||+.|+++.
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 122233678899999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=340.68 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=195.3
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+...+|.+.+.||+|+||+||+|...+ .||+|+++..... .....+.+|++++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 346779999999999999999998653 5999999765432 2345689999999999999999999965 45668999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999863 45699999999999999999999999 99999999999999999999999999997654322
Q ss_pred -CceeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 455 -SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 455 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
........||+.|+|||++. +..++.++||||||+++|||+||+.||......+ .+...+.. . ..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~---~-~~---- 243 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGR---G-SL---- 243 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHH---T-SC----
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhcc---c-cc----
Confidence 22233456999999999986 5678889999999999999999999997533211 11111111 1 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.+.+ .......+..+.+++.+|++.+|.+||+++|+++.|+..
T Consensus 244 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 244 SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 111223346799999999999999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=342.41 Aligned_cols=255 Identities=30% Similarity=0.419 Sum_probs=200.4
Q ss_pred hCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee-CCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM-TPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~l 374 (622)
.+|...+.||+|+||+||+|...+ +..||+|.++..........+.+|++++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998642 34689999887555555567899999999999999999999864 5567899
Q ss_pred EeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999965 45689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC---ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 454 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 454 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.. .......+|+.|+|||.+.+..++.++||||||+++|||+||+.|+....... .... ......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~---~~~~~~------ 249 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV---YLLQGR------ 249 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHH---HHHTTC------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHH---HHhcCC------
Confidence 21 12234457889999999999999999999999999999999555443222111 1111 111000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 250 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 250 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001111223678999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.67 Aligned_cols=260 Identities=23% Similarity=0.259 Sum_probs=201.7
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC----CCchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
++....++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556788999999999999999999974 68899999986432 23345578999999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccC----------------------------------------CCCCChhHHHHHHHHHHH
Q 036225 369 PTERLLVYPYMSNGSVASRLKG----------------------------------------KPILDWSTRKRIALGAAR 408 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~ia~ 408 (622)
.+..++||||+++|+|.+++.. ...+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999988841 112356778889999999
Q ss_pred HHHHHHhcCCCCeeecCCCCCCeeecCCC--ceEEcccccceecCCCCC---ceeeeecCcccccCcccccc--CCCCcc
Q 036225 409 GLLYLHEQCDPKIIHRDVKAANILLDDCC--EAVVGDFGLAKLLDHQDS---HVTTAVRGTVGHIAPEYLST--GQSSEK 481 (622)
Q Consensus 409 ~L~~LH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 481 (622)
||+|||++ +|+||||||+|||++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 899999999987643221 12345569999999999865 678999
Q ss_pred cceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 036225 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR 561 (622)
Q Consensus 482 sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 561 (622)
+|||||||++|||+||+.||......+. ...+..... .............+.+++.+|++.+|.+|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH-------HHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999975432211 111111100 00000011123678999999999999999
Q ss_pred CCHHHHHHH
Q 036225 562 PKMSEVVRM 570 (622)
Q Consensus 562 Pt~~evl~~ 570 (622)
|++.|+++.
T Consensus 323 ps~~~~l~h 331 (345)
T 3hko_A 323 FDAMRALQH 331 (345)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.93 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=202.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeE--EEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
++|...+.||+|+||.||+|... ++.. ||+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999964 5664 4999987655445556789999999999 899999999999999999999
Q ss_pred eeeccCCCccccccCCC----------------CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 376 YPYMSNGSVASRLKGKP----------------ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987543 689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHH
Q 036225 440 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 518 (622)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||...... ....
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHH
Confidence 99999999743211 11223347889999999988889999999999999999998 99998643311 1111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+... .....+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 253 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111 1111122234678999999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.88 Aligned_cols=268 Identities=26% Similarity=0.320 Sum_probs=199.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC----CchhHHHHHHHHHHhccc---cccceeeeeeeeC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAV---HRNLLRLYGFCMT 368 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~ 368 (622)
...++|++.+.||+|+||+||+|.. .+++.||||+++.... ......+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467899999999999999999996 4689999999864321 112335677888777665 9999999999987
Q ss_pred CC-----ceeEEeeeccCCCccccccCCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 036225 369 PT-----ERLLVYPYMSNGSVASRLKGKPI--LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV 441 (622)
Q Consensus 369 ~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 441 (622)
.. ..++||||+. |+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 55 4789999997 599999876543 99999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998654322 23445789999999999999999999999999999999999999975443222111111100000
Q ss_pred hhhhhhh--hccccCCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEKKLEM--LVDKDLKNN-------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~--~~d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....... .....+... ........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 000000000 001123678899999999999999999998763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=345.43 Aligned_cols=280 Identities=22% Similarity=0.348 Sum_probs=209.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999976 58999999986554332 23457899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence 999999998887777899999999999999999999999 999999999999999999999999999986643322 2
Q ss_pred eeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH--------HHHhhhhhhhh
Q 036225 458 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV--------KKIHQEKKLEM 528 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 528 (622)
.....||..|+|||++.+. .++.++|||||||++|||+||+.||......+....+.... ...........
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3345689999999999775 68999999999999999999999997654332211111100 00001111111
Q ss_pred hccccCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCChhhHHHHh
Q 036225 529 LVDKDLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVR--MLEGDGLAERWEAS 583 (622)
Q Consensus 529 ~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~~ 583 (622)
...+....... ...+..+.+++.+||+.||++|||++|+++ .++.....++....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 322 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQE 322 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHHHHH
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhhhHH
Confidence 11111111111 112467899999999999999999999986 45555555554443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.25 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=203.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeee-eCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC-MTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv 375 (622)
..++|...+.||+|+||+||+|.. .+++.||||++...... ..+.+|++++..++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 57899999987654322 2578899999999988877777665 566778999
Q ss_pred eeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~ 451 (622)
|||+ +++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 999999987 345699999999999999999999999 99999999999999 789999999999998775
Q ss_pred CCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 452 HQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 452 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-ch
Confidence 43321 223456999999999999999999999999999999999999999865443333222222211111 00
Q ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... ... .+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 239 ~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 239 IEVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHH-----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhhh-----hcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 1100 011 13578999999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=362.75 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=205.8
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999976 799999999864321 123346889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....+... ...
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~---------~~~ 234 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDG---------IFY 234 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTT---------CCC
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcC---------CcC
Confidence 2334569999999999988765 78999999999999999999999743321 111111111 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+......+.+++.+|++.||.+|||++|+++
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11112356889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.44 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=198.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||++... +++.||+|++...........+.+|++++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356889999999999999999975 6899999999776555556678999999999999999999999999999999999
Q ss_pred eccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceec
Q 036225 378 YMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 378 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~ 450 (622)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998853 35799999999999999999999999 99999999999999 45688999999999865
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
... .......||+.|+|||++. +.++.++||||||+++|||++|+.||....... ........
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~------- 240 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYK------- 240 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC-------
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccC-------
Confidence 432 2234456999999999885 568999999999999999999999997533211 11111000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
....... .......+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Ccccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0002356889999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.90 Aligned_cols=272 Identities=21% Similarity=0.251 Sum_probs=209.0
Q ss_pred ccccCHHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-----cccce
Q 036225 287 LRRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HRNLL 360 (622)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv 360 (622)
...+++.+.....++|.+.+.||+|+||+||+|... +++.||||+++... .....+..|+++++.+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 445566666667889999999999999999999974 68999999987432 23345778999998886 99999
Q ss_pred eeeeeeeCCCceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---
Q 036225 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--- 435 (622)
Q Consensus 361 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--- 435 (622)
++++++...+..++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 89999998643 3589999999999999999999999 9999999999999975
Q ss_pred ----------------------CCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHH
Q 036225 436 ----------------------CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 493 (622)
Q Consensus 436 ----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~e 493 (622)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999999
Q ss_pred HHhcCCccccchhccccccHHHH--------HHHHhhhhhhhhhcccc-----CCCCCC----------------HHHHH
Q 036225 494 LITGQRALEYGKAANQKGAMLDW--------VKKIHQEKKLEMLVDKD-----LKNNYD----------------RIELE 544 (622)
Q Consensus 494 l~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~d~~-----~~~~~~----------------~~~~~ 544 (622)
|+||+.||......+....+... ........ ....++.. ...... .....
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999754432211111110 00000000 00000000 000000 00115
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 545 EMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 545 ~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.+++.+||+.||.+|||++|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 6789999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.47 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=202.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
..++|...+.||+|+||.||+|... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999975 689999999976432 234688888877 799999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC----CceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC----CEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~~~ 451 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998888899999999999999999999999 99999999999998532 359999999998765
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+....
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~------- 239 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGK------- 239 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCC-------
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCC-------
Confidence 4332 233456899999999998888999999999999999999999999743211 1112222221111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+...+....+.++.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111111223467899999999999999999999886
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.55 Aligned_cols=264 Identities=19% Similarity=0.267 Sum_probs=196.1
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
..++|.+.+.||+|+||+||+|... +++.||||+++...... ....+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467889999999999999999964 78999999997553322 234577999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-----CCCceEEcccccceec
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-----DCCEAVVGDFGLAKLL 450 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-----~~~~~kl~Dfgla~~~ 450 (622)
|||+++ +|.+++.....+++..+..|+.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999985 9999998877899999999999999999999999 999999999999994 5556999999999876
Q ss_pred CCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLE 527 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 527 (622)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +........... ...
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTST
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhh
Confidence 53322 23344689999999999775 489999999999999999999999975443222 111111110000 000
Q ss_pred hhc-ccc-------CCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 528 MLV-DKD-------LKNNY-----DRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 528 ~~~-d~~-------~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
... .+. ..... ......++.+++.+||+.||.+|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000 00000 0012367889999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=342.18 Aligned_cols=270 Identities=25% Similarity=0.330 Sum_probs=202.8
Q ss_pred CHHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhc--cccccceeeeeeeeC
Q 036225 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLYGFCMT 368 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~ 368 (622)
.........++|.+.+.||+|+||.||+|... ++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 34444556678999999999999999999986 899999998643 23345556666554 489999999999987
Q ss_pred C----CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCCce
Q 036225 369 P----TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 369 ~----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
. ...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7 6789999999999999999754 5899999999999999999999752 3489999999999999999999
Q ss_pred EEcccccceecCCCCCcee---eeecCcccccCccccccCCCCcc------cceeehhHHHHHHHhc----------CCc
Q 036225 440 VVGDFGLAKLLDHQDSHVT---TAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELITG----------QRA 500 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~------sDvwslGv~l~el~tg----------~~p 500 (622)
||+|||++........... ....||+.|+|||++.+..++.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999999987654332211 24469999999999987766655 9999999999999999 555
Q ss_pred cccchhccccccHHHHHHHHhhhhhhhhhccccCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
|........ ........ .... ...+..... .....+.++.+++.+||+.||.+|||+.|+++.|+.
T Consensus 262 ~~~~~~~~~--~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 262 YHDLVPSDP--SYEDMREI-VCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTSCSSC--CHHHHHHH-HTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhhcCCCC--chhhhHHH-Hhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 543221111 11111111 1000 011111111 112567889999999999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=334.22 Aligned_cols=258 Identities=20% Similarity=0.244 Sum_probs=206.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeee-eCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC-MTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~ 376 (622)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+++++.++|++++..++++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999996 5799999999875432 23588999999999998877666665 5567779999
Q ss_pred eeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~ 452 (622)
||+ +++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 899999986 455799999999999999999999999 99999999999999 5889999999999987754
Q ss_pred CCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 453 QDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 453 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-ch
Confidence 4321 1234569999999999999999999999999999999999999998644333322222222211110 01
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.. +... .+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 240 ~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 240 EV-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred HH-----HHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 10 0111 22678999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=367.60 Aligned_cols=253 Identities=26% Similarity=0.309 Sum_probs=206.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|...++||+|+||.||+|... +|+.||+|++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 69999999986432 122344678999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 376 YPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999886543 489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+...+.. . .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~-------~-- 405 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V-------P-- 405 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---C-------C--
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---c-------c--
Confidence 2 233457999999999999989999999999999999999999999754322211111111111 0 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
..++...+.++.+++.+||+.||.+|| +++|++++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111222336789999999999999999 67777653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=355.19 Aligned_cols=266 Identities=19% Similarity=0.239 Sum_probs=202.9
Q ss_pred HhCCCcCCeeeec--CCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 299 THNFSSKNILGKG--GFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
..+|++.+.||+| +||+||+|... +|+.||||+++...... ....+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999976 69999999997654322 23468889999999999999999999999999999
Q ss_pred EeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 375 VYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999998643 6699999999999999999999999 999999999999999999999999999865432
Q ss_pred CCC------ceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh---
Q 036225 453 QDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH--- 521 (622)
Q Consensus 453 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 521 (622)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ +........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 257 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCL 257 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH---HHHC--------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHhcCCCCcc
Confidence 111 11122368999999999987 5789999999999999999999999975332211 111000000
Q ss_pred -hh------------------hhhhhhccc---------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 -QE------------------KKLEMLVDK---------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 -~~------------------~~~~~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ......... .............+.+++.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000000000 00001122234678999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.04 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=197.7
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
.++.+..++|.+.+.||+|+||.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344455678889999999999999999854 3568999999765432 23456889999999999999999999998
Q ss_pred CCCc-----eeEEeeeccCCCccccc------cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 036225 368 TPTE-----RLLVYPYMSNGSVASRL------KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC 436 (622)
Q Consensus 368 ~~~~-----~~lv~e~~~~gsL~~~l------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~ 436 (622)
..+. .++||||+++|+|.+++ .....+++..+..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 49999999999999988 3445699999999999999999999999 99999999999999999
Q ss_pred CceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHH
Q 036225 437 CEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAML 514 (622)
Q Consensus 437 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~ 514 (622)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |..||....... +.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY 259 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH
Confidence 99999999999866433221 2233457889999999999999999999999999999999 888886433211 11
Q ss_pred HHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 515 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 515 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. ...... ....+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 260 ~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 260 D---YLLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp H---HHHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 111110 011122233678999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.20 Aligned_cols=245 Identities=24% Similarity=0.285 Sum_probs=195.1
Q ss_pred CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 305 KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 568999999999999964 689999999976432 345578999999999999999999999999999999999999999
Q ss_pred ccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--cCCCceEEcccccceecCCCCCceeee
Q 036225 384 VASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DDCCEAVVGDFGLAKLLDHQDSHVTTA 460 (622)
Q Consensus 384 L~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~~ 460 (622)
|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9988854 34689999999999999999999999 99999999999999 5678999999999987654322 233
Q ss_pred ecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCH
Q 036225 461 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540 (622)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 540 (622)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+..... .+......
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~-------~~~~~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------TLNNILACRW-------DLEDEEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC-------CSCSGGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccC-------CCChhhhc
Confidence 469999999999998899999999999999999999999997543221 1111111100 00000001
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 541 IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 541 ~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+.++.+++.+||+.||.+|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12367899999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.95 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=208.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.+.|...+.||+|+||.||+|... +++.||||+++..........+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999964 6899999999866555556689999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 9999999999875 4589999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||...... .....+... ..+.+...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~------~~~~~~~~ 242 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKN------NPPTLEGN 242 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS------CCCCCCSS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhcC------CCCCCccc
Confidence 23456899999999999999999999999999999999999998643211 111111110 11112222
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+..+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 ----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23568999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.72 Aligned_cols=247 Identities=30% Similarity=0.392 Sum_probs=200.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.+.|...+.||+|+||+||+|.. .+|+.||||++....... ....+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34578889999999999999996 579999999987543322 234688999999999999999999999999999999
Q ss_pred eeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+. |+|.+.+. ....+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 57877774 355789999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 455 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
....||+.|+|||++. ++.++.++|||||||++|||+||+.||...... .....+.... .
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~------~ 270 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE------S 270 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC------C
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcC------C
Confidence 2356999999999984 567899999999999999999999998643321 1111111111 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+.. .....+..+.+++.+||+.||++|||++++++.
T Consensus 271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 111223668899999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.68 Aligned_cols=250 Identities=21% Similarity=0.264 Sum_probs=192.2
Q ss_pred hCCCcC-CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHh-ccccccceeeeeeeeC----CCce
Q 036225 300 HNFSSK-NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLYGFCMT----PTER 372 (622)
Q Consensus 300 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~ 372 (622)
++|... ++||+|+||+||+|... +|+.||||+++.. ..+.+|++++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999975 6899999998642 35678888764 5589999999998865 5678
Q ss_pred eEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccc
Q 036225 373 LLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLA 447 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla 447 (622)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999764 3599999999999999999999998 9999999999999997 789999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+...+.. .. .
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---~~-~- 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQ-Y- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH---TC-C-
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc---Cc-c-
Confidence 8654322 233456899999999999999999999999999999999999999755433222222221111 00 0
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+..........++.+++.+||+.||++|||+.|+++.
T Consensus 285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000011223678999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.67 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=201.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC-C-------eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD-G-------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
.++|...+.||+|+||+||+|.... + ..||+|++.... ......+.+|++++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678889999999999999998652 3 579999986543 234457899999999999999999999999999
Q ss_pred ceeEEeeeccCCCccccccCCCC-CChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--------eEE
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--------AVV 441 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl 441 (622)
..++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999975543 89999999999999999999999 9999999999999998887 999
Q ss_pred cccccceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
+|||++..... .....||..|+|||++.+ ..++.++||||||+++|||+||+.|+....... ......
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFY 231 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHh
Confidence 99999865432 123458899999999987 678999999999999999999766554322111 111111
Q ss_pred hhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCh
Q 036225 521 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGL 576 (622)
Q Consensus 521 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 576 (622)
... ..+... .+.++.+++.+||+.||.+|||+.|+++.|+....
T Consensus 232 ~~~--------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDR--------HQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTT--------CCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hcc--------CCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 100 011111 12458899999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=356.34 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=194.7
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-------CchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
...++|...+.||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999975 689999999865321 1122358899999999999999999999865
Q ss_pred CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcccc
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC---CEAVVGDFG 445 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfg 445 (622)
+..++||||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 45789999999999999998888899999999999999999999999 99999999999999754 459999999
Q ss_pred cceecCCCCCceeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+..
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~i~~--- 359 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQITS--- 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHHHHT---
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHHHhc---
Confidence 99876432 22345679999999999853 568899999999999999999999997433211 11111111
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... ..+... ...+..+.+++.+||+.||++||+++|+++.
T Consensus 360 -~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 -GKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -TCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000000 0123678999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.37 Aligned_cols=246 Identities=20% Similarity=0.286 Sum_probs=203.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|.+.+.||+|+||+||+|... ++..||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467889999999999999999975 577899999875433 234578999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999988777899999999999999999999999 99999999999999 788999999999998765332
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......||+.|+|||++.+ .++.++||||||+++|||+||+.||....... ....+.... .
T Consensus 164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 224 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGT---------F 224 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC---------C
T ss_pred --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCC---------C
Confidence 2334569999999999865 48999999999999999999999997543211 111111100 0
Q ss_pred CCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 535 KNNYDR----IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 535 ~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+. ..+..+.+++.+|++.||.+|||+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 12367899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.41 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=192.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccc-cccceeeeeeeeCCC--ce
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPT--ER 372 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~ 372 (622)
..++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 689999999865432 233446788999999997 999999999997544 68
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999997 588888875 3689999999999999999999999 999999999999999999999999999987642
Q ss_pred C--------------------CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccc
Q 036225 453 Q--------------------DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG 511 (622)
Q Consensus 453 ~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~ 511 (622)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 1112344579999999999976 678999999999999999999999997654332221
Q ss_pred cHHHHHHHHhhhhhhhhhc------------------cccCCCCCC------------HHHHHHHHHHHHHccCCCCCCC
Q 036225 512 AMLDWVKKIHQEKKLEMLV------------------DKDLKNNYD------------RIELEEMVQVALLCTQYLPAHR 561 (622)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~------------------d~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~R 561 (622)
.+...+.. .....+..+. .......++ .....++.+++.+||+.||++|
T Consensus 242 ~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 242 RIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 11111000 0000000000 000000000 0123578899999999999999
Q ss_pred CCHHHHHHH
Q 036225 562 PKMSEVVRM 570 (622)
Q Consensus 562 Pt~~evl~~ 570 (622)
||++|++++
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.34 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=206.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||+|... +++.||+|+++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457888999999999999999976 6899999999876544445678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
|+++++|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 9999999999987777999999999999999999999832 7999999999999999999999999999755321 2
Q ss_pred eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHH---------------------HH
Q 036225 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML---------------------DW 516 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~---------------------~~ 516 (622)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+. .+
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 234569999999999999999999999999999999999999997543221100000 00
Q ss_pred H-HHHhh----hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 517 V-KKIHQ----EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 517 ~-~~~~~----~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
. ..... ......+.............+.++.+++.+||+.||.+|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 00000 00000011111111111112357899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=346.84 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=203.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
..++|.+.+.||+|+||.||+|.+ .+++.||||.+...........+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356788999999999999999984 24778999999765545556678999999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEE
Q 036225 372 RLLVYPYMSNGSVASRLKGK-------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVV 441 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl 441 (622)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999998643 3488999999999999999999999 9999999999999984 456999
Q ss_pred cccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHH
Q 036225 442 GDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKK 519 (622)
Q Consensus 442 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 519 (622)
+|||++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHH
Confidence 99999976543222 12233457899999999999999999999999999999998 88888643211 11111
Q ss_pred HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 520 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 520 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+.... ....+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 258 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 258 VTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111 011122234678999999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=338.61 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=203.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456889999999999999999976 6899999998754322 1345789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~ 448 (622)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998777899999999999999999999999 999999999999998877 89999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......|++.|+|||++.+..++.++||||||+++|+|+||+.||...... .....+....
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~---- 227 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVN---- 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC----
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhcc----
Confidence 764322 223456899999999999899999999999999999999999999753321 1111111000
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...........+..+.+++.+|++.||.+||++.|+++.
T Consensus 228 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 ---YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000001123568899999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=374.47 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=199.2
Q ss_pred CeeeecCCceEEEEEEC---CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|.+. +++.||||+++..... .....+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4688999999764332 234579999999999999999999999975 458899999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc--eee
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH--VTT 459 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~ 459 (622)
|+|.+++.....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999998878899999999999999999999999 9999999999999999999999999999876543322 223
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+... .....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~----------~~~~~ 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG----------ERMGC 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT----------CCCCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC----------CCCCC
Confidence 3446789999999999999999999999999999998 999997543211 11111111 11112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+.++.+++.+||+.||++||++++|++.|+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 23345779999999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=341.88 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=210.1
Q ss_pred cCHHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhc--cccccceeeeeeee
Q 036225 290 FQFRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLYGFCM 367 (622)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~ 367 (622)
..+.......++|.+.+.||+|+||.||+|... |+.||||+++.. ....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344555666789999999999999999999985 899999998643 24467788888876 78999999999998
Q ss_pred CCC----ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeeecC
Q 036225 368 TPT----ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDD 435 (622)
Q Consensus 368 ~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlk~~NILl~~ 435 (622)
... ..++||||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+|||++.
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 876 789999999999999999754 5899999999999999999999 66 9999999999999999
Q ss_pred CCceEEcccccceecCCCCCce---eeeecCcccccCccccccC------CCCcccceeehhHHHHHHHhc---------
Q 036225 436 CCEAVVGDFGLAKLLDHQDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG--------- 497 (622)
Q Consensus 436 ~~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~el~tg--------- 497 (622)
++.+||+|||++.......... .....||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998775543322 2344699999999999765 234789999999999999999
Q ss_pred -CCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 498 -QRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 498 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..||......+ .....+...+.. ....+.+... ........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 263 ~~~p~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 263 YQLPYYDLVPSD--PSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCTTTTTSCSS--CCHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCccccCcCc--ccHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 66765332211 112222222111 1111111111 123566789999999999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.80 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=196.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------ 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 370 (622)
.++|+..+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 357889999999999999999965 689999999975432 223456889999999999999999999996553
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+++ ++.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 56999999976 46666643 389999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh------hh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ------EK 524 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~ 524 (622)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......... ..
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 432 2234567999999999999999999999999999999999999999765433221111111100000 00
Q ss_pred hhh---------------hhccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLE---------------MLVDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~---------------~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ..+...+... .......++.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000 011225678999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.51 Aligned_cols=248 Identities=17% Similarity=0.230 Sum_probs=202.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEE------ECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc---cccceeeeeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGI------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLYGFCM 367 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~ 367 (622)
...++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|++++..++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345778899999999999999994 4468899999987542 346777887777776 999999999999
Q ss_pred CCCceeEEeeeccCCCcccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-------
Q 036225 368 TPTERLLVYPYMSNGSVASRLK-----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD------- 435 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~------- 435 (622)
..+..++||||+++|+|.+++. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996 356799999999999999999999998 9999999999999998
Q ss_pred ----CCceEEcccccceecCC-CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcccc
Q 036225 436 ----CCEAVVGDFGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK 510 (622)
Q Consensus 436 ----~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~ 510 (622)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 89999999999987542 223344556799999999999999999999999999999999999999875432111
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHR-PKMSEVVRMLEG 573 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~ 573 (622)
. ....+.... ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 294 --------------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 --------------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp --------------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred --------------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 111111111 13567789999999999998 577777777764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.29 Aligned_cols=265 Identities=21% Similarity=0.304 Sum_probs=195.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||+||+|... +++.||+|+++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999976 78999999997654333333456799999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++ |+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 97 488887764 45689999999999999999999999 999999999999999999999999999986543222 2
Q ss_pred eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc-----
Q 036225 458 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD----- 531 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 531 (622)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+......... ........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE-ETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh-Hhchhhhcchhhc
Confidence 334468999999999876 56899999999999999999999999754432221111111100000 00000000
Q ss_pred ----ccCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 ----KDLKNN----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ----~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+..... ........+.+++.+|++.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 001123568899999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=336.94 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=183.5
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999997 4789999999864321 122356889999999999999999999999999999999
Q ss_pred eeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999998764 5689999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ... ......
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~---------~~~~~~- 229 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNK---------VVLADY- 229 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCC-
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHH---------Hhhccc-
Confidence 22345689999999999988899999999999999999999999975432111 000 000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+...+.++.+++.+|++.||++||+++++++.
T Consensus 230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1112233678899999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=337.95 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=197.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-CceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-TERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 376 (622)
..++|...+.||+|+||+||+|... |+.||||.++... ....+.+|++++++++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3467888999999999999999885 8899999987543 345788999999999999999999997654 5789999
Q ss_pred eeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999987543 378999999999999999999999 9999999999999999999999999999755432
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ . ...+.. .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~---~~~~~~----------~ 230 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----V---VPRVEK----------G 230 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----H---HHHHTT----------T
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHhc----------C
Confidence 123357889999999998999999999999999999998 999986433211 1 111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.....+...+..+.+++.+|++.||.+||++.|+++.|+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1111222334678999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.21 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=196.4
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+|.+.+.||+|+||.||+|.. .+|+.||+|+++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688899999999999999996 4789999999975432 223456889999999999999999999999999999999
Q ss_pred eeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999885 356689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
... ......|+..|+|||++.+..++.++||||||+++|||+||+.||..... ........+....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 254 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCD-------- 254 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTC--------
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhccc--------
Confidence 222 22345689999999999999999999999999999999999999864321 1112222221111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.........+.++.+++.+||+.||.+||++.++++.|+.
T Consensus 255 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 255 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp -SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1100111223678999999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.84 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=206.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56788899999999999999975 588999999875432 223456889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999988777899999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||..|+|||++.+..++.++||||||+++|||+||+.||...... .....+... ...+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-------~~~~~~ 262 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN-------EYSIPK 262 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT-------CCCCCT
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcC-------CCCCCc
Confidence 233456999999999999888999999999999999999999999753321 111111111 001111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.....+.+++.+||+.||++||++.|+++
T Consensus 263 ----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 ----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22356889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.56 Aligned_cols=244 Identities=24% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC--------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-------- 368 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------- 368 (622)
...+|...+.||+|+||.||+|... +++.||+|.++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567889999999999999999976 79999999987543 256789999999999999999998754
Q ss_pred --------CCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 369 --------PTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 369 --------~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 3457899999999999999963 35789999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 518 (622)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||+||..|+.... .+..
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHH
Confidence 9999999998765432 2234468999999999999899999999999999999999998875321 1111
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... +..+...+ +..+.+++.+|++.||.+||++.|+++.|+.
T Consensus 230 ~~~---------~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 230 DLR---------DGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHH---------TTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hhh---------cccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 11111222 2568899999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=347.67 Aligned_cols=269 Identities=25% Similarity=0.371 Sum_probs=197.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHH--Hhccccccceeeeeeee-----CCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLRLYGFCM-----TPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~-----~~~~ 371 (622)
.++|.+.+.||+|+||+||+|.. +++.||||+++... ...+..|.++ +..++||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999987 58999999986432 2334444444 55689999999998543 2335
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC------DPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
.++||||+++|+|.+++.... .++..+..++.||++||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 689999999999999997544 489999999999999999999863 3389999999999999999999999999
Q ss_pred cceecCCCCC-------ceeeeecCcccccCcccccc-------CCCCcccceeehhHHHHHHHhcCCccccchhccccc
Q 036225 446 LAKLLDHQDS-------HVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG 511 (622)
Q Consensus 446 la~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~ 511 (622)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||..|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987653221 11224469999999999976 356778999999999999999988876544322211
Q ss_pred cHH-HHHHHHhhhhhhh-----hhccccCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 512 AML-DWVKKIHQEKKLE-----MLVDKDLKNN--YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 512 ~~~-~~~~~~~~~~~~~-----~~~d~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... ............. ....+.+... .....+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 111 0000000000000 0011111111 123356689999999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.41 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=199.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 374 (622)
..++|...+.||+|+||+||+|... +++.||+|+++.... ......+.+|+..+..+ +||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999999976 799999999976432 33455788899999988 99999999999999999999
Q ss_pred EeeeccCCCccccccCC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--------------
Q 036225 375 VYPYMSNGSVASRLKGK----PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-------------- 436 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-------------- 436 (622)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999743 5689999999999999999999999 99999999999999844
Q ss_pred -----CceEEcccccceecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhcccc
Q 036225 437 -----CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQK 510 (622)
Q Consensus 437 -----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~ 510 (622)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23489999999999766 567899999999999999999877643221
Q ss_pred ccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+ ..+.. . ..+.+.. ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 -----~-~~~~~-~-----~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -----W-HEIRQ-G-----RLPRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----H-HHHHT-T-----CCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----H-HHHHc-C-----CCCCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 11110 0 0111111 223678999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.61 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=203.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeee--CCCceeE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCM--TPTERLL 374 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l 374 (622)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 689999999976543 233456889999999999999999999874 4677899
Q ss_pred EeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCeeecCCCceEEcccc
Q 036225 375 VYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPK-----IIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999863 34589999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
++....... .......||..|+|||.+.+..++.++||||||+++|||+||+.||...... .....+....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~- 232 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGK- 232 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhcc-
Confidence 998654322 1223346899999999999989999999999999999999999998754321 1111111110
Q ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. ..+ +...+.++.+++.+||+.||.+||++.|+++.+..
T Consensus 233 ~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 F-----RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred c-----ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0 111 12234678999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.30 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=205.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888999999999999999975 68899999986432 122245688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 99999999999998777799999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.. .+..+
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-------~~~~~- 231 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVN-------VDLKF- 231 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT-------TCCCC-
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhc-------cccCC-
Confidence 234568999999999999999999999999999999999999997533211 1111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+...+..+.+++.+|++.||.+||++.|+++.
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 12223678899999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.29 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=202.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|...++||+|+||.||+|... +|+.||+|+++.... ......+.+|++++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999975 699999999865321 12334688999999999999999999999999999999
Q ss_pred eeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998864 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......+...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~-------- 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQ-------- 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhc--------
Confidence 4322 23345799999999999999999999999999999999999999975432211 11111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMS 565 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 565 (622)
. ..++...+..+.+++.+||+.||.+||++.
T Consensus 409 -~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 409 -A--VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -c--cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 0 011222346788999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.00 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=206.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999976 588999999865432 22345688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999999988777899999999999999999999999 999999999999999999999999999987653322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..++.++||||||+++|||+||+.||......+ ....+... ...+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~-------~~~~- 234 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKN-------EYSI- 234 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTT-------CCCC-
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhc-------cCCC-
Confidence 2334568999999999998889999999999999999999999997543211 11111110 0011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+......+.+++.+|++.||++|||++|+++.
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 ---PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223568899999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.91 Aligned_cols=194 Identities=23% Similarity=0.354 Sum_probs=155.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC-----CCce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-----PTER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~ 372 (622)
++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+++++.++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999965 689999999865432 2234568899999999999999999999844 3568
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+ +|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 469999998888899999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--------------------------ceeeeecCcccccCcccc-ccCCCCcccceeehhHHHHHHHhc
Q 036225 453 QDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITG 497 (622)
Q Consensus 453 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~el~tg 497 (622)
... ......+||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 122345689999999986 456799999999999999999993
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.65 Aligned_cols=258 Identities=17% Similarity=0.200 Sum_probs=202.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEECC---------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccccee--------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR-------- 361 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-------- 361 (622)
.++|.+.+.||+|+||.||+|.... ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3578899999999999999999763 789999998754 25789999999999999998
Q ss_pred -------eeeeeeC-CCceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 362 -------LYGFCMT-PTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 362 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
+++++.. ....++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5666665 67889999999 99999999864 6799999999999999999999999 999999999999
Q ss_pred eecCCC--ceEEcccccceecCCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCcccc
Q 036225 432 LLDDCC--EAVVGDFGLAKLLDHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEY 503 (622)
Q Consensus 432 Ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~ 503 (622)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999988 9999999999876432211 11334699999999999998999999999999999999999999975
Q ss_pred chhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 504 GKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..... ..+......... ......+.... ....+..+.+++.+|++.||.+||+++++++.|+.
T Consensus 271 ~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTCH--HHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 43211 112222211111 11111111100 00113678999999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.62 Aligned_cols=256 Identities=20% Similarity=0.237 Sum_probs=197.6
Q ss_pred hCCCcC-CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSK-NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+.|.+. +.||+|+||+||+|... +++.||||+++... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 457664 78999999999999954 78999999997653 23345788999999884 7999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEcccccceecCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFGLAKLLDHQ 453 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~ 453 (622)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999998777899999999999999999999999 9999999999999998776 999999999765422
Q ss_pred CC------ceeeeecCcccccCcccccc-----CCCCcccceeehhHHHHHHHhcCCccccchhccccccH--------H
Q 036225 454 DS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM--------L 514 (622)
Q Consensus 454 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~--------~ 514 (622)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+..... .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223459999999999875 45889999999999999999999999754332211100 0
Q ss_pred HHHHHHhhhhhhhhhccccCCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 515 DWVKKIHQEKKLEMLVDKDLKNNYDR----IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 515 ~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.....+. .... .++. ..+..+.+++.+||+.||.+|||++|+++.
T Consensus 248 ~~~~~i~---------~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQ---------EGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHH---------HCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHh---------ccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111 1110 1111 123578999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.37 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=197.7
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc----hhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
..++|...+.||+|+||.||+|... +|+.||||+++...... ....+.+|+++++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999975 68999999997543211 123678999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 LLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
++||||+++ +|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 888877654 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+. +......... .....+.
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~-~~~~~~~ 238 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGT-PTEEQWP 238 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCC-CCTTTSS
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCC-CChhhhh
Confidence 3322 23345689999999998764 489999999999999999999998875432221 1111111100 0000000
Q ss_pred ------cc---cCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 ------DK---DLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 ------d~---~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+. ......+ ......+.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000 1223678999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=340.32 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=206.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-----CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC--c
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT--E 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~ 371 (622)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45678899999999999999984 368999999987643 334457899999999999999999999987654 7
Q ss_pred eeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 79999999999999999754 4689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCcee--eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcc-----ccccHHHHHHHHhhh
Q 036225 451 DHQDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN-----QKGAMLDWVKKIHQE 523 (622)
Q Consensus 451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 523 (622)
........ ....++..|+|||.+.+..++.++||||||+++|||+||..|+....... ..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~----- 270 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF----- 270 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH-----
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH-----
Confidence 54433221 23346788999999998889999999999999999999999886331100 0000000000
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+........+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 271 -HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0011111111111222344679999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=334.49 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=198.8
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC----CCceeE
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT----PTERLL 374 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l 374 (622)
.|...+.||+|+||+||+|... ++..||+|.+..... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667788999999999999975 688999999875432 2334568899999999999999999998864 455799
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeec-CCCceEEcccccceecC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLD-DCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~ 451 (622)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. + |+||||||+|||++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999998777799999999999999999999998 7 99999999999998 78999999999997543
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.. ......||+.|+|||++. +.++.++||||||+++|+|+||+.||...... .............
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~----- 248 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP----- 248 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCC-----
T ss_pred cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCc-----
Confidence 32 234456999999999886 45899999999999999999999999643221 1111211111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111122568999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.75 Aligned_cols=258 Identities=26% Similarity=0.330 Sum_probs=201.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee----CCCce
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM----TPTER 372 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~ 372 (622)
..++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 356788999999999999999997 578999999986532 234457889999999999999999999987 34577
Q ss_pred eEEeeeccCCCccccccC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKG----KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999988863 56799999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCc--------eeeeecCcccccCccccccCC---CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 449 LLDHQDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 449 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~ 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh
Confidence 65321100 011234799999999987554 68899999999999999999999964322111 111100
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.. ..........+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 261 ~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 261 QN-------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HC-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hc-------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00 000011112236789999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.77 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=168.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC-----Cc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 371 (622)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457889999999999999999975 689999999975432 22345788999999999999999999999766 56
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||++ |+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999996 59999998888899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---------------------eeeeecCcccccCcccc-ccCCCCcccceeehhHHHHHHHhcCCcc
Q 036225 452 HQDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRAL 501 (622)
Q Consensus 452 ~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~el~tg~~p~ 501 (622)
..... ......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 33211 23456799999999986 5566999999999999999999865444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.45 Aligned_cols=258 Identities=20% Similarity=0.299 Sum_probs=204.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCch----------------hHHHHHHHHHHhccccccceee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG----------------EIQFQTEVEMISLAVHRNLLRL 362 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~l~H~niv~l 362 (622)
.++|.+.+.||+|+||.||+|.. +|+.||||++........ ...+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788999999999999999999 899999999864321111 1578999999999999999999
Q ss_pred eeeeeCCCceeEEeeeccCCCcccc------ccC--CCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeee
Q 036225 363 YGFCMTPTERLLVYPYMSNGSVASR------LKG--KPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILL 433 (622)
Q Consensus 363 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl 433 (622)
++++...+..++||||+++|+|.++ +.. ...+++..+..++.|++.||.|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665 5679999999999999999999998 7 99999999999999
Q ss_pred cCCCceEEcccccceecCCCCCceeeeecCcccccCccccccC-CCCc-ccceeehhHHHHHHHhcCCccccchhccccc
Q 036225 434 DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELITGQRALEYGKAANQKG 511 (622)
Q Consensus 434 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslGv~l~el~tg~~p~~~~~~~~~~~ 511 (622)
+.++.+||+|||++...... ......||..|+|||++.+. .++. ++||||||+++|||+||+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876432 34455699999999999877 6666 999999999999999999999754321
Q ss_pred cHHHHHHHHhhhhh-hhh----hccccCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 512 AMLDWVKKIHQEKK-LEM----LVDKDLK---NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 512 ~~~~~~~~~~~~~~-~~~----~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
......+..... ... ...+... .......+..+.+++.+||+.||.+||++.|+++
T Consensus 259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111100 000 0000000 0000223467899999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.22 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=207.1
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-------hhHHHHHHHHHHhcc-ccccceeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLA-VHRNLLRLY 363 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l-~H~niv~l~ 363 (622)
.......++|...+.||+|+||.||+|... +|+.||||+++...... ....+.+|++++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999985 79999999987543211 123578899999999 799999999
Q ss_pred eeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 364 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
+++......++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999999998777799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeeecCcccccCcccccc------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 444 FGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ...
T Consensus 244 fG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~ 314 (365)
T 2y7j_A 244 FGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LML 314 (365)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH
T ss_pred cCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HHH
Confidence 99998765432 2334579999999999863 35788999999999999999999999643211 111
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+...... ...+.. . ..+..+.+++.+|++.||++|||+.|+++.
T Consensus 315 ~~i~~~~~~--~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIMEGQYQ--FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHTCCC--CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCC--CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111110000 000000 0 112568899999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=337.33 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=203.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|...+.||+|+||+||++... +|+.||+|.++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467888999999999999999975 789999999975432 223468899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999999999987777799999999999999999999999 99999999999999 78899999999999754322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......||+.|+|||++.+..++.++||||||+++|||+||+.||...... .....+.... . ..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~-----~--~~ 226 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGY-----Y--EF 226 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCC-----C--CC
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCC-----C--CC
Confidence 123345899999999999999999999999999999999999998643321 1111111110 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
........+..+.+++.+|++.||.+||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111223467899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.86 Aligned_cols=241 Identities=14% Similarity=0.133 Sum_probs=189.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCC--CCchhHHHHHHH---HHHhccccccceeee-------ee
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGN--AIGGEIQFQTEV---EMISLAVHRNLLRLY-------GF 365 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~ 365 (622)
.++|...+.||+|+||+||+|.. .+|+.||||+++... .......+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45688889999999999999996 569999999997532 233445788999 455666899999998 55
Q ss_pred eeCCC-----------------ceeEEeeeccCCCccccccCCCCC-------ChhHHHHHHHHHHHHHHHHHhcCCCCe
Q 036225 366 CMTPT-----------------ERLLVYPYMSNGSVASRLKGKPIL-------DWSTRKRIALGAARGLLYLHEQCDPKI 421 (622)
Q Consensus 366 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~~L~~LH~~~~~~i 421 (622)
+..++ ..++||||+ +|+|.+++.....+ ++..+..|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 67999998743333 3588889999999999999999 99
Q ss_pred eecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCccccccC-----------CCCcccceeehhHH
Q 036225 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL 490 (622)
Q Consensus 422 vH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslGv~ 490 (622)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3345567 999999999887 89999999999999
Q ss_pred HHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 491 LLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 491 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+|||+||+.||......... ..+... ... .+..+.+++.+||+.||++|||+.|+++.
T Consensus 303 l~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS----------------EWIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCS----------------GGGGSS--CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccch----------------hhhhhh--ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999643322111 111110 011 23678899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=341.62 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=186.8
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
.+..++|.+.+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 445678999999999999999999954 6899999998765444445578899999999999999999999999999999
Q ss_pred EeeeccCCCcccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 375 VYPYMSNGSVASRLK--------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 375 v~e~~~~gsL~~~l~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999885 245689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC----ceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 447 AKLLDHQDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 447 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||........ . .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~--~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----L--MLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----H--HHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----H--HHHhc
Confidence 976543221 12234568999999999866 5689999999999999999999999975432211 1 01110
Q ss_pred hhh-hh-hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEK-KL-EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~-~~-~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... .. ....+...... .+..+.+++.+||+.||.+||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 00 00111111112 23568899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.64 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=195.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCC------c
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------E 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 371 (622)
++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 56888999999999999999974 6999999998654322 23446889999999999999999999997653 4
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 7899998875 4589999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHH--------HHhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVK--------KIHQ 522 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~ 522 (622)
.. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+..... .+..
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 234568999999999877 6799999999999999999999999975443222111111000 0000
Q ss_pred h---hhhhh---hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 E---KKLEM---LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~---~~~~~---~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ..+.. .....+. .........+.+++.+|++.||.+|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 00000 0000000 0111224678999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.66 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=199.4
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-------CchhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
..++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567899999999999999999975 689999999875421 11223588999999999999999999998766
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEccccc
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFGL 446 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgl 446 (622)
. .++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 899999999999999998888899999999999999999999999 9999999999999987654 99999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
+...... .......||+.|+|||++. ...++.++|||||||++|||+||+.||....... .+...+...
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~--- 235 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQITSG--- 235 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHHHT---
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHHhC---
Confidence 9876432 2223456899999999974 4678999999999999999999999997543221 122211110
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ..+.... ..+..+.+++.+|++.||++||++.|+++.
T Consensus 236 -~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 -KYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -CCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -ccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000 0000000 123678999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.68 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=199.3
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC--------C
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT--------P 369 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~ 369 (622)
++|.+.+.||+|+||+||+|.. .+|+.||||++...... .....+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999997 47899999998654332 234467899999999999999999999876 3
Q ss_pred CceeEEeeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 370 TERLLVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+..++||||+++ +|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 467999999986 6666654 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC---CceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 449 LLDHQD---SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 449 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+......... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP-E 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-T
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-h
Confidence 765322 122234568999999999876 45899999999999999999999999754432221111111100000 0
Q ss_pred hhhhh-----ccc-cC--CCCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEML-----VDK-DL--KNNYD-RI------ELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~-----~d~-~~--~~~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... .+. .. ..... .. ....+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 000 00 00000 00 12458899999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.71 Aligned_cols=273 Identities=19% Similarity=0.251 Sum_probs=200.1
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCch----------hHHHHHHHHHHhcccccccee
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVHRNLLR 361 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~H~niv~ 361 (622)
..++....++|.+.+.||+|+||.||+|...+|+.||||++........ ...+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5677788899999999999999999999988899999999865332211 256889999999999999999
Q ss_pred eeeeeeC-----CCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 036225 362 LYGFCMT-----PTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD 435 (622)
Q Consensus 362 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~ 435 (622)
+++++.. ....++||||++ |+|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 9999843 345799999998 577777754 44799999999999999999999999 9999999999999999
Q ss_pred CCceEEcccccceecCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHH
Q 036225 436 CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML 514 (622)
Q Consensus 436 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~ 514 (622)
++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999754322 22344568999999999877 678999999999999999999999997544322211111
Q ss_pred HHHHHHh-------hhhhhhhhccccCCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 515 DWVKKIH-------QEKKLEMLVDKDLKNN-------YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 515 ~~~~~~~-------~~~~~~~~~d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....... ................ ........+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1110000 0000001111111000 001123568899999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.24 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=196.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999976 78999999986432 122344688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.+++.....+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 99999999999998777799999999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... .....+.... ...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~-------~~~ 230 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGV-------FYI 230 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------CCC
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCc-------ccC
Confidence 2234468999999999987765 68999999999999999999999643211 1111111100 001
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+......+.+++.+|++.||.+|||+.|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123568899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.93 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=206.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
..++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467889999999999999999976 789999999865432 2345578999999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~ 451 (622)
||||+.+|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999998888899999999999999999999999 99999999999999 567899999999998765
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+......
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~----- 245 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYT----- 245 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-----
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC-----
Confidence 4322 234569999999999865 6899999999999999999999999754321 111111111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.........+..+.+++.+||+.+|.+|||+.|++++
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000011223678899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.09 Aligned_cols=256 Identities=18% Similarity=0.241 Sum_probs=199.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeC--CCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMT--PTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv 375 (622)
++|++.+.||+|+||+||+|.. .+++.||||+++... ...+.+|++++++++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788899999999999999996 478999999987432 457889999999997 9999999999987 6678999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999885 378999999999999999999999 999999999999999766 89999999998765432
Q ss_pred CceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc---
Q 036225 455 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV--- 530 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 530 (622)
. .....||..|+|||++.+ ..++.++|||||||++|||+||+.||........ .+........ .......+
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~-~~~~~~~~~~~ 260 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLG-TEDLYDYIDKY 260 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHC-HHHHHHHHHHT
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcC-CchhhhHHHHh
Confidence 2 234468999999999877 6789999999999999999999999964332111 1111111110 00000000
Q ss_pred ------------cc--------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 ------------DK--------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 ------------d~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ............++.+++.+||+.||.+|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00011111134678999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.83 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=184.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeee--------
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCM-------- 367 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~-------- 367 (622)
...+|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457888999999999999999974 68999999986543 233456889999999996 999999999984
Q ss_pred CCCceeEEeeeccCCCcccccc---CCCCCChhHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEEc
Q 036225 368 TPTERLLVYPYMSNGSVASRLK---GKPILDWSTRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDDCCEAVVG 442 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~ 442 (622)
.....++||||+. |+|.+++. ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 3345789999996 68888875 355699999999999999999999998 7 9999999999999999999999
Q ss_pred ccccceecCCCCCce-----------eeeecCcccccCcccc---ccCCCCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 443 DFGLAKLLDHQDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 443 Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||+||+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 1134589999999998 56678999999999999999999999996432111
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
... ..............+.+++.+||+.||.+||++.|+++.|+.
T Consensus 261 -------~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 261 -------IVN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred -------hhc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000 000000111112457899999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.68 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=186.5
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHH-HHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
..++|+..+.||+|+||+||+|.. .+|+.||+|+++.......... +..+...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356788999999999999999997 4799999999976543333333 34444557888999999999999999999999
Q ss_pred eeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 376 YPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 376 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|||+++ +|.+++. ....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999975 8777664 4567999999999999999999999853 89999999999999999999999999998664
Q ss_pred CCCCceeeeecCcccccCcccc----ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
... ......||+.|+|||++ .+..++.++||||||+++|||+||+.||...... ..........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---- 229 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEE---- 229 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHS----
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhcc----
Confidence 322 22334699999999996 5567899999999999999999999999642211 1111111111
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..........+..+.+++.+|++.||++|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 -----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111122367899999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.24 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=205.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc-ccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ..+..|++++..++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36788999999999999999996 56899999988654332 357889999999987 55666666777788889999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcccccceecCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~ 452 (622)
||+ +++|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 9999999873 55799999999999999999999999 99999999999999 6889999999999988754
Q ss_pred CCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 453 QDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 453 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+...... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-cccccH
Confidence 3322 123567999999999999999999999999999999999999999754332221111111111 111111
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
..+.. . .+.++.+++.+||+.+|++||++.+|++.|+..
T Consensus 238 ~~l~~-----~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALCR-----G----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHT-----T----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhc-----C----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 1 136789999999999999999999999988753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=357.93 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.+.|...+.||+|+||+||+|... +++.||+|+++.... ......+.+|+++++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456889999999999999999975 688999999975432 233457889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccceecCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~ 453 (622)
||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999987777799999999999999999999999 9999999999999975 455999999999876543
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
. ......||+.|+|||++. +.++.++|||||||++|+|++|..||...... .....+...... .+..
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---~~~~ 259 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYT---FDSP 259 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC---CCSG
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC---CCch
Confidence 2 234456999999999986 56999999999999999999999999754321 112221111100 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 260 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 EW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 1123568899999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=335.48 Aligned_cols=256 Identities=30% Similarity=0.419 Sum_probs=196.4
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC--CC--eEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ--DG--TVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|...+.||+|+||+||+|.+. ++ ..||||+++.... ......+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457888999999999999999853 23 3699999875432 233457889999999999999999999998765 8
Q ss_pred eEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 899999999999998865 34689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 452 HQDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~---- 241 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEG---- 241 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSC----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHccC----
Confidence 443322 223457889999999988889999999999999999999 99998643321 1111111110
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.........+..+.+++.+|++.+|.+|||+.++++.|+..
T Consensus 242 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 242 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 01111222346789999999999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=369.90 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=203.4
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCc
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 371 (622)
....++|...++||+|+||.||+|... +++.||||+++... .......+..|.+++..+ +||||+++++++...+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345578999999999999999999975 68899999987532 122344677899999887 79999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++|+|.++++....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999998777899999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. +....+..
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~--------- 556 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIME--------- 556 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHS---------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh---------
Confidence 322 2344567999999999999999999999999999999999999999754321 11111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
... .++.....++.+++.+||+.||.+||++
T Consensus 557 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 557 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 111 1222334678999999999999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.90 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=201.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC------------chhHHHHHHHHHHhccccccceeeeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI------------GGEIQFQTEVEMISLAVHRNLLRLYGF 365 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 365 (622)
.++|.+.+.||+|+||+||+|... +++.||+|+++..... .....+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999975 5889999998754321 234568899999999999999999999
Q ss_pred eeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEc
Q 036225 366 CMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC---EAVVG 442 (622)
Q Consensus 366 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 442 (622)
+......++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998777899999999999999999999999 999999999999998765 69999
Q ss_pred ccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...... .....+..
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DIIKKVEK 261 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHc
Confidence 999998765432 234456999999999986 56899999999999999999999999754321 11122111
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.... .+.... ...+.++.+++.+|++.||.+|||+.|+++
T Consensus 262 ~~~~---~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYY---FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCC---CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC---CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1000 000000 012367899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.69 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=196.1
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-----
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP----- 369 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 369 (622)
+...++|...+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45567899999999999999999996 4789999999865432 234799999999999999999998433
Q ss_pred ---------------------------------CceeEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHH
Q 036225 370 ---------------------------------TERLLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLY 412 (622)
Q Consensus 370 ---------------------------------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~ 412 (622)
...++||||+++ +|.+.+. ....+++..+..++.||++||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 347899999985 7666553 56679999999999999999999
Q ss_pred HHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHH
Q 036225 413 LHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGIL 490 (622)
Q Consensus 413 LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~ 490 (622)
||+. +|+||||||+|||++ +++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999998 68999999999998764332 23345689999999998775 48999999999999
Q ss_pred HHHHHhcCCccccchhccccccHHHHHHHHhhh------hhhhhhccccCC-----CCCCHHHHHHHHHHHHHccCCCCC
Q 036225 491 LLELITGQRALEYGKAANQKGAMLDWVKKIHQE------KKLEMLVDKDLK-----NNYDRIELEEMVQVALLCTQYLPA 559 (622)
Q Consensus 491 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~d~~~~-----~~~~~~~~~~l~~li~~cl~~~p~ 559 (622)
+|||++|+.||......+....+.......... .......-+... ..++...+..+.+++.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999997654333222121111000000 000000000000 001122346789999999999999
Q ss_pred CCCCHHHHHHH
Q 036225 560 HRPKMSEVVRM 570 (622)
Q Consensus 560 ~RPt~~evl~~ 570 (622)
+|||+.|++++
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999998863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=358.04 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=203.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||+||+|... +++.||||+++... .......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999975 78999999986432 1223457889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~ 453 (622)
||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999987777899999999999999999999999 999999999999995 5667999999999865432
Q ss_pred CCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+......
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~------- 240 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA------- 240 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-------
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-------
Confidence 22344569999999999875 5999999999999999999999999754321 111221111100
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011223678899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=369.02 Aligned_cols=259 Identities=21% Similarity=0.344 Sum_probs=206.5
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP 369 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 369 (622)
+..+..++|...+.||+|+||+||+|.+. .+..||||.++..........+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34445677888999999999999999974 256899999876554444567899999999999999999999985 4
Q ss_pred CceeEEeeeccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 370 TERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5689999999999999999743 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +....+....
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~--- 609 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGE--- 609 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTC---
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCC---
Confidence 765443333344557889999999998999999999999999999997 88898643321 1111111111
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...+..+.+++.+||+.||.+||++.|+++.|+.
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011222334678999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.27 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=197.0
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
+|....+||+|+||.||+|... +++.||||.++... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455669999999999999964 68899999987653 233456889999999999999999999999999999999999
Q ss_pred cCCCccccccCC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccccceecCCCCC
Q 036225 380 SNGSVASRLKGK---PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 380 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~ 455 (622)
++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 999999998643 3567888999999999999999999 9999999999999987 8999999999998764322
Q ss_pred ceeeeecCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.......||+.|+|||++.+.. ++.++||||||+++|||+||+.||........ ..... . .....+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~-~-----~~~~~~~ 246 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKV-G-----MFKVHPE 246 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHH-H-----HHCCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhh-c-----ccccccc
Confidence 2233456899999999997653 78999999999999999999999964321110 00000 0 0001111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+...+.++.+++.+||+.||++||++.|+++.
T Consensus 247 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 ----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222234678899999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.92 Aligned_cols=266 Identities=20% Similarity=0.302 Sum_probs=202.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-----Cce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 372 (622)
..+|...+.||+|+||.||+|... +++.||||++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357889999999999999999965 68899999997654444446788999999999999999999998765 367
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||++ |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999997 4898888654 589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCce--eeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 453 QDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 453 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+......... ......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ-EDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH-HHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH-HHHHHh
Confidence 32211 234579999999998754 45899999999999999999999999765433322222111100000 000000
Q ss_pred --------ccc-cCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 530 --------VDK-DLKNNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 530 --------~d~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ......+ .....++.+++.+||+.||.+|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000 1123568899999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.17 Aligned_cols=254 Identities=10% Similarity=0.014 Sum_probs=181.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--chhHHHHHHHHHHhcc--ccccceeee-------eee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA--VHRNLLRLY-------GFC 366 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~ 366 (622)
..+|...+.||+|+||+||+|.+. +|+.||||+++..... .....+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345788999999999999999975 7899999999875432 2334577885544444 699988755 333
Q ss_pred eCC-----------------CceeEEeeeccCCCccccccC-CCCCChhHH------HHHHHHHHHHHHHHHhcCCCCee
Q 036225 367 MTP-----------------TERLLVYPYMSNGSVASRLKG-KPILDWSTR------KRIALGAARGLLYLHEQCDPKII 422 (622)
Q Consensus 367 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~iv 422 (622)
... ...++||||++ |+|.+++.. ...+++..+ ..++.||+.||+|||++ +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 322 33799999998 899999974 334566666 78889999999999999 999
Q ss_pred ecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCc
Q 036225 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRA 500 (622)
Q Consensus 423 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p 500 (622)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986542 2224557799999999987 6799999999999999999999999
Q ss_pred cccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
|.......... ......................+..+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97543221100 0000000000111111111123467899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.63 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=200.1
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
...++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|++++..++||||+++++++...+..++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34677899999999999999999976 58999999987643 234688999999999999999999999999999999
Q ss_pred eeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999986 355789999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
. ......||..|+|||++.+..++.++||||||+++|+|++|+.||....... ......... .+.+
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------~~~~ 245 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNP------PPTF 245 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC------CCCC
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCC------Cccc
Confidence 2 2334568999999999999899999999999999999999999997432211 111111000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122367899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.01 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=183.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCC------Cc
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 371 (622)
++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6788899999999999999996 4689999999975432 23345688999999999999999999998754 56
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 6799998876 4689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh-------h
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ-------E 523 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 523 (622)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+......... .
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 184 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 334569999999999877 67899999999999999999999999765432221111111100000 0
Q ss_pred hhhhhhccc--cCC-CCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDK--DLK-NNYD---RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~--~~~-~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+.. ... ..+. ......+.+++.+||+.||.+|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 000 0000 0123568899999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.99 Aligned_cols=263 Identities=19% Similarity=0.252 Sum_probs=192.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCC------c
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------E 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 371 (622)
++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 56888999999999999999965 689999999975432 223446889999999999999999999997665 6
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 78887753 488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HH------
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WV------ 517 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~------ 517 (622)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+.. +.
T Consensus 179 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 223345699999999999999999999999999999999999999975443211100000 00
Q ss_pred -HHHhhh-h-----hhhhhccccCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 -KKIHQE-K-----KLEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 -~~~~~~-~-----~~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...... . ............. ........+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 0 0000000000000 112235678999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=339.62 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=197.7
Q ss_pred HHHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC-
Q 036225 292 FRELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT- 368 (622)
Q Consensus 292 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~- 368 (622)
+.++....++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344445778999999999999999999974 78999999987543 2345788999999998 79999999999876
Q ss_pred -----CCceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 036225 369 -----PTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVV 441 (622)
Q Consensus 369 -----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 441 (622)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 46789999999999999998643 4689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHH
Q 036225 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516 (622)
Q Consensus 442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 516 (622)
+|||++........ ......||+.|+|||++. +..++.++|||||||++|||+||+.||....... .
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~ 242 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------A 242 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------H
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------H
Confidence 99999986543221 223456899999999986 5678999999999999999999999986433211 1
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+.... .+.. .....+..+.+++.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRNP------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHSC------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcCc------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111110 0111 11112367899999999999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.50 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=202.1
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.++.+..++|...+.||+|+||.||+|..++ .||+|+++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444556788999999999999999999864 499999875432 2223457789999999999999999999999999
Q ss_pred eeEEeeeccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 372 RLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999998654 699999999999999999999999 999999999999998 689999999998765
Q ss_pred CCCC----CceeeeecCcccccCcccccc---------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 451 DHQD----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 451 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
.... ........||+.|+|||++.+ ..++.++||||||+++|||+||+.||...... ...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~ 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AII 252 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 3211 111233458999999999864 35788999999999999999999999743321 111
Q ss_pred HHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 036225 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDG 575 (622)
Q Consensus 518 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 575 (622)
...... ..+... ....+.++.+++.+||+.+|.+|||+.++++.|+...
T Consensus 253 ~~~~~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 253 WQMGTG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHTT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHhccC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111 111111 0112246889999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.15 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=200.0
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccc--cccceeeeeeeeCCCc
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLYGFCMTPTE 371 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 371 (622)
+.+..++|.+.+.||+|+||.||++...+++.||||++...... .....+.+|++++.+++ |+||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 33456678899999999999999999988999999999754322 23456889999999997 5999999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||| +.+++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+|||+++ +.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 56889999998777899999999999999999999999 9999999999999975 899999999998764
Q ss_pred CCCCc-eeeeecCcccccCcccccc-----------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHH
Q 036225 452 HQDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK 519 (622)
Q Consensus 452 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 519 (622)
..... ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||...... .....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~- 250 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLH- 250 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHH-
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHH-
Confidence 33222 2234568999999999865 46888999999999999999999998643211 11111
Q ss_pred HhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 520 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 520 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...++.....++...+..+.+++.+||+.||.+||++.|+++.
T Consensus 251 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 --------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1112211112222224678999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.69 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=204.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC--------chhHHHHHHHHHHhccc-cccceeeeeeeeC
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI--------GGEIQFQTEVEMISLAV-HRNLLRLYGFCMT 368 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~ 368 (622)
.++|...+.||+|+||.||+|... +|+.||||+++..... .....+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467889999999999999999975 6899999998754311 11235788999999995 9999999999999
Q ss_pred CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 369 PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
....++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999998777899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccc------cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
...... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+..
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~ 243 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMS 243 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHHHHhc
Confidence 765432 233456899999999985 456889999999999999999999998643321 11111111
Q ss_pred hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 523 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
... ..........+..+.+++.+|++.||.+|||+.|+++
T Consensus 244 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 100 0000011123467899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.82 Aligned_cols=267 Identities=20% Similarity=0.302 Sum_probs=200.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC-----Cce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 372 (622)
.++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 68999999997654444455788999999999999999999987654 678
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
++||||+. |+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 589888865 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc---------eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh
Q 036225 453 QDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522 (622)
Q Consensus 453 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 522 (622)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 2211 1123468999999998765 67899999999999999999999999754422111111100000000
Q ss_pred hhh--------hhhhccc--cCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 523 EKK--------LEMLVDK--DLKNN----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 523 ~~~--------~~~~~d~--~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ..+.... ..... .....+.++.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000 00000 001123678899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.46 Aligned_cols=198 Identities=22% Similarity=0.251 Sum_probs=170.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc------ccccceeeeeeeeCCCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA------VHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~ 371 (622)
..+|.+.+.||+|+||+||+|... +++.||||+++... .....+.+|+++++.+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346888999999999999999865 58999999997532 2234577888887776 56799999999999999
Q ss_pred eeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--eEEcccccc
Q 036225 372 RLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--AVVGDFGLA 447 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla 447 (622)
.++||||+. ++|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 6898888643 3589999999999999999999999 9999999999999999887 999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~ 506 (622)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 865432 2335689999999999999999999999999999999999999976543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=327.67 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=197.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC---CCchhHHHHHHHHHHhccccccceeeeeeee--CCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN---AIGGEIQFQTEVEMISLAVHRNLLRLYGFCM--TPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~ 372 (622)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999974 68899999987532 1234557899999999999999999999984 45678
Q ss_pred eEEeeeccCCCcccccc--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 373 LLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
++||||++++ |.+++. ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 666554 245689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeeeecCcccccCccccccCC--CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 451 DHQD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 451 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
.... ........||..|+|||++.+.. ++.++||||||+++|||+||+.||..... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC---
Confidence 5322 22334556999999999987644 47899999999999999999999974321 11111111110
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..+.. .....+.+++.+|++.||.+|||+.|+++.
T Consensus 230 ----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ----YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 233678899999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.55 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=194.5
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc------ee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE------RL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~ 373 (622)
.+|...+.||+|+||+||+|...++..||+|++...... ..+|+++++.++||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 458889999999999999999887777999988654321 2369999999999999999999864433 78
Q ss_pred EEeeeccCCCccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEccccccee
Q 036225 374 LVYPYMSNGSVASRL---KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKL 449 (622)
Q Consensus 374 lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~ 449 (622)
+||||++++.+.... .....+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875433322 2456789999999999999999999999 999999999999999 899999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh-
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE- 527 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 527 (622)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+......... ..+.
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~-~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR-EQIKT 268 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH-HHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH-HHHHh
Confidence 643322 3345689999999998765 5899999999999999999999999865433322222111100000 0000
Q ss_pred ---hhccccCC---C-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 ---MLVDKDLK---N-----NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ---~~~d~~~~---~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+. . .+....+.++.+++.+||+.||.+|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 0 0111133678999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.92 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=197.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 467889999999999999999976 58999999987543 2334578899999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 9999999998764 45689999999999999999999999 9999999999999999999999999997543211 11
Q ss_pred eeeeecCcccccCcccc-----ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 457 VTTAVRGTVGHIAPEYL-----STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
......||..|+|||++ .+..++.++||||||+++|||+||+.||...... ............
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~----- 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPP----- 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCC-----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCc-----
Confidence 12334689999999998 3667899999999999999999999998743321 111111111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ...+...+..+.+++.+|++.||.+|||+.|+++.
T Consensus 241 -~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 -T--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -C--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -c--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00112223678999999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.80 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=200.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc--------cccceeeeeeee--
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--------HRNLLRLYGFCM-- 367 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~-- 367 (622)
.++|.+.+.||+|+||+||+|... +++.||||+++.. ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467899999999999999999964 6899999999743 223456889999999886 788999999987
Q ss_pred --CCCceeEEeeeccCCCcccccc-C-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC------
Q 036225 368 --TPTERLLVYPYMSNGSVASRLK-G-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC------ 437 (622)
Q Consensus 368 --~~~~~~lv~e~~~~gsL~~~l~-~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~------ 437 (622)
.....++||||+ ++++.+.+. . ...+++..+..|+.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 566889999999 556666554 2 256999999999999999999999864 899999999999999775
Q ss_pred -------------------------------------------ceEEcccccceecCCCCCceeeeecCcccccCccccc
Q 036225 438 -------------------------------------------EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474 (622)
Q Consensus 438 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (622)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999876532 23346899999999999
Q ss_pred cCCCCcccceeehhHHHHHHHhcCCccccchhccccccH--HHHHHHHhhh---------hhhhhhcccc--C-------
Q 036225 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM--LDWVKKIHQE---------KKLEMLVDKD--L------- 534 (622)
Q Consensus 475 ~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~d~~--~------- 534 (622)
+..++.++|||||||++|||+||+.||............ ...+...... ......+... +
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999754332211111 1111110000 0000000000 0
Q ss_pred ----------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 ----------KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...........+.+++.+||+.||++|||++|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345667789999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.52 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred HHhCCCcCCeeeecCCceEEEEEE--CCCeEEEEEEccCCCCC-chhHHHHHHHHHHhcc---ccccceeeeeeee----
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGIL--QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLYGFCM---- 367 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~~~~~---- 367 (622)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 357789999999999999999997 46899999998643321 2223566788777766 8999999999987
Q ss_pred -CCCceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 036225 368 -TPTERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDF 444 (622)
Q Consensus 368 -~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 444 (622)
.....++||||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 5667899999998 699998864 33589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 445 GLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
|++....... ......||..|+|||++.+..++.++||||||+++|||+||+.||...........+...........
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9998654221 22345689999999999999999999999999999999999999975443221111111000000000
Q ss_pred hhhh------hcccc---CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 525 KLEM------LVDKD---LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 525 ~~~~------~~d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.... ..... .........+..+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000 000111223467889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.41 Aligned_cols=271 Identities=20% Similarity=0.250 Sum_probs=190.8
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
.+.....++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 445667789999999999999999999975 689999998865432 22346678888899999999999999865433
Q ss_pred -------eeEEeeeccCCCc---cccccCCCCCChhHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCeeecC-CCc
Q 036225 372 -------RLLVYPYMSNGSV---ASRLKGKPILDWSTRKRIALGAARGLLYLH--EQCDPKIIHRDVKAANILLDD-CCE 438 (622)
Q Consensus 372 -------~~lv~e~~~~gsL---~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlk~~NILl~~-~~~ 438 (622)
.++||||++++.+ ...+.....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987422 233346667899999999999999999999 77 9999999999999996 899
Q ss_pred eEEcccccceecCCCCCceeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 517 (622)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||...........+....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999998765332 233456899999999986654 8999999999999999999999997644322211111110
Q ss_pred --------HHHhhhhhhhhhcccc------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 --------KKIHQEKKLEMLVDKD------LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 --------~~~~~~~~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.............+.. ............+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000000000 0001111235679999999999999999999998853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=332.48 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=202.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEE--CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc------ceeeeeeeeCCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLYGFCMTPT 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~ 370 (622)
.++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 45788999999999999999997 368999999987532 23456889999999888765 999999999999
Q ss_pred ceeEEeeeccCCCccccccCCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-------------
Q 036225 371 ERLLVYPYMSNGSVASRLKGKP--ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD------------- 435 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~------------- 435 (622)
..++||||+ +++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999886543 688999999999999999999999 9999999999999987
Q ss_pred ------CCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc
Q 036225 436 ------CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509 (622)
Q Consensus 436 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~ 509 (622)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999865432 2345689999999999998999999999999999999999999975443221
Q ss_pred cccHHHHHHHHh----hhhh---------------------hhhhccccC-CCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 036225 510 KGAMLDWVKKIH----QEKK---------------------LEMLVDKDL-KNNYDRIELEEMVQVALLCTQYLPAHRPK 563 (622)
Q Consensus 510 ~~~~~~~~~~~~----~~~~---------------------~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt 563 (622)
...+........ .... ......+.. ...........+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 111111000000 0000 000000000 01112345678999999999999999999
Q ss_pred HHHHHHH
Q 036225 564 MSEVVRM 570 (622)
Q Consensus 564 ~~evl~~ 570 (622)
++|+++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.63 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=193.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC------Cce
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TER 372 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~ 372 (622)
.+|...+.||+|+||+||+|.+. +|+.||||++..... .+.+|+++++.++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999975 689999999865432 234799999999999999999988532 235
Q ss_pred eEEeeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccccc
Q 036225 373 LLVYPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-CEAVVGDFGLA 447 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla 447 (622)
++||||+++ ++.+.+. ....+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 5555443 456799999999999999999999998 99999999999999954 67899999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh--h
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--K 524 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 524 (622)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...++.+... .
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 87643322 2345689999999998765 789999999999999999999999976443222 22222211100 0
Q ss_pred hhhhh-------ccccCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEML-------VDKDLKNN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~-------~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+... ..+.+... +....+.++.+|+.+||+.||.+||++.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 01000 00000000 111224678999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.72 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=179.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHH-HHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|...+.||+|+||.||+|... +|+.||||+++..........+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999975 799999999986544444445666666 677889999999999999999999999
Q ss_pred eeccCCCcccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 377 PYMSNGSVASRLK-----GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 377 e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
||+++ +|.+++. ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 7777665 2567899999999999999999999852 79999999999999999999999999998664
Q ss_pred CCCCceeeeecCcccccCcccc----ccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
... ......||+.|+|||++ .+..++.++||||||+++|||+||+.||........ .... ..
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~------~~ 243 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQ------VV 243 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC------CC
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHH------Hh
Confidence 322 22334689999999998 456789999999999999999999999974321100 0000 00
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
....+.+........+..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111111223467899999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.86 Aligned_cols=261 Identities=19% Similarity=0.274 Sum_probs=196.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCce----
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER---- 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---- 372 (622)
.++|...+.||+|+||+||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 356888899999999999999965 68999999997643322 245688999999999999999999999877655
Q ss_pred --eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 373 --LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 373 --~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 588887753 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh---
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL--- 526 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 526 (622)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+...... ......
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 269 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV-PGTEFVQKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCHHHHTTC
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CcHHHHHHh
Confidence 422 234568999999999877 67899999999999999999999999754432221111110000 000000
Q ss_pred -----hh---hccccCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 -----EM---LVDKDLKNNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 -----~~---~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. .........+ .......+.+++.+||+.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0000000000 01124678999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=340.87 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=181.3
Q ss_pred CCCc-CCeeeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee--CCCceeE
Q 036225 301 NFSS-KNILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM--TPTERLL 374 (622)
Q Consensus 301 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l 374 (622)
.|.+ .++||+|+||+||+|... +++.||||++..... ...+.+|++++++++||||+++++++. .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3544 568999999999999965 578899999975432 336789999999999999999999994 4678899
Q ss_pred EeeeccCCCccccccC---------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEE
Q 036225 375 VYPYMSNGSVASRLKG---------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DDCCEAVV 441 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl 441 (622)
||||+++ +|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 77776641 22489999999999999999999999 99999999999999 77899999
Q ss_pred cccccceecCCCCC--ceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccc------ccc
Q 036225 442 GDFGLAKLLDHQDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQ------KGA 512 (622)
Q Consensus 442 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~------~~~ 512 (622)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653221 223446789999999999874 589999999999999999999999974432100 001
Q ss_pred HHHHHHHHhhhh--hhhhh------------ccccCCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 513 MLDWVKKIHQEK--KLEML------------VDKDLKNNYDR---------IELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 513 ~~~~~~~~~~~~--~~~~~------------~d~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+...+..+.... ....+ +.......... .....+.+|+.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111110000 00000 00000000000 01356789999999999999999999987
Q ss_pred H
Q 036225 570 M 570 (622)
Q Consensus 570 ~ 570 (622)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=324.80 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=203.7
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
...++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999975 689999999865432 2345578899999999999999999999999999999
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcccccceecC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC---CEAVVGDFGLAKLLD 451 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~ 451 (622)
||||+++++|.+.+.....+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999887666799999999999999999999999 99999999999999754 479999999998654
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .....+...... .+
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~---~~ 242 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA---FD 242 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC---CC
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC---CC
Confidence 3221 223458999999999865 4899999999999999999999999753321 111221111100 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.. .....+.++.+++.+|++.||++|||+.|+++.
T Consensus 243 --~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 --LP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --SG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 001123578899999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=326.90 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=192.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC---------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--------- 368 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------- 368 (622)
.++|+..+.||+|+||.||+|... +|+.||||+++.. ......+.+|++++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467889999999999999999975 7899999998642 2234568899999999999999999998754
Q ss_pred ----CCceeEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 036225 369 ----PTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGD 443 (622)
Q Consensus 369 ----~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 443 (622)
....++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 3567899999999999999973 44578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCC-------------CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccc
Q 036225 444 FGLAKLLDHQD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509 (622)
Q Consensus 444 fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~ 509 (622)
||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-- 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-- 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence 99998654221 1122345689999999999764 68999999999999999998 44321110
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......+.. ....+...+....+..+.+++.+|++.||.+|||+.|+++.
T Consensus 235 ----~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 ----VNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----HHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111 01112222333445678999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.29 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=196.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc-hhHHHHHHHHHHhccccccceeeeeeeeCCCc------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE------ 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------ 371 (622)
++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999975 69999999997643222 23468899999999999999999999987654
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588888754 489999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhh--hhhhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ--EKKLEM 528 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 528 (622)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+....+ .+.... ......
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEFVQK 250 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHHCBCCHHHHTT
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHHH
Confidence 22 234568999999999877 67899999999999999999999999754432211111 110000 000000
Q ss_pred --------h---ccccCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 --------L---VDKDLK---NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 --------~---~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. +..... ..........+.+++.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 01112234678999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.32 Aligned_cols=201 Identities=24% Similarity=0.301 Sum_probs=170.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cc-----cceeeeeeeeCCC
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HR-----NLLRLYGFCMTPT 370 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~ 370 (622)
..++|.+.+.||+|+||+||+|... +++.||||+++... .....+..|+++++.++ |+ +++++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3578999999999999999999975 68999999997432 22345778888888775 44 4999999999999
Q ss_pred ceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEccccc
Q 036225 371 ERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGL 446 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgl 446 (622)
..++||||++ |+|.+++... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999988643 4689999999999999999999952 22899999999999994 578899999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKA 506 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~ 506 (622)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9876432 2345689999999999999999999999999999999999999985543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.03 Aligned_cols=245 Identities=22% Similarity=0.362 Sum_probs=201.6
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc-----hhHHHHHHHHHHhccc--cccceeeeeeee
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLYGFCM 367 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--H~niv~l~~~~~ 367 (622)
....++|.+.+.||+|+||.||+|.. .+++.||||+++...... ....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33456789999999999999999996 478999999997543221 2235678999999996 599999999999
Q ss_pred CCCceeEEeeeccC-CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccc
Q 036225 368 TPTERLLVYPYMSN-GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFG 445 (622)
Q Consensus 368 ~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfg 445 (622)
..+..++||||+.+ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 89999998777899999999999999999999999 999999999999999 78999999999
Q ss_pred cceecCCCCCceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||+||+.||...... . ..
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------~----~~- 258 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------I----RG- 258 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------H----HC-
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------h----cc-
Confidence 998765322 234569999999999977665 68899999999999999999998643210 0 00
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ...... .+.++.+++.+||+.||++|||++|+++.
T Consensus 259 --~----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 --Q----VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --C----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --c----cccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001111 23578899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.73 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=193.5
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc-----hhHHHHHHHHHHhcc----ccccceeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLA----VHRNLLRLYG 364 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~H~niv~l~~ 364 (622)
.....++|.+.+.||+|+||.||+|.. .+++.||||+++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345567899999999999999999986 468999999997543221 223466789998888 8999999999
Q ss_pred eeeCCCceeEEeee-ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEc
Q 036225 365 FCMTPTERLLVYPY-MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVG 442 (622)
Q Consensus 365 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~ 442 (622)
++...+..++|||| +.+++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+||+++ +++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 78999999998777799999999999999999999999 999999999999999 89999999
Q ss_pred ccccceecCCCCCceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHh
Q 036225 443 DFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIH 521 (622)
Q Consensus 443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 521 (622)
|||++....... .....||..|+|||++.+..+ +.++||||||+++|||+||+.||..... ...
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~--- 247 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------ILE--- 247 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHH---
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------Hhh---
Confidence 999998765432 234568999999999877666 4589999999999999999999864221 000
Q ss_pred hhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ... ++......+.+++.+|++.||++||++.|+++.
T Consensus 248 --~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --A------ELH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --T------CCC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --h------ccC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001 111223578899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.14 Aligned_cols=263 Identities=20% Similarity=0.265 Sum_probs=198.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-----------cccceeeeeee
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLYGFC 366 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~ 366 (622)
..+|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 35788999999999999999996 478999999987432 23446788999988876 89999999998
Q ss_pred eCCC----ceeEEeeeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec------
Q 036225 367 MTPT----ERLLVYPYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD------ 434 (622)
Q Consensus 367 ~~~~----~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~------ 434 (622)
...+ ..++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 7654 779999999 8899998864 345899999999999999999999853 899999999999995
Q ss_pred CCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccc---
Q 036225 435 DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG--- 511 (622)
Q Consensus 435 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~--- 511 (622)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876532 233468999999999999999999999999999999999999997543221111
Q ss_pred cHHHHHHHHhh--------hhhhhhhccc-------------------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 036225 512 AMLDWVKKIHQ--------EKKLEMLVDK-------------------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKM 564 (622)
Q Consensus 512 ~~~~~~~~~~~--------~~~~~~~~d~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 564 (622)
.+......... .......++. .-...++.....++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111111000 0000000000 00112456677889999999999999999999
Q ss_pred HHHHHH
Q 036225 565 SEVVRM 570 (622)
Q Consensus 565 ~evl~~ 570 (622)
+|+++.
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.58 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=172.5
Q ss_pred HhCCCcC-CeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHH-HHHhccccccceeeeeeeeC----CCc
Q 036225 299 THNFSSK-NILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAVHRNLLRLYGFCMT----PTE 371 (622)
Q Consensus 299 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~----~~~ 371 (622)
.++|.+. ++||+|+||+||+|... +|+.||||++.... ...+|+ ..+..+.||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4567774 46999999999999976 68999999986531 222333 34567799999999999876 445
Q ss_pred eeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEccccc
Q 036225 372 RLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGL 446 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl 446 (622)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 79999999999999999754 3699999999999999999999999 9999999999999975 45599999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
++..... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||.................. .
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~--- 248 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---G--- 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc---c---
Confidence 9865432 223456899999999998888999999999999999999999999754322211111100000 0
Q ss_pred hhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
............+..+.+++.+|++.||.+|||+.|+++.
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111111234678999999999999999999999973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.54 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=191.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeee-----------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCM----------- 367 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----------- 367 (622)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 56888999999999999999976 58999999987543 233457889999999999999999999874
Q ss_pred ---CCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcc
Q 036225 368 ---TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGD 443 (622)
Q Consensus 368 ---~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~D 443 (622)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467799999998 599998875 4589999999999999999999999 999999999999997 577999999
Q ss_pred cccceecCCCCCc--eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH
Q 036225 444 FGLAKLLDHQDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI 520 (622)
Q Consensus 444 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 520 (622)
||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||.......... ......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ---LILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhc
Confidence 9999876432211 1233457899999998865 678999999999999999999999997544322111 111100
Q ss_pred hh--hhhhhh-------hccccCC-CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 521 HQ--EKKLEM-------LVDKDLK-NN-----YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 521 ~~--~~~~~~-------~~d~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.. .....+ ....... .. .....+.++.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00 000000 0000000 00 00112367899999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.06 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=186.7
Q ss_pred CCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEeeecc
Q 036225 302 FSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
|...++||+|+||+||.+...+|+.||||++.... ...+.+|++++.++ +||||+++++++...+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44568899999999987776789999999986432 34577899999876 89999999999999999999999996
Q ss_pred CCCccccccCCCCC-------ChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-------------CceE
Q 036225 381 NGSVASRLKGKPIL-------DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDC-------------CEAV 440 (622)
Q Consensus 381 ~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~-------------~~~k 440 (622)
|+|.+++...... ++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999998754322 3345678999999999999999 99999999999999754 4899
Q ss_pred EcccccceecCCCCCc---eeeeecCcccccCcccccc-------CCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 441 VGDFGLAKLLDHQDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 441 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999887543322 1234569999999999965 568999999999999999999 899986432110
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........ ..+..........+.++.+++.+|++.||.+|||+.|+++.
T Consensus 248 ----~~i~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ----SNIIRGIF--------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----HHHHHTCC--------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHhcCCC--------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111000 00111122244566789999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.63 Aligned_cols=261 Identities=18% Similarity=0.234 Sum_probs=199.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-C-CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc------ceeeeeeeeCCC
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-D-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLYGFCMTPT 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~ 370 (622)
.++|.+.+.||+|+||+||+|... + ++.||+|+++... .....+.+|++++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467889999999999999999974 3 4789999987532 23456888999999998776 899999999999
Q ss_pred ceeEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---------------
Q 036225 371 ERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--------------- 433 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl--------------- 433 (622)
..++||||+ ++++.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 56777766533 4689999999999999999999999 99999999999999
Q ss_pred ----cCCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccc
Q 036225 434 ----DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509 (622)
Q Consensus 434 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~ 509 (622)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999865432 2345699999999999999999999999999999999999999975443221
Q ss_pred cccHHHHHHHHhh-----hhhhhhhcccc---------------------CCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 036225 510 KGAMLDWVKKIHQ-----EKKLEMLVDKD---------------------LKNNYDRIELEEMVQVALLCTQYLPAHRPK 563 (622)
Q Consensus 510 ~~~~~~~~~~~~~-----~~~~~~~~d~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 563 (622)
...+......... ........... ............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 1111110000000 00000000000 000112234568899999999999999999
Q ss_pred HHHHHH
Q 036225 564 MSEVVR 569 (622)
Q Consensus 564 ~~evl~ 569 (622)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.15 Aligned_cols=258 Identities=25% Similarity=0.335 Sum_probs=199.6
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC------CCc
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT------PTE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 371 (622)
..+|.+.+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999974 6899999999765544455678999999999999999999999765 677
Q ss_pred eeEEeeeccCCCccccccCCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEcccc
Q 036225 372 RLLVYPYMSNGSVASRLKGKP---ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE---AVVGDFG 445 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfg 445 (622)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999987533 689999999999999999999999 9999999999999997665 9999999
Q ss_pred cceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
++....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ..|.........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~------~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH------HHSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch------hhhhhhhhcccc
Confidence 998765432 234457999999999999999999999999999999999999999753221 111111110000
Q ss_pred hhhhccc----------c--CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 036225 526 LEMLVDK----------D--LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567 (622)
Q Consensus 526 ~~~~~d~----------~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 567 (622)
....... . .........+..+.+++.+|+..||++|||++|+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0 0122334466889999999999999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=350.56 Aligned_cols=239 Identities=20% Similarity=0.280 Sum_probs=193.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC--CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc-----
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ--DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE----- 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 371 (622)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367889999999999999999975 6899999998765444445578899999999999999999999987665
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++++|.+++.. .+++..+..|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 6999999999999998765 689999999999999999999999 99999999999999985 99999999998765
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.. ....||+.|+|||++.++. +.++|||||||++|||++|..|+.........
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------------------- 285 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------------------- 285 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------------
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc---------------------
Confidence 33 3456999999999987654 88999999999999999998887632111000
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPK-MSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~ 573 (622)
...........+.+++.+||+.||.+||+ ++++.+.|.+
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001112356889999999999999995 5555555553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.63 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=179.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHH-HHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|...+.||+|+||.||+|... +|+.||||+++.........+ +..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456788899999999999999975 689999999976543333333 344445678889999999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+ ++.+..+... ...+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 4444444432 4568999999999999999999998 5 89999999999999999999999999997654322
Q ss_pred CceeeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
......||+.|+|||++. ...++.++||||||+++|||+||+.||...... ............
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~---- 247 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEP---- 247 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCC----
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCC----
Confidence 223456899999999984 456889999999999999999999999742211 111111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+.+.. ....+..+.+++.+||+.||.+||+++|+++
T Consensus 248 --~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 --PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00110 0112367889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.42 Aligned_cols=249 Identities=23% Similarity=0.282 Sum_probs=186.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 377 (622)
..+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++.+ +||||+++++++......++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 346788899999999997665566799999999865432 2356899999998 79999999999999999999999
Q ss_pred eccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceEEcccccceecC
Q 036225 378 YMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-----CCEAVVGDFGLAKLLD 451 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~ 451 (622)
|+. |+|.+++.... .+.+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 59999886543 456667789999999999999999 9999999999999953 2357899999998765
Q ss_pred CCCC--ceeeeecCcccccCccccc---cCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhh
Q 036225 452 HQDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 452 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
.... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... ..........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~ 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGACS 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhccCC
Confidence 3321 2234467999999999997 4567889999999999999999 88888532210 0111100000
Q ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 247 ------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 ------LDC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ------CTT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------ccc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 01122344668899999999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.90 Aligned_cols=243 Identities=14% Similarity=0.159 Sum_probs=184.0
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC-------CchhHHHHHHHHHHhccc---------ccc----
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAV---------HRN---- 358 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------H~n---- 358 (622)
.++|.+.+.||+|+||+||+|.. +|+.||||+++.... ......+.+|+++++.++ |||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46688899999999999999998 689999999975532 222356889999988886 544
Q ss_pred -------------ceeeeeeeeC-------------CCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHH
Q 036225 359 -------------LLRLYGFCMT-------------PTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLY 412 (622)
Q Consensus 359 -------------iv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~ 412 (622)
|+++++++.. .+..++||||+++|++.+.+.. ..+++..+..|+.||+.||+|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 4555554443 6889999999999987777754 468999999999999999999
Q ss_pred HH-hcCCCCeeecCCCCCCeeecCCC--------------------ceEEcccccceecCCCCCceeeeecCcccccCcc
Q 036225 413 LH-EQCDPKIIHRDVKAANILLDDCC--------------------EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPE 471 (622)
Q Consensus 413 LH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE 471 (622)
|| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||
T Consensus 177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED 247 (336)
T ss_dssp HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence 99 88 999999999999999887 8999999999876532 346999999999
Q ss_pred ccccCCCCcccceeehhHH-HHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHH
Q 036225 472 YLSTGQSSEKTDVFGFGIL-LLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 550 (622)
Q Consensus 472 ~~~~~~~~~~sDvwslGv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 550 (622)
++.+.. +.++||||+|++ .+++++|..||... .|..........................+.++.+++
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence 998766 889999998777 78888999998531 122111100000000111111112334667899999
Q ss_pred HHccCCCCCCCCCHHHHH
Q 036225 551 LLCTQYLPAHRPKMSEVV 568 (622)
Q Consensus 551 ~~cl~~~p~~RPt~~evl 568 (622)
.+||+.| |++|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999966 898887
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.32 Aligned_cols=229 Identities=12% Similarity=0.034 Sum_probs=182.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
.++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|+.++.+++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 356888999999999999999976 58999999998654332 235788999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.++++.. ....+..+|+.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999654 35567889999999999999999 99999999999999999999998543
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
|++ .++.++|||||||++|||+||+.||............ .........
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~~~~~ 223 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTAGQPI 223 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTTSCBC
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhccCCC
Confidence 333 3678999999999999999999999854432210000 000000000
Q ss_pred --CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 536 --NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 536 --~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
.......+.++.+++.+||+.||++| |+.|+++.|+..
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 00011123678999999999999999 999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.16 Aligned_cols=239 Identities=15% Similarity=0.119 Sum_probs=179.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhcccc-ccceeeeee----------
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVH-RNLLRLYGF---------- 365 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H-~niv~l~~~---------- 365 (622)
.+|...++||+|+||+||+|.+. +|+.||||+++...... ....+.+|+.+++.++| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 44667789999999999999954 79999999987443222 24578899999999977 322111111
Q ss_pred -----------eeC-----CCceeEEeeeccCCCcccccc-------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCee
Q 036225 366 -----------CMT-----PTERLLVYPYMSNGSVASRLK-------GKPILDWSTRKRIALGAARGLLYLHEQCDPKII 422 (622)
Q Consensus 366 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 422 (622)
+.. ....+++|+++ +++|.++++ ....+++..+..++.||++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12345666655 679988873 233578889999999999999999999 999
Q ss_pred ecCCCCCCeeecCCCceEEcccccceecCCCCCceeeeecCcccccCcccc----------ccCCCCcccceeehhHHHH
Q 036225 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL 492 (622)
Q Consensus 423 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslGv~l~ 492 (622)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865422 344567 999999999 5556889999999999999
Q ss_pred HHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 493 ELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 493 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
||+||+.||........ ...++... ... +..+.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432211 11111110 112 267899999999999999999988865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.97 Aligned_cols=225 Identities=20% Similarity=0.267 Sum_probs=176.5
Q ss_pred hCCCcC-CeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHH-hccccccceeeeeeeeC----CCce
Q 036225 300 HNFSSK-NILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLYGFCMT----PTER 372 (622)
Q Consensus 300 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~ 372 (622)
++|... +.||+|+||.||+|.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 445555 7899999999999997 46899999998642 3567888887 56689999999999876 6778
Q ss_pred eEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccc
Q 036225 373 LLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLA 447 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla 447 (622)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999653 3699999999999999999999999 9999999999999997 789999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
.... +..++.++|||||||++|||+||+.||........... ...
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------------~~~ 212 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------------MKT 212 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC------------SCC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH------------HHH
Confidence 7543 23467899999999999999999999964332111000 000
Q ss_pred hhccccCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 MLVDKDLKNNYD----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ~~~d~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.+.... ...+ ...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0111 1124678999999999999999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=287.84 Aligned_cols=187 Identities=14% Similarity=0.042 Sum_probs=133.2
Q ss_pred eeeecCCceEEEEE-ECCCeEEEEEEccCCCCC---------chhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAI---------GGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 307 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
..+.|++|.+..+. ...|+.+|+|++...... ...++|.+|+++|+++ .|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566666555544 334888999999754211 1223689999999999 799999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||++|++|.+++.....++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999988777654 5899999999999999 999999999999999999999999999987654322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCcc
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 501 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~ 501 (622)
.....+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2344679999999999865 5677899999999999887776554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=239.67 Aligned_cols=171 Identities=31% Similarity=0.565 Sum_probs=157.8
Q ss_pred CCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC--ccceEEcCC---CcEEEEecCCCCCcc--ccCCcccCCCccc
Q 036225 28 KGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCS--WTMVTCSPE---SLVIGLGIPSQNLSG--TLSPSIGNLTNLQ 100 (622)
Q Consensus 28 ~~~~~~~~aLl~~k~~~~~~~~~l~~W~~~~~~~C~--w~gv~C~~~---~~v~~L~l~~n~l~~--~~~~~~~~l~~L~ 100 (622)
.|.+.|++||++||+++.||. .+++|... .|||. |.||+|+.. ++|+.|+|++|++.+ .+|+.|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 588999999999999999886 78999764 58998 999999864 689999999999999 9999999999999
Q ss_pred EEEccC-CCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCC
Q 036225 101 IVLLQN-NNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 101 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
+|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|.+++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCc------cccccccccc
Q 036225 180 NLSGPVPRFSA------KTFNIVGNPL 200 (622)
Q Consensus 180 ~l~g~~p~~~~------~~~~l~~N~~ 200 (622)
+++|.+|..+. +.+++++|.+
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCee
Confidence 99999986542 4567778876
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=255.00 Aligned_cols=185 Identities=16% Similarity=0.207 Sum_probs=144.9
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCc-------hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
...+.||+|+||+||+|... ++.+++|+........ ....+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34678999999999999544 7788888765432211 123478999999999999999777777788888999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999986 568999999999999999 9999999999999998 999999999998754322
Q ss_pred ce------eeeecCcccccCcccccc--CCCCcccceeehhHHHHHHHhcCCcc
Q 036225 456 HV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRAL 501 (622)
Q Consensus 456 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~el~tg~~p~ 501 (622)
.. .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235679999999999976 56888899999988888877766544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=243.40 Aligned_cols=156 Identities=27% Similarity=0.421 Sum_probs=104.9
Q ss_pred CCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCccceEEcCCCcEEEEecCCCCCccc---cCC-------------
Q 036225 28 KGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGT---LSP------------- 91 (622)
Q Consensus 28 ~~~~~~~~aLl~~k~~~~~~~~~l~~W~~~~~~~C~w~gv~C~~~~~v~~L~l~~n~l~~~---~~~------------- 91 (622)
.+.+.|++||++||+++.||. .+++|+. +.|||+|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred cCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 346789999999999999998 8999984 4599999999999 78999999999999987 665
Q ss_pred ----------cccCCCcccEEEccCCCCCCCCCC--ccCCCCcccEEEecCccccCCCCchh-ccccCccceeccccccc
Q 036225 92 ----------SIGNLTNLQIVLLQNNNITGPIPA--EIGRLTKLQTLDLSNNFFTGEIPSSL-GHLRSLQYMRFNNNSLS 158 (622)
Q Consensus 92 ----------~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~ 158 (622)
.|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|+++
T Consensus 85 ~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 85 SNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred cCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 455555566666666665555555 55555555666665555555555443 45555555555555555
Q ss_pred cccccc---cccccceeEEeCCCCcCCCcCC
Q 036225 159 GAFPTS---LASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 159 ~~~p~~---~~~l~~L~~l~l~~N~l~g~~p 186 (622)
+..|.. +.++++|+.|+|++|.+++.+|
T Consensus 165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 195 (768)
T 3rgz_A 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD 195 (768)
T ss_dssp EETHHHHHHTTCCTTCCEEECCSSEEESCCB
T ss_pred CcCChhhhhhccCCCCCEEECCCCcccccCC
Confidence 544443 4444444444444444444333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-24 Score=213.05 Aligned_cols=150 Identities=12% Similarity=0.031 Sum_probs=120.8
Q ss_pred HHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-----------------chhHHHHHHHHHHhcccccc
Q 036225 296 QVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAVHRN 358 (622)
Q Consensus 296 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~H~n 358 (622)
......|...+.||+|+||.||+|...+|+.||+|.++..... .....+.+|++++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 3344456677999999999999999977999999999643211 12346889999999998 4
Q ss_pred ceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 359 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCc
Confidence 666665533 56799999999999998 532 34557999999999999999 999999999999999 999
Q ss_pred eEEcccccceecCCCCCceeeeecCcccccCccccc
Q 036225 439 AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (622)
+||+|||+++. +..|+|||++.
T Consensus 231 vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999973 44578899874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-24 Score=243.15 Aligned_cols=170 Identities=24% Similarity=0.310 Sum_probs=150.0
Q ss_pred CCCChHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCC--CCc------------cceEEcCCCcEEEEecCCCCCccc
Q 036225 27 AKGVNYEVQALMGVKHSLHDPHGVLENWDEDA----VDP--CSW------------TMVTCSPESLVIGLGIPSQNLSGT 88 (622)
Q Consensus 27 ~~~~~~~~~aLl~~k~~~~~~~~~l~~W~~~~----~~~--C~w------------~gv~C~~~~~v~~L~l~~n~l~~~ 88 (622)
+++...|++||++||+++.+| +|+.++ .+| |+| .||+|+..++|+.|+|+++++.|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 344568999999999999887 786543 356 999 999999888999999999999999
Q ss_pred cCCcccCCCcccEEEc-cCCCCCCC-------------------------------------------------------
Q 036225 89 LSPSIGNLTNLQIVLL-QNNNITGP------------------------------------------------------- 112 (622)
Q Consensus 89 ~~~~~~~l~~L~~L~L-~~N~l~~~------------------------------------------------------- 112 (622)
+|++|++|++|++|+| ++|.++|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 77765444
Q ss_pred ---------------------CCCccCCCCcccEEEecCccccC-----------------CCCchhc--cccCccceec
Q 036225 113 ---------------------IPAEIGRLTKLQTLDLSNNFFTG-----------------EIPSSLG--HLRSLQYMRF 152 (622)
Q Consensus 113 ---------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l 152 (622)
+|..|++|++|+.|+|++|.|+| .+|..++ ++++|++|+|
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 88899999999999999999998 3999988 9999999999
Q ss_pred cccccccccccccccccceeEEeCCCCc-CCC-cCCCC------------Ccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNN-LSG-PVPRF------------SAKTFNIVGNPLI 201 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~------------~~~~~~l~~N~~~ 201 (622)
++|++.|.+|..|.++++|+.|+|++|+ |+| .+|.. ..+.+++++|.+.
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 9999999999999999999999999998 998 77752 2356788888875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=234.12 Aligned_cols=171 Identities=24% Similarity=0.329 Sum_probs=151.6
Q ss_pred CChHHHHHHHHHHHhCCCCCCC--------CCCCCCCCCCCCCc---cceEEcCCCcEEEEecCCCCCccccCCcccCCC
Q 036225 29 GVNYEVQALMGVKHSLHDPHGV--------LENWDEDAVDPCSW---TMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLT 97 (622)
Q Consensus 29 ~~~~~~~aLl~~k~~~~~~~~~--------l~~W~~~~~~~C~w---~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~ 97 (622)
....|+.||.+|+.++.++.+. .++|+.. .|||.| .||+|+..++|+.|+|+++++.|.+|++|++|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 3457999999999999766433 3479864 699999 999998888999999999999999999999999
Q ss_pred cccEEEccCCC---------------------------------------------------------------------
Q 036225 98 NLQIVLLQNNN--------------------------------------------------------------------- 108 (622)
Q Consensus 98 ~L~~L~L~~N~--------------------------------------------------------------------- 108 (622)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999984
Q ss_pred ---------CCCCCCCccCCCCcccEEEecCccccCC-----------------CCchhc--cccCccceeccccccccc
Q 036225 109 ---------ITGPIPAEIGRLTKLQTLDLSNNFFTGE-----------------IPSSLG--HLRSLQYMRFNNNSLSGA 160 (622)
Q Consensus 109 ---------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~ 160 (622)
++| +|..|+++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 888999999999999999999986 999999 999999999999999999
Q ss_pred cccccccccceeEEeCCCCc-CCC-cCCCC-----------Ccccccccccccc
Q 036225 161 FPTSLASMTQLIFLDLSYNN-LSG-PVPRF-----------SAKTFNIVGNPLI 201 (622)
Q Consensus 161 ~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~-----------~~~~~~l~~N~~~ 201 (622)
+|..|.++++|+.|+|++|+ ++| .+|.. ..+.+++++|.+.
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 99999999999999999999 999 78853 2356788888875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-22 Score=204.81 Aligned_cols=171 Identities=19% Similarity=0.279 Sum_probs=149.4
Q ss_pred CCCChHHHHHHHHHHHhC-CCCCCCCCCCC---CCCCCCCCccceEEcC---------CCcEEEEecCCCCCccccCCcc
Q 036225 27 AKGVNYEVQALMGVKHSL-HDPHGVLENWD---EDAVDPCSWTMVTCSP---------ESLVIGLGIPSQNLSGTLSPSI 93 (622)
Q Consensus 27 ~~~~~~~~~aLl~~k~~~-~~~~~~l~~W~---~~~~~~C~w~gv~C~~---------~~~v~~L~l~~n~l~~~~~~~~ 93 (622)
..+...|++||++||.++ .||.+.+.+|. ....++|.|.|++|.. ...|+.|+|++|++. .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 445679999999999998 67878889994 4456899999999952 357999999999998 788999
Q ss_pred cCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccccccccccccc------
Q 036225 94 GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLAS------ 167 (622)
Q Consensus 94 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------ 167 (622)
+++++|++|+|++|.|+ .+|..++++++|++|+|++|.++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 99999999999999999999999 89999999999999999999999899988765
Q ss_pred ---ccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 168 ---MTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 168 ---l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
+++|+.|+|++|+|+ .+|..+. +.+++++|.+.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 999999999999999 7776433 56788888874
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=182.51 Aligned_cols=145 Identities=23% Similarity=0.279 Sum_probs=129.1
Q ss_pred CCCCccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEec
Q 036225 60 DPCSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLS 129 (622)
Q Consensus 60 ~~C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 129 (622)
+.|+|++|.|+.. ..+..|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 7799999999753 247899999999999999999999999999999999986666678999999999999
Q ss_pred CccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccC
Q 036225 130 NNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICAT 204 (622)
Q Consensus 130 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~ 204 (622)
+|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+. +.+.+.+|++.|.|
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 99999766677899999999999999999 8999999999999999999999976655332 56789999999987
Q ss_pred C
Q 036225 205 G 205 (622)
Q Consensus 205 ~ 205 (622)
.
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.5e-20 Score=177.83 Aligned_cols=145 Identities=23% Similarity=0.293 Sum_probs=129.7
Q ss_pred CCccceEEcCCC----------cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc
Q 036225 62 CSWTMVTCSPES----------LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN 131 (622)
Q Consensus 62 C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 131 (622)
|.|..|.|+..+ .++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 789999997532 4899999999999988889999999999999999999888999999999999999999
Q ss_pred cccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 132 FFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
.|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +.+++++|++.|.|..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 99955555688999999999999999988899999999999999999999987776443 5688999999998753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=175.89 Aligned_cols=145 Identities=19% Similarity=0.264 Sum_probs=129.6
Q ss_pred CCccceEEcCCC----------cEEEEecCCCCCccccC-CcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 62 CSWTMVTCSPES----------LVIGLGIPSQNLSGTLS-PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 62 C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
|.|+.+.|+... .++.|+|++|++++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 789999997532 36789999999998865 4589999999999999999987788999999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|.|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. +.+++++|++.|.|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999987778899999999999999999988899999999999999999999998886553 468899999999875
Q ss_pred C
Q 036225 206 S 206 (622)
Q Consensus 206 ~ 206 (622)
.
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=178.78 Aligned_cols=138 Identities=18% Similarity=0.178 Sum_probs=106.7
Q ss_pred CCcCCeeeecCCceEEEEEE-CCCeE--EEEEEccCCCCC-----------------------chhHHHHHHHHHHhccc
Q 036225 302 FSSKNILGKGGFGIVYKGIL-QDGTV--VAVKRLKDGNAI-----------------------GGEIQFQTEVEMISLAV 355 (622)
Q Consensus 302 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 355 (622)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|++.+..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 68999 999987543211 00125788999999999
Q ss_pred cccc--eeeeeeeeCCCceeEEeeeccC-C----CccccccCCCCCChhHHHHHHHHHHHHHHHHH-hcCCCCeeecCCC
Q 036225 356 HRNL--LRLYGFCMTPTERLLVYPYMSN-G----SVASRLKGKPILDWSTRKRIALGAARGLLYLH-EQCDPKIIHRDVK 427 (622)
Q Consensus 356 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlk 427 (622)
|+++ ..++++ ...++||||+.+ | +|.+.... .++.....++.|++.||.||| +. +|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 8864 334432 367899999942 4 44444321 235577899999999999999 87 99999999
Q ss_pred CCCeeecCCCceEEcccccceecC
Q 036225 428 AANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 428 ~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
|+|||+++ .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999997653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-19 Score=169.30 Aligned_cols=145 Identities=23% Similarity=0.266 Sum_probs=126.3
Q ss_pred CCCccceEEcCCC----------cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 61 PCSWTMVTCSPES----------LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 61 ~C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
.|.|++|.|+..+ .++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 3789999997532 488999999999988777899999999999999999976666789999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+. +.+++++|++.|.++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 999966666789999999999999999977777789999999999999999977665432 567899999988764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=164.88 Aligned_cols=143 Identities=22% Similarity=0.291 Sum_probs=116.6
Q ss_pred CCccceEEcCCC----------cEEEEecCCCCCccccCC-cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 62 CSWTMVTCSPES----------LVIGLGIPSQNLSGTLSP-SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 62 C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
|.|+.|.|+..+ .++.|+|++|++++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 788888887532 478899999999877664 488999999999999999988888999999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc----cccccccccccccC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICAT 204 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N~~~c~~ 204 (622)
|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+|++..+-... +...+.++...|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence 999987777888999999999999999988888999999999999999999987763221 22244556555654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=167.44 Aligned_cols=127 Identities=24% Similarity=0.238 Sum_probs=96.2
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|++.+..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 116 (251)
T 3m19_A 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG 116 (251)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence 66788888888888777888888888888888888877777788888888888888888866666677788888888888
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
|+|++..+..|..+++|+.|+|++|+|++..|..+. +.+++++|.+.
T Consensus 117 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 888755555667777777888877777765553322 45566676653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=198.77 Aligned_cols=134 Identities=33% Similarity=0.578 Sum_probs=123.6
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
.++++.|.+.|.+|..++++++|++|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 35677789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccceeEEeCCCCcCCCcCCCCCc----cccccccccccccCCCCCCCc
Q 036225 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATGSEPDCY 211 (622)
Q Consensus 157 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N~~~c~~~~~~~c~ 211 (622)
++|.+|..+..+++|+.|+|++|+|+|.||.... ....+.|||.+|+.+.. .|.
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~ 749 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD 749 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence 9999999999999999999999999999997532 34678999999997644 664
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-19 Score=195.42 Aligned_cols=138 Identities=19% Similarity=0.239 Sum_probs=96.1
Q ss_pred CCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccC-CCCcccEEEecCccccCCCCch
Q 036225 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG-RLTKLQTLDLSNNFFTGEIPSS 140 (622)
Q Consensus 62 C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~ 140 (622)
|.+.++.|.....+..|+|++|++++..|..|+++++|++|+|++|.|++.+|..+. ++++|+.|+|++|.|++. |.
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 556666665555677777777777777777777777777777777777776776665 677777777777777744 32
Q ss_pred hccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccccc
Q 036225 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICA 203 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~ 203 (622)
+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|..+. +.+++++|++.|+
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 3357777777888887774 44457777778888888887775 443321 4566777777665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=154.13 Aligned_cols=126 Identities=24% Similarity=0.276 Sum_probs=101.7
Q ss_pred CCccceEEcCCC----------cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc
Q 036225 62 CSWTMVTCSPES----------LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN 131 (622)
Q Consensus 62 C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 131 (622)
|+|++|.|+..+ .++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 789999997532 4778888888888777777888888888888888888666666788888888888888
Q ss_pred cccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCC
Q 036225 132 FFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
.|++..+..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 88866666678888888888888888855555667888888888888888887763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=172.14 Aligned_cols=143 Identities=14% Similarity=0.122 Sum_probs=102.1
Q ss_pred CCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-------------chhHHHHHHHHHHhccccccceeeeeeee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-------------GGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
-|.+...||+|+||.||+|...+|+.||||+++..... ........+.++.....|+|+.+++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 37889999999999999999999999999987643110 00112223333333334555444433222
Q ss_pred CC------CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---
Q 036225 368 TP------TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE--- 438 (622)
Q Consensus 368 ~~------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~--- 438 (622)
.. ...++||||++++.|..+... +....++.|++.+|.|||+. +||||||||.|||+++++.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence 11 233699999999888766532 23467889999999999998 9999999999999988773
Q ss_pred -------eEEcccccceecCC
Q 036225 439 -------AVVGDFGLAKLLDH 452 (622)
Q Consensus 439 -------~kl~Dfgla~~~~~ 452 (622)
+.|+||+-+....+
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp TTSEEEEEEECCCTTCEETTS
T ss_pred ccccccceEEEEeCCcccCCC
Confidence 89999998875543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.2e-17 Score=154.81 Aligned_cols=133 Identities=23% Similarity=0.343 Sum_probs=116.6
Q ss_pred ceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCC-ccCCCCcccEEEecCccccCCCCchhccc
Q 036225 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPA-EIGRLTKLQTLDLSNNFFTGEIPSSLGHL 144 (622)
Q Consensus 66 gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 144 (622)
+.+|.. ..|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+
T Consensus 5 ~C~C~~----~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 77 (192)
T 1w8a_A 5 MCHCEG----TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77 (192)
T ss_dssp TSEEET----TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred CCEECC----CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc
Confidence 456754 47899999995 67776654 999999999999966664 48999999999999999998889999999
Q ss_pred cCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 145 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|++.|.++
T Consensus 78 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999999999999988888899999999999999999998887553 568899999998875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-17 Score=168.07 Aligned_cols=130 Identities=25% Similarity=0.429 Sum_probs=92.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.|+|++|.+++.+|..+..++ |++|+|++|.+++.+|..|.++++|+.|+|++|.+++.+|. +..+++|++|+|++
T Consensus 176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~ 253 (313)
T 1ogq_A 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRN 253 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCS
T ss_pred CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcC
Confidence 44555555555555555555554 55555555556556666667777777777777777755554 67778888888888
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccccccCCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLICATGS 206 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c~~~~ 206 (622)
|+|++.+|..+..+++|+.|+|++|+|+|.+|... .+.+++.+|+++|+.+.
T Consensus 254 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp SCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred CcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence 88888888888888888888888888888888752 14577889998888643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=158.08 Aligned_cols=133 Identities=21% Similarity=0.215 Sum_probs=108.6
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 35788888888888877777888888999999999888777777888888999999999888666666788888999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
++|++++..+..+..+++|+.|+|++|++++..|..+. +.+++.+|++.|.++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99988877777788888899999999998887775432 457888898887764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.9e-17 Score=169.47 Aligned_cols=123 Identities=27% Similarity=0.294 Sum_probs=99.2
Q ss_pred CCccceEEcCC----------CcEEEEecCCCCCccccCCccc-CCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 62 CSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIG-NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 62 C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
|.|+.|.|+.. ..+..|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 67888888642 1367899999999888777777 888889999988888877677788888888888888
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCc
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGP 184 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~ 184 (622)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l 151 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF 151 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee
Confidence 888866666788888888888888888876677888888888888888888753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=150.01 Aligned_cols=125 Identities=23% Similarity=0.323 Sum_probs=97.1
Q ss_pred EecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccc
Q 036225 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157 (622)
Q Consensus 78 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 157 (622)
+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 455566666 4565543 57888888888888 7778888888888888888888876677788888888888888888
Q ss_pred ccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 158 SGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
++..|..|..+++|+.|+|++|+|++..+..+. +.+++.+|+|.|.|..
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 877777888888888888888888865554332 4677888998887753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=156.27 Aligned_cols=126 Identities=25% Similarity=0.344 Sum_probs=87.8
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.|+|++|++++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 39 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 118 (270)
T 2o6q_A 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118 (270)
T ss_dssp CSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCS
T ss_pred CCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCC
Confidence 56677777777766666777777777777777777744444567777777777777777755555667777777777777
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
|++++..|..|..+++|+.|+|++|+|++..+..+. +.+++++|.+
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 119 NQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 777766666677777777777777777755443322 4456666665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=149.10 Aligned_cols=125 Identities=24% Similarity=0.313 Sum_probs=111.8
Q ss_pred CCCccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 61 PCSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 61 ~C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
.|.|..|.|+.. ..++.|+|++|+++ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 367888888653 24889999999998 6788999999999999999999988888899999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99998778889999999999999999996666679999999999999999986544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.2e-16 Score=157.17 Aligned_cols=130 Identities=23% Similarity=0.230 Sum_probs=104.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++. .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence 4677888888877 567788888889999999999987666788889999999999999986666667888899999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
+|+|++..+..|..+++|+.|+|++|+|+ .+|.... +.+.+.+|||.|.|.
T Consensus 157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 99998555556788889999999999988 4554332 457788999998874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.3e-16 Score=154.78 Aligned_cols=131 Identities=24% Similarity=0.265 Sum_probs=71.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|.+.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.|++..+..|..+++|+.|+|++
T Consensus 87 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 166 (270)
T 2o6q_A 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYN 166 (270)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecC
Confidence 44555555555544444455555555555555555544444455555555555555555533333455566666666666
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|++++..+..|..+++|+.|+|++|++++..+..+. +.+++.+|||.|.|.
T Consensus 167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 666544444555566666666666666644333221 345566666666553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=177.60 Aligned_cols=129 Identities=19% Similarity=0.177 Sum_probs=114.4
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|||++|+|++..+.+|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 48899999999999888899999999999999999997777889999999999999999996666789999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCC-cCCCCCc-----cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-----KTFNIVGNPLIC 202 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~-----~~~~l~~N~~~c 202 (622)
+|+|++..+..|+++++|+.|+|++|.+++ .+|.... +.+++++|.+..
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence 999997767789999999999999999986 4565433 567888888743
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=3.9e-16 Score=157.00 Aligned_cols=131 Identities=21% Similarity=0.246 Sum_probs=76.1
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 186 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (285)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCC
Confidence 45555555555555555555566666666666666544444455566666666666666543334455666666666666
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCC-----ccccccccccccccCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS-----AKTFNIVGNPLICATG 205 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-----~~~~~l~~N~~~c~~~ 205 (622)
|++++..|..|..+++|+.|+|++|++++..|..+ .+.+++++|++.|.|.
T Consensus 187 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 66665556666666666666666666665433211 1446677777776654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=150.21 Aligned_cols=130 Identities=24% Similarity=0.277 Sum_probs=79.0
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 60 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 139 (251)
T 3m19_A 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECc
Confidence 35666666666666666666666666666666666665555556666666666666666664444445666666666666
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICA 203 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~ 203 (622)
+|+|++..+..|..+++|+.|+|++|+|++..|..+. +.+++.+|++.|.
T Consensus 140 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 140 TNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6666644444566666666666666666655443321 3455666666554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.8e-16 Score=165.93 Aligned_cols=133 Identities=20% Similarity=0.219 Sum_probs=122.6
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++.+.+|..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|++|+|+
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 355 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence 58899999999999999999999999999999999998889999999999999999999998888999999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
+|++++..|..|..+++|+.|+|++|+|++..+..+. +.+++++|++.|.|+.
T Consensus 356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 9999988899999999999999999999976664432 5688999999998863
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.6e-16 Score=149.10 Aligned_cols=115 Identities=17% Similarity=0.190 Sum_probs=108.2
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 35889999999999988889999999999999999999888888999999999999999999888999999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
++|+|++..|..|..+++|+.|+|++|++++..+-
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 99999988899999999999999999999987763
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=7.1e-16 Score=156.76 Aligned_cols=132 Identities=20% Similarity=0.276 Sum_probs=91.9
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCC-CCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.+..|+|++|.+.+..+..|.++++|++|+|++|.+++ .+|..+.++++|++|+|++|.+++..|..|..+++|+.|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 35667777777776666667777777777777777765 46667777777777777777777666667777777777777
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc------cccccccccccccCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA------KTFNIVGNPLICATG 205 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~------~~~~l~~N~~~c~~~ 205 (622)
++|++++..+..+..+++|+.|+|++|++++.+|..+. +.+++++|++.|.|.
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 77777755555677777777777777777776664322 346677777777654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.3e-15 Score=137.49 Aligned_cols=133 Identities=21% Similarity=0.252 Sum_probs=111.5
Q ss_pred ceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhcccc
Q 036225 66 MVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLR 145 (622)
Q Consensus 66 gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 145 (622)
+-+|+. ..+++++++++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..++
T Consensus 4 ~C~C~~----~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 76 (177)
T 2o6r_A 4 RCSCSG----TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT 76 (177)
T ss_dssp TCEEET----TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEeCC----CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCC
Confidence 456753 568899999885 45444 47999999999999977777789999999999999999966666789999
Q ss_pred CccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 146 SLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 146 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
+|++|+|++|+|++..+..+..+++|+.|+|++|+|++..+..+. +.+++++|++.|.++
T Consensus 77 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 77 KLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999999999999977777789999999999999999976665432 567899999988764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-15 Score=136.46 Aligned_cols=126 Identities=19% Similarity=0.193 Sum_probs=108.5
Q ss_pred CcEEEEecCCCCCc-cccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 73 SLVIGLGIPSQNLS-GTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 73 ~~v~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
..++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34889999999998 88999999999999999999999965 7899999999999999999987898888899999999
Q ss_pred cccccccccc-ccccccccceeEEeCCCCcCCCcCC---CCC-----ccccccccccc
Q 036225 152 FNNNSLSGAF-PTSLASMTQLIFLDLSYNNLSGPVP---RFS-----AKTFNIVGNPL 200 (622)
Q Consensus 152 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g~~p---~~~-----~~~~~l~~N~~ 200 (622)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+ .+.+++.+|..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 9999999532 2789999999999999999997655 111 24566666665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.8e-15 Score=169.33 Aligned_cols=133 Identities=20% Similarity=0.276 Sum_probs=121.0
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCC-CCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNI-TGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.+..++++.|++.+..+..+..+++|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L 525 (635)
T 4g8a_A 446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 525 (635)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence 367889999999999999999999999999999985 4467889999999999999999999888999999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc------cccccccccccccCCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA------KTFNIVGNPLICATGS 206 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~------~~~~l~~N~~~c~~~~ 206 (622)
++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|||.|+|..
T Consensus 526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999988888999999999999999999999887542 4578999999999864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.4e-15 Score=161.67 Aligned_cols=128 Identities=19% Similarity=0.170 Sum_probs=111.6
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 48899999999999999999999999999999999998888999999999999999999996666779999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCC-C-----cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-S-----AKTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~-----~~~~~l~~N~~~ 201 (622)
+|+|++..+..|..+++|+.|+|++|+..+.+|.. + .+.+++++|.+.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 99999666678999999999999996665566542 1 256778888764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-15 Score=135.47 Aligned_cols=111 Identities=21% Similarity=0.241 Sum_probs=101.9
Q ss_pred cEEEEecCCCCCc-cccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLS-GTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.++.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..++++++|++|+|++|.+++.+|..+..+++|++|+|
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 4789999999999 88999999999999999999999965 68999999999999999999879998989999999999
Q ss_pred cccccccc-cccccccccceeEEeCCCCcCCCcCC
Q 036225 153 NNNSLSGA-FPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 153 ~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
++|++++. .|..+..+++|+.|++++|++++..+
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999963 45889999999999999999997654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=6.9e-15 Score=135.77 Aligned_cols=108 Identities=25% Similarity=0.310 Sum_probs=95.1
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
.|++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45667778875 67666 3899999999999998889999999999999999999997666678999999999999999
Q ss_pred cccccccccccccceeEEeCCCCcCCCcCCC
Q 036225 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 157 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
|++..+..|..+++|+.|+|++|++++..+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9976667899999999999999999987663
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=5.3e-15 Score=147.93 Aligned_cols=127 Identities=19% Similarity=0.185 Sum_probs=108.3
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 38899999999998877789999999999999999997777789999999999999999997777889999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCC-cCCCCCc-----cccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~-----~~~~l~~N~~ 200 (622)
+|++++..+..+..+++|+.|+|++|++++ .+|..+. +.+++++|.+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 999997666689999999999999999986 3565433 4566777765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.2e-15 Score=142.76 Aligned_cols=114 Identities=17% Similarity=0.182 Sum_probs=104.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 35889999999999999999999999999999999999655566899999999999999999888899999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
++|+|++..+..|..+++|+.|+|++|++....+
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9999997777889999999999999999986543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=160.97 Aligned_cols=141 Identities=20% Similarity=0.229 Sum_probs=122.2
Q ss_pred CCCccc--eEEcCC---------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCC-CCccCCCCcccEEEe
Q 036225 61 PCSWTM--VTCSPE---------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPI-PAEIGRLTKLQTLDL 128 (622)
Q Consensus 61 ~C~w~g--v~C~~~---------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L 128 (622)
.|.|.+ |.|+.. ..++.|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 455555 777643 34899999999999999999999999999999999998766 567999999999999
Q ss_pred cCccccCCCCchhccccCccceeccccccccccccc--cccccceeEEeCCCCcCCCcCCCC-C-----ccccccccccc
Q 036225 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTS--LASMTQLIFLDLSYNNLSGPVPRF-S-----AKTFNIVGNPL 200 (622)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~g~~p~~-~-----~~~~~l~~N~~ 200 (622)
++|.+++..|..|.++++|++|+|++|++++.+|.. +..+++|++|+|++|++++..|.. + .+.+++++|.+
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 999999888999999999999999999999866665 999999999999999999988864 2 25678888886
Q ss_pred c
Q 036225 201 I 201 (622)
Q Consensus 201 ~ 201 (622)
.
T Consensus 167 ~ 167 (455)
T 3v47_A 167 K 167 (455)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.1e-15 Score=142.11 Aligned_cols=126 Identities=19% Similarity=0.210 Sum_probs=110.7
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 35889999999999877778899999999999999999776777899999999999999999766667899999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~N~~ 200 (622)
++|++++..+..+..+++|+.|+|++|++.+..|.. +.+.+.+|.+
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~L~~~~n~~ 177 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKH 177 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT--HHHHHHHHHC
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCCCH--HHHHHHHHhC
Confidence 999999766677999999999999999999988854 4555666665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=8.1e-15 Score=146.58 Aligned_cols=86 Identities=17% Similarity=0.317 Sum_probs=43.3
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCC-CCchhccccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE-IPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~ 153 (622)
+..|+|++|.+++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|.+++. +|..+..+++|++|+|+
T Consensus 78 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls 157 (276)
T 2z62_A 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECC
T ss_pred CCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECC
Confidence 44455555555544444455555555555555555543333455555555555555555432 35555555555555555
Q ss_pred ccccccc
Q 036225 154 NNSLSGA 160 (622)
Q Consensus 154 ~N~l~~~ 160 (622)
+|++++.
T Consensus 158 ~N~l~~~ 164 (276)
T 2z62_A 158 SNKIQSI 164 (276)
T ss_dssp SSCCCEE
T ss_pred CCCCCcC
Confidence 5555533
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=134.54 Aligned_cols=108 Identities=22% Similarity=0.248 Sum_probs=95.4
Q ss_pred EEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccc
Q 036225 76 IGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155 (622)
Q Consensus 76 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 155 (622)
+.+++++|++. .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46889999986 6777664 89999999999999888999999999999999999999655556799999999999999
Q ss_pred ccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 156 SLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
+|++..+..|..+++|+.|+|++|+|....+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9996655669999999999999999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4.7e-15 Score=165.42 Aligned_cols=129 Identities=19% Similarity=0.163 Sum_probs=113.6
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 35889999999999988889999999999999999999888889999999999999999999877999999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCC-cCCCCCc-----ccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~-----~~~~l~~N~~~ 201 (622)
++|++++..|..+.++++|++|+|++|.+++ .+|..+. +.+++++|.+.
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~ 166 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcce
Confidence 9999997777889999999999999999986 6676543 46778888764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=7e-15 Score=147.78 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=117.9
Q ss_pred CCccceEEcCC---CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcc-ccCCC
Q 036225 62 CSWTMVTCSPE---SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF-FTGEI 137 (622)
Q Consensus 62 C~w~gv~C~~~---~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~ 137 (622)
|++.|++..+. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...
T Consensus 18 c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~ 97 (285)
T 1ozn_A 18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97 (285)
T ss_dssp CCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCC
T ss_pred cCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccC
Confidence 44444443332 358899999999999888889999999999999999998889999999999999999997 77666
Q ss_pred CchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 138 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+. +.+++++|.+.
T Consensus 98 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 88899999999999999999988888999999999999999999976665432 56778888763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.9e-15 Score=165.05 Aligned_cols=140 Identities=21% Similarity=0.282 Sum_probs=120.4
Q ss_pred CCCccceEEcCC------------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEe
Q 036225 61 PCSWTMVTCSPE------------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDL 128 (622)
Q Consensus 61 ~C~w~gv~C~~~------------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 128 (622)
.|.|.|+ |+.. ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888887 7532 25899999999999999999999999999999999999888899999999999999
Q ss_pred cCccccCCCCchhccccCccceecccccccc-ccccccccccceeEEeCCCCcCCCcCCC-CCc-----ccccccccccc
Q 036225 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSG-AFPTSLASMTQLIFLDLSYNNLSGPVPR-FSA-----KTFNIVGNPLI 201 (622)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~-----~~~~l~~N~~~ 201 (622)
++|.+++..|..|+++++|++|+|++|++++ .+|..+.++++|+.|++++|++.+.+|. .+. +.+++++|.+.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997777779999999999999999986 4678899999999999999997777763 222 45677777763
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.5e-15 Score=157.70 Aligned_cols=113 Identities=25% Similarity=0.344 Sum_probs=93.4
Q ss_pred cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccce
Q 036225 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQL 171 (622)
Q Consensus 92 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 171 (622)
.|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..|..|..+++|
T Consensus 180 ~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 257 (440)
T 3zyj_A 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257 (440)
T ss_dssp TTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTC
T ss_pred hhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCC
Confidence 4566777777777777777 556 47788888888888898887778889999999999999999998888889999999
Q ss_pred eEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 172 IFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 172 ~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
+.|+|++|+|++..+..+. +.+++.+|||.|+|..
T Consensus 258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 9999999999976665432 5688999999999864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-15 Score=172.89 Aligned_cols=108 Identities=30% Similarity=0.483 Sum_probs=60.3
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 4555555554 34444555555555555555555 55555555555555555555555 555555555555555555555
Q ss_pred cccccccccccccceeEEeCCCCcCCCcCCCC
Q 036225 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188 (622)
Q Consensus 157 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~ 188 (622)
|+ .+|..|..|++|+.|+|++|+|+|.+|..
T Consensus 305 l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~ 335 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKI 335 (727)
T ss_dssp CC-CCCSSTTSCTTCCCEECTTSCCCSHHHHH
T ss_pred CC-ccChhhhcCCCccEEeCCCCccCCCChHH
Confidence 54 55555555555555555555555555543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.2e-15 Score=166.76 Aligned_cols=133 Identities=20% Similarity=0.229 Sum_probs=112.9
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCC-CCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.+..|+|++|++.+..|..+.++++|++|+|++|.+++ .+|..|.++++|+.|+|++|++++..|..|.++++|++|+|
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 47788888888888888888888899999999998887 47888899999999999999999888888999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC------ccccccccccccccCCCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS------AKTFNIVGNPLICATGSE 207 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~------~~~~~l~~N~~~c~~~~~ 207 (622)
++|++++.+|..+..+++|+.|+|++|+|+ .+|..+ .+.+++++||+.|.|+..
T Consensus 505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 999999888899999999999999999998 455432 256789999999988753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.2e-15 Score=146.16 Aligned_cols=146 Identities=16% Similarity=0.196 Sum_probs=116.1
Q ss_pred CCCCCCCCCCccceE--EcC-------CCcEEEEecCCCCCccccCCcccCCCcccEEEccCCC-CCCCCCCccCCCCcc
Q 036225 54 WDEDAVDPCSWTMVT--CSP-------ESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNN-ITGPIPAEIGRLTKL 123 (622)
Q Consensus 54 W~~~~~~~C~w~gv~--C~~-------~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L 123 (622)
|++..+.|..|.+++ |.. ...++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|
T Consensus 3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L 82 (239)
T 2xwt_C 3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82 (239)
T ss_dssp CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTC
T ss_pred CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCC
Confidence 444433322335554 854 2358899999999998888899999999999999997 886666689999999
Q ss_pred cEEEecC-ccccCCCCchhccccCccceecccccccccccccccccccee---EEeCCCC-cCCCcCCCCCc-----c-c
Q 036225 124 QTLDLSN-NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLI---FLDLSYN-NLSGPVPRFSA-----K-T 192 (622)
Q Consensus 124 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~l~l~~N-~l~g~~p~~~~-----~-~ 192 (622)
++|+|++ |.+++..+..|.++++|++|+|++|++++ +|. +..+++|+ .|++++| .+++..+..+. + .
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEE
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeE
Confidence 9999999 99996666789999999999999999995 776 88888887 9999999 88866554332 3 6
Q ss_pred ccccccccc
Q 036225 193 FNIVGNPLI 201 (622)
Q Consensus 193 ~~l~~N~~~ 201 (622)
+++++|.+.
T Consensus 161 L~l~~n~l~ 169 (239)
T 2xwt_C 161 LKLYNNGFT 169 (239)
T ss_dssp EECCSCCCC
T ss_pred EEcCCCCCc
Confidence 677788764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.4e-15 Score=154.13 Aligned_cols=139 Identities=20% Similarity=0.290 Sum_probs=115.7
Q ss_pred CCCCccceEEcCC------------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEE
Q 036225 60 DPCSWTMVTCSPE------------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLD 127 (622)
Q Consensus 60 ~~C~w~gv~C~~~------------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 127 (622)
.+|.|.|+ |+.. ..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 56888887 6421 2488999999999987777999999999999999999988888899999999999
Q ss_pred ecCccccCCCCchhccccCccceecccccccccccc--ccccccceeEEeCCCCc-CCCcCCCCCc-----ccccccccc
Q 036225 128 LSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPT--SLASMTQLIFLDLSYNN-LSGPVPRFSA-----KTFNIVGNP 199 (622)
Q Consensus 128 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~-l~g~~p~~~~-----~~~~l~~N~ 199 (622)
|++|.+++..+..|.++++|++|+|++|+++ .+|. .+..+++|+.|++++|+ +++..|..+. +.+++++|.
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 9999999544445999999999999999999 5555 78999999999999995 5554444432 456777877
Q ss_pred c
Q 036225 200 L 200 (622)
Q Consensus 200 ~ 200 (622)
+
T Consensus 186 l 186 (353)
T 2z80_A 186 L 186 (353)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=140.88 Aligned_cols=113 Identities=22% Similarity=0.214 Sum_probs=104.3
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++.+..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 35889999999998777778899999999999999999777777899999999999999999 89999999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999997666789999999999999999998776
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=144.06 Aligned_cols=126 Identities=21% Similarity=0.218 Sum_probs=112.6
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|++|+|
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 35889999999999888888999999999999999999777777899999999999999999777777899999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~N~~ 200 (622)
++|++++..|..+..+++|+.|+|++|++.+.+|.. +.+.+.+|.+
T Consensus 189 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~l~~~~n~~ 234 (272)
T 3rfs_A 189 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKH 234 (272)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT--HHHHHHHHHT
T ss_pred CCCcCCccCHHHHhCCcCCCEEEccCCCccccCcHH--HHHHHHHHhC
Confidence 999999888888999999999999999999998854 4455555554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.3e-15 Score=151.31 Aligned_cols=127 Identities=20% Similarity=0.248 Sum_probs=115.6
Q ss_pred CcEEEEecCCCCCccccCCcccC---------CCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhcc
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGN---------LTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 143 (622)
..+..|+|++|++.+.+|..+.. +++|++|+|++|+|+ .+|..++++++|++|+|++|.++ .+|..+..
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~ 227 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhcc
Confidence 35899999999999999988765 999999999999999 89999999999999999999999 57778999
Q ss_pred ccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 144 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+. +.+++++|+..
T Consensus 228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 99999999999999999999999999999999999999999997553 46788898863
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=155.46 Aligned_cols=131 Identities=24% Similarity=0.296 Sum_probs=105.1
Q ss_pred cEEEEecCCCCCccccCC-------------------------cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEe
Q 036225 74 LVIGLGIPSQNLSGTLSP-------------------------SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDL 128 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 128 (622)
.+..|+|++|++.+..+. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|
T Consensus 148 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~L 225 (452)
T 3zyi_A 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEM 225 (452)
T ss_dssp TCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEEC
T ss_pred CCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEEC
Confidence 467777777776654333 3556677777777777777 445 5778888888999
Q ss_pred cCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccccc
Q 036225 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICA 203 (622)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~ 203 (622)
++|.|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+. +.+++.+|||.|.
T Consensus 226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 99999888888899999999999999999988888999999999999999999976665442 5688999999999
Q ss_pred CCC
Q 036225 204 TGS 206 (622)
Q Consensus 204 ~~~ 206 (622)
|..
T Consensus 306 C~~ 308 (452)
T 3zyi_A 306 CDI 308 (452)
T ss_dssp TTT
T ss_pred CCc
Confidence 864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=156.14 Aligned_cols=138 Identities=20% Similarity=0.177 Sum_probs=115.9
Q ss_pred ccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccc
Q 036225 64 WTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133 (622)
Q Consensus 64 w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 133 (622)
|..|.|... ..+..|+|++|++.+..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 567777642 2478899999999999999999999999999999999977778999999999999999999
Q ss_pred cCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCC-C-----cccccccccccc
Q 036225 134 TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-S-----AKTFNIVGNPLI 201 (622)
Q Consensus 134 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~-----~~~~~l~~N~~~ 201 (622)
++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+..+.+|.. + .+.+++++|.+.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9666667999999999999999999666678999999999999996665565542 2 245677888764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.5e-15 Score=171.90 Aligned_cols=131 Identities=24% Similarity=0.307 Sum_probs=105.7
Q ss_pred cEEEEecCCCCCccccCC-cccCCCcccEEEccCCCCC-----CCCCCccCCCCcccEEEecCccccCCCCchhccccCc
Q 036225 74 LVIGLGIPSQNLSGTLSP-SIGNLTNLQIVLLQNNNIT-----GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 147 (622)
.+..|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|..+++|
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 506 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence 466777777777765443 3556788888888888886 4445678889999999999999998888888999999
Q ss_pred cceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc--cccccccccccccCCC
Q 036225 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA--KTFNIVGNPLICATGS 206 (622)
Q Consensus 148 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~~~~l~~N~~~c~~~~ 206 (622)
+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+. +.++++|||+.|.|..
T Consensus 507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 9999999999976666665 8899999999999999887654 5678999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=156.51 Aligned_cols=138 Identities=16% Similarity=0.151 Sum_probs=120.8
Q ss_pred CccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcc
Q 036225 63 SWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF 132 (622)
Q Consensus 63 ~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 132 (622)
.|..|.|+.. ..+..|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4678888642 247899999999999989999999999999999999998889999999999999999999
Q ss_pred ccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 133 FTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 133 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+. +.+++++|.+
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 9955556689999999999999999988899999999999999999999987775443 4567778765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.4e-15 Score=163.49 Aligned_cols=151 Identities=13% Similarity=0.087 Sum_probs=95.5
Q ss_pred CCCCCCCCCCCCCCC----ccceEEcC------C-----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCC
Q 036225 49 GVLENWDEDAVDPCS----WTMVTCSP------E-----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNN 107 (622)
Q Consensus 49 ~~l~~W~~~~~~~C~----w~gv~C~~------~-----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 107 (622)
..+++|.+. .+||. |.++.|+. . ..+..|++++|.+....+..|.++++|++|+|++|
T Consensus 7 ~~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 7 YNVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ----CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred ccccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 357889764 36663 66655531 0 12455666666666554445666777777777777
Q ss_pred CCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCC
Q 036225 108 NITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 108 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|..+++|+.|+|++|.|++.+|.
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 77766666777777777777777777766666677777777777777777744444457777777777777777766665
Q ss_pred CCc-----cccccccccc
Q 036225 188 FSA-----KTFNIVGNPL 200 (622)
Q Consensus 188 ~~~-----~~~~l~~N~~ 200 (622)
.+. +.+++++|.+
T Consensus 166 ~~~~l~~L~~L~L~~N~l 183 (597)
T 3oja_B 166 TFQATTSLQNLQLSSNRL 183 (597)
T ss_dssp TTTTCTTCCEEECTTSCC
T ss_pred hhhcCCcCcEEECcCCCC
Confidence 332 3456666655
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=161.30 Aligned_cols=138 Identities=19% Similarity=0.145 Sum_probs=122.0
Q ss_pred ccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccc
Q 036225 64 WTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133 (622)
Q Consensus 64 w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 133 (622)
+.-|.|+.. ..++.|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455777542 2489999999999999999999999999999999999988899999999999999999999
Q ss_pred cCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCC-cCCCCCc----ccccccccccc
Q 036225 134 TGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA----KTFNIVGNPLI 201 (622)
Q Consensus 134 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~----~~~~l~~N~~~ 201 (622)
++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++ .+|.... +.+++++|.+.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 98889999999999999999999997768889999999999999999997 4465432 56788888764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.9e-15 Score=149.90 Aligned_cols=140 Identities=23% Similarity=0.279 Sum_probs=117.2
Q ss_pred CCCccceEEcCCC----------cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCC--CCCCccCCCCcccEEEe
Q 036225 61 PCSWTMVTCSPES----------LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG--PIPAEIGRLTKLQTLDL 128 (622)
Q Consensus 61 ~C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L 128 (622)
.|.|++|.|+..+ .++.|+|++|+++...+..|.++++|++|+|++|.++. ..|..+.++++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 3899999997532 48899999999996655668999999999999999983 33667778999999999
Q ss_pred cCccccCCCCchhccccCccceeccccccccccc-cccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFP-TSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+++..|..+. +.+++++|.+.
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 999998 678889999999999999999995554 5789999999999999999987776543 46778888764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-14 Score=162.45 Aligned_cols=130 Identities=22% Similarity=0.293 Sum_probs=90.4
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCC---CCCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG---PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
+..|+|++|.+.+..|..+.++++|++|+|++|.+++ ..+..+..+++|++|+|++|.+++..|..|..+++|+.|+
T Consensus 427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 506 (606)
T 3t6q_A 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506 (606)
T ss_dssp CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence 5566666666666666666666667777777776664 2234566677777777777777766667777777777777
Q ss_pred ccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 152 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|++|++++..|..+..+++| .|+|++|++++.+|..+. +.+++++||+.|.|.
T Consensus 507 Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 77777777777777777777 777777777766665332 567888888888765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.8e-14 Score=140.92 Aligned_cols=125 Identities=23% Similarity=0.225 Sum_probs=86.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|++++..+..|.++++|++|+|++|.|++ +|.. +.+++|++|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 47788888888887777778888888888888777774 3322 66777777777777776 666666777777777777
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
+|+|++..|..|..+++|+.|+|++|+|++..|..+. +.+++++|.+.
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 7777755556677777777777777777755444322 34566666653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-14 Score=148.32 Aligned_cols=132 Identities=16% Similarity=0.156 Sum_probs=105.6
Q ss_pred CCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccC-CCCCCCCCCccCCCCcccEEEecCccccCCCCch
Q 036225 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQN-NNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140 (622)
Q Consensus 62 C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 140 (622)
|.|..|.|++. |+|++ +|. |..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..
T Consensus 8 C~~~~v~~~~~----------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCTRD----------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECCSS----------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcCCC----------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 88888887532 25664 788 99999999999996 9999777789999999999999999999988889
Q ss_pred hccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC------ccccccccccccccCCC
Q 036225 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS------AKTFNIVGNPLICATGS 206 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~------~~~~~l~~N~~~c~~~~ 206 (622)
|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|+|.....-.. .....+..+...|..+.
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99999999999999999965556666665 9999999999986543111 12233455667776543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=158.96 Aligned_cols=132 Identities=20% Similarity=0.294 Sum_probs=101.2
Q ss_pred EEEEecCCCCCccccC-CcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcccc-CCCCchhccccCccceec
Q 036225 75 VIGLGIPSQNLSGTLS-PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT-GEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l 152 (622)
+..|+|++|.+.+..| ..+.++++|++|+|++|.+++..|..|.++++|+.|+|++|.++ +.+|..+..+++|+.|+|
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l 477 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence 4556666666666555 45777788888888888888777777888888888888888887 567878888888888888
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
++|++++..|..|..+++|+.|+|++|++++.+|..+. +.+++++|++.|.|+.
T Consensus 478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 88888877788888888888888888888877665432 4577888888887764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.8e-14 Score=156.95 Aligned_cols=108 Identities=24% Similarity=0.314 Sum_probs=101.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++++++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 6789999999997 565 999999999999999999 899999999999999999999995 78 899999999999999
Q ss_pred ccccccc-ccccccccceeEEeCCCCcCCCcCCC
Q 036225 155 NSLSGAF-PTSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 155 N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
|+|++.. |..|..+++|+.|+|++|+|++.+|.
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 9999776 99999999999999999999987764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-14 Score=162.92 Aligned_cols=127 Identities=22% Similarity=0.344 Sum_probs=117.7
Q ss_pred CcEEEEecCCCCCccc-----------------cCCccc--CCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcc-
Q 036225 73 SLVIGLGIPSQNLSGT-----------------LSPSIG--NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF- 132 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~- 132 (622)
..+..|+|++|.++|. +|+.++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 4588999999999996 999999 99999999999999999999999999999999999998
Q ss_pred ccC-CCCchhccc------cCccceecccccccccccc--ccccccceeEEeCCCCcCCCcCCCCCc-----cccccccc
Q 036225 133 FTG-EIPSSLGHL------RSLQYMRFNNNSLSGAFPT--SLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGN 198 (622)
Q Consensus 133 l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N 198 (622)
++| .+|..++.+ ++|++|+|++|+++ .+|. .+..+++|+.|+|++|+++|.+| .+. +.+++++|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 998 899999887 99999999999999 8998 99999999999999999999999 432 56788899
Q ss_pred ccc
Q 036225 199 PLI 201 (622)
Q Consensus 199 ~~~ 201 (622)
.+.
T Consensus 364 ~l~ 366 (636)
T 4eco_A 364 QIT 366 (636)
T ss_dssp EEE
T ss_pred ccc
Confidence 875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.8e-14 Score=144.37 Aligned_cols=137 Identities=23% Similarity=0.306 Sum_probs=117.7
Q ss_pred CCccceEEcCCC----------cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc
Q 036225 62 CSWTMVTCSPES----------LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN 131 (622)
Q Consensus 62 C~w~gv~C~~~~----------~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 131 (622)
|.|+.+.|+..+ .++.|+|++|++.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 789999997432 4789999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCC--cCCCCC----cccccccccccc
Q 036225 132 FFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG--PVPRFS----AKTFNIVGNPLI 201 (622)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~~----~~~~~l~~N~~~ 201 (622)
.++ .+|..+. ++|++|+|++|++++..+..|..+++|+.|++++|+++. ..|..+ .+.+++++|.+.
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 999 7787765 899999999999996666779999999999999999963 445433 245677777763
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.3e-14 Score=150.79 Aligned_cols=126 Identities=14% Similarity=0.116 Sum_probs=100.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|++++|.+....+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 47 l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 126 (390)
T 3o6n_A 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126 (390)
T ss_dssp CSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCC
Confidence 56788888887765444578889999999999999877777888999999999999999877777788899999999999
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
|+++...+..|..+++|++|+|++|++++..|..+. +.+++++|.+
T Consensus 127 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 127 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred CccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC
Confidence 999843334468889999999999999877665432 4567777775
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=7.5e-14 Score=128.79 Aligned_cols=104 Identities=25% Similarity=0.267 Sum_probs=92.4
Q ss_pred ccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCC
Q 036225 99 LQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSY 178 (622)
Q Consensus 99 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 178 (622)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887774 8999999999999988888999999999999999999977777789999999999999
Q ss_pred CcCCCcCCCCCc-----cccccccccccccCC
Q 036225 179 NNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 179 N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|+|++..|..+. +.+++++|++.|.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999987775442 568899999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=4e-14 Score=164.01 Aligned_cols=138 Identities=22% Similarity=0.190 Sum_probs=104.3
Q ss_pred CCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCC-CCccCCCCcccEEEecCccccCCCCch
Q 036225 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPI-PAEIGRLTKLQTLDLSNNFFTGEIPSS 140 (622)
Q Consensus 62 C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 140 (622)
|.|..|.+ -...++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56777776 4456888999999998888888888888888888888666566 667888888888888888888777888
Q ss_pred hccccCccceeccccccccccccc--cccccceeEEeCCCCcCCCcCCC-CC-----ccccccccccc
Q 036225 141 LGHLRSLQYMRFNNNSLSGAFPTS--LASMTQLIFLDLSYNNLSGPVPR-FS-----AKTFNIVGNPL 200 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~g~~p~-~~-----~~~~~l~~N~~ 200 (622)
|.++++|++|+|++|.+++.+|.. |.++++|+.|+|++|.+++..|. .+ .+.+++++|.+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i 160 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence 888888888888888888766654 77888888888888888766542 21 13456666654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7e-14 Score=158.16 Aligned_cols=128 Identities=19% Similarity=0.208 Sum_probs=111.1
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 35889999999999988888999999999999999999888989999999999999999999544457999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
++|++++..|..|..+++|++|+|++|++++..|..+. +.+++++|.+
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc
Confidence 99999977778899999999999999999988776543 4567778765
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=4.3e-14 Score=144.33 Aligned_cols=126 Identities=18% Similarity=0.231 Sum_probs=80.7
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccC-CCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG-RLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
.+..|+|++|++++..+..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|.+++. |. ...+++|++|+|
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~L 198 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDL 198 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEEC
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEEC
Confidence 456666667777666666666777777777777777755555553 567777777777777633 32 234677777777
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICA 203 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~ 203 (622)
++|+++ .+|..+..+++|+.|+|++|+|++ +|..+. +.+++++|++.|+
T Consensus 199 s~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CSSCCC-EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCCcCC-cchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 777777 344557777777777777777773 443321 4566777777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=140.92 Aligned_cols=137 Identities=24% Similarity=0.369 Sum_probs=116.7
Q ss_pred CCCccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 61 PCSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 61 ~C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
.|.|+.+.|+.. ..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 368999999742 2478899999999998888999999999999999999988899999999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCC--cCCCCCc-----cccccccccc
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG--PVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~~~-----~~~~l~~N~~ 200 (622)
|.++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|+++. ..|..+. +.+++++|.+
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999 7777665 799999999999997777889999999999999999963 4443322 4566777765
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.2e-14 Score=157.20 Aligned_cols=132 Identities=23% Similarity=0.308 Sum_probs=103.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCC----C----CccCCCCcccEEEecCccccCCCCc-hhccc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPI----P----AEIGRLTKLQTLDLSNNFFTGEIPS-SLGHL 144 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----p----~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 144 (622)
.++.|+|++|++++..+..|.++++|++|+|++|++++.. | ..|.++++|+.|+|++|+++ .+|. .|.++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l 559 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDL 559 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccc
Confidence 4677888888888777777888888888888888887431 1 23677888888888888888 4554 58888
Q ss_pred cCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC------ccccccccccccccCCC
Q 036225 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS------AKTFNIVGNPLICATGS 206 (622)
Q Consensus 145 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~------~~~~~l~~N~~~c~~~~ 206 (622)
++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+ .+.+++++|||.|.|..
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999999986656667888999999999999988766432 25688999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=8.1e-14 Score=153.99 Aligned_cols=131 Identities=20% Similarity=0.281 Sum_probs=82.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCC--CCCccCCCCcccEEEecCccccCCCCch-hccc-----
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGP--IPAEIGRLTKLQTLDLSNNFFTGEIPSS-LGHL----- 144 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l----- 144 (622)
..++.|+|++|.+++.+|..++++++|++|+|++|++++. +|..|.++++|+.|+|++|.+++.+|.. +..+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 3466777777777776666777777777777777776642 2345666666666666666666544432 3333
Q ss_pred -----------------cCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCC-Cc-----ccccccccccc
Q 036225 145 -----------------RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-SA-----KTFNIVGNPLI 201 (622)
Q Consensus 145 -----------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~-----~~~~l~~N~~~ 201 (622)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. +. +.+++++||+.
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcC
Confidence 45666666666666 566666677777777777777773 4432 21 45677788877
Q ss_pred ccCC
Q 036225 202 CATG 205 (622)
Q Consensus 202 c~~~ 205 (622)
|.|+
T Consensus 511 c~c~ 514 (562)
T 3a79_B 511 CTCP 514 (562)
T ss_dssp CCHH
T ss_pred CCcc
Confidence 7664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=6.7e-14 Score=153.10 Aligned_cols=131 Identities=23% Similarity=0.349 Sum_probs=80.5
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCC--CCCCccCCCCcccEEEecCccccCCCCch-hccccC---
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITG--PIPAEIGRLTKLQTLDLSNNFFTGEIPSS-LGHLRS--- 146 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~--- 146 (622)
..+..|+|++|++++.+|..++++++|++|+|++|++++ .+|..+.++++|++|+|++|.+++.+|.. +..+++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 346677777777777777777777777777777777775 44555667777777777777776545543 444444
Q ss_pred -------------------ccceeccccccccccccccccccceeEEeCCCCcCCCcCCCC-C-----cccccccccccc
Q 036225 147 -------------------LQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF-S-----AKTFNIVGNPLI 201 (622)
Q Consensus 147 -------------------L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~-----~~~~~l~~N~~~ 201 (622)
|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. + .+.+++++|++.
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCc
Confidence 555555555555 455555566666666666666663 3332 1 134566666666
Q ss_pred ccCC
Q 036225 202 CATG 205 (622)
Q Consensus 202 c~~~ 205 (622)
|.|.
T Consensus 482 c~c~ 485 (520)
T 2z7x_B 482 CSCP 485 (520)
T ss_dssp CCHH
T ss_pred ccCC
Confidence 6553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=126.61 Aligned_cols=103 Identities=32% Similarity=0.357 Sum_probs=90.6
Q ss_pred cEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCC
Q 036225 100 QIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 100 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 78999999998 8888775 89999999999999888999999999999999999999665666899999999999999
Q ss_pred cCCCcCCCCCc-----cccccccccccccCC
Q 036225 180 NLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 180 ~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
+|++..+..+. +.+++++|++.|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99976665332 568899999998864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=8.4e-14 Score=131.76 Aligned_cols=122 Identities=20% Similarity=0.279 Sum_probs=77.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.|+|++|++. .+| .+..+++|++|+|++|.++ .+ ..+.++++|++|+|++|.+++..|..+..+++|++|+|++
T Consensus 46 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 46 LTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp CCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred ccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 566777777666 344 5666777777777777554 23 3566677777777777777665666667777777777777
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPL 200 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~ 200 (622)
|++++..|..+..+++|+.|+|++|++.+.+|.+. .+.+++++|.+
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCC
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCC
Confidence 77776666666777777777777776333444221 13455566554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=9e-14 Score=131.56 Aligned_cols=123 Identities=15% Similarity=0.249 Sum_probs=104.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|.+.. ++.+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..+..+++|++|+|+
T Consensus 67 ~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 58899999996653 4589999999999999999998888899999999999999999998888999999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~ 200 (622)
+|++.+.+| .+..+++|+.|++++|++++. +... .+.+++++|++
T Consensus 145 ~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 145 YNGAITDIM-PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp SCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC--
T ss_pred CCCCccccH-hhcCCCCCCEEECCCCCCcCh-HHhccCCCCCEEEeeCccc
Confidence 998333676 699999999999999999964 3211 25677888875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.3e-14 Score=151.07 Aligned_cols=130 Identities=24% Similarity=0.206 Sum_probs=93.0
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
.|+|++|++.+.+|+.+....+|++|+|++|+|++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 204 ~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (477)
T 2id5_A 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283 (477)
T ss_dssp EEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSC
T ss_pred eeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCc
Confidence 33333333333333333333455556666666663333467788888888888888887777778888889999999999
Q ss_pred cccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCCC
Q 036225 157 LSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATGS 206 (622)
Q Consensus 157 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~~ 206 (622)
+++..|..|..+++|+.|+|++|+|++..+..+. +.+++++|++.|.|..
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp CSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred cceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 9887788899999999999999999876554432 5678999999998753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-13 Score=151.50 Aligned_cols=127 Identities=19% Similarity=0.107 Sum_probs=110.9
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++.+..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 47899999999999988899999999999999999998888889999999999999999995555557999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc--cccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA--KTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~~~~l~~N~~ 200 (622)
+|.|++..|..|..+++|+.|+|++|.|++..+..+. ..+++++|.+
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcc
Confidence 9999988888999999999999999999975332221 4456666655
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=143.08 Aligned_cols=133 Identities=21% Similarity=0.198 Sum_probs=114.3
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 45889999999999988889999999999999999999777778999999999999999999888899999999999999
Q ss_pred ccccccccccccc---ccccceeEEeCCCCcCCCcCCCCC-------ccccccccccccccCC
Q 036225 153 NNNSLSGAFPTSL---ASMTQLIFLDLSYNNLSGPVPRFS-------AKTFNIVGNPLICATG 205 (622)
Q Consensus 153 ~~N~l~~~~p~~~---~~l~~L~~l~l~~N~l~g~~p~~~-------~~~~~l~~N~~~c~~~ 205 (622)
++|+|++..+..| ..+++|+.|+|++|+|++..+..+ .+.+.+.+|||.|.|.
T Consensus 144 ~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999995433444 679999999999999996443221 2468899999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=9.6e-14 Score=153.40 Aligned_cols=125 Identities=19% Similarity=0.187 Sum_probs=108.0
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 46899999999999988899999999999999999999888999999999999999999999 77776 8999999999
Q ss_pred ccccccc-ccccccccccceeEEeCCCCcCCCcCCC----CCccccccccccc
Q 036225 153 NNNSLSG-AFPTSLASMTQLIFLDLSYNNLSGPVPR----FSAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~N~~ 200 (622)
++|++++ .+|..|.++++|++|+|++|++++.... ...+.+++++|.+
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 9999996 4568999999999999999999863211 1115567777765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=157.15 Aligned_cols=127 Identities=21% Similarity=0.275 Sum_probs=114.7
Q ss_pred CcEEEEecCCCCCcc-----------------ccCCccc--CCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcc-
Q 036225 73 SLVIGLGIPSQNLSG-----------------TLSPSIG--NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF- 132 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~- 132 (622)
..+..|+|++|+++| .+|+.++ ++++|++|+|++|++.+.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 458899999999999 4999988 99999999999999999999999999999999999998
Q ss_pred ccC-CCCchhcccc-------Cccceecccccccccccc--ccccccceeEEeCCCCcCCCcCCCCCc----cccccccc
Q 036225 133 FTG-EIPSSLGHLR-------SLQYMRFNNNSLSGAFPT--SLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGN 198 (622)
Q Consensus 133 l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N 198 (622)
|+| .+|..+++++ +|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+++ .+|.+.. +.+++++|
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N 605 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence 998 8999888877 9999999999999 8998 9999999999999999999 8883321 46788888
Q ss_pred ccc
Q 036225 199 PLI 201 (622)
Q Consensus 199 ~~~ 201 (622)
.+.
T Consensus 606 ~l~ 608 (876)
T 4ecn_A 606 QIE 608 (876)
T ss_dssp CCS
T ss_pred ccc
Confidence 875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-13 Score=151.13 Aligned_cols=128 Identities=19% Similarity=0.178 Sum_probs=103.3
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|++++..+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 47888999998888888888888999999999998887777788888899999999888887677788888888888888
Q ss_pred ccccccccccccccccceeEEeCCCCcCCC-cCCCCCc-----ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSG-PVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~-----~~~~l~~N~~~ 201 (622)
+|++++..+..++.+++|++|+|++|.+++ .+|..+. +.+++++|.+.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 888885555568888888888888888886 4665433 45677777653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.2e-14 Score=144.07 Aligned_cols=108 Identities=21% Similarity=0.262 Sum_probs=53.5
Q ss_pred EEEEecCCCCC-ccccCCccc-------CCCcccEEEccCCCCCCCCCCcc--CCCCcccEEEecCccccCCCCchhccc
Q 036225 75 VIGLGIPSQNL-SGTLSPSIG-------NLTNLQIVLLQNNNITGPIPAEI--GRLTKLQTLDLSNNFFTGEIPSSLGHL 144 (622)
Q Consensus 75 v~~L~l~~n~l-~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l 144 (622)
++.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+ .++++|++|+|++|++++. |..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 44445555555 233443333 45555555555555555555443 4555555555555555533 4444444
Q ss_pred -----cCccceeccccccccccccccccccceeEEeCCCCcCCC
Q 036225 145 -----RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 145 -----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
++|++|+|++|++++..|..|..+++|+.|+|++|++.|
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence 455555555555554444555555555555555555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.42 E-value=8.7e-14 Score=152.41 Aligned_cols=134 Identities=21% Similarity=0.406 Sum_probs=102.6
Q ss_pred CCCCCCCCCCCCC-----Cccce-EEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcc
Q 036225 50 VLENWDEDAVDPC-----SWTMV-TCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123 (622)
Q Consensus 50 ~l~~W~~~~~~~C-----~w~gv-~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 123 (622)
.+.+|.. +.+|| .|.|+ .|.. +.++.|+|++|++++ +|..+ +++|++|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCC
Confidence 3456754 34778 79999 7864 358899999999987 77766 378999999999998 777 457889
Q ss_pred cEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC--cccccccccccc
Q 036225 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--AKTFNIVGNPLI 201 (622)
Q Consensus 124 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~N~~~ 201 (622)
+.|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|... .+.+++++|.+.
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLT 173 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCC
Confidence 999999999985 777 655 88888888888885 666 57888888888888886 55432 245677777764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-13 Score=126.64 Aligned_cols=110 Identities=22% Similarity=0.258 Sum_probs=98.2
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCC--chhccccCccce
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP--SSLGHLRSLQYM 150 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L 150 (622)
..+..|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|.+++ +| ..+..+++|+.|
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEE
Confidence 3588999999999987 889999999999999999998788888889999999999999995 44 789999999999
Q ss_pred eccccccccccc---cccccccceeEEeCCCCcCCCcCC
Q 036225 151 RFNNNSLSGAFP---TSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 151 ~l~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
+|++|.+++..+ ..+..+++|+.|++++|.+. .+|
T Consensus 126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~ 163 (168)
T 2ell_A 126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAP 163 (168)
T ss_dssp ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCC
T ss_pred EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcc
Confidence 999999995544 48999999999999999987 444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.9e-13 Score=140.02 Aligned_cols=126 Identities=20% Similarity=0.152 Sum_probs=109.0
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCch-hccccCccceec
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSS-LGHLRSLQYMRF 152 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l 152 (622)
.+..|+|++|++.+..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++ .+|.. |.++++|++|+|
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEEC
Confidence 4778999999999988889999999999999999999888888999999999999999999 55554 789999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC--ccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--AKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~N~~ 200 (622)
++|++++..|..+..+++|+.|+|++|++++...... .+.+++++|.+
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccc
Confidence 9999998888889999999999999999986432221 14556667654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.40 E-value=5.5e-13 Score=123.70 Aligned_cols=109 Identities=20% Similarity=0.190 Sum_probs=93.1
Q ss_pred CcEEEEecCCCCCccccCCcccCCC-cccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLT-NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
..+..|+|++|+++.. | .+..+. +|++|+|++|.|++. ..|.++++|++|+|++|.|++..|..+..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 3578999999999954 4 455655 999999999999964 5899999999999999999955445569999999999
Q ss_pred cccccccccccc--ccccccceeEEeCCCCcCCCcCCC
Q 036225 152 FNNNSLSGAFPT--SLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 152 l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~ 130 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKH 130 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHh
Confidence 9999997 6776 8999999999999999998 4454
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-13 Score=141.12 Aligned_cols=127 Identities=17% Similarity=0.211 Sum_probs=87.8
Q ss_pred cEEEEecCCCCCccccCCcc--cCCCcccEEEccCCCCCCCCCCccCCC-----CcccEEEecCccccCCCCchhccccC
Q 036225 74 LVIGLGIPSQNLSGTLSPSI--GNLTNLQIVLLQNNNITGPIPAEIGRL-----TKLQTLDLSNNFFTGEIPSSLGHLRS 146 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 146 (622)
.+..|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++++ ++|++|+|++|++++..|..|+.+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 46777788787777777765 7777788888888877755 6666666 77777777777777666677777777
Q ss_pred ccceeccccccccc--ccccc--ccccceeEEeCCCCcCCC--cCCCC------Ccccccccccccc
Q 036225 147 LQYMRFNNNSLSGA--FPTSL--ASMTQLIFLDLSYNNLSG--PVPRF------SAKTFNIVGNPLI 201 (622)
Q Consensus 147 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~g--~~p~~------~~~~~~l~~N~~~ 201 (622)
|++|+|++|++.|. +|..+ ..+++|+.|+|++|+|++ .++.. ..+.+++++|.+.
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 241 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 77777777777654 23333 677777777777777773 22211 2255667777653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=6.8e-13 Score=136.16 Aligned_cols=124 Identities=26% Similarity=0.282 Sum_probs=84.3
Q ss_pred cEEEEecCCCCCcc--ccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 74 LVIGLGIPSQNLSG--TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 74 ~v~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
.+..|+|++|.+.. ..+..+.++++|++|+|++|.++ .+|..+. ++|+.|+|++|.+++..|..|..+++|+.|+
T Consensus 146 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 222 (330)
T 1xku_A 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLG 222 (330)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 46778888888853 66677778888888888777777 4555443 6777777777777766666677777777777
Q ss_pred ccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 152 FNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 152 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
|++|++++..+..+..+++|+.|+|++|+++ .+|..+. +.+++++|++.
T Consensus 223 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred CCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 7777777655556677777777777777776 4444322 34566666653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.6e-13 Score=139.56 Aligned_cols=111 Identities=20% Similarity=0.155 Sum_probs=55.0
Q ss_pred EEEEecCCCCCccccC----CcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCC--CC--chhccccC
Q 036225 75 VIGLGIPSQNLSGTLS----PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE--IP--SSLGHLRS 146 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p--~~~~~l~~ 146 (622)
+..|+|++|.+.+..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|++|++.+. ++ ..+..+++
T Consensus 119 L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~ 198 (310)
T 4glp_A 119 LSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPA 198 (310)
T ss_dssp CSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCC
T ss_pred CCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCC
Confidence 4455555555555433 2233455555555555555555555555555555555555555431 11 11244555
Q ss_pred ccceecccccccccccc----ccccccceeEEeCCCCcCCCcCC
Q 036225 147 LQYMRFNNNSLSGAFPT----SLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 147 L~~L~l~~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
|++|+|++|+++ .+|. .+..+++|++|+|++|+|++.+|
T Consensus 199 L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p 241 (310)
T 4glp_A 199 IQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVN 241 (310)
T ss_dssp CCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCC
T ss_pred CCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccch
Confidence 555555555554 2222 13444555555555555555433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.5e-13 Score=140.82 Aligned_cols=127 Identities=19% Similarity=0.205 Sum_probs=109.1
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCc--hhccccCccce
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS--SLGHLRSLQYM 150 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L 150 (622)
..+..|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|.++ .+|. .+..+++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 35899999999999988899999999999999999999554445999999999999999999 5665 78999999999
Q ss_pred ecccc-ccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccc
Q 036225 151 RFNNN-SLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPL 200 (622)
Q Consensus 151 ~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~ 200 (622)
++++| .+++..|..|..+++|+.|++++|++++..|..+. +.+++++|.+
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 99999 57766678899999999999999999988776554 3456666654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.3e-13 Score=147.29 Aligned_cols=31 Identities=23% Similarity=0.049 Sum_probs=26.1
Q ss_pred hhHHHHHHHHHHhccccccceeeeeeeeCCC
Q 036225 340 GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT 370 (622)
Q Consensus 340 ~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 370 (622)
+..+|..|++++.+++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 4568999999999999999999999997654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=137.10 Aligned_cols=112 Identities=24% Similarity=0.268 Sum_probs=69.1
Q ss_pred cEEEEecCCCCCc--cccCCcccCC--------------------CcccEEEccCCCCCCCCCCccCCCCcccEEEecCc
Q 036225 74 LVIGLGIPSQNLS--GTLSPSIGNL--------------------TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN 131 (622)
Q Consensus 74 ~v~~L~l~~n~l~--~~~~~~~~~l--------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 131 (622)
.+..|+|++|.++ +..+..+..+ ++|++|+|++|.+++..|..|.++++|+.|+|++|
T Consensus 148 ~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N 227 (332)
T 2ft3_A 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227 (332)
T ss_dssp SCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSS
T ss_pred cCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 4667777777774 3555555544 35555566666666555556666666666666666
Q ss_pred cccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 132 FFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+
T Consensus 228 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~ 281 (332)
T 2ft3_A 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGV 281 (332)
T ss_dssp CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCT
T ss_pred cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccCh
Confidence 666555555666666666666666666 566666666666666666666664433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.7e-13 Score=151.74 Aligned_cols=168 Identities=24% Similarity=0.256 Sum_probs=108.2
Q ss_pred CChHHHHHHHHHHHhCCCCC-CCCCCCCCCCCCCCCccceEEcCCCcEEE------------------EecCCCCCcc--
Q 036225 29 GVNYEVQALMGVKHSLHDPH-GVLENWDEDAVDPCSWTMVTCSPESLVIG------------------LGIPSQNLSG-- 87 (622)
Q Consensus 29 ~~~~~~~aLl~~k~~~~~~~-~~l~~W~~~~~~~C~w~gv~C~~~~~v~~------------------L~l~~n~l~~-- 87 (622)
....++++|+++..+...+. ..-.+|......++.|.+++++.. .++. ++|++|+|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTP-LTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCC-ccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 44677889999988764322 233557555545678988877642 2333 4445554443
Q ss_pred -------ccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccc
Q 036225 88 -------TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGA 160 (622)
Q Consensus 88 -------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 160 (622)
..+..+..+++|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 33667889999999999999999 88988999999999999999999 99999999999999999999999 8
Q ss_pred cccccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccccc
Q 036225 161 FPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLI 201 (622)
Q Consensus 161 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~ 201 (622)
+|..|..|++|++|+|++|.|+ .+|..+. +.++|++|++.
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 8999999999999999999997 7776543 56788999874
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-13 Score=122.24 Aligned_cols=104 Identities=19% Similarity=0.223 Sum_probs=93.4
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCC-CCchhccccCcccee
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE-IPSSLGHLRSLQYMR 151 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ 151 (622)
..+..|+|++|++++. +.++++++|++|+|++|.+++.+|..+.++++|++|+|++|.+++. .|..+..+++|++|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 4588999999999987 8899999999999999999987898888899999999999999953 347899999999999
Q ss_pred ccccccccccc---cccccccceeEEeCCC
Q 036225 152 FNNNSLSGAFP---TSLASMTQLIFLDLSY 178 (622)
Q Consensus 152 l~~N~l~~~~p---~~~~~l~~L~~l~l~~ 178 (622)
+++|.+++..+ ..+..+++|+.|++++
T Consensus 120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999996655 5799999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.36 E-value=5.4e-13 Score=130.23 Aligned_cols=124 Identities=18% Similarity=0.203 Sum_probs=105.7
Q ss_pred CcEEEEecCCCC-CccccCCcccCCCcccEEEccC-CCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcc--
Q 036225 73 SLVIGLGIPSQN-LSGTLSPSIGNLTNLQIVLLQN-NNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ-- 148 (622)
Q Consensus 73 ~~v~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-- 148 (622)
..+..|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|.+++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 358899999997 8877777899999999999998 99997667789999999999999999995 776 88888888
Q ss_pred -ceecccc-cccccccccccccccee-EEeCCCCcCCCcCCCCC-----cccccccccc
Q 036225 149 -YMRFNNN-SLSGAFPTSLASMTQLI-FLDLSYNNLSGPVPRFS-----AKTFNIVGNP 199 (622)
Q Consensus 149 -~L~l~~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~~-----~~~~~l~~N~ 199 (622)
+|++++| ++++..+..|..+++|+ .|++++|+++ .+|... .+.+++++|+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99966667799999999 9999999998 665432 2457788885
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=4.8e-13 Score=147.26 Aligned_cols=127 Identities=18% Similarity=0.185 Sum_probs=110.9
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccC-CCCchhccccCcccee
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG-EIPSSLGHLRSLQYMR 151 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 151 (622)
..+..|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|..+.++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 358999999999999999999999999999999999998777779999999999999999996 3678899999999999
Q ss_pred ccccccccccc-cccccccceeEEeCCCCcCCCcCCCCCc-----ccccccccc
Q 036225 152 FNNNSLSGAFP-TSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNP 199 (622)
Q Consensus 152 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~ 199 (622)
|++|.+.+.+| ..|..+++|+.|++++|++++.+|..+. +.+.+.+|.
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 99999655666 6899999999999999999998887654 234555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=9.4e-13 Score=136.12 Aligned_cols=105 Identities=18% Similarity=0.225 Sum_probs=93.4
Q ss_pred cEEEccCC-CCCCCCCCccCCCCcccEEEecC-ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCC
Q 036225 100 QIVLLQNN-NITGPIPAEIGRLTKLQTLDLSN-NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177 (622)
Q Consensus 100 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 177 (622)
..+++++| +|+ .+|. |..+++|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 899 6898 99999999999996 99997777889999999999999999999888999999999999999
Q ss_pred CCcCCCcCCCCC----ccccccccccccccCCC
Q 036225 178 YNNLSGPVPRFS----AKTFNIVGNPLICATGS 206 (622)
Q Consensus 178 ~N~l~g~~p~~~----~~~~~l~~N~~~c~~~~ 206 (622)
+|+|++..|..+ .+.+++.+|++.|.|..
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l 121 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCcc
Confidence 999997666544 35688999999998763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.4e-12 Score=127.62 Aligned_cols=121 Identities=22% Similarity=0.324 Sum_probs=92.5
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++..+ +.++++|++|+|++|++++ +|. +.. ++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 347888888888887554 8888888888998888884 553 333 888888999988885 44 5888889999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC----cccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLICA 203 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c~ 203 (622)
++|++++ +| .+..+++|+.|+|++|++++. +.+. .+.+++++|++.+.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 9999884 44 688888999999999998876 3221 14577888887554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-12 Score=143.73 Aligned_cols=125 Identities=22% Similarity=0.239 Sum_probs=106.9
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 46889999999999888889999999999999999999888889999999999999999999 67776 8999999999
Q ss_pred ccccccc-ccccccccccceeEEeCCCCcCCCcCC----CCCccccccccccc
Q 036225 153 NNNSLSG-AFPTSLASMTQLIFLDLSYNNLSGPVP----RFSAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p----~~~~~~~~l~~N~~ 200 (622)
++|++++ .+|..|+.+++|++|+|++|++++... ....+.+++++|.+
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccc
Confidence 9999987 578999999999999999999986321 11115667777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.33 E-value=4.7e-13 Score=124.14 Aligned_cols=105 Identities=22% Similarity=0.250 Sum_probs=94.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCc--hhccccCcccee
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS--SLGHLRSLQYMR 151 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ 151 (622)
.+..|+|++|++++. +.|..+++|++|+|++|+|++..|..|.++++|++|+|++|.|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 588999999999986 78999999999999999999554444599999999999999997 6776 799999999999
Q ss_pred ccccccccccccc----cccccceeEEeCCCCcCC
Q 036225 152 FNNNSLSGAFPTS----LASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 152 l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~ 182 (622)
|++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999998 66764 899999999999999876
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-14 Score=136.34 Aligned_cols=125 Identities=20% Similarity=0.345 Sum_probs=91.8
Q ss_pred EEEEecCCCCCccccCC------cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCcc
Q 036225 75 VIGLGIPSQNLSGTLSP------SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ 148 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 148 (622)
++.++|+.+++.|.+|. .|.++++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 55566666677776666 78888888888888888885 66 7888888888888888888 6777777778888
Q ss_pred ceeccccccccccccccccccceeEEeCCCCcCCCcCC--C---C-CccccccccccccccC
Q 036225 149 YMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP--R---F-SAKTFNIVGNPLICAT 204 (622)
Q Consensus 149 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p--~---~-~~~~~~l~~N~~~c~~ 204 (622)
.|+|++|++++ +| .+..+++|+.|+|++|++++..+ . . ..+.+++++|++.|.+
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 88888888884 55 57778888888888888875221 1 1 1256677788775553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=3.8e-12 Score=128.15 Aligned_cols=119 Identities=28% Similarity=0.417 Sum_probs=88.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++..+ +.++++|++|+|++|.+++ +| .+.++++|+.|+|++|++++ + +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 347788888888887544 8888888888888888874 44 48888888888888888884 3 45778888888888
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~ 200 (622)
++|++++. ..+..+++|+.|+|++|++++..| +. .+.+++++|.+
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 88888743 567788888888888888886554 21 14566777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.2e-12 Score=133.25 Aligned_cols=128 Identities=13% Similarity=0.143 Sum_probs=106.3
Q ss_pred EEEEecCCCCCccccCCcc--cCCCcccEEEccCCCCCCCCC----CccCCCCcccEEEecCccccCCCCchhccccCcc
Q 036225 75 VIGLGIPSQNLSGTLSPSI--GNLTNLQIVLLQNNNITGPIP----AEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQ 148 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 148 (622)
+..|+|++|++.+..|..+ .++++|++|+|++|.+++..| ..+..+++|++|+|++|.+++..|..|..+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 7899999999999999988 899999999999999998666 3456799999999999999988888999999999
Q ss_pred ceeccccccccc--cc--cccccccceeEEeCCCCcCCCcCC--C------CCccccccccccccc
Q 036225 149 YMRFNNNSLSGA--FP--TSLASMTQLIFLDLSYNNLSGPVP--R------FSAKTFNIVGNPLIC 202 (622)
Q Consensus 149 ~L~l~~N~l~~~--~p--~~~~~l~~L~~l~l~~N~l~g~~p--~------~~~~~~~l~~N~~~c 202 (622)
+|+|++|++.+. ++ ..+..+++|++|+|++|+++...+ . ...+.+++++|.+.-
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~ 238 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRA 238 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCC
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCc
Confidence 999999998753 32 334789999999999999973211 1 123678899998744
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-12 Score=129.27 Aligned_cols=122 Identities=25% Similarity=0.359 Sum_probs=91.5
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+.+. +.+.++++|++|+|++|++++ +| .+.++++|+.|+|++|.+++ ++. +..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 3578899999988864 368888889999999998885 44 38888888888888888884 443 788888888888
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCC---Cccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF---SAKTFNIVGNPLIC 202 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~~~l~~N~~~c 202 (622)
++|++++ ++. +..+++|+.|+|++|++++..|-. ..+.+++++|.+..
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCc
Confidence 8888884 443 788888888888888887654311 11456777777643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.29 E-value=4.5e-12 Score=127.64 Aligned_cols=121 Identities=25% Similarity=0.344 Sum_probs=103.0
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+++. +.+.++++|++|+|++|++++ + ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 4588999999999873 459999999999999999995 4 4799999999999999999954 67999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLIC 202 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c 202 (622)
++|++++..| +..+++|+.|+|++|++++ +|.+. .+.+++++|++.+
T Consensus 164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEEC
T ss_pred cCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccC
Confidence 9999996554 9999999999999999986 34322 2567888998754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.9e-12 Score=126.19 Aligned_cols=118 Identities=25% Similarity=0.436 Sum_probs=84.7
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++.+..+ +.++++|++|+|++|++++ +| .+.++++|+.|+|++|.+++ +|. +..+++|++|+|+
T Consensus 64 ~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLD 137 (308)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECC
T ss_pred CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECC
Confidence 46778888888776544 7788888888888888874 44 67788888888888888874 443 7778888888888
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~ 200 (622)
+|++++..+ +..+++|+.|+|++|++++..+ +. .+.+++++|.+
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCcc
Confidence 888874433 7778888888888888876443 11 14566677765
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.8e-12 Score=129.08 Aligned_cols=106 Identities=28% Similarity=0.389 Sum_probs=48.4
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|++++..+ +..+++|++|+|++|.+++ + ..+..+++|+.|+|++|.+++ + +.+..+++|+.|+|++
T Consensus 223 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~ 296 (347)
T 4fmz_A 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNN 296 (347)
T ss_dssp CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCS
T ss_pred CCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcC
Confidence 3444444444443322 4444444444444444442 2 234444444444444444442 2 2344444455555555
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
|++++..|..+..+++|+.|+|++|++++..|
T Consensus 297 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp SCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 54444444444444555555555555444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.6e-12 Score=128.61 Aligned_cols=122 Identities=23% Similarity=0.206 Sum_probs=83.7
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhc-cccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG-HLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~ 153 (622)
+..|++++|++++..+. .+++|++|+|++|++++..|..+..+++|++|+|++|.+++..|..+. .+++|++|+|+
T Consensus 101 L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~ 177 (317)
T 3o53_A 101 IETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (317)
T ss_dssp CCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred cCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECC
Confidence 44555666666554433 256778888888888866666777888888888888888866666653 67888888888
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC----cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~ 201 (622)
+|.+++. |. ...+++|+.|+|++|++++..|.+. .+.+++++|.+.
T Consensus 178 ~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 178 YNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp TSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 8888743 33 3347788888888888886544421 145677777764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.25 E-value=6e-12 Score=130.28 Aligned_cols=121 Identities=20% Similarity=0.233 Sum_probs=88.6
Q ss_pred CCccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCC-ccCCCCcccE-EEec
Q 036225 62 CSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPA-EIGRLTKLQT-LDLS 129 (622)
Q Consensus 62 C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~Ls 129 (622)
|+|+.|.|+.. ..++.|+|++|+|+...+.+|.+|++|++|+|++|++.+.+|. .|.++++|.. ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 78999999642 1367888888888865556788888888888888887766654 5677777664 5666
Q ss_pred CccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCC-CcCC
Q 036225 130 NNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSY-NNLS 182 (622)
Q Consensus 130 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~ 182 (622)
+|+|+...|..|..+++|++|++++|++++..+..+....++..|++.+ |++.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~ 142 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc
Confidence 7888866677788888888888888888865555666666777777755 4444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=136.68 Aligned_cols=119 Identities=29% Similarity=0.394 Sum_probs=75.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++.+..| +.+|++|+.|+|++|.|++ +| .+..|++|+.|+|++|.|++ + +.+..|++|+.|+|+
T Consensus 66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls 139 (605)
T 1m9s_A 66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 139 (605)
T ss_dssp TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence 46677777777776544 6677777777777777763 33 56677777777777777763 3 346666777777777
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~ 200 (622)
+|+|++. ..+..+++|+.|+|++|+|++..|-.. .+.++|++|.+
T Consensus 140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred CCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCC
Confidence 7776643 456666666677776666666544110 13455555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.8e-11 Score=119.79 Aligned_cols=144 Identities=14% Similarity=0.072 Sum_probs=112.8
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 376 (622)
.-..|.....++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. |..+.++++++...+..++||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3456777778888888999999865 67899999864321 12235889999998884 677889999998888999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC--------------------------------------- 417 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 417 (622)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999998877642 22334578899999999999810
Q ss_pred -----------------CCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 418 -----------------DPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 418 -----------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
.+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799999875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=134.57 Aligned_cols=111 Identities=25% Similarity=0.362 Sum_probs=74.4
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++|.|++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 4677788888777 455 446777777777777775 666 555 77777777777774 565 56777777777
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC--cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--AKTFNIVGNPLI 201 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~N~~~ 201 (622)
+|+|++ +|. .+++|+.|+|++|+|++ +|.+. .+.+++++|.+.
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELPESLEALDVSTNLLE 193 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhhCCCCEEECcCCCCC
Confidence 777774 555 45677777777777776 55421 134566666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=122.53 Aligned_cols=121 Identities=23% Similarity=0.310 Sum_probs=100.0
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|+++. ++ .+..+++|++|+|++|+|++. |. +.++++|+.|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 347899999999985 45 799999999999999999954 44 9999999999999999994 55533 3 99999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC----cccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLICA 203 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c~ 203 (622)
++|++++ ++ .+..+++|+.|+|++|++++. |.+. .+.+++++|.+...
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 9999995 44 699999999999999999975 3221 25678889987543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-11 Score=135.20 Aligned_cols=101 Identities=25% Similarity=0.370 Sum_probs=90.1
Q ss_pred cccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCC
Q 036225 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177 (622)
Q Consensus 98 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 177 (622)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46789999999995 786 999999999999999999 899999999999999999999995 77 89999999999999
Q ss_pred CCcCCCcC-CCCCc-----ccccccccccccc
Q 036225 178 YNNLSGPV-PRFSA-----KTFNIVGNPLICA 203 (622)
Q Consensus 178 ~N~l~g~~-p~~~~-----~~~~l~~N~~~c~ 203 (622)
+|+|++.+ |..+. +.+++++|++...
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 99999986 76543 5688999998443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=135.78 Aligned_cols=121 Identities=25% Similarity=0.334 Sum_probs=103.6
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+.+. +.+..+++|+.|+|++|.|++ +| .+..|++|+.|+|++|.|++. ..+..+++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 3588999999999873 479999999999999999995 44 699999999999999999954 67999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLIC 202 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c 202 (622)
++|+|++..| +..+++|+.|+|++|+|++. |.+. .+.+++++|++..
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 9999997666 99999999999999999974 4322 2567888998754
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-13 Score=130.12 Aligned_cols=110 Identities=24% Similarity=0.255 Sum_probs=98.2
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++ +| .+.++++|++|+|++|.|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|++|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 358899999999998 66 9999999999999999999 788888889999999999999995 66 6899999999999
Q ss_pred cccccccccc-cccccccceeEEeCCCCcCCCcCCC
Q 036225 153 NNNSLSGAFP-TSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 153 ~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
++|++++..+ ..+..+++|+.|++++|++++.+|.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999994322 4789999999999999999988765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.8e-11 Score=130.30 Aligned_cols=101 Identities=28% Similarity=0.428 Sum_probs=52.5
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|.+.+..+ +..+++|++|+|++|.+++..| +..+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 245 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~ 318 (466)
T 1o6v_A 245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318 (466)
T ss_dssp CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCS
T ss_pred CCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcC
Confidence 5556666666655433 5555556666666665553322 5555555555555555553222 44555555555555
Q ss_pred cccccccccccccccceeEEeCCCCcCCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
|++++..| +..+++|+.|++++|++++
T Consensus 319 n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 319 NNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp SCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CcCCCchh--hccCccCCEeECCCCccCC
Confidence 55554333 4444455555555554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.1e-12 Score=139.40 Aligned_cols=135 Identities=22% Similarity=0.307 Sum_probs=97.0
Q ss_pred CCCCCCCCCCCCCCCccceEE--------cCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCC
Q 036225 49 GVLENWDEDAVDPCSWTMVTC--------SPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120 (622)
Q Consensus 49 ~~l~~W~~~~~~~C~w~gv~C--------~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 120 (622)
...++|.. ..+||.|.|..| .. ..++.|++++|+++ .+|..+. ++|++|+|++|+|+ .+|. .+
T Consensus 10 ~~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~-~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 10 AVWSAWRR-AAPAEESRGRAAVVQKMRACLN-NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp CHHHHHHH-TCCGGGHHHHHHHHHHHHHHHH-HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHHh-cCCcchhccccccCcccccccC-CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 34566764 347899976432 22 23788999999988 6777665 78999999999988 6675 57
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC--ccccccccc
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS--AKTFNIVGN 198 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~N 198 (622)
++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|... .+.+++++|
T Consensus 81 ~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N 151 (622)
T 3g06_A 81 PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDN 151 (622)
T ss_dssp TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCC
Confidence 88899999999988 5666 6788888888888888 4555 45777888888888775 44322 245667777
Q ss_pred ccc
Q 036225 199 PLI 201 (622)
Q Consensus 199 ~~~ 201 (622)
.+.
T Consensus 152 ~l~ 154 (622)
T 3g06_A 152 QLA 154 (622)
T ss_dssp CCS
T ss_pred cCC
Confidence 653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=5.4e-11 Score=117.30 Aligned_cols=129 Identities=16% Similarity=0.075 Sum_probs=98.9
Q ss_pred eecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc--ceeeeeeeeCCCceeEEeeeccCCCccc
Q 036225 309 GKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLYGFCMTPTERLLVYPYMSNGSVAS 386 (622)
Q Consensus 309 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 386 (622)
+.|..+.||++...+|+.+++|..... ....+..|+++++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 455669999998777888999997643 1235778999998886544 556888888888889999999998884
Q ss_pred cccCCCCCChhHHHHHHHHHHHHHHHHHhcC-------------------------------------------------
Q 036225 387 RLKGKPILDWSTRKRIALGAARGLLYLHEQC------------------------------------------------- 417 (622)
Q Consensus 387 ~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------------- 417 (622)
... . ....++.++++.|..||+..
T Consensus 104 -~~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 -SSH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp -TSC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred -cCc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 221 1 23467888899999999742
Q ss_pred ------CCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 418 ------DPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 418 ------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999999863
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.4e-11 Score=123.39 Aligned_cols=104 Identities=25% Similarity=0.368 Sum_probs=92.5
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+++. +.+..+++|++|+|++|++++ +| .+..+++|+.|+|++|.+++..|..+..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 243 SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 3588999999999975 578999999999999999995 44 6899999999999999999888899999999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCC
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
++|++++..| +..+++|+.|++++|+|+
T Consensus 319 ~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCccccccC--hhhhhccceeehhhhccc
Confidence 9999997666 889999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=124.08 Aligned_cols=114 Identities=25% Similarity=0.315 Sum_probs=60.3
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|++++ +| +|+++++|++|+|++|++++ +|..+ .+|++|+|++|.+++ +| .++++++|++|++++
T Consensus 133 L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 133 LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp CCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 4555555555554 44 35556666666666666553 44332 355555555555553 44 355566666666666
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCC----cccccccccccc
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLI 201 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~ 201 (622)
|++++ +|... ++|+.|++++|+++ .+|.+. .+.+++++|.+.
T Consensus 205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 205 NSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp SCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred CcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 66553 33322 35555555555555 445321 134566677653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.13 E-value=8.4e-11 Score=126.58 Aligned_cols=121 Identities=28% Similarity=0.392 Sum_probs=96.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++.+. +.+..+++|++|+|++|.+++..| +.++++|+.|+|++|.+++. |. +..+++|+.|+|+
T Consensus 222 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELN 295 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECC
T ss_pred CCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcC
Confidence 478899999988864 468888999999999999986554 88899999999999999854 43 8888999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---ccccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPLIC 202 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~~c 202 (622)
+|++++..| +..+++|+.|+|++|++++..|-.. .+.+++++|++..
T Consensus 296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCC
Confidence 999986544 7888999999999999988766211 2456778887644
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.5e-10 Score=117.36 Aligned_cols=143 Identities=14% Similarity=0.199 Sum_probs=107.1
Q ss_pred cCCeeeecCCceEEEEEECCCeEEEEEEcc--CCCCCchhHHHHHHHHHHhccc--cccceeeeeeeeCC---CceeEEe
Q 036225 304 SKNILGKGGFGIVYKGILQDGTVVAVKRLK--DGNAIGGEIQFQTEVEMISLAV--HRNLLRLYGFCMTP---TERLLVY 376 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 376 (622)
..+.++.|.++.||+....+ ..+++|+.. ..........+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988764 578888775 3322222346788999999886 45688899988776 4589999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC--------------------------------------- 417 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 417 (622)
||++|..+.+... ..++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999987755322 23678888999999999999999731
Q ss_pred ----------------CCCeeecCCCCCCeeecCCCc--eEEccccccee
Q 036225 418 ----------------DPKIIHRDVKAANILLDDCCE--AVVGDFGLAKL 449 (622)
Q Consensus 418 ----------------~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~ 449 (622)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999999874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.3e-10 Score=124.52 Aligned_cols=119 Identities=23% Similarity=0.249 Sum_probs=95.1
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++ +| ++.+++|+.|+|++|++++. .++++++|+.|+|++|++++ +| +..+++|+.|+|
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 357889999999998 44 88899999999999999964 38899999999999999996 66 888999999999
Q ss_pred ccccccccccccccccc-------ceeEEeCCCCcCCCcCCCCC---ccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMT-------QLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~-------~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~ 200 (622)
++|++++..+..+..+. +|+.|++++|++.|.+|... .+.+++++|+.
T Consensus 241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298 (457)
T ss_dssp CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTT
T ss_pred eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcc
Confidence 99999976655565555 55677788888777777422 25677788864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-11 Score=127.78 Aligned_cols=108 Identities=19% Similarity=0.255 Sum_probs=55.0
Q ss_pred EEEEecCCCCCccccC----CcccCCC-cccEEEccCCCCCCCCCCccCCC-----CcccEEEecCccccCCCCchhccc
Q 036225 75 VIGLGIPSQNLSGTLS----PSIGNLT-NLQIVLLQNNNITGPIPAEIGRL-----TKLQTLDLSNNFFTGEIPSSLGHL 144 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l 144 (622)
++.|+|++|++++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++|++|+|++|.+++..+..+...
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 5555555555554444 4445555 55555555555554444444443 555555555555554444433322
Q ss_pred -----cCccceecccccccccccccccc-----ccceeEEeCCCCcCC
Q 036225 145 -----RSLQYMRFNNNSLSGAFPTSLAS-----MTQLIFLDLSYNNLS 182 (622)
Q Consensus 145 -----~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~ 182 (622)
++|++|+|++|+|++..+..+.. .++|+.|+|++|+++
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 55555555555555443333222 135555555555555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-10 Score=122.02 Aligned_cols=117 Identities=25% Similarity=0.287 Sum_probs=88.3
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|++++. .++++++|++|+|++|+..+.+ .+..+++|+.|+|++|++++ +| +..+++|+.|++
T Consensus 127 ~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l 198 (457)
T 3bz5_A 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC 198 (457)
T ss_dssp TTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred CcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence 4578899999998884 3778888888888888666566 47788888888888888885 55 777888888888
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCCC---cccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPLI 201 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~~ 201 (622)
++|++++. .+..+++|+.|+|++|++++ +|-.. .+.+++++|.+.
T Consensus 199 ~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 199 DTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp CSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCS
T ss_pred cCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEeeCCcCC
Confidence 88888854 37778888888888888887 55211 145677777764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.9e-11 Score=125.75 Aligned_cols=59 Identities=27% Similarity=0.391 Sum_probs=37.8
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCC--cCCC
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG--PVPR 187 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g--~~p~ 187 (622)
++|+.|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|+|++|++++ .+|.
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~ 377 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence 466677777777664 5543 466777777777776 4555 35667777777777776 5554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.07 E-value=6.8e-12 Score=128.84 Aligned_cols=118 Identities=23% Similarity=0.271 Sum_probs=73.4
Q ss_pred CCCccceEEcCCCcEEEEecCCCCCccccCCcccCC--CcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCC-C
Q 036225 61 PCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNL--TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE-I 137 (622)
Q Consensus 61 ~C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 137 (622)
|..|.++.|+ ...+..|+++++++. +..+..+ ++|+.|+|++|.+.+..|. +.++++|++|+|++|.+++. +
T Consensus 36 c~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 36 CKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp CHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 3457777664 233556666666655 3445555 6666666666666655443 45666666666666666644 5
Q ss_pred CchhccccCccceeccccccccccccccccccceeEEeCCCC-cCCC
Q 036225 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN-NLSG 183 (622)
Q Consensus 138 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N-~l~g 183 (622)
|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++| .+++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~ 157 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCH
Confidence 666666666666666666666666666666666666666666 4554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.07 E-value=9.4e-12 Score=130.58 Aligned_cols=110 Identities=19% Similarity=0.266 Sum_probs=55.9
Q ss_pred cEEEEecCCCCCcc----ccCCcccCC---------CcccEEEccCCCCC-CCCC---CccCCCCcccEEEecCcccc--
Q 036225 74 LVIGLGIPSQNLSG----TLSPSIGNL---------TNLQIVLLQNNNIT-GPIP---AEIGRLTKLQTLDLSNNFFT-- 134 (622)
Q Consensus 74 ~v~~L~l~~n~l~~----~~~~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~-- 134 (622)
.+..|+|++|++++ .++..+..+ ++|++|+|++|+|+ +.+| ..+..+++|+.|+|++|+++
T Consensus 123 ~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~ 202 (386)
T 2ca6_A 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202 (386)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred CCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh
Confidence 35555666655542 233444444 55555555555554 2333 23444555555555555554
Q ss_pred C---CCCchhccccCccceeccccccc----cccccccccccceeEEeCCCCcCCC
Q 036225 135 G---EIPSSLGHLRSLQYMRFNNNSLS----GAFPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 135 ~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
| .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++
T Consensus 203 g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence 1 22224555555555555555553 3455555555555555555555553
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-11 Score=128.96 Aligned_cols=129 Identities=20% Similarity=0.269 Sum_probs=107.7
Q ss_pred CcEEEEecCCCCCc-cccC---CcccCCCcccEEEccCCCCC--C---CCCCccCCCCcccEEEecCcccc----CCCCc
Q 036225 73 SLVIGLGIPSQNLS-GTLS---PSIGNLTNLQIVLLQNNNIT--G---PIPAEIGRLTKLQTLDLSNNFFT----GEIPS 139 (622)
Q Consensus 73 ~~v~~L~l~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~ 139 (622)
..+..|+|++|+++ +.++ ..+..+++|++|+|++|+|+ | .+|..+.++++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 56899999999998 4555 46778999999999999998 3 45658899999999999999996 57888
Q ss_pred hhccccCccceeccccccccc----ccccccc--ccceeEEeCCCCcCCC----cCCCCC------cccccccccccc
Q 036225 140 SLGHLRSLQYMRFNNNSLSGA----FPTSLAS--MTQLIFLDLSYNNLSG----PVPRFS------AKTFNIVGNPLI 201 (622)
Q Consensus 140 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~--l~~L~~l~l~~N~l~g----~~p~~~------~~~~~l~~N~~~ 201 (622)
.+..+++|++|+|++|.|++. +|..+.. +++|+.|+|++|++++ .+|... .+.+++++|++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 999999999999999999865 5677743 8999999999999998 365432 256788999874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-11 Score=126.62 Aligned_cols=105 Identities=17% Similarity=0.166 Sum_probs=49.6
Q ss_pred ecCCCCCccccCCcccCCCcccEEEccCCCCCCCCC----CccCCCC-cccEEEecCccccCCCCchhccc-----cCcc
Q 036225 79 GIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP----AEIGRLT-KLQTLDLSNNFFTGEIPSSLGHL-----RSLQ 148 (622)
Q Consensus 79 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~ 148 (622)
.|+.|+++|.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 444555555544444444445555555555553333 3344444 45555555555554444444443 4555
Q ss_pred ceeccccccccccccccccc-----cceeEEeCCCCcCCC
Q 036225 149 YMRFNNNSLSGAFPTSLASM-----TQLIFLDLSYNNLSG 183 (622)
Q Consensus 149 ~L~l~~N~l~~~~p~~~~~l-----~~L~~l~l~~N~l~g 183 (622)
+|+|++|++++..+..+... ++|+.|+|++|+|++
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 123 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS 123 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence 55555555554433332222 455555555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.6e-11 Score=126.09 Aligned_cols=111 Identities=23% Similarity=0.237 Sum_probs=99.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCC-CCCccCCCCcccEEEecCccccCCCCchhccccCcccee
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGP-IPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 151 (622)
..+..|++++|.+.+..+. +.++++|++|+|++|.+++. +|..+.++++|++|+|++|.+++..|..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4588999999999987765 56899999999999999866 888899999999999999999988899999999999999
Q ss_pred cccc-cccc-ccccccccccceeEEeCCCC-cCCCc
Q 036225 152 FNNN-SLSG-AFPTSLASMTQLIFLDLSYN-NLSGP 184 (622)
Q Consensus 152 l~~N-~l~~-~~p~~~~~l~~L~~l~l~~N-~l~g~ 184 (622)
|++| .+++ .+|..+..+++|+.|+|++| .+++.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 184 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence 9999 7886 37788999999999999999 98853
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.1e-10 Score=125.69 Aligned_cols=72 Identities=29% Similarity=0.402 Sum_probs=42.4
Q ss_pred CcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----ccccc
Q 036225 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNI 195 (622)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l 195 (622)
++|+.|+|++|.|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+. +.+++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 556666666666663 45 34466666666666666 4554 4466666666666666 4554322 34566
Q ss_pred cccccc
Q 036225 196 VGNPLI 201 (622)
Q Consensus 196 ~~N~~~ 201 (622)
++|++.
T Consensus 292 ~~N~l~ 297 (622)
T 3g06_A 292 EGNPLS 297 (622)
T ss_dssp CSCCCC
T ss_pred cCCCCC
Confidence 666653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.98 E-value=6.1e-10 Score=115.08 Aligned_cols=115 Identities=13% Similarity=0.133 Sum_probs=94.7
Q ss_pred eEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCc-hhcccc
Q 036225 67 VTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLR 145 (622)
Q Consensus 67 v~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~ 145 (622)
.+|+.. .++.++++++ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.+++
T Consensus 7 C~C~~~----~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSNR----VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEETT----EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeCC----EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 567642 4678889998 567766 46899999999999954445799999999999999999877765 578898
Q ss_pred Cccc-eeccccccccccccccccccceeEEeCCCCcCCCcCCCC
Q 036225 146 SLQY-MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188 (622)
Q Consensus 146 ~L~~-L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~ 188 (622)
+|.+ +.+++|+|++..|..|..+++|++|++++|+|++..+..
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~ 123 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 123 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCT
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchh
Confidence 8775 677789999777889999999999999999999765543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=6.4e-10 Score=112.52 Aligned_cols=187 Identities=20% Similarity=0.185 Sum_probs=121.9
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-ccc--ceeeeeeeeCCC---ceeEEeee
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRN--LLRLYGFCMTPT---ERLLVYPY 378 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~ 378 (622)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..++|||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4678999999999863 45888885432 23446889999998873 333 345555543333 34789999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ------------------------------------------ 416 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 416 (622)
++|.++.+... ..++..++..++.++++.+..||+.
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988765322 2356777888899999999999861
Q ss_pred -------------CCCCeeecCCCCCCeeecC--CCceEEcccccceecCCCCCceeee-------------ecCccccc
Q 036225 417 -------------CDPKIIHRDVKAANILLDD--CCEAVVGDFGLAKLLDHQDSHVTTA-------------VRGTVGHI 468 (622)
Q Consensus 417 -------------~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~-------------~~gt~~y~ 468 (622)
..+.++|+|+++.||++++ ...+.|+||+.+..-.......... +....++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1245899999999999998 5667899999987543210000000 00000111
Q ss_pred C-ccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 469 A-PEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 469 a-PE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
. |+.... .....+.|++|.++|++.+|..++.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 221110 1123588999999999999988764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=9.2e-11 Score=115.12 Aligned_cols=124 Identities=19% Similarity=0.169 Sum_probs=82.0
Q ss_pred CCCccceEEcCCC-cEEEEecCC---CCCccccCC------------------------cccCCCcccE--EEccCCCCC
Q 036225 61 PCSWTMVTCSPES-LVIGLGIPS---QNLSGTLSP------------------------SIGNLTNLQI--VLLQNNNIT 110 (622)
Q Consensus 61 ~C~w~gv~C~~~~-~v~~L~l~~---n~l~~~~~~------------------------~~~~l~~L~~--L~L~~N~l~ 110 (622)
.|.|.|+.|+.++ +|+.+...+ ..+.+.+++ .|...+.|.. ++++.|...
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 5789999998654 444333333 122222221 1333444554 566666433
Q ss_pred CCCCC----ccCCCCcccEEEecCccccC--CCCchhccccCccceecccccccccccccccccc--ceeEEeCCCCcCC
Q 036225 111 GPIPA----EIGRLTKLQTLDLSNNFFTG--EIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMT--QLIFLDLSYNNLS 182 (622)
Q Consensus 111 ~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~l~l~~N~l~ 182 (622)
.++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|+++
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence 2222 12457899999999999997 4567788899999999999999854 3455555 8999999999999
Q ss_pred CcCCC
Q 036225 183 GPVPR 187 (622)
Q Consensus 183 g~~p~ 187 (622)
+.+|.
T Consensus 234 ~~~~~ 238 (267)
T 3rw6_A 234 DTFRD 238 (267)
T ss_dssp GGCSS
T ss_pred cccCc
Confidence 87773
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.79 E-value=8.5e-11 Score=126.16 Aligned_cols=128 Identities=19% Similarity=0.174 Sum_probs=81.0
Q ss_pred CcEEEEecCCCCCcccc-----CCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCCCCchhcc
Q 036225 73 SLVIGLGIPSQNLSGTL-----SPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 143 (622)
..+..|+|++|.+.... +..+..+++|++|+|++|.++.. ++..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 34677888888776532 22233577788888888877743 5656666777888888887776443333333
Q ss_pred c-----cCccceeccccccccc----cccccccccceeEEeCCCCcCCCcCCC----------CCccccccccccc
Q 036225 144 L-----RSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSGPVPR----------FSAKTFNIVGNPL 200 (622)
Q Consensus 144 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~~p~----------~~~~~~~l~~N~~ 200 (622)
. ++|++|+|++|.+++. ++..+..+++|+.|+|++|++++..+. ...+.+++++|.+
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 2 5777777777777754 456666667777777777777643221 1224566666655
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.69 E-value=5.5e-10 Score=119.81 Aligned_cols=129 Identities=21% Similarity=0.153 Sum_probs=100.8
Q ss_pred CcEEEEecCCCCCccc----cCCcccCCCcccEEEccCCCCCCCCCCccCC-----CCcccEEEecCccccCC----CCc
Q 036225 73 SLVIGLGIPSQNLSGT----LSPSIGNLTNLQIVLLQNNNITGPIPAEIGR-----LTKLQTLDLSNNFFTGE----IPS 139 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~ 139 (622)
..+..|+|++|+++.. ++..+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4688999999999875 6777888999999999999987543333332 36999999999999865 566
Q ss_pred hhccccCccceecccccccccccccccc-----ccceeEEeCCCCcCCC----cCCCC-----Ccccccccccccc
Q 036225 140 SLGHLRSLQYMRFNNNSLSGAFPTSLAS-----MTQLIFLDLSYNNLSG----PVPRF-----SAKTFNIVGNPLI 201 (622)
Q Consensus 140 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~g----~~p~~-----~~~~~~l~~N~~~ 201 (622)
.+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|++++ .+|.. ..+.+++++|++.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 7778899999999999998665555543 6799999999999986 55532 1256788888863
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.65 E-value=2.8e-09 Score=104.58 Aligned_cols=80 Identities=25% Similarity=0.394 Sum_probs=67.2
Q ss_pred cCCCcccEEEccCCCCCC--CCCCccCCCCcccEEEecCccccCCCCchhcccc--Cccceecccccccccccc------
Q 036225 94 GNLTNLQIVLLQNNNITG--PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLR--SLQYMRFNNNSLSGAFPT------ 163 (622)
Q Consensus 94 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 163 (622)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999997 4567778999999999999999954 3455555 999999999999987762
Q ss_pred -ccccccceeEEe
Q 036225 164 -SLASMTQLIFLD 175 (622)
Q Consensus 164 -~~~~l~~L~~l~ 175 (622)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 477889998876
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.6e-09 Score=112.56 Aligned_cols=128 Identities=20% Similarity=0.183 Sum_probs=88.9
Q ss_pred CcEEEEecCCCCCccccCCcc-cCCCcccEEEccCCCCCCCCCCcc-----CCCCcccEEEecCccccC----CCCchhc
Q 036225 73 SLVIGLGIPSQNLSGTLSPSI-GNLTNLQIVLLQNNNITGPIPAEI-----GRLTKLQTLDLSNNFFTG----EIPSSLG 142 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 142 (622)
..+..|+|++|+++..-...+ ..+++|+.|+|++|.|+......+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 358888999888875433333 346788899999998874333333 345788999999998863 2445557
Q ss_pred cccCccceeccccccccc----cccccccccceeEEeCCCCcCCCcC----CC-----CCccccccccccc
Q 036225 143 HLRSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSGPV----PR-----FSAKTFNIVGNPL 200 (622)
Q Consensus 143 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~~----p~-----~~~~~~~l~~N~~ 200 (622)
.+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|++.- +. ...+.+++++|++
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 788899999999988742 3566777788999999999887421 11 1135677888875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=3e-09 Score=110.54 Aligned_cols=111 Identities=21% Similarity=0.262 Sum_probs=88.9
Q ss_pred cEEEEecCCCCCccccCCcc-----cCCCcccEEEccCCCCCC----CCCCccCCCCcccEEEecCccccCC----CCch
Q 036225 74 LVIGLGIPSQNLSGTLSPSI-----GNLTNLQIVLLQNNNITG----PIPAEIGRLTKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
.+..|+|++|+++..-...+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|.|++. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 48999999999986544444 346889999999999974 2444557789999999999999842 3566
Q ss_pred hccccCccceecccccccc----ccccccccccceeEEeCCCCcCCCc
Q 036225 141 LGHLRSLQYMRFNNNSLSG----AFPTSLASMTQLIFLDLSYNNLSGP 184 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~g~ 184 (622)
+..+++|+.|+|++|.|+. .++..+...++|+.|+|++|+|++.
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 7788899999999999984 3445666779999999999999854
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.40 E-value=3.1e-07 Score=93.75 Aligned_cols=99 Identities=13% Similarity=0.089 Sum_probs=48.7
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCccc-EEEecCccccCCCCchhccccCccceecc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQ-TLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
++.|+|++|+++.+-+.+|.++++|+.|+|.+| ++..-+..|.+|++|+ .|+|++ +++..-+..|.+|++|+.|+|+
T Consensus 228 L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~ 305 (329)
T 3sb4_A 228 LVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLAT 305 (329)
T ss_dssp CCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEEC
T ss_pred CeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeC
Confidence 445555555555444445555555555555554 4433334455555555 555554 4442333445555555555555
Q ss_pred ccccccccccccccccceeEEe
Q 036225 154 NNSLSGAFPTSLASMTQLIFLD 175 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~ 175 (622)
+|+++..-+..|.++++|+.|+
T Consensus 306 ~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 306 GDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp SSCCCEECTTTTCTTCCCCEEE
T ss_pred CCccCccchhhhcCCcchhhhc
Confidence 5555533333555555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=2.4e-08 Score=93.00 Aligned_cols=110 Identities=15% Similarity=0.242 Sum_probs=79.5
Q ss_pred CcEEEEecCCC-CCccc----cCCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCC----CCc
Q 036225 73 SLVIGLGIPSQ-NLSGT----LSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPS 139 (622)
Q Consensus 73 ~~v~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 139 (622)
..++.|+|++| ++... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 45788889888 77642 445566678889999999988732 233445567888999999988743 445
Q ss_pred hhccccCccceec--cccccccc----cccccccccceeEEeCCCCcCC
Q 036225 140 SLGHLRSLQYMRF--NNNSLSGA----FPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 140 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
.+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5667788999999 77888743 3455566688889998888875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.3e-06 Score=84.53 Aligned_cols=136 Identities=18% Similarity=0.130 Sum_probs=98.3
Q ss_pred CeeeecCCc-eEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFG-IVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.+..|..| .||+.... ++..+++|+-... ....+..|...++.+. +--+.++++++...+..++|||+++|.
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 356667766 58988754 4677899985432 3346788999888774 334778889999889999999999987
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ---------------------------------------------- 416 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 416 (622)
++.+.... .......+..++++.|..||..
T Consensus 106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 77654421 1233455667777777777742
Q ss_pred ---------CCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 417 ---------CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 417 ---------~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877777999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.6e-06 Score=87.81 Aligned_cols=144 Identities=12% Similarity=0.115 Sum_probs=90.3
Q ss_pred Cee-eecCCceEEEEEEC-------CCeEEEEEEccCCCC--CchhHHHHHHHHHHhcccc---ccceeeeeeeeCC---
Q 036225 306 NIL-GKGGFGIVYKGILQ-------DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVH---RNLLRLYGFCMTP--- 369 (622)
Q Consensus 306 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~--- 369 (622)
+.| +.|....+|+.... +++.+++|+...... ......+..|+.+++.+.. -.+.++++++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998754 267788998654320 1012357788888887753 3567788887655
Q ss_pred CceeEEeeeccCCCcccccc----C--CCCCChhHHHHHHHHHHHHH---------------------------------
Q 036225 370 TERLLVYPYMSNGSVASRLK----G--KPILDWSTRKRIALGAARGL--------------------------------- 410 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~----~--~~~l~~~~~~~i~~~ia~~L--------------------------------- 410 (622)
+..++||||++|..+.+.+. . -..++..++..++.++++.|
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 35689999999877664310 0 00112222222233333332
Q ss_pred ---------------------HHHHhcC-------CCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 411 ---------------------LYLHEQC-------DPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 411 ---------------------~~LH~~~-------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.+|.+.. .+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 3332211 34789999999999999655578999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.6e-06 Score=84.79 Aligned_cols=136 Identities=18% Similarity=0.176 Sum_probs=94.7
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccc---cceeeeeeee-CCCceeEEeeecc
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLYGFCM-TPTERLLVYPYMS 380 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~ 380 (622)
.+.++.|....||+. |..+++|+... ......+..|.+++..+.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888888899987 56688887432 22344688999999988653 3556666664 4556789999999
Q ss_pred CCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 036225 381 NGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ-------------------------------------------- 416 (622)
Q Consensus 381 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 416 (622)
|..+.+..- ..++...+..++.++++.|..||+.
T Consensus 97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 987765321 1234455556666666666666642
Q ss_pred -------------CCCCeeecCCCCCCeeecC---CCce-EEccccccee
Q 036225 417 -------------CDPKIIHRDVKAANILLDD---CCEA-VVGDFGLAKL 449 (622)
Q Consensus 417 -------------~~~~ivH~Dlk~~NILl~~---~~~~-kl~Dfgla~~ 449 (622)
..+.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235699999999999987 4554 8999998864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.8e-06 Score=87.95 Aligned_cols=79 Identities=15% Similarity=0.137 Sum_probs=52.9
Q ss_pred CCcccEEEecCccccCCCCchhccccCccceecccccccccccccccccccee-EEeCCCCcCCCcCCCCCc-----ccc
Q 036225 120 LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLI-FLDLSYNNLSGPVPRFSA-----KTF 193 (622)
Q Consensus 120 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~~~-----~~~ 193 (622)
+++|+.|+|++|+++..-+..|.+|++|+.|+|.+| ++..-+.+|.++++|+ .|++.+ .++..-+..+. +.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 567888888888888444455888888888888887 6644456788888888 888877 55533233322 344
Q ss_pred ccccccc
Q 036225 194 NIVGNPL 200 (622)
Q Consensus 194 ~l~~N~~ 200 (622)
.+.+|..
T Consensus 303 ~l~~n~i 309 (329)
T 3sb4_A 303 LATGDKI 309 (329)
T ss_dssp EECSSCC
T ss_pred EeCCCcc
Confidence 5555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.4e-08 Score=107.73 Aligned_cols=127 Identities=17% Similarity=0.090 Sum_probs=87.8
Q ss_pred cEEEEecCCCCCccccCCcccC-CCcccEEEcc----CCCCCCC-----CCCccCCCCcccEEEecCc--cccCCCCchh
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGN-LTNLQIVLLQ----NNNITGP-----IPAEIGRLTKLQTLDLSNN--FFTGEIPSSL 141 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~ 141 (622)
.+..|+|..|++++..+..+.. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|++| .+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 4677888888888877666665 8889999986 6777753 2333666888888888743 3665544444
Q ss_pred c-cccCccceecccccccc-ccccccccccceeEEeCCCCcCCCc-CCCC-----Cccccccccccc
Q 036225 142 G-HLRSLQYMRFNNNSLSG-AFPTSLASMTQLIFLDLSYNNLSGP-VPRF-----SAKTFNIVGNPL 200 (622)
Q Consensus 142 ~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~-----~~~~~~l~~N~~ 200 (622)
. .+++|++|+|++|++++ .++..+..+++|+.|+|++|+|++. ++.. ..+.+++++|.+
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 4 37788888888888875 3455667778888888888887643 2211 125677777774
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.09 E-value=3e-07 Score=101.75 Aligned_cols=103 Identities=11% Similarity=0.123 Sum_probs=68.6
Q ss_pred EEEEecCCCC-Ccc-ccCCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCcccc----CCCCchhccc
Q 036225 75 VIGLGIPSQN-LSG-TLSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFT----GEIPSSLGHL 144 (622)
Q Consensus 75 v~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l 144 (622)
+..|+|+++. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 7778887765 111 1222334678888888888887654 3334456778888888888876 2344455677
Q ss_pred cCccceeccccccccccccccccccceeEEeCCC
Q 036225 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSY 178 (622)
Q Consensus 145 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 178 (622)
++|++|+|++|.+.+ +|..+..+++|+.|++++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 888888888887774 666677777777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.97 E-value=1.2e-06 Score=81.36 Aligned_cols=96 Identities=24% Similarity=0.251 Sum_probs=76.7
Q ss_pred ccCCcccCCCcccEEEccCC-CCCCC----CCCccCCCCcccEEEecCccccCC----CCchhccccCccceeccccccc
Q 036225 88 TLSPSIGNLTNLQIVLLQNN-NITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHLRSLQYMRFNNNSLS 158 (622)
Q Consensus 88 ~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 158 (622)
.+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 44556778899999999999 88732 344566788999999999999732 3445666789999999999998
Q ss_pred cc----cccccccccceeEEeC--CCCcCCC
Q 036225 159 GA----FPTSLASMTQLIFLDL--SYNNLSG 183 (622)
Q Consensus 159 ~~----~p~~~~~l~~L~~l~l--~~N~l~g 183 (622)
.. +...+...++|+.|+| ++|.|+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 43 5677888899999999 8899974
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.5e-05 Score=77.75 Aligned_cols=137 Identities=17% Similarity=0.255 Sum_probs=79.7
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccc--cceeeee------eeeCCCceeEEee
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLYG------FCMTPTERLLVYP 377 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~------~~~~~~~~~lv~e 377 (622)
+.|+.|..+.||+....+| .+++|+.... ...+..|.+++..+... .+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987655 4889988652 12334455555544321 2334443 1123566789999
Q ss_pred eccCCCccc--------------ccc----CC--C--------CCChhHHH-----------------------------
Q 036225 378 YMSNGSVAS--------------RLK----GK--P--------ILDWSTRK----------------------------- 400 (622)
Q Consensus 378 ~~~~gsL~~--------------~l~----~~--~--------~l~~~~~~----------------------------- 400 (622)
|++|..+.. .++ .. + .-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999865430 111 00 0 11232110
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 401 --RIALGAARGLLYLHE----------QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 401 --~i~~~ia~~L~~LH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
.+...+..++++|+. ...+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446666763 124589999999999999888899999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=1.6e-06 Score=89.25 Aligned_cols=108 Identities=16% Similarity=0.190 Sum_probs=63.3
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccC--CCCcccEEEecC--ccccCC-----CCchh--
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIG--RLTKLQTLDLSN--NFFTGE-----IPSSL-- 141 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~-- 141 (622)
..+..|+|++|.-. .+++ +. +++|+.|+|..|.++...-..+. .+++|+.|+|+. |...|. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 35778888766211 2333 33 77888888887776532222232 577788887753 222111 11122
Q ss_pred ccccCccceeccccccccccccccc---cccceeEEeCCCCcCCC
Q 036225 142 GHLRSLQYMRFNNNSLSGAFPTSLA---SMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 142 ~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~l~l~~N~l~g 183 (622)
..+++|++|+|++|.+.+..+..+. .+++|+.|+|+.|.|++
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 2467788888888877654443333 46778888888888765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.9e-05 Score=81.18 Aligned_cols=76 Identities=12% Similarity=0.005 Sum_probs=49.3
Q ss_pred CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC------CchhHHHHHHHHHHhcccc--c-cceeeeeeeeCCCceeE
Q 036225 305 KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA------IGGEIQFQTEVEMISLAVH--R-NLLRLYGFCMTPTERLL 374 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~H--~-niv~l~~~~~~~~~~~l 374 (622)
.+.||.|.++.||++... +++.++||....... ......+..|.+++..+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899998653221 1122356778888887642 3 34455554 3455689
Q ss_pred EeeeccCC
Q 036225 375 VYPYMSNG 382 (622)
Q Consensus 375 v~e~~~~g 382 (622)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.6e-07 Score=99.52 Aligned_cols=125 Identities=12% Similarity=0.114 Sum_probs=86.6
Q ss_pred cEEEEecCCCCCccccCCccc-CCCcccEEEcc--C----CCCCCCCCC------ccCCCCcccEEEecCccccCCCCch
Q 036225 74 LVIGLGIPSQNLSGTLSPSIG-NLTNLQIVLLQ--N----NNITGPIPA------EIGRLTKLQTLDLSNNFFTGEIPSS 140 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~ 140 (622)
.+..|++..|++++.....+. .+++|+.|+|+ + |.++ ..|. .+.++++|+.|+|++ .+++..+..
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 466778888888876666665 58899999998 4 5665 2221 256678899999977 666555555
Q ss_pred hcc-ccCccceecccccccccccccc-ccccceeEEeCCCCcCCCcCCCC------Cccccccccccc
Q 036225 141 LGH-LRSLQYMRFNNNSLSGAFPTSL-ASMTQLIFLDLSYNNLSGPVPRF------SAKTFNIVGNPL 200 (622)
Q Consensus 141 ~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~g~~p~~------~~~~~~l~~N~~ 200 (622)
+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+.. ..+.+++++|+.
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 555 7889999999998876555544 66888999999999886433221 124566777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.8e-07 Score=99.42 Aligned_cols=127 Identities=16% Similarity=0.224 Sum_probs=86.1
Q ss_pred CcEEEEec---------CCCCCccccCCccc-CCCcccEEEccCCCCCCCCCCccC-CCCcccEEEec--C----ccccC
Q 036225 73 SLVIGLGI---------PSQNLSGTLSPSIG-NLTNLQIVLLQNNNITGPIPAEIG-RLTKLQTLDLS--N----NFFTG 135 (622)
Q Consensus 73 ~~v~~L~l---------~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~ 135 (622)
..+..|+| ..+++++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 34677877 33455543333333 478899999988998865555554 58899999998 4 56652
Q ss_pred C-----CCchhccccCccceecccccccccccccccc-ccceeEEeCCCCcCCCcCCCC------Cccccccccccc
Q 036225 136 E-----IPSSLGHLRSLQYMRFNNNSLSGAFPTSLAS-MTQLIFLDLSYNNLSGPVPRF------SAKTFNIVGNPL 200 (622)
Q Consensus 136 ~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~l~l~~N~l~g~~p~~------~~~~~~l~~N~~ 200 (622)
. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+.. ..+.+++++|++
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 1 122366788999999977 676665566655 788999999999987543211 125678888876
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00015 Score=72.78 Aligned_cols=136 Identities=18% Similarity=0.169 Sum_probs=90.6
Q ss_pred cCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc---cccceeeeeeeeCCCceeEEeeecc
Q 036225 304 SKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLYGFCMTPTERLLVYPYMS 380 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~ 380 (622)
..+.|+.|.+..+|+.... +..+++|+.... ....+..|.+.++.+. ...+.++++++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3467899999999998864 667888986532 2446888999888774 2568888998888888999999999
Q ss_pred CCCccc-----------cccC--C-C-------------------CCChhHHH---HHHHH----------------HHH
Q 036225 381 NGSVAS-----------RLKG--K-P-------------------ILDWSTRK---RIALG----------------AAR 408 (622)
Q Consensus 381 ~gsL~~-----------~l~~--~-~-------------------~l~~~~~~---~i~~~----------------ia~ 408 (622)
+..+.. .++. . + .-+|.... ++..+ +..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876531 1111 1 1 01343321 11111 111
Q ss_pred HH-HHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 409 GL-LYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 409 ~L-~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
.+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 23321 2356899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00026 Score=70.31 Aligned_cols=79 Identities=19% Similarity=0.216 Sum_probs=56.1
Q ss_pred CCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc---ccceeeeeeeeCCCceeEEee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH---RNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~~~~~lv~e 377 (622)
.....+.+|.|..+.||+....||+.|++|+...... .....|..|.+.|+.+.- --+.+++++ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3445677999999999999999999999998654332 222357889998887742 234455554 23578999
Q ss_pred eccCCCc
Q 036225 378 YMSNGSV 384 (622)
Q Consensus 378 ~~~~gsL 384 (622)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=1.3e-05 Score=72.79 Aligned_cols=83 Identities=16% Similarity=0.116 Sum_probs=45.6
Q ss_pred cccEEEccCCCCCCCCCCccCCCCcccEEEecCcc-ccCCCCchhccc----cCccceeccccc-cccccccccccccce
Q 036225 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNF-FTGEIPSSLGHL----RSLQYMRFNNNS-LSGAFPTSLASMTQL 171 (622)
Q Consensus 98 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 171 (622)
+|+.|||+++.|+..--..+.++++|+.|+|+++. ++..--..+..+ ++|++|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 56666666666653323345566666666666664 442211223332 356677776653 553322345566677
Q ss_pred eEEeCCCCc
Q 036225 172 IFLDLSYNN 180 (622)
Q Consensus 172 ~~l~l~~N~ 180 (622)
+.|+|++.+
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777776653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.59 E-value=7.3e-05 Score=78.17 Aligned_cols=101 Identities=17% Similarity=0.129 Sum_probs=65.0
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcccc-----CCCCchhccccCccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT-----GEIPSSLGHLRSLQY 149 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~ 149 (622)
+..|+|++ +++.+-..+|.+ .+|+.++| .|.++..-+..|.+|++|+.++|.+|.+. ..-+..|.+|++|+.
T Consensus 228 L~~l~l~~-~l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~ 304 (401)
T 4fdw_A 228 LKTIEIPE-NVSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLAR 304 (401)
T ss_dssp CCCEECCT-TCCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCE
T ss_pred CCEEecCC-CccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCe
Confidence 55666665 355454556666 67777777 44555344567777777777777777654 233455777777777
Q ss_pred eeccccccccccccccccccceeEEeCCCC
Q 036225 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 150 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
++|.+ .++..-...|.++++|+.|+|..|
T Consensus 305 l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 305 FEIPE-SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred EEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence 77773 465333456777777777777544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00019 Score=75.52 Aligned_cols=79 Identities=11% Similarity=0.042 Sum_probs=48.3
Q ss_pred CCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee-cCcccccCccccccC---CCCcccceeehhHHHHH
Q 036225 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV-RGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLE 493 (622)
Q Consensus 418 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~e 493 (622)
.+.++|+|+++.|||++.++ ++|+||+.+..-..... ..... .-...|++|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34799999999999999776 99999999875321100 00000 012346666655311 11223455677888888
Q ss_pred HHhcC
Q 036225 494 LITGQ 498 (622)
Q Consensus 494 l~tg~ 498 (622)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00066 Score=68.45 Aligned_cols=154 Identities=9% Similarity=0.010 Sum_probs=85.8
Q ss_pred CHHHHHHHHhCCCc-----CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc--ceeee
Q 036225 291 QFRELQVATHNFSS-----KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLY 363 (622)
Q Consensus 291 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~ 363 (622)
+.+++......|.. .+.|+.|....+|+....+| .+++|+..... ....+..|..++..+...+ +.+++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 33444444444544 23466788889999987766 57889876531 1224556777777664322 23333
Q ss_pred ee------eeCCCceeEEeeeccCCCcccc--------------cc----C--CCC------CChhHHHH----------
Q 036225 364 GF------CMTPTERLLVYPYMSNGSVASR--------------LK----G--KPI------LDWSTRKR---------- 401 (622)
Q Consensus 364 ~~------~~~~~~~~lv~e~~~~gsL~~~--------------l~----~--~~~------l~~~~~~~---------- 401 (622)
.. ....+..+++|+|++|..+... ++ . .+. ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 22 1123556899999988654220 11 1 000 11322110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 402 --IALGAARGLLYLHEQ----CDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 402 --i~~~ia~~L~~LH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
+...+.+.++++++. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 23478999999999999987666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00059 Score=68.21 Aligned_cols=128 Identities=16% Similarity=0.133 Sum_probs=75.7
Q ss_pred CCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccc-eeeeeeeeCCCceeEEeeec-cCC
Q 036225 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLYGFCMTPTERLLVYPYM-SNG 382 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~g 382 (622)
.+.|+.|....+|+. +.+++|+....... ......|..+++.+...++ .+++++ ..+..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 678999999999998 45888887643211 1234568877776653333 355544 344567899999 554
Q ss_pred CccccccCCCCCChhHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 036225 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHE----------------------------------------------- 415 (622)
Q Consensus 383 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------------------- 415 (622)
++...-. ..+..++.++++.|.-||+
T Consensus 94 ~l~~~~~-------~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 94 TMSPEKF-------KTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp ECCHHHH-------HHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred cCCHhhH-------hhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 4421000 0000112222222222222
Q ss_pred ---cCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 416 ---QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 416 ---~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...+.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12235799999999999 5667889999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.37 E-value=4.4e-05 Score=78.49 Aligned_cols=124 Identities=15% Similarity=0.174 Sum_probs=76.9
Q ss_pred cEEEEecCCCCCc---------cccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhc--
Q 036225 74 LVIGLGIPSQNLS---------GTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG-- 142 (622)
Q Consensus 74 ~v~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-- 142 (622)
.+..|.+..+... +.+...+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.+....-..+.
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHc
Confidence 4667777654321 234455677899999999888311 2343 4 388999999998887643333444
Q ss_pred cccCccceeccc--cccccc-----ccccc--ccccceeEEeCCCCcCCCcCCC-------C-Cccccccccccc
Q 036225 143 HLRSLQYMRFNN--NSLSGA-----FPTSL--ASMTQLIFLDLSYNNLSGPVPR-------F-SAKTFNIVGNPL 200 (622)
Q Consensus 143 ~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~g~~p~-------~-~~~~~~l~~N~~ 200 (622)
.+++|++|+|+. |...|. +...+ ..+++|+.|+|++|.+.+..+. . ..+.++++.|.+
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 689999999863 322221 11222 2478999999999988743211 1 125567776654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00063 Score=71.03 Aligned_cols=77 Identities=17% Similarity=0.117 Sum_probs=35.1
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.+.|.+ ++..+-+.+|.++++|+.++|++|+++ .+|.....+.+|+.+.|.+| ++..-...|.++++|+.++|.+
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 34444443 444444445555555555555555555 33322222455555555432 3322233455555555555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.24 E-value=5e-05 Score=68.99 Aligned_cols=85 Identities=12% Similarity=0.167 Sum_probs=65.3
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCC-CCCCCCCccCCC----CcccEEEecCcc-ccCCCCchhccccCc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNN-ITGPIPAEIGRL----TKLQTLDLSNNF-FTGEIPSSLGHLRSL 147 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 147 (622)
.++.|||+++.++..--..+.++++|+.|+|++|. |+..--..++.+ ++|++|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 59999999999886555668899999999999995 663222234553 479999999985 774333457789999
Q ss_pred cceeccccc-cc
Q 036225 148 QYMRFNNNS-LS 158 (622)
Q Consensus 148 ~~L~l~~N~-l~ 158 (622)
++|+|+++. ++
T Consensus 142 ~~L~L~~c~~It 153 (176)
T 3e4g_A 142 KYLFLSDLPGVK 153 (176)
T ss_dssp CEEEEESCTTCC
T ss_pred CEEECCCCCCCC
Confidence 999999985 54
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00066 Score=68.86 Aligned_cols=138 Identities=17% Similarity=0.081 Sum_probs=71.1
Q ss_pred CeeeecCCce-EEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc--ccceeeeeeeeCCCceeEEeeeccCC
Q 036225 306 NILGKGGFGI-VYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 306 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 382 (622)
+.|+.|.... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+.... .+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 4565565544 6677654466777776543210 234466777666642 2355666664333 37899998765
Q ss_pred Ccccccc---------------------C-----CCCCChhHHH-------H-H------------HHHHHHHHHHHHh-
Q 036225 383 SVASRLK---------------------G-----KPILDWSTRK-------R-I------------ALGAARGLLYLHE- 415 (622)
Q Consensus 383 sL~~~l~---------------------~-----~~~l~~~~~~-------~-i------------~~~ia~~L~~LH~- 415 (622)
.+.+.+. . .+.++..... . + ...+...++.+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 5532221 1 0111111100 0 0 0011122222211
Q ss_pred --cCCCCeeecCCCCCCeeecCC----CceEEccccccee
Q 036225 416 --QCDPKIIHRDVKAANILLDDC----CEAVVGDFGLAKL 449 (622)
Q Consensus 416 --~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~ 449 (622)
...+.++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999874 6789999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=69.53 Aligned_cols=73 Identities=16% Similarity=0.229 Sum_probs=49.4
Q ss_pred CCeeeecCCceEEEEEECC--------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccc-eeeeeeeeCCCceeEE
Q 036225 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLYGFCMTPTERLLV 375 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 375 (622)
.+.|+.|....+|++...+ ++.+.+|+..... ....+..|..++..+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3567888889999998753 4789999874321 11345578888887754444 566766542 389
Q ss_pred eeeccCCCc
Q 036225 376 YPYMSNGSV 384 (622)
Q Consensus 376 ~e~~~~gsL 384 (622)
+||++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0017 Score=65.63 Aligned_cols=139 Identities=15% Similarity=0.112 Sum_probs=80.9
Q ss_pred CeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc--ceeeeee-----eeCCCceeEEeee
Q 036225 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLYGF-----CMTPTERLLVYPY 378 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~ 378 (622)
..++ |....||+....+|+.+++|+...... ....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 888899998877787899999864321 2335667888777664322 3444443 1123455789999
Q ss_pred ccCCCccc-----------c---cc----C-----CCCCChhHH----HHH---------------HHHHHHHHHHHHhc
Q 036225 379 MSNGSVAS-----------R---LK----G-----KPILDWSTR----KRI---------------ALGAARGLLYLHEQ 416 (622)
Q Consensus 379 ~~~gsL~~-----------~---l~----~-----~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~ 416 (622)
++|..+.. . ++ . .+..++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98755421 0 11 0 111222211 001 11111223333321
Q ss_pred ----CCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 417 ----CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 417 ----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0023 Score=65.96 Aligned_cols=139 Identities=17% Similarity=0.176 Sum_probs=82.8
Q ss_pred CCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc-ceeeeeeeeCCCceeEE
Q 036225 305 KNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLYGFCMTPTERLLV 375 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv 375 (622)
.+.|..|-...+|+.... +++.+.+|+.... ......+.+|.++++.+.-.+ ..++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 346777888899998864 2478999986332 122345668999888775322 3566666653 399
Q ss_pred eeeccCCCcccc-----------------ccCC-----CCC--ChhHHHHHHHHHHH-------------------HHHH
Q 036225 376 YPYMSNGSVASR-----------------LKGK-----PIL--DWSTRKRIALGAAR-------------------GLLY 412 (622)
Q Consensus 376 ~e~~~~gsL~~~-----------------l~~~-----~~l--~~~~~~~i~~~ia~-------------------~L~~ 412 (622)
|||++|..+... ++.- ... -|.++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655321 0111 111 24455555544322 2333
Q ss_pred HH----hc-CCCCeeecCCCCCCeeecCC----CceEEccccccee
Q 036225 413 LH----EQ-CDPKIIHRDVKAANILLDDC----CEAVVGDFGLAKL 449 (622)
Q Consensus 413 LH----~~-~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~ 449 (622)
|. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 21 23368999999999999876 7899999998863
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.03 E-value=7.4e-05 Score=69.18 Aligned_cols=106 Identities=19% Similarity=0.242 Sum_probs=49.1
Q ss_pred cEEEEecCCC-CCcc----ccCCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCC----CCch
Q 036225 74 LVIGLGIPSQ-NLSG----TLSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 74 ~v~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
.++.|+|++| +|.. .+-..+..-+.|+.|+|++|+|... +-..+..-+.|+.|+|++|.|... +-..
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a 121 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 121 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence 3556666654 4432 1233344445566666666666521 112222345566666666666521 1122
Q ss_pred hccccCccceecccc---cccc----ccccccccccceeEEeCCCC
Q 036225 141 LGHLRSLQYMRFNNN---SLSG----AFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N---~l~~----~~p~~~~~l~~L~~l~l~~N 179 (622)
+..-+.|++|+|++| .+.. .+...+..-+.|+.|+|+.|
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 167 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCC
Confidence 333345666666543 2221 12333444455555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00088 Score=57.79 Aligned_cols=56 Identities=21% Similarity=0.297 Sum_probs=35.2
Q ss_pred EEecCCCCCc-cccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCcccc
Q 036225 77 GLGIPSQNLS-GTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFT 134 (622)
Q Consensus 77 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 134 (622)
.++.++++|+ ..+|..+. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4666677776 34554332 35777777777777444455666777777777777654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00065 Score=58.63 Aligned_cols=56 Identities=21% Similarity=0.275 Sum_probs=31.1
Q ss_pred EEEccCCCCC-CCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccc
Q 036225 101 IVLLQNNNIT-GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLS 158 (622)
Q Consensus 101 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 158 (622)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666777665 34554332 25666666666666333334555556665555555543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.003 Score=66.85 Aligned_cols=74 Identities=14% Similarity=0.137 Sum_probs=48.1
Q ss_pred CCeeeecCCceEEEEEECC-CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccc-eeeeeeeeCCCceeEEeeeccCC
Q 036225 305 KNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLYGFCMTPTERLLVYPYMSNG 382 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g 382 (622)
.+.|+.|-...+|+....+ +..+++|+..... ........|..++..+...++ .++++.+. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4568888889999998765 5788899874322 111123578888888865444 46777663 2 3599999875
Q ss_pred Cc
Q 036225 383 SV 384 (622)
Q Consensus 383 sL 384 (622)
.+
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0026 Score=65.50 Aligned_cols=73 Identities=10% Similarity=0.025 Sum_probs=44.3
Q ss_pred CeeeecCCceEEEEEECC---------CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccc-eeeeeeeeCCCceeEE
Q 036225 306 NILGKGGFGIVYKGILQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLYGFCMTPTERLLV 375 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 375 (622)
+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...++ .++++.. ..++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 467778888999998754 26788888654321 11134578888887754343 4666544 23789
Q ss_pred eeeccCCCc
Q 036225 376 YPYMSNGSV 384 (622)
Q Consensus 376 ~e~~~~gsL 384 (622)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.01 Score=60.30 Aligned_cols=31 Identities=23% Similarity=0.307 Sum_probs=27.7
Q ss_pred CCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 419 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4789999999999999888899999988764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.00082 Score=62.12 Aligned_cols=89 Identities=12% Similarity=0.137 Sum_probs=66.0
Q ss_pred CcccCCCcccEEEccCC-CCCC----CCCCccCCCCcccEEEecCccccC----CCCchhccccCccceeccccccccc-
Q 036225 91 PSIGNLTNLQIVLLQNN-NITG----PIPAEIGRLTKLQTLDLSNNFFTG----EIPSSLGHLRSLQYMRFNNNSLSGA- 160 (622)
Q Consensus 91 ~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~- 160 (622)
..+.+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|+|.. .+-..+..-+.|++|+|++|.|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34556688999999986 7762 133345667899999999999973 2344555668999999999999843
Q ss_pred ---cccccccccceeEEeCCCC
Q 036225 161 ---FPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 161 ---~p~~~~~l~~L~~l~l~~N 179 (622)
+-..+..-+.|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 3455666678999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.007 Score=56.30 Aligned_cols=97 Identities=15% Similarity=0.119 Sum_probs=62.0
Q ss_pred Ccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceeeee
Q 036225 383 SVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAV 461 (622)
Q Consensus 383 sL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 461 (622)
+|.+.|+ .+.++++++++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-------------
Confidence 6777776 356799999999999999998776221111 1233456899999999988753 1110
Q ss_pred cCcccccCccccccCCCCcccceeehhHHHHHHHh
Q 036225 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 496 (622)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t 496 (622)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1233456888763 345678889999999998775
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0065 Score=63.08 Aligned_cols=86 Identities=16% Similarity=0.076 Sum_probs=65.6
Q ss_pred CcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccc
Q 036225 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170 (622)
Q Consensus 91 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 170 (622)
..|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-...|.+|++|+.++|..| ++..-..+|.++++
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 46778889999998765 65344567889999999999755 66334567889999999999877 66334568889999
Q ss_pred eeEEeCCCC
Q 036225 171 LIFLDLSYN 179 (622)
Q Consensus 171 L~~l~l~~N 179 (622)
|+.+++..|
T Consensus 368 L~~i~lp~~ 376 (394)
T 4fs7_A 368 LKKVELPKR 376 (394)
T ss_dssp CCEEEEEGG
T ss_pred CCEEEECCC
Confidence 999988654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0076 Score=62.11 Aligned_cols=92 Identities=13% Similarity=0.089 Sum_probs=48.2
Q ss_pred CccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccc
Q 036225 85 LSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTS 164 (622)
Q Consensus 85 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 164 (622)
+...-...|.+..+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.+|.++..-...
T Consensus 228 ~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~a 305 (379)
T 4h09_A 228 VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRV 305 (379)
T ss_dssp CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTT
T ss_pred eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhh
Confidence 33333445556666666666544 33233345555666666666443 33122334556666666666666555222345
Q ss_pred cccccceeEEeCCC
Q 036225 165 LASMTQLIFLDLSY 178 (622)
Q Consensus 165 ~~~l~~L~~l~l~~ 178 (622)
|.++.+|+.+.|..
T Consensus 306 F~~c~~L~~i~lp~ 319 (379)
T 4h09_A 306 FMDCVKLSSVTLPT 319 (379)
T ss_dssp TTTCTTCCEEECCT
T ss_pred hcCCCCCCEEEcCc
Confidence 66666666666643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0072 Score=62.71 Aligned_cols=103 Identities=13% Similarity=0.166 Sum_probs=76.4
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..+.+.++ +...-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.+|++|+.+.|..
T Consensus 267 L~~i~lp~~-~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~ 343 (394)
T 4gt6_A 267 LASVKMPDS-VVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPS 343 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECT
T ss_pred ccEEecccc-cceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECc
Confidence 455666543 333445678889999999996 5566344567899999999999865 5534456799999999999975
Q ss_pred cccccccccccccccceeEEeCCCCcC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNL 181 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l 181 (622)
+ ++..-..+|.++++|+.+++.+|..
T Consensus 344 s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 344 S-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp T-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred c-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 5 6633356899999999999988754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.013 Score=60.74 Aligned_cols=95 Identities=13% Similarity=0.133 Sum_probs=72.5
Q ss_pred CCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccccccccc
Q 036225 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPT 163 (622)
Q Consensus 84 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 163 (622)
++...-..+|.++.+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 344444567889999999999877654 556789999999999996 4566344456999999999999865 5533356
Q ss_pred ccccccceeEEeCCCCcCC
Q 036225 164 SLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 164 ~~~~l~~L~~l~l~~N~l~ 182 (622)
+|.++.+|+.+.|..| ++
T Consensus 329 aF~~C~~L~~i~ip~s-v~ 346 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VT 346 (394)
T ss_dssp TTTTCTTCCEEEECTT-CC
T ss_pred HhhCCCCCCEEEECcc-cC
Confidence 8999999999999655 54
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.015 Score=60.21 Aligned_cols=101 Identities=12% Similarity=0.045 Sum_probs=74.3
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..+.+..+ +.......|.+...|+.+.+..+.+. ...|..+.+|+.+.+.++ ++..-...|.++++|+.++|.+
T Consensus 255 l~~~~~~~~-~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 255 LESISIQNN-KLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CCEEEECCT-TCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred ceeEEcCCC-cceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCC
Confidence 334445443 33345567888999999988876543 346889999999999866 6634456799999999999975
Q ss_pred cccccccccccccccceeEEeCCCCcCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
+ ++..-..+|.++.+|+.+++..| ++
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 5 66333578999999999999776 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.095 Score=54.63 Aligned_cols=138 Identities=10% Similarity=0.060 Sum_probs=83.6
Q ss_pred CCeeeecCCceEEEEEECC--------CeEEEEEEccCCCCCchhHHHHHHHHHHhcccccc-ceeeeeeeeCCCceeEE
Q 036225 305 KNILGKGGFGIVYKGILQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLYGFCMTPTERLLV 375 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv 375 (622)
.+.+..|-...+|+....+ ++.+++|+..... .......+|.++++.+.-.+ ..++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 3466778888999998763 5789998864432 11123457888887775333 345555332 3789
Q ss_pred eeeccCCCcccc-c----------------cC-------------CCCCChhHHHHHHHHH-------------------
Q 036225 376 YPYMSNGSVASR-L----------------KG-------------KPILDWSTRKRIALGA------------------- 406 (622)
Q Consensus 376 ~e~~~~gsL~~~-l----------------~~-------------~~~l~~~~~~~i~~~i------------------- 406 (622)
|||++|..|..- + |. ..+.-|.++.++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 999998654210 0 00 0111244444443322
Q ss_pred HHHHHHHHh---------------------cCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 407 ARGLLYLHE---------------------QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 407 a~~L~~LH~---------------------~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
...+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333321 11235889999999999 8888999999998863
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.075 Score=54.47 Aligned_cols=88 Identities=11% Similarity=0.095 Sum_probs=40.1
Q ss_pred cccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccce
Q 036225 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQL 171 (622)
Q Consensus 92 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 171 (622)
.+....+|+.+.+..+ +...-...|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|..+++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444455555555433 22123334555555555555444 33222334555555555555433 331222345555555
Q ss_pred eEEeCCCCcCC
Q 036225 172 IFLDLSYNNLS 182 (622)
Q Consensus 172 ~~l~l~~N~l~ 182 (622)
+.+.+.+|.++
T Consensus 289 ~~i~l~~~~i~ 299 (379)
T 4h09_A 289 TKVVMDNSAIE 299 (379)
T ss_dssp CEEEECCTTCC
T ss_pred ccccccccccc
Confidence 55555555444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.13 E-value=0.13 Score=53.22 Aligned_cols=29 Identities=28% Similarity=0.434 Sum_probs=24.8
Q ss_pred eeecCCCCCCeee------cCCCceEEccccccee
Q 036225 421 IIHRDVKAANILL------DDCCEAVVGDFGLAKL 449 (622)
Q Consensus 421 ivH~Dlk~~NILl------~~~~~~kl~Dfgla~~ 449 (622)
++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567799999998863
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.24 E-value=0.072 Score=35.36 Aligned_cols=28 Identities=14% Similarity=0.312 Sum_probs=16.2
Q ss_pred EeeeehhhHHHHHHHHHHHhhhhhhccc
Q 036225 241 VFGLSVGCVSLIILVFGLFLWWRQRRNQ 268 (622)
Q Consensus 241 vi~~~~~~~~l~il~~~~~~~~~~~~~~ 268 (622)
+.+.++|+++++++++.+++|+|+|+.+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4455566555555566666666666544
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.54 E-value=0.098 Score=34.88 Aligned_cols=28 Identities=21% Similarity=0.400 Sum_probs=14.9
Q ss_pred EeeeehhhHHHHHHHHHHHhhhhhhccc
Q 036225 241 VFGLSVGCVSLIILVFGLFLWWRQRRNQ 268 (622)
Q Consensus 241 vi~~~~~~~~l~il~~~~~~~~~~~~~~ 268 (622)
..+++.|++.++++++..++++|+|+.+
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3344444555555555556666666544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.63 E-value=0.14 Score=34.02 Aligned_cols=27 Identities=19% Similarity=0.361 Sum_probs=14.0
Q ss_pred eeehhhHHHHHHHHHHHhhhhhhccch
Q 036225 243 GLSVGCVSLIILVFGLFLWWRQRRNQQ 269 (622)
Q Consensus 243 ~~~~~~~~l~il~~~~~~~~~~~~~~~ 269 (622)
+++.|++.++++++..++++|+|+.++
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 333344444555555566666665443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.49 E-value=1.3 Score=41.11 Aligned_cols=116 Identities=10% Similarity=0.073 Sum_probs=77.2
Q ss_pred ccccceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 036225 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 434 (622)
Q Consensus 355 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~ 434 (622)
.||+++.. .+-...+...+.|+.-+.+.=...++ .++...+++++.+|+....+++.. +|--|.|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence 57877755 45556666666665544222222232 367889999999999988777654 8889999999999
Q ss_pred CCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 435 DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 435 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
.++.+++.-.|+-..+. |.- .++..=.-.+=+++..+++++..|+
T Consensus 114 ~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999998777643222 211 0111112245678888899988876
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.47 E-value=1.3 Score=41.21 Aligned_cols=115 Identities=14% Similarity=0.122 Sum_probs=75.5
Q ss_pred ccccceeeeeeeeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCCCeee
Q 036225 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLL-YLHEQCDPKIIHRDVKAANILL 433 (622)
Q Consensus 355 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlk~~NILl 433 (622)
.||.+ -..+-...+...+.|+.-+++.=...++ .++...+++++.+|+.... +++.. +|--|.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEE
Confidence 57777 4444466677766666554433333332 3678889999999988777 66644 888999999999
Q ss_pred cCCCceEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccc
Q 036225 434 DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALE 502 (622)
Q Consensus 434 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~ 502 (622)
|.++.++|.-.|+-..+ +|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 118 ~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999877764322 22211 111112245677788888887765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.53 E-value=0.2 Score=52.93 Aligned_cols=61 Identities=5% Similarity=-0.028 Sum_probs=18.1
Q ss_pred cCCeeeecCCceEEEEEECC-CeEEEE------EEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeee
Q 036225 304 SKNILGKGGFGIVYKGILQD-GTVVAV------KRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCM 367 (622)
Q Consensus 304 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 367 (622)
..+.|| ||+||+|.+.. ..+||| |..+..... .....|.+|..+....+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456676 99999999864 367888 766543322 22335778888888899999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 622 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-66
Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
LG G FG V+ G T VAVK LK G+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQC 417
+RLY T ++ YM NGS+ LK L + +A A G+ ++ E+
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
IHRD++AANIL+ D + DFGLA+L++ + + + APE ++ G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
+ K+DV+ FGILL E++T G+ + ++ + + ++
Sbjct: 187 FTIKSDVWSFGILLTEIVTH------GRIPYPGMTNPEVIQNLERGYRMVR--------- 231
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EE+ Q+ LC + P RP + +LE
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 3e-64
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 24/278 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 359
+ +G G FG VYKG VAVK L ++Q F+ EV ++ H N+
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCD 418
L G+ T + +V + S+ L + + IA A+G+ YLH +
Sbjct: 67 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH-QDSHVTTAVRGTVGHIAPEYLSTGQ 477
IIHRD+K+ NI L + +GDFGLA + SH + G++ +APE +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 478 S---SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534
S ++DV+ FGI+L EL+TGQ N + ++ V + + L +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN-- 237
Query: 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ M ++ C + RP +++ +E
Sbjct: 238 -------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 5e-63
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 22/273 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+ +G G FG+V+ G + VA+K +++G E F E E++ H L+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLV 63
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPIL-DWSTRKRIALGAARGLLYLHEQCDP 419
+LYG C+ LV+ +M +G ++ L+ + L T + L G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+IHRD+ A N L+ + V DFG+ + + +T + V +PE S + S
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
K+DV+ FG+L+ E+ + GK + + + V+ I +L
Sbjct: 181 SKSDVWSFGVLMWEVFSE------GKIPYENRSNSEVVEDISTGFRLY----------KP 224
Query: 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
R+ + Q+ C + P RP S ++R L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 5e-63
Identities = 75/301 (24%), Positives = 126/301 (41%), Gaps = 37/301 (12%)
Query: 290 FQFRELQVATHNFSSK---------NILGKGGFGIVYKGIL----QDGTVVAVKRLKDGN 336
F F + A F+ + ++G G FG V G L + VA+K LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 337 AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-PILD 395
F +E ++ H N++ L G T +++ +M NGS+ S L+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 396 WSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
+ G A G+ YL + +HRD+ A NIL++ V DFGL++ L+ S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 456 HVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG 511
T + + APE + + + +DV+ +GI++ E+++ YG+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWDM 237
Query: 512 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRML 571
D + I Q+ +L +D + Q+ L C Q HRPK ++V L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 572 E 572
+
Sbjct: 288 D 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-62
Identities = 72/330 (21%), Positives = 135/330 (40%), Gaps = 13/330 (3%)
Query: 295 LQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 353
+++ +F + LG G G+V+K G V+A K + Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 354 AVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYL 413
++ YG + E + +M GS+ LK + ++++ +GL YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYL 473
E+ KI+HRDVK +NIL++ E + DFG++ L + + GT +++PE L
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL 175
Query: 474 STGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533
S ++D++ G+ L+E+ G+ + A + V+ E
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAER---WEASQRAEATK 590
++Y M LL + PK+ V LE + ++RA+ +
Sbjct: 236 PLSSYGMDSRPPMAIFELL-DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 591 SKPHE-FSSSDRYSDLTDDSSLLVQAMELS 619
H SD ++ D + L + L+
Sbjct: 295 LMVHAFIKRSD--AEEVDFAGWLCSTIGLN 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-62
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 27/287 (9%)
Query: 293 RELQVATHNFSSKNI-LGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEV 348
++L + N +I LG G FG V +G+ + VA+K LK G + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 349 EMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAA 407
+++ + ++RL G C +LV G + L GK + S + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT--TAVRGTV 465
G+ YL E+ +HRD+ A N+LL + A + DFGL+K L DS+ T +A + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525
APE ++ + S ++DV+ +G+ + E ++ YG+ +K + + I Q K+
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKR 230
Query: 526 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+E + E+ + C Y RP V + +
Sbjct: 231 MECPPECP----------PELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-62
Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 27/286 (9%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGILQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEM 350
++ + + ++G G FG VYKG+L+ + VA+K LK G + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASR-LKGKPILDWSTRKRIALGAARG 409
+ H N++RL G +++ YM NG++ + + G A G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 410 LLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGH 467
+ YL +HRD+ A NIL++ V DFGL+++L D + ++ T+ + +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 468 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527
APE +S + + +DV+ FGI++ E++T + ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVM 223
Query: 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573
++ + + Q+ + C Q A RPK +++V +L+
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 1e-61
Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 24/288 (8%)
Query: 288 RRFQFRELQVATHNFSSKNILGKGGFGIVYKGILQD-GTVVAVKRLKDGNAIGGEIQFQT 346
+ + ++ + + K+ LG G +G VY+G+ + VAVK LK+ E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 347 EVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRL--KGKPILDWSTRKRIAL 404
E ++ H NL++L G C ++ +M+ G++ L + + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 405 GAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGT 464
+ + YL + IHRD+ A N L+ + V DFGL++L+ +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 465 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
+ APE L+ + S K+DV+ FG+LL E+ T + G
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLS 223
Query: 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++ L++KD + E++ ++ C Q+ P+ RP +E+ + E
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (520), Expect = 1e-61
Identities = 68/313 (21%), Positives = 128/313 (40%), Gaps = 50/313 (15%)
Query: 291 QFRELQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQF 344
+ L+ +N +G+G FG V++ + T+VAVK LK+ + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 345 QTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLK--------------- 389
Q E +++ + N+++L G C L++ YM+ G + L+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 390 ---------GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAV 440
G P L + + IA A G+ YL E+ K +HRD+ N L+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 441 VGDFGLAKLLDHQD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 499
+ DFGL++ + D + + PE + + + ++DV+ +G++L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 500 ALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPA 559
YG E+ + + D ++ + E+ + LC LPA
Sbjct: 241 QPYYGM---------------AHEEVIYYVRDGNILACPENCP-LELYNLMRLCWSKLPA 284
Query: 560 HRPKMSEVVRMLE 572
RP + R+L+
Sbjct: 285 DRPSFCSIHRILQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-61
Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 22/273 (8%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+ + LG G FG+V G + VA+K +K+G+ E +F E +++ H L+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLV 62
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDP 419
+LYG C ++ YM+NG + + L+ + + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+HRD+ A N L++D V DFGL++ + + + + V PE L + S
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
K+D++ FG+L+ E+ + + + + + L+
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYER----------------FTNSETAEHIAQGLRLYRP 223
Query: 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ E++ + C RP ++ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 77/281 (27%), Positives = 116/281 (41%), Gaps = 30/281 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 356
+F ++G+G FG VY G L D AVK L IG QF TE ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 357 RNLLRLYGFCM-TPTERLLVYPYMSNGSVAS-RLKGKPILDWSTRKRIALGAARGLLYLH 414
N+L L G C+ + L+V PYM +G + + L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS---HVTTAVRGTVGHIAPE 471
K +HRD+ A N +LD+ V DFGLA+ + ++ H T + V +A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
L T + + K+DV+ FG+LL EL+T D + Q ++L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL---- 254
Query: 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + +V L C RP SE+V +
Sbjct: 255 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-61
Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 24/275 (8%)
Query: 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+ + LG+G FG V+ G T VA+K LK G F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQC 417
++LY + +V YMS GS+ LKG+ L +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+HRD++AANIL+ + V DFGLA+L++ + + + APE G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
+ K+DV+ FGILL EL T R G +++ V++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMP 234
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
E + + C + P RP + LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-60
Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 26/290 (8%)
Query: 305 KNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+ +GKG FG V++G G VAVK + E+ + H N+L
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64
Query: 365 FCM----TPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC--- 417
T T+ LV Y +GS+ L + ++AL A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 418 --DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV---TTAVRGTVGHIAPEY 472
P I HRD+K+ NIL+ + D GLA D + GT ++APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 473 LST------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML---DWVKKIHQE 523
L +S ++ D++ G++ E+ + L D + ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 524 KKLEMLVDKDLKNNYDRIE-LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
E + ++ N + E L M ++ C A R + + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 44/301 (14%)
Query: 300 HNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 352
+ S LG G FG V + VAVK LK + +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 353 LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK------------------PIL 394
L H N++ L G C L++ Y G + + L+ K L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 395 DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
D + A+G+ +L + IHRD+ A NILL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 455 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM 513
++ V R V +APE + + ++DV+ +GI L EL + + G
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------- 251
Query: 514 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573
+ K ++ + + EM + C P RP ++V+++E
Sbjct: 252 -------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 574 D 574
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 68/303 (22%), Positives = 111/303 (36%), Gaps = 49/303 (16%)
Query: 301 NFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-L 353
N +LG G FG V VAVK LK+ +E++M++ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 354 AVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK---------------------- 391
H N++ L G C L++ Y G + + L+ K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 392 -PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
+L + A A+G+ +L + +HRD+ A N+L+ + DFGLA+ +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 451 DHQDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509
++V R V +APE L G + K+DV+ +GILL E+ + G
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG----- 269
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
I + L+ K + EE+ + C + RP +
Sbjct: 270 ----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 570 MLE 572
L
Sbjct: 320 FLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 41/293 (13%)
Query: 300 HNFSSKNILGKGGFGIVYKGILQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAV 355
++ ++++G+G FG V K ++ A+KR+K+ + F E+E++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 356 HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPI----------------LDWSTR 399
H N++ L G C L Y +G++ L+ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 400 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459
A ARG+ YL + + IHRD+ A NIL+ + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKK 519
R V +A E L+ + +DV+ +G+LL E+++ G + +K
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 238
Query: 520 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ Q +LE ++ D +E+ + C + P RP ++++ L
Sbjct: 239 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-58
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 305 KNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 362
+G+G F VYKG+ + VA L+D E Q F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 363 YGFCMTPTER----LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
Y + + +LV M++G++ + LK ++ + +GL +LH +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT- 132
Query: 419 PKIIHRDVKAANILLDD-CCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
P IIHRD+K NI + +GD GLA L + AV GT +APE +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EK 188
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
E DV+ FG+ +LE+ T + + + + + + +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVKPAS 233
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+D++ + E+ ++ C + R + +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-58
Identities = 66/273 (24%), Positives = 107/273 (39%), Gaps = 26/273 (9%)
Query: 306 NILGKGGFGIVYKGILQD---GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLR 361
LG G FG V KG Q VAVK LK+ + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 362 LYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKI 421
+ G C + +LV G + L+ + + + G+ YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+HRD+ A N+LL A + DFGL+K L D T + V APE ++ + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
K+DV+ FG+L+ E + + G + ++ +++K +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGM----------------KGSEVTAMLEKGERMGCP 232
Query: 540 RIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
EM + LC Y +RP + V L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-58
Identities = 72/275 (26%), Positives = 114/275 (41%), Gaps = 30/275 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 360
+GKG FG V G G VAVK +K+ F E +++ H NL+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLV 63
Query: 361 RLYGFCMTPTERL-LVYPYMSNGSVASRL--KGKPILDWSTRKRIALGAARGLLYLHEQC 417
+L G + L +V YM+ GS+ L +G+ +L + +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+HRD+ A N+L+ + A V DFGL K S + V APE L +
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKK 176
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
S K+DV+ FGILL E+ + +G+ + + D V ++ + K++
Sbjct: 177 FSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP---- 226
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ +V C A RP ++ LE
Sbjct: 227 ------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-55
Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 21/272 (7%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
++ LG+G +G V + VAVK + A+ + E+ + + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
++ YG + L Y S G + R++ + +R G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLD-HQDSHVTTAVRGTVGHIAPEYLSTGQ- 477
I HRD+K N+LLD+ + DFGLA + + + + GT+ ++APE L +
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
+E DV+ GI+L ++ G+ + + Q+ DW +K + +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNPWKKID------- 233
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+ + P+ R + ++ +
Sbjct: 234 ------SAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 28/279 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 358
++ +G G +G K DG ++ K L G+ E Q +EV ++ H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 359 LLRLYGFCMTPTERLL--VYPYMSNGSVASRL----KGKPILDWSTRKRIALGAARGLLY 412
++R Y + T L V Y G +AS + K + LD R+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 413 LHEQ--CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
H + ++HRD+K AN+ LD +GDFGLA++L+H D+ A GT +++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
E ++ +EK+D++ G LL EL A +QK + KI + K
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQK----ELAGKIREGKFRR--- 233
Query: 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+ Y +E+ ++ HRP + E++
Sbjct: 234 ---IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-55
Identities = 62/316 (19%), Positives = 127/316 (40%), Gaps = 26/316 (8%)
Query: 302 FSSKNILGKGGFGIVYKGILQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 356
F +LG G FG VYKG+ VA+K L++ + + E +++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
++ RL G C+T T +L+ + + K + + A+G+ YL ++
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLST 475
+++HRD+ A N+L+ + DFGLAKLL ++ + + + +A E +
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ ++DV+ +G+ + EL+T G A++ + +++K +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGER 231
Query: 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEATKSKPHE 595
I ++ + + C RPK E++ + +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQGDERMHLPS 290
Query: 596 FSSSDRYSDLTDDSSL 611
+ S+ Y L D+ +
Sbjct: 291 PTDSNFYRALMDEEDM 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-54
Identities = 58/271 (21%), Positives = 118/271 (43%), Gaps = 25/271 (9%)
Query: 307 ILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 362
+G+G FG V++GI VA+K K+ + +F E + H ++++L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 363 YGFCMTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKI 421
G T ++ + G + S L+ + LD ++ A + L YL + +
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RF 129
Query: 422 IHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
+HRD+ A N+L+ +GDFGL++ ++ + + + + +APE ++ + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 482 TDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 541
+DV+ FG+ + E++ +G Q D + +I ++L M +
Sbjct: 190 SDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIENGERLPMPPNCP-------- 235
Query: 542 ELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + C Y P+ RP+ +E+ L
Sbjct: 236 --PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 74/272 (27%), Positives = 114/272 (41%), Gaps = 27/272 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHR 357
+F LGKG FG VY Q ++A+K L G E Q + EVE+ S H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
N+LRLYG+ T L+ Y G+V L+ D A L Y H +
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 125
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
++IHRD+K N+LL E + DFG + H S T + GT+ ++ PE +
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
EK D++ G+L E + G+ E AN + ++ E V + ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV--EFTFPDFVTEGARD- 233
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+ ++ P+ RP + EV+
Sbjct: 234 -----------LISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 1e-53
Identities = 70/274 (25%), Positives = 103/274 (37%), Gaps = 30/274 (10%)
Query: 302 FSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRN 358
FS +G G FG VY +++ VVA+K++ E EV + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCD 418
++ G + LV Y + K L + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 419 PKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST--- 475
+IHRDVKA NILL + +GDFG A ++ +S V GT +APE +
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDE 188
Query: 476 GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
GQ K DV+ GI +EL + L ++ L + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF----------------NMNAMSALYHIAQNESP 232
Query: 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
E C Q +P RP +++
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-53
Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 36/298 (12%)
Query: 294 ELQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTE 347
E +VA + LG+G FG+VY+G+ + T VA+K + + ++ I+F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 348 VEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK----------PILDWS 397
++ +++RL G L++ M+ G + S L+ S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-H 456
++A A G+ YL+ K +HRD+ A N ++ + +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516
V ++PE L G + +DV+ FG++L E+ T G
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----------- 239
Query: 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574
E+ L +++ L + D + + ++ +C QY P RP E++ ++ +
Sbjct: 240 ----SNEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 75/281 (26%), Positives = 110/281 (39%), Gaps = 28/281 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLA 354
+ LG G FG+V +G VAVK LK E F EV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 355 VHRNLLRLYGFCMTPTERLLVYPYMSNGSVASR-LKGKPILDWSTRKRIALGAARGLLYL 413
HRNL+RLYG +TP + +V GS+ R K + T R A+ A G+ YL
Sbjct: 69 DHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 414 HEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH--VTTAVRGTVGHIAPE 471
+ IHRD+ A N+LL +GDFGL + L D H + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 472 YLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531
L T S +D + FG+ L E+ T + G + + L +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---------------NGSQILHKIDK 229
Query: 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ + +++ V + C + P RP + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 9e-50
Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 300 HNFSSKNILGKGGFGIVYKGI------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 353
LG+G FG V + VAVK LK+G +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 354 AVHR-NLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGK----------------PILD 395
H N++ L G C P L ++ + G++++ L+ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 396 WSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
+ A+G+ +L + K IHRD+ A NILL + + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 456 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML 514
+V R + +APE + + ++DV+ FG+LL E+ + + G ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244
Query: 515 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++ +++ + ++ EM Q L C P+ RP SE+V L
Sbjct: 245 EFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 37/274 (13%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG G FG VYK + + A K + + E + E+++++ H N+++L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 78
Query: 367 MTPTERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
++ + + G+V + + + + L S + + L YLH+ KIIHRD
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRD 135
Query: 426 VKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-----SE 480
+KA NIL + + DFG++ + + GT +APE + S
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDY 194
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 540
K DV+ GI L+E+ + H E ++ K K+
Sbjct: 195 KADVWSLGITLIEMAEIEPP--------------------HHELNPMRVLLKIAKSEPPT 234
Query: 541 IEL-----EEMVQVALLCTQYLPAHRPKMSEVVR 569
+ C + R S++++
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 72/299 (24%), Positives = 116/299 (38%), Gaps = 45/299 (15%)
Query: 300 HNFSSKNILGKGGFGIVYKGIL--------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 351
LG+G FG V T VAVK LK +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 352 S-LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGK----------------PIL 394
+ H+N++ L G C ++ Y S G++ L+ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 395 DWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454
A ARG+ YL K IHRD+ A N+L+ + + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 455 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAM 513
+ T R V +APE L + ++DV+ FG+LL E+ T + G
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 240
Query: 514 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
++L L+ + + + E+ + C +P+ RP ++V L+
Sbjct: 241 -------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 58/299 (19%), Positives = 113/299 (37%), Gaps = 35/299 (11%)
Query: 273 DVKERHHEEVSLGNLR-RFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVK 330
++ E+ VS+G+ + ++ E +G+G G VY + + G VA++
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEK------------IGQGASGTVYTAMDVATGQEVAIR 51
Query: 331 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKG 390
++ E E+ ++ + N++ + E +V Y++ GS+ +
Sbjct: 52 QMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 391 KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450
+ D + + L +LH ++IHRD+K+ NILL + DFG +
Sbjct: 111 TCM-DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 451 DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQK 510
+ S +T V GT +APE ++ K D++ GI+ +E+I G+
Sbjct: 167 TPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA- 224
Query: 511 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
+ I E+ + L C R E+++
Sbjct: 225 ------LYLIATNGTPELQNPEKLS--------AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (415), Expect = 5e-46
Identities = 58/314 (18%), Positives = 115/314 (36%), Gaps = 17/314 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
++ LG G FG+V++ G A K + + E + E++ +S+ H L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTL 85
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCD 418
+ L+ E +++Y +MS G + ++ + + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 419 PKIIHRDVKAANILL--DDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
+H D+K NI+ E + DFGL LD + S T GT APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGK 200
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE------KKLEMLV 530
TD++ G+L L++G + + + + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 531 DKDL-KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQRAEAT 589
K L + R+ + + ++ L P ++ D + +++A
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
Query: 590 KSKPHEFSSSDRYS 603
+ +SS ++
Sbjct: 321 LGRISNYSSLRKHR 334
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-46
Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 29/278 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHR 357
+F ILG+G F V L A+K L+ + I E +++S H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++LY + Y NG + ++ D + + L YLH +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTG 476
IIHRD+K NILL++ + DFG AK+L + + GT +++PE L+
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
+ + +D++ G ++ +L+ G + ++ K +K
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP--------------------FRAGNEYLIFQKIIKL 225
Query: 537 NYDRIE--LEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
YD E + + R E+
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (410), Expect = 3e-45
Identities = 53/266 (19%), Positives = 101/266 (37%), Gaps = 24/266 (9%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG G FG+V++ + G V K + + + E+ +++ H L+ L+
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 95
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
E +L+ ++S G + R+ + + + A GL ++HE I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD 152
Query: 426 VKAANILLD--DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
+K NI+ + + DFGLA L+ + T APE + TD
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 484 VFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543
++ G+L L++G D ++ + K+ + D+D ++
Sbjct: 211 MWAIGVLGYVLLSGLSPFA----------GEDDLETLQNVKRCDWEFDEDAFSSVS---- 256
Query: 544 EEMVQVALLCTQYLPAHRPKMSEVVR 569
E Q P R + + +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-44
Identities = 51/279 (18%), Positives = 100/279 (35%), Gaps = 17/279 (6%)
Query: 292 FRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 350
+++ + + +++LG G F V + +VA+K + G E + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
+ H N++ L + L+ +S G + R+ K R+ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
YLH+ + LD+ + ++ DFGL+K+ D V + GT G++AP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAP 178
Query: 471 EYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530
E L+ S+ D + G++ L+ G A Q K E
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------FEQILKAEYEF 228
Query: 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
D ++ + + P R + ++
Sbjct: 229 DSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 4e-44
Identities = 60/285 (21%), Positives = 103/285 (36%), Gaps = 39/285 (13%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAI--------GGEIQFQTEVE-M 350
N+ K ILG+G +V + I AVK + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 351 ISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
++ H N+++L T T LV+ M G + L K L ++I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAP 470
LH+ I+HRD+K NILLDD + DFG + LD V GT ++AP
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178
Query: 471 EYLSTGQS------SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524
E + + ++ D++ G+++ L+ G + Q
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----------------KQML 222
Query: 525 KLEMLVDKDLKNNYDRIEL--EEMVQVALLCTQYLPAHRPKMSEV 567
L M++ + + + + + + P R E
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (401), Expect = 6e-44
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-- 355
+FS I+G+GGFG VY G + A+K L GE E M+SL
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 356 -HRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLH 414
++ + TP + + M+ G + L + + + A GL ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 415 EQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLS 474
+ +++RD+K ANILLD+ + D GLA + H + GT G++APE L
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 178
Query: 475 TGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQ 509
G + D F G +L +L+ G K ++
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 7e-43
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 27/276 (9%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLY 363
ILG GG V+ L+ VAVK L+ A +F+ E + + H ++ +Y
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 364 GFCMTPTERL----LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
T +V Y+ ++ + + + + A + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 130
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV--TTAVRGTVGHIAPEYLSTGQ 477
IIHRDVK ANI++ V DFG+A+ + + V T AV GT +++PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
++DV+ G +L E++TG+ + + + ++ + L
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPSARHEGLS-- 242
Query: 538 YDRIELEEMVQVALLCTQYLPAHRPK-MSEVVRMLE 572
++ V L P +R + +E+ L
Sbjct: 243 ------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 8/203 (3%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAV-H 356
+F +LGKG FG V+ + A+K LK + + E ++SLA H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 357 RNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ 416
L ++ T V Y++ G + ++ D S A GL +LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 417 CDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
I++RD+K NILLD + DFG+ K D+ T GT +IAPE L
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 477 QSSEKTDVFGFGILLLELITGQR 499
+ + D + FG+LL E++ GQ
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 4e-42
Identities = 50/281 (17%), Positives = 105/281 (37%), Gaps = 15/281 (5%)
Query: 301 NFSSKNILGKGGFGIVYKGILQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 359
+ +G+G +G+VYK G A+K+++ + G E+ ++ H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 360 LRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDP 419
++LY T +LV+ ++ + L+ T K L G+ Y H++
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 420 KIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 479
+++HRD+K N+L++ E + DFGLA+ T + + + + S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 539
D++ G + E++ G A+Q + + + + + N+
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 540 RIEL-----------EEMVQVALLCTQYLPAHRPKMSEVVR 569
E E + + + P R + +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 8e-42
Identities = 61/291 (20%), Positives = 109/291 (37%), Gaps = 26/291 (8%)
Query: 298 ATHNFSSKNILGKGGFGIVYKG--ILQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLA 354
A + +G+G +G V+K + G VA+KR++ G + EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 355 V---HRNLLRLYGFCMTPTERLLVYPYMSNGSVAS------RLKGKPILDWSTRKRIALG 405
H N++RL+ C + V +P + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 406 AARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTV 465
RGL +LH +++HRD+K NIL+ + + DFGLA++ Q + + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 466 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAML---------DW 516
+ APE L + D++ G + E+ + +Q G +L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+ + ++ + E + L C + PA R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (377), Expect = 3e-41
Identities = 46/278 (16%), Positives = 91/278 (32%), Gaps = 29/278 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLYGF 365
+G+G FG++++G L + VA+K + Q + E L + +Y F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 366 CMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
+LV + T A + +HE+ +++RD
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126
Query: 426 VKAANILLDDCCEAVVG-----DFGLAKLLD------HQDSHVTTAVRGTVGHIAPEYLS 474
+K N L+ DFG+ K H + GT +++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 475 TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534
+ S + D+ G + + + G + KAA ++I ++K+ L ++L
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEKKQSTPL--REL 240
Query: 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572
+ EE + P + +
Sbjct: 241 CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 50/266 (18%), Positives = 94/266 (35%), Gaps = 25/266 (9%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG+G FGIV++ + K +K ++ + E+ ++++A HRN+L L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 367 MTPTERLLVYPYMSNGSVASRLKGKPI-LDWSTRKRIALGAARGLLYLHEQCDPKIIHRD 425
+ E ++++ ++S + R+ L+ L +LH I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 426 VKAANILLD--DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
++ NI+ + +FG A+ L D+ + APE S TD
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTATD 185
Query: 484 VFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543
++ G L+ L++G I E D++
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQI----------IENIMNAEYTFDEEAFKEIS---- 231
Query: 544 EEMVQVALLCTQYLPAHRPKMSEVVR 569
E + R SE ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 20/281 (7%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLL 360
+ LG+G F VYK +VA+K++K G+ G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 361 RLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
L + LV+ +M +L S K L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-S 479
I+HRD+K N+LLD+ + DFGLAK + T V T + APE L +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179
Query: 480 EKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM--LVDKDLKNN 537
D++ G +L EL+ L +Q + + + +E+ +M L D +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 538 YDRIELEEMVQVA------LL--CTQYLPAHRPKMSEVVRM 570
+ I L + A L+ + P R ++ ++M
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 57/316 (18%), Positives = 118/316 (37%), Gaps = 28/316 (8%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYG 364
+ +G+G +G+V + VA+K++ + E++++ H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 365 FCMTPTERLLVYPYM----SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
PT + Y+ + LK + L RGL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---N 129
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLSTGQ- 477
++HRD+K +N+LL+ C+ + DFGLA++ DH + T T + APE + +
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
++ D++ G +L E+++ + +Q +L + QE ++ K
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 538 YDRIEL-------------EEMVQVALLCTQYLPAHRPKMSEVVRMLEGDGLAERWEASQ 584
+ + + + P R ++ + L L + ++ S
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA---LAHPYLEQYYDPSD 306
Query: 585 RAEATKSKPHEFSSSD 600
A + D
Sbjct: 307 EPIAEAPFKFDMELDD 322
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 4e-41
Identities = 55/303 (18%), Positives = 93/303 (30%), Gaps = 41/303 (13%)
Query: 281 EVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIG 339
E+ +GN R++ +G G FG +Y G + G VA+K
Sbjct: 2 ELRVGN--RYRLGRK------------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-- 45
Query: 340 GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL-LVYPYMSNGSVASRLKGKPILDWST 398
Q E ++ + + +C + +V + T
Sbjct: 46 -HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT 104
Query: 399 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL---LDDCCEAVVGDFGLAKLLDHQDS 455
+A + Y+H + IHRDVK N L + DFGLAK +
Sbjct: 105 VLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 456 HV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQ 509
H + GT + + + S + D+ G +L+ G + KAA +
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
K +K + L Y E C +P S + +
Sbjct: 222 ------RQKYERISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQ 271
Query: 570 MLE 572
+
Sbjct: 272 LFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 3e-40
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 10/202 (4%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHR 357
+F LG G FG V+ +G A+K LK + + E M+S+ H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++R++G + ++ Y+ G + S L+ K A L YLH +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
II+RD+K NILLD + DFG AK + + GT +IAPE +ST
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKP 177
Query: 478 SSEKTDVFGFGILLLELITGQR 499
++ D + FGIL+ E++ G
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYT 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 54/281 (19%), Positives = 101/281 (35%), Gaps = 17/281 (6%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 358
NF +G+G +G+VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGSVAS-RLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
+++L T + LV+ ++ + K +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
++HRD+K N+L++ + DFGLA+ T V L
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 478 SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537
S D++ G + E++T + +Q + + + + D K +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 538 YDRIELEEMVQV---------ALL--CTQYLPAHRPKMSEV 567
+ + ++ +V +LL Y P R
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 61/289 (21%), Positives = 105/289 (36%), Gaps = 31/289 (10%)
Query: 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 359
+++ ++G G FG+VY+ L G +VA+K++ + E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 360 LRLYGFCMTPTER------LLVYPYMSNG---SVASRLKGKPILDWSTRKRIALGAARGL 410
+RL F + E+ LV Y+ + K L K R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 411 LYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIA 469
Y+H I HRD+K N+LLD D + DFG AK L + +V+ +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 470 PEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD-----------WVK 518
+ DV+ G +L EL+ GQ +Q ++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+ E K + + E + + +Y P R E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 52/273 (19%), Positives = 92/273 (33%), Gaps = 30/273 (10%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
+LG G G V + + A+K L+D E++ + +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73
Query: 366 CMTPTER----LLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDP 419
L+V + G + SR++ G I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 420 KIIHRDVKAANILLDDCCE---AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
I HRDVK N+L + DFG AK +S T T ++APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 477 QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536
+ + D++ G+++ L+ G M ++ E +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS--- 245
Query: 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
EE+ + + P R ++E +
Sbjct: 246 -------EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 56/274 (20%), Positives = 103/274 (37%), Gaps = 41/274 (14%)
Query: 307 ILGKGGFGIVYKGI-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL--AVHRN 358
+LG GGFG VY GI + D VA+K ++ D + + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 359 LLRLYGFCMTPTERLLVYPYMSNGS-VASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
++RL + P +L+ + + + L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 418 DPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTG 476
++HRD+K NIL+D + E + DFG LL T GT + PE++
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 477 Q-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535
+ V+ GILL +++ G E+ + + + + +++ E + L+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFRQRVSSE--CQHLIRW--- 237
Query: 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
C P+ RP E+
Sbjct: 238 -----------------CLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 48/278 (17%), Positives = 94/278 (33%), Gaps = 17/278 (6%)
Query: 306 NILGKGGFGIVYKGI-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLY 363
+G+G +G V+K + +VA+KR++ D + G E+ ++ H+N++RL+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 364 GFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIH 423
+ + LV+ + LD K + L L ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSRNVLH 124
Query: 424 RDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 483
RD+K N+L++ E + +FGLA+ + V S D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 484 VFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 543
++ G + EL R L G + + + + E++ + Y
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 544 ------------EEMVQVALLCTQYLPAHRPKMSEVVR 569
+ + P R E ++
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 57/287 (19%), Positives = 99/287 (34%), Gaps = 38/287 (13%)
Query: 302 FSSKNI---------LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI-----QFQT 346
F +N+ LG G F +V K G A K +K +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 347 EVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGA 406
EV ++ H N++ L+ T+ +L+ ++ G + L K L
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 407 ARGLLYLHEQCDPKIIHRDVKAANILLDDC----CEAVVGDFGLAKLLDHQDSHVTTAVR 462
G+ YLH I H D+K NI+L D + DFGLA +D + +
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 177
Query: 463 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522
GT +APE ++ + D++ G++ L++G + K L V ++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLANVSAVNY 233
Query: 523 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569
E + E + P R + + ++
Sbjct: 234 EFEDEYFSNTS----------ALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-36
Identities = 47/202 (23%), Positives = 77/202 (38%), Gaps = 7/202 (3%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHR 357
+F +LGKG FG V G A+K L+ I + TE ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
L L T V Y + G + L + + + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYLH 122
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+++RD+K N++LD + DFGL K + GT ++APE L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDND 181
Query: 478 SSEKTDVFGFGILLLELITGQR 499
D +G G+++ E++ G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-35
Identities = 70/321 (21%), Positives = 130/321 (40%), Gaps = 30/321 (9%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRN 358
+ +G+G FG V+K + G VA+K++ N G I E++++ L H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 359 LLRLYGFCMTPTER--------LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
++ L C T LV+ + + S KR+ GL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 411 LYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS---HVTTAVRGTVGH 467
+ KI+HRD+KAAN+L+ + DFGLA+ + + T T+ +
Sbjct: 131 ---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 468 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526
PE L + D++G G ++ E+ T ++ N + L + ++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ----GNTEQHQLALISQLCGSITP 243
Query: 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVV-RMLEGDGLAERWEASQR 585
E+ + D Y+++EL + + + P +++ ++L + +QR
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV-------LDPAQR 296
Query: 586 AEATKSKPHEFSSSDRY-SDL 605
++ + H+F SD SDL
Sbjct: 297 IDSDDALNHDFFWSDPMPSDL 317
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-34
Identities = 61/303 (20%), Positives = 113/303 (37%), Gaps = 33/303 (10%)
Query: 290 FQFRELQVATHNFSSK----NILGKGGFGIVYKGI-LQDGTVVAVKRL-KDGNAIGGEIQ 343
F +E+ + +G G +G V + + G VA+K+L + + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 344 FQTEVEMISLAVHRNLLRLYGFCMTP------TERLLVYPYMSNGSVASRLKGKPILDWS 397
E+ ++ H N++ L T+ LV P+M G+ +L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGED 121
Query: 398 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457
+ + +GL Y+H IIHRD+K N+ +++ CE + DFGLA+ DS +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175
Query: 458 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV 517
T V L+ + ++ D++ G ++ E+ITG+ + +Q ++
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 518 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL-------------CTQYLPAHRPKM 564
E + D+ ELE+ ++L R
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 565 SEV 567
E
Sbjct: 296 GEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 8e-34
Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 10/202 (4%)
Query: 301 NFSSKNILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHR 357
F LG G FG V + G A+K L + + E ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 358 NLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC 417
L++L + +V Y++ G + S L+ + A YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 418 DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQ 477
+I+RD+K N+L+D V DFG AK + T + GT +APE + +
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 478 SSEKTDVFGFGILLLELITGQR 499
++ D + G+L+ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 7e-32
Identities = 56/341 (16%), Positives = 121/341 (35%), Gaps = 44/341 (12%)
Query: 267 NQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFSSKNILGKGGFGIVYKGI-LQDGT 325
N + + V GN +Q LG+G + V++ I + +
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRK------------LGRGKYSEVFEAINITNNE 61
Query: 326 VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLYGFCMTPTERL--LVYPYMSNG 382
V VK LK + + + E++ + +L N++ L P R LV+ +++N
Sbjct: 62 KVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 383 SVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVV 441
+ L + + L Y H I+HRDVK N+++D + + +
Sbjct: 118 DFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 171
Query: 442 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRA 500
D+GLA+ + + PE L Q D++ G +L +I +
Sbjct: 172 IDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
Query: 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAH 560
+G + ++ K + E + + +++ + ++ +
Sbjct: 230 FFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287
Query: 561 RPKMSE-----VVRMLEGDGLAERWEASQRAEATKSKPHEF 596
+ +S + ++L ++ R A ++ H +
Sbjct: 288 QHLVSPEALDFLDKLLR-------YDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 296 QVATHNFSSKNILGKGGFGIVYKGIL----QDGTVVAVKRLKDGNAIGGEI---QFQTEV 348
+V NF +LG G +G V+ G + A+K LK + +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 349 EMIS-LAVHRNLLRLYGFCMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAA 407
+++ + L+ L+ T T+ L+ Y++ G + + L + + +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYVG 136
Query: 408 RGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGH 467
+L L II+RD+K NILLD V+ DFGL+K ++ GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 468 IAPEYLSTGQS--SEKTDVFGFGILLLELITGQR 499
+AP+ + G S + D + G+L+ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 60/327 (18%), Positives = 109/327 (33%), Gaps = 36/327 (11%)
Query: 291 QFRELQVATHNFSSKN------ILGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEI- 342
QF ++V F+ +G G GIV VA+K+L
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 343 QFQTEVEMISLAVHRNLLRLYGFCMTP------TERLLVYPYMSNGSVASRLKGKPILDW 396
+ E+ ++ H+N++ L + LV M
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118
Query: 397 STRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456
+ G+ +LH IIHRD+K +NI++ C + DFGLA+ S
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSF 173
Query: 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDW 516
+ T T + APE + E D++ G ++ E++ + +Q +++
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 517 VKKIHQE--KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSE-----VVR 569
+ E KKL+ V ++N L H + + +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 570 MLEGDGLAERWEASQRAEATKSKPHEF 596
ML + ++R + H +
Sbjct: 294 MLV-------IDPAKRISVDDALQHPY 313
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 55/281 (19%), Positives = 104/281 (37%), Gaps = 29/281 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 365
+G G +G V + G VAVK+L + +I + E+ ++ H N++ L
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 366 CMTPT-----ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPK 420
+ + ++ + + +K + L + + RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD--- 141
Query: 421 IIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
IIHRD+K +N+ +++ CE + DFGLA H D +T V L+ ++
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 481 KTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE--------------KKL 526
D++ G ++ EL+TG+ +Q +L V E + L
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 527 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEV 567
+ + N + V + R ++
Sbjct: 259 TQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 1e-24
Identities = 43/234 (18%), Positives = 80/234 (34%), Gaps = 24/234 (10%)
Query: 308 LGKGGFGIVYKGI-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366
LG G F V+ + + T VA+K ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 367 MTPTERLLVY----------------PYMSNGSVASRLKGKPILDWSTRKRIALGAARGL 410
+LL + N + + K+I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 411 LYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDSHVTTA-VRGTVGHI 468
Y+H +C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 469 APEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQ 522
+PE L D++ L+ ELITG L + D + +I +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 9e-23
Identities = 20/163 (12%), Positives = 48/163 (29%), Gaps = 24/163 (14%)
Query: 306 NILGKGGFGIVYKGILQDGTVVAVKRLKDGNA---------IGGEIQFQTEVEMISLAVH 356
++G+G V+ + VK K G+ G++ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 357 RNLLRLYGFCMTPT----ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLY 412
R L +L G + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAK 118
Query: 413 LHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455
+ + I+H D+ N+L+ + + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.3 bits (212), Expect = 5e-19
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 12/279 (4%)
Query: 33 EVQALMGVKHSLHDPHGVLENWDEDAVDPC--SWTMVTCSPESL---VIGLGIPSQNLSG 87
+ QAL+ +K L +P L +W D C +W V C ++ V L + NL
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 88 --TLSPSIGNLTNLQIVLLQNN-NITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHL 144
+ S+ NL L + + N+ GPIP I +LT+L L +++ +G IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 145 RSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICAT 204
++L + F+ N+LSG P S++S+ L+ + N +SG +P + + I
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 205 GSEPDCYGTQLMPMSMNLNSSQTASPGRTRSHKLSLVFGLSVGCVSLIILVFGLFLWWRQ 264
T ++ S+ G S + + + +
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 265 RRNQQMFFDVKERHHEEVSLGNLRRFQFRELQVATHNFS 303
N + + L L+ L V+ +N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLH--SLNVSFNNLC 281
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 4e-14
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 97 TNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
NL + L+NN I G +P + +L L +L++S N GEIP G+L+ + NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 157 LSGAFP 162
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 1/77 (1%)
Query: 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLT 121
++ + + GL + + + GTL + L L + + NN+ G IP + G L
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 122 KLQTLDLSNNFFTGEIP 138
+ +NN P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 127 DLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL--SGP 184
DL NN G +P L L+ L + + N+L G P ++ + + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 185 VP 186
+P
Sbjct: 309 LP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 5e-10
Identities = 16/64 (25%), Positives = 27/64 (42%), Gaps = 4/64 (6%)
Query: 143 HLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF----SAKTFNIVGN 198
++L + NN + G P L + L L++S+NNL G +P+ N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 199 PLIC 202
+C
Sbjct: 302 KCLC 305
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
NL NL + L NNI+ P + LTKLQ L +NN + SSL +L ++ ++ +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYN 179
N +S P LA++T++ L L+
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 5e-13
Identities = 31/129 (24%), Positives = 49/129 (37%), Gaps = 26/129 (20%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP--------------------AEI 117
L + + +S + LT L + L N I+ P + I
Sbjct: 246 LDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303
Query: 118 GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177
L L L L N + P + L LQ + F NN +S +SLA++T + +L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 178 YNNLSGPVP 186
+N +S P
Sbjct: 360 HNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 5e-13
Identities = 19/114 (16%), Positives = 43/114 (37%), Gaps = 6/114 (5%)
Query: 42 HSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQI 101
++ G+ + + + + S + L + N+S + +LT LQ
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQR 333
Query: 102 VLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
+ NN ++ + + LT + L +N + P L +L + + N+
Sbjct: 334 LFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 3e-10
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 26/127 (20%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
L + L ++ +LTNL + L NN I+ P + LTKL L L N +
Sbjct: 224 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279
Query: 138 P--------------------SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLS 177
P S + +L++L Y+ N++S P ++S+T+L L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 178 YNNLSGP 184
N +S
Sbjct: 338 NNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 5e-08
Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 6/137 (4%)
Query: 94 GNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153
LTNL+ ++ NN I+ P I T L L L+ N +L L +L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSAKTFNIVGNPLICATGSEPDCYGT 213
NN +S P L+ +T+L L L N +S P + P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 214 QLMPMSMNLNSSQTASP 230
L +++ N+ SP
Sbjct: 308 NLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 18/73 (24%), Positives = 30/73 (41%), Gaps = 6/73 (8%)
Query: 83 QNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLG 142
N++ T+S + +L + + I + L L ++ SNN T P L
Sbjct: 32 TNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LK 85
Query: 143 HLRSLQYMRFNNN 155
+L L + NNN
Sbjct: 86 NLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 14/92 (15%), Positives = 25/92 (27%), Gaps = 28/92 (30%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L +L N+T + L ++ TL
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL---------------------GI 56
Query: 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
S+ G + + L ++ S N L+ P
Sbjct: 57 KSIDG-----VEYLNNLTQINFSNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 4e-14
Identities = 32/174 (18%), Positives = 59/174 (33%), Gaps = 19/174 (10%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
C +V CS L + +P + ++ LQNN IT + L
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLP---------------PDTALLDLQNNKITEIKDGDFKNL 54
Query: 121 TKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNN 180
L TL L NN + P + L L+ + + N L ++ +L +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 181 LSGPV-PRFSAKTFNIVGNPLICATGSEPDCYG--TQLMPMSMNLNSSQTASPG 231
+ V + +G + ++G E + +L + + + T G
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 30/141 (21%), Positives = 46/141 (32%), Gaps = 3/141 (2%)
Query: 45 HDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSI--GNLTNLQIV 102
L + + + ++ T +I G +L +
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL 176
Query: 103 LLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFP 162
L N IT A + L L L LS N + SL + L+ + NNN L P
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VP 235
Query: 163 TSLASMTQLIFLDLSYNNLSG 183
LA + + L NN+S
Sbjct: 236 GGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 7/141 (4%)
Query: 64 WTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKL 123
++ + +V+ LG SG + + + L + + + NIT IP + L
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 173
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
L L N T +SL L +L + + NS+S SLA+ L L L+ N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 184 PVPRFSA----KTFNIVGNPL 200
+ + + N +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNI 254
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 24/111 (21%), Positives = 42/111 (37%), Gaps = 6/111 (5%)
Query: 81 PSQNLSGTLSPSIGNLTNLQIVLL---QNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI 137
+N + S+ N N IV+ +G + KL + +++ T I
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165
Query: 138 PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF 188
P L SL + + N ++ SL + L L LS+N++S
Sbjct: 166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 6/97 (6%)
Query: 84 NLSG-TLSP-SIGNLTNLQIVLLQ--NNNITGPIPAEIGRLTKLQTLDLSNNFFTGE-IP 138
+L+G L P G L + ++ + + + P+ E ++Q +DLSN+ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 139 SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLD 175
L LQ + LS +LA + L+ L+
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 12/75 (16%), Positives = 28/75 (37%), Gaps = 1/75 (1%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSS 140
++ + +Q + L N+ I + + + +KLQ L L + I ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 141 LGHLRSLQYMRFNNN 155
L +L + +
Sbjct: 91 LAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 11/60 (18%), Positives = 23/60 (38%), Gaps = 2/60 (3%)
Query: 124 QTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
QTLDL+ ++ L + + R + + S ++ +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 26/103 (25%)
Query: 104 LQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF----------- 152
L + ++T + + +L + LDLS+N P+ L LR L+ ++
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGV 61
Query: 153 ------------NNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
NN A L S +L+ L+L N+L
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 91 PSIGNLTNLQIVLLQNNNITG-PIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
+ NL LQ +LL NN + + +L L+L N + L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 1e-08
Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 98 NLQIVLLQNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGE----IPSSLGHLRSLQYMRF 152
++Q + +Q ++ AE+ L + Q + L + T I S+L +L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
+N L + Q + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 5e-07
Identities = 15/77 (19%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 121 TKLQTLDLSNNFFTGE----IPSSLGHLRSLQYMRFNNNSLSGAFPTSLAS-----MTQL 171
+ L+ L L++ + + ++L SL+ + +NN L A L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 172 IFLDLSYNNLSGPVPRF 188
L L S +
Sbjct: 429 EQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 18/123 (14%), Positives = 42/123 (34%), Gaps = 15/123 (12%)
Query: 45 HDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGT----LSPSIGNLTNLQ 100
+ N + P S++ L + ++S + L+ ++ +L+
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400
Query: 101 IVLLQNNNITGPIPAEIGR-----LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
+ L NN + ++ L+ L L + +++ E+ L L +
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK------DKP 454
Query: 156 SLS 158
SL
Sbjct: 455 SLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 78 LGIPSQNLSGT-LSPSIGNLTNLQIVLLQNNNITG----PIPAEIGRLTKLQTLDLSNNF 132
L I + LS + + L Q+V L + +T I + + L L+L +N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 133 FTGEIPSSLGHLRSLQYMRFNNNSLSG 159
+ + SL
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 4e-08
Identities = 10/65 (15%), Positives = 22/65 (33%), Gaps = 3/65 (4%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMR 151
+ + + V N+T +P ++ + L LS N ++L L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 152 FNNNS 156
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 11/65 (16%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 116 EIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLD 175
E+ ++ ++ T +P L + + + N L +L T+L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 176 LSYNN 180
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 14/53 (26%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 105 QNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157
NNN+T + L L TL L N IP L + + N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 12/52 (23%), Positives = 21/52 (40%), Gaps = 3/52 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133
+NL+ L P + + I+ L N + A + T+L L+L
Sbjct: 19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 4e-04
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 1/50 (2%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFF 133
NL+ + + L NL +LLQ N++ IP L L N +
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 5e-08
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYM 150
+ NL+ L + +N I+ P + L L + L NN + P L + +L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 151 RFNN 154
N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 9e-06
Identities = 11/63 (17%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L N + +N+T + L + TL T + +L +L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 155 NSL 157
N +
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 8e-04
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 2/58 (3%)
Query: 129 SNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
S + L +L L ++ ++N +S P LAS+ LI + L N +S P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 7e-08
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 28/130 (21%)
Query: 78 LGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLT---------------- 121
L + +S + L +L +LL N + P L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 122 --------KLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIF 173
LQ L L++N + + + LQ R +++ + + P LA
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD---L 273
Query: 174 LDLSYNNLSG 183
L+ N+L G
Sbjct: 274 KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.7 bits (122), Expect = 9e-08
Identities = 26/125 (20%), Positives = 41/125 (32%), Gaps = 4/125 (3%)
Query: 84 NLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143
L + +L NL + L N I+ L L L L N P +
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP----RFSAKTFNIVGNP 199
L L + N+LS +LA + L +L L+ N + F +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSE 259
Query: 200 LICAT 204
+ C+
Sbjct: 260 VPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 8e-05
Identities = 31/156 (19%), Positives = 49/156 (31%), Gaps = 35/156 (22%)
Query: 63 SWTMVTCSPESL-VIGLGIPSQ---------NLSGTLSPSIGNLTNLQIVLLQNNNITGP 112
+C + L + +GIP+ +S + S NL I+ L +N +
Sbjct: 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 113 I-------------------------PAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSL 147
PA L +L TL L P L +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 148 QYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183
QY+ +N+L + + L L L N +S
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 8/80 (10%)
Query: 104 LQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPT 163
N + I + L+ L++SNN E+P+ L L + N L+ P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321
Query: 164 SLASMTQLIFLDLSYNNLSG 183
+ L L + YN L
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 19/113 (16%), Positives = 31/113 (27%), Gaps = 13/113 (11%)
Query: 42 HSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQI 101
+ + N + P SL L + + L L L L
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE-LNVSNNKLI-ELPALPPRLERLI- 310
Query: 102 VLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
N++ +P L+ L + N E P + L R N+
Sbjct: 311 --ASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL---RMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 18/68 (26%), Positives = 27/68 (39%), Gaps = 8/68 (11%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L+ L N ++ +P L++L S N T E+P L+SL N
Sbjct: 39 QAHELE---LNNLGLSS-LPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 155 NSLSGAFP 162
+LS P
Sbjct: 91 KALSDLPP 98
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 3e-07
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQY 149
+ N + + L+ I I L + +D S+N LR L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182
+ NNN + ++ L L L+ N+L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 3e-06
Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITG--PIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+++ TL N+ L + L NN + + + + + L+ L+LS N E
Sbjct: 50 RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 140 SLGHLRSLQYMRFNNNSLSGAFP-------TSLASMTQLIFLD 175
L+ + + NSLS F +L+ LD
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 19/106 (17%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 84 NLSG-TLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTG--EIPSS 140
+L G P + ++ +++ + + +L +L+LSNN ++ S
Sbjct: 28 DLKGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 141 LGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186
+ +L+ + + N L +L L L N+LS
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 21/144 (14%), Positives = 43/144 (29%), Gaps = 4/144 (2%)
Query: 38 MGVKHSLHDPHGVLENWDEDAVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLT 97
L L + S + L + + + L
Sbjct: 43 RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLH 102
Query: 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157
L+ + L +N I+ +P L L +L+L++N F + L+ N +
Sbjct: 103 QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAA 161
Query: 158 SGAFPTSLASMTQLIFLDLSYNNL 181
P+ + + DL ++
Sbjct: 162 RCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 34/161 (21%), Positives = 54/161 (33%), Gaps = 15/161 (9%)
Query: 62 CSWTMVTCSPESLV-IGLGIPSQNLSGTLS----------PSIGNLTNLQIVLLQNNNIT 110
C T V C+ L I IP L+ G L +L + L+ N +T
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 111 GPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170
G P + +Q L L N L L+ + +N +S P S +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 171 LIFLDLSYNNLSGPVP----RFSAKTFNIVGNPLICATGSE 207
L L+L+ N + + ++ G C S+
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 15/86 (17%), Positives = 31/86 (36%), Gaps = 12/86 (13%)
Query: 104 LQNNNITGPIPAEIGR------LTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSL 157
L + IT +P I + + +L T + + L S+ + NN+ +
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58
Query: 158 SGAFPTSLASMTQLIFLDLSYNNLSG 183
+ + + L L+ N L+
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 12/40 (30%), Positives = 20/40 (50%), Gaps = 2/40 (5%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130
+ LT LQ + L N+I+ + A + L L L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFS 209
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 8e-05
Identities = 10/53 (18%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 105 QNNNITGPIPAEI-GRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156
+NN +P ++ + LD+S L +L+ L+ N
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 1e-04
Identities = 7/48 (14%), Positives = 15/48 (31%), Gaps = 3/48 (6%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPS 139
+ I+ + I + L KL+ N ++P+
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 8/58 (13%), Positives = 20/58 (34%), Gaps = 3/58 (5%)
Query: 98 NLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNN 155
+ ++ L Q + +T IP+++ L + L+ + + N
Sbjct: 9 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 10/77 (12%), Positives = 19/77 (24%), Gaps = 16/77 (20%)
Query: 62 CSWTMVTCSPESL-VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRL 120
CS + C + I +P N + +
Sbjct: 8 CSNRVFLCQESKVTEIPSDLP---------------RNAIELRFVLTKLRVIQKGAFSGF 52
Query: 121 TKLQTLDLSNNFFTGEI 137
L+ +++S N I
Sbjct: 53 GDLEKIEISQNDVLEVI 69
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 14/61 (22%), Positives = 23/61 (37%), Gaps = 6/61 (9%)
Query: 92 SIGNLTNLQIVLLQNNNITGPIPAEI-----GRLTKLQTLDLSNNFFTGEIPSSLGHLRS 146
S LQ + LQ N I + ++ L L+L+ N F E + +R
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIRE 326
Query: 147 L 147
+
Sbjct: 327 V 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 13/92 (14%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 98 NLQIVLLQNNNITG----PIPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHLRSLQY 149
+++ L+ + IT + A + ++ + LS N E + ++ + L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 150 MRFNNNSLSGAFPTSLASMTQLIFLDLSYNNL 181
F++ ++ L+ L L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 13/80 (16%), Positives = 26/80 (32%), Gaps = 12/80 (15%)
Query: 104 LQNNNITGPIPAEIGR------LTKLQTLDLSNNFFTGEIPSSL-----GHLRSLQYMRF 152
L + ++ A + LQTL L N + +L + L ++
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 153 NNNSLSGAFPTSLASMTQLI 172
N N S + + ++
Sbjct: 310 NGNRFSE-EDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 11/80 (13%), Positives = 24/80 (30%), Gaps = 4/80 (5%)
Query: 82 SQNLSGTLSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGEI 137
+ ++ + +++ ++L N I + I L+ + S+ F
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 138 PSSLGHLRSLQYMRFNNNSL 157
LR L L
Sbjct: 76 DEIPEALRLLLQALLKCPKL 95
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 4/65 (6%)
Query: 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154
L +L N+T + L ++ TL + +L +L + F+N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 155 NSLSG 159
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 14/45 (31%), Positives = 23/45 (51%), Gaps = 4/45 (8%)
Query: 105 QNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQY 149
+N +T P + LT L+ LD+S+N + S L L +L+
Sbjct: 158 SSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLES 198
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.004
Identities = 9/36 (25%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTL 126
+ NLT L+ + + +N ++ + + +LT L++L
Sbjct: 166 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 622 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.57 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.56 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.39 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.38 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.31 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.29 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.26 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.1 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.09 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.07 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.05 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.77 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.27 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.25 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.97 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.5 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.74 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=417.94 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=199.9
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|+..+.||+|+||+||+|.+.+++.||||+++... ....+|.+|++++++++|||||+++|+|..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 5678889999999999999999989999999997643 23457999999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++|+|.+++.. ...++|..+..|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999998864 45689999999999999999999999 999999999999999999999999999987765444444
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....||+.|+|||++.+..++.++|||||||++|||+|++.|+..... ..+....+.... +...
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~----------~~~~ 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF----------RLYK 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTC----------CCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcC----------CCCC
Confidence 456799999999999999999999999999999999996555443221 111222221111 1112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+..++.++.+++.+||+.||++|||++||++.|+.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 22334678999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=416.74 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=205.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999975 69999999997655444455789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-ce
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 457 (622)
+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999999888899999999999999999999999 999999999999999999999999999987754332 22
Q ss_pred eeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 458 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
....+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ .. ......... .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~---~~~~~~~~~---------~ 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EY---SDWKEKKTY---------L 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HH---HHHHTTCTT---------S
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HH---HHHhcCCCC---------C
Confidence 345679999999999988776 6789999999999999999999975432211 10 111100000 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
......+.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112356789999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-53 Score=419.71 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=210.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|++.+.||+|+||+||+|.+++++.||||+++... .....|.+|++++++++|||||+++|++.. +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4456788899999999999999999988999999997543 234579999999999999999999998765 5678999
Q ss_pred eeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++|+|.+++... ..++|..+.+|+.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999987643 3589999999999999999999998 99999999999999999999999999999876554
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
........||+.|+|||++.++.++.++|||||||++|||+||+.|+...... .+....+... .
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~----------~ 227 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG----------Y 227 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------C
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----------C
Confidence 44445567899999999999999999999999999999999977665532211 1111221111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+...+.++.+++.+||+.||++|||++||++.|+.
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 111122334678999999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-52 Score=422.34 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=216.8
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCc
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTE 371 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 371 (622)
+++++..++|+..+.||+|+||+||+|.+. +|+.||||+++.... ..++|.+|++++++++|||||+++|+|.+++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 344556678889999999999999999976 589999999875432 34579999999999999999999999999999
Q ss_pred eeEEeeeccCCCcccccc--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 372 RLLVYPYMSNGSVASRLK--GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
.++||||+++|+|.+++. ....+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999985 345789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.............|++.|+|||++.+..++.++|||||||++|||+||+.|+........ +.+ .
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---~~~---~---------- 228 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE---L---------- 228 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---H----------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---HHH---H----------
Confidence 765555445556689999999999999999999999999999999998877754332111 111 1
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+........+...+.++.+++.+||+.||++|||++||++.|+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11112222233345779999999999999999999999998874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=416.14 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=202.4
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCC-CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
+..++|.+.+.||+|+||+||+|.+++ .||||+++... .......|.+|++++++++|||||+++|++.. +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 345778999999999999999998753 59999997543 23445679999999999999999999998765 568999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++|+|.+++.. ...+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999999964 45699999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-ceeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 455 S-HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||........ +...+.. .. .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~---~~-----~ 227 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGR---GY-----L 227 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHH---TS-----C
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhc---CC-----C
Confidence 2 23345679999999999864 3579999999999999999999999974332111 1111111 10 0
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+.+ .......+.++.+++.+||+.||++|||++|+++.|+.
T Consensus 228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1110 01122334679999999999999999999999999873
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-52 Score=418.75 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=199.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CC---eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
++|+..++||+|+||+||+|.++ ++ ..||||.+.........+.|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 44566789999999999999975 22 369999987765555566799999999999999999999999999999999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++|+|.+++.. ...++|.++..|+.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999998865 45799999999999999999999998 99999999999999999999999999998765432
Q ss_pred Cce----eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 455 SHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 455 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||...... +.+..+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~~~~~i~~~------ 249 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQD------ 249 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC------
Confidence 221 122457899999999999999999999999999999998 89998643321 122222111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+...+.++.+++.+||+.||++|||++||++.|+.
T Consensus 250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111223345779999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=405.35 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=213.8
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
++|+..+.||+|+||+||+|.+++++.||||+++.... ...+|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57899999999999999999999899999999986543 3457999999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
++|+|.+++.. ...+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999998653 45689999999999999999999998 999999999999999999999999999987765544444
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 537 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 537 (622)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+... .+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~----------~~~~ 221 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------LRLY 221 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT----------CCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhC----------CCCC
Confidence 55679999999999999999999999999999999998 78888644321 111222111 1111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 538 YDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 538 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+.++.+++.+||+.||++|||++|+++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223344679999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=408.26 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=207.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|..+ +++.||+|++.... .......+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56889999999999999999975 68999999986432 1233456889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|.+++.....+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 9999999999998777899999999999999999999999 9999999999999999999999999999865432
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
......||+.|||||++.+..++.++|||||||++|||+||+.||...... +....+.... ..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~-------~~--- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVE-------FT--- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC-------CC---
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-------CC---
Confidence 234567999999999999999999999999999999999999999743321 1112211110 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
++...++++.+++.+||+.||++|||++|+++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12223467889999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=410.59 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=203.3
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCC-----eEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
.+.|+..++||+|+||+||+|.+++. ..||||+++.........+|.+|++++++++|||||+++|++...+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35677889999999999999997532 4799999976655555567999999999999999999999999999999
Q ss_pred EEeeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+.+|++.+.+. ....++|..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999988775 446799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC--ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhc
Q 036225 453 QDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLV 530 (622)
Q Consensus 453 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (622)
... .......||+.|+|||++.++.++.++|||||||++|||+||+.|+....... +....+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~--------- 227 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAIN--------- 227 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH---------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHh---------
Confidence 322 22234568999999999999999999999999999999999777765432211 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 531 DKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 531 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+...+.++.+|+.+||+.||++|||+.||++.|+.
T Consensus 228 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 228 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111222333345779999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=407.65 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=207.9
Q ss_pred hCCCcCCe-eeecCCceEEEEEEC---CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNI-LGKGGFGIVYKGILQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
++|...+. ||+|+||+||+|.++ ++..||||+++.........+|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45556664 999999999999864 4568999999876555556689999999999999999999999875 468999
Q ss_pred eeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
|||+++|+|.+++.. +..+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999998754 46799999999999999999999999 99999999999999999999999999999876543
Q ss_pred Cce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 455 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 455 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +....+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~------- 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGK------- 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTC-------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-------
Confidence 322 223458999999999999999999999999999999998 89998743321 1111221111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+...+.++.+++.+||+.+|++|||+.+|++.|+.
T Consensus 230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111223345778999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=422.99 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=209.3
Q ss_pred HHhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
..++|++.+.||+|+||+||+|... +|+.||+|+++..........+.+|++++++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999974 789999999987655555667899999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.....+++..+..++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999877789999999999999999999997 5 8999999999999999999999999999866432
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH-HHHh-------------
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV-KKIH------------- 521 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~------------- 521 (622)
.....+||+.|+|||++.+..|+.++||||+||++|||+||+.||................ ....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2234679999999999999999999999999999999999999997543211100000000 0000
Q ss_pred --------h----hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 --------Q----EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 --------~----~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ......................++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 000000000000000001123568899999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=415.72 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=208.0
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECC------CeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTP 369 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 369 (622)
+..++|++.++||+|+||+||+|.+.. ...||+|.+...........+.+|+.++.++ +|||||++++++...
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445788999999999999999999642 2369999987665555566789999999988 899999999999999
Q ss_pred CceeEEeeeccCCCccccccCC-----------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 036225 370 TERLLVYPYMSNGSVASRLKGK-----------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 426 (622)
+..++||||+++|+|.++++.. ..+++..++.|+.||++||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 9999999999999999998643 2489999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccc
Q 036225 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYG 504 (622)
Q Consensus 427 k~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~ 504 (622)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544333 2334568999999999999999999999999999999998 89998643
Q ss_pred hhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 036225 505 KAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLE 572 (622)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 572 (622)
.... .+...+ ....+...+...++++.+|+.+||+.||++|||++||+++|.
T Consensus 271 ~~~~---~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDA---NFYKLI-------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSH---HHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH---HHHHHH-------------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 111111 111112223334578999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=406.79 Aligned_cols=249 Identities=20% Similarity=0.307 Sum_probs=206.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|+..+.||+|+||+||+|.. .+|+.||||+++..... ....+.+|++++++++|||||++++++...+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4689999999999999999996 46999999998754432 345789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+++|+|.+++... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+..... ..
T Consensus 99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 9999999987654 589999999999999999999999 999999999999999999999999999998754332 33
Q ss_pred eeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 459 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
....||+.|+|||++.+..++.++|||||||++|||+||+.||....... .+......... .+ ..
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~~~~~~~~------~~--~~ 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTP------EL--QN 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHHCSC------CC--SS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCCC------CC--CC
Confidence 45579999999999999999999999999999999999999996433211 11111111100 00 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+...+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223467899999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=405.52 Aligned_cols=247 Identities=27% Similarity=0.355 Sum_probs=201.3
Q ss_pred CeeeecCCceEEEEEEC---CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeeccC
Q 036225 306 NILGKGGFGIVYKGILQ---DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYMSN 381 (622)
Q Consensus 306 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 381 (622)
+.||+|+||+||+|.++ .++.||||+++.... ......|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 356899999975432 2334579999999999999999999999965 457899999999
Q ss_pred CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee--e
Q 036225 382 GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT--T 459 (622)
Q Consensus 382 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~ 459 (622)
|+|.++++....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999998888899999999999999999999998 999999999999999999999999999998765443332 3
Q ss_pred eecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCCCC
Q 036225 460 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 538 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 538 (622)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....+... .+...
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~----------~~~~~ 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG----------ERMGC 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT----------CCCCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcC----------CCCCC
Confidence 4568999999999999999999999999999999998 89998743221 111111111 11122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 539 DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 539 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+.++.+++.+||+.||++|||+++|++.|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 33345778999999999999999999999998874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=406.05 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=193.7
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC--CCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT--PTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 375 (622)
++|++.+.||+|+||+||+|... +|+.||||.++..... .....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67899999999999999999975 6899999999765433 234468899999999999999999999865 4567999
Q ss_pred eeeccCCCcccccc----CCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 376 YPYMSNGSVASRLK----GKPILDWSTRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 376 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
|||+++|+|.+++. ....+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885 3457999999999999999999999872 12499999999999999999999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... +....+.... .
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~-~--- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGK-F--- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTC-C---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCC-C---
Confidence 654322 334567999999999999999999999999999999999999999743321 1112211111 1
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+.+.. ..++++.+++.+||+.||++|||++|+++
T Consensus 232 --~~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11112 23367899999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=408.17 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=204.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+..++|++.+.||+|+||+||+|.+++++.||||+++.... ....|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 34567899999999999999999999888999999975532 34579999999999999999999999854 5688999
Q ss_pred eeccCCCccccccC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 377 PYMSNGSVASRLKG--KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 377 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
||+++|+|.+++.. ...++|..+..|+.||++||+|||++ +|+||||||+|||+|+++++||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999988864 34699999999999999999999999 99999999999999999999999999998775544
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
........||+.|+|||++.++.++.++|||||||++|||+||+.|+...... .+.+..+... .
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~----------~ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG----------Y 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------C
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----------C
Confidence 44445567999999999999999999999999999999999987776543321 1112221111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
....+...++++.+++.+||+.||++||++++|+++|+.
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 112233345679999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-50 Score=409.15 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=193.2
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
.+.|++.+.||+|+||+||+|... +|+.||||++...........+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999975 6899999999765544445568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCCCC
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~ 454 (622)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999998888899999999999999999999999 999999999999994 57899999999998664322
Q ss_pred CceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
......||+.|||||++.+..++.++|||||||++|||+||+.||....... ....+.... ...
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~-------~~~ 228 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAE-------YEF 228 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTC-------CCC
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccC-------CCC
Confidence 2344679999999999999999999999999999999999999997433211 111111110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
........++++.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111112234678999999999999999999999883
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=407.33 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=205.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|... +|+.||||+++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57899999999999999999974 68999999986432 1223456899999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC-
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS- 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 455 (622)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999998878899999999999999999999999 999999999999999999999999999998754332
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .....+.... ..+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~-------~~~- 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIKLE-------YDF- 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTC-------CCC-
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHcCC-------CCC-
Confidence 2334567999999999999999999999999999999999999999754321 1111111110 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1222367889999999999999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=398.42 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=197.5
Q ss_pred CcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC----CCceeEEe
Q 036225 303 SSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT----PTERLLVY 376 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 376 (622)
...+.||+|+||+||+|.+. +++.||+|.+...... .....+.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 6889999998765432 334568999999999999999999999864 34578999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccccceecCCCCC
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-DCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~ 455 (622)
||+++|+|.+++.....+++..+..++.||++||+|||++ +++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 9999999999998877899999999999999999999998 12399999999999996 5899999999999864322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|||||++.+ .++.++|||||||++|||+||+.||...... ....+.+......
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~--------- 231 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP--------- 231 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCC---------
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCC---------
Confidence 2345679999999999865 6999999999999999999999999643211 1111222111110
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...+....+++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111112356889999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-50 Score=405.88 Aligned_cols=246 Identities=28% Similarity=0.364 Sum_probs=203.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
+.|+..+.||+|+||+||+|... +|+.||||+++...... ....+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999964 78999999997654332 2346889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|||++|+|..++.....+++..+..|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999987777777899999999999999999999999 999999999999999999999999999986543
Q ss_pred eeeeecCcccccCcccccc---CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhcccc
Q 036225 457 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKD 533 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 533 (622)
.....||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... +.+..+.... .+.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~~~------~~~ 233 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE------SPA 233 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC------CCC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCC------CCC
Confidence 234569999999999864 46899999999999999999999999743221 1111111111 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 534 LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 534 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
+ .+...++.+.+++.+||+.||++|||++|+++
T Consensus 234 ~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11122367899999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=403.09 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=203.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
+.|++.+.||+|+||+||+|... +|+.||||+++... ......+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 45788999999999999999975 68999999997643 33455789999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 379 MSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 379 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999998753 45699999999999999999999999 99999999999999999999999999997653221 12
Q ss_pred eeeecCcccccCccccc-----cCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 458 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
.....||+.|+|||++. +..|+.++|||||||++|||+||+.||......+ .. ..+..... +
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~---~~i~~~~~------~ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VL---LKIAKSEP------P 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HH---HHHHHSCC------C
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HH---HHHHcCCC------C
Confidence 23456999999999984 4568999999999999999999999997543221 11 11111110 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+ ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 111223467899999999999999999999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-50 Score=405.74 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=212.5
Q ss_pred HHHHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeee
Q 036225 293 RELQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFC 366 (622)
Q Consensus 293 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 366 (622)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++.........+|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445556788999999999999999999864 45789999998765555566799999999999999999999999
Q ss_pred eCCCceeEEeeeccCCCccccccC------------------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCee
Q 036225 367 MTPTERLLVYPYMSNGSVASRLKG------------------------KPILDWSTRKRIALGAARGLLYLHEQCDPKII 422 (622)
Q Consensus 367 ~~~~~~~lv~e~~~~gsL~~~l~~------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 422 (622)
...+..+++|||+++|+|.+++.. ...+++..+..|+.|++.||+|||++ +|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 999999999999999999998852 12489999999999999999999999 999
Q ss_pred ecCCCCCCeeecCCCceEEcccccceecCCCCC-ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCC-c
Q 036225 423 HRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR-A 500 (622)
Q Consensus 423 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~-p 500 (622)
||||||+|||+|.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+||.. |
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986643322 23345568999999999999999999999999999999999964 5
Q ss_pred cccchhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 501 LEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
|...... +....+..... ...+...+.++.+|+.+||+.+|++||||.||+++|+.
T Consensus 243 ~~~~~~~-------e~~~~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 243 YYGMAHE-------EVIYYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp TTTSCHH-------HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHH-------HHHHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 5432211 11222211111 11222334678999999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=399.62 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=198.2
Q ss_pred HHhCCCcCCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCcee
Q 036225 298 ATHNFSSKNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 298 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
..++|++.+.||+|+||+||+|.+.. +..||||.++..........|.+|++++++++|||||+++|++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35678899999999999999998642 45799999876655555567999999999999999999999986 46789
Q ss_pred EEeeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCC
Q 036225 374 LVYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDH 452 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 452 (622)
+||||+++|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999998765 455789999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 453 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
..........||+.|+|||++.+..++.++|||||||++|||+| |.+||......+ +.. .+.....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~---~i~~~~~------ 227 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG---RIENGER------ 227 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH---HHHTTCC------
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHH---HHHcCCC------
Confidence 55545556678999999999999999999999999999999998 788886543221 111 1111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222344679999999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-49 Score=404.09 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=207.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999974 79999999997654 23345788999999999999999999999999999999999
Q ss_pred ccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+++|+|.+++. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 99999999885 445799999999999999999999999 999999999999996 46889999999999775433
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|||||++.+..++.++|||||||++|||+||+.||...... +.+..+..... ...
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~-------~~~ 245 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW-------NMD 245 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC-------CSC
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC-------CCC
Confidence 344567999999999999999999999999999999999999999743321 11222211110 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......++++.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111223578899999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=397.87 Aligned_cols=252 Identities=20% Similarity=0.272 Sum_probs=206.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.+.|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999974 7999999998654321 2345789999999999999999999999999999
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccccce
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC----EAVVGDFGLAK 448 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~ 448 (622)
++||||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999998777899999999999999999999999 999999999999998776 49999999998
Q ss_pred ecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 449 LLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+....
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~---- 232 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVN---- 232 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTC----
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcC----
Confidence 765332 2344569999999999999999999999999999999999999997533211 111111110
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 ---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000112356889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-48 Score=401.57 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=207.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|++.+.||+|+||+||+|... +|+.||||+++.... .....+.+|++++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 56899999999999999999974 799999999876542 3345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKGK-PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--DCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~~~ 455 (622)
+++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999877654 4699999999999999999999999 999999999999998 67899999999999876432
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+... +..+.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~-------~~~~~ 248 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRC-------DWEFD 248 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHC-------CCCCC
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC-------CCCCC
Confidence 3445679999999999999999999999999999999999999997543211 11111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.......+.++.+++.+||+.||.+|||++|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112233678899999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=389.70 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=196.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC-CCceeEEee
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PTERLLVYP 377 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 377 (622)
.++|+..+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 456778899999999999999986 7889999997543 34578999999999999999999999865 466899999
Q ss_pred eccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 378 YMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 378 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|+++|+|.+++... ..++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999998643 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhccccC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDL 534 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 534 (622)
.....+|..|+|||++.++.+++++|||||||++|||+| |+.||..... ..+..++ .. ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i---~~----------~~ 217 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV---EK----------GY 217 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHH---TT----------TC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHH---Hc----------CC
Confidence 233458899999999999999999999999999999999 5766654321 1222222 11 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 535 KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 535 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
+...+...+.++.+++.+||+.||.+|||+.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 122233344678999999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=400.02 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=201.5
Q ss_pred CHHHHHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeee
Q 036225 291 QFRELQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLY 363 (622)
Q Consensus 291 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~ 363 (622)
+..++++..++|.+.+.||+|+||+||+|.+. +++.||||+++..........+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44556666788999999999999999999863 35789999998765555566788888888776 689999999
Q ss_pred eeeeCC-CceeEEeeeccCCCccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 036225 364 GFCMTP-TERLLVYPYMSNGSVASRLKG----------------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDV 426 (622)
Q Consensus 364 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 426 (622)
+++... ...++||||+++|+|.++++. ...+++..+..++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 467899999999999999853 23589999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCC-ccccc
Q 036225 427 KAANILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR-ALEYG 504 (622)
Q Consensus 427 k~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~-p~~~~ 504 (622)
||+|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||.. ||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543332 2334579999999999999999999999999999999999754 55432
Q ss_pred hhccccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 505 KAANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.... .+.. .+.... ....+...+.++.+++.+||+.||++|||++|++++|+.
T Consensus 241 ~~~~---~~~~---~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KIDE---EFCR---RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCSH---HHHH---HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH---HHHH---HHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2111 1111 111111 111222234678999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=398.42 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=201.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCe----EEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 374 (622)
++|+..++||+|+||+||+|.+. +|+ .||+|+++........++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46889999999999999999964 443 68999987665556667899999999999999999999999875 5678
Q ss_pred EeeeccCCCcccccc-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 375 VYPYMSNGSVASRLK-GKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 375 v~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
++||+.+|+|.+.+. ....+++..+.+|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 889999999988775 456799999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhhhcc
Q 036225 454 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVD 531 (622)
Q Consensus 454 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 531 (622)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+.. .
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~~---~-------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK---G-------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHHH---T--------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHc---C--------
Confidence 3332 334568999999999999999999999999999999999 67777543211 12221111 1
Q ss_pred ccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 532 KDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 532 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1111223345678999999999999999999999998864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=396.39 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=201.9
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCe--EEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 375 (622)
++|++.++||+|+||+||+|.++ +|. .||||+++........+.|.+|++++.++ +|||||+++|+|...+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999975 444 57888886555445556799999999998 799999999999999999999
Q ss_pred eeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 036225 376 YPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEA 439 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 439 (622)
|||+++|+|.++++.. ..+++..+.+++.|||+||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998643 5699999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCc-cccchhccccccHHHHHH
Q 036225 440 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA-LEYGKAANQKGAMLDWVK 518 (622)
Q Consensus 440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p-~~~~~~~~~~~~~~~~~~ 518 (622)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||+||..| |.... ..+...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence 999999998553221 12334589999999999999999999999999999999998764 43221 111122
Q ss_pred HHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 519 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 519 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+... .+...+...++++.+++.+||+.||++||||+||++.|+.
T Consensus 238 ~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 238 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22111 1112223344789999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=396.91 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=207.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEE
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 375 (622)
-++|++.+.||+|+||+||+|..+ +|+.||||++++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357889999999999999999974 79999999997532 122345688999999999999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 99999999999998888899999999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......+||+.|+|||++.+..|+.++||||+||++|||+||+.||...+.. ......... ...
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~-------~~~-- 223 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILME-------EIR-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------CCC--
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcC-------CCC--
Confidence 2334567999999999999999999999999999999999999999754321 111111111 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
++...+.++.+++.+||+.||.+||+ +.|+++
T Consensus 224 --~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12223356889999999999999995 677765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-48 Score=393.56 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=207.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|..+ +|+.||||+++... .......+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999974 69999999986432 1223456889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999876533
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||...... .....+.... ..
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~-------~~--- 219 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAE-------LR--- 219 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCC-------CC---
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCC-------CC---
Confidence 23467999999999999999999999999999999999999999754321 1111211110 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVRM 570 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 570 (622)
++...+.++.+++.+|++.||.+|| |++|++++
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1122235688999999999999996 88888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=394.61 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=213.4
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEE------CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGIL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+++..++|+..+.||+|+||.||+|++ .+++.||||+++..........|.+|+.++.++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 344567888999999999999999985 246789999998766555566799999999998 6999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK------------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 429 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~ 429 (622)
.++..++||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 999999999999999999988532 2589999999999999999999999 9999999999
Q ss_pred CeeecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhcc
Q 036225 430 NILLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAAN 508 (622)
Q Consensus 430 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~ 508 (622)
|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+|++.|+.......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999987654333 3345678999999999999999999999999999999999655554322211
Q ss_pred ccccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 509 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...+. ...+...+...+..+.+|+.+||+.||++|||++||+++|++
T Consensus 255 --~~~~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 --SKFYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp --HHHHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11112111 111122222344679999999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=387.72 Aligned_cols=255 Identities=30% Similarity=0.412 Sum_probs=196.1
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC--C--CeEEEEEEccCCCC--CchhHHHHHHHHHHhccccccceeeeeeeeCCCce
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ--D--GTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTER 372 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 372 (622)
.++|++.+.||+|+||+||+|.+. + ...||||+++.... ....++|.+|++++++++|||||+++|++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 356888999999999999999863 2 24789999875432 23345799999999999999999999999764 67
Q ss_pred eEEeeeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 373 LLVYPYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
++||||+++|++.+++.. ...+++..+..++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 899999999999987753 34699999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCCce--eeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 452 HQDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
...... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~----- 230 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKE----- 230 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTS-----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhC-----
Confidence 543332 233457889999999999999999999999999999998 89998643321 111222111
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
..+...+...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 231 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 ----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111222334678999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=389.94 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=202.1
Q ss_pred CCeeeecCCceEEEEEECC----CeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC-CCceeEEeeec
Q 036225 305 KNILGKGGFGIVYKGILQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT-PTERLLVYPYM 379 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 379 (622)
.++||+|+||+||+|.+.+ +..||||+++.........+|.+|++++++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999753 236999999765555555689999999999999999999999875 56789999999
Q ss_pred cCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc--
Q 036225 380 SNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH-- 456 (622)
Q Consensus 380 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 456 (622)
++|+|.+++.. ...+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999998874 44577889999999999999999999 9999999999999999999999999999876543222
Q ss_pred -eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 457 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
......||..|+|||++.++.++.++||||||+++|||+||+.||....... ++...+.....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~------~~~~~i~~g~~---------- 252 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRR---------- 252 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCC----------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCC----------
Confidence 2233568999999999999999999999999999999999888876433211 11112111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...+...+.++.+++.+||+.||++||+|.||+++|+.
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122334678999999999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=390.15 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=205.2
Q ss_pred HHHhCCCcCCeeeecCCceEEEEEEC--------CCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeee
Q 036225 297 VATHNFSSKNILGKGGFGIVYKGILQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCM 367 (622)
Q Consensus 297 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 367 (622)
+..++|.+.+.||+|+||.||+|... ++..||||+++..........+.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34567888999999999999999853 23579999998766555556788999988888 8999999999999
Q ss_pred CCCceeEEeeeccCCCccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 036225 368 TPTERLLVYPYMSNGSVASRLKGK----------------PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 431 (622)
Q Consensus 368 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 431 (622)
+++..++||||+++|+|.+++... ..+++..+.+++.||+.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 999999999999999999998633 3589999999999999999999999 999999999999
Q ss_pred eecCCCceEEcccccceecCCCCCc-eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHh-cCCccccchhccc
Q 036225 432 LLDDCCEAVVGDFGLAKLLDHQDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALEYGKAANQ 509 (622)
Q Consensus 432 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~t-g~~p~~~~~~~~~ 509 (622)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |..||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 9999999999999999877543332 2344568999999999999999999999999999999998 57776533211
Q ss_pred cccHHHHHHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 510 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
.+.. .+... .....+...+.++.+++.+||+.||.+|||+.||++.|++
T Consensus 245 --~~~~---~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 245 --ELFK---LLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp --HHHH---HHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHH---HHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1111 11111 1111222234678999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-47 Score=382.88 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=205.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc--------hhHHHHHHHHHHhccc-cccceeeeeeeeCC
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG--------GEIQFQTEVEMISLAV-HRNLLRLYGFCMTP 369 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 369 (622)
++|++.+.||+|+||+||+|.. .+|+.||||+++...... ....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999997 479999999987543221 1225789999999997 99999999999999
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+..++||||+++|+|.++++....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999998878899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeeeecCcccccCcccccc------CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE 523 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 523 (622)
..... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ...+...
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~~~i~~~ 230 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMIMSG 230 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHT
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------HHHHHhC
Confidence 75432 2344679999999999853 3468899999999999999999999975432111 1111111
Q ss_pred hhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. . ..........++++.+++.+||+.||++|||++|++++
T Consensus 231 ~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 N-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 0 01111112234678999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-47 Score=382.08 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=201.7
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCc--hhHHHHHHHHHHhccccccceeeeeeeeCCC----c
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLYGFCMTPT----E 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~ 371 (622)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.....+ ....+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688999999999999999996 479999999997654332 2346899999999999999999999987654 3
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+++|+|.+++.....+++.++..|+.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 789999999999999998777899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC--ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 452 HQDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 452 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP-- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCC--
Confidence 3322 2334567999999999999999999999999999999999999999753321 1111111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRP-KMSEVVRMLEG 573 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~ 573 (622)
...... ..+.++.+++.+|++.||.+|| |++++++.|..
T Consensus 234 -~~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 -PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -GGGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -Cchhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 001111 1236788999999999999999 89999887753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=392.49 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=212.0
Q ss_pred HHHHHhCCCcCCeeeecCCceEEEEEEC------CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeC
Q 036225 295 LQVATHNFSSKNILGKGGFGIVYKGILQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMT 368 (622)
Q Consensus 295 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 368 (622)
+++..++|...+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4445678889999999999999999863 3578999999866555555678999999999999999999999999
Q ss_pred CCceeEEeeeccCCCccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 036225 369 PTERLLVYPYMSNGSVASRLKG----------KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCE 438 (622)
Q Consensus 369 ~~~~~lv~e~~~~gsL~~~l~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 438 (622)
.+..++||||+++|+|.+++.. ...+++..+.+++.|+|+||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 9999999999999999998752 23578999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCce-eeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcC-CccccchhccccccHHHH
Q 036225 439 AVVGDFGLAKLLDHQDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALEYGKAANQKGAMLDW 516 (622)
Q Consensus 439 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~-~p~~~~~~~~~~~~~~~~ 516 (622)
+||+|||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+||+ .||.... ..++
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~ 244 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQV 244 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence 9999999998765433222 23345899999999999999999999999999999999996 5554322 1122
Q ss_pred HHHHhhhhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 036225 517 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEGD 574 (622)
Q Consensus 517 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 574 (622)
...+..... ...+...+..+.+++.+||+.+|++|||+.||+++|+..
T Consensus 245 ~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222221111 111222346799999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=386.74 Aligned_cols=262 Identities=24% Similarity=0.290 Sum_probs=198.7
Q ss_pred CCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCc----hhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeeec
Q 036225 305 KNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPYM 379 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 379 (622)
.++||+|+||+||+|... +|+.||||+++...... ....+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 69999999997543221 1346889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCceee
Q 036225 380 SNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVTT 459 (622)
Q Consensus 380 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 459 (622)
.++++..+...+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9988888888778899999999999999999999999 999999999999999999999999999987654332 233
Q ss_pred eecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh--hhhhcc-ccCC
Q 036225 460 AVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK--LEMLVD-KDLK 535 (622)
Q Consensus 460 ~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d-~~~~ 535 (622)
...||+.|+|||++.+. .++.++|||||||++|||+||+.||......+....+............ ...... ....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45699999999998654 5799999999999999999999998754433221111111000000000 000000 0000
Q ss_pred --CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 536 --NNYD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 536 --~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+ ....+++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0001 1123578999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=387.42 Aligned_cols=249 Identities=19% Similarity=0.253 Sum_probs=205.3
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++++.++|||||++++++.+.+..++||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 56889999999999999999975 68999999997643 2344688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccccceecCCCCC
Q 036225 379 MSNGSVASRLKGKP-ILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD--CCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 379 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~ 455 (622)
|++|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999997654 699999999999999999999999 9999999999999984 458999999999876533
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......+|+.|+|||.+.+..++.++||||+||++|||+||+.||...... +....+..... .++....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~---~~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY---TFDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC---CCCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC---CCChhhc
Confidence 2344556999999999999999999999999999999999999999754322 11222111110 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
. ..+.++.+++.+|+..||++|||++|+++
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 12356889999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-47 Score=392.10 Aligned_cols=245 Identities=21% Similarity=0.250 Sum_probs=206.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEe
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 376 (622)
++|++.+.||+|+||+||+|..+ +|+.||||+++... .......+.+|+++++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999975 79999999986432 1223446889999999999999999999999999999999
Q ss_pred eeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 377 PYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 377 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
||+.+|+|.+++.....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999998777899999999999999999999999 9999999999999999999999999999977533
Q ss_pred eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCCC
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 536 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 536 (622)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ......+.... ...
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-------~~~-- 257 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-------VRF-- 257 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CCC--
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCC-------CCC--
Confidence 2345699999999999999999999999999999999999999974321 11122211110 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 036225 537 NYDRIELEEMVQVALLCTQYLPAHRP-----KMSEVVR 569 (622)
Q Consensus 537 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 569 (622)
+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112236788999999999999994 8898876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=389.46 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=204.0
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCC--CCchhHHHHHHHHHHh-ccccccceeeeeeeeCCCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS-LAVHRNLLRLYGFCMTPTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 375 (622)
++|.+.+.||+|+||+||+|... +|+.||||+++... .......+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999975 69999999996432 1222345667777665 68999999999999999999999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDS 455 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 455 (622)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999998878899999999999999999999999 99999999999999999999999999998664332
Q ss_pred ceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccccCC
Q 036225 456 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDKDLK 535 (622)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 535 (622)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+... .+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~-------~~~-- 221 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD-------NPF-- 221 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC-------CCC--
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC-------CCC--
Confidence 23344679999999999999999999999999999999999999997543211 11111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 036225 536 NNYDRIELEEMVQVALLCTQYLPAHRPKMS-EVVR 569 (622)
Q Consensus 536 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 569 (622)
++...+.++.+++.+||+.||++||++. |+++
T Consensus 222 --~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1222346789999999999999999995 6754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=385.31 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=198.2
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC----ceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT----ERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 375 (622)
++|...+.||+|+||+||+|+++ |+.||||+++... .....+..|+..+.+++|||||+++|++...+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45677889999999999999974 8999999986432 11112334555566789999999999998654 57899
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
|||+++|+|.++++.. .++|..+.+++.|+|.||.|||+.+ .++|+||||||+|||+++++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999865 5899999999999999999999731 349999999999999999999999999999887
Q ss_pred CCCCCc---eeeeecCcccccCccccccCC------CCcccceeehhHHHHHHHhcCCccccchhcccc-------ccHH
Q 036225 451 DHQDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITGQRALEYGKAANQK-------GAML 514 (622)
Q Consensus 451 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~-------~~~~ 514 (622)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+......... ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 544322 233567999999999986542 577999999999999999998887543221110 0011
Q ss_pred HHHHHHhhhhhhhhhccccCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 515 DWVKKIHQEKKLEMLVDKDLKNNY-DRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 515 ~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
......... ...++.+.... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 239 ~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111111 11112221111 22345678999999999999999999999999873
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-47 Score=392.60 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=199.6
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC--CchhHHHHH---HHHHHhccccccceeeeeeeeCCCcee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA--IGGEIQFQT---EVEMISLAVHRNLLRLYGFCMTPTERL 373 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~H~niv~l~~~~~~~~~~~ 373 (622)
++|++.++||+|+||+||+|... +|+.||||++..... ......+.+ |+++++.++|||||++++++...+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 699999999864321 111223334 466777888999999999999999999
Q ss_pred EEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCC
Q 036225 374 LVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 374 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 453 (622)
+||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999998878899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhhccc
Q 036225 454 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEMLVDK 532 (622)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 532 (622)
. .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+. ....... ...
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~---------~~~ 224 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMT---------LTM 224 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHS---------SSC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhc---------ccC
Confidence 2 234569999999999975 4689999999999999999999999975432211 1111110 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 533 DLKNNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 533 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
....+...+.++.+++.+||+.||++||| ++|+++
T Consensus 225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111123367899999999999999999 577765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=384.50 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=196.6
Q ss_pred hCCCcC-CeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhcc-ccccceeeeeeeeC----CCce
Q 036225 300 HNFSSK-NILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLYGFCMT----PTER 372 (622)
Q Consensus 300 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~ 372 (622)
++|.+. ++||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 567765 5699999999999996 57899999998642 3577899886654 89999999999865 4667
Q ss_pred eEEeeeccCCCccccccCC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcccccc
Q 036225 373 LLVYPYMSNGSVASRLKGK--PILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD---CCEAVVGDFGLA 447 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla 447 (622)
++|||||++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999653 4699999999999999999999999 9999999999999985 567999999999
Q ss_pred eecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 448 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...........+ ..
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~-------- 227 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KT-------- 227 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HH--------
Confidence 87654332 34457999999999999999999999999999999999999999754322211100 00
Q ss_pred hhcccc--CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 528 MLVDKD--LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 528 ~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.+.... +........++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000111 111111223467899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=379.00 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=199.4
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 47999999999754322 234578899999999999999999999999999999999
Q ss_pred eccCCCccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCc
Q 036225 378 YMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSH 456 (622)
Q Consensus 378 ~~~~gsL~~~l-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 456 (622)
|+.++.+.... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 99765444333 2355699999999999999999999999 99999999999999999999999999998765332 2
Q ss_pred eeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhhh-hccc
Q 036225 457 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLEM-LVDK 532 (622)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~d~ 532 (622)
......||+.|+|||.+.... ++.++|||||||++|||+||+.||...+..+. +........... .... ...+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhcccccccc
Confidence 233456999999999887665 57899999999999999999999975433221 111111110000 0000 0000
Q ss_pred cCCCC------CC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 533 DLKNN------YD-----RIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 533 ~~~~~------~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... .. .....++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00 0112568899999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-46 Score=376.22 Aligned_cols=266 Identities=20% Similarity=0.293 Sum_probs=204.0
Q ss_pred hCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEeee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYPY 378 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 378 (622)
++|...+.||+|+||+||+|.+++|+.||||+++.... ......+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999976532 22345789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCcee
Q 036225 379 MSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHVT 458 (622)
Q Consensus 379 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 458 (622)
+.++.+..+.+....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 99888888888788899999999999999999999998 99999999999999999999999999998765432 223
Q ss_pred eeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh--hhhhh--cccc
Q 036225 459 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK--KLEML--VDKD 533 (622)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~d~~ 533 (622)
....|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........... ..... .+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 444689999999998654 568999999999999999999999975443222111111000000000 00000 0000
Q ss_pred CC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 534 LK-------NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 534 ~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
.. ..........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011112357889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=375.82 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=198.4
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-----chhHHHHHHHHHHhccc--cccceeeeeeeeCCCc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAV--HRNLLRLYGFCMTPTE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 371 (622)
++|++.+.||+|+||+||+|... +|+.||||+++..... ....++.+|+.++++++ |||||++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999974 7899999998753221 11234678999999986 8999999999999999
Q ss_pred eeEEeeeccC-CCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEccccccee
Q 036225 372 RLLVYPYMSN-GSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-CCEAVVGDFGLAKL 449 (622)
Q Consensus 372 ~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~ 449 (622)
.++||||+.+ +++.+++.....+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 57778887777899999999999999999999999 9999999999999985 57999999999987
Q ss_pred cCCCCCceeeeecCcccccCccccccCCC-CcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhh
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEM 528 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (622)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... +...
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~----- 219 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG----- 219 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC-----
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhc-----
Confidence 5432 2345679999999999987765 5778999999999999999999974321 0000
Q ss_pred hccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 529 LVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 529 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...++... +.++.+++.+||+.||++|||++|+++.
T Consensus 220 --~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111222 3678999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=374.52 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=198.5
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-C-CeEEEEEEccCCCC-CchhHHHHHHHHHHhcc---ccccceeeeeeeeC----
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-D-GTVVAVKRLKDGNA-IGGEIQFQTEVEMISLA---VHRNLLRLYGFCMT---- 368 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~---- 368 (622)
.++|++.+.||+|+||+||+|.+. + ++.||||+++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 67899999865332 22233566788777665 79999999999853
Q ss_pred -CCceeEEeeeccCCCccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccc
Q 036225 369 -PTERLLVYPYMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGL 446 (622)
Q Consensus 369 -~~~~~lv~e~~~~gsL~~~l-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 446 (622)
....+++|||++++.+.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 34678999999988775443 3456789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhh
Q 036225 447 AKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKL 526 (622)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (622)
++..... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||......+....+.............
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9865422 23345679999999999999999999999999999999999999997554332221111111100000000
Q ss_pred h------hhccccC---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 527 E------MLVDKDL---KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 527 ~------~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ....... ...+.....+.+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000 000111223568899999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=364.26 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=198.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeC--------C
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMT--------P 369 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~ 369 (622)
++|++.+.||+|+||+||+|.+. +|+.||||+++.... .....++.+|++++++++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57889999999999999999974 799999999865433 2334568899999999999999999998865 3
Q ss_pred CceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccccccee
Q 036225 370 TERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 370 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
+..++||||+.++.+.........++...++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 45789999999888877777777899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---eeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhh
Q 036225 450 LDHQDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKK 525 (622)
Q Consensus 450 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (622)
....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+......... ..
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP-EV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh-hh
Confidence 6533221 12334699999999998765 6899999999999999999999999754322221111111100000 00
Q ss_pred hhhhc--------cccCCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 526 LEMLV--------DKDLKNNYDR-------IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 526 ~~~~~--------d~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
..... .......... .....+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 0000000000 112456789999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=365.43 Aligned_cols=267 Identities=20% Similarity=0.296 Sum_probs=197.3
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCCC----ceeE
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT----ERLL 374 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l 374 (622)
++|++.+.||+|+||+||+|.. .+|+.||||+++..........+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688899999999999999996 4799999999976554444557889999999999999999999987653 2355
Q ss_pred EeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCC
Q 036225 375 VYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 375 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 454 (622)
+++|+.+|+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 88 l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 66777799999999754 589999999999999999999999 99999999999999999999999999998764322
Q ss_pred Cc--eeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhh-------h
Q 036225 455 SH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQE-------K 524 (622)
Q Consensus 455 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~ 524 (622)
.. ......||+.|+|||++.. ..++.++||||+||++|||+||+.||......+............... .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 21 2244569999999999854 567899999999999999999999997544322211111000000000 0
Q ss_pred hhhh-hccccCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 525 KLEM-LVDKDLKNNYDR-----IELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 525 ~~~~-~~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
.... ..........+. ....++.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000000000010 112468899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-43 Score=355.19 Aligned_cols=257 Identities=19% Similarity=0.213 Sum_probs=196.3
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceee-eeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL-YGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l-~~~~~~~~~~~lv~e 377 (622)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... ..++..|+++++.++|+|++.. .++....+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4688999999999999999996 4689999999876432 2357889999999987765555 555567788899999
Q ss_pred eccCCCccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcccccceecCCC
Q 036225 378 YMSNGSVASRL-KGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---DCCEAVVGDFGLAKLLDHQ 453 (622)
Q Consensus 378 ~~~~gsL~~~l-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~ 453 (622)
|+.+ ++.+.+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9954 555544 4566799999999999999999999999 999999999999875 4567999999999987543
Q ss_pred CCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh
Q 036225 454 DSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE 527 (622)
Q Consensus 454 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (622)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..............+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChh
Confidence 322 233457999999999999999999999999999999999999999754433332222222111110 0011
Q ss_pred hhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 528 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 528 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
. +... .+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 239 ~-----~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 V-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp H-----HTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred H-----hccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1 1111 23678999999999999999999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=369.50 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=193.5
Q ss_pred CCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccceeeeeeeeCC------Ccee
Q 036225 301 NFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTP------TERL 373 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~ 373 (622)
+|...++||+|+||+||+|++. +|+.||||+++.... .+.+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999975 699999999975432 234799999999999999999998543 3468
Q ss_pred EEeeeccCCCcccc---ccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEccccccee
Q 036225 374 LVYPYMSNGSVASR---LKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKL 449 (622)
Q Consensus 374 lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~ 449 (622)
+||||++++.+... ......+++..++.|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999987643333 34566799999999999999999999998 999999999999999765 899999999987
Q ss_pred cCCCCCceeeeecCcccccCcccccc-CCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhh-
Q 036225 450 LDHQDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLE- 527 (622)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 527 (622)
...... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+........ .....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~-~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT-REQIRE 249 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC-HHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh-HHhhhh
Confidence 754332 334569999999998865 4689999999999999999999999975543322111111100000 00000
Q ss_pred ---hhccccCC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 528 ---MLVDKDLK--------NNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 528 ---~~~d~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
...+..+. .........++.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00111234568899999999999999999998863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=357.57 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=207.1
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCC-CchhHHHHHHHHHHhccccccceeeeeeeeCCCceeEEee
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLYGFCMTPTERLLVYP 377 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 377 (622)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999974 789999999975543 2345578999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecCCCCCce
Q 036225 378 YMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLDHQDSHV 457 (622)
Q Consensus 378 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 457 (622)
++.++++..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 999999999888888899999999999999999999999 999999999999999999999999999987754332 2
Q ss_pred eeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh---h---hhhhc
Q 036225 458 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK---K---LEMLV 530 (622)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~ 530 (622)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||..+...... ..-+....... . .....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTGGGST
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH---HHHHHhhcCCCChhhhhhhhhcc
Confidence 33445788999999987665 689999999999999999999998654332211 11111110000 0 00000
Q ss_pred cc---------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 531 DK---------DLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 531 d~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
+. .............+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00001112223568899999999999999999998763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=364.73 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=204.5
Q ss_pred hCCCcCCeeeecCCceEEEEEEC----CCeEEEEEEccCCCC---CchhHHHHHHHHHHhcccc-ccceeeeeeeeCCCc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ----DGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH-RNLLRLYGFCMTPTE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~ 371 (622)
++|++.+.||+|+||+||+|... +|+.||||.++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999852 488999999875321 1223467899999999977 899999999999999
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.+++|||+.+|+|.+++.....+.......++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999998877888999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCceeeeecCcccccCccccccC--CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhhhhhhh
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEKKLEML 529 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (622)
...........|++.|+|||.+.+. .++.++|||||||++|||+||+.||......+....+ .......
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~------ 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKS------ 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHC------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcccC------
Confidence 4444444556799999999999764 4688999999999999999999999765433321111 1111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 036225 530 VDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPK-----MSEVVR 569 (622)
Q Consensus 530 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 569 (622)
.. ..+...+.++.+++.+||+.||++||| ++|+++
T Consensus 252 -~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01 112233477999999999999999995 677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=360.79 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=192.9
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCCC------
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTPT------ 370 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 370 (622)
.++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999975 6999999999754332 23446889999999999999999999997654
Q ss_pred ceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceec
Q 036225 371 ERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLL 450 (622)
Q Consensus 371 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 450 (622)
..++||||+ +.+|....+. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 469999999 5567666653 4699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHH--------HHHh
Q 036225 451 DHQDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWV--------KKIH 521 (622)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~ 521 (622)
... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.... ....
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 533 2345699999999998764 56899999999999999999999997543322111111000 0000
Q ss_pred h------hhhhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 522 Q------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 522 ~------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
. ...........+. .........+.+++.+||..||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000000000 0111123567899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-42 Score=347.96 Aligned_cols=258 Identities=18% Similarity=0.239 Sum_probs=203.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc-ccceeeeeeeeCCCceeEEe
Q 036225 299 THNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLYGFCMTPTERLLVY 376 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 376 (622)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ...+.+|++.+..+.| +|++++++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357889999999999999999965 689999999865432 2356788999998865 89999999999999999999
Q ss_pred eeccCCCccccccC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceEEcccccceec
Q 036225 377 PYMSNGSVASRLKG-KPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDD-----CCEAVVGDFGLAKLL 450 (622)
Q Consensus 377 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~ 450 (622)
||+ +++|.++++. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 6799888864 44699999999999999999999999 9999999999999974 578999999999887
Q ss_pred CCCCCc------eeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHHhhhh
Q 036225 451 DHQDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKIHQEK 524 (622)
Q Consensus 451 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 524 (622)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||............ ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCC
Confidence 543221 233457999999999999999999999999999999999999999754332221111 1111111111
Q ss_pred hhhhhccccCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 036225 525 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRMLEG 573 (622)
Q Consensus 525 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 573 (622)
...++ .... ++++.+++..|+..+|++||+++.+.+.|++
T Consensus 236 ~~~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111 1112 3568899999999999999999998887763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-42 Score=355.20 Aligned_cols=258 Identities=18% Similarity=0.235 Sum_probs=196.8
Q ss_pred hCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeC--CCceeEE
Q 036225 300 HNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMT--PTERLLV 375 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv 375 (622)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ..++.+|+++++++. ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999997 479999999987532 456889999999995 9999999999874 4568999
Q ss_pred eeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccccceecCCCC
Q 036225 376 YPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCC-EAVVGDFGLAKLLDHQD 454 (622)
Q Consensus 376 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~ 454 (622)
|||+++++|....+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+......
T Consensus 111 ~e~~~~~~L~~~~~---~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EECCCSCBGGGTTT---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EeecCCCcHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999999987753 589999999999999999999999 999999999999998654 69999999998765432
Q ss_pred CceeeeecCcccccCccccccC-CCCcccceeehhHHHHHHHhcCCccccchhccc-cccHHHHH---------HHHhhh
Q 036225 455 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALEYGKAANQ-KGAMLDWV---------KKIHQE 523 (622)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~---------~~~~~~ 523 (622)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ...+.... ......
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23445689999999998765 479999999999999999999999975433211 11111111 000000
Q ss_pred --hhhhhhccccC--------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 036225 524 --KKLEMLVDKDL--------KNNYDRIELEEMVQVALLCTQYLPAHRPKMSEVVR 569 (622)
Q Consensus 524 --~~~~~~~d~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 569 (622)
........... ..........++.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 00011122356889999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=356.64 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=190.2
Q ss_pred hCCCcCCeeeecCCceEEEEEEC-CCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeC------CCc
Q 036225 300 HNFSSKNILGKGGFGIVYKGILQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMT------PTE 371 (622)
Q Consensus 300 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 371 (622)
++|++.++||+|+||+||+|.+. +|+.||||+++..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46888999999999999999975 6999999999765432 233468899999999999999999999864 367
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.++||||+.++.+ +.+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 7999999976544 4443 3589999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccccHHH--------HH------
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLD--------WV------ 517 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~------ 517 (622)
.. .......||+.|+|||++.+..+++++||||+||++|||++|+.||...........+.. +.
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 32 233455699999999999999999999999999999999999999975432221111110 00
Q ss_pred -HHHhhhh------hhhhhccccCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 518 -KKIHQEK------KLEMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 518 -~~~~~~~------~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
....... ............ .........+.+++.+|+..||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000011111111 1112345678999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=349.78 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=195.8
Q ss_pred HhCCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCC-chhHHHHHHHHHHhccccccceeeeeeeeCC-----Cc
Q 036225 299 THNFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLYGFCMTP-----TE 371 (622)
Q Consensus 299 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 371 (622)
.++|++.+.||+|+||+||+|.. .+|+.||||+++..... .....+.+|++++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45789999999999999999996 47999999999765432 2334688999999999999999999998643 34
Q ss_pred eeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccccceecC
Q 036225 372 RLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFGLAKLLD 451 (622)
Q Consensus 372 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 451 (622)
.+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 57778888999999998754 599999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeeeecCcccccCccccccCC-CCcccceeehhHHHHHHHhcCCccccchhccccccHHHHHHHH----hh---h
Q 036225 452 HQDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALEYGKAANQKGAMLDWVKKI----HQ---E 523 (622)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~---~ 523 (622)
. ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+....... .. .
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 2 223456899999999876654 6889999999999999999999997544322211111110000 00 0
Q ss_pred hhhhhhccc--cCC-CCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 036225 524 KKLEMLVDK--DLK-NNY---DRIELEEMVQVALLCTQYLPAHRPKMSEVVRM 570 (622)
Q Consensus 524 ~~~~~~~d~--~~~-~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 570 (622)
......... ... ... .......+.+++.+||+.||.+|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000 000 000 00123567899999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-37 Score=316.90 Aligned_cols=261 Identities=20% Similarity=0.222 Sum_probs=188.5
Q ss_pred CCCcCCeeeecCCceEEEEEE-CCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-----------cccceeeeeeeeC
Q 036225 301 NFSSKNILGKGGFGIVYKGIL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLYGFCMT 368 (622)
Q Consensus 301 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~ 368 (622)
+|.++++||+|+||+||+|+. .+|+.||||+++... .....+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 488899999999999999997 479999999997542 22345778888887765 5789999988764
Q ss_pred --CCceeEEeeeccCCCcccc---ccCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCc----
Q 036225 369 --PTERLLVYPYMSNGSVASR---LKGKPILDWSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCE---- 438 (622)
Q Consensus 369 --~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~---- 438 (622)
....+++++++..+..... ......+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3556677777655443222 2345578899999999999999999998 5 8999999999999986653
Q ss_pred --eEEcccccceecCCCCCceeeeecCcccccCccccccCCCCcccceeehhHHHHHHHhcCCccccchhccccc---cH
Q 036225 439 --AVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEYGKAANQKG---AM 513 (622)
Q Consensus 439 --~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~el~tg~~p~~~~~~~~~~~---~~ 513 (622)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.......... .+
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865432 234569999999999999999999999999999999999999987433221111 11
Q ss_pred HHHHHHHhh--------hhhhhhhccc-----c--------------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 036225 514 LDWVKKIHQ--------EKKLEMLVDK-----D--------------LKNNYDRIELEEMVQVALLCTQYLPAHRPKMSE 566 (622)
Q Consensus 514 ~~~~~~~~~--------~~~~~~~~d~-----~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 566 (622)
...+..+.. ........+. . ...........++.+++.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111111100 0000001110 0 011234556778999999999999999999999
Q ss_pred HHHH
Q 036225 567 VVRM 570 (622)
Q Consensus 567 vl~~ 570 (622)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9763
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=1.4e-27 Score=242.19 Aligned_cols=161 Identities=31% Similarity=0.583 Sum_probs=149.4
Q ss_pred CCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--CccceEEcCCC---cEEEEecCCCCCcc--ccCCcccCCCccc
Q 036225 28 KGVNYEVQALMGVKHSLHDPHGVLENWDEDAVDPC--SWTMVTCSPES---LVIGLGIPSQNLSG--TLSPSIGNLTNLQ 100 (622)
Q Consensus 28 ~~~~~~~~aLl~~k~~~~~~~~~l~~W~~~~~~~C--~w~gv~C~~~~---~v~~L~l~~n~l~~--~~~~~~~~l~~L~ 100 (622)
-|.+.|++||++||+++.||. .+++|... .||| .|.||+|+..+ +|+.|+|+++++.| .+|++|++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 488999999999999999885 68999864 5999 59999998653 69999999999998 5889999999999
Q ss_pred EEEccC-CCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCC
Q 036225 101 IVLLQN-NNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 101 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
+|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|.+.+.+|..+..++.|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCc
Q 036225 180 NLSGPVPRFSA 190 (622)
Q Consensus 180 ~l~g~~p~~~~ 190 (622)
.++|.+|....
T Consensus 160 ~l~~~ip~~~~ 170 (313)
T d1ogqa_ 160 RISGAIPDSYG 170 (313)
T ss_dssp CCEEECCGGGG
T ss_pred ccccccccccc
Confidence 99999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=7e-24 Score=198.32 Aligned_cols=163 Identities=11% Similarity=0.096 Sum_probs=121.0
Q ss_pred CcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCC-----------------chhHHHHHHHHHHhccccccceeeeee
Q 036225 303 SSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAVHRNLLRLYGF 365 (622)
Q Consensus 303 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 365 (622)
.+++.||+|+||+||+|...+|+.||||+++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 357899999999999999989999999987632110 001234567888899999999988766
Q ss_pred eeCCCceeEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccc
Q 036225 366 CMTPTERLLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDCCEAVVGDFG 445 (622)
Q Consensus 366 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 445 (622)
. ..+++|||++++.+.+ ++......++.|+++++.|||++ +|+||||||+|||++++ .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 3 2479999998765543 34556678999999999999999 99999999999999965 58999999
Q ss_pred cceecCCCCCceeeeecCcccccCc------cccccCCCCcccceeehhHH
Q 036225 446 LAKLLDHQDSHVTTAVRGTVGHIAP------EYLSTGQSSEKTDVFGFGIL 490 (622)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwslGv~ 490 (622)
.|....++... .|... |.+ ...|+.++|+||..--
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99876543221 11111 111 3567888999996543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=9.4e-18 Score=156.21 Aligned_cols=144 Identities=21% Similarity=0.277 Sum_probs=120.2
Q ss_pred CCccceEEcCC----------CcEEEEecCCCCCcccc-CCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 62 CSWTMVTCSPE----------SLVIGLGIPSQNLSGTL-SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 62 C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
|+|..|.|+.. ..++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 67888888743 24789999999998755 56789999999999999999988889999999999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccccccCC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPLICATG 205 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c~~~ 205 (622)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++.+..+... .+...+.+|...|..+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 99997777789999999999999999997778889999999999999999987654322 1334566777777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=6.2e-17 Score=150.55 Aligned_cols=134 Identities=22% Similarity=0.346 Sum_probs=116.4
Q ss_pred cceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCC-CCccCCCCcccEEEecCccccCCCCchhcc
Q 036225 65 TMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPI-PAEIGRLTKLQTLDLSNNFFTGEIPSSLGH 143 (622)
Q Consensus 65 ~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 143 (622)
.|.+|+. +.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+..+..|..
T Consensus 4 ~~C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 4677864 36899999999 5777663 78999999999998655 567899999999999999999888899999
Q ss_pred ccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 144 LRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 144 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. +.+.+.+|++.|.+.
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999999999999977788899999999999999999987776543 568899999988864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=3.8e-15 Score=145.77 Aligned_cols=129 Identities=23% Similarity=0.224 Sum_probs=90.1
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|+|++|++.+ ++..+.++++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 79 L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~ 157 (266)
T d1p9ag_ 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (266)
T ss_dssp CCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred ccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccc
Confidence 4444444444443 233444555555555555555544444555556666666666677755555677889999999999
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccccCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLICATG 205 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c~~~ 205 (622)
|+|++..+..|..+++|+.|+|++|+|+ .+|.... +.+.+.||||.|+|.
T Consensus 158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 9999777788999999999999999999 6775432 568899999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.56 E-value=1.1e-15 Score=153.50 Aligned_cols=134 Identities=25% Similarity=0.464 Sum_probs=104.1
Q ss_pred EEEEecCCCCCccccCCcccCCCcc-cE-----------------------EEccCCCCCCCCCCccCCCCcccEEEecC
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNL-QI-----------------------VLLQNNNITGPIPAEIGRLTKLQTLDLSN 130 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L-~~-----------------------L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 130 (622)
+..+++++|.+.|.+|..+..+..+ +. +++++|.+.|.+|..+..+++|+.|++++
T Consensus 151 L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~ 230 (313)
T d1ogqa_ 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred cceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4455555555555555555544443 44 45555555566677777888999999999
Q ss_pred ccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCCc----cccccccccccccCCC
Q 036225 131 NFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA----KTFNIVGNPLICATGS 206 (622)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~~~~l~~N~~~c~~~~ 206 (622)
|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.... +.+.+.||+.+|+.+
T Consensus 231 ~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p- 308 (313)
T d1ogqa_ 231 NSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308 (313)
T ss_dssp SEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT-
T ss_pred cccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC-
Confidence 99997655 688899999999999999999999999999999999999999999997531 457899999999865
Q ss_pred CCCC
Q 036225 207 EPDC 210 (622)
Q Consensus 207 ~~~c 210 (622)
.|.|
T Consensus 309 lp~c 312 (313)
T d1ogqa_ 309 LPAC 312 (313)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 4566
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3e-15 Score=148.00 Aligned_cols=133 Identities=21% Similarity=0.240 Sum_probs=118.6
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+|++|++....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+++
T Consensus 106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~ 185 (284)
T d1ozna_ 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (284)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence 47889999999988888889999999999999999997667789999999999999999997778889999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC-----ccccccccccccccCCC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS-----AKTFNIVGNPLICATGS 206 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-----~~~~~l~~N~~~c~~~~ 206 (622)
+|++++..|..|..+++|++|++++|++++..|..+ .+.++++|||+.|.|+.
T Consensus 186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999998889999999999999999999998766543 26789999999998753
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=7.5e-15 Score=125.56 Aligned_cols=102 Identities=25% Similarity=0.355 Sum_probs=90.3
Q ss_pred EEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccc
Q 036225 77 GLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNS 156 (622)
Q Consensus 77 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 156 (622)
.|+|++|+++. ++ .++++++|++|+|++|+|+ .+|..|+.+++|+.|+|++|.|+ .+| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 48999999984 44 5899999999999999999 78888999999999999999999 566 48999999999999999
Q ss_pred ccccc-ccccccccceeEEeCCCCcCCC
Q 036225 157 LSGAF-PTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 157 l~~~~-p~~~~~l~~L~~l~l~~N~l~g 183 (622)
|+... ...+..+++|+.|++++|++++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 98432 2578999999999999999984
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.1e-13 Score=123.37 Aligned_cols=112 Identities=17% Similarity=0.156 Sum_probs=89.9
Q ss_pred CCCCCCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCC-CCCCCCCCccCCCCcccEEEecCccccCC
Q 036225 58 AVDPCSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNN-NITGPIPAEIGRLTKLQTLDLSNNFFTGE 136 (622)
Q Consensus 58 ~~~~C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 136 (622)
.+.||.+.+|+|+. +++. ..|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+..
T Consensus 4 ~C~c~~~~~l~c~~-----------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i 71 (156)
T d2ifga3 4 ACCPHGSSGLRCTR-----------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (156)
T ss_dssp SSCCSSSSCEECCS-----------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred CCCcCCCCeEEecC-----------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCc
Confidence 34556678888764 3343 45677888999999999866 58855567799999999999999999976
Q ss_pred CCchhccccCccceeccccccccccccccccccceeEEeCCCCcCC
Q 036225 137 IPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 137 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
.|..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|+|.
T Consensus 72 ~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 7788999999999999999999 66655545557999999888886
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.7e-13 Score=122.81 Aligned_cols=107 Identities=21% Similarity=0.188 Sum_probs=88.8
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+.+|+|++|+|+.. +..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 3477899999999864 666778999999999999998 555 5889999999999999999544555678999999999
Q ss_pred cccccccccc--cccccccceeEEeCCCCcCCC
Q 036225 153 NNNSLSGAFP--TSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 153 ~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~g 183 (622)
++|+|+ .++ ..+..+++|+.|++++|+++.
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcccc
Confidence 999998 444 468889999999999998863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=9.4e-14 Score=137.05 Aligned_cols=130 Identities=21% Similarity=0.211 Sum_probs=114.7
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..+++++|++++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..|..+++|++|+++
T Consensus 130 ~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~ 209 (284)
T d1ozna_ 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (284)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccc
Confidence 47889999999998888899999999999999999998888899999999999999999998889999999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCC----Ccccccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF----SAKTFNIVGNPLICA 203 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~~~~l~~N~~~c~ 203 (622)
+|++++..|..|..+++|+.|+|++|++.+..+.. +.+.+....+...|.
T Consensus 210 ~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred ccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 99999888899999999999999999999876532 123445555666664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.38 E-value=5.9e-13 Score=113.51 Aligned_cols=98 Identities=26% Similarity=0.379 Sum_probs=83.5
Q ss_pred cEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccceeEEeCCCC
Q 036225 100 QIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 100 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
++|+|++|+|+ .+| .+.++++|++|||++|.|+ .+|+.++.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 666 5999999999999999999 78889999999999999999999 555 5899999999999999
Q ss_pred cCCCcCC-CCC-----ccccccccccccc
Q 036225 180 NLSGPVP-RFS-----AKTFNIVGNPLIC 202 (622)
Q Consensus 180 ~l~g~~p-~~~-----~~~~~l~~N~~~c 202 (622)
+++...+ ..+ .+.++++||++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9985332 111 2567899999844
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.4e-12 Score=127.15 Aligned_cols=126 Identities=23% Similarity=0.194 Sum_probs=103.3
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++ .++..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 4889999999999887788999999999999999998 566 4688999999999999998 567788899999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCCc-----cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFSA-----KTFNIVGNPLIC 202 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-----~~~~l~~N~~~c 202 (622)
+|.+.+..+..+..+.+|+.|++++|.+++..+..+. +.+++++|.+..
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 9998876677777888888888888888755544332 346677776643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=6.6e-13 Score=118.16 Aligned_cols=111 Identities=17% Similarity=0.162 Sum_probs=93.1
Q ss_pred CCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc-cccCCCCchhccccCccceeccccccccccccccccccceeE
Q 036225 95 NLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN-FFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIF 173 (622)
Q Consensus 95 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 173 (622)
.....+.++.+++++. .+|..+.++++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|+.
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3445667999999998 78889999999999999866 588555677999999999999999999776888999999999
Q ss_pred EeCCCCcCCCcCCCCC----ccccccccccccccCCC
Q 036225 174 LDLSYNNLSGPVPRFS----AKTFNIVGNPLICATGS 206 (622)
Q Consensus 174 l~l~~N~l~g~~p~~~----~~~~~l~~N~~~c~~~~ 206 (622)
|+|++|+|+...+..+ ...+++++|||.|.|..
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred eeccCCCCcccChhhhccccccccccCCCcccCCchH
Confidence 9999999995444333 25688999999998854
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.31 E-value=3.2e-12 Score=127.09 Aligned_cols=73 Identities=29% Similarity=0.413 Sum_probs=65.0
Q ss_pred CCccceEEcCC----------CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc
Q 036225 62 CSWTMVTCSPE----------SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN 131 (622)
Q Consensus 62 C~w~gv~C~~~----------~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 131 (622)
|.|++|.|++. ..++.|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 78999999752 24889999999999877778999999999999999999777888999999999999998
Q ss_pred ccc
Q 036225 132 FFT 134 (622)
Q Consensus 132 ~l~ 134 (622)
+++
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.1e-12 Score=117.41 Aligned_cols=107 Identities=21% Similarity=0.216 Sum_probs=88.1
Q ss_pred CcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccccccccccccccccccc
Q 036225 91 PSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQ 170 (622)
Q Consensus 91 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 170 (622)
+.+.+...|++|+|++|+|+ .+|..+..+++|+.|||++|.|+ .++ .|..+++|++|+|++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 45778889999999999999 67877788999999999999999 564 5889999999999999999554555678999
Q ss_pred eeEEeCCCCcCCCc--CCCC----Cccccccccccc
Q 036225 171 LIFLDLSYNNLSGP--VPRF----SAKTFNIVGNPL 200 (622)
Q Consensus 171 L~~l~l~~N~l~g~--~p~~----~~~~~~l~~N~~ 200 (622)
|+.|+|++|+|+.. +..+ ..+.+++.+|++
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCcc
Confidence 99999999999842 1111 125678888887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.26 E-value=5.8e-12 Score=125.23 Aligned_cols=126 Identities=24% Similarity=0.243 Sum_probs=106.5
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..+++++|++.. +|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|+
T Consensus 151 ~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred ccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 46789999998874 45443 6899999999999998889999999999999999999998888889999999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC-----------cccccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS-----------AKTFNIVGNPLICA 203 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-----------~~~~~l~~N~~~c~ 203 (622)
+|+|+ .+|.+|..+++|+.|+|++|+|+..-+..+ .+.++++|||+.+.
T Consensus 228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999 789999999999999999999984322111 14577899998654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.10 E-value=1.1e-10 Score=108.19 Aligned_cols=100 Identities=28% Similarity=0.373 Sum_probs=53.7
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
++.|++++|++... +.++.+++|++|+|++|+|++. + .++++++|++|++++|.+. .++ .+.++++|+.|++++
T Consensus 42 l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 42 VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFN 115 (199)
T ss_dssp CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCS
T ss_pred CCEEECCCCCCCCc--cccccCCCcCcCccccccccCc-c-cccCCcccccccccccccc-ccc-ccccccccccccccc
Confidence 45556666555532 2355556666666666666532 2 2555666666666666555 333 255555566666655
Q ss_pred cccccccccccccccceeEEeCCCCcCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
|.+... ..+..+++|+.|++++|++.
T Consensus 116 ~~~~~~--~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 116 NQITDI--DPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp SCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred cccccc--cccchhhhhHHhhhhhhhhc
Confidence 555522 23455555556666555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.09 E-value=7.9e-13 Score=122.66 Aligned_cols=88 Identities=19% Similarity=0.348 Sum_probs=48.6
Q ss_pred CCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecccccccccccccccccc
Q 036225 90 SPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNNNSLSGAFPTSLASMT 169 (622)
Q Consensus 90 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 169 (622)
+.++..|++|++|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++ .++ .+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHH
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccc
Confidence 344555566666666666655 343 3555566666666666655 44544444455666666666655 232 355555
Q ss_pred ceeEEeCCCCcCC
Q 036225 170 QLIFLDLSYNNLS 182 (622)
Q Consensus 170 ~L~~l~l~~N~l~ 182 (622)
+|+.|+|++|+++
T Consensus 116 ~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 116 NLRVLYMSNNKIT 128 (198)
T ss_dssp HSSEEEESEEECC
T ss_pred cccccccccchhc
Confidence 5666666666555
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.07 E-value=1.6e-10 Score=106.91 Aligned_cols=120 Identities=28% Similarity=0.419 Sum_probs=98.5
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|.+++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhh
Confidence 458899999999987543 899999999999999998 555 58999999999999999884 3 34788999999999
Q ss_pred cccccccccccccccccceeEEeCCCCcCCCcCCCC---Cccccccccccc
Q 036225 153 NNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF---SAKTFNIVGNPL 200 (622)
Q Consensus 153 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~~~l~~N~~ 200 (622)
++|++. .++ .+..+++|+.|++++|++++..|-. ..+.+++++|++
T Consensus 136 ~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 136 SSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKV 184 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred hhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCC
Confidence 999998 444 5888999999999999998643311 125677888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.05 E-value=3.3e-12 Score=118.40 Aligned_cols=109 Identities=24% Similarity=0.289 Sum_probs=93.2
Q ss_pred CcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceec
Q 036225 73 SLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRF 152 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 152 (622)
..+..|+|++|+|+. ++ .|.+|++|++|+|++|.|+ .+|..+..+++|+.|++++|+++ .++ .+..+++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 358899999999985 44 6999999999999999998 67766667789999999999999 453 5889999999999
Q ss_pred cccccccccc--cccccccceeEEeCCCCcCCCcCCC
Q 036225 153 NNNSLSGAFP--TSLASMTQLIFLDLSYNNLSGPVPR 187 (622)
Q Consensus 153 ~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~g~~p~ 187 (622)
++|+|+ .++ ..+..+++|+.|+|++|+++...+.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccchhc-cccccccccCCCccceeecCCCccccCccc
Confidence 999998 444 4789999999999999998865543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=3.3e-10 Score=105.75 Aligned_cols=119 Identities=28% Similarity=0.390 Sum_probs=69.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|.+++.. .++++++|++|+|++|+|+ .+| .+.++++|+.|++++|.+. .++ .+..+++|+.++++
T Consensus 69 ~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccccc
Confidence 3566666666666532 2556666666666666666 344 4666666666666666665 332 45666666666666
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCC---Cccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRF---SAKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~~~l~~N~~ 200 (622)
+|.+++ +..+..+++|+.+++++|++++..|-. ..+.+++++|.+
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred cccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCC
Confidence 666653 234556667777777777776432210 114455666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=2.8e-10 Score=106.30 Aligned_cols=119 Identities=22% Similarity=0.298 Sum_probs=98.1
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|++++|++.... .+..+++|++|+|++|+|++ ++ .++++++|+.|+|++|+++ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 3788999999998643 48899999999999999995 44 4789999999999999999 566 58899999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---ccccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGNPL 200 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N~~ 200 (622)
+|.+. .+ ..+..++.|+.+++++|.+++..+... .+.+.+.+|.+
T Consensus 121 ~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 121 HNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp TSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred ccccc-cc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 99997 44 468899999999999999986433211 25567778776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.98 E-value=3.4e-10 Score=115.56 Aligned_cols=119 Identities=26% Similarity=0.341 Sum_probs=64.1
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCC-----------------
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEI----------------- 137 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----------------- 137 (622)
+..|++++|.++.. +.+..+++|+.|++++|.+++.. .+..+++|+.|++++|.+++..
T Consensus 221 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~ 296 (384)
T d2omza2 221 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296 (384)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred CCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccccccc
Confidence 45566666655542 24555555555555555555322 2445555555555555444211
Q ss_pred ---CchhccccCccceeccccccccccccccccccceeEEeCCCCcCCCcCCCCC----ccccccccccc
Q 036225 138 ---PSSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS----AKTFNIVGNPL 200 (622)
Q Consensus 138 ---p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~----~~~~~l~~N~~ 200 (622)
...+..+++++.|+|++|++++. + .+..+++|+.|+|++|+|++ +|.+. .+.+++++|++
T Consensus 297 l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 297 LEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCC
T ss_pred cccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcC
Confidence 12345556667777777777643 2 26666777777777777664 33211 14456666665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.91 E-value=7.5e-10 Score=112.97 Aligned_cols=117 Identities=25% Similarity=0.331 Sum_probs=95.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..|+++++.+.+.. .+.+++.++.++++.|.+++ + ..+..+++|+.|+|++|++++. + .+..+++|+.|+|+
T Consensus 264 ~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~ 337 (384)
T d2omza2 264 KLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFA 337 (384)
T ss_dssp TCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECC
T ss_pred cCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECC
Confidence 4788999999998764 47889999999999999985 3 3588899999999999999954 3 38899999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcCCCCC---ccccccccc
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPVPRFS---AKTFNIVGN 198 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~~~~l~~N 198 (622)
+|+|+ .++ .+.++++|++|+|++|+|++.+|-.. .+.+++++|
T Consensus 338 ~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 338 NNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 99998 455 68999999999999999997665211 145666666
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=1.1e-09 Score=104.46 Aligned_cols=107 Identities=16% Similarity=0.268 Sum_probs=50.0
Q ss_pred CCccceEEcCCCcEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCC-ch
Q 036225 62 CSWTMVTCSPESLVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP-SS 140 (622)
Q Consensus 62 C~w~gv~C~~~~~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~ 140 (622)
|.++.|.|+. ++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..
T Consensus 8 C~~~~i~c~~-----------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~ 73 (242)
T d1xwdc1 8 CSNRVFLCQE-----------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73 (242)
T ss_dssp ECSSEEEEES-----------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSS
T ss_pred CcCCEEEEeC-----------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccc
Confidence 5677777753 2333 3333321 344555555555542222334555555555555555443322 23
Q ss_pred hccccCccceecc-ccccccccccccccccceeEEeCCCCcCC
Q 036225 141 LGHLRSLQYMRFN-NNSLSGAFPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 141 ~~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
|..++++++|++. .|++....+..|..+++|+.|++++|.+.
T Consensus 74 f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp EESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhc
Confidence 4445555555443 23444344444455555555555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.77 E-value=4.1e-09 Score=99.33 Aligned_cols=104 Identities=28% Similarity=0.404 Sum_probs=81.8
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.+..++++++...+. ..+...+.++.+.++++.+.... .+.++++|+.|++++|.+++. + .+.++++|+.|+|+
T Consensus 108 ~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls 181 (227)
T d1h6ua2 108 SIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKAD 181 (227)
T ss_dssp TCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECC
T ss_pred ccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc-h-hhcccccceecccC
Confidence 467888888877764 34667888899999998887443 477888999999999988743 3 37888999999999
Q ss_pred ccccccccccccccccceeEEeCCCCcCCCcC
Q 036225 154 NNSLSGAFPTSLASMTQLIFLDLSYNNLSGPV 185 (622)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~ 185 (622)
+|++++ +|. +..+++|++|+|++|++++..
T Consensus 182 ~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 182 DNKISD-ISP-LASLPNLIEVHLKNNQISDVS 211 (227)
T ss_dssp SSCCCC-CGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred CCccCC-Chh-hcCCCCCCEEECcCCcCCCCc
Confidence 999984 443 788899999999999988543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=6.9e-09 Score=98.63 Aligned_cols=111 Identities=16% Similarity=0.205 Sum_probs=91.2
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCC-CccCCCCcccEEEecC-ccccCCCCchhccccCcccee
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIP-AEIGRLTKLQTLDLSN-NFFTGEIPSSLGHLRSLQYMR 151 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 151 (622)
.++.|+|++|+++...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 48899999999997666789999999999999999986554 4688999999999874 778877778899999999999
Q ss_pred ccccccccccc-cccccccceeEEeCCCCcCCCc
Q 036225 152 FNNNSLSGAFP-TSLASMTQLIFLDLSYNNLSGP 184 (622)
Q Consensus 152 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~ 184 (622)
+++|+++...+ ..+..+..|..+..+++.+...
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred cchhhhcccccccccccccccccccccccccccc
Confidence 99999984322 2455667777778888887643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.77 E-value=9.2e-09 Score=96.85 Aligned_cols=104 Identities=29% Similarity=0.446 Sum_probs=55.4
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCC---------------
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIP--------------- 138 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------------- 138 (622)
.+..|+|++|.+.+..| +.++++|++|++++|.++ .++ .+.++++|+.|++++|...+..+
T Consensus 64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~ 139 (227)
T d1h6ua2 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139 (227)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred CCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhh
Confidence 35566666666655432 556666666666666665 333 45566666666666555442111
Q ss_pred -----chhccccCccceeccccccccccccccccccceeEEeCCCCcCCC
Q 036225 139 -----SSLGHLRSLQYMRFNNNSLSGAFPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 139 -----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
..+..+++|+.|++++|.+++.. .+..+++|+.|+|++|++++
T Consensus 140 ~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 140 QITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred hhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC
Confidence 12333445555555555554221 25555666666666666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.62 E-value=3.5e-08 Score=98.68 Aligned_cols=98 Identities=23% Similarity=0.323 Sum_probs=80.6
Q ss_pred EEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceeccc
Q 036225 75 VIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFNN 154 (622)
Q Consensus 75 v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 154 (622)
+..|||++++++. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|++
T Consensus 40 l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 5689999999984 7754 578999999999999 888654 57899999999998 55532 24699999999
Q ss_pred cccccccccccccccceeEEeCCCCcCCCcCC
Q 036225 155 NSLSGAFPTSLASMTQLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p 186 (622)
|.++ .+|. ++.+++|+.|++++|.+++..+
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred cccc-cccc-hhhhccceeecccccccccccc
Confidence 9999 6775 6789999999999999985544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=1.2e-06 Score=83.71 Aligned_cols=148 Identities=14% Similarity=0.089 Sum_probs=99.2
Q ss_pred HHHHHHhCCCcCCeeeecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccc-cccceeeeeeeeCCCce
Q 036225 294 ELQVATHNFSSKNILGKGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLYGFCMTPTER 372 (622)
Q Consensus 294 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 372 (622)
++...-+.|+..+..+-++.+.||+...+ ++.+.+|+...... .....+.+|...+..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 44444566665555444445689998754 55577887654321 12224677888877663 43467778888888889
Q ss_pred eEEeeeccCCCccccccCCCCCChhHHHHHHHHHHHHHHHHHhc------------------------------------
Q 036225 373 LLVYPYMSNGSVASRLKGKPILDWSTRKRIALGAARGLLYLHEQ------------------------------------ 416 (622)
Q Consensus 373 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------ 416 (622)
++||++++|..+.+..... .....++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999998776544321 22344566666677777642
Q ss_pred --------------------CCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 417 --------------------CDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 417 --------------------~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
..+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987667799999886
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=5.3e-08 Score=86.26 Aligned_cols=85 Identities=22% Similarity=0.229 Sum_probs=49.4
Q ss_pred CCcccCCCcccEEEccCCCCCCC--CCCccCCCCcccEEEecCccccCCCCc-hhccccCccceecccccccccccc---
Q 036225 90 SPSIGNLTNLQIVLLQNNNITGP--IPAEIGRLTKLQTLDLSNNFFTGEIPS-SLGHLRSLQYMRFNNNSLSGAFPT--- 163 (622)
Q Consensus 90 ~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~--- 163 (622)
+..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+ .+++ .+....+|+.|+|++|.++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 33345567777777777777632 1234556677777777777777 3333 233344567777777777644332
Q ss_pred ----ccccccceeEEe
Q 036225 164 ----SLASMTQLIFLD 175 (622)
Q Consensus 164 ----~~~~l~~L~~l~ 175 (622)
.+..+|+|+.||
T Consensus 137 y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 137 YISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHTTSTTCCEET
T ss_pred HHHHHHHHCCCCCEEC
Confidence 244566666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=2.7e-08 Score=103.21 Aligned_cols=110 Identities=25% Similarity=0.286 Sum_probs=85.6
Q ss_pred cEEEEecCCCCCcccc-CCcccCCCcccEEEccCCCCCC----CCCCccCCCCcccEEEecCccccCC----CCchhc-c
Q 036225 74 LVIGLGIPSQNLSGTL-SPSIGNLTNLQIVLLQNNNITG----PIPAEIGRLTKLQTLDLSNNFFTGE----IPSSLG-H 143 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 143 (622)
.+..||++.|++++.. ...+..+++|++|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4789999999998732 3446678999999999999872 3344567899999999999998621 122222 2
Q ss_pred ccCccceeccccccccc----cccccccccceeEEeCCCCcCCC
Q 036225 144 LRSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSG 183 (622)
Q Consensus 144 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g 183 (622)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999743 46678889999999999999874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.22 E-value=5.1e-06 Score=82.36 Aligned_cols=76 Identities=26% Similarity=0.379 Sum_probs=62.9
Q ss_pred cEEEEecCCCCCccccCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCCCCchhccccCccceecc
Q 036225 74 LVIGLGIPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGEIPSSLGHLRSLQYMRFN 153 (622)
Q Consensus 74 ~v~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 153 (622)
.++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. +. +.|++|+|++|.++ .+|. ++.+++|+.|+++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~ 128 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 128 (353)
T ss_dssp TCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-CC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECC
T ss_pred CCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-hc--cccccccccccccc-cccc-hhhhccceeeccc
Confidence 4789999999999 56765 457899999999998 5553 21 46999999999999 6775 6889999999999
Q ss_pred cccccc
Q 036225 154 NNSLSG 159 (622)
Q Consensus 154 ~N~l~~ 159 (622)
+|.++.
T Consensus 129 ~~~~~~ 134 (353)
T d1jl5a_ 129 NNSLKK 134 (353)
T ss_dssp SSCCSC
T ss_pred cccccc
Confidence 999873
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=2.2e-08 Score=88.77 Aligned_cols=92 Identities=17% Similarity=0.101 Sum_probs=64.1
Q ss_pred ccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCccccCC--CCchhccccCccceecccccccccccc-cccccc
Q 036225 93 IGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNNFFTGE--IPSSLGHLRSLQYMRFNNNSLSGAFPT-SLASMT 169 (622)
Q Consensus 93 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~ 169 (622)
+..+..+..|++.+|... .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+ .++. .+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhcc
Confidence 444455555555555444 4444456788999999999999843 2345778899999999999998 4443 334455
Q ss_pred ceeEEeCCCCcCCCcCC
Q 036225 170 QLIFLDLSYNNLSGPVP 186 (622)
Q Consensus 170 ~L~~l~l~~N~l~g~~p 186 (622)
+|+.|+|++|++++...
T Consensus 116 ~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 116 KLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CCSSCCCTTSTTSSSSS
T ss_pred ccceeecCCCCcCcCcc
Confidence 78899999999886544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=5.3e-06 Score=78.60 Aligned_cols=130 Identities=17% Similarity=0.077 Sum_probs=87.4
Q ss_pred eeeecCC-ceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhcccc--ccceeeeeeeeCCCceeEEeeeccCCC
Q 036225 307 ILGKGGF-GIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLYGFCMTPTERLLVYPYMSNGS 383 (622)
Q Consensus 307 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs 383 (622)
.+..|.. +.||+...+++..+.+|...... ...+..|...++.+.. -.+.+++++...++..++||+|++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 4455654 57899998888889999865443 2246678887776643 335677888888888999999998866
Q ss_pred ccccccCCCCCChhHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 036225 384 VASRLKGKPILDWSTRKRIALGAARGLLYLHE------------------------------------------------ 415 (622)
Q Consensus 384 L~~~l~~~~~l~~~~~~~i~~~ia~~L~~LH~------------------------------------------------ 415 (622)
+.+... . ....+.++++.|.-||+
T Consensus 93 ~~~~~~-----~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 93 LLSSHL-----A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTTSCC-----C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccccc-----c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 543211 0 11122333333334432
Q ss_pred ---c----CCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 416 ---Q----CDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 416 ---~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12247999999999999987777899999875
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.97 E-value=4.4e-07 Score=90.72 Aligned_cols=127 Identities=19% Similarity=0.198 Sum_probs=83.3
Q ss_pred cEEEEecCCCCCcc----ccCCcccCCCcccEEEccCCCCCCC-----CCCccCCCCcccEEEecCccccCC----CCch
Q 036225 74 LVIGLGIPSQNLSG----TLSPSIGNLTNLQIVLLQNNNITGP-----IPAEIGRLTKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 74 ~v~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
.+..++++.|++.. .+...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 46778888887763 2334456677888888888887631 334567778888888888887632 3445
Q ss_pred hccccCccceeccccccccccc----ccccc--ccceeEEeCCCCcCCCcC----C------CCCccccccccccc
Q 036225 141 LGHLRSLQYMRFNNNSLSGAFP----TSLAS--MTQLIFLDLSYNNLSGPV----P------RFSAKTFNIVGNPL 200 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~~p----~~~~~--l~~L~~l~l~~N~l~g~~----p------~~~~~~~~l~~N~~ 200 (622)
+..+++|++|+|++|.|++.-. ..+.. .+.|+.|++++|+++..- . ....+.++++||.+
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 6677888888888888874322 22222 356888888888876310 0 01125677788876
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.85 E-value=8.1e-07 Score=88.70 Aligned_cols=128 Identities=16% Similarity=0.199 Sum_probs=88.7
Q ss_pred CcEEEEecCCCCCc----cccC---------CcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccC
Q 036225 73 SLVIGLGIPSQNLS----GTLS---------PSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTG 135 (622)
Q Consensus 73 ~~v~~L~l~~n~l~----~~~~---------~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 135 (622)
..+..|+|++|.+. ..+. ......+.|+.|++++|.++.. +...+..++.|+.|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 35788999988762 1111 1123567899999999988622 22334567889999999999873
Q ss_pred C-----CCchhccccCccceeccccccccc----cccccccccceeEEeCCCCcCCCc-----------CCCCCcccccc
Q 036225 136 E-----IPSSLGHLRSLQYMRFNNNSLSGA----FPTSLASMTQLIFLDLSYNNLSGP-----------VPRFSAKTFNI 195 (622)
Q Consensus 136 ~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~-----------~p~~~~~~~~l 195 (622)
. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|+|++. .+....+.+++
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 2 334467788999999999998632 456677889999999999998743 12222356788
Q ss_pred ccccc
Q 036225 196 VGNPL 200 (622)
Q Consensus 196 ~~N~~ 200 (622)
++|.+
T Consensus 281 s~N~i 285 (344)
T d2ca6a1 281 QYNEI 285 (344)
T ss_dssp CSSCC
T ss_pred CCCcC
Confidence 88864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=1.6e-06 Score=89.35 Aligned_cols=129 Identities=17% Similarity=0.166 Sum_probs=87.8
Q ss_pred CcEEEEecCCCCCccccCCcc-----cCCCcccEEEccCCCCCCCCCCc----cCCCCcccEEEecCccccCC----CCc
Q 036225 73 SLVIGLGIPSQNLSGTLSPSI-----GNLTNLQIVLLQNNNITGPIPAE----IGRLTKLQTLDLSNNFFTGE----IPS 139 (622)
Q Consensus 73 ~~v~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~ 139 (622)
..+..++++.|.+.......+ .....|+.+++++|.++...... +...++|++|+|++|+|++. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 347788999998864322221 23467999999999887442222 34456899999999998742 333
Q ss_pred hhc-cccCccceecccccccc----ccccccccccceeEEeCCCCcCCCcC----------CCCCcccccccccccc
Q 036225 140 SLG-HLRSLQYMRFNNNSLSG----AFPTSLASMTQLIFLDLSYNNLSGPV----------PRFSAKTFNIVGNPLI 201 (622)
Q Consensus 140 ~~~-~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~g~~----------p~~~~~~~~l~~N~~~ 201 (622)
.+. ..+.|++|+|++|.|+. .++..+..+++|++|+|++|+|+... +....+.+.+.+|.+.
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 443 45679999999999973 25566777899999999999997421 1222355667777663
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.64 E-value=2.9e-06 Score=82.18 Aligned_cols=81 Identities=17% Similarity=0.234 Sum_probs=41.4
Q ss_pred EEEEecCCCCCccc-cCCcccCCCcccEEEccCCCCCCCCCCccCCCCcccEEEecCc-cccCC-CCchhccccCcccee
Q 036225 75 VIGLGIPSQNLSGT-LSPSIGNLTNLQIVLLQNNNITGPIPAEIGRLTKLQTLDLSNN-FFTGE-IPSSLGHLRSLQYMR 151 (622)
Q Consensus 75 v~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~ 151 (622)
+..|||+++.++.. ++..+.++++|++|+|++|.++...+..++++++|++|+|+++ .++.. +...+.++++|++|+
T Consensus 48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ 127 (284)
T d2astb2 48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN 127 (284)
T ss_dssp CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccc
Confidence 45556655555432 2333455566666666666555444455555566666666553 34311 112233455666666
Q ss_pred cccc
Q 036225 152 FNNN 155 (622)
Q Consensus 152 l~~N 155 (622)
|+++
T Consensus 128 ls~c 131 (284)
T d2astb2 128 LSWC 131 (284)
T ss_dssp CCCC
T ss_pred cccc
Confidence 6553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=7.3e-05 Score=75.45 Aligned_cols=78 Identities=13% Similarity=0.050 Sum_probs=48.3
Q ss_pred CCeeeecCCceEEEEEECC-CeEEEEEEccCC------CCCchhHHHHHHHHHHhccc-c--ccceeeeeeeeCCCceeE
Q 036225 305 KNILGKGGFGIVYKGILQD-GTVVAVKRLKDG------NAIGGEIQFQTEVEMISLAV-H--RNLLRLYGFCMTPTERLL 374 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~l 374 (622)
.+.||.|....||+....+ ++.|+||.-... .......+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 678999965321 11112224556787776553 2 345566654 4556789
Q ss_pred EeeeccCCCc
Q 036225 375 VYPYMSNGSV 384 (622)
Q Consensus 375 v~e~~~~gsL 384 (622)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=5.9e-06 Score=72.99 Aligned_cols=106 Identities=19% Similarity=0.213 Sum_probs=55.5
Q ss_pred cEEEEecCCC-CCccc----cCCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCC----CCch
Q 036225 74 LVIGLGIPSQ-NLSGT----LSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 74 ~v~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
.+++|+|+++ .+... +-..+...++|++|+|++|.+... +...+...+.|+.|+|++|.|+.. +-..
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~a 95 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 95 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHH
Confidence 4666777653 34321 223455556677777777766521 112233456667777777766522 1123
Q ss_pred hccccCccceeccccccccc-------cccccccccceeEEeCCCC
Q 036225 141 LGHLRSLQYMRFNNNSLSGA-------FPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 141 ~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~l~l~~N 179 (622)
+...++|++|+|++|.+... +...+...++|+.|+++.+
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 44456666666666654311 2334444556666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.50 E-value=1.8e-05 Score=76.27 Aligned_cols=106 Identities=14% Similarity=0.166 Sum_probs=79.7
Q ss_pred cEEEEecCCC-CCcc-ccCCcccC-CCcccEEEccCC--CCCCC-CCCccCCCCcccEEEecCc-cccCCCCchhccccC
Q 036225 74 LVIGLGIPSQ-NLSG-TLSPSIGN-LTNLQIVLLQNN--NITGP-IPAEIGRLTKLQTLDLSNN-FFTGEIPSSLGHLRS 146 (622)
Q Consensus 74 ~v~~L~l~~n-~l~~-~~~~~~~~-l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~ 146 (622)
.+..|+|+++ +++. .+...+.. .++|+.|+|+++ .++.. +...+.++++|++|+|++| .+++.....+..+++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 5889999985 4543 22233433 478999999975 34421 2223456899999999986 577777788999999
Q ss_pred ccceeccc-cccccccccccccccceeEEeCCCC
Q 036225 147 LQYMRFNN-NSLSGAFPTSLASMTQLIFLDLSYN 179 (622)
Q Consensus 147 L~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N 179 (622)
|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 99999999 4788777778899999999999887
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.22 E-value=3.7e-05 Score=67.64 Aligned_cols=89 Identities=13% Similarity=0.157 Sum_probs=66.7
Q ss_pred cCCCcccEEEccCC-CCCCC----CCCccCCCCcccEEEecCccccC----CCCchhccccCccceeccccccccc----
Q 036225 94 GNLTNLQIVLLQNN-NITGP----IPAEIGRLTKLQTLDLSNNFFTG----EIPSSLGHLRSLQYMRFNNNSLSGA---- 160 (622)
Q Consensus 94 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---- 160 (622)
.+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+.. .+...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999974 56521 22346677899999999999873 2334556678999999999999843
Q ss_pred cccccccccceeEEeCCCCcCC
Q 036225 161 FPTSLASMTQLIFLDLSYNNLS 182 (622)
Q Consensus 161 ~p~~~~~l~~L~~l~l~~N~l~ 182 (622)
+-..+...++|+.|+|++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 3346677788999999999765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.001 Score=64.83 Aligned_cols=132 Identities=15% Similarity=0.125 Sum_probs=77.0
Q ss_pred ceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccc--eeeee-----eeeCCCceeEEeeeccCCCccc
Q 036225 314 GIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL--LRLYG-----FCMTPTERLLVYPYMSNGSVAS 386 (622)
Q Consensus 314 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 386 (622)
-.||++..++|+.|++|+.+.... ...++..|...+..+...++ +..+. .....+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 479999999999999999765432 23457778887776653332 11111 2234556788899987644321
Q ss_pred c--------------cc----C-----CCCCCh-------------------hHHHHHHHHHHHHHHHHHh----cCCCC
Q 036225 387 R--------------LK----G-----KPILDW-------------------STRKRIALGAARGLLYLHE----QCDPK 420 (622)
Q Consensus 387 ~--------------l~----~-----~~~l~~-------------------~~~~~i~~~ia~~L~~LH~----~~~~~ 420 (622)
. ++ . ....++ ..+..+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 00 0 111111 1111222223333333332 22457
Q ss_pred eeecCCCCCCeeecCCCceEEccccccee
Q 036225 421 IIHRDVKAANILLDDCCEAVVGDFGLAKL 449 (622)
Q Consensus 421 ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 449 (622)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999753 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.80 E-value=0.0046 Score=59.57 Aligned_cols=155 Identities=9% Similarity=-0.018 Sum_probs=81.6
Q ss_pred cCHHHHHHHHhCCCcCCeee-----ecCCceEEEEEECCCeEEEEEEccCCCCCchhHHHHHHHHHHhccccccce--ee
Q 036225 290 FQFRELQVATHNFSSKNILG-----KGGFGIVYKGILQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL--RL 362 (622)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv--~l 362 (622)
.+.++++....+|.+++... .|---+.|+....+|+ +++|++...... .++..|++++..+.+.++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 34566777777887765543 4555678999887665 889987653222 2344566666666433321 11
Q ss_pred ee------eeeCCCceeEEeeeccCCCccccc--------------c----C---C---CCC-----------------C
Q 036225 363 YG------FCMTPTERLLVYPYMSNGSVASRL--------------K----G---K---PIL-----------------D 395 (622)
Q Consensus 363 ~~------~~~~~~~~~lv~e~~~~gsL~~~l--------------~----~---~---~~l-----------------~ 395 (622)
+. +.........++.++.+......- + . . ... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 111233445566666553332110 0 0 0 000 0
Q ss_pred hhHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccccce
Q 036225 396 WSTRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDDCCEAVVGDFGLAK 448 (622)
Q Consensus 396 ~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 448 (622)
.......+..+...+...+. ....++||+|+.+.||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111222222222222221 234589999999999999988777899999885
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.71 E-value=6.8e-05 Score=65.76 Aligned_cols=108 Identities=15% Similarity=0.248 Sum_probs=65.0
Q ss_pred cEEEEecCC-CCCccc----cCCcccCCCcccEEEccCCCCCCC----CCCccCCCCcccEEEecCccccCC----CCch
Q 036225 74 LVIGLGIPS-QNLSGT----LSPSIGNLTNLQIVLLQNNNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPSS 140 (622)
Q Consensus 74 ~v~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 140 (622)
.++.|+|++ ++++.. +-..+...++|++|+|++|.++.. +-..+...+.|+.|++++|.++.. +-..
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~ 97 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA 97 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHH
Confidence 466777776 345421 334455677788888888877632 112344567788888888877522 2234
Q ss_pred hccccCccceec--ccccccc----ccccccccccceeEEeCCCCcC
Q 036225 141 LGHLRSLQYMRF--NNNSLSG----AFPTSLASMTQLIFLDLSYNNL 181 (622)
Q Consensus 141 ~~~l~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l 181 (622)
+...++|+.++| ++|.+.. .+...+...++|+.|+++.|+.
T Consensus 98 l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 98 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 556677775444 4566642 2445566677788887766643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0064 Score=60.68 Aligned_cols=73 Identities=16% Similarity=0.213 Sum_probs=48.6
Q ss_pred CCeeeecCCceEEEEEECCC--------eEEEEEEccCCCCCchhHHHHHHHHHHhccccccc-eeeeeeeeCCCceeEE
Q 036225 305 KNILGKGGFGIVYKGILQDG--------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLYGFCMTPTERLLV 375 (622)
Q Consensus 305 ~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 375 (622)
++.|+.|-.=.+|++...++ +.|.+++.-.. .......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 35677788889999986543 45667665421 223456688888887753344 477777643 689
Q ss_pred eeeccCCCc
Q 036225 376 YPYMSNGSV 384 (622)
Q Consensus 376 ~e~~~~gsL 384 (622)
+||+++..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.74 E-value=0.00034 Score=61.04 Aligned_cols=94 Identities=23% Similarity=0.248 Sum_probs=65.7
Q ss_pred cCCcccCCCcccEEEccC-CCCCCC----CCCccCCCCcccEEEecCccccCC----CCchhccccCccceecccccccc
Q 036225 89 LSPSIGNLTNLQIVLLQN-NNITGP----IPAEIGRLTKLQTLDLSNNFFTGE----IPSSLGHLRSLQYMRFNNNSLSG 159 (622)
Q Consensus 89 ~~~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 159 (622)
+.....+.+.|++|+|++ |.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.++.
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 333445678999999997 556521 223456788999999999998733 22345667899999999999863
Q ss_pred c----cccccccccceeEEeC--CCCcCC
Q 036225 160 A----FPTSLASMTQLIFLDL--SYNNLS 182 (622)
Q Consensus 160 ~----~p~~~~~l~~L~~l~l--~~N~l~ 182 (622)
. +-..+...++|+.++| ++|++.
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 3 3356777788887555 566664
|